Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
translation (GO:0006412),115/214,2.67E-24,1.32E-20,0,0,4.200898391,228.0226745,RPL4;RPL5;RPL3;RPL32;RPL31;RPL34;RPL8;RPL9;RPL6;RPL7;EEF1B2;RPS14;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS18B;MRPS18A;MRPS18C;TUFM;EEF1A1;LARS2;PPA1;RPL27;RPL26;RPL28;MRPL18;MRPL16;MRPL13;GSPT1;MRPL11;EIF4EBP2;ZC3H15;RPL41;TMA7;MRPL28;MRPL23;EEF2;MRPL24;AIMP1;RPS26;AIMP2;RPS25;RPS28;RPS27;RPS29;RPL27A;AGO2;RPS21;RSL24D1;RPS24;FARSB;MRPS17;HBS1L;MRPS16;GFM2;MRPS14;RPLP1;RPLP0;MRPL36;MRPL34;MRPL41;RPS4X;MRPL42;TRMT112;RPL7A;MRPL9;MRPS28;PABPC4;MRPS21;DARS2;RPL13A;MRPL47;MRPL52;EEF1G;MRPL51;EEF1D;RPL37A;ETF1;EEF1E1;MRRF;RPL10;MRPS33;RPL12;RPL11;RPL36A;RRBP1;MRPL57;MRPL55;RPS15A;RPS3;IARS2;RPL15;RPS27A;RPL17;ABCF1;PTCD3;RWDD1;NDUFA7;RPL35A;RPL23A;DRG1;RPL22L1;ABCE1
cytoplasmic translation (GO:0002181),66/93,8.01E-24,1.98E-20,0,0,8.780827887,466.9715736,RPL4;EIF4A1;RPL5;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL8;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPL37A;ETF1;RPL27;RPL26;RPL28;RPL10;RPL12;RPL11;RPL36A;GSPT1;RPS15A;RPS3;RPL15;RPS27A;RPL17;ZC3H15;RWDD1;EIF2B3;RPL41;TMA7;RPL35A;RPL23A;RPS26;RPS25;EIF3M;RPS28;RPS27;RPS29;EIF3I;RPL27A;DRG1;RPL22L1;RPS21;RPS24
rRNA processing (GO:0006364),97/173,1.64E-22,2.71E-19,0,0,4.603217937,230.8955829,RPL4;RPL5;RPL3;RPL32;RPL31;POP4;RPL34;FCF1;RPL8;RPL9;RPL6;RPL7;RPS14;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;WDR74;WDR75;EBNA1BP2;MRTO4;NHP2;SBDS;RPL27;RPL26;RPL28;NOLC1;SNU13;RPF1;EMG1;LYAR;MDN1;RPL41;WDR55;RPS25;RPS28;RPS27;EIF6;RPL27A;MPHOSPH10;NOL11;RPS24;DDX47;NVL;RPLP1;WDR3;RPLP0;NAT10;WDR43;RPL7A;MRPL1;UTP14A;RRP15;WDR36;UTP11;DIS3;TEX10;RPL13A;DDX52;SENP3;NSA2;C1D;RPL37A;DDX27;RPL10;RPL12;HEATR1;MAK16;RPL11;RPL36A;NOL8;EXOSC7;BMS1;PES1;EXOSC8;RPL15;EXOSC3;EXOSC2;RPL17;NOP58;UTP6;RIOK3;WDR18;RPL35A;RPL23A;RRP1B;WDR12;RSL1D1;ESF1
ribosome biogenesis (GO:0042254),103/192,7.84E-22,9.71E-19,0,0,4.176308814,202.9582917,RPL4;RPL5;RPL3;RPL32;RPL31;POP4;RPL34;FCF1;NOC2L;RPL8;RPL9;RPL6;RPL7;RPS14;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;EIF2A;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;WDR74;WDR75;EBNA1BP2;MRTO4;SBDS;RPL27;RPL26;RPL28;NOLC1;SNU13;RPF2;RPF1;EMG1;LYAR;MDN1;RPL41;NOP16;MRPL22;WDR55;RPS25;RPS28;RPS27;EIF6;RPL27A;MPHOSPH10;NOL11;RPS24;DDX47;NVL;PAK1IP1;RPLP1;WDR3;RPLP0;MRPL36;WDR43;RPL7A;XPO1;UTP14A;WDR36;UTP11;DIS3;TEX10;RPL13A;DDX52;SENP3;LSG1;C1D;RPL37A;DDX27;RPL10;RPL12;HEATR1;RPL11;RPL36A;NOL8;SDAD1;EXOSC7;BMS1;PES1;EXOSC8;RPL15;EXOSC3;EXOSC2;RPL17;NOP58;NPM1;UTP6;WDR18;RPL35A;RPL23A;RRP1B;WDR12;ESF1;ABCE1;RAN;CUL4B
cotranslational protein targeting to membrane (GO:0006613),64/94,1.36E-21,1.35E-18,0,0,7.658258397,367.9371887,RPL4;RPL5;SRP19;TRAM1;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL8;SRP14;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;SEC61A1;RPS17;RPS16;RPL35;RPL38;RPL37;SEC62;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;SSR2;RPL22;RPS6;RPL13A;SRP9;RPL37A;RPL27;RPL26;RPL28;RPL10;RPL12;RPL11;RPL36A;RPS15A;SRP72;RPS3;SSR1;RPL15;RPS27A;RPL17;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS21;RPS24
gene expression (GO:0010467),157/356,6.37E-21,5.26E-18,0,0,2.862806019,133.1287527,RPL4;RPL5;NUP107;RPL3;RPL32;RPL31;RPL34;EIF4A3;HNRNPU;RPL8;RPL9;RPL6;RPL7;RPS14;RPS17;RPS16;MAGOH;RPL35;RPL38;RPL37;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS18B;THOC1;MRPS18A;THOC7;MRPS18C;SRRM1;EEF1A1;DDX39B;SARNP;SRSF3;RPL27;RPL26;SRSF5;SRSF6;RPL28;SRSF7;SRSF9;SLBP;NUP205;POM121;SEH1L;MRPL18;MRPL13;GSPT1;NUP160;MRPL11;NUP85;TPR;EIF4EBP2;RPL41;RBPMS;CPSF3;CPSF2;MRPL28;NUP153;MAGOHB;MRPL23;MRPL24;HNRNPL;RPS26;SETX;RPS25;RPS28;HNRNPK;RPS27;FUBP3;RPS29;RPL27A;AGO2;HNRNPD;MPHOSPH10;RNPS1;RPS21;RSL24D1;RPS24;FARSB;MRPS17;HBS1L;MRPS16;MRPS14;RPLP1;RPLP0;MRPL36;MRPL34;SMG7;MRPL41;RBM3;RPS4X;MRPL42;SYNCRIP;RPL7A;MRPL9;NDC1;SEC13;PABPC4;MRPS21;RPL13A;MLF1;MRPL44;WDR33;MRPL52;MRPL51;HNRNPH1;RPL37A;RBMS1;MRRF;PTMA;RPL10;DDX25;POLDIP3;MRPS33;RPL12;RPL11;SRSF1;RPL36A;RRBP1;U2AF1;MRPL55;HSPD1;NXF1;RPS15A;FIP1L1;POLR2B;RPS3;POLR2F;NUP43;POLR2G;RPL15;POLR2H;RPS27A;POLR2I;RAE1;RPL17;EIF4E;POLR2J;SRSF11;POLR2K;ABCF1;POLR2L;RANBP2;RBM39;RPL35A;RPL23A;GOLPH3;HNRNPA2B1;DRG1;NUP37
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),61/90,1.73E-20,1.22E-17,0,0,7.546241856,343.3861663,RPL4;RPL5;SRP19;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL8;SRP14;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;SEC61A1;RPS17;RPS16;RPL35;RPL38;RPL37;SEC61B;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;SRP9;RPL37A;RPL27;RPL26;RPL28;RPL10;RPL12;RPL11;RPL36A;RPS15A;SRP72;RPS3;RPL15;RPS27A;RPL17;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS21;RPS24
protein targeting to ER (GO:0045047),66/103,4.88E-20,3.02E-17,0,0,6.403516319,284.7404563,RPL4;RPL5;SRP19;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL8;SRP14;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;SEC61A1;RPS17;RPS16;SEC61G;RPL35;RPL38;RPL37;SEC62;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;SRP9;RPL37A;RPL27;RPL26;RPL28;RPL10;RPL12;RPL11;RPL36A;RPS15A;SRP72;RPS3;RPL15;RPS27A;RPL17;RPL41;EDEM1;RPL35A;RPL23A;RPS26;RPS25;SPCS3;RPS28;SPCS2;RPS27;SPCS1;RPS29;RPL27A;RPS21;RPS24
peptide biosynthetic process (GO:0043043),88/162,2.50E-19,1.24E-16,0,0,4.280584781,183.3505672,RPL4;MRPS17;RPL5;HBS1L;RPL3;MRPS16;RPL32;RPL31;MRPS14;RPL34;RPLP1;RPLP0;MRPL36;RPL8;MRPL34;RPL9;RPL6;RPL7;MRPL41;RPS4X;RPS14;MRPL42;RPL7A;RPS17;RPS16;RPL35;RPL38;RPL37;MRPL9;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;PABPC4;RPL22;RPS6;MRPS18B;MRPS18A;MRPS21;RPL13A;MRPS18C;EEF1A1;MRPL52;MRPL51;RPL37A;RPL27;RPL26;RPL28;MRRF;RPL10;MRPL18;MRPS33;RPL12;RPL11;RPL36A;RRBP1;MRPL13;GSPT1;MRPL11;MRPL55;RPS15A;RPS3;EIF4EBP2;RPL15;RPS27A;RPL17;ABCF1;RPL41;MRPL28;RPL35A;RPL23A;MRPL23;MRPL24;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;AGO2;RPS21;RSL24D1;RPS24;FARSB
rRNA metabolic process (GO:0016072),88/162,2.50E-19,1.24E-16,0,0,4.280584781,183.3505672,RPL4;RPL5;RPL3;RPL32;RPL31;DDX47;NVL;POP4;RPL34;RPLP1;WDR3;RPLP0;FCF1;RPL8;RPL9;RPL6;WDR43;RPL7;RPS14;RPL7A;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;UTP14A;RPS9;WDR36;RPL21;RPS7;UTP11;DIS3;RPL23;TEX10;RPL22;RPS6;WDR74;WDR75;RPL13A;DDX52;SENP3;EBNA1BP2;MRTO4;C1D;RPL37A;SBDS;RPL27;RPL26;RPL28;DDX27;RPL10;RPL12;HEATR1;RPL11;RPL36A;NOLC1;NOL8;SNU13;RPF1;EXOSC7;EMG1;BMS1;PES1;EXOSC8;RPL15;EXOSC3;LYAR;EXOSC2;RPL17;MDN1;RPL41;NOP58;UTP6;WDR18;RPL35A;RPL23A;RRP1B;WDR12;WDR55;RPS25;RPS28;RPS27;RPL27A;MPHOSPH10;ESF1;NOL11;RPS24
regulation of mRNA stability (GO:0043488),79/146,2.30E-17,1.03E-14,0,0,4.237355564,162.3459722,CELF1;YWHAB;HNRNPU;YBX1;ELAVL1;PSMD8;PSMD6;ZFP36;PSMD7;XPO1;PSMD4;PSMD2;MEIOC;PSMD1;METTL16;TNPO1;DIS3;RC3H1;YWHAZ;PSMA5;PSMA6;CARHSP1;PSMA3;PSMA4;PSMA1;PDE12;PSMA2;THRAP3;PSME3;PSME4;PSME2;PABPC1;PSMD12;PSMD11;SET;PSMD14;ROCK1;ROCK2;PARN;GIGYF2;PSMA7;PSMB10;ZFP36L1;FXR1;EXOSC7;PSMB6;PSMB7;PSMB4;RIDA;LARP1;PSMB5;UBB;PSMB2;PCBP4;PSMB3;NOCT;DND1;UBC;EXOSC8;PSMB1;IGF2BP1;EXOSC3;RPS27A;ZC3H14;EXOSC2;PAIP1;HSPA8;NPM1;YTHDF1;YTHDF2;PUM2;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;SERBP1;HNRNPD
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",66/113,5.27E-17,2.17E-14,0,0,5.037826695,188.8292879,RPL4;RPL5;RPL3;RPL32;RPL31;RPL34;RPLP1;EIF4A3;RPLP0;RPL8;SMG7;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS17;RPS16;MAGOH;RPL35;RPL38;RPL37;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPL37A;RPL27;ETF1;RPL26;PABPC1;RPL28;RPL10;RPL12;RPL11;RPL36A;GSPT1;PPP2CA;RPS15A;RPS3;RPL15;RPS27A;RPL17;RPL41;RPL35A;RPL23A;MAGOHB;PNRC2;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RNPS1;EIF3E;RPS21;RPS24
ncRNA processing (GO:0034470),97/201,1.51E-16,5.75E-14,0,0,3.35782233,122.3212145,RPL4;RPL5;RPL3;RPL32;RPL31;POP4;RPL34;RPP30;FCF1;RPL8;RPL9;RPL6;RPL7;RPS14;RPS17;RPS16;RPL35;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;WDR74;WDR75;DICER1;EBNA1BP2;MRTO4;SBDS;RPL27;RPL26;RPL28;NOLC1;SNU13;RPF1;EMG1;LYAR;MDN1;RPL41;WDR55;RPS25;RPS28;LIN28B;RPS27;LIN28A;RPL27A;AGO2;MPHOSPH10;NOL11;RPS24;DDX47;NVL;RPLP1;WDR3;RPLP0;WDR43;RPL7A;UTP14A;WDR36;UTP11;DIS3;TEX10;RPL13A;DDX52;SENP3;MRPL44;C1D;RPL37A;DDX27;RPL10;RPL12;HEATR1;RPL11;SRRT;RPL36A;NOL8;EXOSC7;PES1;BMS1;EXOSC8;RPL15;EXOSC3;EXOSC2;RPL17;UTP6;NOP58;SSB;WDR18;RPL35A;RPL23A;RRP1B;WDR12;HNRNPA2B1;ESF1
"mRNA splicing, via spliceosome (GO:0000398)",119/274,1.39E-15,4.91E-13,0,0,2.769034669,94.72945486,EIF4A3;HNRNPU;EFTUD2;PNN;SNRPD2;SNRPD1;MAGOH;RAVER2;PAPOLA;SNRPD3;TXNL4A;SRRM2;IK;SCAF11;PRPF4B;ZCRB1;WBP11;GTF2F2;SRRM1;WDR77;DDX39B;CLNS1A;SNRPG;GEMIN5;PPIE;SNRNP27;SRSF3;GEMIN6;PPIH;SNRPE;SNRPF;SRSF5;SNRNP200;SNRPC;SRSF6;SRSF7;SNRPA;SRSF9;DDX5;DHX9;DDX1;SNU13;PRPF8;ZMAT2;PCBP1;PCBP2;SRPK2;HSPA8;CPSF3;NONO;CPSF2;CWC15;MAGOHB;LSM5;LSM3;SRPK1;HNRNPL;SMU1;LSM8;LSM7;HNRNPK;HNRNPD;RNPS1;HNRNPC;CDK13;ISY1;DDX46;CELF4;PPWD1;YBX1;ELAVL1;SYNCRIP;UBL5;PTBP1;SNRNP70;DHX15;BCAS2;RBM17;BUD31;PRPF40B;PRPF40A;WDR33;SFPQ;HNRNPH1;SYF2;HNRNPH2;SNRPA1;PABPC1;DNAJC8;SF3B2;SF3B6;SRRT;SRSF1;U2AF1;FIP1L1;POLR2B;TRA2B;POLR2F;POLR2G;SNRPB2;POLR2H;HNRNPA1;POLR2I;SF3B1;SRSF10;POLR2J;SMNDC1;SRSF11;POLR2K;HNRNPA0;POLR2L;SF3A3;SF3A1;HNRNPA3;PPIL1;U2SURP;PHF5A;HNRNPA2B1;PPIL3
mRNA processing (GO:0006397),127/300,1.72E-15,5.66E-13,0,0,2.649576279,90.0824477,TCERG1;EIF4A3;HNRNPU;EFTUD2;PNN;SNRPD2;SNRPD1;MAGOH;RAVER2;PAPOLA;SNRPD3;TXNL4A;SRRM2;IK;SCAF11;THOC1;PRPF4B;ZCRB1;WBP11;GTF2F2;THOC7;SRRM1;DDX39B;SARNP;SNRPG;GEMIN5;PPIE;SNRNP27;SRSF3;GEMIN6;PPIH;SNRPE;SNRPF;SRSF5;AURKAIP1;SNRNP200;SNRPC;SRSF6;SRSF7;SNRPA;SRSF9;DDX5;DHX9;SNU13;PRPF8;ZMAT2;PCBP1;PCBP2;HSPA8;CPSF6;CPSF3;NONO;CPSF2;CWC15;MAGOHB;LSM5;LSM3;HNRNPL;SMU1;LSM8;CDK7;LSM7;HNRNPK;SON;HNRNPD;RNPS1;HNRNPC;MNAT1;ISY1;DDX46;CELF1;PPWD1;YBX1;ELAVL1;SYNCRIP;UBL5;PTBP1;SNRNP70;DHX15;BCAS2;RBM17;BUD31;PRPF40B;PRPF40A;WDR33;KIN;SFPQ;HNRNPH1;SYF2;HNRNPH2;SNRPA1;PABPC1;DNAJC8;SF3B2;RNMT;POLDIP3;SF3B6;SRRT;SRSF1;U2AF1;FIP1L1;POLR2B;TRA2B;POLR2F;POLR2G;SNRPB2;POLR2H;HNRNPA1;POLR2I;SF3B1;SRSF10;POLR2J;SMNDC1;SRSF11;POLR2K;HNRNPA0;POLR2L;SF3A3;SF3A1;HNRNPA3;PPIL1;GTF2H3;GTF2H5;U2SURP;PHF5A;HNRNPA2B1;PPIL3
cellular macromolecule biosynthetic process (GO:0034645),131/314,2.45E-15,7.58E-13,0,0,2.58442559,86.94777453,RPL4;RPL5;RPL3;RPL32;RPL31;RPL34;RPL8;RPL9;RPL6;RPL7;EEF1B2;RPS14;RPS17;RPS16;PCLAF;RPL35;RPL38;RPL37;RPL39;RPS13;TIPIN;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS18B;MRPS18A;MRPS18C;TUFM;EEF1A1;RPL27;RPL26;RPL28;RHNO1;SET;MRPL18;MRPL13;GSPT1;MRPL11;ORC4;ORC2;EIF4EBP2;RPL41;MRPL28;MRPL23;EEF2;MRPL24;EXT1;RPS26;RPS25;POLA2;RPS28;RPS27;FUBP3;RPS29;RPL27A;AGO2;CDK1;RNPS1;RPS21;RSL24D1;RPS24;EIF4G2;FARSB;MRPS17;HBS1L;MRPS16;MCM7;MRPS14;RPLP1;RPLP0;MRPL36;MRPL34;MRPL41;RPS4X;MRPL42;RPL7A;MRPL9;RFC4;RFC2;PABPC4;MRPS21;RPL13A;MLF1;MRPL52;EEF1G;KIN;MRPL51;DBF4;EEF1D;RPL37A;MCM4;RBMS1;MRRF;PTMA;MCM2;RPL10;MRPS33;RPL12;RPL11;RPL36A;RRBP1;MRPL55;TBRG1;RPS15A;POLR2B;RPS3;POLR2F;POLR2G;RPL15;POLR2H;RPS27A;POLR2I;RPL17;POLR2J;POLR2K;ABCF1;POLR2L;DUT;RPA1;RPL35A;NAP1L1;RPL23A;GOLPH3;RPA3;DRG1;RAD1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",111/251,2.70E-15,7.86E-13,0,0,2.857057942,95.84479525,EIF4A3;HNRNPU;EFTUD2;PNN;SNRPD2;SNRPD1;MAGOH;RAVER2;PAPOLA;SNRPD3;TXNL4A;SRRM2;IK;PRPF4B;ZCRB1;WBP11;GTF2F2;SRRM1;DDX39B;SNRPG;GEMIN5;PPIE;SNRNP27;SRSF3;GEMIN6;PPIH;SNRPE;SNRPF;SRSF5;SNRNP200;SNRPC;SRSF6;SRSF7;SNRPA;SRSF9;DDX5;DHX9;SNU13;PRPF8;ZMAT2;PCBP1;PCBP2;HSPA8;CPSF3;NONO;CPSF2;CWC15;MAGOHB;LSM5;LSM3;HNRNPL;SMU1;LSM8;LSM7;HNRNPK;HNRNPD;RNPS1;HNRNPC;ISY1;DDX46;PPWD1;YBX1;ELAVL1;SYNCRIP;UBL5;PTBP1;SNRNP70;DHX15;BCAS2;RBM17;BUD31;PRPF40B;PRPF40A;WDR33;SFPQ;HNRNPH1;SYF2;HNRNPH2;SNRPA1;PABPC1;DNAJC8;SF3B2;SF3B6;SRRT;SRSF1;U2AF1;FIP1L1;POLR2B;TRA2B;POLR2F;POLR2G;SNRPB2;POLR2H;HNRNPA1;POLR2I;SF3B1;SRSF10;POLR2J;SMNDC1;SRSF11;POLR2K;HNRNPA0;POLR2L;SF3A3;SF3A1;HNRNPA3;PPIL1;U2SURP;PHF5A;HNRNPA2B1;PPIL3
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),47/75,3.92E-14,1.08E-11,0,0,6.002993963,185.314713,PSMD12;PSMD11;PSMD14;HIF3A;LIMD1;RBPJ;HIGD1A;HIF1A;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;EP300;PSMD1;ELOB;ELOC;RPS27A;EGLN1;EGLN3;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
nuclear-transcribed mRNA catabolic process (GO:0000956),82/171,5.12E-14,1.33E-11,0,0,3.308662274,101.2546317,RPL4;RPL5;RPL3;RPL32;RPL31;RPL34;RPLP1;EIF4A3;RPLP0;RPL8;SMG7;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS17;ZFP36;RPS16;MAGOH;RPL35;RPL38;RPL37;RPL39;RPS13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RC3H1;RPL13A;PDE12;THRAP3;CSDE1;MRTO4;RPL37A;RPL27;ETF1;RPL26;PABPC1;RPL28;DDX5;RPL10;RPL12;RPL11;PARN;RPL36A;GSPT1;ZFP36L1;EXOSC7;PPP2CA;RPS15A;EXOSC8;RPS3;POLR2G;RPL15;RPS27A;RPL17;RPL41;LSM1;RPL35A;RPL23A;MAGOHB;PNRC2;RPS26;RPS25;CNOT6;RPS28;CNOT7;RPS27;RPS29;RPL27A;RNPS1;EIF3E;CNOT9;RPS21;RPS24
pre-replicative complex assembly (GO:0036388),42/64,8.60E-14,2.13E-11,0,0,6.822186073,205.2397888,PSMD12;PSMD11;MCM7;PSMD14;GMNN;PSMA7;PSMB10;PSMD8;PSMB6;ORC4;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;ORC2;PSMB1;UBC;PSMD1;RPS27A;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;MCM4;PSME2;MCM2
regulation of mRNA catabolic process (GO:0061013),64/122,1.65E-13,3.82E-11,0,0,3.954044191,116.3695444,YWHAB;ELAVL1;PSMD8;PSMD6;ZFP36;PSMD7;XPO1;PSMD4;PSMD2;PSMD1;TNPO1;DIS3;RC3H1;YWHAZ;PSMA5;PSMA6;CARHSP1;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;PABPC1;PSMD12;PSMD11;SET;PSMD14;PARN;PSMA7;PSMB10;ZFP36L1;FXR1;EXOSC7;PSMB6;PSMB7;PSMB4;PSMB5;UBB;PSMB2;PCBP4;PSMB3;UBC;EXOSC8;PSMB1;IGF2BP1;EXOSC3;RPS27A;ZC3H14;EXOSC2;HSPA8;YTHDF1;YTHDF2;PUM2;PSMB9;CNOT7;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;SERBP1;HNRNPD
regulation of cellular amine metabolic process (GO:0033238),36/51,1.70E-13,3.82E-11,0,0,8.568522337,251.9616074,PSMD12;PSMD11;PSMD14;ODC1;OAZ1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;AZIN1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
regulation of cellular amino acid metabolic process (GO:0006521),37/54,3.39E-13,7.31E-11,0,0,7.771256807,223.1273997,PSMD12;PSMD11;PSMD14;ODC1;OAZ1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;AZIN1;PSMB9;PSMA5;BCKDK;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
translational elongation (GO:0006414),55/104,5.39E-12,1.11E-09,0,0,4.016125548,104.204905,MRPS17;MRPS16;GFM2;MRPS14;MRPL36;MRPL34;EEF1B2;MRPL41;MRPL42;MRPL1;MRPL40;RACK1;MRPL9;CHCHD1;MRPS28;MRPS27;MRPS25;MRPS23;MRPS18B;MRPS18A;MRPS21;MRPL47;MRPL45;MRPS18C;TUFM;MRPL44;EEF1A1;EEF1G;MRPL52;MRPL50;MRPL51;NEMF;EEF1D;AURKAIP1;DAP3;MRPL18;MRPS33;MRPL16;MRPL14;MRPL15;MRPL12;MRPL13;MRPL57;MRPL54;MRPL11;MRPL55;MRPL20;PTCD3;MRPL28;EEF2;MRPL23;MRPL24;MRPL21;MRPL22;MRPL30
translational termination (GO:0006415),52/96,6.05E-12,1.20E-09,0,0,4.226990531,109.188681,MRPS17;MRPS16;GFM2;MRPS14;MRPL36;MRPL34;MRPL41;MRPL42;TRMT112;MRPL1;MRPL40;MRPL9;CHCHD1;MRPS28;MRPS27;MRPS25;MRPS23;MRPS18B;MRPS18A;MRPS21;MRPL47;MRPL45;MRPL44;MRPS18C;MRPL52;MRPL50;MRPL51;ETF1;AURKAIP1;MRRF;DAP3;MRPL18;MRPS33;MRPL16;MRPL14;MRPL15;MRPL12;MRPL13;MRPL57;GSPT1;MRPL54;MRPL11;MRPL55;MRPL20;PTCD3;MRPL28;MRPL23;MRPL24;MRPL21;MRPL22;MRPL30;ABCE1
regulation of translation (GO:0006417),80/178,7.29E-12,1.39E-09,0,0,2.928460438,75.09823858,TRIM71;APP;RPL5;DDX3X;EIF4A3;NAT10;YBX1;ELAVL1;RBM3;RPS4X;SYNCRIP;RPS6KA1;ENC1;RACK1;SOX4;EIF2A;EIF5B;DAPK1;RPL13A;LARP4B;PUS7;ILF3;IMPACT;NEMF;NCL;CSDE1;GEMIN5;ETF1;RPL26;EIF4E2;GAPDH;DDX6;GRB7;MTPN;RPL10;DHX9;DDX25;POLDIP3;DDX1;NOLC1;RPS27L;MRPL13;THBS1;GIGYF2;GSPT1;FXR1;ATXN2;RIDA;LARP1;EIF4H;IGF2BP1;RPS3;METTL5;PAIP2;EIF4E;EIF4B;PAIP1;NPM1;YTHDF1;EEF2;LARP4;PUM3;DHFR;CNOT7;EIF5;LIN28A;EIF6;RPS6KB1;CAPRIN1;HNRNPD;EIF3H;EIF3E;CALR;EIF3C;CNOT9;EIF4G3;EIF3D;EIF4G2;METAP1;EIF3B
negative regulation of cell cycle G2/M phase transition (GO:1902750),36/57,2.71E-11,4.80E-09,0,0,6.118016691,148.8524009,PSMD12;PSMD11;PSMD14;FHL1;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
ribosomal large subunit biogenesis (GO:0042273),36/57,2.71E-11,4.80E-09,0,0,6.118016691,148.8524009,RPL5;RPL3;RPL10;NVL;PAK1IP1;RPLP0;MAK16;RPL11;SNU13;NOC2L;RPF2;SDAD1;RPL6;RPL7;RPF1;RPL7A;MRPL20;MRPL1;PES1;BRIX1;RRP15;MDN1;NPM1;NOP16;WDR74;RPL35A;RPL23A;WDR12;RSL1D1;EBNA1BP2;NSA2;EIF6;MRTO4;NHP2;RPL26;RSL24D1
mitochondrial translational elongation (GO:0070125),48/89,4.78E-11,7.90E-09,0,0,4.184296784,99.43293943,MRPS17;MRPS16;GFM2;MRPS14;MRPL18;MRPS33;MRPL16;MRPL36;MRPL14;MRPL15;MRPL34;MRPL12;MRPL13;MRPL57;MRPL54;MRPL11;MRPL55;MRPL41;MRPL42;MRPL20;MRPL1;MRPL40;MRPL9;CHCHD1;MRPS28;PTCD3;MRPS27;MRPS25;MRPS23;MRPS18B;MRPS18A;MRPS21;MRPL28;MRPL47;MRPL45;MRPL23;MRPL24;MRPL21;MRPL44;MRPS18C;TUFM;MRPL22;MRPL52;MRPL30;MRPL50;MRPL51;AURKAIP1;DAP3
mitochondrial translational termination (GO:0070126),48/89,4.78E-11,7.90E-09,0,0,4.184296784,99.43293943,MRPS17;MRPS16;GFM2;MRPS14;MRPL18;MRPS33;MRPL16;MRPL36;MRPL14;MRPL15;MRPL34;MRPL12;MRPL13;MRPL57;MRPL54;MRPL11;MRPL55;MRPL41;MRPL42;MRPL20;MRPL1;MRPL40;MRPL9;CHCHD1;MRPS28;PTCD3;MRPS27;MRPS25;MRPS23;MRPS18B;MRPS18A;MRPS21;MRPL28;MRPL47;MRPL45;MRPL23;MRPL24;MRPL21;MRPL44;MRPS18C;MRPL22;MRPL52;MRPL30;MRPL50;MRPL51;AURKAIP1;MRRF;DAP3
anaphase-promoting complex-dependent catabolic process (GO:0031145),46/84,6.01E-11,9.61E-09,0,0,4.325373134,101.7948467,PSMD12;PSMD11;PSMD14;CUL3;BUB1B;PSMA7;PSMB10;CDC20;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;CDC26;PSMD2;CDC27;PSMB1;UBC;PSMD1;BUB3;SKP2;RPS27A;UBE2E1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;CDK1;PSME2;MAD2L1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),47/87,7.03E-11,1.09E-08,0,0,4.198857373,98.16434709,PSMD12;PSMD11;PSMD14;HIF3A;LIMD1;HIGD1A;HIF1A;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;EP300;PSMD1;ELOB;ELOC;RPS27A;EGLN1;EGLN3;RBX1;PSMB9;PSMA5;PSMA6;IMPACT;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),39/66,7.70E-11,1.16E-08,0,0,5.156554078,120.081898,PSMD12;PSMD11;PSMD14;FHL1;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;CDK5RAP3;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;NABP2;PSME2;NABP1
ribonucleoprotein complex assembly (GO:0022618),63/136,2.58E-10,3.76E-08,0,0,3.088785312,68.18948067,ISY1;RPL5;RPL3;HSP90AB1;CELF1;RPLP0;CELF4;RPL6;CDC73;RPS14;SNRPD2;SNRPD1;LUC7L;DENR;EIF2D;RPL38;SNRPD3;TXNL4A;HSP90AA1;SCAF11;RPS5;DICER1;WDR77;DDX39B;CLNS1A;SNRPG;GEMIN5;LUC7L3;GEMIN6;SNRPE;SNRPF;SRSF5;SNRNP200;SNRPC;SRSF6;SRSF9;RPL10;DHX9;DDX1;RPL11;SRSF1;RPS27L;RPF2;MRPL20;EIF4H;BRIX1;SF3B1;SRSF10;MDN1;EIF4B;MCTS1;SRPK2;CPSF6;PTGES3;RPL23A;SRPK1;SETX;RPS28;EIF5;RPS27;EIF6;RSL24D1;EIF3A
cellular response to hypoxia (GO:0071456),61/131,3.81E-10,5.39E-08,0,0,3.118067808,67.62501392,SUV39H2;HIF3A;LIMD1;PSMD8;NPEPPS;PSMD6;PSMD7;PSMD4;FAM162A;MYC;PSMD2;EP300;PSMD1;ELOB;ELOC;BNIP3L;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;MGARP;PSMD12;PSMD11;PSMD14;HIGD1A;HIF1A;PSMA7;PSMB10;ZFP36L1;PSMB6;PSMB7;PSMB4;PSMB5;UBB;PSMB2;PSMB3;UBC;LMNA;PSMB1;PGK1;UBQLN1;PMAIP1;RPS27A;EGLN1;PLK3;EGLN3;BNIP3;MT3;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;P4HB
mitochondrial translation (GO:0032543),52/105,4.74E-10,6.53E-08,0,0,3.507169291,75.29531917,MRPS17;MRPS16;GFM2;MRPS14;MRPL36;MRPL34;MRPL41;MRPL42;MRPL1;MRPL40;MRPL9;CHCHD1;MRPS28;MRPS27;MRPS25;MRPS23;MRPS18B;MRPS18A;MRPS21;MRPL47;MRPL45;MRPS18C;TUFM;MRPL44;MRPL52;LARS2;MRPL50;MRPL51;AURKAIP1;MRRF;DAP3;MRPL18;MRPS33;MRPL16;MRPL14;MRPL15;MRPL12;MRPL13;MRPL57;MRPL54;MRPL11;MRPL55;MRPL20;IARS2;PTCD3;NDUFA7;MRPL28;MRPL23;MRPL24;MRPL21;MRPL22;MRPL30
DNA-dependent DNA replication (GO:0006261),60/129,5.60E-10,7.50E-08,0,0,3.110884088,66.27134289,MCM7;GMNN;PSMD8;PSMD6;PSMD7;PSMD4;PSMD2;PSMD1;RFC4;RFC1;RFC2;BAZ1A;PSMA5;PSMA6;PSMA3;CDC34;DBF4;PSMA4;POLG2;PSMA1;PSMA2;PSME3;PSME4;PSME2;MCM4;MCM2;PSMD12;PSMD11;PSMD14;DDX21;PSMA7;PSMB10;PSMB6;ORC4;PSMB7;PURA;PSMB4;PSMB5;UBB;PSMB2;PSMB3;ORC2;UBC;PSMB1;MCMBP;RPS27A;SRPK2;HMGA1;RPA1;LRWD1;PSMB9;POLA2;PSMC6;PSMC3;PSMC4;PSMC1;RPA3;PSMC2;CDK2AP1;SSBP1
regulation of hematopoietic stem cell differentiation (GO:1902036),39/71,1.51E-09,1.97E-07,0,0,4.349445495,88.33721431,YAP1;PSMD12;PSMD11;KMT2A;PSMD14;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;MYB;PSMB1;PSMD1;YTHDF2;TCF15;PUS7;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
regulation of cellular ketone metabolic process (GO:0010565),36/64,2.69E-09,3.42E-07,0,0,4.586450663,90.50553481,PSMD12;PSMD11;PSMD14;ODC1;OAZ1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;AZIN1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),18/22,4.11E-09,5.08E-07,0,0,16.01129363,309.1869885,PSMA7;PSMB10;PSMB9;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMA4;PSMB5;PSMA1;PSMB2;PSMA2;PSMB3;ENC1;PSMB1;PSME4
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",43/85,6.50E-09,7.85E-07,0,0,3.654750978,68.89677599,PSMD12;PSMD11;PSMD14;CLTC;AP2A2;PSMA7;PSMB10;PSMD8;CDC42;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;RAC1;AP2M1;RYK;FZD7;AP2B1;RHOA;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;PFN1
proteasomal protein catabolic process (GO:0010498),81/205,1.02E-08,1.20E-06,0,0,2.339969758,43.05820739,TRIM71;GSK3A;FAF1;UBE2D3;ARRB1;TNFAIP1;PSMD8;PSMD6;UCHL1;PSMD7;MAEA;PSMD4;PSMD2;ENC1;PSMD1;SKP2;FBXW7;USP44;UBE4B;PPP2R5C;KCTD5;RAD23B;RBX1;DDB1;PSMA5;RCN3;PSMA6;PSMA3;CDC34;PSMA4;PSMA1;KCTD10;PSMA2;PSME3;PSME4;PSME2;PLAA;SPOPL;RNF122;PSMD12;VCP;PSMD11;PSMD14;CUL3;PSMA7;PSMB10;PCNP;PSMB6;PSMB7;PSMB4;PSMB5;RMND5A;PSMB2;PSMB3;PCBP2;PSMB1;SPOP;PMAIP1;FEM1C;TBL1X;UBE2B;FEM1B;FBXL19;HUWE1;WWP1;UBE2G1;UBE2A;PML;PSMB9;GID4;PSMC6;PSMC3;APPBP2;PSMC4;NEDD4;PSMC1;PSMC2;CTNNB1;UBE2K;RNF187;CUL4B
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",38/73,1.78E-08,2.05E-06,0,0,3.873036246,69.11428204,PSMD12;PSMD11;PSMD14;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;PDIA3;CHUK;TAPBP;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;CALR;VAMP3
regulation of stem cell differentiation (GO:2000736),44/91,2.54E-08,2.86E-06,0,0,3.341592644,58.44334174,YAP1;PSMD12;PSMD11;KMT2A;PSMD14;TACSTD2;HNRNPU;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;MYB;PSMB1;PSMD1;YTHDF2;TCF15;NSUN2;PUS7;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;OCIAD1;PSME2;BMPR1A
regulation of cell cycle phase transition (GO:1901987),45/95,3.88E-08,4.28E-06,0,0,3.212603306,54.81850267,PSMD12;PSMD11;PSMD14;CUL1;BUB1B;PSMA7;PSMB10;CDC20;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;CDC26;PSMD2;CDC27;PSMB1;PSMD1;BUB3;FBXW7;UBE2E1;PSMB9;DDB1;PSMA5;PSMA6;PSMA3;DBF4;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;CDK1;PSME2;MAD2L1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),38/75,4.61E-08,4.96E-06,0,0,3.663212146,61.88397049,YAP1;PSMD12;PSMD11;KMT2A;PSMD14;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;MYB;PSMB1;PSMD1;YTHDF2;PUS7;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
Fc-epsilon receptor signaling pathway (GO:0038095),50/111,5.42E-08,5.71E-06,0,0,2.927158256,48.97535531,PIK3CB;PSMD8;PSMD6;PPP3CB;PSMD7;PSMD4;PSMD2;PSMD1;RAC1;CHUK;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;SOS1;PSMD12;PSMD11;PSMD14;SHC1;CUL1;PSMA7;PSMB10;PSMB6;PSMB7;PPP3R1;MAPK8;PAK1;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;MAPK1;PAK2;MAPK3;JUN;MAP3K1;NFKB1;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;CALM1
transcription-coupled nucleotide-excision repair (GO:0006283),37/73,6.82E-08,7.03E-06,0,0,3.665285416,60.48153477,ISY1;PCNA;COPS7A;UBB;POLR2B;UBC;EP300;POLR2F;POLR2G;POLR2H;POLR2I;RPS27A;POLR2J;POLR2K;HMGN1;POLR2L;USP7;RFC4;RFC1;RFC2;RPA1;GTF2H3;GTF2H5;RBX1;DDB1;COPS4;COPS3;CDK7;COPS6;COPS2;ERCC1;RPA3;UVSSA;PPIE;TCEA1;MNAT1;CUL4B
Fc receptor signaling pathway (GO:0038093),50/112,7.70E-08,7.79E-06,0,0,2.879760678,47.16730337,PIK3CB;PSMD8;PSMD6;PPP3CB;PSMD7;PSMD4;PSMD2;PSMD1;RAC1;CHUK;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;SOS1;PSMD12;PSMD11;PSMD14;SHC1;CUL1;PSMA7;PSMB10;PSMB6;PSMB7;PPP3R1;MAPK8;PAK1;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;MAPK1;PAK2;MAPK3;JUN;MAP3K1;NFKB1;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;CALM1
regulation of establishment of planar polarity (GO:0090175),42/88,8.35E-08,8.27E-06,0,0,3.257757563,53.09675217,PSMD12;PSMD11;PSMD14;CLTC;AP2A2;PSMA7;PSMB10;PSMD8;CDC42;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;RAC1;AP2M1;FZD7;AP2B1;RHOA;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;PFN1
NIK/NF-kappaB signaling (GO:0038061),37/74,1.08E-07,1.04E-05,0,0,3.5659945,57.21808098,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;CARD10;CHUK;DICER1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
RNA splicing (GO:0008380),45/98,1.23E-07,1.17E-05,0,0,3.030173086,48.20470191,TCERG1;SF3B2;DDX47;U2AF1;PRPF8;PPP2CA;PTBP1;SYNCRIP;SNRPD2;SNRPD1;TRA2B;MAGOH;DHX15;SNRPD3;TXNL4A;SF3B1;SMNDC1;SRSF10;BCAS2;SRSF11;IVNS1ABP;SRPK2;SF3A3;SCAF11;NONO;LSM1;PRPF4B;ZCRB1;MAGOHB;SRRM1;SRPK1;SMU1;SFPQ;DDX39B;SNRPG;MPHOSPH10;LUC7L3;RNPS1;SNRPA1;PPIG;SNRPF;CDK12;HNRNPC;TARDBP;SRSF7
RNA processing (GO:0006396),70/179,1.60E-07,1.49E-05,0,0,2.29686133,35.94804238,TCERG1;CELF1;DDX47;HNRNPU;RBM3;PTBP1;SYNCRIP;SNRPD2;SNRPD1;MAGOH;DHX15;SNRPD3;BCAS2;SCAF11;PABPC4;THOC1;PRPF4B;DICER1;ZCRB1;SRRM1;MRPL44;KIN;SFPQ;DDX39B;HNRNPH1;SNRPG;LUC7L3;RBMS1;SNRPA1;PPIG;SNRPF;SRSF5;AURKAIP1;SRSF7;SRSF9;SF3B2;SRSF1;U2AF1;PRPF8;PPP2CA;SF3B1;SRSF11;HNRNPA0;IVNS1ABP;SRPK2;SF3A3;RBM39;SF3A1;CPSF6;RBPMS;NONO;LSM1;LSM5;MAGOHB;LSM3;SRPK1;HNRNPL;SETX;SMU1;LIN28B;HNRNPK;LIN28A;SON;HNRNPA2B1;HNRNPD;MPHOSPH10;RNPS1;CDK12;HNRNPC;TARDBP
regulation of primary metabolic process (GO:0080090),55/130,1.64E-07,1.50E-05,0,0,2.619481516,40.93299643,CHD9;PSMD8;PSMD6;PSMD7;PSMD4;PSMD2;PSMD1;MED1;GGPS1;HMGCS1;LSS;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;IDI1;PSMD12;PSMD11;HDAC3;PSMD14;ROCK2;ODC1;HMGCR;ADIPOR1;OAZ1;ACACA;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PMVK;PSMB1;SC5D;TBL1X;NFYB;AZIN1;PSMB9;SQLE;PSMC6;PSMC3;SP1;PSMC4;ID2;CARM1;PSMC1;PSMC2
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),38/78,1.74E-07,1.57E-05,0,0,3.387818015,52.73096681,PSMD12;PSMD11;PSMD14;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;PDIA3;CHUK;TAPBP;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;CALR;VAMP3
interleukin-1-mediated signaling pathway (GO:0070498),43/94,2.66E-07,2.35E-05,0,0,3.008053703,45.53895089,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;MAPK3;CHUK;NFKB1;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;UBE2N;PSME2;UBE2V1
maturation of LSU-rRNA (GO:0000470),18/26,3.47E-07,3.01E-05,0,0,8.003593429,119.0463952,DDX18;MAK16;SNU13;RPF2;WDR12;RPF1;RPL7;FTSJ3;RPL7A;RSL1D1;NSA2;MRPL1;EIF6;PES1;RPL7L1;NHP2;RPL35;RRP15
regulation of G2/M transition of mitotic cell cycle (GO:0010389),60/149,3.68E-07,3.14E-05,0,0,2.408703012,35.68383548,CEP57;YWHAE;FHL1;PSMD8;PSMD6;PCM1;PSMD7;TUBA1A;PSMD4;PSMD2;PSMD1;YWHAG;HSP90AA1;HAUS3;CDC25C;DYNLL1;CKAP5;RBX1;HAUS1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;AKAP9;PSME4;PSME2;MAPRE1;SFI1;DYNC1I2;PSMD12;PSMD11;PSMD14;VPS4B;DCTN3;CUL1;HMMR;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;RCC2;TUBB4B;RAB11A;PSMB9;TPX2;PSMC6;PSMC3;CDK4;PSMC4;PSMC1;PSMC2;CDK1
negative regulation of mitotic cell cycle phase transition (GO:1901991),42/92,3.91E-07,3.28E-05,0,0,2.996366139,44.21007003,PSMD12;PSMD11;PSMD14;FHL1;PTEN;CUL1;CDC73;PSMA7;PSMB10;ZFP36L1;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;E2F7;PRMT2;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;CDK4;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2
regulation of mitotic cell cycle phase transition (GO:1901990),71/188,6.27E-07,5.17E-05,0,0,2.169759776,30.99083925,CEP57;YWHAE;BUB1B;CDC14B;CDC20;PSMD8;PSMD6;PCM1;PSMD7;TUBA1A;PSMD4;CDC26;PSMD2;CDC27;PSMD1;YWHAG;HSP90AA1;UBE2E1;HAUS3;DYNLL1;CKAP5;HAUS1;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;AKAP9;PSME4;PSME2;MAPRE1;SFI1;DYNC1I2;PSMD12;PSMD11;PSMD14;CUL3;DCTN3;CUL1;HMMR;PSMA7;PSMB10;ZFP36L1;PSMB6;PSMB7;PSMB4;PSMB5;UBB;PSMB2;PSMB3;UBC;PSMB1;BUB3;RPS27A;NEK6;TUBB4B;PSMB9;ANLN;TPX2;CENPE;PSMC6;PSMC3;PSMC4;ID2;PSMC1;PSMC2;CDK1;MAD2L1
protein-DNA complex assembly (GO:0065004),57/143,1.06E-06,8.57E-05,0,0,2.366913465,32.57238581,MCM7;GMNN;PSMD8;PSMD6;PSMD7;PSMD4;PSMD2;PSMD1;PARP1;ATRX;RAD23B;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;MCM4;MCM2;PSMD12;PSMD11;PSMD14;PSMA7;PSMB10;PSMB6;ORC4;PSMB7;PSMB4;PSMB5;UBB;PSMB2;PSMB3;ORC2;UBC;PSMB1;RPS27A;NPM1;RPA1;NAP1L1;GTF2H3;GTF2H5;PSMB9;CDK7;PSMC6;PSMC3;PSMC4;PSMC1;RPA3;PSMC2;ANP32B;MNAT1;CUL4B
positive regulation of canonical Wnt signaling pathway (GO:0090263),53/130,1.10E-06,8.78E-05,0,0,2.457215737,33.71651207,DDX3X;USP34;PSMD8;PSMD6;PSMD7;PSMD4;PSMD2;RUVBL1;PSMD1;SOX4;PSMA5;PSMA6;PSMA3;SFRP2;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;TMEM9;CSNK1G2;PSMD12;VCP;PSMD11;PSMD14;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;TNKS2;PSMB3;UBR5;PSMB1;GPC3;TBL1X;JUP;UBE2B;NFKB1;PSMB9;PSMC6;PSMC3;PTK7;WNK1;PSMC4;PSMC1;PSMC2;LGR5;FGFR2;LGR4
non-canonical Wnt signaling pathway (GO:0035567),51/124,1.27E-06,9.99E-05,0,0,2.493547473,33.85101024,CLTC;AP2A2;PSMD8;PSMD6;PPP3CB;PSMD7;PSMD4;PSMD2;PSMD1;RAC1;AP2M1;RHOA;PSMA5;PSMA6;PSMA3;SFRP2;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;PFN1;PSMD12;PSMD11;PSMD14;PSMA7;PSMB10;CDC42;PSMB6;PSMB7;PPP3R1;PSMB4;GNG2;PSMB5;PSMB2;PSMB3;PSMB1;RYK;FZD7;AP2B1;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;AGO2;GNB1;PSMC2;CTNNB1;CALM1
regulation of mitotic cell cycle (GO:0007346),67/178,1.47E-06,1.14E-04,0,0,2.157040289,28.97233636,CDKN1C;APP;BTG3;BUB1B;HNRNPU;SRA1;MKI67;CKS1B;CDC20;PSMD8;PSMD6;MAEA;PSMD7;PSMD4;CDC26;PSMD2;CDC27;PSMD1;PIM3;CDK5RAP3;DUSP3;UBE2E1;CDC25C;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;KIF20B;CUL9;PSMD12;PSMD11;PSMD14;CUL1;IQGAP1;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;BUB3;EIF4E;AFAP1L2;NEK6;USP22;CDK11B;PSMB9;PSMC6;PSMC3;RPS6KB1;PSMC4;PSMC1;PSMC2;CDK1;PKN2;CDK13;MAD2L1;PTPN3
negative regulation of translation (GO:0017148),40/90,1.71E-06,1.31E-04,0,0,2.852373309,37.86870954,TRIM71;DDX6;GRB7;DDX3X;ROCK1;CELF1;ROCK2;EIF4A3;YBX1;MRPL13;GIGYF2;FXR1;SYNCRIP;RIDA;LARP1;ENC1;TPR;RACK1;IGF2BP1;RPS3;EIF4EBP2;METTL16;PAIP2;YTHDF1;YTHDF2;DAPK1;RPL13A;PUS7;DHFR;ILF3;CNOT7;LIN28A;NCL;CAPRIN1;AGO2;EIF3E;CALR;EIF4E2;GAPDH;CNOT9
protein stabilization (GO:0050821),67/179,1.85E-06,1.39E-04,0,0,2.137642973,28.22145836,RPL5;HSP90AB1;CTNND1;PTEN;PARK7;CLU;PHB2;SUMO1;TMEM88;FLOT1;CHP1;EP300;FLOT2;GOLGA7;SOX4;CCT3;CCT2;USP7;HSP90AA1;COG7;RPS7;FBXW7;RPL23;ANK2;ATP1B3;GTPBP4;CREB1;CDC37;TCP1;PFN1;PPIB;IFT46;CRYAB;GAPDH;TELO2;RPL11;TAF9;PHB;STK4;HSPD1;TBRG1;BAG2;PDCD10;FLNA;CCT8;TBL1X;ZSWIM7;CCT7;CCT5;TRIM44;CCT4;PEX19;UBE2B;USP9X;SEC16A;PTGES3;PARVA;MT3;HYPK;SMAD7;CCT6A;PDCL3;CDK7;PER3;NAA16;CALR;NAA15
RNA export from nucleus (GO:0006405),45/106,1.88E-06,1.39E-04,0,0,2.631418507,34.69349763,SLBP;NUP205;POM121;NUP107;SEH1L;DDX25;POLDIP3;EIF4A3;SRSF1;U2AF1;SMG7;NUP160;NXF1;FIP1L1;NUP85;MAGOH;TPR;NUP43;HNRNPA1;EIF4E;RAE1;SRSF11;NDC1;RANBP2;SEC13;CPSF3;CPSF2;THOC1;NUP153;MAGOHB;THOC7;SRRM1;WDR33;DDX39B;SARNP;HNRNPA2B1;SRSF3;RNPS1;SRSF5;SRSF6;NUP62CL;SRSF7;RAN;SRSF9;NUP37
mRNA transport (GO:0051028),44/104,2.72E-06,1.96E-04,0,0,2.615392854,33.51736847,SLBP;NUP205;POM121;NUP107;SEH1L;DDX25;POLDIP3;EIF4A3;SRSF1;U2AF1;SMG7;NUP160;ZFP36L1;NXF1;ZFP36;FIP1L1;NUP85;MAGOH;TPR;NUP43;EIF4E;RAE1;SRSF11;NDC1;RANBP2;SEC13;CPSF3;CPSF2;THOC1;NUP153;MAGOHB;THOC7;SRRM1;WDR33;DDX39B;SARNP;HNRNPA2B1;SRSF3;RNPS1;SRSF5;SRSF6;SRSF7;SRSF9;NUP37
regulation of gene silencing by miRNA (GO:0060964),32/67,2.77E-06,1.96E-04,0,0,3.257025145,41.68021644,TRIM71;NUP205;POM121;NUP107;SEH1L;DHX9;LIMD1;ELAVL1;NUP160;FXR1;ZFP36;NUP85;POLR2B;DND1;TPR;POLR2F;NUP43;POLR2G;POLR2H;POLR2I;POLR2J;RAE1;POLR2K;POLR2L;NDC1;RANBP2;SEC13;NUP153;PUM2;AGO2;AJUBA;NUP37
RNA transport (GO:0050658),35/76,2.77E-06,1.96E-04,0,0,3.041965074,38.92540361,SLBP;POM121;POLDIP3;EIF4A3;SRSF1;U2AF1;YBX1;ZFP36L1;NXF1;ZFP36;ATXN2;MAGOH;TPR;FLOT1;HNRNPA1;EIF4E;RAE1;SRSF11;RTRAF;THOC1;NUP153;MAGOHB;CKAP5;THOC7;SRRM1;DDX39B;SARNP;HNRNPA2B1;SRSF3;RNPS1;SRSF5;NUP62CL;SRSF6;SRSF7;SRSF9
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),15-Dec,2.94E-06,2.05E-04,0,0,14.21371611,181.0359178,CCT3;CCT6A;CCT2;RUVBL2;RUVBL1;TCP1;NHP2;CCT8;CCT7;CCT5;NOP10;CCT4
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),42/99,4.17E-06,2.87E-04,0,0,2.627208075,32.5434271,SLBP;NUP205;POM121;NUP107;SEH1L;DDX25;POLDIP3;EIF4A3;SRSF1;U2AF1;SMG7;NUP160;NXF1;FIP1L1;NUP85;MAGOH;TPR;NUP43;EIF4E;RAE1;SRSF11;NDC1;RANBP2;SEC13;CPSF3;CPSF2;THOC1;NUP153;MAGOHB;THOC7;SRRM1;WDR33;DDX39B;SARNP;HNRNPA2B1;SRSF3;RNPS1;SRSF5;SRSF6;SRSF7;SRSF9;NUP37
mitotic nuclear membrane organization (GO:0101024),26/51,5.20E-06,3.48E-04,0,0,3.702162286,45.04413866,AHCTF1;ANKLE2;NUP205;POM121;NUP107;SEH1L;NUP160;PPP2CA;CCNB2;SUMO1;NUP85;LMNA;BANF1;NUP43;EMD;LBR;NDC1;SEC13;UBE2I;RANGAP1;CDK1;CHMP2A;CHMP3;KPNB1;RAN;NUP37
mitotic nuclear membrane reassembly (GO:0007084),26/51,5.20E-06,3.48E-04,0,0,3.702162286,45.04413866,AHCTF1;ANKLE2;NUP205;POM121;NUP107;SEH1L;NUP160;PPP2CA;CCNB2;SUMO1;NUP85;LMNA;BANF1;NUP43;EMD;LBR;NDC1;SEC13;UBE2I;RANGAP1;CDK1;CHMP2A;CHMP3;KPNB1;RAN;NUP37
nuclear export (GO:0051168),37/84,5.36E-06,3.54E-04,0,0,2.805468339,34.04937073,POM121;POLDIP3;CSE1L;EIF4A3;SRSF1;PHAX;U2AF1;NXF1;XPO1;XPO4;MAGOH;TPR;CHP1;HNRNPA1;EIF4E;RAE1;SRSF11;THOC1;XPO7;NUTF2;NUP153;MAGOHB;THOC7;SRRM1;LSG1;DDX39B;NEMF;SARNP;SRSF3;RNPS1;SRSF5;CALR;NUP62CL;SRSF6;SRSF7;RAN;SRSF9
positive regulation of Wnt signaling pathway (GO:0030177),58/153,5.59E-06,3.64E-04,0,0,2.179507253,26.35895985,DDX3X;USP34;CDC73;PSMD8;PSMD6;PSMD7;PSMD4;PSMD2;RUVBL1;SPIN1;PSMD1;SOX4;CSNK2A1;PSMA5;PSMA6;PSMA3;SFRP2;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;TMEM9;CSNK1G2;PSMD12;VCP;PSMD11;PSMD14;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;TNKS2;PSMB3;UBR5;PSMB1;GPC3;TBL1X;ZRANB1;JUP;UBE2B;NFKB1;SMARCA4;PSMB9;PSMC6;PSMC3;PTK7;WNK1;PSMC4;PSMC1;PSMC2;LGR5;FGFR2;LGR4
positive regulation of translation (GO:0045727),42/100,5.67E-06,3.65E-04,0,0,2.58174526,31.18668963,RPL5;KHDRBS1;CDC123;DDX3X;DHX9;POLDIP3;EIF4A3;NAT10;RPS27L;ELAVL1;YBX3;THBS1;FXR1;RBM3;RPS4X;LARP1;C1QBP;METTL5;POLR2G;SOX4;EIF5A;COA3;RPS9;NPM1;YTHDF1;MRPS27;YTHDF2;UQCC2;CNBP;LARP4B;EEF2;LARP4;LIN28A;PKM;EIF6;RPS6KB1;AGO2;HNRNPD;EIF3E;RPL26;EIF3C;EIF3D
ribonucleoprotein complex biogenesis (GO:0022613),29/60,5.97E-06,3.79E-04,0,0,3.331109996,40.07074999,RPL5;NVL;PAK1IP1;RPL11;MRPL36;NOC2L;RPF2;SDAD1;RPL7;RPS17;EMG1;RPS16;XPO1;PES1;RPL38;NPM1;RPS7;NOP16;RPS6;WDR74;RPL35A;WDR12;RPS25;EBNA1BP2;RPS28;MRTO4;RPL26;RPS24;CUL4B
spliceosomal complex assembly (GO:0000245),24/46,7.11E-06,4.45E-04,0,0,3.882360272,46.02361385,SF3A3;SRPK2;SF3A1;CELF1;SCAF11;DDX1;SRSF1;CELF4;SRPK1;SETX;SNRPD2;DDX39B;SNRPD1;SNRPG;LUC7L;LUC7L3;SNRPE;SRSF5;TXNL4A;SNRNP200;SRSF6;SF3B1;SRSF10;SRSF9
regulation of telomerase RNA localization to Cajal body (GO:1904872),13/18,7.69E-06,4.76E-04,0,0,9.239835916,108.8026795,CCT3;CCT2;PARN;CCT6A;RUVBL2;RUVBL1;TCP1;NHP2;CCT8;CCT7;CCT5;NOP10;CCT4
ubiquitin-dependent protein catabolic process (GO:0006511),113/354,8.63E-06,5.28E-04,0,0,1.679350266,19.58101719,UBE2D3;BUB1B;UBE3B;UBE2L3;CDC20;PSMD8;PSMD6;PSMD7;MAEA;PSMD4;CDC26;PSMD2;CDC27;PSMD1;SKP2;ARRDC1;FBXW7;UBE2E1;RC3H1;UBE4B;KCTD5;RBX1;TOM1L1;CDC34;RNF128;KCTD10;PSME3;PSME4;PSME2;PLAA;RNF122;PSMD12;VCP;PSMD11;TSG101;PSMD14;UBA6;CUL3;UBR4;PCBP2;XBP1;ZRANB1;UBE2I;UBE2B;UBE2A;NTAN1;COPS3;APPBP2;UBA1;UBE2K;RNF187;TRIM71;GSK3A;PPP1R11;RNF14;FAF1;ARRB1;TNFAIP1;UCHL1;ELOC;USP44;PPP2R5C;RAD23B;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;UBE2R2;PSMA2;SPOPL;BIRC6;VPS4B;NEDD8;PSMA7;PSMB10;PCNP;PSMB6;PSMB7;PSMB4;PSMB5;RMND5A;PSMB2;PSMB3;PSMB1;SPOP;UBQLN1;FEM1C;RBBP6;TBL1X;BUB3;UBQLN4;USP9X;FEM1B;FBXL19;HUWE1;WWP1;UBE2G1;PML;MIB1;PSMB9;GID4;PSMC6;PSMC3;PSMC4;NEDD4;PSMC1;PSMC2;RLIM;CTNNB1;TRIP12;MAD2L1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),38/89,9.83E-06,5.94E-04,0,0,2.655233627,30.6155617,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;SKP2;FBXW7;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;CUL4B
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",12-Oct,1.12E-05,6.66E-04,0,0,17.7601913,202.5088607,CCT3;CCT6A;CCT2;GNL3L;TCP1;CCT8;CCT7;CCT5;CCT4;GNL3
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",21/39,1.40E-05,8.25E-04,0,0,4.150190259,46.38390407,NDUFB9;NDUFA8;NDUFB8;NDUFA7;NDUFB10;NDUFB6;NDUFA5;NDUFA12;NDUFB11;NDUFB5;NDUFA4;NDUFB4;NDUFA3;NDUFB3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;NDUFS6;NDUFAB1;NDUFS1
mRNA export from nucleus (GO:0006406),43/107,1.67E-05,9.74E-04,0,0,2.395038578,26.34279406,SLBP;ENY2;NUP205;POM121;NUP107;SEH1L;DDX25;POLDIP3;EIF4A3;SRSF1;U2AF1;SMG7;NUP160;NXF1;FIP1L1;NUP85;MAGOH;TPR;NUP43;EIF4E;RAE1;SRSF11;NDC1;RANBP2;SEC13;CPSF3;CPSF2;THOC1;NUP153;MAGOHB;THOC7;SRRM1;WDR33;DDX39B;SARNP;HNRNPA2B1;SRSF3;RNPS1;SRSF5;SRSF6;SRSF7;SRSF9;NUP37
nuclear membrane reassembly (GO:0031468),26/54,1.95E-05,0.001123501,0,0,3.304865306,35.83962965,AHCTF1;ANKLE2;NUP205;POM121;NUP107;SEH1L;NUP160;PPP2CA;CCNB2;SUMO1;NUP85;LMNA;BANF1;NUP43;EMD;LBR;NDC1;SEC13;UBE2I;RANGAP1;CDK1;CHMP2A;CHMP3;KPNB1;RAN;NUP37
mRNA metabolic process (GO:0016071),39/95,2.28E-05,0.001296189,0,0,2.481565632,26.52785206,TCERG1;SLBP;DDX5;SF3B2;CELF1;SRSF1;U2AF1;PRPF8;PTBP1;ZFP36;RIDA;PCBP2;DHX15;SNRPD3;METTL16;SRSF11;HNRNPA0;SF3A3;SF3A1;CPSF6;SSB;YTHDF2;SCAF11;CPSF3;NONO;NUDT16L1;LSM5;LSM3;KIN;SFPQ;SON;HNRNPA2B1;SNRPG;SNRPE;SNRPF;SRSF5;AURKAIP1;SRSF7;SRSF9
cellular protein metabolic process (GO:0044267),127/417,3.11E-05,0.001749235,0,0,1.568621012,16.2803831,RPL4;RPL5;APP;RPL3;RPL32;RPL31;RPL34;UBE2D3;RPL8;RPL9;RPL6;RPL7;UBE2L3;LOXL2;TGM1;PCMT1;RPS14;RPS17;LGALS1;RPS16;RPL35;RPL38;RPL37;SEPHS1;RPL39;RPS13;RPS9;RPL21;RPS7;IGFBP4;RPS8;RPL23;IGFBP3;RPS5;APLP2;RPL22;IGFBP2;RPS6;MRPS18B;MRPS18A;PDIA6;MRPS18C;EEF1A1;CDC34;YME1L1;RPL27;RPL26;RPL28;RPN2;MRPL18;MRPL13;GSPT1;MRPL11;HSP90B1;EIF4EBP2;RPL41;UBE2I;IGF2;MRPL28;MRPL23;MRPL24;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;AGO2;UBA3;RSL24D1;RPS21;RPS24;FARSB;MRPS17;HBS1L;MRPS16;MRPS14;RPLP1;RPLP0;MRPL36;MIA3;IDE;MRPL34;MRPL41;RPS4X;MRPL42;UBL5;RPL7A;SERP1;MRPL9;PABPC4;RPL13A;MRPS21;RABGGTB;MRPL52;MRPL51;RPL37A;MRRF;MATN3;RPL10;RPL12;MRPS33;RPL11;RPL36A;NEDD8;RRBP1;FSTL1;PARL;MRPL55;RPS15A;RPS3;GPC3;RPL15;RPS27A;RPL17;ABCF1;UBL4A;USP25;RPL35A;RPL23A;UBE2G1;LAMB1;KTN1;SPCS3;SPCS2;SPCS1;P4HB
nucleic acid metabolic process (GO:0090304),31/71,3.73E-05,0.002075205,0,0,2.759319222,28.13569044,DDX24;DDX1;HNRNPU;PTBP1;ATXN2;POLR2B;PCBP1;PCBP2;POLR2F;POLR2G;POLR2H;HNRNPA1;POLR2I;POLR2J;POLR2K;HNRNPA0;POLR2L;HNRNPA3;WDR74;LSM1;GTF2F2;HNRNPL;LSM8;HNRNPK;HNRNPH1;PDE12;HNRNPA2B1;HNRNPD;HNRNPH2;HNRNPC;RAN
ribosome assembly (GO:0042255),24/50,4.31E-05,0.002355944,0,0,3.284230506,33.01388525,RPL5;NPM1;DDX3X;RPL3;RPL10;RPS5;RPLP0;RPL11;RPS27L;RPL23A;RPF2;RPL6;MRPL22;RPS14;MRPL20;RPS28;RPS27;EIF6;C1QBP;SBDS;BRIX1;RSL24D1;MDN1;EIF2A
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),26/56,4.33E-05,0.002355944,0,0,3.084144762,30.98794807,YWHAE;GSK3A;YWHAB;UBE2D3;UBE2J2;BBC3;UBE2L3;NPEPPS;UBL5;MAPK8;PPP3R1;YWHAQ;PMAIP1;SFN;YWHAG;YWHAH;SH3GLB1;FBXW7;CSNK2A2;HUWE1;YWHAZ;TFDP1;NMT1;TOMM7;RHOU;SAE1
nucleotide-excision repair (GO:0006289),41/105,5.72E-05,0.00307733,0,0,2.282593893,22.29968981,ISY1;PCNA;COPS7A;UBB;POLR2B;UBC;EP300;POLR2F;POLR2G;POLR2H;POLR2I;RPS27A;POLR2J;POLR2K;HMGN1;POLR2L;SLC30A9;USP7;RFC4;PARP1;RFC1;RFC2;RPA1;COMMD1;GTF2H3;RAD23B;GTF2H5;RBX1;COPS4;DDB1;COPS3;CDK7;COPS6;COPS2;UVSSA;ERCC1;RPA3;PPIE;TCEA1;MNAT1;CUL4B
aerobic electron transport chain (GO:0019646),30/70,7.55E-05,0.004017879,0,0,2.66969801,25.34063591,NDUFB9;COX7B;NDUFB8;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;COX4I1;NDUFB4;NDUFB3;COX7C;NDUFA8;NDUFA7;NDUFA5;NDUFA4;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;SDHD;COX6C;COX7A2L;SDHAF2;NDUFS6;UQCRQ;NDUFAB1;CYCS;NDUFS1
positive regulation of intracellular protein transport (GO:0090316),53/148,8.38E-05,0.004413783,0,0,1.989328427,18.67437339,YWHAE;GSK3A;ITGAM;YWHAB;UBE2D3;IPO5;UBE2L3;BBC3;NPEPPS;UBL5;PCM1;TRIM28;XPO4;YWHAQ;CDH1;CHP1;EMD;YWHAG;YWHAH;SH3GLB1;FBXW7;CSNK2A2;YWHAZ;TFDP1;RHOU;KIF20B;HDAC3;SAR1A;AKAP5;UBE2J2;OAZ1;PPP3R1;MAPK8;PDCD10;TPR;UBR5;PMAIP1;FLNA;SFN;ECT2;FIS1;PLK3;PRNP;TCAF2;JUP;SEC16A;HUWE1;MYO1C;NMT1;TOMM7;ANP32B;SAE1;RAN
"regulation of mRNA splicing, via spliceosome (GO:0048024)",36/90,8.83E-05,0.00460398,0,0,2.374188622,22.16187319,KHDRBS1;DAZAP1;DDX5;CELF1;CELF4;HNRNPU;RBM3;FXR1;PTBP1;PCBP4;C1QBP;TRA2B;MAGOH;SAP18;METTL16;HNRNPA1;MBNL3;SRSF10;SRPK2;RBM39;TIA1;MBNL2;PRDX6;SRPK1;HNRNPL;SMU1;REST;HNRNPK;SON;THRAP3;NCL;SRSF3;RNPS1;SRSF6;SRSF7;SRSF9
MAPK cascade (GO:0000165),95/303,9.17E-05,0.0047046,0,0,1.632499598,15.17663025,YWHAE;PLVAP;YWHAB;NRK;PEBP1;PIK3CB;PSMD8;PPP1CB;PSMD6;ZFP36;SPRED1;PSMD7;PSMD4;MYC;PSMD2;PSMD1;GOLGA7;SPTAN1;JAK1;CHUK;NRG1;DUSP9;DUSP6;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;SOS1;HBEGF;PSMD12;PSMD11;PSMD14;SHC1;CUL3;PDGFB;CUL1;ARL2;ABHD17C;PSMA7;RASGRP4;PSMB10;ZFP36L1;PSMB6;SPTA1;PSMB7;NRAS;PAK1;PSMB4;MAPK8;PSMB5;PSMB2;UBB;PSMB3;PSMB1;UBC;MAP3K20;MAPK1;SHOC2;RPS27A;MARK3;SPTBN1;MAPK3;BRAF;MT3;IL2;NFKB1;MAPK12;PSMB9;MAPK13;SETX;FGF17;PSMC6;PSMC3;TAOK3;PSMC4;PTPRA;PSMC1;TAOK1;PSMC2;CDK1;LAMTOR2;CCM2;KRAS;CALM1;LAMTOR3;FGFR2;BCL2L1;FGFR1;PTPN3
regulation of gene silencing by RNA (GO:0060966),25/55,9.31E-05,0.0047046,0,0,2.96484613,27.51909091,TRIM71;NUP205;POM121;NUP107;SEH1L;NUP160;NUP85;POLR2B;TPR;POLR2F;NUP43;POLR2G;POLR2H;POLR2I;POLR2J;RAE1;POLR2K;POLR2L;NDC1;RANBP2;SEC13;NUP153;PUM2;AGO2;NUP37
regulation of posttranscriptional gene silencing (GO:0060147),25/55,9.31E-05,0.0047046,0,0,2.96484613,27.51909091,TRIM71;NUP205;POM121;NUP107;SEH1L;NUP160;NUP85;POLR2B;TPR;POLR2F;NUP43;POLR2G;POLR2H;POLR2I;POLR2J;RAE1;POLR2K;POLR2L;NDC1;RANBP2;SEC13;NUP153;PUM2;AGO2;NUP37
mitochondrial ATP synthesis coupled electron transport (GO:0042775),30/71,1.03E-04,0.005171047,0,0,2.604416024,23.90100469,NDUFB9;COX7B;NDUFB8;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;COX4I1;NDUFB4;NDUFB3;COX7C;NDUFA8;NDUFA7;NDUFA5;NDUFA4;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;SDHD;COX6C;COX7A2L;SDHAF2;NDUFS6;UQCRQ;NDUFAB1;CYCS;NDUFS1
cytoplasmic translational initiation (GO:0002183),19-Dec,1.33E-04,0.006499978,0,0,6.09003027,54.3741211,MCTS1;EIF4A1;EIF2B3;EIF3M;EIF5;EIF3I;EIF4H;DENR;EIF2D;EIF3D;EIF3A;EIF4B
negative regulation of RNA splicing (GO:0033119),19-Dec,1.33E-04,0.006499978,0,0,6.09003027,54.3741211,RPS26;PTBP1;PCBP4;C1QBP;SAP18;RNPS1;TMBIM6;SRSF6;SRSF10;SRSF7;RPS13;SRSF9
positive regulation of establishment of protein localization to telomere (GO:1904851),10-Aug,1.60E-04,0.007743716,0,0,14.2016845,124.1716851,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
regulation of cellular response to heat (GO:1900034),32/79,1.61E-04,0.007758122,0,0,2.423574215,21.16224492,YWHAE;CAMK2D;NUP205;POM121;HSP90AB1;NUP107;SEH1L;HIKESHI;NUP160;BAG2;NUP85;CHORDC1;TPR;EP300;MAPK1;NUP43;CAMK2G;RAE1;MAPK3;NDC1;RANBP2;HSPA8;HSP90AA1;SEC13;PTGES3;RPA1;NUP153;DNAJC2;RPA3;FKBP4;CRYAB;NUP37
mRNA splice site selection (GO:0006376),16/30,1.73E-04,0.008218976,0,0,4.061899332,35.19418712,ISY1;SF3A3;SF3A1;CELF1;SRSF1;CELF4;PSIP1;SETX;PRPF39;LUC7L;LUC7L3;SRSF5;SNRPC;SRSF6;SRSF10;SRSF9
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),20/42,2.12E-04,0.009985672,0,0,3.232346289,27.34626518,RPL5;CSNK2A1;RPS7;FBXW7;RPL23;RPL11;CSNK2A2;GLMN;PTEN;UBE3A;COMMD1;CLU;RAD23B;PML;PDCL3;XPO1;GNA12;PTK2B;UBQLN4;CDK5RAP3
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),98/321,2.14E-04,0.009998937,0,0,1.57033835,13.26839204,UBE2D3;BUB1B;CDC20;PSMD8;PSMD6;PSMD7;MAEA;PSMD4;CDC26;PSMD2;CDC27;PSMD1;SKP2;FBXW7;UBE2E1;UBE4B;KCTD5;RBX1;CDC34;KCTD10;PSME3;PSME4;PSME2;PLAA;RNF122;PSMD12;VCP;PSMD11;PSMD14;CUL3;CUL1;UBE2J2;HSP90B1;UBB;PCBP2;UBC;HSPA5;UBE2B;EDEM1;UBE2A;APPBP2;CDK1;STT3B;UBE2K;RNF187;TRIM71;GSK3A;FAF1;ARRB1;TNFAIP1;UCHL1;SEC61B;USP44;PPP2R5C;RAD23B;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;NEMF;PSMA2;SPOPL;PSMA7;PSMB10;PCNP;PSMB6;PSMB7;PSMB4;PSMB5;RMND5A;PSMB2;PSMB3;PSMB1;SPOP;UBQLN1;FEM1C;TBL1X;BUB3;RPS27A;FEM1B;FBXL19;HUWE1;WWP1;UBE2G1;PML;PSMB9;GID4;PSMC6;PSMC3;PSMC4;NEDD4;PSMC1;PSMC2;CTNNB1;MAD2L1;CUL4B
regulation of cellular response to stress (GO:0080135),43/118,2.42E-04,0.011185318,0,0,2.042319107,17.00817061,YWHAE;NUP205;POM121;CAMK2D;CEBPB;NUP107;SEH1L;HSP90AB1;ROCK2;HIKESHI;NUP160;NUAK1;BAG2;NUP85;CHORDC1;TPR;EP300;MAPK1;NUP43;SLC38A2;CAMK2G;RAE1;IER3;MCL1;MAPK3;NDC1;RANBP2;HSPA8;HSP90AA1;SEC13;NPM1;NEK6;PTGES3;RPA1;NUP153;MANF;DNAJC2;RSL1D1;RPA3;FKBP4;AJUBA;CRYAB;NUP37
positive regulation of DNA biosynthetic process (GO:2000573),26/61,2.47E-04,0.011345753,0,0,2.642703673,21.94587646,HSP90AB1;PCNA;NVL;PARN;PDGFB;TNKS2;MYC;MAPK1;CCT8;CCT7;HNRNPA1;MAP3K4;CCT5;CCT4;MAPK3;CCT3;CCT2;HSP90AA1;RFC4;RFC2;PTGES3;GRHL2;CCT6A;POLG2;TCP1;CTNNB1
mitochondrial respiratory chain complex I assembly (GO:0032981),25/58,2.62E-04,0.01180061,0,0,2.694795302,22.223089,NDUFB9;NDUFB8;DMAC1;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFB3;NDUFA8;NDUFA7;NDUFA5;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;TIMM21;NDUFS6;NDUFAF7;NDUFAF4;NDUFAB1;NDUFAF2;NDUFS1
NADH dehydrogenase complex assembly (GO:0010257),25/58,2.62E-04,0.01180061,0,0,2.694795302,22.223089,NDUFB9;NDUFB8;DMAC1;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFB3;NDUFA8;NDUFA7;NDUFA5;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;TIMM21;NDUFS6;NDUFAF7;NDUFAF4;NDUFAB1;NDUFAF2;NDUFS1
positive regulation of cellular amide metabolic process (GO:0034250),32/81,2.78E-04,0.012412688,0,0,2.324353866,19.0296076,RPL5;GSK3A;DDX3X;POLDIP3;ROCK2;EIF4A3;NAT10;RPS27L;PLA2G6;CLU;ELAVL1;THBS1;RBM3;RPS4X;FXR1;RACK1;METTL5;SOX4;NPM1;YTHDF1;IFNGR1;LARP4B;EEF2;LARP4;EIF6;RPS6KB1;SP1;HNRNPD;EIF3E;RPL26;EIF3C;EIF3D
interleukin-12-mediated signaling pathway (GO:0035722),21/46,3.09E-04,0.013660579,0,0,2.986794521,24.14013647,HSPA9;ARF1;ANXA2;RPLP0;MSN;MIF;LMNB1;CDC42;CNN2;RAP1B;CAPZA1;CFL1;BOLA2;HNRNPA2B1;TCP1;PSME2;SNRPA1;P4HB;PAK2;PPIA;JAK1
tumor necrosis factor-mediated signaling pathway (GO:0033209),42/116,3.32E-04,0.01444928,0,0,2.021446774,16.19032113,PLVAP;PSMD12;PSMD11;PSMD14;PSMA7;PSMB10;TXNDC17;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;TMSB4X;PSMB1;PSMD1;PTK2B;EIF5A;CHUK;TNFRSF12A;ACTN4;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;LIMS1
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",13/23,3.33E-04,0.01444928,0,0,4.618436645,36.98656078,PARP1;COPS7A;RAD23B;RBX1;COPS4;DDB1;COPS3;COPS6;UBB;COPS2;UBC;RPS27A;CUL4B
ribosomal subunit export from nucleus (GO:0000054),13-Sep,3.57E-04,0.015388126,0,0,7.989241803,63.40880501,NPM1;LSG1;XPO1;EIF6;NMD3;SDAD1;ABCE1;NOP9;RAN
mRNA 3'-end processing (GO:0031124),31/79,3.96E-04,0.016887377,0,0,2.298250381,18.00712609,APP;SLBP;AHCYL1;POLDIP3;EIF4A3;SRSF1;U2AF1;CDC73;FIP1L1;MAGOH;PAPOLA;LEO1;SRSF11;CPSF6;CPSF3;CPSF2;SSU72;THOC1;MAGOHB;THOC7;SRRM1;WDR33;DDX39B;SARNP;SRSF3;RNPS1;PABPC1;SRSF5;SRSF6;SRSF7;SRSF9
negative regulation of cellular amide metabolic process (GO:0034249),33/86,4.22E-04,0.017882074,0,0,2.216022185,17.21700631,TRIM71;DDX6;GRB7;DDX3X;ROCK1;EIF4A3;YBX1;CLU;MRPL13;GIGYF2;FXR1;SYNCRIP;RIDA;LARP1;ENC1;RACK1;IGF2BP1;RPS3;PAIP2;PRNP;DAPK1;RPL13A;PUS7;DHFR;ILF3;CNOT7;LIN28A;NCL;CAPRIN1;CALR;EIF4E2;GAPDH;CNOT9
positive regulation of viral genome replication (GO:0045070),15/29,4.26E-04,0.017897339,0,0,3.8071624,29.54344851,TOP2A;SRPK2;DDX3X;STAU1;SRPK1;DDB1;LARP1;CNOT7;PDE12;PPIE;PKN2;PPIH;PABPC1;PPIA;PPID
regulation of cellular amide metabolic process (GO:0034248),16/32,4.53E-04,0.018782986,0,0,3.553705815,27.36429861,APP;MTPN;SAMD8;TMED10;ROCK1;RPL10;DDX25;PGAM1;NOLC1;PUM3;RBM3;ATXN2;GEMIN5;EIF4E;METAP1;EIF2A
mitotic spindle organization (GO:0007052),53/157,4.55E-04,0.018782986,0,0,1.816120144,13.97478819,AHCTF1;NUP107;ZWILCH;BCCIP;BUB1B;KIF11;SMC3;CDC20;XPO1;STMN1;NUDC;SEC13;KIF23;KNL1;DYNLL1;RANGAP1;SMC1A;CKAP5;RHOA;KIF2A;KIFC2;SBDS;BIRC5;MAPRE1;KPNB1;DYNC1I2;VCP;SEH1L;CDCA8;PMF1;CENPA;NUP160;PTPA;NUP85;FLNA;NUP43;BUB3;BUB1;RANBP2;NEK6;RCC2;RAB11A;TPX2;CENPE;RPS27;STAG2;TAOK1;CENPK;RAN;CENPS;MAD2L1;NUP37;SPC25
positive regulation of protein localization to Cajal body (GO:1904871),11-Aug,4.71E-04,0.018833705,0,0,9.467182639,72.51854514,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
regulation of establishment of protein localization to telomere (GO:0070203),11-Aug,4.71E-04,0.018833705,0,0,9.467182639,72.51854514,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
regulation of protein localization to Cajal body (GO:1904869),11-Aug,4.71E-04,0.018833705,0,0,9.467182639,72.51854514,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
ncRNA export from nucleus (GO:0097064),18/38,4.72E-04,0.018833705,0,0,3.198973306,24.50212798,NDC1;RANBP2;NUP205;POM121;NPM1;SEC13;NUP107;SEH1L;SSB;PHAX;NUP153;NUP160;NUP85;TPR;NUP43;RAE1;RAN;NUP37
stress granule assembly (GO:0034063),21-Dec,4.95E-04,0.019597137,0,0,4.736082631,36.04918967,ATXN2L;DDX6;GRB7;YTHDF1;ATXN2;DDX3X;YTHDF2;CSDE1;G3BP1;PRRC2C;UBAP2L;EIF2S1
CRD-mediated mRNA stabilization (GO:0070934),05-May,5.15E-04,0.020081767,0,0,77995,590523.755,SYNCRIP;DHX9;IGF2BP1;HNRNPU;YBX1
ribosome localization (GO:0033750),05-May,5.15E-04,0.020081767,0,0,77995,590523.755,LSG1;XPO1;EIF6;ABCE1;RAN
cellular response to lectin (GO:1990858),41/115,5.60E-04,0.021494233,0,0,1.972864493,14.77222737,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;NRAS;PAK1;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;EP300;PSMD1;PAK2;CHUK;NFKB1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;KRAS
stimulatory C-type lectin receptor signaling pathway (GO:0002223),41/115,5.60E-04,0.021494233,0,0,1.972864493,14.77222737,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;NRAS;PAK1;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;EP300;PSMD1;PAK2;CHUK;NFKB1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;KRAS
RNA metabolic process (GO:0016070),46/133,5.79E-04,0.022046884,0,0,1.883294403,14.03919963,DDX3X;DDX24;DHX9;PARN;HNRNPU;RBM3;EXOSC7;PTBP1;SYNCRIP;ATXN2;POLR2B;PCBP1;PCBP2;PAPOLA;POLR2F;POLR2G;POLR2H;HNRNPA1;POLR2I;POLR2J;POLR2K;HNRNPA0;POLR2L;RBM39;HNRNPA3;RBPMS;PABPC4;THOC1;WDR74;LSM1;DICER1;GTF2F2;MRPL44;HNRNPL;SETX;LSM8;HNRNPK;DDX39B;HNRNPH1;AGO2;HNRNPA2B1;HNRNPD;MPHOSPH10;RBMS1;HNRNPH2;HNRNPC
negative regulation of ubiquitin protein ligase activity (GO:1904667),09-Jul,5.85E-04,0.022116325,0,0,12.42364588,92.47899529,RPL5;BAG2;RPS7;RPL23;USP44;RPL11;MAD2L1
cellular response to interleukin-12 (GO:0071349),21/48,6.27E-04,0.023504492,0,0,2.765195332,20.39416892,HSPA9;ARF1;ANXA2;RPLP0;MSN;MIF;LMNB1;CDC42;CNN2;RAP1B;CAPZA1;CFL1;BOLA2;HNRNPA2B1;TCP1;PSME2;SNRPA1;P4HB;PAK2;PPIA;JAK1
protein localization to cytoplasmic stress granule (GO:1903608),07-Jun,6.43E-04,0.023772234,0,0,21.29419795,156.4898691,TIA1;DDX3X;SSB;DHX9;DDX1;YBX1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),07-Jun,6.43E-04,0.023772234,0,0,21.29419795,156.4898691,LSG1;NPM1;XPO1;EIF6;ABCE1;RAN
regulation of canonical Wnt signaling pathway (GO:0060828),78/253,6.49E-04,0.023790732,0,0,1.590260732,11.67367657,GSK3A;DDX3X;CTNND1;USP34;LIMD1;GLI3;PSMD8;PSMD6;PSMD7;PSMD4;TMEM88;MDK;PSMD2;RUVBL2;RUVBL1;PSMD1;DACT3;EMD;SOX4;TLE4;IGFBP4;IGFBP2;RBX1;PSMA5;PSMA6;PSMA3;SFRP2;PSMA4;LATS2;PSMA1;SDHAF2;PSMA2;PSME3;PSME4;PSME2;TMEM9;PFDN5;CSNK1G2;PSMD12;VCP;PSMD11;PSMD14;CUL3;STK4;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;TNKS2;PSMB3;PSMB1;UBR5;GPC3;TBL1X;JUP;UBE2B;CSNK1A1;FZD7;NFKB1;PPP1CA;PSMB9;DAB2;PSMC6;PSMC3;PTK7;WNK1;PSMC4;PSMC1;PSMC2;CTNNB1;CDK14;LGR5;FOLR1;LGR4;FGFR2
mitochondrial gene expression (GO:0140053),19/42,6.80E-04,0.024751675,0,0,2.936360209,21.4170892,MRPS17;MRPS28;PTCD3;NDUFA7;MRPS16;GFM2;MRPS14;MRPL16;MRPS18B;MRPS18A;MRPS21;MRPL47;MRPL12;MRPL23;MRPL57;LARS2;MRPL51;TFAM;IARS2
positive regulation of protein localization to nucleus (GO:1900182),27/68,7.37E-04,0.026455971,0,0,2.342366757,16.89447609,YAP1;HDAC3;TFRC;NMD3;PARK7;IPO5;TRIM28;CDH1;TPR;UBR5;FLNA;CCT8;CCT7;ECT2;CDK5RAP3;CCT5;CCT4;CCT3;CARD10;CCT2;JUP;LIMK2;CCT6A;TCP1;CDK1;FERMT2;RAN
regulation of translational initiation (GO:0006446),27/68,7.37E-04,0.026455971,0,0,2.342366757,16.89447609,KHDRBS1;CDC123;CEBPB;DDX3X;DDX1;LARP1;TPR;EIF4H;EIF4EBP2;POLR2G;PAIP2;EIF4B;PAIP1;EIF5B;NPM1;YTHDF1;YTHDF2;IMPACT;EIF5;RPS6KB1;CSDE1;AGO2;EIF3H;EIF3E;EIF4G3;EIF4G2;EIF3B
fibroblast growth factor receptor signaling pathway (GO:0008543),29/75,7.95E-04,0.028336978,0,0,2.242715502,16.00549927,CEP57;TRIM71;TIAL1;PTBP1;SPRED2;SPRED1;POLR2B;MAPK1;POLR2F;POLR2G;SHOC2;POLR2H;HNRNPA1;POLR2I;POLR2J;POLR2K;MAPK3;POLR2L;FGFBP1;TIA1;GALNT3;GTF2F2;FGF17;SETX;RAB14;HNRNPH1;ESRP1;FGFR2;FGFR1
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",14-Sep,8.05E-04,0.028466951,0,0,6.390983607,45.53522046,PTBP1;PCBP4;C1QBP;SAP18;RNPS1;SRSF6;SRSF10;SRSF7;SRSF9
negative regulation of canonical Wnt signaling pathway (GO:0090090),54/165,9.31E-04,0.032701634,0,0,1.733310951,12.09698022,GSK3A;CTNND1;LIMD1;GLI3;PSMD8;PSMD6;PSMD7;PSMD4;TMEM88;MDK;PSMD2;RUVBL2;PSMD1;DACT3;EMD;TLE4;IGFBP4;IGFBP2;RBX1;PSMA5;PSMA6;PSMA3;SFRP2;LATS2;PSMA4;PSMA1;SDHAF2;PSMA2;PSME3;PSME4;PSME2;PFDN5;PSMD12;PSMD11;PSMD14;CUL3;STK4;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;CSNK1A1;PSMB9;DAB2;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2
ribosomal large subunit assembly (GO:0000027),13/25,9.66E-04,0.033685741,0,0,3.848203434,26.71576909,RPL5;RPL3;RPL10;RPL11;RPLP0;RPL23A;RPF2;RPL6;DHX30;MRPL20;BRIX1;RSL24D1;MDN1
ribosomal small subunit biogenesis (GO:0042274),18/40,0.001008917,0.034938175,0,0,2.907784208,20.06044675,NPM1;RPS7;RIOK3;WDR3;RPS5;RPS6;RPS27L;SNU13;DDX52;RPS14;RPS25;EMG1;RPS17;RPS28;RPS16;RPS27;NOL11;RPS24
regulation of ATP metabolic process (GO:1903578),23/56,0.001029889,0.035416728,0,0,2.478079101,17.04498277,NDC1;RANBP2;FIS1;SEC13;NUP205;POM121;NUP107;SEH1L;UQCC2;PGAM1;COX7A2;NUP153;HIF1A;NUP160;COX7A2L;EIF6;NUP85;TPR;BEND3;EP300;NUP43;RAE1;NUP37
tRNA transport (GO:0051031),17/37,0.00103887,0.035479192,0,0,3.020563412,20.75012874,NDC1;RANBP2;NUP205;POM121;SEC13;NUP107;SEH1L;SSB;NUP153;YBX1;NUP160;NUP85;TPR;NUP43;RAE1;RAN;NUP37
tRNA export from nucleus (GO:0006409),16/34,0.001054779,0.035532406,0,0,3.158444191,21.64931691,NDC1;RANBP2;NUP205;POM121;SEC13;NUP107;SEH1L;SSB;NUP153;NUP160;NUP85;TPR;NUP43;RAE1;RAN;NUP37
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),16/34,0.001054779,0.035532406,0,0,3.158444191,21.64931691,NDC1;RANBP2;NUP205;POM121;SEC13;NUP107;SEH1L;SSB;NUP153;NUP160;NUP85;TPR;NUP43;RAE1;RAN;NUP37
negative regulation of amyloid fibril formation (GO:1905907),12-Aug,0.00114034,0.03815515,0,0,7.09993171,48.11218368,VBP1;PFDN1;PFDN2;PFDN4;CLU;CRYAB;PFDN5;PFDN6
positive regulation of viral process (GO:0048524),25/63,0.001152219,0.038293891,0,0,2.339465265,15.82897501,DDX3X;STAU1;DHX9;LARP1;POLR2B;KPNA6;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L;SRPK2;GTF2F2;SRPK1;DDB1;CNOT7;PDE12;PPIE;PPIH;PKN2;PABPC1;PPIA;PPID
innate immune response activating cell surface receptor signaling pathway (GO:0002220),41/119,0.001216119,0.040148133,0,0,1.871209715,12.55972964,PSMD12;PSMD11;PSMD14;CUL1;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;NRAS;PAK1;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;EP300;PSMD1;PAK2;CHUK;NFKB1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;PSME2;KRAS
mRNA stabilization (GO:0048255),19/44,0.001357125,0.044506506,0,0,2.701104518,17.83373705,DHX9;HNRNPU;YBX1;MAPK14;ELAVL1;YBX3;SYNCRIP;ZFP36;LARP1;THRAP3;NOCT;DND1;IGF2BP1;MEIOC;HNRNPC;PABPC1;TARDBP;HNRNPA0;PAIP1
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),13/26,0.001545176,0.049686426,0,0,3.551959891,22.99047852,YWHAE;YWHAB;YWHAZ;BBC3;MAPK8;PPP3R1;TFDP1;YWHAQ;NMT1;PMAIP1;SFN;YWHAG;YWHAH
purine-containing compound biosynthetic process (GO:0072522),13/26,0.001545176,0.049686426,0,0,3.551959891,22.99047852,PRPS2;ADSL;ADK;GMPS;AMPD2;PAICS;APRT;DGUOK;PNP;MTHFD1;PPAT;GART;ADA
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),13/26,0.001545176,0.049686426,0,0,3.551959891,22.99047852,YWHAE;YWHAB;YWHAZ;BBC3;MAPK8;PPP3R1;TFDP1;YWHAQ;NMT1;PMAIP1;SFN;YWHAG;YWHAH
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",14/29,0.001582129,0.050435895,0,0,3.315492744,21.38156022,PARP1;RPA1;GTF2H3;RAD23B;GTF2H5;RBX1;DDB1;CDK7;UBB;RPA3;UBC;RPS27A;MNAT1;CUL4B
negative regulation of mRNA processing (GO:0050686),15-Sep,0.001619408,0.050435895,0,0,5.325478142,34.21989703,PTBP1;PCBP4;C1QBP;SAP18;RNPS1;SRSF6;SRSF10;SRSF7;SRSF9
negative regulation of ubiquitin-protein transferase activity (GO:0051444),15-Sep,0.001619408,0.050435895,0,0,5.325478142,34.21989703,RPL5;RPS7;BAG2;RPL23;USP44;RPL11;PARK7;SMAD7;MAD2L1
protein localization to cell-cell junction (GO:0150105),15-Sep,0.001619408,0.050435895,0,0,5.325478142,34.21989703,TJP1;LSR;F11R;PAK2;ACTB;CGNL1;ACTG1;JAK1;TJP2
regulation of amyloid fibril formation (GO:1905906),15-Sep,0.001619408,0.050435895,0,0,5.325478142,34.21989703,APP;VBP1;PFDN1;PFDN2;PFDN4;CLU;CRYAB;PFDN5;PFDN6
microtubule cytoskeleton organization involved in mitosis (GO:1902850),43/128,0.001658953,0.051344582,0,0,1.800885457,11.52849225,DYNC1I2;AHCTF1;NUP107;SEH1L;ZWILCH;BCCIP;BUB1B;CDCA8;KIF11;PMF1;CENPA;NUP160;CDC20;PTPA;XPO1;NUP85;STMN1;NUP43;BUB3;BUB1;RANBP2;NUDC;SEC13;NEK6;RCC2;KNL1;DYNLL1;RANGAP1;CKAP5;CENPE;RPS27;KIF2A;TAOK1;CENPK;SBDS;BIRC5;MAPRE1;KPNB1;RAN;CENPS;MAD2L1;NUP37;SPC25
protein sumoylation (GO:0016925),22/55,0.001973881,0.060712175,0,0,2.369795235,14.7585005,NDC1;RANBP2;NUP205;POM121;NUP107;SEH1L;UBE2I;NUP153;RANGAP1;NUP160;PIAS1;SUMO1;TRIM28;NUP85;SUMO3;SUMO2;TPR;UBA2;NUP43;SAE1;RAE1;NUP37
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),08-Jun,0.00209062,0.063905856,0,0,10.64641638,65.69152715,EGLN1;RACK1;CALM3;CALM1;CALM2;SLC39A14
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),16/36,0.002225437,0.067197356,0,0,2.842234892,17.35980728,CCT3;CCT2;PARN;CCT6A;TNKS2;HNRNPA2B1;TCP1;MAPK1;CTNNB1;CCT8;CCT7;HNRNPA1;CCT5;MAP3K4;CCT4;MAPK3
regulation of mRNA processing (GO:0050684),16/36,0.002225437,0.067197356,0,0,2.842234892,17.35980728,SRPK2;KHDRBS1;RBM39;TIA1;AHCYL1;DHX9;CDK11B;ZFP36L1;SRPK1;HNRNPK;SON;SLTM;PAPOLA;SRSF3;METTL16;SRSF10
mitochondrial respiratory chain complex assembly (GO:0033108),32/90,0.002255508,0.067692575,0,0,1.962541732,11.96047533,NDUFB9;NDUFB8;COX16;DMAC1;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;COX17;NDUFB3;COA3;NDUFA8;NDUFA7;SURF1;NDUFA5;UQCC2;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;TIMM21;SDHAF2;NDUFS6;NDUFAF7;NDUFAF4;NDUFAB1;NDUFAF2;NDUFS1;SDHAF4
regulation of RNA splicing (GO:0043484),28/76,0.00227899,0.06798528,0,0,2.074414971,12.62078858,KHDRBS1;CELF1;PTBP1;SNRNP70;TRA2B;METTL4;METTL16;MBNL3;RBM12;SLC38A2;SRSF10;RPS13;SRPK2;RBM39;TIA1;MBNL2;RRP1B;SRPK1;HNRNPL;RPS26;SETX;HNRNPK;SON;HNRNPH1;ESRP1;SRSF3;HNRNPH2;TMBIM6
positive regulation of telomere maintenance via telomerase (GO:0032212),15/33,0.002313643,0.068605763,0,0,2.960366317,17.9662611,CCT3;CCT2;PARN;CCT6A;TNKS2;TCP1;MAPK1;CTNNB1;CCT8;CCT7;HNRNPA1;CCT5;MAP3K4;CCT4;MAPK3
negative regulation of cellular protein metabolic process (GO:0032269),33/94,0.00246398,0.072628742,0,0,1.924405513,11.55793598,TRIM71;DDX6;GRB7;DDX3X;SERPINE2;EIF4A3;YBX1;MRPL13;GIGYF2;FXR1;SYNCRIP;RIDA;LARP1;ENC1;RACK1;IGF2BP1;RPS3;PAIP2;CDK5RAP3;DAPK1;RPL13A;PUS7;NFKB1;DHFR;ILF3;CNOT7;LIN28A;NCL;CAPRIN1;CALR;EIF4E2;GAPDH;CNOT9
N-terminal peptidyl-methionine acetylation (GO:0017196),06-May,0.002524,0.073889809,0,0,17.7411283,106.1258417,NAA30;NAA20;NAA25;NAA16;NAA15
posttranscriptional regulation of gene expression (GO:0010608),19/46,0.002536605,0.073889809,0,0,2.500701523,14.94651481,TRIM71;APP;MTPN;RPL10;DDX25;NOLC1;RC3H1;LARP4;PUM3;PUM2;RBM3;ATXN2;LARP1;GEMIN5;MATR3;METTL16;EIF4E;METAP1;EIF2A
regulation of carbohydrate catabolic process (GO:0043470),18/43,0.002736423,0.078783515,0,0,2.55835729,15.09713203,NDC1;RANBP2;NUP205;POM121;SEC13;NUP107;SEH1L;PGAM1;NUP153;HIF1A;NUP160;EIF6;NUP85;TPR;EP300;NUP43;RAE1;NUP37
regulation of purine nucleotide metabolic process (GO:1900542),18/43,0.002736423,0.078783515,0,0,2.55835729,15.09713203,NDC1;RANBP2;NUP205;POM121;SEC13;NUP107;SEH1L;PGAM1;NUP153;HIF1A;NUP160;EIF6;NUP85;TPR;EP300;NUP43;RAE1;NUP37
positive regulation of cellular protein metabolic process (GO:0032270),35/102,0.002876455,0.082336446,0,0,1.858390138,10.87380614,CYFIP2;RPL5;DDX3X;POLDIP3;FAF1;EIF4A3;NAT10;RPS27L;ELAVL1;THBS1;CLN6;FXR1;RBM3;RPS4X;PERP;METTL5;SOX4;HSP90AA1;NPM1;YTHDF1;RDX;MSN;LARP4B;EEF2;LARP4;EIF6;RPS6KB1;PLA2G10;HNRNPD;EIF3E;RPL26;AURKAIP1;EZR;EIF3C;EIF3D
apical junction assembly (GO:0043297),23/60,0.003029818,0.086227913,0,0,2.209610707,12.81409119,PATJ;PRKCI;PDCD6IP;WDR1;ARL2;PARD6G;F11R;RHOC;GRHL2;RHOA;CLDN6;AFDN;CLDN4;PARD6B;CLDN3;MARVELD2;CLDN7;CTNNA1;PKN2;STRN;ECT2;PAK2;CRB3
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",16/37,0.003129491,0.088190057,0,0,2.706716621,15.60932295,PCNA;RFC4;PARP1;RFC1;RFC2;RPA1;GTF2H3;GTF2H5;RBX1;DDB1;UBB;ERCC1;RPA3;UBC;RPS27A;CUL4B
transcription elongation from RNA polymerase II promoter (GO:0006368),25/67,0.00313438,0.088190057,0,0,2.116114956,12.20008807,ELOF1;WDR61;RTF1;AFF4;CDC73;POLR2B;LEO1;POLR2F;ELOB;POLR2G;ELOC;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L;SSRP1;GTF2H3;GTF2F2;GTF2H5;CDK7;TCEA1;CDK12;CDK13;MNAT1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),15/34,0.003307487,0.092534881,0,0,2.804377565,16.01738951,YWHAE;GSK3A;YWHAB;YWHAZ;BBC3;MAPK8;PPP3R1;TFDP1;YWHAQ;NMT1;PMAIP1;BAX;SFN;YWHAG;YWHAH
cellular response to fibroblast growth factor stimulus (GO:0044344),32/92,0.003349521,0.092716308,0,0,1.89687953,10.81019848,CEP57;TRIM71;ZFP36L1;TIAL1;PTBP1;SPRED2;SPRED1;ZFP36;POLR2B;MAPK1;POLR2F;POLR2G;SHOC2;POLR2H;HNRNPA1;POLR2I;POLR2J;POLR2K;MAPK3;POLR2L;FGFBP1;TIA1;GALNT3;GTF2F2;FGF17;SETX;RAB14;HNRNPH1;ESRP1;TDGF1;FGFR2;FGFR1
positive regulation of establishment of protein localization (GO:1904951),19-Oct,0.003351417,0.092716308,0,0,3.944937878,22.47972319,CCT3;CCT6A;CCT2;CEP295;TCP1;CHP1;CCT8;CCT7;CCT5;CCT4
positive regulation of protein targeting to mitochondrion (GO:1903955),14/31,0.003457789,0.095127613,0,0,2.925059333,16.57667966,SH3GLB1;GSK3A;FBXW7;PDCD5;UBE2D3;CSNK2A2;HUWE1;UBE2J2;UBE2L3;NPEPPS;UBL5;TOMM7;RHOU;SAE1
positive regulation of signal transduction by p53 class mediator (GO:1901798),22-Nov,0.003543855,0.096956742,0,0,3.550797267,20.03551612,EIF5A;SPRED2;DDX5;SPRED1;RPS7;UBB;RPL23;PMAIP1;RPL37;EEF1E1;CDK5RAP3
"RNA splicing, via transesterification reactions (GO:0000375)",25-Dec,0.003602108,0.098009006,0,0,3.277985173,18.4427183,SF3A3;SCAF11;TRA2B;LSM1;MPHOSPH10;TXNL4A;PRPF8;SF3B1;SMNDC1;SRSF10;BCAS2;SRRM1
regulation of proteasomal protein catabolic process (GO:0061136),21/54,0.003693333,0.099942005,0,0,2.261560814,12.66751295,RHBDF1;USP14;HSP90AB1;PSMD14;FBXW7;GLMN;ECSCR;COMMD1;RAD23B;UCHL5;XPO1;PSMC6;BAG2;UBB;PSMC3;LAMP3;PSME3;GNA12;PSMC2;PSME2;UBQLN4
regulation of substrate adhesion-dependent cell spreading (GO:1900024),20/51,0.004068381,0.109492525,0,0,2.292597801,12.61962764,CARMIL1;RCC2;SPRY4;TACSTD2;ACTN4;EFNA5;CORO1C;CDC42;MDK;C1QBP;PDPN;MYADM;FLNA;RAC1;CALR;P4HB;CRK;FERMT2;S100A10;LIMS1
establishment of protein localization to mitochondrion (GO:0072655),19/48,0.004472769,0.119453864,0,0,2.32794032,12.59356974,TIMM8B;FIS1;PAM16;TIMM13;TOMM34;TIMM23;TIMM21;DNAJC15;HK2;HSPD1;TOMM22;TIMM10B;GRPEL1;TIMM17A;TOMM7;TSPO;ROMO1;MGARP;TOMM5
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",14-Aug,0.004510879,0.119453864,0,0,4.73268078,25.56245478,DDX18;PES1;RPL7L1;RPL35;RPF2;WDR12;FTSJ3;RPL7
ribonucleoside monophosphate biosynthetic process (GO:0009156),14-Aug,0.004510879,0.119453864,0,0,4.73268078,25.56245478,ADSL;ATIC;IMPDH2;PPAT;ADK;GMPS;PAICS;GART
maturation of SSU-rRNA (GO:0030490),15/35,0.004625877,0.121202862,0,0,2.663987688,14.32183595,UTP6;RIOK3;RPS8;WDR3;HEATR1;NAT10;SNU13;DDX52;RPS14;RPS28;RPS16;BMS1;TSR1;NOL10;NOL11
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",15/35,0.004625877,0.121202862,0,0,2.663987688,14.32183595,DDX6;HBS1L;DIS3;LSM1;WDR61;LSM5;LSM3;EXOSC7;CNOT6;LSM7;CNOT7;EXOSC8;POLR2G;EXOSC3;EXOSC2
protein targeting to mitochondrion (GO:0006626),21/55,0.00475535,0.123939433,0,0,2.194903304,11.73940744,TIMM8B;FIS1;HSP90AA1;HSPA4;PAM16;TOMM34;TIMM13;TIMM23;TIMM21;DNAJC15;TOMM22;HSPD1;TIMM10B;GRPEL1;TIMM17A;TOMM7;PMPCB;TSPO;ROMO1;MGARP;TOMM5
"DNA-templated transcription, elongation (GO:0006354)",25/69,0.004905834,0.124892428,0,0,2.019668232,10.7392427,ELOF1;WDR61;RTF1;AFF4;CDC73;POLR2B;LEO1;POLR2F;ELOB;POLR2G;ELOC;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L;SSRP1;GTF2H3;GTF2F2;GTF2H5;CDK7;TCEA1;CDK12;CDK13;MNAT1
RNA 3'-end processing (GO:0031123),25/69,0.004905834,0.124892428,0,0,2.019668232,10.7392427,POLDIP3;EIF4A3;SRSF1;U2AF1;FIP1L1;MAGOH;PAPOLA;SRSF11;CPSF3;CPSF2;THOC1;MAGOHB;THOC7;SRRM1;WDR33;LIN28B;LIN28A;DDX39B;SARNP;SRSF3;RNPS1;SRSF5;SRSF6;SRSF7;SRSF9
7-methylguanosine mRNA capping (GO:0006370),14/32,0.004918018,0.124892428,0,0,2.762378745,14.68162796,RNMT;GTF2H3;GTF2F2;GTF2H5;CDK7;POLR2B;POLR2F;POLR2G;POLR2H;POLR2I;MNAT1;POLR2J;POLR2K;POLR2L
7-methylguanosine RNA capping (GO:0009452),14/32,0.004918018,0.124892428,0,0,2.762378745,14.68162796,RNMT;GTF2H3;GTF2F2;GTF2H5;CDK7;POLR2B;POLR2F;POLR2G;POLR2H;POLR2I;MNAT1;POLR2J;POLR2K;POLR2L
peptidyl-proline modification (GO:0018208),14/32,0.004918018,0.124892428,0,0,2.762378745,14.68162796,FKBP10;PPIL1;PPWD1;FKBP1A;NTMT1;PPIE;PPIH;PPIG;FKBP4;PPIB;PPIL3;PPIA;PPID;NKTR
negative regulation of membrane potential (GO:0045837),09-Jun,0.005101744,0.127718419,0,0,7.097155859,37.46001578,HEBP2;PRELID1;BNIP3;BAX;PMAIP1;RNF122
establishment of protein localization to endoplasmic reticulum (GO:0072599),17-Sep,0.005106673,0.127718419,0,0,3.993596311,21.07503469,RAB10;SEC61A1;SPCS3;SPCS2;SPCS1;EDEM1;SEC61G;RAB3GAP2;SRP14
maturation of 5.8S rRNA (GO:0000460),17-Sep,0.005106673,0.127718419,0,0,3.993596311,21.07503469,NSA2;EIF6;PES1;MAK16;C1D;WDR12;RRP15;FTSJ3;RPF1
establishment of endothelial barrier (GO:0061028),13/29,0.005173434,0.128737908,0,0,2.885411919,15.18943925,RDX;MSN;F11R;RAP1B;TJP1;AFDN;CLDN3;RAP2B;MARVELD2;MYADM;F2RL1;EZR;TJP2
regulation of telomere maintenance via telomerase (GO:0032210),20/52,0.00526556,0.130375265,0,0,2.220811459,11.65163784,CCT3;CCT2;STN1;PARN;HNRNPU;NAT10;CCT6A;GNL3L;TNKS2;TCP1;MAPK1;CTNNB1;CCT8;HNRNPC;CCT7;HNRNPA1;MAP3K4;CCT5;CCT4;MAPK3
protein-DNA complex disassembly (GO:0032986),20-Oct,0.005392565,0.132855635,0,0,3.550216352,18.541836,SMARCE1;SMARCD1;SMARCC1;SET;RPL23;MYC;HMGA1;ARID1A;ARID2;SMARCA4
"nucleotide-excision repair, DNA incision (GO:0033683)",16/39,0.005845634,0.143304851,0,0,2.471032671,12.70619877,PCNA;RFC4;PARP1;RFC1;RFC2;RPA1;GTF2H3;GTF2H5;RBX1;DDB1;UBB;ERCC1;RPA3;UBC;RPS27A;CUL4B
tight junction assembly (GO:0120192),21/56,0.006057741,0.147773073,0,0,2.132054795,10.88716364,PATJ;PRKCI;PDCD6IP;ARL2;PARD6G;LSR;F11R;GRHL2;ACTG1;CLDN6;AFDN;CLDN4;PARD6B;CLDN3;MARVELD2;CLDN12;CLDN7;STRN;ECT2;PAK2;CRB3
positive regulation of nucleocytoplasmic transport (GO:0046824),18/46,0.00642866,0.155291334,0,0,2.283807568,11.52635211,YWHAE;KHDRBS1;HDAC3;CPSF6;JUP;DHX9;IPO5;TRIM28;XPO4;CDH1;NEDD4;TPR;UBR5;FLNA;ANP32B;ECT2;EMD;RAN
postreplication repair (GO:0006301),18/46,0.00642866,0.155291334,0,0,2.283807568,11.52635211,VCP;PCNA;RFC4;RFC1;UBE2B;RFC2;RPA1;UBE2A;WDR33;UBB;UBE2NL;RPA3;UBC;PCLAF;UBE2N;UBE2V1;RPS27A;RAD18
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),14/33,0.006837034,0.161273845,0,0,2.61682243,13.04590981,DDX6;HBS1L;DIS3;LSM1;WDR61;LSM5;LSM3;EXOSC7;CNOT6;LSM7;CNOT7;EXOSC8;EXOSC3;EXOSC2
dosage compensation by inactivation of X chromosome (GO:0009048),12-Jul,0.006839157,0.161273845,0,0,4.968502503,24.76843584,SMCHD1;PCGF5;PCGF3;RLIM;HNRNPU;CDYL;LRIF1
peptidyl-methionine modification (GO:0018206),12-Jul,0.006839157,0.161273845,0,0,4.968502503,24.76843584,NAA30;NAA20;NAA25;NAA16;NAA15;METAP1;METAP2
purine nucleoside monophosphate biosynthetic process (GO:0009127),12-Jul,0.006839157,0.161273845,0,0,4.968502503,24.76843584,ADSL;ATIC;IMPDH2;PPAT;GMPS;GART;PAICS
purine nucleotide biosynthetic process (GO:0006164),12-Jul,0.006839157,0.161273845,0,0,4.968502503,24.76843584,PRPS2;ADSL;MTHFD1;PPAT;AMPD2;GART;ADA
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),07-May,0.007225842,0.166429624,0,0,8.86999545,43.72988936,VMP1;AHCYL1;ATP2A2;CALM1;PDZD8
positive regulation of cytoplasmic translation (GO:2000767),07-May,0.007225842,0.166429624,0,0,8.86999545,43.72988936,LIN28A;PKM;DHX9;CNBP;YBX3
"posttranslational protein targeting to membrane, translocation (GO:0031204)",07-May,0.007225842,0.166429624,0,0,8.86999545,43.72988936,SEC61A1;HSPA5;SEC61G;SEC61B;SEC62
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),07-May,0.007225842,0.166429624,0,0,8.86999545,43.72988936,FBXW7;NONO;PARK7;HIF1A;MCL1
ribosomal large subunit export from nucleus (GO:0000055),07-May,0.007225842,0.166429624,0,0,8.86999545,43.72988936,NPM1;XPO1;NMD3;SDAD1;RAN
regulation of generation of precursor metabolites and energy (GO:0043467),19/50,0.007488082,0.171671208,0,0,2.177470885,10.65750631,NDC1;RANBP2;SEC13;NUP205;POM121;NUP107;SEH1L;PGAM1;NUP153;HIF1A;NUP160;KHK;EIF6;NUP85;TPR;EP300;NUP43;RAE1;NUP37
positive regulation of gene silencing by miRNA (GO:2000637),27-Dec,0.007749706,0.175235354,0,0,2.840555935,13.80538708,FXR1;DDX6;DDX5;ZFP36;LIN28A;MYCN;DHX9;AGO2;LIMD1;EIF4E2;AJUBA;PUM2
protein peptidyl-prolyl isomerization (GO:0000413),27-Dec,0.007749706,0.175235354,0,0,2.840555935,13.80538708,FKBP1A;PPIL1;PPWD1;PPIE;PPIH;PPIG;FKBP4;PPIB;PPIL3;PPIA;PPID;NKTR
stress-activated protein kinase signaling cascade (GO:0031098),27-Dec,0.007749706,0.175235354,0,0,2.840555935,13.80538708,MAPK8;UBB;CHUK;UBC;CUL1;MAP3K20;MAPK1;CCM2;RPS27A;NFKB1;MAPK3;MAPK13
nucleocytoplasmic transport (GO:0006913),16/40,0.007785285,0.175239693,0,0,2.367920943,11.49748711,NUP205;NPM1;PHAX;NUTF2;LSG1;XPO1;SNRPD2;NEMF;SNRPD1;SNRPG;GEMIN5;GEMIN6;SNRPE;SNRPD3;SNRPF;HNRNPA1
"alternative mRNA splicing, via spliceosome (GO:0000380)",18-Sep,0.008238801,0.182918425,0,0,3.549635701,17.03434835,RBM17;DDX5;SFPQ;DHX9;SRSF1;CELF4;CDK13;SRSF6;SRSF9
regulation of early endosome to late endosome transport (GO:2000641),18-Sep,0.008238801,0.182918425,0,0,3.549635701,17.03434835,MTMR2;DAB2;RDX;MSN;CHMP3;MAPK1;DNAJC13;EZR;MAPK3
RNA destabilization (GO:0050779),18-Sep,0.008238801,0.182918425,0,0,3.549635701,17.03434835,YTHDF1;LIN28B;RIDA;YTHDF2;ROCK1;CELF1;ROCK2;METTL16;GIGYF2
regulation of ubiquitin protein ligase activity (GO:1904666),21-Oct,0.008288143,0.182918425,0,0,3.227262376,15.46804033,CDC20;RPL5;RPS7;BAG2;RPL23;USP44;RPL11;PTEN;CDC14B;MAD2L1
protein modification by small protein removal (GO:0070646),78/276,0.008311116,0.182918425,0,0,1.403437568,6.72269247,OTUD4;USP31;USP34;PTEN;MYSM1;ACTB;CDC20;PSMD8;PSMD6;UCHL1;PSMD7;PSMD4;MYC;PSMD2;RUVBL1;PSMD1;EP300;SKP2;USP7;DDX58;USP44;UCHL3;RAD23B;SENP3;RHOA;UCHL5;SENP1;PSMA5;CCNA2;PSMA6;PSMA3;PSMA4;RNF128;PSMA1;PSMA2;PSME3;PSME4;PSME2;USP14;PSMD12;VCP;USP15;PSMD11;PSMD14;USP11;COPS7A;NEDD8;BRCC3;HIF1A;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;UBB;PSMB3;PSMB1;UBC;USP1;RPS27A;USP25;ZRANB1;USP9X;USP22;PSMB9;SMAD7;COPS4;COPS3;COPS6;PSMC6;PSMC3;PSMC4;PSMC1;COPS2;PSMC2;CDK1
positive regulation of telomerase activity (GO:0051973),14/34,0.009307722,0.203946186,0,0,2.485821746,11.62596689,CCT2;HSP90AA1;HSP90AB1;NVL;PTGES3;PARN;GRHL2;MYC;TCP1;MAPK1;CTNNB1;MAP3K4;CCT4;MAPK3
DNA duplex unwinding (GO:0032508),19/51,0.009518532,0.20599333,0,0,2.109289423,9.817718535,MCM7;PARP1;DHX9;DDX1;HMGA1;RPA1;GTF2H3;RAD23B;GTF2H5;RBX1;DDB1;PURA;UBB;UBC;MCM4;SSBP1;RPS27A;MCM2;CUL4B
cellular response to interleukin-1 (GO:0071347),47/155,0.009645229,0.20599333,0,0,1.548335715,7.186277992,PSMD12;PSMD11;PSMD14;CUL1;HIF1A;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;GBP2;RPS27A;MAPK3;CHUK;RC3H1;NFKB1;RBX1;MAPK13;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;UBE2N;PSME2;UBE2V1
cellular response to indole-3-methanol (GO:0071681),05-Apr,0.009650738,0.20599333,0,0,14.18967478,65.85032078,JUP;CDH1;CTNNA1;CTNNB1
mature ribosome assembly (GO:0042256),05-Apr,0.009650738,0.20599333,0,0,14.18967478,65.85032078,DDX3X;EIF6;C1QBP;SBDS
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),05-Apr,0.009650738,0.20599333,0,0,14.18967478,65.85032078,EIF5A;RPS7;UBB;RPL26
response to indole-3-methanol (GO:0071680),05-Apr,0.009650738,0.20599333,0,0,14.18967478,65.85032078,JUP;CDH1;CTNNA1;CTNNB1
protein methylation (GO:0006479),16/41,0.010206937,0.216003206,0,0,2.273058153,10.42126182,PRMT2;EHMT1;GSPT1;PCMT1;TRMT112;NSD1;NTMT1;CARM1;ETFBKMT;ETF1;FAM98B;SNRPD3;RAB6A;EEF1AKMT2;EEF1AKMT1;EZH2
regulation of protein dephosphorylation (GO:0035304),16/41,0.010206937,0.216003206,0,0,2.273058153,10.42126182,ANKLE2;YWHAB;PPP2R5A;ARPP19;HSP90B1;PTPA;PPP1R2;PTBP1;PPP1R7;ENSA;TIPRL;CAMTA1;CALM3;CALM1;CALM2;PPIA
formation of translation preinitiation complex (GO:0001731),10-Jun,0.010387306,0.216543681,0,0,5.322525597,24.30888369,MCTS1;EIF5;EIF4H;DENR;EIF2D;EIF4B
nuclear pore complex assembly (GO:0051292),10-Jun,0.010387306,0.216543681,0,0,5.322525597,24.30888369,NDC1;AHCTF1;NUP205;NUP107;TPR;NUP153
regulation of protein neddylation (GO:2000434),10-Jun,0.010387306,0.216543681,0,0,5.322525597,24.30888369,RPL5;DCUN1D5;RPL11;DCUN1D1;HIF1A;COPS9
regulation of organelle organization (GO:0033043),27/80,0.01040739,0.216543681,0,0,1.810621943,8.265922146,USP6NL;CLIC4;SAR1A;NEXN;F11R;PARL;PDCD10;CAPN2;EP300;MAPK1;DNM1L;PAK2;MAPK3;FIS1;TMED9;RDX;SURF4;MSN;MYO5A;TJP1;GOLPH3;SYT11;TAOK1;AKAP9;PLXNB1;EZR;ARHGEF5
peptidyl-lysine modification (GO:0018205),34/106,0.010478082,0.21710236,0,0,1.679000331,7.65367196,NUP205;POM121;NUP107;SEH1L;PARK7;NUP160;LOXL2;TRIM28;SUMO1;BLOC1S1;NUP85;SUMO3;TPR;SUMO2;NNAT;EP300;NUP43;RAE1;NDC1;RANBP2;UBE2I;ESCO1;NUP153;RANGAP1;SENP3;PIAS1;SENP1;NDUFAB1;UBA2;ETFBKMT;SAE1;EEF1AKMT2;EEF1AKMT1;NUP37
pyruvate metabolic process (GO:0006090),20/55,0.010684644,0.219693662,0,0,2.030064891,9.21435839,TPI1;PDHA1;SLC16A1;PGAM1;GLO1;ENO1;PDHB;ENO3;HK2;LDHA;PFKL;PKM;BSG;PGK1;VDAC1;ME2;ALDOA;SLC16A3;DLD;GAPDH
negative regulation of Wnt signaling pathway (GO:0030178),56/191,0.010691877,0.219693662,0,0,1.476339769,6.700030002,GSK3A;CTNND1;LIMD1;GLI3;PSMD8;PSMD6;PSMD7;PSMD4;TMEM88;MDK;PSMD2;RUVBL2;RACK1;PSMD1;DACT3;EMD;TLE4;IGFBP4;IGFBP2;RBX1;PSMA5;PSMA6;PSMA3;SFRP2;LATS2;PSMA4;PSMA1;SDHAF2;PSMA2;PSME3;PSME4;PSME2;PFDN5;PSMD12;PSMD11;PSMD14;CUL3;STK4;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;HMGXB4;PSMB5;PSMB2;PSMB3;PSMB1;CSNK1A1;PSMB9;DAB2;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2
mRNA destabilization (GO:0061157),15/38,0.011277943,0.229828705,0,0,2.31606495,10.38733447,TRIM71;YTHDF1;YTHDF2;ROCK1;CELF1;ROCK2;RC3H1;GIGYF2;ZFP36L1;RIDA;ZFP36;PDE12;DND1;METTL16;TARDBP
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),15/38,0.011277943,0.229828705,0,0,2.31606495,10.38733447,RPL5;USP7;HSP90AB1;CSNK2A1;RPS7;RPL23;RPL11;TAF9;CSNK2A2;PARK7;PML;UCHL5;PDCL3;TLK2;EIF3H
import into nucleus (GO:0051170),26/77,0.011705622,0.237566553,0,0,1.811755742,8.058120759,IPO13;POM121;NUP107;CSE1L;HIKESHI;PHB2;IPO5;IPO9;SNRPD2;SNRPD1;NUP85;TPR;SNRPD3;TNPO1;HNRNPA1;SEC13;NUTF2;NUP153;SNRPG;GEMIN5;GEMIN6;SNRPE;SNRPF;NUP62CL;KPNB1;RAN
protein neddylation (GO:0045116),13-Jul,0.012026218,0.243076862,0,0,4.140153239,18.30223543,UBE2F;DCUN1D5;DCUN1D1;UBA3;NEDD8;NAE1;RBX1
chaperone-mediated protein complex assembly (GO:0051131),22-Oct,0.012241725,0.244439604,0,0,2.958134062,13.02438351,CCT2;HSP90AA1;MKKS;HSP90AB1;HSPA4;PTGES3;PSMG2;CLU;PFDN6;HSPD1
error-free translesion synthesis (GO:0070987),22-Oct,0.012241725,0.244439604,0,0,2.958134062,13.02438351,VCP;PCNA;RFC4;RFC1;UBB;RFC2;RPA3;UBC;RPA1;RPS27A
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",22-Oct,0.012241725,0.244439604,0,0,2.958134062,13.02438351,DDB1;PARP1;UBB;UBC;GTF2H3;RPS27A;RAD23B;GTF2H5;RBX1;CUL4B
"DNA-templated transcription, termination (GO:0006353)",24/70,0.012332135,0.245255963,0,0,1.853920195,8.148992953,SLBP;CAVIN1;CPSF3;CPSF2;SSU72;GTF2H3;GTF2H5;WDR33;SETX;TAF1D;CDK7;FIP1L1;POLR1C;PAPOLA;SNRPG;POLR2F;SNRPE;SNRPD3;SNRPF;POLR2H;MNAT1;POLR3K;POLR2K;POLR2L
N-terminal protein amino acid acetylation (GO:0006474),16-Aug,0.012649484,0.248572399,0,0,3.549055315,15.50986454,NAA50;NAA30;NAA10;NAA20;NAA25;EP300;NAA16;NAA15
positive regulation by host of viral transcription (GO:0043923),16-Aug,0.012649484,0.248572399,0,0,3.549055315,15.50986454,JUN;SP1;HPN;EP300;NUCKS1;RRP1B;CHD1;SMARCA4
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),16-Aug,0.012649484,0.248572399,0,0,3.549055315,15.50986454,ADSL;ATIC;IMPDH2;PPAT;GMPS;AMPD2;PAICS;GART
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",20/56,0.013255149,0.259444652,0,0,1.973547389,8.532374019,PLK3;PCNA;GADD45A;CDC25C;PML;CNOT6;TFDP1;CNOT7;PCBP4;CARM1;CDK1;EP300;BAX;SFN;RPL26;E2F4;CNOT9;SOX4;E2F7;E2F8
transcription initiation from RNA polymerase I promoter (GO:0006361),13/32,0.013650697,0.266134852,0,0,2.42935278,10.43155504,RRN3;CAVIN1;GTF2H3;GTF2H5;TAF1D;CDK7;POLR1C;POLR2F;POLR2H;MNAT1;POLR2K;MAPK3;POLR2L
T cell receptor signaling pathway (GO:0050852),47/158,0.01389329,0.269802245,0,0,1.506197056,6.441024701,KHDRBS1;PSMD12;PSMD11;PSMD14;CUL1;PIK3CB;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PAK1;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;EIF2B1;PAK2;CD276;EIF2B3;CHUK;RC3H1;NFKB1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;WNK1;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;UBE2N;PSME2;BCAR1
regulation of protein targeting to mitochondrion (GO:1903214),15/39,0.014673141,0.283833578,0,0,2.219419745,9.369805512,SH3GLB1;GSK3A;FBXW7;UBE2D3;CSNK2A2;HUWE1;UBE2J2;PARL;UBE2L3;NPEPPS;UBL5;HAX1;TOMM7;RHOU;SAE1
negative regulation of mitochondrial membrane potential (GO:0010917),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,HEBP2;PRELID1;BAX;PMAIP1;RNF122
negative regulation of sodium ion transport (GO:0010766),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,CAMK2D;WNK1;NEDD4;WNK3;COMMD1
positive regulation of early endosome to late endosome transport (GO:2000643),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,DAB2;MTMR2;RDX;MSN;EZR
progesterone receptor signaling pathway (GO:0050847),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,YAP1;NEDD4;UBR5;UBE3A;PHB
protein localization to microtubule (GO:0035372),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,CRIPT;HNRNPU;KIF20B;MAPRE1;MID1
ribosome disassembly (GO:0032790),08-May,0.015784571,0.298340442,0,0,5.912951168,24.53119255,MCTS1;GFM2;DENR;EIF2D;MRRF
global genome nucleotide-excision repair (GO:0070911),26-Nov,0.016214462,0.301857194,0,0,2.60324981,10.73020978,DDB1;UBB;PARP1;ERCC1;UBC;RPS27A;GTF2H3;RAD23B;GTF2H5;RBX1;CUL4B
hippo signaling (GO:0035329),26-Nov,0.016214462,0.301857194,0,0,2.60324981,10.73020978,YAP1;YWHAE;TJP1;LATS2;YWHAB;WWC1;AMOTL2;STK4;TEAD1;AMOT;TJP2
mRNA polyadenylation (GO:0006378),26-Nov,0.016214462,0.301857194,0,0,2.60324981,10.73020978,APP;AHCYL1;FIP1L1;CPSF3;CPSF2;LEO1;PAPOLA;SSU72;PABPC1;CDC73;WDR33
RNA polyadenylation (GO:0043631),26-Nov,0.016214462,0.301857194,0,0,2.60324981,10.73020978,APP;AHCYL1;FIP1L1;CPSF3;CPSF2;LEO1;PAPOLA;SSU72;PABPC1;CDC73;WDR33
substantia nigra development (GO:0021762),16/43,0.01680352,0.311651809,0,0,2.104413193,8.598983464,YWHAE;HSPA5;SEC16A;DYNLL1;ACTB;RHOA;CDC42;GLUD1;YWHAQ;BASP1;CALM3;RAD1;CALM1;CALM2;INA;YWHAH
RNA stabilization (GO:0043489),13/33,0.018079584,0.334067542,0,0,2.30773701,9.260883814,NSUN2;PARN;HNRNPU;PHAX;YBX1;ELAVL1;LARP1;THRAP3;NOCT;DND1;MEIOC;PABPC1;PAIP1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",19/54,0.018342732,0.337669919,0,0,1.928121536,7.709636121,KHDRBS1;DDX5;MBNL2;CELF1;CELF4;HNRNPU;FXR1;HNRNPL;SMU1;PTBP1;REST;THRAP3;TRA2B;MAGOH;SAP18;RNPS1;SRSF6;HNRNPA1;MBNL3
purine ribonucleoside monophosphate metabolic process (GO:0009167),20-Sep,0.018565103,0.339253511,0,0,2.903874814,11.57621459,ADSL;ATIC;IMPDH2;PPAT;GMPS;AK3;AMPD2;PAICS;GART
positive regulation of posttranscriptional gene silencing (GO:0060148),11-Jun,0.01863428,0.339253511,0,0,4.25774744,16.95755375,FXR1;ZFP36;DHX9;LIMD1;AJUBA;PUM2
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),11-Jun,0.01863428,0.339253511,0,0,4.25774744,16.95755375,TCERG1;LEO1;CDK12;CDK13;EAPP;CDC73
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),15/40,0.01880586,0.341123149,0,0,2.130506156,8.465751024,EIF5A;FIS1;RPS7;BBC3;BCLAF1;SFPQ;BCL2L11;UBB;RACK1;RPS3;PMAIP1;BAX;DNM1L;BCL2L1;GSDME
protein polyubiquitination (GO:0000209),85/314,0.018917024,0.341887236,0,0,1.321830823,5.244618935,TRIM71;RNF14;UBE2D3;UBE3A;UBE3B;UBE2L3;PSMD8;NPEPPS;PSMD6;TRIM6;PSMD7;PSMD4;UBE2Q1;CDC26;PSMD2;CDC27;PSMD1;SKP2;FBXW8;FBXW7;UBE2E1;RC3H1;UBE2E2;UBE4B;RBX1;PSMA5;PSMA6;PSMA3;CDC34;PSMA4;PSMA1;UBE2R2;PSMA2;PSME3;PSME4;PSME2;UBE2V1;ANAPC13;PSMD12;PSMD11;PSMD14;CUL3;CUL1;UBE2J2;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;HECTD1;RMND5A;PSMB2;UBB;TNKS2;PSMB3;UBE2NL;PSMB1;UBC;UBR5;SPOP;RBBP6;RPS27A;UBE2B;FBXL19;HUWE1;WWP1;UBE2G1;UBE2A;PSMB9;PSMC6;PSMC3;PSMC4;NEDD4;PSMC1;PSMC2;MKRN1;RLIM;UBE2N;CTNNB1;TPP2;TRIP12;BLMH;UBE2K;RNF187
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),17-Aug,0.019354216,0.348093033,0,0,3.154513494,12.44406671,SPRED2;SPRED1;DDIT4;SPRY2;CALM3;CALM1;CALM2;SMAD7
N-terminal protein amino acid modification (GO:0031365),14-Jul,0.019541572,0.348093033,0,0,3.548475193,13.96399933,NAA50;NAA10;NTMT1;NAA16;NAA15;METAP1;METAP2
nuclear pore organization (GO:0006999),14-Jul,0.019541572,0.348093033,0,0,3.548475193,13.96399933,NDC1;AHCTF1;NUP205;NUP107;SEH1L;TPR;NUP153
regulation of chromatin organization (GO:1902275),14-Jul,0.019541572,0.348093033,0,0,3.548475193,13.96399933,IGF2;METTL4;TLK2;HNRNPU;TLK1;SSRP1;MKI67
positive regulation of protein import (GO:1904591),30-Dec,0.019995962,0.354910411,0,0,2.366674261,9.25896202,HDAC3;TRIM28;JUP;CDH1;PDCD5;TPR;UBR5;FLNA;ECT2;ARHGEF5;RAN;IPO5
nucleobase-containing small molecule interconversion (GO:0015949),27-Nov,0.022033989,0.389686837,0,0,2.440390091,9.310500759,DUT;RRM1;RRM2;GUK1;TXNRD1;AK2;NME2;CTPS2;NME4;AK6;NME1
transcription by RNA polymerase I (GO:0006360),13/34,0.023509791,0.406783053,0,0,2.197703694,8.242132309,RRN3;CAVIN1;GTF2H3;GTF2H5;TAF1D;CDK7;POLR1C;POLR2F;POLR2H;MNAT1;POLR2K;MAPK3;POLR2L
L-serine biosynthetic process (GO:0006564),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,PSAT1;PHGDH;SERINC3;PSPH
membrane raft assembly (GO:0001765),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,ANXA2;FLOT1;FLOT2;S100A10
mRNA 5'-splice site recognition (GO:0000395),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,PRPF39;SRSF1;PSIP1;SNRPC
negative regulation of lens fiber cell differentiation (GO:1902747),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,SPRED2;SPRED1;SPRY2;SPRY1
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,EXOSC7;EXOSC8;EXOSC3;EXOSC2
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,EXOSC7;EXOSC8;EXOSC3;EXOSC2
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,EXOSC7;EXOSC8;EXOSC3;EXOSC2
regulation of hepatocyte proliferation (GO:2000345),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,XBP1;FBXW7;MDK;HPN
snRNA modification (GO:0040031),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,METTL4;NHP2;METTL16;NOP10
tRNA surveillance (GO:0106354),06-Apr,0.023904255,0.406783053,0,0,7.094382534,26.48828771,EXOSC7;EXOSC8;EXOSC3;EXOSC2
canonical glycolysis (GO:0061621),24-Oct,0.024152771,0.406818102,0,0,2.535218141,9.439520095,PFKL;TPI1;PKM;PGAM1;PGK1;ENO1;ALDOA;ENO3;GAPDH;HK2
glucose catabolic process to pyruvate (GO:0061718),24-Oct,0.024152771,0.406818102,0,0,2.535218141,9.439520095,PFKL;TPI1;PKM;PGAM1;PGK1;ENO1;ALDOA;ENO3;GAPDH;HK2
protein insertion into mitochondrial membrane (GO:0051204),24-Oct,0.024152771,0.406818102,0,0,2.535218141,9.439520095,TIMM8B;TIMM10B;HSP90AA1;BCL2L11;HSPA4;TIMM13;BAX;PMAIP1;ROMO1;TOMM22
regulation of stress fiber assembly (GO:0051492),24/74,0.0247842,0.416038499,0,0,1.705167923,6.304941838,CARMIL1;ROCK1;ROCK2;TPM1;TACSTD2;F11R;RHOC;SORBS3;RHOA;ACTG1;CDC42;TJP1;PAK1;STMN1;RAC1;RHPN2;EPHA1;PFN1;PAK2;WASF2;CGNL1;ARHGEF5;FERMT2;S100A10
negative regulation of protein metabolic process (GO:0051248),18/52,0.025267585,0.422719868,0,0,1.880057978,6.915291164,PRNP;HSP90AB1;ROCK1;VBP1;HMGCR;PHB;CLU;AZIN1;NFKB1;FLOT2;PFDN1;FLNA;PFDN2;PFDN4;CRYAB;PFDN5;PFDN6;MAD2L1
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),31-Dec,0.026244129,0.430094209,0,0,2.241968558,8.161467213,FKBP1A;BCL9;TWSG1;LATS2;ITGA3;LTBP4;SOX11;NREP;FSTL1;FOLR1;TRIM33;SMAD7
error-prone translesion synthesis (GO:0042276),21-Sep,0.026272834,0.430094209,0,0,2.661714481,9.686564092,PCNA;RFC4;RFC1;UBB;RFC2;RPA3;UBC;RPA1;RPS27A
histone ubiquitination (GO:0016574),21-Sep,0.026272834,0.430094209,0,0,2.661714481,9.686564092,PHC1;UBE2B;USP22;HUWE1;UBE2E1;LEO1;UBE2N;UBE2A;CDC73
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",21-Sep,0.026272834,0.430094209,0,0,2.661714481,9.686564092,DDB1;PARP1;ERCC1;RPA3;RPA1;GTF2H3;GTF2H5;RBX1;CUL4B
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",21-Sep,0.026272834,0.430094209,0,0,2.661714481,9.686564092,DDB1;PARP1;ERCC1;RPA3;RPA1;GTF2H3;GTF2H5;RBX1;CUL4B
regulation of cell-substrate junction assembly (GO:0090109),21-Sep,0.026272834,0.430094209,0,0,2.661714481,9.686564092,DUSP3;SLK;ROCK1;ROCK2;PTPRA;EFNA5;RHOA;ACTG1;CORO1C
positive regulation of protein localization to membrane (GO:1905477),31/101,0.026316346,0.430094209,0,0,1.573713632,5.724485647,ITGB1;YWHAE;ITGAM;RAMP3;YWHAB;PDCD5;AKAP5;BBC3;PPP3R1;MAPK8;YWHAQ;KIF5B;CHP1;PMAIP1;SFN;SPTBN1;YWHAG;YWHAH;FIS1;PRNP;TCAF2;PRKCI;ITGA3;ARHGEF16;YWHAZ;CLIP3;TFDP1;MYO1C;WNK3;NMT1;ARF6
cellular protein-containing complex assembly (GO:0034622),48/168,0.02698849,0.436688271,0,0,1.422375373,5.138110265,SRP19;NUP205;AHCTF1;NUP107;PSMD11;HSP90AB1;DHX9;CLTC;POMP;ARL2;COX7A2;HIGD1A;PIK3C2A;CLU;CENPA;HSPD1;PSMD4;POGZ;TPR;EIF4H;RPL38;EPS15;AP2M1;EIF4B;NDC1;CCT2;HSP90AA1;MKKS;CENPW;GPX4;HSPA4;VBP1;MID1IP1;PTGES3;NUP153;NRG1;TBCA;FKBP1A;ANLN;CENPE;COX7A2L;TCP1;CHMP2A;CHMP3;PSMG2;PFDN6;CCDC40;VAMP3
negative regulation of programmed cell death (GO:0043069),100/381,0.027003535,0.436688271,0,0,1.267436771,4.57771228,ANKLE2;TFRC;ZFAND6;PARK7;PHB2;IGF1R;HMGN5;MYC;ARHGDIA;RPS6KA1;CFL1;PIM3;MED1;BNIP3L;PRKCI;MIF;YME1L1;VDAC1;PHIP;SHC1;GLO1;HPN;HIGD1A;FOXO1;MTDH;HSP90B1;PRDX2;PRDX5;UBB;PDCD10;UBC;MCL1;HSPA9;PLK3;PRELID1;XBP1;HSPA5;API5;BRAF;DHCR24;PA2G4;MT3;IL2;NFKB1;SETX;AHI1;DAB2;GCLC;HNRNPK;SON;WNK3;CDK1;TDGF1;BCL2L1;ARF4;TNFAIP8;DDX3X;SIX4;MYO18A;GPX4;NME2;PLAUR;YWHAZ;HAX1;TAX1BP1;BIRC5;BIRC6;TMBIM6;CRYAB;PTMA;HDAC3;RPL10;TAF9;LRP2;FSTL1;THBS1;HSPD1;MAPK8;MIEN1;PDPN;BNIP1;FLNA;PTK2B;RPS27A;PAK2;NPM1;BNIP3;CFLAR;HYPK;TJP1;GOLPH3;UFM1;KRT18;RPS6KB1;CTNNB1;SPRY2;NAA16;NAA15;TPT1;MAD2L1
mitochondrial transport (GO:0006839),19/56,0.027072556,0.436688271,0,0,1.823664376,6.582032827,TIMM8B;FIS1;HSP90AA1;BNIP3;TOMM34;TIMM13;TIMM23;TOMM22;TIMM10B;TIMM17A;TOMM7;TSPO;PMAIP1;MGARP;SLC25A5;SLC25A4;TOMM5;SLC25A24;BCL2L1
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",19/56,0.027072556,0.436688271,0,0,1.823664376,6.582032827,HBS1L;DDX6;DIS3;PARN;LSM1;RC3H1;WDR61;LSM5;LSM3;EXOSC7;ZFP36;CNOT6;LSM7;CNOT7;PDE12;EXOSC8;EXOSC3;EXOSC2;CNOT9
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),23/71,0.027952568,0.448323633,0,0,1.70203765,6.088607728,CYFIP2;ACTR3;NCKAP1;ACTR2;HSP90AA1;HSP90AB1;WIPF3;ARPC4;PIK3CB;WASL;ARPC5;PLA2G6;ACTB;ACTG1;CDC42;PAK1;MYO1C;ARPC2;MAPK1;RAC1;CRK;WASF2;MAPK3
chromatin disassembly (GO:0031498),18-Aug,0.028246562,0.448323633,0,0,2.838880036,10.12567058,SMARCE1;SMARCD1;SMARCC1;SET;HMGA1;ARID1A;ARID2;SMARCA4
nucleosome disassembly (GO:0006337),18-Aug,0.028246562,0.448323633,0,0,2.838880036,10.12567058,SMARCE1;SMARCD1;SMARCC1;SET;HMGA1;ARID1A;ARID2;SMARCA4
nucleotide biosynthetic process (GO:0009165),18-Aug,0.028246562,0.448323633,0,0,2.838880036,10.12567058,PRPS2;ADSL;RRM1;RRM2;PNP;MTHFD1;PPAT;GART
release of cytochrome c from mitochondria (GO:0001836),18-Aug,0.028246562,0.448323633,0,0,2.838880036,10.12567058,GGCT;FIS1;BAX;SFN;DNM1L;CLU;BBC3;BCL2L1
positive regulation of macromolecule biosynthetic process (GO:0010557),38/129,0.028913188,0.457438043,0,0,1.48426957,5.259446066,RPL5;MTPN;DDX3X;PCNA;DHX9;POLDIP3;FAF1;EIF4A3;PDGFB;NAT10;RPS27L;NMD3;ELAVL1;THBS1;FXR1;RBM3;RPS4X;MYC;NAMPT;METTL5;SOX4;TGFB2;XBP1;NPM1;STN1;YTHDF1;IGF2;LARP4B;EEF2;LARP4;NFKB1;EIF6;RPS6KB1;HNRNPD;EIF3E;RPL26;EIF3C;EIF3D
L-ascorbic acid metabolic process (GO:0019852),09-May,0.029138132,0.458069939,0,0,4.434429026,15.6788443,CYB5A;CYB5R3;SLC23A1;SLC2A1;SLC2A3
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),09-May,0.029138132,0.458069939,0,0,4.434429026,15.6788443,CDK7;CDK12;CDK13;GTF2H3;GTF2H5
contractile actin filament bundle assembly (GO:0030038),15-Jul,0.029801964,0.465549929,0,0,3.104716659,10.90743149,ITGB1;PDCD10;CUL3;ZYX;ARRB1;TNFAIP1;RHOA
stress fiber assembly (GO:0043149),15-Jul,0.029801964,0.465549929,0,0,3.104716659,10.90743149,ITGB1;PDCD10;CUL3;ZYX;ARRB1;TNFAIP1;RHOA
regulation of amyloid precursor protein catabolic process (GO:1902991),12-Jun,0.030429423,0.469428353,0,0,3.547895336,12.39047555,FKBP1A;PRNP;TMED10;ROCK1;ROCK2;FLOT2
regulation of histone H3-K9 methylation (GO:0051570),12-Jun,0.030429423,0.469428353,0,0,3.547895336,12.39047555,KDM1A;RIF1;ATRX;MYB;DNMT3B;JARID2
regulation of RNA export from nucleus (GO:0046831),12-Jun,0.030429423,0.469428353,0,0,3.547895336,12.39047555,KHDRBS1;CPSF6;DHX9;NSUN2;TPR;NUP153
serine family amino acid biosynthetic process (GO:0009070),12-Jun,0.030429423,0.469428353,0,0,3.547895336,12.39047555,MTHFD1;PSAT1;PHGDH;SEPHS1;SERINC3;PSPH
bicellular tight junction assembly (GO:0070830),18/53,0.030604846,0.470668319,0,0,1.826224699,6.36730939,PATJ;PRKCI;PDCD6IP;ARL2;PARD6G;F11R;GRHL2;CLDN6;AFDN;CLDN4;PARD6B;CLDN3;MARVELD2;CLDN7;STRN;ECT2;PAK2;CRB3
protein deubiquitination (GO:0016579),72/267,0.031125587,0.477194764,0,0,1.313844022,4.558677516,OTUD4;USP31;USP34;PTEN;MYSM1;ACTB;CDC20;PSMD8;PSMD6;UCHL1;PSMD7;PSMD4;MYC;PSMD2;RUVBL1;PSMD1;EP300;SKP2;USP7;DDX58;USP44;UCHL3;RAD23B;RHOA;UCHL5;PSMA5;CCNA2;PSMA6;PSMA3;PSMA4;RNF128;PSMA1;PSMA2;PSME3;PSME4;PSME2;USP14;ENY2;PSMD12;VCP;USP15;PSMD11;PSMD14;USP11;NEDD8;BRCC3;HIF1A;PSMA7;PSMB10;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;UBB;PSMB3;PSMB1;UBC;USP1;RPS27A;USP25;ZRANB1;USP9X;USP22;PSMB9;SMAD7;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;CDK1
glycolytic process through glucose-6-phosphate (GO:0061620),25-Oct,0.032505039,0.495276774,0,0,2.366051773,8.106945543,PFKL;TPI1;PKM;PGAM1;PGK1;ENO1;ALDOA;ENO3;GAPDH;HK2
positive regulation of release of cytochrome c from mitochondria (GO:0090200),25-Oct,0.032505039,0.495276774,0,0,2.366051773,8.106945543,MLLT11;BCL2L11;FAM162A;BNIP3;PDCD5;PLAUR;PMAIP1;BAX;DNM1L;BBC3
Fc-gamma receptor signaling pathway (GO:0038094),23/72,0.03275915,0.497617525,0,0,1.667194973,5.69942764,CYFIP2;ACTR3;NCKAP1;ACTR2;HSP90AA1;HSP90AB1;WIPF3;ARPC4;PIK3CB;WASL;ARPC5;PLA2G6;ACTB;ACTG1;CDC42;PAK1;MYO1C;ARPC2;MAPK1;RAC1;CRK;WASF2;MAPK3
mitotic G1 DNA damage checkpoint signaling (GO:0031571),21/65,0.035630976,0.536765316,0,0,1.69497198,5.651951722,PLK3;PCNA;GADD45A;RPS27L;CDC25C;PML;CNOT6;TFDP1;CNOT7;PCBP4;CARM1;CDK1;EP300;BAX;SFN;RPL26;E2F4;CNOT9;SOX4;E2F7;E2F8
regulation of RNA metabolic process (GO:0051252),21/65,0.035630976,0.536765316,0,0,1.69497198,5.651951722,MED1;MBNL2;YTHDF2;CELF1;RC3H1;RRP1B;HNRNPL;PTBP1;SON;SNRNP70;HNRNPH1;PCBP4;ESRP1;PCBP1;TRA2B;PCBP2;IGF2BP1;METTL4;HNRNPH2;MBNL3;RBM12
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",22-Sep,0.035986689,0.536765316,0,0,2.456809584,8.167924261,EXOSC7;PES1;EXOSC8;WDR12;EXOSC3;EXOSC2;RPS21;NOP9;FTSJ3
negative regulation of DNA recombination at telomere (GO:0048239),22-Sep,0.035986689,0.536765316,0,0,2.456809584,8.167924261,POLR2B;ATRX;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L
negative regulation of protein dephosphorylation (GO:0035308),22-Sep,0.035986689,0.536765316,0,0,2.456809584,8.167924261,YWHAE;FKBP1A;PTPA;PPP1R11;YWHAB;ENSA;TIPRL;MASTL;ARPP19
regulation of DNA recombination at telomere (GO:0072695),22-Sep,0.035986689,0.536765316,0,0,2.456809584,8.167924261,POLR2B;ATRX;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L
positive regulation of protein transport (GO:0051222),22/69,0.0369686,0.549755281,0,0,1.662402278,5.482081328,PLK3;TGFB2;TMED10;PLA2G1B;IER3IP1;OAZ1;CD2AP;PCM1;GOLPH3;PDCD10;TPR;MYO18A;RACK1;CHP1;DNM1L;EZR;KIF20B;PPIA;MYH10;ARHGEF5;PPID;ARF6
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),13/36,0.037831637,0.560004276,0,0,2.006341405,6.569984762,CARMIL1;CDC42;MDK;C1QBP;MYADM;FLNA;RAC1;CALR;P4HB;CRK;FERMT2;S100A10;LIMS1
glycolytic process (GO:0006096),29-Nov,0.037997059,0.560004276,0,0,2.168957226,7.093024809,LDHA;PFKL;TPI1;PKM;PGAM1;PGK1;ENO1;ALDOA;ENO3;GAPDH;HK2
negative regulation of epithelial to mesenchymal transition (GO:0010719),29-Nov,0.037997059,0.560004276,0,0,2.168957226,7.093024809,PPP2CA;SPRED2;SPRED1;SFRP2;SDHAF2;HPN;PTEN;SPRY2;SPRY1;ADIPOR1;SMAD7
DNA alkylation (GO:0006305),19-Aug,0.039598652,0.578444028,0,0,2.58063448,8.332766021,HELLS;DNMT3L;ATRX;DNMT3A;BEND3;DNMT3B;EHMT1;GATAD2A
DNA methylation or demethylation (GO:0044728),19-Aug,0.039598652,0.578444028,0,0,2.58063448,8.332766021,HELLS;DNMT3L;ATRX;DNMT3A;BEND3;DNMT3B;EHMT1;GATAD2A
regulation of mitotic spindle assembly (GO:1901673),19-Aug,0.039598652,0.578444028,0,0,2.58063448,8.332766021,PDCD6IP;VPS4B;TPR;CHMP2A;DRG1;HNRNPU;CHMP3;CHMP5
G1/S transition of mitotic cell cycle (GO:0000082),26/85,0.040976728,0.595063799,0,0,1.565288136,5.000705823,TRIM71;KHDRBS1;PCNA;CUL3;CUL1;GSPT1;NPAT;MYC;EIF4E;CDK17;PLK3;RRM2;DHFR;CDK7;CDC34;DBF4;LATS2;TFDP1;CCNE2;NASP;RPS6KB1;CCNE1;CDK4;MNAT1;CDK14;CUL4B
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",26/85,0.040976728,0.595063799,0,0,1.565288136,5.000705823,ARF4;COPB2;TMED10;PITPNB;COPB1;KIF11;KIF15;TMED3;BNIP1;TMED2;RAB6A;TMED9;COG7;SURF4;KIF23;COPZ1;TAPBP;ARCN1;CENPE;GOLPH3;KIF2A;RER1;ERGIC3;ERGIC2;ARF5;ERGIC1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),26-Oct,0.042686659,0.612157986,0,0,2.2180312,6.995379484,RPL5;PDCL3;HSP90AB1;CSNK2A1;RPS7;LAMP3;RPL23;RPL11;CSNK2A2;PML
positive regulation of viral transcription (GO:0050434),26-Oct,0.042686659,0.612157986,0,0,2.2180312,6.995379484,DHX9;POLR2B;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;GTF2F2;POLR2K;POLR2L
apoptotic mitochondrial changes (GO:0008637),12/33,0.04278341,0.612157986,0,0,2.028187351,6.392045108,GGCT;FIS1;BNIP3;BAX;SFN;NDUFS1;DNM1L;CLU;HK2;BBC3;HSPD1;BCL2L1
DNA unwinding involved in DNA replication (GO:0006268),16-Jul,0.043142798,0.612157986,0,0,2.759571132,8.673993745,PURA;MCM7;HMGA1;RPA1;MCM4;SSBP1;MCM2
epiboly involved in wound healing (GO:0090505),16-Jul,0.043142798,0.612157986,0,0,2.759571132,8.673993745,DDR1;CD151;PDCD10;PDPN;FLNA;RHOC;RHOA
"mRNA cis splicing, via spliceosome (GO:0045292)",16-Jul,0.043142798,0.612157986,0,0,2.759571132,8.673993745,PRPF39;SRSF1;PSIP1;CWC15;WBP11;SNRNP200;SNRPC
nuclear transport (GO:0051169),16-Jul,0.043142798,0.612157986,0,0,2.759571132,8.673993745,NPM1;NUP205;XPO1;HMGA1;PSIP1;NUTF2;BANF1
regulation of establishment of cell polarity (GO:2000114),16-Jul,0.043142798,0.612157986,0,0,2.759571132,8.673993745,RAP1B;GSN;ROCK1;ROCK2;RACK1;PTK2B;KIF20B
regulation of protein ubiquitination (GO:0031396),32/109,0.044056525,0.621705229,0,0,1.476470885,4.609958195,GSK3A;HSP90AB1;HDAC3;CUL3;MYCBP2;DCUN1D1;UBE3A;ARRB1;PARK7;UBE2L3;BAG2;UBB;SVBP;RPS3;UBQLN1;CHP1;CDK5RAP3;SOX4;IVNS1ABP;HSP90AA1;FBXW7;HUWE1;COMMD1;GTPBP4;SMAD7;FKBP1A;GNL3L;TBC1D7;UBE2N;SPOPL;SPRY2;CENPS
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",23/74,0.044192294,0.621705229,0,0,1.601608757,4.995745795,PLK3;PCNA;GADD45A;ATRX;RPS27L;CDC25C;PML;RPS6KA6;CNOT6;TFDP1;CNOT7;PCBP4;CARM1;CDK1;EP300;BAX;SFN;RPL26;E2F4;CNOT9;SOX4;E2F7;E2F8
Fc receptor mediated stimulatory signaling pathway (GO:0002431),23/74,0.044192294,0.621705229,0,0,1.601608757,4.995745795,CYFIP2;ACTR3;NCKAP1;ACTR2;HSP90AA1;HSP90AB1;WIPF3;ARPC4;PIK3CB;WASL;ARPC5;PLA2G6;ACTB;ACTG1;CDC42;PAK1;MYO1C;ARPC2;MAPK1;RAC1;CRK;WASF2;MAPK3
positive regulation of mRNA catabolic process (GO:0061014),15/44,0.04448219,0.622516105,0,0,1.836171518,5.715389396,YTHDF1;YTHDF2;ROCK1;CELF1;ROCK2;RC3H1;GIGYF2;ZFP36L1;RIDA;ZFP36;CNOT7;AGO2;POLR2G;PABPC1;METTL16
cellular protein complex disassembly (GO:0043624),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,TRMT112;VPS4B;ETF1;ABCE1
gland morphogenesis (GO:0022612),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,TGFB2;MSN;EZR;FGFR2
nose development (GO:0043584),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,SMCHD1;SIX4;CHD7;GLI3
nucleobase biosynthetic process (GO:0046112),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,GMPS;CTPS2;UMPS;PAICS
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,PSMC6;PSMC3;PSMC4;PSMC2
regulation of lens fiber cell differentiation (GO:1902746),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,SPRED2;SPRED1;SPRY2;SPRY1
regulation of metallopeptidase activity (GO:1905048),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,CLDN4;CLDN3;SVBP;TIMP2
regulation of myosin-light-chain-phosphatase activity (GO:0035507),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,NUAK1;PPP1R12A;ROCK1;ROCK2
ribosomal small subunit export from nucleus (GO:0000056),07-Apr,0.046142177,0.622516105,0,0,4.729285119,14.54741276,NPM1;XPO1;NOP9;RAN
mitochondrial outer membrane permeabilization (GO:0097345),13-Jun,0.046203618,0.622516105,0,0,3.040858118,9.349717853,BNIP3L;BCL2L11;BNIP3;BAX;PMAIP1;VDAC2
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),13-Jun,0.046203618,0.622516105,0,0,3.040858118,9.349717853,RCC2;SPRY4;TACSTD2;ACTN4;EFNA5;CORO1C
negative regulation of nucleocytoplasmic transport (GO:0046823),13-Jun,0.046203618,0.622516105,0,0,3.040858118,9.349717853,UFM1;TPR;CHP1;NUP153;PARK7;RANGAP1
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),13-Jun,0.046203618,0.622516105,0,0,3.040858118,9.349717853,RCC2;SPRY4;TACSTD2;ACTN4;EFNA5;CORO1C
purine-containing compound salvage (GO:0043101),13-Jun,0.046203618,0.622516105,0,0,3.040858118,9.349717853,DGUOK;PNP;ADK;AMPD2;ADA;APRT
cell cycle G1/S phase transition (GO:0044843),20/63,0.047185442,0.622516105,0,0,1.651529066,5.043224533,TRIM71;KHDRBS1;PLK3;CUL3;CUL1;GSPT1;CCNA2;CDK7;CDC34;DBF4;LATS2;CCNE2;NASP;RPS6KB1;CCNE1;CDK4;MYC;MNAT1;EIF4E;CUL4B
modulation by symbiont of host process (GO:0044003),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,UBB;UBC;PGK1;ENO1;RPS27A
nucleic acid transport (GO:0050657),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,ATXN2;HNRNPA2B1;YBX1;CKAP5;RTRAF
positive regulation of receptor recycling (GO:0001921),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,RAMP3;ANXA2;INPP5F;ECE1;VAMP3
positive regulation of rRNA processing (GO:2000234),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,TRMT112;HEATR1;WDR75;BUD23;WDR43
protein deneddylation (GO:0000338),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,COPS4;COPS3;COPS6;COPS2;COPS7A
regulation of DNA methylation (GO:0044030),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,DNMT3L;KMT2A;MYC;GRHL2;MPHOSPH8
regulation of organ growth (GO:0046620),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,LATS2;WWC1;PTEN;DUSP9;DUSP6
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,PSMC6;PSMC3;PSMC4;PSMC2;HMGB1
rRNA 3'-end processing (GO:0031125),10-May,0.047888985,0.622516105,0,0,3.547315742,10.77983053,EXOSC7;EXOSC8;EXOSC3;EXOSC2;RPS21
DNA methylation (GO:0006306),23-Sep,0.047895524,0.622516105,0,0,2.281176815,6.931887767,HELLS;DNMT3L;ATRX;DNMT3A;BEND3;DNMT3B;METTL4;EHMT1;GATAD2A
positive regulation of mRNA processing (GO:0050685),23-Sep,0.047895524,0.622516105,0,0,2.281176815,6.931887767,RBM3;DAZAP1;THRAP3;NCL;TRA2B;CELF4;LEO1;PRDX6;CDC73
protein alkylation (GO:0008213),23-Sep,0.047895524,0.622516105,0,0,2.281176815,6.931887767,PCMT1;PRMT2;ETFBKMT;ETF1;FAM98B;SNRPD3;EEF1AKMT2;GSPT1;EEF1AKMT1
regulation of necroptotic process (GO:0060544),23-Sep,0.047895524,0.622516105,0,0,2.281176815,6.931887767,HSP90AA1;PDCD6IP;CDC37;FLOT1;FLOT2;CFLAR;ARHGEF2;YBX3;SLC25A4
maintenance of blood-brain barrier (GO:0035633),30-Nov,0.048418755,0.626030489,0,0,2.054669704,6.221268709,ITGB1;TJP1;GJA1;CLDN3;CLDN12;WNK3;LSR;F11R;ACTB;ACTG1;TJP2
termination of RNA polymerase I transcription (GO:0006363),30-Nov,0.048418755,0.626030489,0,0,2.054669704,6.221268709,TAF1D;CDK7;CAVIN1;POLR1C;POLR2F;POLR2H;GTF2H3;MNAT1;POLR2K;GTF2H5;POLR2L
regulation of intrinsic apoptotic signaling pathway (GO:2001242),17/52,0.049553123,0.63902882,0,0,1.724374348,5.181244824,FIS1;URI1;DDX3X;PLAUR;NOC2L;BBC3;BCLAF1;BCL2L11;RACK1;UBQLN1;PMAIP1;BAX;P4HB;DNM1L;MCL1;BCL2L1;GSDME
positive regulation of protein-containing complex assembly (GO:0031334),34/118,0.049745166,0.639638994,0,0,1.438030903,4.315303511,VCP;DDX3X;TFRC;FAF1;PARK7;CLU;RAP1B;BCL2L11;SUMO1;RACK1;RPS3;SH3GLB1;HSP90AA1;PARP1;RPA1;NRG1;RHOC;GTF2H3;GTF2H5;RBX1;DDB1;FERMT1;TPPP3;GNL3L;PSMC6;PSMC3;PSMC4;ERCC1;RPA3;PSMC2;BAX;AJUBA;FERMT2;CUL4B
G2/M transition of mitotic cell cycle (GO:0000086),37/130,0.049858775,0.639638994,0,0,1.413623685,4.238836538,CEP57;YWHAE;KHDRBS1;DYNC1I2;DCTN3;CUL1;ARPP19;PPP1CB;CCNB2;PCM1;TUBA1A;ENSA;SKP2;PHLDA1;YWHAG;PLK3;HSP90AA1;PPP1R12A;HAUS3;CDC25C;DYNLL1;MASTL;TUBB4B;CKAP5;HAUS1;CCNA2;CDK7;MELK;AKAP9;CDK1;MNAT1;MAPRE1;AJUBA;CDK14;SFI1;OPTN;TAF2
regulation of release of cytochrome c from mitochondria (GO:0090199),14/41,0.050508423,0.64629899,0,0,1.840522081,5.495090648,PRELID1;BNIP3;PDCD5;PLAUR;GHITM;CLU;BBC3;MLLT11;BCL2L11;FAM162A;PMAIP1;BAX;DNM1L;BCL2L1
termination of RNA polymerase II transcription (GO:0006369),12/34,0.053296301,0.680214651,0,0,1.93587274,5.675762718,SETX;SLBP;FIP1L1;CPSF3;CPSF2;PAPOLA;SSU72;SNRPG;SNRPE;SNRPD3;SNRPF;WDR33
endoplasmic reticulum calcium ion homeostasis (GO:0032469),20-Aug,0.053621031,0.680849607,0,0,2.365429851,6.920807568,FIS1;CAMK2D;RAP1GDS1;ATP2A2;BAX;SELENOK;PML;TMCO1
establishment of epithelial cell polarity (GO:0090162),20-Aug,0.053621031,0.680849607,0,0,2.365429851,6.920807568,CDC42;CYTH3;FERMT1;GOLPH3;MYO18A;MSN;EZR;RHOA
chromatin remodeling (GO:0006338),30/103,0.054900821,0.695316787,0,0,1.459745583,4.23651302,SUV39H2;SMARCD1;SATB1;CHD4;NUDT5;MYSM1;ACTB;CECR2;PAK1;MYC;RUVBL2;MYB;RUVBL1;GATAD1;JARID2;BPTF;MBD3;SMARCE1;SMARCC1;PBRM1;NPM1;CBX3;ATRX;BAZ1A;SMARCA1;ARID1A;NPM3;SMARCA4;TADA2A;HNRNPC
cell cycle G2/M phase transition (GO:0044839),37/131,0.055214377,0.69750407,0,0,1.398494939,4.05078521,CEP57;YWHAE;KHDRBS1;DYNC1I2;DCTN3;CUL1;ARPP19;PPP1CB;CCNB2;PCM1;TUBA1A;ENSA;SKP2;PHLDA1;YWHAG;PLK3;HSP90AA1;PPP1R12A;HAUS3;CDC25C;DYNLL1;MASTL;TUBB4B;CKAP5;HAUS1;CCNA2;CDK7;MELK;AKAP9;CDK1;MNAT1;MAPRE1;AJUBA;CDK14;SFI1;OPTN;TAF2
protein ubiquitination (GO:0016567),131/525,0.056484501,0.711733459,0,0,1.183950713,3.40242453,UBE2D3;UBE3A;UBE3B;UBE2L3;PSMD8;NPEPPS;PSMD6;PSMD7;PSMD4;PSMD2;CDC27;PSMD1;SKP2;ARRDC4;USP7;FBXW8;FBXW7;ARRDC1;UBE2E1;RC3H1;UBE2E2;UBE4B;RBX1;CDC34;KCTD10;PSME3;PSME4;PSME2;UBE2V1;RNF122;CUL9;PSMD12;VCP;PSMD11;PSMD14;UBA6;CUL3;MYCBP2;CUL1;WDR61;RTF1;KLHL13;UBE2J2;HIF1A;UBB;UBR5;HLTF;UBC;PHC1;UBE2B;UBE2A;BSPRY;UVSSA;MKRN1;UBE2N;TPP2;BLMH;UBA1;UBE2K;RAD18;RNF187;TRIM71;RNF10;RNF14;ARRB1;HIF3A;TNFAIP1;CDC73;TRIM6;UBE2Q1;ENC1;RACK1;ELOB;ELOC;PEX2;COMMD1;UCHL3;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;UBE2R2;PSMA2;NFX1;BIRC6;PCNA;RNF38;NEDD8;PSMA7;PSMB10;PSMB6;PCNP;PSMB7;PSMB4;PSMB5;CAND1;RMND5A;PSMB2;TNKS2;PSMB3;UBE2NL;PSMB1;LEO1;SPOP;RBBP6;RPS27A;TRIM44;USP9X;FBXL19;USP22;HUWE1;WWP1;UBE2G1;PSMB9;MIB1;KLHL9;PSMC6;PSMC3;PSMC4;PSMC1;KLHL7;NEDD4;PSMC2;RLIM;CTNNB1;TRIP12;RNF141;TRIM33;CUL4B
cell junction organization (GO:0034330),22/72,0.057337625,0.716419598,0,0,1.562356702,4.466462584,APP;PRKCI;TGFB2;WNT7B;SEMA3E;GRHL2;ACTB;RHOA;ACTG1;CDC42;TJP1;VMP1;PPFIBP1;CLDN3;MARVELD2;CAPZA1;FLNA;FLNC;AGRN;FERMT2;LIMS1;TJP2
DNA replication initiation (GO:0006270),13/38,0.057435093,0.716419598,0,0,1.845597083,5.273055032,MCM7;GMNN;RPA1;LRWD1;ORC4;PURA;POLA2;CDC34;DBF4;RPA3;ORC2;MCM4;MCM2
regulation of phosphoprotein phosphatase activity (GO:0043666),13/38,0.057435093,0.716419598,0,0,1.845597083,5.273055032,HSP90AB1;PPP1R12A;PPP1R11;MASTL;HSP90B1;PTPA;FKBP1A;PPP1R2;NUAK1;TIPRL;CALM3;CALM1;CALM2
spliceosomal snRNP assembly (GO:0000387),13/38,0.057435093,0.716419598,0,0,1.845597083,5.273055032,PRPF8;WDR77;SNRPD2;SNRPD1;CLNS1A;SNRPG;GEMIN5;GEMIN6;SNRPE;SNRPD3;SNRPF;SNRPC;SRSF10
protein import into nucleus (GO:0006606),23/76,0.058286541,0.72521344,0,0,1.540972444,4.380035537,IPO13;RANBP2;SEC13;POM121;NUP107;CSE1L;RPL23;HIKESHI;NUTF2;NUP153;PHB2;IPO5;IPO9;NUP85;TPR;KPNA6;KPNA4;TNPO1;NUP62CL;KPNA3;KPNB1;RAN;KPNA1
regulation of cytokinesis (GO:0032465),25/84,0.05974317,0.731740677,0,0,1.504740805,4.23990877,AHCTF1;CUL3;KLHL13;CDC14B;CDC42;KIF13A;FSD1;ECT2;GIT1;E2F7;E2F8;SH3GLB1;PLK3;KIF23;PRPF40A;RHOA;RAB11A;KLHL9;BIRC6;CALM3;PKN2;KIF20B;CALM1;CALM2;BCL2L1
cellular response to gamma radiation (GO:0071480),17-Jul,0.059794821,0.731740677,0,0,2.483454711,6.995485203,YAP1;XRCC6;KDM1A;MAP3K20;TLK2;RPL26;CRYAB
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",17-Jul,0.059794821,0.731740677,0,0,2.483454711,6.995485203,COX7B;COX7A2L;NDUFA4;COX4I1;CYCS;COX6C;COX7C
positive regulation of stem cell proliferation (GO:2000648),17-Jul,0.059794821,0.731740677,0,0,2.483454711,6.995485203,GJA1;KDM1A;CCNE1;EPCAM;HNRNPU;SOX11;FERMT2
regulation of receptor recycling (GO:0001919),17-Jul,0.059794821,0.731740677,0,0,2.483454711,6.995485203,RAMP3;ANXA2;INPP5F;ECE1;LAMTOR1;OPTN;VAMP3
regulation of stem cell proliferation (GO:0072091),17-Jul,0.059794821,0.731740677,0,0,2.483454711,6.995485203,YAP1;GJA1;KDM1A;EPCAM;HNRNPU;SOX11;ZFP36L1
positive regulation of transferase activity (GO:0051347),41/148,0.059845512,0.731740677,0,0,1.361510761,3.833999109,DDR1;GSK3A;FLT1;HSP90AB1;PCNA;DCUN1D5;NVL;DCUN1D1;PARN;DBI;IGF1R;UBE2L3;MYC;MAPK1;MAP3K4;CCT4;MAPK3;ARRDC4;CCT2;HSP90AA1;UBE2I;RFC4;FBXW7;LMO4;RFC2;RYK;PTGES3;ARRDC3;IGF2;LMTK2;GRHL2;POLG2;TCP1;HNRNPA2B1;HNRNPD;UBE2N;CTNNB1;SERINC1;EPHA1;FGFR2;FGFR1
"positive regulation of gene expression, epigenetic (GO:0045815)",18/57,0.060435553,0.737135118,0,0,1.638498394,4.597917693,SMARCD1;ELOF1;CDCA4;HMGA1;DDX21;DEK;ARID1A;ACTB;TAF1D;MYO1C;ZMIZ2;POLR1C;EP300;POLR2F;POLR2H;SF3B1;POLR2K;POLR2L
negative regulation of stress fiber assembly (GO:0051497),24-Sep,0.062141187,0.750544288,0,0,2.128961749,5.914992938,TJP1;STMN1;TACSTD2;RHPN2;F11R;PFN1;PAK2;WASF2;CGNL1
"nucleotide-excision repair, DNA gap filling (GO:0006297)",24-Sep,0.062141187,0.750544288,0,0,2.128961749,5.914992938,PCNA;RFC4;RFC1;UBB;RFC2;RPA3;UBC;RPA1;RPS27A
purine nucleotide metabolic process (GO:0006163),24-Sep,0.062141187,0.750544288,0,0,2.128961749,5.914992938,PRPS2;NT5C;ADSL;PNP;MTHFD1;GUK1;PPAT;GART;ITPA
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),24-Sep,0.062141187,0.750544288,0,0,2.128961749,5.914992938,BCL9;LATS2;ITGA3;LTBP4;SOX11;NREP;FOLR1;TRIM33;SMAD7
regulation of telomerase activity (GO:0051972),15/46,0.063903324,0.769949541,0,0,1.717488196,4.723751877,CCT2;HSP90AA1;HSP90AB1;NVL;PTGES3;PARN;GRHL2;MYC;TCP1;NABP2;MAPK1;CTNNB1;MAP3K4;CCT4;MAPK3
cellular response to tumor necrosis factor (GO:0071356),52/194,0.064852734,0.77787902,0,0,1.301519857,3.560484858,PLVAP;ZFAND6;YBX3;TXNDC17;PSMD8;PSMD6;ZFP36;PSMD7;PSMD4;PSMD2;TMSB4X;PSMD1;EIF5A;TNFRSF12A;CHUK;ACTN4;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;ARHGEF2;PSMD12;PSMD11;PSMD14;DHX9;PSMA7;PSMB10;ZFP36L1;PSMB6;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;RPS3;PTK2B;GBP2;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;PSMC2;TDGF1;GSDME;LIMS1
cellular response to virus (GO:0098586),12/35,0.065420868,0.77787902,0,0,1.851585485,5.049114376,EIF5A;ARF1;HSP90AA1;DDX3X;CHUK;DDX58;RIOK3;BAX;RRP1B;MAPK14;HIF1A;GSDME
regulation of mitotic spindle organization (GO:0060236),12/35,0.065420868,0.77787902,0,0,1.851585485,5.049114376,TPX2;PDCD6IP;VPS4B;CLTC;TPR;CHMP2A;DRG1;HNRNPU;CHMP3;FSD1;RAE1;CHMP5
negative regulation of translational initiation (GO:0045947),14-Jun,0.066200171,0.77787902,0,0,2.660580205,7.223667423,LARP1;AGO2;TPR;EIF4EBP2;EIF3E;PAIP2
protein localization to kinetochore (GO:0034501),14-Jun,0.066200171,0.77787902,0,0,2.660580205,7.223667423,IK;ZWILCH;RCC2;CDK1;KNL1;BUB3
protein modification by small protein conjugation or removal (GO:0070647),14-Jun,0.066200171,0.77787902,0,0,2.660580205,7.223667423,UBA6;UBA3;UBA2;UBA1;NAE1;SAE1
regulation of response to interferon-gamma (GO:0060330),14-Jun,0.066200171,0.77787902,0,0,2.660580205,7.223667423,HSP90AB1;SUMO1;IFNGR1;CDC37;PIAS1;JAK1
regulation of phosphorylation (GO:0042325),35/125,0.067777645,0.77787902,0,0,1.381419555,3.718122317,CDKN1C;APP;ANKLE2;NUP205;POM121;NUP107;SEH1L;MCM7;ROCK1;PRKRIP1;HIF1A;THBS1;NUP160;CORO1C;PPP2CA;NUP85;TPR;EP300;NUP43;RAE1;NDC1;RANBP2;SEC13;FZD7;PGAM1;PTGES3;GLMN;NUP153;MIF;DYNLL1;PML;EIF6;PHIP;ITGA6;NUP37
cytoplasmic microtubule organization (GO:0031122),17/54,0.068501074,0.77787902,0,0,1.630955317,4.372437651,PLK3;DST;VPS4B;LIMK2;CRIPT;FIGNL2;FIGN;RHOA;RAB11A;CLIP3;PCM1;SLK;HOOK1;CHP1;FSD1;EZR;KPNB1
regulation of cyclin-dependent protein kinase activity (GO:1904029),17/54,0.068501074,0.77787902,0,0,1.630955317,4.372437651,CDKN1C;HSP90AB1;CCNI;GADD45A;BCCIP;CDC25C;ACTB;GTPBP4;CCNA2;CCNB2;CDK7;CCNE2;CCNE1;CDC37;CCNG2;MNAT1;CDK5RAP3
regulation of focal adhesion assembly (GO:0051893),17/54,0.068501074,0.77787902,0,0,1.630955317,4.372437651,DUSP3;ROCK1;ROCK2;RCC2;PTEN;EFNA5;THBS1;RHOA;ACTG1;CORO1C;DUSP22;SLK;PTPRA;RAC1;FERMT2;S100A10;LIMS1
positive regulation of protein import into nucleus (GO:0042307),28-Oct,0.069052006,0.77787902,0,0,1.971330246,5.269159455,HDAC3;TRIM28;JUP;CDH1;TPR;UBR5;FLNA;ECT2;RAN;IPO5
protein depolymerization (GO:0051261),28-Oct,0.069052006,0.77787902,0,0,1.971330246,5.269159455,GSN;WDR1;KIF2A;VPS4B;CFL2;CFL1;STMN1;STMN2;DSTN;CKAP5
regulation of exit from mitosis (GO:0007096),13/39,0.069414057,0.77787902,0,0,1.774498633,4.733769469,UBE2E1;BUB1B;PHB2;CDC14B;CDC20;ANLN;UBB;CDC26;CDC27;UBC;BUB3;RPS27A;MAD2L1
regulation of peptidyl-threonine phosphorylation (GO:0010799),13/39,0.069414057,0.77787902,0,0,1.774498633,4.733769469,APP;SMAD7;SPRED2;SPRED1;TRIM6;DDIT4;WNK3;MAPK1;SPRY2;CALM3;CALM1;CALM2;UBE2K
actin filament depolymerization (GO:0030042),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,GSN;WDR1;CFL2;CFL1;DSTN
cell-cell junction maintenance (GO:0045217),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,TJP1;F2R;MYADM;F2RL1;FERMT2
chromatin-mediated maintenance of transcription (GO:0048096),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,SMARCD1;ELOF1;CDCA4;ZMIZ2;ARID1A
establishment of endothelial intestinal barrier (GO:0090557),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,TJP1;AFDN;RAP2B;F11R;TJP2
hepatocyte growth factor receptor signaling pathway (GO:0048012),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,PAK1;HPN;STMN1;RAC1;BCAR1
negative regulation of oxidative stress-induced neuron death (GO:1903204),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,REST;NONO;RACK1;PARK7;HIF1A
negative regulation of sprouting angiogenesis (GO:1903671),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,SEMA6A;PIK3CB;SYNJ2BP;THBS1;EPN1
positive regulation of cytoplasmic transport (GO:1903651),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,DAB2;MTMR2;RDX;MSN;EZR
positive regulation of DNA-dependent DNA replication (GO:2000105),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,DBF4;ATRX;SSBP1;E2F7;E2F8
positive regulation of viral release from host cell (GO:1902188),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,DDB1;TSG101;VAPA;CHMP2A;CHMP3
regulation of cytoplasmic transport (GO:1903649),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,USP7;CHMP3;MAPK1;DNAJC13;MAPK3
regulation of gene expression by genetic imprinting (GO:0006349),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,DNMT3L;PCGF5;DNMT3A;PCGF3;IGF2
regulation of mRNA 3'-end processing (GO:0031440),11-May,0.07226793,0.77787902,0,0,2.955906885,7.76627533,AHCYL1;LEO1;PAPOLA;CDC73;ZFP36L1
cardiac muscle cell myoblast differentiation (GO:0060379),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,REST;NRG1;RBPJ
cell fate commitment involved in formation of primary germ layer (GO:0060795),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,LEO1;RTF1;CDC73
deoxyribonucleotide metabolic process (GO:0009262),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,RRM1;RRM2;SAMHD1
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,SLBP;CPSF3;CPSF2
negative regulation of anion transmembrane transport (GO:1903960),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,TCAF2;SLC43A2;GOPC
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,NONO;PARK7;HIF1A
negative regulation of protein polyubiquitination (GO:1902915),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,PLAA;PPIA;TRIM44
nucleoside triphosphate catabolic process (GO:0009143),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,ENPP3;DCTPP1;ITPA
p38MAPK cascade (GO:0038066),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,ZFP36;MAPK14;ZFP36L1
PML body organization (GO:0030578),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,SERBP1;ETS1;PML
positive regulation by host of viral genome replication (GO:0044829),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,VAPA;NUCKS1;PPIB
positive regulation of DNA demethylation (GO:1901537),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,OTUD4;USP7;USP9X
positive regulation of necrotic cell death (GO:0010940),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,HEBP2;SLC6A6;MT3
positive regulation of nucleobase-containing compound transport (GO:0032241),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,KHDRBS1;CPSF6;DHX9
positive regulation of oxidative stress-induced neuron death (GO:1903223),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,REST;FBXW7;MCL1
positive regulation of RNA export from nucleus (GO:0046833),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,KHDRBS1;CPSF6;DHX9
regulation of chromosome separation (GO:1905818),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,CSNK2A1;CSNK2A2;TPR
regulation of cyclase activity (GO:0031279),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,MAPK8;MAPK14;MAPK3
regulation of cytochrome-c oxidase activity (GO:1904959),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,NDUFA4;COX17;PHB2
regulation of heart growth (GO:0060420),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,BASP1;DUSP9;DUSP6
regulation of mitophagy (GO:1901524),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,VDAC1;SLC25A5;SLC25A4
regulation of mRNA binding (GO:1902415),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,EIF3E;EIF3C;EIF3D
regulation of protein import (GO:1904589),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,HSPA8;TPR;ARHGEF5
RNA localization to Cajal body (GO:0090670),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,CCT2;TCP1;CCT4
scaRNA localization to Cajal body (GO:0090666),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,CCT2;TCP1;CCT4
tight junction organization (GO:0120193),05-Mar,0.074452873,0.77787902,0,0,5.31957708,13.81807456,PATJ;CLDN12;ACTG1
gene silencing by miRNA (GO:0035195),11/32,0.074660566,0.77787902,0,0,1.858748237,4.823085918,TRIM71;ZFP36;CNOT6;CNOT7;EIF6;AGO2;DICER1;LIMD1;AJUBA;RAN;PUM2
positive regulation of telomere maintenance (GO:0032206),11/32,0.074660566,0.77787902,0,0,1.858748237,4.823085918,TNKS2;ERCC1;ATRX;HNRNPA2B1;HNRNPD;NABP2;MAPK1;MAP3K4;PML;MAPK3;GNL3
regulation of cell morphogenesis (GO:0022604),11/32,0.074660566,0.77787902,0,0,1.858748237,4.823085918,ZRANB1;CLDN4;CLDN3;CAPZB;CFL1;PDPN;PHIP;EFNA5;LARP4;PDZD8;FERMT2
positive regulation of protein ubiquitination (GO:0031398),24/82,0.075738568,0.77787902,0,0,1.469216043,3.791264646,ARRDC4;GSK3A;HDAC3;KDM1A;DCUN1D5;FBXW7;PDCD6;CUL3;ARRDC3;MYCBP2;DCUN1D1;HUWE1;UBE3A;COMMD1;UBE2L3;RBX1;SMAD7;FKBP1A;UBB;TBC1D7;UBQLN1;UBE2N;CDK5RAP3;CENPS
"transcription, DNA-templated (GO:0006351)",58/221,0.075850419,0.77787902,0,0,1.264693626,3.261634807,AFF4;CDC73;SNAPC3;ELOB;ELOC;KLF13;PARP1;GTF2F2;MLF1;TFDP1;NFX1;POLR1C;TFAM;PTMA;GTF2A1;DDX5;GTF2A2;RNMT;GTF3C6;TAF9;DDX21;WDR61;RTF1;MRPL12;PMF1;GTF2E2;POLR2B;NOCT;LEO1;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L;TCFL5;BTF3;IVNS1ABP;XBP1;TAF12;DEK;SSRP1;GTF2H3;GTF2H5;NFKB1;SETX;CDK7;FUBP3;COPS2;PIR;DRG1;TCEA1;POLR3G;RNPS1;MNAT1;POLR3K;TAF2
regulation of cell cycle process (GO:0010564),30/106,0.0761871,0.77787902,0,0,1.401853123,3.609159357,CUL9;AHCTF1;KLHL13;KIF11;MKI67;CDC42;KIF13A;FSD1;ECT2;BUB1;GIT1;SH3GLB1;PLK3;TIPIN;YTHDF2;CSNK2A1;CSNK2A2;PRPF40A;CDC25C;RAB11A;KLHL9;DBF4;CTNNB1;CALM3;BIRC6;KIF20B;CALM1;CDK13;CALM2;BCL2L1
mitotic sister chromatid segregation (GO:0000070),29/102,0.076325755,0.77787902,0,0,1.410764642,3.62953747,SEH1L;SET;CUL3;VPS4B;CDCA8;PDS5A;SMC4;SMC2;RAD21;POGZ;KMT5A;NAA50;NUDC;PDCD6IP;CSNK2A1;NCAPH2;CSNK2A2;KIF23;SMC1A;RAB11A;CENPE;CENPK;CDK1;CHMP2A;CHMP3;NCAPD2;KPNB1;RAN;CHMP5
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),29/102,0.076325755,0.77787902,0,0,1.410764642,3.62953747,VCP;GSK3A;HSP90AB1;RNF14;RPL11;TAF9;PARK7;CLU;XPO1;HECTD1;BAG2;SUMO1;SUMO2;GNA12;RACK1;TLK2;ELOB;UBQLN4;USP7;CSNK1A1;GLMN;COMMD1;RAD23B;UCHL5;PIAS1;RBX1;SMAD7;DAB2;EIF3H
dendritic spine maintenance (GO:0097062),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,PRNP;MTMR2;ITGA3;IGF1R
establishment of Golgi localization (GO:0051683),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,CDC42;ARHGAP21;PDCD10;YWHAZ
histone H2A-K119 monoubiquitination (GO:0036353),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,PCGF5;PCGF2;PCGF3;RNF2
negative regulation by symbiont of host apoptotic process (GO:0033668),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,SFPQ;MAPK1;BCL2L1;MAPK3
positive regulation of homotypic cell-cell adhesion (GO:0034112),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,PDPN;PLAUR;F11R;JAK1
positive regulation of protein localization to early endosome (GO:1902966),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,ROCK2;RDX;MSN;EZR
positive regulation of protein localization to endosome (GO:1905668),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,ROCK2;RDX;MSN;EZR
protein localization to microtubule cytoskeleton (GO:0072698),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,CRIPT;KIF20B;MAPRE1;MID1
regulation of protein localization to early endosome (GO:1902965),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,ROCK2;RDX;MSN;EZR
RNA secondary structure unwinding (GO:0010501),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,DDX3X;DDX39B;DHX9;AGO2
rRNA base methylation (GO:0070475),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,TRMT112;EMG1;BUD23;METTL16
tubulin complex assembly (GO:0007021),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,VBP1;TCP1;ARL2;TBCA
U4 snRNA 3'-end processing (GO:0034475),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,EXOSC7;EXOSC8;EXOSC3;EXOSC2
ventricular trabecula myocardium morphogenesis (GO:0003222),08-Apr,0.076499815,0.77787902,0,0,3.546736411,9.11676876,TGFB2;NRG1;RBPJ;BMPR1A
mitotic cell cycle phase transition (GO:0044772),55/209,0.078656668,0.789463456,0,0,1.269229505,3.227222743,CEP57;TRIM71;YWHAE;CCNI;PPP1CB;PCM1;TUBA1A;MYC;CDC27;ENSA;SKP2;PHLDA1;YWHAG;HSP90AA1;PPP1R12A;HAUS3;DYNLL1;CDC25C;MASTL;CKAP5;HAUS1;CCNA2;CDC34;MELK;DBF4;LATS2;CCNE2;CCNE1;AKAP9;MAPRE1;SFI1;AJUBA;OPTN;DYNC1I2;KHDRBS1;CUL3;DCTN3;CUL1;ARPP19;GSPT1;CCNB2;EIF4E;PLK3;TUBB4B;CDK7;NASP;RPS6KB1;CDK4;CCNG2;CDK1;CHMP2A;MNAT1;CDK14;TAF2;CUL4B
endosome transport via multivesicular body sorting pathway (GO:0032509),25-Sep,0.078811531,0.789463456,0,0,1.995773566,5.070653843,LAPTM4B;VCP;SORT1;TMEM50A;VPS4B;VTA1;CHMP2A;CHMP3;CHMP5
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",25-Sep,0.078811531,0.789463456,0,0,1.995773566,5.070653843,TCERG1;DDX39B;LEO1;THOC1;CDK12;CDK13;EAPP;CDC73;HMGN1
regulation of cardiac muscle cell action potential (GO:0098901),25-Sep,0.078811531,0.789463456,0,0,1.995773566,5.070653843,CAMK2D;JUP;AKAP9;PKP2;ATP2A2;ANK2;CALM3;CALM1;DSC2
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),25-Sep,0.078811531,0.789463456,0,0,1.995773566,5.070653843,RHBDF1;USP14;PSMD14;UBB;PSME3;PTK2B;PSME2;UBE3A;UCHL5
platelet aggregation (GO:0070527),12/36,0.07921549,0.789463456,0,0,1.774322169,4.498941873,RAP2B;ACTN1;FLNA;MYH9;PIK3CB;TLN1;MYL9;PPIA;ACTB;MYL12A;METAP1;ACTG1
regulation of protein import into nucleus (GO:0042306),12/36,0.07921549,0.789463456,0,0,1.774322169,4.498941873,UFM1;HDAC3;TRIM28;JUP;CDH1;TPR;UBR5;CHP1;FLNA;ECT2;RAN;IPO5
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),17/55,0.079588388,0.789463456,0,0,1.587933394,4.018880097,IVNS1ABP;RPL5;RPL11;ARRB1;PARK7;GTPBP4;SMAD7;GNL3L;BAG2;SVBP;RPS3;CHP1;SPOPL;CTNNB1;SPRY2;SOX4;COPS9
3'-UTR-mediated mRNA stabilization (GO:0070935),18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,ZFP36;HNRNPC;MAPK14;TARDBP;ELAVL1;YBX3;HNRNPA0
establishment of vesicle localization (GO:0051650),18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,CCDC186;SNAPIN;SYT11;LIMK2;KIF5B;RAB27A;RAB11A
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,RBM3;DAZAP1;THRAP3;NCL;TRA2B;CELF4;PRDX6
regulation of chromosome segregation (GO:0051983),18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,CSNK2A1;CSNK2A2;SMC6;MKI67;BUB1;RAD18;PUM2
regulation of protein sumoylation (GO:0033233),18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,GNL3L;CTNNB1;UBA2;PARK7;SAE1;GNL3;PIAS1
regulation of transcription by RNA polymerase I (GO:0006356),18-Jul,0.079871,0.789463456,0,0,2.257541275,5.705579892,HEATR1;WDR75;FLNA;LYAR;WDR43;POLR2K;POLR2L
regulation of glycolytic process (GO:0006110),21/71,0.083998478,0.828606503,0,0,1.491,3.693142285,NDC1;RANBP2;APP;SEC13;NUP205;POM121;NUP107;PFKFB3;SEH1L;PGAM1;NUP153;HIF1A;NUP160;EIF6;NUP85;TPR;EP300;NUP43;RAE1;GIT1;NUP37
post-translational protein modification (GO:0043687),87/345,0.084197846,0.828921936,0,0,1.199148796,2.967396749,APP;MIA3;HIF3A;PSMD8;PSMD6;LGALS1;PSMD7;PSMD4;PSMD2;PSMD1;UBXN7;ELOB;ELOC;SKP2;RAB2A;ESCO1;CISH;FBXW8;FBXW7;IGFBP4;APLP2;IGFBP3;COMMD1;UCHL3;RABGGTB;PDIA6;RBX1;DDB1;PSMA5;PSMA6;PTP4A2;PSMA3;PSMA4;PSMA1;PSMA2;PSME3;PSME4;PSME2;MATN3;CUL9;PSMD12;PSMD11;PSMD14;CUL3;DCUN1D1;CUL1;COPS7A;NEDD8;KLHL13;HIF1A;FSTL1;PSMA7;PSMB10;HSP90B1;PSMB6;PSMB7;PSMB4;PSMB5;CAND1;PSMB2;PSMB3;PSMB1;GPC3;FEM1C;NAE1;RBBP7;UBE2F;FEM1B;FBXL19;LAMB1;RAB11A;KTN1;PSMB9;KLHL9;COPS4;COPS3;COPS6;PSMC6;PSMC3;PSMC4;PSMC1;COPS2;PSMC2;UBA3;STT3B;P4HB;CUL4B
actin filament organization (GO:0007015),41/152,0.085092068,0.834091859,0,0,1.312108439,3.233063349,PLA2G1B;RHOBTB3;WASL;PPP1R9A;ARHGAP12;CORO1C;SPTA1;CDC42;EFS;MPRIP;FLNA;RAC1;CGNL1;CARMIL1;MARCKSL1;GSN;TPM4;ACTN1;TMOD3;TPM2;TMOD2;TPM1;SHROOM2;DSTN;MYO5A;ARPC4;RHOC;RHOA;SHROOM4;CD2AP;ENAH;ACTA1;MARCKS;MYO1C;ABI2;FAT1;SPIRE1;ARHGEF2;ALDOA;DBN1;BCAR1
negative regulation of mRNA catabolic process (GO:1902373),29-Oct,0.085396723,0.834091859,0,0,1.86745616,4.594777936,LARP1;THRAP3;NOCT;DND1;MEIOC;HNRNPU;YBX1;PABPC1;ELAVL1;PAIP1
positive regulation of dephosphorylation (GO:0035306),29-Oct,0.085396723,0.834091859,0,0,1.86745616,4.594777936,PTPA;PTBP1;ANKLE2;PPP1R7;CAMTA1;PPP2R5A;CALM3;CALM1;CALM2;PPIA
regulation of ubiquitin-protein transferase activity (GO:0051438),29-Oct,0.085396723,0.834091859,0,0,1.86745616,4.594777936,ARRDC4;DCUN1D5;FBXW7;FEM1B;ARRDC3;DCUN1D1;UBE2N;PARK7;UBE2L3;SMAD7
homotypic cell-cell adhesion (GO:0034109),14/44,0.085908881,0.835797203,0,0,1.656150748,4.064969136,ACTN1;PIK3CB;ACTB;MYL12A;ACTG1;RAP2B;FLNA;MYH9;TLN1;MYL9;PPIA;DSC2;METAP1;TJP2
intracellular protein transmembrane transport (GO:0065002),14/44,0.085908881,0.835797203,0,0,1.656150748,4.064969136,HSPA5;PAM16;TIMM23;PEX2;TIMM21;DNAJC15;HSPD1;SEC61A1;GRPEL1;SEC61G;TIMM17A;ROMO1;SEC61B;SEC62
cellular response to ionizing radiation (GO:0071479),15/48,0.088324593,0.85593617,0,0,1.613190731,3.914789147,YAP1;XRCC6;KDM1A;GADD45A;NUCKS1;MAPK14;EEF1D;SWI5;MAP3K20;TLK2;RAD1;RPL26;ECT2;CRYAB;RHNO1
regulation of protein metabolic process (GO:0051246),15/48,0.088324593,0.85593617,0,0,1.613190731,3.914789147,APP;MTPN;HSP90AB1;ROCK2;FAF1;ODC1;LTBP4;PLAUR;NEDD8;PARL;FKBP1A;MAPK8;SPOP;SPOPL;TMEM9
positive regulation of peptidase activity (GO:0010952),22-Aug,0.090144437,0.869875619,0,0,2.027251146,4.878259647,RCN3;PRELID1;VCP;CLDN4;CLDN3;PSME3;PSME2;MAPK12
positive regulation of translational initiation (GO:0045948),22-Aug,0.090144437,0.869875619,0,0,2.027251146,4.878259647,KHDRBS1;CDC123;YTHDF1;DDX3X;YTHDF2;LARP1;RPS6KB1;POLR2G
Arp2/3 complex-mediated actin nucleation (GO:0034314),15-Jun,0.090465659,0.869875619,0,0,2.364808495,5.68212628,ACTR3;ACTR2;ARPC2;ARPC5L;ARPC4;ARPC5
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",15-Jun,0.090465659,0.869875619,0,0,2.364808495,5.68212628,SPRED2;DDX5;SPRED1;PMAIP1;RPL26;EEF1E1
centromere complex assembly (GO:0034508),12/37,0.09471268,0.908729349,0,0,1.703239918,4.014378749,HELLS;CENPE;NPM1;CENPW;NASP;POGZ;RUVBL1;CENPK;RBBP7;KNL1;CENPA;CENPS
positive regulation of cellular component biogenesis (GO:0044089),26/92,0.094935485,0.908729349,0,0,1.398642424,3.293184326,VCP;TSG101;TFRC;FAF1;VPS4B;PARK7;CLU;BCL2L11;SUMO1;TPR;FLOT1;RACK1;RPS3;SH3GLB1;PDCD6IP;NRG1;RHOC;CLDN3;GNL3L;ERCC1;CHMP2A;BAX;SDC1;PFN1;AJUBA;CRB3
actomyosin structure organization (GO:0031032),22/76,0.095240414,0.908729349,0,0,1.44625443,3.400651664,ITGB1;WDR1;ROCK1;ROCK2;TMOD3;CUL3;TMOD2;TPM1;ARRB1;TNFAIP1;F11R;RHOA;TJP1;KRT19;CSRP2;SIX4;PDCD10;EPB41L2;MYO18A;ZYX;MYH9;MYH10
regulation of epithelial to mesenchymal transition (GO:0010717),22/76,0.095240414,0.908729349,0,0,1.44625443,3.400651664,TGFB2;HPN;PTEN;ADIPOR1;LOXL2;SMAD7;PPP2CA;SPRED2;SPRED1;DAB2;SFRP2;SDHAF2;GLIPR2;MDK;MCRIP1;PDPN;DAG1;CTNNB1;SPRY2;SPRY1;FERMT2;EZH2
negative regulation of gene expression (GO:0010629),81/322,0.096804022,0.921872143,0,0,1.194865145,2.790089861,TRIM71;APP;DDX3X;PPP1R11;CELF1;EIF4A3;PARK7;YBX1;SYNCRIP;PTBP1;TRIM6;ZFP36;ENC1;RACK1;DNMT3B;FLOT2;JARID2;METTL16;RPS13;HELLS;DAPK1;FBXW7;SFMBT2;DNMT3A;RPL13A;SOX11;DICER1;MIF;PPHLN1;NUDT16L1;PUS7;FOXP1;TWSG1;ILF3;CLDN3;SFRP2;MYCN;PTRH2;NCL;MYADM;TMBIM6;EIF4E2;GAPDH;YAP1;GRB7;DDX6;ROCK2;PDGFB;HIF1A;MRPL13;GIGYF2;FXR1;RIDA;LARP1;PDCD10;NOCT;RPS3;IGF2BP1;RBBP7;PAIP2;TGFB2;YTHDF2;TIPARP;LSM5;NFKB1;DHFR;RPS26;REST;CNOT7;LIN28A;SYT11;ID2;CAPRIN1;AGO2;CALR;TARDBP;MPHOSPH8;CNOT9;LGR4;EZH2;BMPR1A
clathrin-dependent endocytosis (GO:0072583),26-Sep,0.097936472,0.930866428,0,0,1.878254581,4.364004791,ITSN2;INPP5F;CLTC;CANX;AP2B1;SIGLEC1;FNBP1L;AP2A2;AP2M1
cell cycle checkpoint signaling (GO:0000075),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,ZWILCH;NABP2;BUB1B;NABP1;BUB1
Golgi localization (GO:0051645),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,CDC42;ARHGAP21;PDCD10;YWHAZ;ARCN1
morphogenesis of a polarized epithelium (GO:0001738),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,RAB10;AHI1;LAMA5;ACTB;ACTG1
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,FKBP1A;CALM3;SRI;CALM1;CALM2
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,FKBP1A;CALM3;SRI;CALM1;CALM2
P-body assembly (GO:0033962),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,DDX6;ATXN2;RC3H1;LIMD1;LSM3
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,SEC61A1;HSPA5;SEC61G;SEC61B;SEC62
protein localization to condensed chromosome (GO:1903083),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,IK;ZWILCH;CDK1;BUB3;KNL1
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,CAMK2D;CALM3;SRI;CALM1;CALM2
regulation of oxidative stress-induced cell death (GO:1903201),12-May,0.102152597,0.952654725,0,0,2.533471988,5.77957807,REST;STK26;UBQLN1;P4HB;PARK7
NLS-bearing protein import into nucleus (GO:0006607),19-Jul,0.103363215,0.952670479,0,0,2.069280079,4.696243835,RANBP2;KPNA6;KPNA4;KPNA3;KPNB1;IPO5;KPNA1
pore complex assembly (GO:0046931),19-Jul,0.103363215,0.952670479,0,0,2.069280079,4.696243835,NDC1;AFDN;AHCTF1;NUP205;NUP107;TPR;NUP153
protein import into mitochondrial matrix (GO:0030150),19-Jul,0.103363215,0.952670479,0,0,2.069280079,4.696243835,GRPEL1;PAM16;TIMM17A;TIMM23;ROMO1;TIMM21;DNAJC15
regulation of autophagy of mitochondrion (GO:1903146),19-Jul,0.103363215,0.952670479,0,0,2.069280079,4.696243835,GSK3A;HAX1;FBXW7;CSNK2A2;VDAC1;PARK7;DNM1L
protein modification by small protein conjugation (GO:0032446),101/409,0.103786952,0.952670479,0,0,1.166106161,2.641714411,NUP107;UBE2D3;UBE2L3;TRIM28;CDC27;CDK5RAP3;ARRDC4;USP7;FBXW8;FBXW7;ARRDC1;UBE2E1;PIAS1;RBX1;CDC34;KCTD10;CUL9;NUP205;POM121;VCP;SEH1L;DCUN1D5;UBA6;CUL3;MYCBP2;CUL1;DCUN1D1;WDR61;RTF1;KLHL13;UBE2J2;HIF1A;NUP160;UBB;NUP85;TPR;HLTF;UBC;NAE1;UBE2F;UBE2I;UBE2B;NUP153;UBE2A;BSPRY;UVSSA;MKRN1;UBA3;UBE2N;UBA2;UBA1;SAE1;UBE2K;RAD18;RNF187;RNF14;ARRB1;HIF3A;TNFAIP1;CDC73;TRIM6;SUMO1;SUMO3;SUMO2;ENC1;RACK1;ELOB;ELOC;NDC1;PEX2;COMMD1;RANGAP1;UCHL3;DDB1;UBE2R2;NFX1;BIRC6;PCNA;RNF38;NEDD8;PCNP;CAND1;LEO1;NUP43;RPS27A;RAE1;TRIM44;RANBP2;USP9X;HUWE1;WWP1;UBE2G1;MIB1;KLHL9;UFM1;KLHL7;NEDD4;RLIM;TRIM33;CUL4B;NUP37
Golgi to plasma membrane protein transport (GO:0043001),30-Oct,0.103885715,0.952670479,0,0,1.773969483,4.017089823,RAB10;GOLGA4;GOLPH3;KRT18;RAB31;SEC16A;KIF13A;GOLGA7;SPTBN1;OPTN
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",30-Oct,0.103885715,0.952670479,0,0,1.773969483,4.017089823,RPS14;UTP6;RPS16;RPS8;BMS1;HEATR1;TSR1;NOL10;RPS21;NOP9
regulation of protein localization to membrane (GO:1905475),30-Oct,0.103885715,0.952670479,0,0,1.773969483,4.017089823,MMP14;GSN;GPC1;STX7;GPC3;CRIPT;GPC4;ACTB;SPTBN1;VTI1B
RNA-dependent DNA biosynthetic process (GO:0006278),30-Oct,0.103885715,0.952670479,0,0,1.773969483,4.017089823,ANKRD28;HSP90AA1;HSP90AB1;RFC1;PTGES3;RPA1;NHP2;PPIA;NOP10;TELO2
protein import (GO:0017038),25/89,0.10581567,0.968575231,0,0,1.386736603,3.114688978,IPO13;POM121;NUP107;CSE1L;HIKESHI;CLU;PHB2;IPO5;TOMM22;IPO9;NUP85;TPR;TNPO1;ATAD1;FIS1;HSP90AA1;SEC13;PEX19;HSPA4;NUTF2;PEX2;NUP153;NUP62CL;KPNB1;RAN
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),22/77,0.106773204,0.972520896,0,0,1.41986755,3.176312267,GSK3A;HDAC3;DCUN1D5;FBXW7;CUL3;MYCBP2;DCUN1D1;HUWE1;UBE3A;COMMD1;UBE2L3;GNL3;PIAS1;SMAD7;FKBP1A;UBB;TBC1D7;UBQLN1;UBA2;SAE1;CDK5RAP3;CENPS
positive regulation of type I interferon production (GO:0032481),22/77,0.106773204,0.972520896,0,0,1.41986755,3.176312267,HSP90AA1;XRCC6;DDX3X;CHUK;DDX58;DHX9;RIOK3;NFKB1;HSPD1;POLR1C;G3BP1;FLOT1;EP300;POLR2F;CTNNB1;POLR3G;LRRFIP1;POLR2H;GAPDH;POLR3K;POLR2K;POLR2L
endoplasmic reticulum organization (GO:0007029),21/73,0.106835898,0.972520896,0,0,1.433469442,3.205898908,APP;CYB5A;PRNP;TRAM1;SEC16A;ATL2;MIA3;MOSPD3;UBE2J2;RAB10;SEC61A1;SERP1;REEP5;VAPA;SEC61G;BNIP1;RAB18;SEC61B;DNM1L;EMD;SEC31A
modification-dependent protein catabolic process (GO:0019941),52/201,0.108126083,0.982459382,0,0,1.239812902,2.757910856,PPP1R11;RNF14;BUB1B;ARRB1;UBE3B;UBE2L3;CDC20;CDC26;CDC27;ELOC;ARRDC1;UBE2E1;RC3H1;UBE4B;RBX1;DDB1;CDC34;RNF128;UBE2R2;KCTD10;BIRC6;PCYOX1;PSMD11;PSMD14;UBA6;CUL3;UBR4;NEDD8;UBB;UBC;UBQLN1;FEM1C;RBBP6;BUB3;RPS27A;UBQLN4;XBP1;UBE2I;UBE2B;UBE2G1;UBE2A;NTAN1;MIB1;COPS3;NEDD4;PSMC2;PCYOX1L;RLIM;TRIP12;UBA1;UBE2K;MAD2L1
positive regulation of protein dephosphorylation (GO:0035307),11/34,0.108439652,0.983503947,0,0,1.696900069,3.769767807,PTPA;PTBP1;ANKLE2;HSP90AB1;PPP1R7;CAMTA1;PPP2R5A;CALM3;CALM1;CALM2;PPIA
cytoskeleton-dependent intracellular transport (GO:0030705),23-Aug,0.112677201,0.999996398,0,0,1.891979665,4.130623315,DYNC1I2;TUBA1B;CCDC186;TUBA1A;HOOK1;KIF5B;KIF1B;KIF1A
nucleotide metabolic process (GO:0009117),23-Aug,0.112677201,0.999996398,0,0,1.891979665,4.130623315,PNP;GUK1;NME2;CTPS2;PARK7;ENPP3;NUDT5;REXO2
regulation of protein export from nucleus (GO:0046825),23-Aug,0.112677201,0.999996398,0,0,1.891979665,4.130623315,YWHAE;XPO4;TPR;PARK7;ANP32B;RANGAP1;PTPN14;EMD
chromosome organization (GO:0051276),29/106,0.113546669,0.999996398,0,0,1.337133589,2.908989405,TOP2A;HDAC3;SATB1;SETD7;EHMT1;CDCA8;NUCKS1;COPS7A;UBB;MYC;UBC;GATAD1;HMGN2;RPS27A;RAE1;HMGN1;CENPW;PARP1;LRWD1;RAD23B;RBX1;SMARCA4;COPS4;DDB1;COPS3;COPS6;COPS2;EZH2;CUL4B
protein localization to nucleus (GO:0034504),29/106,0.113546669,0.999996398,0,0,1.337133589,2.908989405,IPO13;YWHAE;POM121;NUP107;CSE1L;RPL11;HNRNPU;ARL2;NOL8;HIKESHI;RPF2;PHB2;IPO5;TBRG1;IPO9;SIX4;NUP85;TPR;LMNA;TNPO1;GBP2;SEC13;NUP153;NUTF2;PML;CALR;NUP62CL;KPNB1;RAN
antigen receptor-mediated signaling pathway (GO:0050851),48/185,0.114256519,0.999996398,0,0,1.244507941,2.699722511,KHDRBS1;PSMD12;PSMD11;PSMD14;CUL1;PIK3CB;PSMA7;PSMB10;PSMD8;PSMB6;PSMB7;PSMD6;PAK1;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;EIF2B1;PAK2;CD276;EIF2B3;CHUK;PLEKHA1;RC3H1;NFKB1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMC6;PSMA1;PSMC3;WNK1;PSMA2;PSMC4;PSME3;PSMC1;PSME4;PSMC2;UBE2N;PSME2;BCAR1
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),48/185,0.114256519,0.999996398,0,0,1.244507941,2.699722511,COPB2;ARF4;DYNC1I2;TMED10;SAR1A;PDCD6;COPB1;CUL3;GOSR2;ATL2;DCTN3;USO1;MIA3;IER3IP1;SPTA1;NRBP2;CAPZB;TMED3;TMED2;SPTAN1;YKT6;SPTBN1;SEC31A;VTI1B;RAB2A;SEC13;TMED9;COG7;TRAPPC1;SEC16A;TRAPPC4;ANK2;DYNLL1;COPZ1;ARCN1;TRAPPC6A;CNIH1;VAPA;CAPZA1;CAPZA2;GOPC;ERGIC3;ERGIC2;ACTR10;FOLR1;SEC24C;CNIH4;ERGIC1
actin-mediated cell contraction (GO:0070252),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,CAMK2D;GSN;PDPN;PARVA
astral microtubule organization (GO:0030953),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,LIMK2;EZR;KPNB1;RAB11A
ATF6-mediated unfolded protein response (GO:0036500),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,XBP1;HSPA5;CALR;HSP90B1
axon regeneration (GO:0031103),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,DHFR;GAP43;NREP;FOLR1
exonucleolytic trimming involved in rRNA processing (GO:0000459),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,EXOSC7;EXOSC8;EXOSC3;EXOSC2
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,EXOSC7;EXOSC8;EXOSC3;EXOSC2
kinetochore assembly (GO:0051382),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,CENPE;CENPW;POGZ;CENPA
mitochondrial fragmentation involved in apoptotic process (GO:0043653),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,FIS1;BNIP3;BAX;DNM1L
positive regulation of autophagy of mitochondrion (GO:1903599),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,VDAC1;PARK7;SLC25A5;SLC25A4
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,PCNA;RFC4;POLG2;RFC2
positive regulation of ligase activity (GO:0051351),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,AIMP2;MID1IP1;TMSB4X;GCLM
regulation of DNA-directed DNA polymerase activity (GO:1900262),09-Apr,0.114389186,0.999996398,0,0,2.837207187,6.151487177,PCNA;RFC4;POLG2;RFC2
ATP-dependent chromatin remodeling (GO:0043044),13/42,0.114552803,0.999996398,0,0,1.59062333,3.44643443,MBD3;SMARCE1;PBRM1;SMARCC1;CHD4;ARID1A;SMARCA1;ACTB;SMARCA4;CECR2;NASP;ANP32E;HNRNPC
nucleic acid-templated transcription (GO:0097659),13/42,0.114552803,0.999996398,0,0,1.59062333,3.44643443,MLF1;FUBP3;POLR2B;DRG1;POLR2F;POLR2G;RNPS1;POLR2H;POLR2I;POLR2J;PTMA;POLR2K;POLR2L
regulation of apoptotic process (GO:0042981),177/742,0.116822948,0.999996398,0,0,1.115001508,2.394015006,ANKRD13C;MTCH1;ANKLE2;MTCH2;TFRC;ZFAND6;PDCD5;PARK7;PHB2;CLU;IGF1R;HMGN5;SLK;LGALS1;FAM162A;MYC;ARHGDIA;CFL1;RPS6KA1;PIM3;SKP2;PHLDA1;SOX4;MED1;BNIP3L;PRKCI;DAPK1;IGFBP3;ACTN1;RPS6;ACTN4;MIF;CLIP3;MELK;SFRP2;YME1L1;PHIP;VDAC1;PPIA;RNF122;PPID;VCP;SHC1;GLO1;HPN;PHB;HIGD1A;STK4;FOXO1;MTDH;HSP90B1;PRDX2;PRDX5;BCL2L11;UBB;PDCD10;UBC;MAP3K20;PMAIP1;NAE1;ECT2;MCL1;HSPA9;PLK3;JUN;PRELID1;XBP1;HSPA5;API5;GADD45A;BRAF;DHCR24;PA2G4;MT3;NFKB1;IL2;GADD45G;MLLT11;SETX;AHI1;DAB2;GCLC;HNRNPK;SON;STK26;WNK3;CDK1;ANP32E;RNPS1;ANP32B;CALR;TDGF1;BCL2L1;ITGB1;TOP2A;ARF4;RARG;TNFAIP8;DDX3X;FAF1;SRA1;HMGB1;IER3IP1;SIX4;C1QBP;RACK1;MYO18A;DNM1L;HSP90AA1;PLEKHG2;PRMT2;TNFRSF12A;UTP11;ARHGEF16;NME2;PLAUR;RABGGTB;DUSP9;YWHAZ;DUSP6;NME1;HAX1;LATS2;TAX1BP1;BIRC5;BIRC6;ITGA6;TMBIM6;ARHGEF2;SOS1;EEF1E1;CRYAB;PTMA;ARHGEF5;HDAC3;RPL10;TAF9;LRP2;FSTL1;THBS1;HSPD1;PTPA;BCLAF1;MAPK8;MIEN1;PERP;PDPN;RPS3;BNIP1;FLNA;SAP18;PTK2B;RPS27A;PAK2;EGLN3;NPM1;BNIP3;RRP1B;CFLAR;PNMA2;HYPK;TJP1;RSL1D1;GOLPH3;REST;UFM1;KRT18;RPS6KB1;CTNNB1;BAX;SPRY2;NAA16;NAA15;TARDBP;BCAR1;TPT1;MAD2L1
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),15/50,0.117944749,0.999996398,0,0,1.520812976,3.250797041,CARMIL1;FBXW8;CDC42;MDK;C1QBP;CAPRIN1;MYADM;FLNA;RAC1;CALR;P4HB;CRK;FERMT2;S100A10;LIMS1
"regulation of gene expression, epigenetic (GO:0040029)",23/82,0.118587993,0.999996398,0,0,1.383729123,2.950248919,DNMT3A;GLMN;IGF2;DDX21;PPHLN1;DEK;ACTB;DNMT3L;TAF1D;MYO1C;TDG;POLR1C;DNMT3B;EP300;POLR2F;POLR2H;RBBP7;JARID2;SF3B1;MPHOSPH8;POLR2K;POLR2L;EZH2
3'-UTR-mediated mRNA destabilization (GO:0061158),16-Jun,0.118859389,0.999996398,0,0,2.128191126,4.532651449,TRIM71;ZFP36;DND1;RC3H1;TARDBP;ZFP36L1
cellular response to corticosteroid stimulus (GO:0071384),16-Jun,0.118859389,0.999996398,0,0,2.128191126,4.532651449,REST;ZFP36;BCL2L11;HNRNPU;UBE2L3;ZFP36L1
regulation of rRNA processing (GO:2000232),16-Jun,0.118859389,0.999996398,0,0,2.128191126,4.532651449,TRMT112;YTHDF2;HEATR1;WDR75;BUD23;WDR43
mitotic chromosome condensation (GO:0007076),27-Sep,0.119487067,0.999996398,0,0,1.77379326,3.768507404,SET;CSNK2A1;NCAPH2;CSNK2A2;CDK1;NCAPD2;KMT5A;SMC4;SMC2
negative regulation of actin filament bundle assembly (GO:0032232),27-Sep,0.119487067,0.999996398,0,0,1.77379326,3.768507404,TJP1;STMN1;TACSTD2;RHPN2;F11R;PFN1;PAK2;WASF2;CGNL1
protein export from nucleus (GO:0006611),27-Sep,0.119487067,0.999996398,0,0,1.77379326,3.768507404,XPO1;XPO4;CSE1L;TPR;CHP1;XPO7;NUTF2;CALR;RAN
regulation of cell junction assembly (GO:1901888),27-Sep,0.119487067,0.999996398,0,0,1.77379326,3.768507404,RAP1B;TJP1;CLDN3;MYO1C;ROCK1;ROCK2;FLOT1;F11R;CRB3
snRNA transcription by RNA polymerase II (GO:0042795),20/70,0.11986982,0.999996398,0,0,1.419675873,3.011627931,GTF2A1;GTF2A2;SRRT;TAF9;PHAX;GTF2F2;GTF2E2;CDK7;POLR2B;SP1;SNAPC3;NABP2;POLR2F;NABP1;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L
stress-activated MAPK cascade (GO:0051403),18/62,0.119898709,0.999996398,0,0,1.451838716,3.079506695,CHUK;CUL1;MAPK14;DUSP9;NFKB1;ZFP36L1;MAPK13;ZFP36;MAPK8;UBB;UBC;MAP3K20;UBE2N;MAPK1;CCM2;UBE2V1;RPS27A;MAPK3
cell-cell junction assembly (GO:0007043),19/66,0.119987031,0.999996398,0,0,1.434728143,3.042156831,PATJ;WDR1;JUP;CTNND1;RHOC;ACTB;RHOA;ACTG1;SMAD7;TJP1;GJA1;PARD6B;CLDN12;PKP2;CTNNA1;CTNNB1;PKN2;TLN1;PAK2
multivesicular body organization (GO:0036257),31-Oct,0.124490915,0.999996398,0,0,1.689386299,3.519874434,TSG101;PDCD6IP;VPS4B;VTA1;CHMP2A;RAB27A;CHMP3;VPS36;RAB11A;CHMP5
positive regulation of ubiquitin-protein transferase activity (GO:0051443),31-Oct,0.124490915,0.999996398,0,0,1.689386299,3.519874434,CDC20;ARRDC4;DCUN1D5;FBXW7;ARRDC3;DCUN1D1;PTEN;UBE2N;CDC14B;UBE2L3
protein acetylation (GO:0006473),31-Oct,0.124490915,0.999996398,0,0,1.689386299,3.519874434,NAA50;ESCO1;NAA10;BLOC1S1;HAT1;NAT10;EP300;NAA16;NAA15;FOXO1
acetyl-CoA biosynthetic process from pyruvate (GO:0006086),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,PDHA1;PDHB;DLD
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,JUP;PKP2;DSC2
centromeric sister chromatid cohesion (GO:0070601),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,NAA50;BUB1B;BUB1
COPI coating of Golgi vesicle (GO:0048205),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,TMED9;TMED10;TMED2
COPI-coated vesicle budding (GO:0035964),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,TMED9;TMED10;TMED2
Golgi transport vesicle coating (GO:0048200),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,TMED9;TMED10;TMED2
mitochondrial protein catabolic process (GO:0035694),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,BNIP3L;BNIP3;YME1L1
monoubiquitinated protein deubiquitination (GO:0035520),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,USP15;USP7;USP1
mRNA 3'-splice site recognition (GO:0000389),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,ISY1;SF3A3;SF3A1
negative regulation of cell size (GO:0045792),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,RDX;PTEN;RHOA
negative regulation of erythrocyte differentiation (GO:0045647),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,HSPA9;ZFP36;ZFP36L1
negative regulation of glial cell proliferation (GO:0060253),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,RNF10;SOX11;DICER1
neuroepithelial cell differentiation (GO:0060563),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,BCCIP;SOX11;SOX4
oxygen homeostasis (GO:0032364),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,EGLN1;WNT7B;HIF1A
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,HUWE1;TOMM7;HK2
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,PTEN;PMAIP1;THBS1
positive regulation of RNA binding (GO:1905216),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,EIF3E;EIF3C;EIF3D
positive regulation of tau-protein kinase activity (GO:1902949),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,HSP90AA1;HSP90AB1;CLU
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,BCL2L11;BAX;PMAIP1
protein localization to nucleolus (GO:1902570),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,NOL8;RPF2;RAN
purine nucleobase biosynthetic process (GO:0009113),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,GMPS;GART;PAICS
regulation of anion channel activity (GO:0010359),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,PRNP;TCAF2;GOPC
regulation of centriole elongation (GO:1903722),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,CEP295;VPS4B;CHMP2A
regulation of DNA demethylation (GO:1901535),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,OTUD4;USP7;USP9X
regulation of extracellular exosome assembly (GO:1903551),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,PDCD6IP;TSG101;SDC1
regulation of glomerular filtration (GO:0003093),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,F2R;PDGFB;F2RL1
regulation of hyaluronan biosynthetic process (GO:1900125),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,CLTC;PDGFB;NFKB1
regulation of keratinocyte apoptotic process (GO:1902172),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,ZFP36;GSN;ZFP36L1
regulation of response to reactive oxygen species (GO:1901031),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,DHFR;HEBP2;STK26
response to angiotensin (GO:1990776),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,ROCK1;ROCK2;NFKB1
ruffle assembly (GO:0097178),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,RAC1;AIF1L;ARF6
SCF complex assembly (GO:0010265),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,CAND1;CUL1;RBX1
tRNA 3'-end processing (GO:0042780),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,SSB;TRNT1;HSD17B10
vesicle localization (GO:0051648),06-Mar,0.125001527,0.999996398,0,0,3.546157344,7.37398358,SYT11;LIMK2;RAB11A
cholesterol biosynthetic process (GO:0006695),11/35,0.1281566,0.999996398,0,0,1.626091496,3.340808758,IDI1;SQLE;GGPS1;HMGCS1;PMVK;SC5D;DHCR24;HMGCR;LBR;LSS;ACAT2
miRNA metabolic process (GO:0010586),20-Jul,0.130147477,0.999996398,0,0,1.909982143,3.894619815,TRIM71;LIN28B;LIN28A;AGO2;PARN;DICER1;RAN
mitotic cytokinetic process (GO:1902410),20-Jul,0.130147477,0.999996398,0,0,1.909982143,3.894619815,PDCD6IP;VPS4B;CHMP2A;CHMP3;MITD1;RHOA;CHMP5
negative regulation of dephosphorylation (GO:0035305),20-Jul,0.130147477,0.999996398,0,0,1.909982143,3.894619815,PTPA;URI1;YWHAB;ZCCHC9;ENSA;CHP1;ARPP19
positive regulation of peptidyl-lysine acetylation (GO:2000758),20-Jul,0.130147477,0.999996398,0,0,1.909982143,3.894619815,TADA2A;RUVBL2;ARRB1;DIP2B;SOX4;GLYR1;MAPK3
post-transcriptional gene silencing by RNA (GO:0035194),20-Jul,0.130147477,0.999996398,0,0,1.909982143,3.894619815,CNOT6;CNOT7;EIF6;CELF1;AGO2;LIMD1;AJUBA
snRNA transcription (GO:0009301),20/71,0.133937016,0.999996398,0,0,1.391749578,2.797953337,GTF2A1;GTF2A2;SRRT;TAF9;PHAX;GTF2F2;GTF2E2;CDK7;POLR2B;SP1;SNAPC3;NABP2;POLR2F;NABP1;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L
cellular biogenic amine metabolic process (GO:0006576),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,MAOA;AMD1;ODC1;SMS;SRM
cellular component maintenance (GO:0043954),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,PRNP;MTMR2;CLDN3;ITGA3;IGF1R
chromatin organization involved in regulation of transcription (GO:0034401),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,SMARCD1;ELOF1;CDCA4;ZMIZ2;ARID1A
negative regulation of hippo signaling (GO:0035331),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,WWC1;LIMD1;MAPK14;AJUBA;MARK3
positive regulation of neuron migration (GO:2001224),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,SEMA6A;MDK;PLAA;ARHGEF2;KIF20B
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,ZFP36;CNOT7;AGO2;POLR2G;PABPC1
positive regulation of vascular endothelial cell proliferation (GO:1905564),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,MDK;SP1;IGF2;HMGB1;FGFR1
regulation of actomyosin structure organization (GO:0110020),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,CDC42;ROCK1;ROCK2;RAC1;ACTG1
regulation of cell aging (GO:0090342),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,RSL1D1;NUAK1;NEK6;LMNA;MIF
regulation of cell communication by electrical coupling (GO:0010649),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,CAMK2D;CALM3;SRI;CALM1;CALM2
regulation of mRNA metabolic process (GO:1903311),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,SRPK2;SLTM;DHX9;CDK11B;SRPK1
transport along microtubule (GO:0010970),13-May,0.137120723,0.999996398,0,0,2.216645814,4.404239273,CDC42;CLIP3;APP;DYNC1I2;ARHGAP21
positive regulation of lamellipodium assembly (GO:0010592),24-Aug,0.137945216,0.999996398,0,0,1.773617118,3.513355776,ACTR3;CDC42;ACTR2;NCKAP1;ABI2;ARPC2;RAC1;WASF2
positive regulation of neuron apoptotic process (GO:0043525),24-Aug,0.137945216,0.999996398,0,0,1.773617118,3.513355776,SRPK2;PRNP;TGFB2;ITGAM;FBXW7;BAX;CTNNB1;MCL1
regulation of cell size (GO:0008361),24-Aug,0.137945216,0.999996398,0,0,1.773617118,3.513355776,MTPN;RARG;RDX;PTEN;MSN;RAC1;EZR;RHOA
regulation of keratinocyte proliferation (GO:0010837),24-Aug,0.137945216,0.999996398,0,0,1.773617118,3.513355776,TGM1;MED1;ZFP36;MDK;PTPRK;SRSF6;FGFR2;ZFP36L1
response to gamma radiation (GO:0010332),24-Aug,0.137945216,0.999996398,0,0,1.773617118,3.513355776,YAP1;XRCC6;KDM1A;MYC;MAP3K20;TLK2;RPL26;CRYAB
negative regulation of apoptotic process (GO:0043066),117/485,0.139356329,0.999996398,0,0,1.130360568,2.227625429,ANKLE2;TFRC;ZFAND6;PARK7;PHB2;IGF1R;NRBP2;HMGN5;MAEA;MYC;LAMP3;ARHGDIA;CFL1;RPS6KA1;PIM3;MED1;BNIP3L;PRKCI;CSNK2A1;CSNK2A2;F2R;MIF;YME1L1;PHIP;VDAC1;BEX3;SET;SHC1;GLO1;HPN;HIGD1A;FOXO1;MTDH;HSP90B1;PRDX2;PRDX5;UBB;PDCD10;UBC;SFN;MCL1;SNX6;HSPA9;PLK3;PRELID1;XBP1;HSPA5;API5;BRAF;DHCR24;PA2G4;MT3;NFKB1;IL2;SETX;AHI1;DAB2;GCLC;HNRNPK;SON;WNK3;CDK1;TDGF1;BCL2L1;ITGB1;YWHAE;ARF4;TNFAIP8;DDX3X;SIX4;MDK;MYO18A;NME2;PLAUR;YWHAZ;SFPQ;HAX1;PTRH2;TAX1BP1;BIRC5;BIRC6;TMBIM6;CRYAB;PTMA;YAP1;HDAC3;RPL10;TAF9;LRP2;FSTL1;THBS1;HSPD1;MAPK8;MIEN1;PDPN;BNIP1;FLNA;MAPK1;PTK2B;RPS27A;PAK2;MAPK3;NPM1;BNIP3;CFLAR;HYPK;TJP1;GOLPH3;UFM1;KRT18;RPS6KB1;CTNNB1;SPRY2;NAA16;NAA15;TPT1;MAD2L1
cellular response to epidermal growth factor stimulus (GO:0071364),28-Sep,0.143377365,0.999996398,0,0,1.680327869,3.263659164,DUSP22;EEF1A1;MED1;ZFP36;DUSP3;IQGAP1;PTPN12;TDGF1;ZFP36L1
histone mRNA metabolic process (GO:0008334),28-Sep,0.143377365,0.999996398,0,0,1.680327869,3.263659164,SLBP;SSB;CPSF3;CPSF2;LSM1;SNRPG;SNRPE;SNRPD3;SNRPF
negative regulation of phosphatase activity (GO:0010923),28-Sep,0.143377365,0.999996398,0,0,1.680327869,3.263659164,PTPA;FKBP1A;URI1;TGFB2;PPP1R11;ZCCHC9;TIPRL;CHP1;MASTL
positive regulation of microtubule polymerization (GO:0031116),28-Sep,0.143377365,0.999996398,0,0,1.680327869,3.263659164,PAK1;AKAP9;RPS3;DRG1;ARL2;RAC1;MAPRE1;CKAP5;GIT1
regulation of multicellular organismal development (GO:2000026),28-Sep,0.143377365,0.999996398,0,0,1.680327869,3.263659164,RAB14;GBX1;TDG;CDK1;EHMT1;TRIP12;MYSM1;DUSP9;DUSP6
chromatin remodeling at centromere (GO:0031055),10/32,0.147141078,0.999996398,0,0,1.612492495,3.090121658,HELLS;NPM1;CENPW;NASP;RUVBL1;CENPK;RBBP7;KNL1;CENPA;CENPS
mitochondrial membrane organization (GO:0007006),10/32,0.147141078,0.999996398,0,0,1.612492495,3.090121658,HSPA9;APOO;CHCHD3;TMEM11;BNIP3;PMAIP1;GHITM;SLC25A5;SLC25A4;BCL2L1
modulation by host of symbiont process (GO:0051851),10/32,0.147141078,0.999996398,0,0,1.612492495,3.090121658,JUN;REST;SP1;HPN;EP300;NUCKS1;RRP1B;TARDBP;CHD1;SMARCA4
positive regulation of lamellipodium organization (GO:1902745),10/32,0.147141078,0.999996398,0,0,1.612492495,3.090121658,CDC42;ACTR3;NCKAP1;ACTR2;CARMIL1;ABI2;ARPC2;RAC1;WASF2;CORO1C
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),10/32,0.147141078,0.999996398,0,0,1.612492495,3.090121658,CDK17;DHFR;NPAT;PCNA;RRM2;TFDP1;CCNE1;ID2;CDK14;E2F7
establishment of protein localization to organelle (GO:0072594),21/76,0.147701471,0.999996398,0,0,1.35501868,2.591557414,IPO13;SEC13;POM121;NUP107;PEX19;CSE1L;HIKESHI;NUTF2;NUP153;PHB2;HK2;RAB11A;IPO5;IPO9;NUP85;LAMP3;TPR;TNPO1;NUP62CL;KPNB1;RAN
regulation of cell division (GO:0051302),21/76,0.147701471,0.999996398,0,0,1.35501868,2.591557414,SH3GLB1;PLK3;AHCTF1;PRPF40A;KLHL13;RAB11A;KLHL9;SFRP2;MYC;KIF13A;RACK1;TXNIP;BIRC6;SFN;CALM3;FSD1;CALM1;CALM2;GIT1;FGFR2;BCL2L1
establishment of protein localization to plasma membrane (GO:0061951),11/36,0.149690693,0.999996398,0,0,1.560947608,2.964526971,RAB10;AFDN;GOLGA4;GOLPH3;RAB31;RILPL1;KIF13A;GOLGA7;NECTIN3;SPTBN1;OPTN
regulation of androgen receptor signaling pathway (GO:0060765),11/36,0.149690693,0.999996398,0,0,1.560947608,2.964526971,DDX5;DAB2;KDM1A;PRMT2;RNF14;FOXH1;EP300;PARK7;PHB;FOXP1;SMARCA4
negative regulation of cell cycle process (GO:0010948),18/64,0.151001531,0.999996398,0,0,1.388536738,2.624980521,CBX5;PHC1;RRM2;CBX3;MGA;PCGF2;EHMT1;RNF2;WAPL;TOM1L1;TFDP1;NME6;CHMP2A;RBBP7;AURKAIP1;E2F7;E2F8;EZH2
embryo development ending in birth or egg hatching (GO:0009792),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,TGFB2;CELF1;USP22;CELF4;TDGF1;FGFR1
histone H2A monoubiquitination (GO:0035518),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,DDB1;PCGF5;PCGF2;PCGF3;RNF2;CUL4B
midbody abscission (GO:0061952),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,PDCD6IP;VPS4B;CHMP2A;CHMP3;MITD1;CHMP5
positive regulation of telomere capping (GO:1904355),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,TNKS2;HNRNPD;NABP2;MAPK1;MAP3K4;MAPK3
"protein localization to chromosome, centromeric region (GO:0071459)",17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,IK;ZWILCH;CDK1;KNL1;BUB3;CENPA
regulation of Golgi organization (GO:1903358),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,USP6NL;PDCD10;AKAP9;MYO5A;MAPK1;MAPK3
RNA interference (GO:0016246),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,CELF1;DHX9;AGO2;DICER1;TSN;MRPL44
ruffle organization (GO:0031529),17-Jun,0.151076436,0.999996398,0,0,1.934595098,3.656325484,CARMIL1;PLEKHA1;TPM1;RAC1;AIF1L;ARF6
mitotic spindle assembly (GO:0090307),13/44,0.152289494,0.999996398,0,0,1.487811333,2.800019275,BCCIP;KIF23;KIF11;SMC3;SMC1A;RAB11A;RHOA;TPX2;STAG2;KIF2A;KIFC2;FLNA;KPNB1
positive regulation of stress fiber assembly (GO:0051496),13/44,0.152289494,0.999996398,0,0,1.487811333,2.800019275,CARMIL1;ROCK2;TPM1;RHOC;SORBS3;RHOA;CDC42;PAK1;RAC1;EPHA1;ARHGEF5;FERMT2;S100A10
negative regulation of mitotic cell cycle (GO:0045930),14/48,0.152711534,0.999996398,0,0,1.460934043,2.745393883,CDKN1C;BTG3;ZWILCH;BUB1B;ZFP36L1;TOM1L1;NME6;NABP2;CTNNB1;NABP1;AURKAIP1;BUB1;MAD2L1;PTPN3
transforming growth factor beta receptor signaling pathway (GO:0007179),24/89,0.157504234,0.999996398,0,0,1.310402278,2.422020384,ITGB1;LEFTY1;USP15;JUN;TGFB2;USP9X;FOXH1;PTPRK;CGN;F11R;SMAD5;RHOA;SMAD7;DUSP22;FKBP1A;TWSG1;UBB;ZMIZ2;UBC;ID1;ZYX;RPS27A;FERMT2;BMPR1A
adherens junction assembly (GO:0034333),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,CTNNB1;PAK2;ACTB;SMAD7
dicarboxylic acid biosynthetic process (GO:0043650),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,GLUD1;GOT1;MTHFD1;GLS
endothelial tube morphogenesis (GO:0061154),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,CTNNB1;CCM2;RBPJ;RHOA
ESCRT complex disassembly (GO:1904896),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,VPS4B;VTA1;CHMP2A;CHMP5
ESCRT III complex disassembly (GO:1904903),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,VPS4B;VTA1;CHMP2A;CHMP5
L-serine metabolic process (GO:0006563),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,PSAT1;PHGDH;SERINC3;PSPH
low-density lipoprotein particle receptor catabolic process (GO:0032802),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,CLTC;AP2B1;AP2A2;AP2M1
low-density lipoprotein receptor particle metabolic process (GO:0032799),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,CLTC;AP2B1;AP2A2;AP2M1
modification-dependent macromolecule catabolic process (GO:0043632),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,UBB;UBC;NEDD8;RPS27A
neuron projection regeneration (GO:0031102),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,DHFR;GAP43;NREP;FOLR1
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,EXOSC7;EXOSC8;EXOSC3;EXOSC2
peptidyl-amino acid modification (GO:0018193),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,FKBP10;TTLL4;METAP1;METAP2
positive regulation of lipase activity (GO:0060193),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,RHOC;FGFR2;RHOA;FGFR1
positive regulation of protein sumoylation (GO:0033235),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,UBA2;SAE1;GNL3;PIAS1
production of siRNA involved in RNA interference (GO:0030422),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,AGO2;DICER1;TSN;MRPL44
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,XBP1;HSPA5;RACK1;BAX
regulation of epithelial cell apoptotic process (GO:1904035),10-Apr,0.158722669,0.999996398,0,0,2.364187704,4.351516374,YAP1;ZFP36;MDK;ZFP36L1
actin nucleation (GO:0045010),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,ACTR3;ACTR2;ARPC2;ARPC5L;SPIRE1;ARPC4;ARPC5
epithelial cell development (GO:0002064),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,ACTA2;SLC4A7;CLDN3;RAB25;RILPL1;WNT7B;GRHL2
mitotic spindle assembly checkpoint signaling (GO:0007094),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,CDC20;IK;TPR;BUB1B;BUB3;BUB1;MAD2L1
mitotic spindle checkpoint signaling (GO:0071174),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,CDC20;IK;TPR;BUB1B;BUB3;BUB1;MAD2L1
negative regulation of small GTPase mediated signal transduction (GO:0051058),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,TGFB2;SPRY4;SPRY2;SPRY1;CGNL1;ARHGAP12;CD2AP
rRNA modification (GO:0000154),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,TRMT112;NHP2;NAT10;METTL5;BUD23;NOP10;FTSJ3
spindle assembly checkpoint signaling (GO:0071173),21-Jul,0.159995872,0.999996398,0,0,1.773441056,3.250020966,CDC20;IK;TPR;BUB1B;BUB3;BUB1;MAD2L1
cellular response to UV (GO:0034644),21/77,0.163049573,0.999996398,0,0,1.330736301,2.413557755,NPM1;PCNA;KDM1A;PARP1;PTPRK;NOC2L;CRIP1;EIF2S1;MAPK13;DDB1;IMPACT;MYC;RUVBL2;ERCC1;NEDD4;EP300;RPL26;PPID;RHNO1;COPS9;CUL4B
negative regulation of response to endoplasmic reticulum stress (GO:1903573),25-Aug,0.165772838,0.999996398,0,0,1.669179577,2.999744171,USP25;XBP1;RACK1;TXNDC12;TMBIM6;PARK7;CLU;BCL2L1
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),25-Aug,0.165772838,0.999996398,0,0,1.669179577,2.999744171,APP;TRIM6;WNK3;MAPK1;CALM3;CALM1;CALM2;UBE2K
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25-Aug,0.165772838,0.999996398,0,0,1.669179577,2.999744171,FKBP1A;SELENON;CAMK2D;CALM3;SRI;CALM1;JPH1;CALM2
regulation of spindle assembly (GO:0090169),25-Aug,0.165772838,0.999996398,0,0,1.669179577,2.999744171,PDCD6IP;VPS4B;TPR;CHMP2A;DRG1;HNRNPU;CHMP3;CHMP5
aggrephagy (GO:0035973),29-Sep,0.169468658,0.999996398,0,0,1.596209016,2.833410315,DYNC1I2;UBB;UBC;UBQLN1;UBE2N;PARK7;UBE2V1;RPS27A;DYNLL1
beta-catenin-TCF complex assembly (GO:1904837),29-Sep,0.169468658,0.999996398,0,0,1.596209016,2.833410315,TLE4;BCL9;MYC;RUVBL1;LEO1;EP300;CTNNB1;CDC73;SMARCA4
production of miRNAs involved in gene silencing by miRNA (GO:0035196),29-Sep,0.169468658,0.999996398,0,0,1.596209016,2.833410315,TRIM71;LIN28B;LIN28A;SRRT;AGO2;HNRNPA2B1;DICER1;MRPL44;PUM2
telomere maintenance via telomerase (GO:0007004),29-Sep,0.169468658,0.999996398,0,0,1.596209016,2.833410315,ANKRD28;HSP90AA1;HSP90AB1;RFC1;PTGES3;RPA1;NHP2;NOP10;TELO2
IRE1-mediated unfolded protein response (GO:0036498),15/53,0.171950029,0.999996398,0,0,1.400478796,2.465614871,KLHDC3;GSK3A;XBP1;HSPA5;SHC1;GOSR2;EDEM1;WIPI1;PDIA6;SERP1;LMNA;SSR1;HDGF;TLN1;SEC31A
regulation of DNA replication (GO:0006275),15/53,0.171950029,0.999996398,0,0,1.400478796,2.465614871,STN1;PCNA;ESCO1;DHX9;FAF1;GMNN;NUCKS1;SMC3;PDS5A;GTPBP4;WAPL;CCNA2;PPP2CA;RBBP6;S100A11
regulation of cellular protein metabolic process (GO:0032268),14/49,0.172803415,0.999996398,0,0,1.419101892,2.491376215,APP;MTPN;RPL10;DDX25;NOLC1;NFKB1;PUM3;RBM3;ATXN2;PLA2G10;GEMIN5;EIF4E;METAP1;EIF2A
response to unfolded protein (GO:0006986),14/49,0.172803415,0.999996398,0,0,1.419101892,2.491376215,HSPA9;HSPA8;HSP90AA1;HSP90AB1;HSPA5;HSPA4;HSPB2;HSPE1;HSPD1;SERPINH1;BAX;TMBIM6;STT3B;OPTN
protein insertion into ER membrane (GO:0045048),11/37,0.172950625,0.999996398,0,0,1.500814789,2.633553443,UBL4A;APP;CYB5A;PRNP;TRAM1;SERP1;VAPA;SEC61G;SEC61B;UBE2J2;EMD
regulation of protein autophosphorylation (GO:0031952),11/37,0.172950625,0.999996398,0,0,1.500814789,2.633553443,TOM1L1;IMPACT;DDX3X;PPP2R5E;PDGFB;CHP1;PPP2R5A;CALM3;PPP2R5C;CALM1;CALM2
positive regulation of RNA metabolic process (GO:0051254),13/45,0.173326993,0.999996398,0,0,1.441224647,2.525854769,DDX5;HEATR1;WDR75;NMD3;WDR43;NFKB1;SETX;TRMT112;LIN28B;LIN28A;MYCN;BUD23;SLC38A2
regulation of DNA repair (GO:0006282),13/45,0.173326993,0.999996398,0,0,1.441224647,2.525854769,PCNA;DHX9;BRCC3;DEK;PML;SMCHD1;TRIM28;UBR5;RPS3;USP1;UBE2N;TRIP12;UBE2V1
regulation of G0 to G1 transition (GO:0070316),12/41,0.173421353,0.999996398,0,0,1.467933156,2.57186451,CBX5;PHC1;RRM2;TFDP1;CBX3;MGA;PCGF2;EHMT1;RBBP7;RNF2;EZH2;RHNO1
COPII-coated vesicle cargo loading (GO:0090110),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,SEC13;SAR1A;MIA3;SEC24C;SEC31A
covalent chromatin modification (GO:0016569),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,HELLS;PARP2;PARK7;CHD1;MT3
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,GPC1;SPRY4;SPRY2;SPRY1;THBS1
nucleoside triphosphate metabolic process (GO:0009141),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,NME2;AK3;ENPP3;DCTPP1;ITPA
polarized epithelial cell differentiation (GO:0030859),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,CDC42;RAB10;MSN;EZR;RHOA
pre-miRNA processing (GO:0031054),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,LIN28B;LIN28A;AGO2;DICER1;MRPL44
regulation of lamellipodium organization (GO:1902743),14-May,0.176521039,0.999996398,0,0,1.970225457,3.416991977,CDC42;CARMIL1;CAPZB;PDPN;RAC1
ephrin receptor signaling pathway (GO:0048013),22/82,0.176878527,0.999996398,0,0,1.301126589,2.253931272,ACTR3;ACTR2;ROCK1;ROCK2;ARPC4;WASL;AP2B1;ARPC5;EFNA5;AP2A2;ACTB;RHOA;ACTG1;CDC42;EFNB2;PAK1;ARPC2;RAC1;EPHA1;CRK;AP2M1;GIT1
COPII-coated vesicle budding (GO:0090114),19/70,0.183849592,0.999996398,0,0,1.321860374,2.238752018,ANKRD28;SEC13;TMED10;TRAPPC1;SAR1A;PDCD6;CUL3;GOSR2;SEC16A;TRAPPC4;USO1;MIA3;TRAPPC6A;CNIH1;VAPA;TMED2;FOLR1;SEC24C;SEC31A
positive regulation of cell-substrate adhesion (GO:0010811),19/70,0.183849592,0.999996398,0,0,1.321860374,2.238752018,CARMIL1;JUP;PDGFB;ARL2;CDC42;MDK;C1QBP;MYADM;FLNA;PTK2B;RAC1;CALR;P4HB;EPHA1;UTRN;CRK;FERMT2;S100A10;LIMS1
autophagosome membrane docking (GO:0016240),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,VMP1;ATP2A2;CALM1
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,JUP;PKP2;DSC2
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,VCP;VPS4B;CHMP3
gas homeostasis (GO:0033483),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,EGLN1;WNT7B;HIF1A
histone H3-K9 methylation (GO:0051567),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,SUV39H2;PRDM5;BEND3
malate metabolic process (GO:0006108),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,MDH1;MDH2;ME2
membrane biogenesis (GO:0044091),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,CLIP3;SERINC1;SPTBN1
membrane fission (GO:0090148),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,SH3GLB1;DNM1L;CORO1C
miRNA catabolic process (GO:0010587),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,LIN28B;LIN28A;PARN
modulation by symbiont of host apoptotic process (GO:0052150),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,SFPQ;MAPK1;MAPK3
modulation by symbiont of host defense response (GO:0052031),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,UBB;UBC;RPS27A
negative regulation of DNA repair (GO:0045738),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,UBR5;RPS3;TRIP12
negative regulation of membrane protein ectodomain proteolysis (GO:0051045),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,ROCK1;TIMP2;PTPN3
negative regulation of protein K63-linked ubiquitination (GO:1900045),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,UBR5;PLAA;TRIP12
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,NPM1;CDK5RAP3;CORO1C
negative regulation of protein sumoylation (GO:0033234),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,GNL3L;CTNNB1;PARK7
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,MYC;PPIA;FOXO1
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,ZFP36;PNRC2;ZFP36L1
pharyngeal arch artery morphogenesis (GO:0061626),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,TGFB2;FOLR1;BMPR1A
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,PARN;EXOSC3;EXOSC2
polyamine biosynthetic process (GO:0006596),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,AMD1;SMS;SRM
positive regulation of histone H3-K9 methylation (GO:0051574),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,RIF1;MYB;JARID2
positive regulation of microtubule nucleation (GO:0090063),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,PAK1;CKAP5;GIT1
positive regulation of miRNA mediated inhibition of translation (GO:1905618),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,DDX6;AGO2;EIF4E2
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,HUWE1;TOMM7;OPTN
positive regulation of mRNA binding (GO:1902416),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,EIF3E;EIF3C;EIF3D
positive regulation of potassium ion import across plasma membrane (GO:1903288),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,WNK1;WNK3;ATP1B3
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,ATXN2L;ATXN2;CNOT6
regulation of miRNA mediated inhibition of translation (GO:1905616),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,DDX6;AGO2;EIF4E2
regulation of necrotic cell death (GO:0010939),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,HEBP2;SLC6A6;MT3
regulation of transforming growth factor beta2 production (GO:0032909),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,TGFB2;HIF1A;BMPR1A
response to host defenses (GO:0052200),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,UBB;UBC;RPS27A
response to lead ion (GO:0010288),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,PPP2CA;PPP2CB;PPP1CA
RIG-I signaling pathway (GO:0039529),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,DDX58;PHB;PHB2
sphingosine-1-phosphate receptor signaling pathway (GO:0003376),07-Mar,0.184146058,0.999996398,0,0,2.659447476,4.499854391,PIK3CB;RAC1;EZR
cellular response to dsRNA (GO:0071359),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,NPM1;DDX58;DHX9;RIOK3;PDE12;FLOT1
cellular response to glucocorticoid stimulus (GO:0071385),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,REST;ZFP36;BCL2L11;HNRNPU;UBE2L3;ZFP36L1
positive regulation of phosphoprotein phosphatase activity (GO:0032516),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,PTPA;HSP90AB1;PPP1R12A;CALM3;CALM1;CALM2
regulation of cellular protein catabolic process (GO:1903362),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,HSP90AA1;FAF1;RDX;MSN;EZR;CDK5RAP3
regulation of establishment or maintenance of cell polarity (GO:0032878),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,RAP1B;ROCK1;ROCK2;RACK1;PTK2B;KIF20B
regulation of vascular endothelial cell proliferation (GO:1905562),18-Jun,0.18667916,0.999996398,0,0,1.773265074,2.976184012,FLT1;MDK;SP1;IGF2;HMGB1;FGFR1
positive regulation of mitochondrion organization (GO:0010822),16/58,0.19037506,0.999996398,0,0,1.351533909,2.241869239,FIS1;GSK3A;BNIP3;PDCD5;PLAUR;ZDHHC6;PARK7;BBC3;MLLT11;BCL2L11;FAM162A;PMAIP1;BAX;SPIRE1;MGARP;DNM1L
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),22-Jul,0.192593212,0.999996398,0,0,1.655105447,2.726248356,CDC20;IK;TPR;BUB1B;BUB3;BUB1;MAD2L1
negative regulation of myeloid cell differentiation (GO:0045638),22-Jul,0.192593212,0.999996398,0,0,1.655105447,2.726248356,HSPA9;ZFP36;LEO1;PTK2B;WDR61;CDC73;ZFP36L1
regulation of centrosome cycle (GO:0046605),22-Jul,0.192593212,0.999996398,0,0,1.655105447,2.726248356,NPM1;PDCD6IP;VPS4B;CHMP2A;NAT10;CHMP3;CHMP5
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),22-Jul,0.192593212,0.999996398,0,0,1.655105447,2.726248356,XBP1;BCL2L11;PMAIP1;TXNDC12;TMBIM6;PARK7;BCL2L1
regulation of cellular component movement (GO:0051270),14/50,0.194137343,0.999996398,0,0,1.379593749,2.261415474,YTHDF1;PRAG1;ROCK1;ROCK2;ACTN1;MYCBP2;NRG1;ACTN4;ETS1;RHOA;INPP5F;PDPN;PKN2;HBEGF
regulation of DNA metabolic process (GO:0051052),13/46,0.195706265,0.999996398,0,0,1.397461396,2.279455732,WDR18;THOC1;NUCKS1;GRHL2;TOM1L1;MYC;SUB1;USP1;HNRNPD;UBE2N;UBE2V1;MPHOSPH8;KPNA1
endothelial cell development (GO:0001885),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,RAP1B;COL18A1;MARVELD2;RDX;MYADM;MSN;F2RL1;EZR
glial cell development (GO:0021782),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,APP;EIF2B3;MYRF;MDK;SOX11;EIF2B1;MT3;SOX4
histone methylation (GO:0016571),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,SUV39H2;TRMT112;PRMT2;NSD1;NTMT1;CARM1;EHMT1;EZH2
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,STN1;GNL3L;TNKS2;PARP1;HNRNPU;NAT10;HNRNPC;HNRNPA1
positive regulation of histone methylation (GO:0031062),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,KMT2A;RIF1;MYB;DNMT3B;TET1;CTNNB1;WDR61;JARID2
positive regulation of microtubule polymerization or depolymerization (GO:0031112),26-Aug,0.195922337,0.999996398,0,0,1.576346207,2.569502547,PAK1;AKAP9;STMN2;RPS3;DRG1;ARL2;RAC1;MAPRE1
CENP-A containing chromatin organization (GO:0061641),30-Sep,0.197575637,0.999996398,0,0,1.520101483,2.465047939,NPM1;CENPW;NASP;RUVBL1;CENPK;RBBP7;KNL1;CENPA;CENPS
CENP-A containing nucleosome assembly (GO:0034080),30-Sep,0.197575637,0.999996398,0,0,1.520101483,2.465047939,NPM1;CENPW;NASP;RUVBL1;CENPK;RBBP7;KNL1;CENPA;CENPS
multivesicular body assembly (GO:0036258),30-Sep,0.197575637,0.999996398,0,0,1.520101483,2.465047939,TSG101;PDCD6IP;VPS4B;VTA1;CHMP2A;CHMP3;VPS36;RAB11A;CHMP5
ncRNA catabolic process (GO:0034661),30-Sep,0.197575637,0.999996398,0,0,1.520101483,2.465047939,EXOSC7;LIN28B;LIN28A;DIS3;EXOSC8;PARN;EXOSC3;NUDT16L1;EXOSC2
negative regulation of G0 to G1 transition (GO:0070317),11/38,0.197815882,0.999996398,0,0,1.445136252,2.341725617,CBX5;PHC1;RRM2;TFDP1;CBX3;MGA;PCGF2;EHMT1;RBBP7;RNF2;EZH2
sterol biosynthetic process (GO:0016126),11/38,0.197815882,0.999996398,0,0,1.445136252,2.341725617,IDI1;SQLE;GGPS1;HMGCS1;PMVK;SC5D;DHCR24;HMGCR;LBR;LSS;ACAT2
autophagosome maturation (GO:0097352),10/34,0.19809323,0.999996398,0,0,1.477928338,2.392791846,VMP1;VCP;GABARAPL1;TSG101;MAP1LC3A;UBQLN1;ATP2A2;CHMP3;CALM1;VTI1B
organelle disassembly (GO:1903008),10/34,0.19809323,0.999996398,0,0,1.477928338,2.392791846,MCTS1;PLK3;VCP;UFM1;GFM2;KIF5B;CDK1;DENR;EIF2D;MRRF
protein insertion into membrane (GO:0051205),10/34,0.19809323,0.999996398,0,0,1.477928338,2.392791846,APP;CYB5A;PRNP;TRAM1;SERP1;VAPA;SEC61G;SEC61B;UBE2J2;EMD
secondary alcohol biosynthetic process (GO:1902653),10/34,0.19809323,0.999996398,0,0,1.477928338,2.392791846,IDI1;SQLE;GGPS1;HMGCS1;PMVK;DHCR24;HMGCR;LBR;LSS;ACAT2
ventricular cardiac muscle tissue morphogenesis (GO:0055010),10/34,0.19809323,0.999996398,0,0,1.477928338,2.392791846,FKBP1A;TGFB2;TPM1;PKP2;NRG1;LRP2;RBPJ;FGFR2;SMAD7;BMPR1A
nucleic acid phosphodiester bond hydrolysis (GO:0090305),20/75,0.199133375,0.999996398,0,0,1.290199415,2.082098599,RFC4;PCNA;PARP1;RFC1;RFC2;DDX1;RPA1;DICER1;GTF2H3;GTF2H5;RBX1;PNRC2;DDB1;UBB;PDE12;ERCC1;RPA3;UBC;RPS27A;CUL4B
vascular endothelial growth factor receptor signaling pathway (GO:0048010),18/67,0.205046321,0.999996398,0,0,1.303272849,2.065061074,CYFIP2;NCKAP1;HSP90AA1;FLT1;ROCK1;ROCK2;PDCD6;PIK3CB;MAPK14;RHOA;CDC42;MAPKAPK3;PTK2B;RAC1;CRK;PAK2;WASF2;BCAR1
cellular response to reactive oxygen species (GO:0034614),17/63,0.20799934,0.999996398,0,0,1.311096676,2.058710707,OSER1;JUN;CHUK;PLEKHA1;TPM1;PARK7;PTPRK;MAPK13;SETX;IMPACT;MAPK8;PRDX5;RPS3;MAPK1;ROMO1;ECT2;MAPK3
positive regulation of DNA metabolic process (GO:0051054),17/63,0.20799934,0.999996398,0,0,1.311096676,2.058710707,OTUD4;USP7;PCNA;DHX9;USP9X;ATRX;PDGFB;HMGB1;BRCC3;PML;GNL3;DNMT3L;SMCHD1;TRIM28;MYC;RPS3;UBE2N
cellular response to interleukin-2 (GO:0071352),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,SHC1;PTK2B;IL2;JAK1
establishment of epithelial cell apical/basal polarity (GO:0045198),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,CDC42;MSN;EZR;RHOA
Golgi inheritance (GO:0048313),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,PLK3;PDCD10;CDK1;YWHAZ
interleukin-2-mediated signaling pathway (GO:0038110),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,SHC1;PTK2B;IL2;JAK1
miRNA mediated inhibition of translation (GO:0035278),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,TRIM71;ZFP36;EIF6;AGO2
negative regulation of calcium ion transmembrane transport (GO:1903170),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,FKBP1A;YWHAE;SESTD1;VDAC1
"negative regulation of translation, ncRNA-mediated (GO:0040033)",11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,TRIM71;ZFP36;EIF6;AGO2
peptidyl-lysine monomethylation (GO:0018026),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,SETD7;EHMT1;KMT5A;EEF1AKMT2
positive regulation by host of viral process (GO:0044794),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,VAPA;CFL1;NUCKS1;PPIB
positive regulation of actin nucleation (GO:0051127),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,NCKAP1;GSN;ABI2;WASF2
proteasome assembly (GO:0043248),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,PSMD11;PSMD4;POMP;PSMG2
regulation of mitochondrial fusion (GO:0010635),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,TFRC;BNIP3;HUWE1;ZDHHC6
signal peptide processing (GO:0006465),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,SPCS3;SPCS2;SPCS1;PARL
tetrahydrobiopterin metabolic process (GO:0046146),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,DHFR;GCHFR;HSP90AA1;CALM1
tetrahydrofolate metabolic process (GO:0046653),11-Apr,0.208125384,0.999996398,0,0,2.026316644,3.180536132,DHFR;MTHFD1;MTHFD2;MTHFD2L
response to reactive oxygen species (GO:0000302),16/59,0.210929601,0.999996398,0,0,1.320018032,2.054252775,PLK3;JUN;CHUK;PTPRN;TPM1;PTPRK;HIF1A;MAPK8;PRDX5;STK24;PDCD10;STK26;RPS3;MAPK1;ROMO1;MAPK3
positive regulation of response to DNA damage stimulus (GO:2001022),15/55,0.21381535,0.999996398,0,0,1.330283858,2.0521524,DDX5;PCNA;DHX9;BRCC3;FXR1;SPRED2;SMCHD1;SPRED1;BCLAF1;TRIM28;MYC;RPS3;UBE2N;PMAIP1;EEF1E1
regulation of protein localization to plasma membrane (GO:1903076),21/80,0.213922147,0.999996398,0,0,1.262827954,1.947461454,ITGB1;PRKCI;RAMP3;ITGA3;CLTC;ARHGEF16;STX7;PPP2R5A;AKAP5;ACTB;CLIP3;TMEM59;MMP14;DAB2;KIF5B;WNK3;AP2M1;SPTBN1;ARF6;VTI1B;BCL2L1
positive regulation of actin filament bundle assembly (GO:0032233),14/51,0.216627349,0.999996398,0,0,1.342221182,2.053030229,CARMIL1;ROCK2;TPM1;RHOC;SORBS3;RHOA;CDC42;PAK1;RAC1;EPHA1;PFN1;ARHGEF5;FERMT2;S100A10
regulation of protein localization to nucleus (GO:1900180),13/47,0.219325834,0.999996398,0,0,1.356272454,2.057732264,YAP1;CARD10;TFRC;NVL;LIMK2;PARK7;LATS2;SUMO3;TPR;CTNNA1;CDK1;CDK5RAP3;FERMT2
establishment of apical/basal cell polarity (GO:0035089),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,CDC42;PATJ;MSN;EZR;RHOA
membrane raft organization (GO:0031579),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,ANXA2;FLOT1;MYADM;FLOT2;S100A10
microvillus assembly (GO:0030033),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,RAP1B;RAP2B;STK26;ESPN;EZR
myoblast differentiation (GO:0045445),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,DDX5;REST;SDC1;NRG1;MAPK12
negative regulation of androgen receptor signaling pathway (GO:0060766),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,DAB2;FOXH1;PHB;FOXP1;SMARCA4
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,XBP1;TXNDC12;TMBIM6;PARK7;BCL2L1
positive regulation of exosomal secretion (GO:1903543),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,PDCD6IP;TSG101;VPS4B;CHMP2A;SDC1
positive regulation of histone H3-K4 methylation (GO:0051571),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,KMT2A;MYB;DNMT3B;CTNNB1;WDR61
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,ZFP36;CNOT7;AGO2;PABPC1;ZFP36L1
positive regulation of protein export from nucleus (GO:0046827),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,YWHAE;XPO4;TPR;ANP32B;EMD
regulation of aerobic respiration (GO:1903715),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,VCP;COX7A2L;UQCC2;COX7A2;IDE
regulation of clathrin-dependent endocytosis (GO:2000369),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,DAB2;DGKD;BMP2K;PIK3CB;WASL
regulation of cytoplasmic translation (GO:2000765),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,LIN28A;PKM;DHX9;CNBP;YBX3
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,ZFP36;CNOT7;AGO2;PABPC1;ZFP36L1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,ZFP36;CNOT7;AGO2;POLR2G;PABPC1
tRNA 5'-end processing (GO:0099116),15-May,0.219548733,0.999996398,0,0,1.773089172,2.688324211,SSB;POP4;RPP30;RPP14;HSD17B10
negative regulation of supramolecular fiber organization (GO:1902904),19/72,0.221146047,0.999996398,0,0,1.27181523,1.919082637,HSPA8;VBP1;MID1IP1;STMN2;CLU;CLIP3;TPX2;TAOK1;STMN1;MYADM;PFDN1;PFDN2;ARHGEF2;MAPRE1;PFDN4;PFN1;CRYAB;PFDN5;PFDN6
DNA replication-independent nucleosome assembly (GO:0006336),11/39,0.224140309,0.999996398,0,0,1.393434754,2.083858045,NPM1;CENPW;NASP;RUVBL1;ATRX;CENPK;HAT1;RBBP7;KNL1;CENPA;CENPS
regulation of ion transmembrane transporter activity (GO:0032412),11/39,0.224140309,0.999996398,0,0,1.393434754,2.083858045,YWHAE;TCAF2;AHCYL1;NEDD4;FHL1;WNK3;ANK2;UTRN;PHB2;YWHAH;PTPN3
peptidyl-lysine dimethylation (GO:0018027),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,SUV39H2;KMT2A;SETD1B;SETD7;EHMT1;EEF1AKMT2
positive regulation of cellular protein catabolic process (GO:1903364),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,HSP90AA1;RNF128;FAF1;RDX;MSN;EZR
regulation of bicellular tight junction assembly (GO:2000810),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,TJP1;CLDN3;MYO1C;ROCK1;ROCK2;F11R
regulation of exosomal secretion (GO:1903541),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,PDCD6IP;TSG101;VPS4B;CHMP2A;CHMP3;SDC1
regulation of histone H3-K4 methylation (GO:0051569),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,KDM1A;KMT2A;MYB;DNMT3B;CTNNB1;WDR61
regulation of mitochondrial membrane permeability (GO:0046902),19-Jun,0.225132675,0.999996398,0,0,1.636755054,2.440508803,HEBP2;BNIP3;PMAIP1;SLC25A5;SLC25A4;BCL2L1
'de novo' posttranslational protein folding (GO:0051084),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,HSPA9;CCT2;HSPA8;HSPA5;ST13;PTGES3;SELENOF;SDF2;HSPE1
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,USP14;USP7;HSP90AB1;RPL11;TAF9;TLK2;EIF3H;PARK7;UCHL5
negative regulation of response to DNA damage stimulus (GO:2001021),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,SFRP2;KDM1A;DDX39B;RPS3;THOC1;MIF;CLU;TPT1;BCL2L1
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,PSMC6;BAG2;PSMC3;FBXW7;PSMC2;ECSCR;PTEN;CLU;CDK5RAP3
positive regulation of RNA splicing (GO:0033120),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,RBM3;SETX;DAZAP1;THRAP3;TRA2B;NCL;CELF4;SLC38A2;PRDX6
regulation of cellular component size (GO:0032535),9/31,0.227473933,0.999996398,0,0,1.450912817,2.148395085,MTPN;RARG;RDX;PTEN;MSN;RAC1;EZR;AP2M1;PPP1CA
mitotic cell cycle checkpoint signaling (GO:0007093),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,PLK3;ZWILCH;NABP2;BUB1B;NABP1;BUB1;CDK5RAP3
negative regulation of GTPase activity (GO:0034260),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,WNK1;RCC2;RDX;ARL2;TMED2;RRP1B;F11R
negative regulation of phosphoprotein phosphatase activity (GO:0032515),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,FKBP1A;PTPA;PPP1R11;ROCK1;ROCK2;TIPRL;MASTL
positive regulation of cell cycle G2/M phase transition (GO:1902751),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,NPM1;CDK4;RCC2;VPS4B;CDK1;CDC25C;RAB11A
positive regulation of transcription by RNA polymerase I (GO:0045943),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,NCL;HEATR1;WDR75;NOL11;LYAR;WDR43;SMARCA4
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,MED1;MED14;PSMC6;PSMC3;PSMC4;SUB1;PSMC2
regulation of telomere capping (GO:1904353),23-Jul,0.227556468,0.999996398,0,0,1.551561789,2.296865138,USP7;TNKS2;HNRNPD;NABP2;MAPK1;MAP3K4;MAPK3
dendritic spine organization (GO:0097061),27-Aug,0.228105609,0.999996398,0,0,1.493284771,2.206995088,CDC42;PRNP;ARF1;MTMR2;ITGA3;PTEN;WASL;IGF1R
peptidyl-lysine methylation (GO:0018022),27-Aug,0.228105609,0.999996398,0,0,1.493284771,2.206995088,SUV39H2;TRMT112;SETD7;EHMT1;ETFBKMT;KMT5A;EEF1AKMT2;EEF1AKMT1
regulation of cardiac muscle cell contraction (GO:0086004),27-Aug,0.228105609,0.999996398,0,0,1.493284771,2.206995088,CAMK2D;JUP;AKAP9;PKP2;ATP2A2;ANK2;SRI;DSC2
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),27-Aug,0.228105609,0.999996398,0,0,1.493284771,2.206995088,TCERG1;LEO1;HNRNPU;CDK12;CDK13;EAPP;CDC73;WDR43
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),17/64,0.228615569,0.999996398,0,0,1.283118497,1.893515189,URI1;XBP1;DDX3X;PLAUR;TXNDC12;ENO1;PARK7;NOC2L;CLU;YBX3;SFRP2;TMBIM6;ARHGEF2;PPIA;TPT1;MCL1;BCL2L1
regulation of cell death (GO:0010941),26/102,0.228973354,0.999996398,0,0,1.213828571,1.789364952,RAMP3;CELF1;FAF1;VPS4B;TXNDC12;PARK7;PHB;CLU;UBB;CHP1;SOX4;SLC25A24;BNIP3L;BNIP3;RRAS2;SOX11;DHCR24;MT3;IMPACT;PDE12;RILPL1;CHMP2A;SRSF6;CRYAB;FERMT2;RAD18
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),95/404,0.246609197,0.999996398,0,0,1.091688124,1.528309217,CYFIP2;CEP57;TRIM71;DDR1;NCKAP1;GSK3A;FLT1;PIK3CB;IDE;WASL;PIK3C2A;AP2A2;ACTB;ACTG1;IGF1R;TIAL1;PTBP1;SPRED2;SPRED1;NAMPT;STMN1;RAC1;AP2M1;GIT1;ACTR3;ACTR2;FGFBP1;HSP90AA1;ATP6V1G1;GAB1;LMTK2;NRG1;SLC39A14;GTF2F2;MTSS1;RHOA;CNKSR1;MAPKAPK3;COL4A2;HNRNPH1;ESRP1;DDIT4;PHIP;SOS1;EPHA1;CRK;GRB7;ROCK1;SHC1;ROCK2;HPN;PDGFB;EFNA5;GIGYF2;FOXO1;RASGRP4;CDC42;EFNB2;PAK1;EFS;POLR2B;POLR2F;MAPK1;PTK2B;POLR2G;SHOC2;POLR2H;HNRNPA1;POLR2I;POLR2J;WASF2;PAK2;ATP6V1D;POLR2K;POLR2L;ATP6V1F;MAPK3;NUS1;TIA1;GALNT3;RYK;SORT1;IGF2;ARPC4;ARPC5;AP2B1;MAPK14;SETX;FGF17;AHI1;ARPC2;RAB14;BCAR1;FGFR2;FGFR1
cardiac ventricle morphogenesis (GO:0003208),12/44,0.247943301,0.999996398,0,0,1.3300581,1.854839416,FKBP1A;GSK3A;TGFB2;SFRP2;TPM1;PKP2;SOX11;RBPJ;SOX4;FGFR2;SMAD7;BMPR1A
hexose biosynthetic process (GO:0019319),12/44,0.247943301,0.999996398,0,0,1.3300581,1.854839416,TPI1;GOT1;MDH1;MDH2;PGAM1;CHST15;PGK1;ENO1;ALDOA;ENO3;SLC39A14;GAPDH
actin filament reorganization (GO:0090527),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,EFS;GSN;BCAR1
box C/D snoRNP assembly (GO:0000492),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,RUVBL2;RUVBL1;TAF9
chromatin silencing at telomere (GO:0006348),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,RIF1;DPY30;EZH2
cytoplasmic sequestering of NF-kappaB (GO:0007253),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,FAF1;TMSB4X;G3BP2
entry of bacterium into host cell (GO:0035635),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,CDH1;CTNND1;CTNNB1
folic acid transport (GO:0015884),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,PDPN;FOLR1;SLC19A1
internal protein amino acid acetylation (GO:0006475),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,NAA10;HAT1;EP300
macromolecule modification (GO:0043412),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,PARP1;PARN;CHD1
negative regulation by symbiont of host programmed cell death (GO:0052041),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,SFPQ;MAPK1;MAPK3
negative regulation of B cell apoptotic process (GO:0002903),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,NOC2L;IL2;FOXP1
negative regulation of chromosome organization (GO:2001251),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,TOP2A;ERCC1;WAPL
negative regulation of keratinocyte proliferation (GO:0010839),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,MED1;PTPRK;FGFR2
negative regulation of mitochondrial fusion (GO:0010637),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,TFRC;BNIP3;HUWE1
negative regulation of mitotic nuclear division (GO:0045839),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,TOM1L1;NME6;AURKAIP1
negative regulation of muscle cell differentiation (GO:0051148),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,PTBP1;ID2;IGF2
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,EGLN1;EGLN3;P4HB
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,NCKAP1;ABI2;WASF2
positive regulation of chromosome segregation (GO:0051984),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,RCC2;SMC6;RAD18
positive regulation of isomerase activity (GO:0010912),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,ITGAM;DHX9;HNRNPU
positive regulation of leukocyte differentiation (GO:1902107),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,XRCC6;LGALS1;HMGB1
positive regulation of muscle contraction (GO:0045933),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,CTTN;F2R;ENO1
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,CALM3;CALM1;CALM2
positive regulation of vascular associated smooth muscle cell migration (GO:1904754),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,ADAMTS1;DOCK7;PDGFB
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,MCM7;MCM4;MCM2
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,CAMK2D;AKAP9;ATP2A2
regulation of chaperone-mediated autophagy (GO:1904714),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,EEF1A1;PLK3;SNRNP70
regulation of endodeoxyribonuclease activity (GO:0032071),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,NPM1;RPS3;HMGB1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,EIF5A;RPS7;UBB
regulation of potassium ion import (GO:1903286),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,WNK1;WNK3;ATP1B3
regulation of response to wounding (GO:1903034),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,STK24;TNFRSF12A;SRSF6
regulation of RNA biosynthetic process (GO:2001141),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,MED1;NMD3;ACTN4
regulation of toll-like receptor 3 signaling pathway (GO:0034139),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,FLOT1;F2RL1;FLOT2
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,FERMT1;PTEN;FERMT2
response to hydroperoxide (GO:0033194),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,DAPK1;GPX3;SP1
translocation of molecules into host (GO:0044417),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,DDX39B;THOC1;THOC7
viral mRNA export from host cell nucleus (GO:0046784),08-Mar,0.248733807,0.999996398,0,0,2.127421555,2.96003479,DDX39B;THOC1;THOC7
chromatin organization (GO:0006325),35/142,0.250894535,0.999996398,0,0,1.160668034,1.604881929,SUV39H2;SMARCD1;HDAC3;SATB1;SETD7;EHMT1;NUCKS1;NUDT5;CHD1;MYSM1;LOXL2;PAK1;MYC;RUVBL2;MYB;RUVBL1;GATAD1;HMGN2;JARID2;HMGN1;BPTF;SMARCE1;SMARCC1;PBRM1;NPM1;CBX3;ATRX;BAZ1A;LRWD1;SMARCA1;ARID1A;NPM3;SMARCA4;TADA2A;EZH2
protein-containing complex subunit organization (GO:0043933),28/112,0.253077624,0.999996398,0,0,1.182635872,1.625011492,YAP1;NUP205;SEH1L;KMT2A;SLC2A1;WASL;PARD6B;TPR;TSPAN4;PTK2B;ELOB;DNM1L;KPNA3;TEAD1;MDN1;NDC1;CARD10;ST13;PML;CD2AP;TAPBP;CAPZA1;CAPZA2;GEMIN5;PPIH;MNAT1;PPID;VAMP3
cellular response to heat (GO:0034605),10/36,0.255443723,0.999996398,0,0,1.36406636,1.861613868,YWHAE;VCP;HSP90AA1;HSP90AB1;SUMO1;PDCD6;TPR;HIKESHI;RBBP7;THBS1
telomere maintenance via telomere lengthening (GO:0010833),10/36,0.255443723,0.999996398,0,0,1.36406636,1.861613868,ANKRD28;HSP90AA1;STN1;HSP90AB1;RFC1;PTGES3;RPA1;NHP2;NOP10;TELO2
negative regulation of apoptotic signaling pathway (GO:2001234),20/78,0.256395299,0.999996398,0,0,1.223228833,1.664857119,URI1;PRELID1;DDX3X;CSNK2A1;CSNK2A2;PLAUR;GHITM;PARK7;CFLAR;NOC2L;CLU;THBS1;PSME3;BIRC6;ITGA6;PHIP;TMBIM6;SLC25A5;MCL1;BCL2L1
DNA replication (GO:0006260),27/108,0.258008698,0.999996398,0,0,1.182594117,1.60213355,SET;MCM7;TBRG1;ORC4;ORC2;PCLAF;MCMBP;TIPIN;DUT;RFC4;RFC1;RFC2;RPA1;NAP1L1;BAZ1A;KIN;POLA2;DBF4;POLG2;RPA3;CDK1;MCM4;RBMS1;CDK2AP1;RAD1;RHNO1;MCM2
ERBB2 signaling pathway (GO:0038128),9/32,0.258908527,0.999996398,0,0,1.387740556,1.875226692,GRB7;HSP90AA1;SHC1;CDC37;GAB1;NRG1;PTPN12;SOS1;HBEGF
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),9/32,0.258908527,0.999996398,0,0,1.387740556,1.875226692,CDC42;PRKCI;PDCD6IP;WDR1;MSN;LIN7C;SYNJ2BP;EZR;RHOA
negative regulation of microtubule polymerization or depolymerization (GO:0031111),9/32,0.258908527,0.999996398,0,0,1.387740556,1.875226692,CLIP3;TPX2;MID1IP1;TAOK1;STMN1;STMN2;ARHGEF2;FKBP4;MAPRE1
protein transmembrane import into intracellular organelle (GO:0044743),9/32,0.258908527,0.999996398,0,0,1.387740556,1.875226692,GRPEL1;PAM16;TIMM17A;TIMM23;ROMO1;PEX2;TIMM21;DNAJC15;HSPD1
protein K48-linked ubiquitination (GO:0070936),15/57,0.259661548,0.999996398,0,0,1.266774152,1.708088161,UBE2B;CUL3;UBE2D3;UBE2E1;UBE2E2;UBE3A;UBE2G1;UBE2A;RBX1;CDC34;UBE2R2;UBR5;SKP2;UBE2K;RNF187
early endosome to Golgi transport (GO:0034498),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,TMED9;SNX2;SURF4;RAB6A
hemidesmosome assembly (GO:0031581),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,CD151;DST;ITGA6;PLEC
lysine catabolic process (GO:0006554),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,OGDH;DLST;ALDH7A1;DLD
lysine metabolic process (GO:0006553),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,OGDH;DLST;ALDH7A1;DLD
negative regulation of cardiac muscle hypertrophy (GO:0010614),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,GSK3A;GLRX3;LMNA;FOXO1
negative regulation of cell division (GO:0051782),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,MYC;TXNIP;E2F7;E2F8
negative regulation of cilium assembly (GO:1902018),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,YAP1;ODF2L;LIMK2;TBC1D7
negative regulation of microtubule polymerization (GO:0031115),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,CLIP3;STMN1;STMN2;MAPRE1
nuclear body organization (GO:0030575),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,SRPK2;SERBP1;ETS1;PML
positive regulation of actin filament depolymerization (GO:0030836),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,CARMIL1;WDR1;CFL2;F2RL1
positive regulation of protein depolymerization (GO:1901881),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,WDR1;CFL2;STMN2;F2RL1
protein auto-ADP-ribosylation (GO:0070213),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,PARP1;TNKS2;PARP2;TIPARP
protein insertion into mitochondrial inner membrane (GO:0045039),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,TIMM10B;TIMM8B;TIMM13;ROMO1
pyrimidine nucleobase metabolic process (GO:0006206),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,DPYSL2;CRMP1;CTPS2;UMPS
regulation of actin filament depolymerization (GO:0030834),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,MTPN;WDR1;CFL2;F2RL1
regulation of DNA-dependent DNA replication (GO:0090329),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,TIPIN;WDR18;GMNN;METTL4
regulation of muscle system process (GO:0090257),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,TPM1;ANXA6;SRI;MYL9
regulation of myoblast fusion (GO:1901739),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,EHD2;FLOT1;CFLAR;MAPK14
regulation of nucleobase-containing compound metabolic process (GO:0019219),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,PCBP4;PCBP1;PCBP2;IGF2BP1
regulation of plasminogen activation (GO:0010755),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,SERPINE2;HPN;ENO1;THBS1
regulation of sister chromatid cohesion (GO:0007063),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,RAD21;CTNNB1;BUB1;WAPL
regulation of vascular associated smooth muscle cell migration (GO:1904752),12-Apr,0.261111778,0.999996398,0,0,1.77291335,2.38067992,ADAMTS1;DOCK7;TPM1;PDGFB
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",28-Aug,0.261996906,0.999996398,0,0,1.418529479,1.900010422,SPRED2;DDX5;SPRED1;KDM1A;PMAIP1;KMT5A;MIF;EEF1E1
regulation of phosphatase activity (GO:0010921),28-Aug,0.261996906,0.999996398,0,0,1.418529479,1.900010422,PTPA;PPP1R2;URI1;ZCCHC9;TIPRL;CHP1;CDK5RAP3;HSP90B1
apoptotic nuclear changes (GO:0030262),24-Jul,0.264455218,0.999996398,0,0,1.460199738,1.942187362,TOP2A;CECR2;DICER1;HMGB1;CDK5RAP3;KPNB1;KPNA1
positive regulation of cell-substrate junction organization (GO:0150117),24-Jul,0.264455218,0.999996398,0,0,1.460199738,1.942187362,DUSP3;ROCK1;RAC1;FERMT2;ARF6;LIMS1;S100A10
positive regulation of viral life cycle (GO:1903902),24-Jul,0.264455218,0.999996398,0,0,1.460199738,1.942187362,DDB1;TSG101;LGALS1;CHMP2A;KPNA6;CHMP3;P4HB
protein exit from endoplasmic reticulum (GO:0032527),24-Jul,0.264455218,0.999996398,0,0,1.460199738,1.942187362,SEC13;TMED9;VCP;SEC16A;SURF4;SEC61B;HSP90B1
"wound healing, spreading of cells (GO:0044319)",24-Jul,0.264455218,0.999996398,0,0,1.460199738,1.942187362,DDR1;CD151;PDCD10;PDPN;FLNA;RHOC;RHOA
apoptotic DNA fragmentation (GO:0006309),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,CECR2;DICER1;HMGB1;KPNB1;KPNA1
mitotic sister chromatid cohesion (GO:0007064),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,NAA50;RAD21;POGZ;PDS5A;SMC1A
negative regulation of cell-substrate junction organization (GO:0150118),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,DUSP22;RCC2;PTEN;THBS1;CORO1C
negative regulation of DNA replication (GO:0008156),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,GMNN;PDS5A;GTPBP4;WAPL;S100A11
negative regulation of focal adhesion assembly (GO:0051895),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,DUSP22;RCC2;PTEN;THBS1;CORO1C
nucleotide catabolic process (GO:0009166),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,NT5C;VCP;PNP;SAMHD1;ITPA
protein localization to endoplasmic reticulum (GO:0070972),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,HSPA5;VAPA;SEC16A;ANK2;MIA3
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,SFRP2;RPS3;CLU;TPT1;BCL2L1
regulation of oxidative phosphorylation (GO:0002082),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,VCP;COX7A2L;UQCC2;PDE12;COX7A2
retrograde axonal transport (GO:0008090),16-May,0.265316615,0.999996398,0,0,1.611795847,2.138581331,DST;KIF5B;KIF1A;MGARP;ACTR10
branched-chain amino acid catabolic process (GO:0009083),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,BCKDK;ECHS1;HIBADH;HSD17B10;DLD;BCAT2
branched-chain amino acid metabolic process (GO:0009081),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,BCKDK;ECHS1;HIBADH;HSD17B10;DLD;BCAT2
negative regulation of telomere maintenance via telomerase (GO:0032211),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,STN1;GNL3L;HNRNPU;NAT10;HNRNPC;HNRNPA1
nucleobase-containing compound biosynthetic process (GO:0034654),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,DGUOK;PNP;ADK;AMPD2;ADA;APRT
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,CDK4;RCC2;VPS4B;CDK1;CDC25C;RAB11A
positive regulation of nitrogen compound metabolic process (GO:0051173),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,APP;MTPN;MAPK8;HPN;PDGFB;NFKB1
production of small RNA involved in gene silencing by RNA (GO:0070918),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,TRIM71;AGO2;DICER1;TSN;MRPL44;PUM2
regulation of hippo signaling (GO:0035330),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,WWC1;SOX11;LIMD1;MAPK14;AJUBA;MARK3
regulation of programmed necrotic cell death (GO:0062098),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,HSP90AA1;PDCD6IP;CDC37;FLOT1;FLOT2;CFLAR
regulation of protein modification by small protein conjugation or removal (GO:1903320),20-Jun,0.265840615,0.999996398,0,0,1.519746465,2.013448781,HSP90AA1;HSP90AB1;DCUN1D5;DCUN1D1;UBQLN1;HIF1A
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),25/100,0.26836842,0.999996398,0,0,1.182510664,1.555468073,CDKN1C;HSP90AB1;LTBP4;NREP;THBS1;SPRED2;SPRED1;UBB;PEG10;UBC;EP300;RPS27A;SKIL;SNX6;ITGA3;SOX11;SMAD7;FKBP1A;BCL9;DAB2;LATS2;SPRY2;SPRY1;FOLR1;TRIM33
adherens junction organization (GO:0034332),13/49,0.269802824,0.999996398,0,0,1.280759394,1.677876606,JUP;CTNND1;ACTB;SMAD7;TJP1;AFDN;CDH1;CTNNA1;CTNNB1;PAK2;NECTIN3;FERMT2;NECTIN2
mitotic cytokinesis (GO:0000281),13/49,0.269802824,0.999996398,0,0,1.280759394,1.677876606,PDCD6IP;ROCK1;ROCK2;KIF23;RHOC;CENPA;ANLN;SON;STMN1;MITD1;ECT2;MYH10;SPTBN1
regulation of stress-activated MAPK cascade (GO:0032872),13/49,0.269802824,0.999996398,0,0,1.280759394,1.677876606,TGFB2;MID1;FOXO1;IGF1R;MAPK8IP1;TAOK3;PDCD10;MYC;TAOK1;MAPK1;F2RL1;PPIA;MAPK3
ERBB signaling pathway (GO:0038127),17/66,0.272249011,0.999996398,0,0,1.230588038,1.601041983,GRB7;HSP90AA1;DGKD;SHC1;GAB1;NRG1;BRAF;IQGAP1;PTPN12;PIK3C2A;CDC37;MAPK1;PTK2B;SOS1;TDGF1;BCAR1;HBEGF
Wnt signaling pathway (GO:0016055),23/92,0.279468499,0.999996398,0,0,1.182427288,1.507435989,VPS29;RARG;ZRANB1;DDX3X;CSNK1A1;RYK;FZD7;WNT7B;USP34;PTEN;CUL1;RBX1;BCL9;PORCN;SFRP2;UBB;UBC;CTNNB1;STRN;GPC4;RPS27A;CSNK1G2;FERMT2
carbohydrate catabolic process (GO:0016052),11/41,0.28047904,0.999996398,0,0,1.300372058,1.653106145,LDHA;PFKL;TPI1;PKM;PGAM1;PGK1;ENO1;ALDOA;ENO3;GAPDH;HK2
gluconeogenesis (GO:0006094),11/41,0.28047904,0.999996398,0,0,1.300372058,1.653106145,TPI1;GOT1;MDH1;MDH2;PGAM1;PGK1;ENO1;ALDOA;ENO3;SLC39A14;GAPDH
regulation of mitochondrial membrane potential (GO:0051881),11/41,0.28047904,0.999996398,0,0,1.300372058,1.653106145,HEBP2;VCP;PRELID1;UBB;TUSC2;PMAIP1;BAX;NDUFS1;PARK7;RNF122;BCL2L1
regulation of viral transcription (GO:0046782),11/41,0.28047904,0.999996398,0,0,1.300372058,1.653106145,ZFP36;DHX9;POLR2B;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;GTF2F2;POLR2K;POLR2L
response to growth factor (GO:0070848),11/41,0.28047904,0.999996398,0,0,1.300372058,1.653106145,URI1;RPS6KB1;SHC1;MYC;TBC1D7;PDGFB;RACK1;CTNNB1;LRP2;EMD;BMPR1A
positive regulation of cellular component organization (GO:0051130),28/114,0.287125655,0.999996398,0,0,1.154983807,1.441229608,VCP;CD151;TFRC;FAF1;PARK7;CLU;IGF1R;CDC20;BCL2L11;SUMO1;FLOT1;RACK1;GPC3;RPS3;SH3GLB1;TGFB2;TMED9;BNIP3;SURF4;NRG1;RHOC;CLIP3;DAB2;CLDN3;GNL3L;BAX;AJUBA;CRB3
neuron projection extension (GO:1990138),9/33,0.291602523,0.999996398,0,0,1.32983265,1.638837386,PPP3CB;HSP90AA1;IMPACT;HSP90AB1;USP9X;MAP1B;CTNNB1;IQGAP1;LLPH
regulation of histone acetylation (GO:0035065),9/33,0.291602523,0.999996398,0,0,1.32983265,1.638837386,SET;TADA2A;KMT2A;RUVBL2;ARRB1;PARK7;NOC2L;MAPK3;GLYR1
regulation of viral genome replication (GO:0045069),17/67,0.295097924,0.999996398,0,0,1.205898723,1.471736724,SRPK2;DDX3X;STAU1;SRPK1;DDB1;TRIM6;ILF3;LARP1;CNOT7;PDE12;PPIE;BANF1;PPIH;PKN2;PABPC1;PPIA;PPID
negative regulation of ERK1 and ERK2 cascade (GO:0070373),13/50,0.29638799,0.999996398,0,0,1.246064205,1.515321116,DUSP3;SEMA6A;PTEN;PHB;SYNJ2BP;DUSP9;DUSP6;SPRED2;RPS6KA6;SPRED1;SPRY2;SPRY1;EZR
positive regulation of cellular biosynthetic process (GO:0031328),43/180,0.296540547,0.999996398,0,0,1.113592588,1.353651209,RPL5;DDX3X;HSP90AB1;PCNA;DHX9;POLDIP3;FAF1;EIF4A3;PDGFB;NAT10;RPS27L;NMD3;PARK7;CLU;ARPP19;HIF1A;ELAVL1;THBS1;FXR1;RBM3;RPS4X;MYC;CHP1;METTL5;SOX4;HSP90AA1;NPM1;STN1;YTHDF1;MID1IP1;IGF2;LARP4B;EEF2;LARP4;DDB1;EIF6;RPS6KB1;SP1;HNRNPD;EIF3E;RPL26;EIF3C;EIF3D
protein K11-linked ubiquitination (GO:0070979),29-Aug,0.297245758,0.999996398,0,0,1.350893738,1.638898899,ANAPC13;UBE2B;CDC26;UBE2D3;CDC27;UBE2E2;UBE2A;UBE2L3
regulation of calcium ion transmembrane transporter activity (GO:1901019),29-Aug,0.297245758,0.999996398,0,0,1.350893738,1.638898899,YWHAE;FKBP1A;SELENON;CAMK2D;ANK2;CALM1;JPH1;CALM2
neutrophil degranulation (GO:0043312),111/481,0.299483756,0.999996398,0,0,1.064965035,1.284023124,SRP14;PSMD6;PSMD7;PNP;PSMD2;ANPEP;FTH1;PSMD1;GOLGA7;KCMF1;ATP11B;MIF;ILF2;EEF1A1;RAB31;PPIE;PPIA;KPNB1;PSMD12;VCP;PSMD11;PSMD14;COPB1;UBR4;MGST1;IQGAP1;GNS;PLAC8;RAP1B;CNN2;CYB5R3;RAB6A;ATP6V1D;S100A11;HSPA8;XRCC6;TRAPPC1;JUP;SURF4;RAB27A;DNAJC13;PA2G4;ARPC5;EEF2;PRDX6;NFKB1;CYSTM1;CDK13;NIT2;HSP90AB1;ITGAM;DDX3X;SLC44A2;GDI2;SLC2A3;HMGB1;AP2A2;HEBP2;NAPRT;TIMP2;PGM2;RAC1;SPTAN1;ACTR2;CCT2;HSP90AA1;ANXA2;ANXA3;PGAM1;NME2;PLAUR;NDUFC2;DYNLL1;DDOST;RHOA;APRT;PSMA5;PKM;RAP2B;PSMA2;DNAJC5;ALDOA;ROCK1;PSMB7;NRAS;PGRMC1;CAND1;PSMB1;CXCR2;MAPK1;CCT8;GSN;GCA;HUWE1;PDAP1;TUBB4B;MAPK14;RAB10;PFKL;FABP5;PSMC3;RAB14;VAPA;IMPDH2;PSMC2;RAB18;LAMTOR2;LAMTOR1;YPEL5;LAMTOR3;ACTR10
COPII vesicle coating (GO:0048208),16/63,0.301733875,0.999996398,0,0,1.207365535,1.446677286,ANKRD28;SEC13;TMED10;TRAPPC1;PDCD6;CUL3;GOSR2;SEC16A;TRAPPC4;USO1;TRAPPC6A;CNIH1;TMED2;FOLR1;SEC24C;SEC31A
vesicle coating (GO:0006901),16/63,0.301733875,0.999996398,0,0,1.207365535,1.446677286,ANKRD28;SEC13;TMED10;TRAPPC1;PDCD6;CUL3;GOSR2;SEC16A;TRAPPC4;USO1;TRAPPC6A;CNIH1;TMED2;FOLR1;SEC24C;SEC31A
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",16/63,0.301733875,0.999996398,0,0,1.207365535,1.446677286,ANKRD28;SEC13;TMED10;TRAPPC1;PDCD6;CUL3;GOSR2;SEC16A;TRAPPC4;USO1;TRAPPC6A;CNIH1;TMED2;FOLR1;SEC24C;SEC31A
cellular response to hexose stimulus (GO:0071331),25-Jul,0.302831694,0.999996398,0,0,1.378989025,1.64731008,XBP1;LIN28A;TRA2B;RACK1;SLC39A14;SOX4;IGF1R
negative regulation of cell junction assembly (GO:1901889),25-Jul,0.302831694,0.999996398,0,0,1.378989025,1.64731008,DUSP22;ROCK1;ROCK2;RCC2;PTEN;THBS1;CORO1C
regulation of epidermal cell differentiation (GO:0045604),25-Jul,0.302831694,0.999996398,0,0,1.378989025,1.64731008,KLF7;ZFP36;ROCK1;ROCK2;MAFF;SFN;ZFP36L1
positive regulation of response to stimulus (GO:0048584),12/46,0.303089524,0.999996398,0,0,1.251658558,1.494138688,FXR1;SELENON;BCLAF1;TGFB2;DHX9;PLA2G1B;DDX58;MYC;TAF9;HMGA1;EEF1E1;YPEL3
regulation of fibroblast proliferation (GO:0048145),12/46,0.303089524,0.999996398,0,0,1.251658558,1.494138688,DHX9;PLA2G1B;CDK4;FTH1;MYC;PDGFB;S100A6;CTNNB1;PEX2;MIF;EMD;CDC73
vesicle organization (GO:0016050),12/46,0.303089524,0.999996398,0,0,1.251658558,1.494138688,PI4K2B;LAPTM4B;ALS2CL;SAR1A;SORT1;HOOK1;DNAJC13;WASL;LAMTOR1;FNBP1L;EPS15;PLEKHJ1
activation of protein kinase C activity (GO:1990051),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PHB;PHB2
ADP transport (GO:0015866),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SLC25A5;SLC25A4
AMP biosynthetic process (GO:0006167),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ADSL;APRT
axon choice point recognition (GO:0016198),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,APP;GAP43
caveolin-mediated endocytosis (GO:0072584),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MAPK1;MAPK3
cellular response to antibiotic (GO:0071236),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RPL23;CRIP1
cellular response to sodium arsenite (GO:1903936),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,HNRNPA1;MAPK13
cellular response to testosterone stimulus (GO:0071394),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ROCK2;MSN
determination of pancreatic left/right asymmetry (GO:0035469),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ZIC3;CCDC40
DNA protection (GO:0042262),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,NUDT1;DCTPP1
dopamine catabolic process (GO:0042420),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MOXD1;MAOA
endothelin receptor signaling pathway (GO:0086100),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PTK2B;BCAR1
extracellular exosome biogenesis (GO:0097734),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RAB27A;RAB11A
folate transmembrane transport (GO:0098838),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,LRP2;SLC19A1
glomerular visceral epithelial cell migration (GO:0090521),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ANLN;ROCK1
glucose import across plasma membrane (GO:0098708),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SLC2A1;SLC2A3
inosine metabolic process (GO:0046102),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PNP;ADA
intracellular distribution of mitochondria (GO:0048312),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ARMC1;DNM1L
intracellular sequestering of iron ion (GO:0006880),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,FTH1;SRI
isopentenyl diphosphate biosynthetic process (GO:0009240),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,IDI1;PMVK
kidney morphogenesis (GO:0060993),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,WNT7B;SOX4
left/right axis specification (GO:0070986),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,AHI1;PITX2
lung morphogenesis (GO:0060425),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,WNT7B;SOX11
mitochondrial RNA 3'-end processing (GO:0000965),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,TRNT1;HSD17B10
negative regulation of calcium ion transport into cytosol (GO:0010523),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,FKBP1A;TMBIM6
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RC3H1;HMGB1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PLAUR;PARK7
negative regulation of gene silencing by RNA (GO:0060967),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,DND1;ELAVL1
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RACK1;PARK7
negative regulation of keratinocyte differentiation (GO:0045617),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SRSF6;GRHL2
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ROCK1;ROCK2
negative regulation of organ growth (GO:0046621),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,WWC1;PTEN
negative regulation of plasminogen activation (GO:0010757),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SERPINE2;THBS1
negative regulation of posttranscriptional gene silencing (GO:0060149),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,DND1;ELAVL1
nuclear retention of pre-mRNA at the site of transcription (GO:0071033),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,EXOSC3;EXOSC2
oocyte development (GO:0048599),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ZGLP1;MEIOC
oxaloacetate metabolic process (GO:0006107),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MDH1;NIT2
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RCC2;HNRNPU
positive regulation of blood-brain barrier permeability (GO:1905605),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,TJP1;TJP2
positive regulation of dendritic cell differentiation (GO:2001200),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,LGALS1;HMGB1
positive regulation of deoxyribonuclease activity (GO:0032077),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PCNA;RPS3
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,DHX9;HNRNPU
positive regulation of low-density lipoprotein receptor activity (GO:1905599),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,HNRNPK;ANXA2
positive regulation of macrophage proliferation (GO:0120041),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MAPK1;MAPK3
positive regulation of membrane permeability (GO:1905710),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,HEBP2;MT3
positive regulation of metallopeptidase activity (GO:1905050),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,CLDN4;CLDN3
positive regulation of mitochondrial depolarization (GO:0051901),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MLLT11;RACK1
positive regulation of phospholipase A2 activity (GO:0032430),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PLA2G1B;PLAA
positive regulation of protein catabolic process in the vacuole (GO:1904352),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RNF128;LRP2
positive regulation of protein monoubiquitination (GO:1902527),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,UBB;PDCD6
positive regulation of protein neddylation (GO:2000436),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,DCUN1D5;DCUN1D1
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RBPJ;HIF1A
positive regulation of translation in response to stress (GO:0032056),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,IMPACT;DDX3X
protein lipoylation (GO:0009249),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,NDUFAB1;NNAT
protein localization to membrane raft (GO:1903044),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,FLOT1;FLOT2
pyrimidine nucleobase biosynthetic process (GO:0019856),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,CTPS2;UMPS
pyrimidine nucleotide metabolic process (GO:0006220),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,CTPS2;ENPP3
R-loop disassembly (GO:0062176),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SRPK2;DDX21
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,GSK3A;APLP1
regulation of barbed-end actin filament capping (GO:2000812),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,CARMIL1;MTPN
regulation of chaperone-mediated protein folding (GO:1903644),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PDCL3;PDCD5
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RPS3;PAK2
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,DHX9;HNRNPU
regulation of inflammatory response to wounding (GO:0106014),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,MDK;GIT1
regulation of miRNA metabolic process (GO:2000628),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,RC3H1;NFKB1
regulation of plasma membrane organization (GO:1903729),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,GSN;MYH9
regulation of protein monoubiquitination (GO:1902525),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,UBB;PDCD6
regulation of sodium:proton antiporter activity (GO:0032415),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,CHP1;ACTN4
regulation of synaptic vesicle recycling (GO:1903421),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ROCK1;PLAA
renal tubule development (GO:0061326),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,COL4A1;MTSS1
rescue of stalled ribosome (GO:0072344),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,NEMF;RACK1
response to fructose (GO:0009750),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,XBP1;KHK
response to sodium arsenite (GO:1903935),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,HNRNPA1;MAPK13
"RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PDE12;PARN
rRNA transport (GO:0051029),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,NPM1;MRPL18
salivary gland morphogenesis (GO:0007435),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,TGFB2;FGFR2
spliceosomal conformational changes to generate catalytic conformation (GO:0000393),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,ISY1;SNRNP200
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,SEC61A1;SEC61B
stress granule disassembly (GO:0035617),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,VCP;KIF5B
succinyl-CoA metabolic process (GO:0006104),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,OGDH;DLST
trophoblast giant cell differentiation (GO:0060707),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,E2F7;E2F8
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,PDCD6IP;VPS4B
vesicle fusion with Golgi apparatus (GO:0048280),05-Feb,0.304214516,0.999996398,0,0,2.363567477,2.812697727,GOSR2;VTI1B
positive regulation of gene expression (GO:0010628),111/482,0.308146382,0.999996398,0,0,1.062024768,1.250194679,RPL5;APP;TFRC;PDCD5;EIF4A3;PARK7;RBPJ;CLU;ETS1;ACTB;ACTG1;GJA1;HMGN5;MYC;LAMP3;EP300;SOX4;MED1;RPS7;RPL23;SOX11;ANK2;LARP4B;MIF;POU3F1;CLDN3;MYCN;RPL26;EZR;DDX5;HPN;PDGFB;PHB;HIF1A;FXR1;PDCD10;UBR5;MBIP;SLC38A2;SRPK2;RDX;GLMN;RAB27A;MSN;BRAF;LARP4;EEF2;MT3;SETX;FGF17;AFDN;LIN28A;EIF6;FUBP3;SP1;FUBP1;ID2;AGO2;HNRNPD;GSK3A;DDX3X;CELF1;NAT10;PIK3CB;ELAVL1;RBM3;RPS4X;DNMT3B;FLOT1;IFNGR1;DDX58;F3;ACTA2;ACTA1;POLR1C;GAPDH;YAP1;RAMP3;ROCK1;ROCK2;POLDIP3;RPL11;RPS27L;DDX21;THBS1;MAPK8;TAF1D;RPS3;POLR2F;METTL5;MAPK1;POLR2H;SF3B1;POLR2K;POLR2L;MAPK3;YTHDF1;NPM1;GSN;DEK;MAPK14;PDCL3;MYO1C;RPS6KB1;SPRY2;EIF3E;FAM98B;KRAS;EIF3C;EIF3D;LIMS1
negative regulation of protein localization to cell periphery (GO:1904376),21-Jun,0.308178507,0.999996398,0,0,1.418339022,1.669492958,TMEM59;DAB2;CLTC;PPP2R5A;AP2M1;BCL2L1
negative regulation of protein localization to plasma membrane (GO:1903077),21-Jun,0.308178507,0.999996398,0,0,1.418339022,1.669492958,TMEM59;DAB2;CLTC;PPP2R5A;AP2M1;BCL2L1
negative regulation of response to wounding (GO:1903035),21-Jun,0.308178507,0.999996398,0,0,1.418339022,1.669492958,PTPRS;CLDN3;INPP5F;MDK;CRK;GIT1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),21-Jun,0.308178507,0.999996398,0,0,1.418339022,1.669492958,XBP1;EP300;RBPJ;HIF1A;MT3;SMAD5
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),21-Jun,0.308178507,0.999996398,0,0,1.418339022,1.669492958,CAMK2D;ATP2A2;ANK2;CALM3;CALM1;CALM2
positive regulation of cell migration (GO:0030335),63/269,0.308517773,0.999996398,0,0,1.085193168,1.276160934,ITGB1;FLT1;MIA3;ACTG1;CXCL16;IGF1R;GLIPR2;MDK;C1QBP;RACK1;SEMA6A;F2R;GAB1;ACTN4;RHOC;F3;PTP4A1;CLDN4;MMP14;CLDN3;MYADM;PLAA;ITGA6;ARHGEF2;EPHA1;KIF20B;PFN1;MAPRE1;HBEGF;GRB7;CD151;ROCK2;PDGFB;SEMA3E;HIF1A;THBS1;FAM83H;PAK1;MIEN1;RAB25;PDCD10;PODXL;PDPN;PTK2B;S100A11;CARMIL1;TCAF2;XBP1;TGFB2;HSPA5;RDX;LAMB1;RAB11A;TJP1;FERMT1;DAB2;MYO1C;AGO2;F2RL1;SPRY2;TDGF1;FERMT2;BCAR1
protein polymerization (GO:0051258),15/59,0.308684083,0.999996398,0,0,1.209038055,1.421147957,GSN;GPX4;MID1IP1;WASL;CKAP5;TRIM6;TPPP3;MAP7D3;PSTPIP2;CHMP2A;CHMP3;SPIRE1;RAC1;UBE2K;WASHC3
translesion synthesis (GO:0019985),11/42,0.310111711,0.999996398,0,0,1.258343743,1.473297405,VCP;PCNA;RFC4;UBB;RFC1;RFC2;RPA3;UBC;PCLAF;RPA1;RPS27A
positive regulation of protein secretion (GO:0050714),18/72,0.311280337,0.999996398,0,0,1.18221918,1.379722332,TGFB2;TMED10;PLA2G1B;ACSL4;IER3IP1;CD2AP;GLUD1;GOLPH3;NNAT;MYO18A;F2RL1;DNM1L;EZR;PPIA;MYH10;SOX4;PPID;ARF6
copper ion homeostasis (GO:0055070),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,APP;PRNP;ARF1;COMMD1;ATOX1
epithelial cell morphogenesis (GO:0003382),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,COL18A1;CLDN3;RAB25;RILPL1;GRHL2
histone H2A ubiquitination (GO:0033522),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,DDB1;UBE2B;UBE2A;RNF2;CUL4B
positive regulation of muscle hypertrophy (GO:0014742),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,MTPN;CAMK2D;PARP1;ROCK1;ROCK2
positive regulation of smooth muscle cell migration (GO:0014911),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,ADAMTS1;MDK;DOCK7;PDGFB;S100A11
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,NCKAP1;ARF1;GMFB;ABI2;WASF2
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,CAMK2D;ANK2;CALM3;CALM1;CALM2
ribosomal small subunit assembly (GO:0000028),17-May,0.312916683,0.999996398,0,0,1.477384744,1.716452652,RPS14;RPS28;RPS27;RPS5;RPS27L
regulation of cell motility (GO:2000145),32/133,0.314233471,0.999996398,0,0,1.123885884,1.301031688,BEX4;PRAG1;SERPINE2;ROCK1;ROCK2;CCDC25;TACSTD2;NEXN;SPINT2;AMOT;PARD6B;SLK;INPP5F;TMSB4X;LMNA;FLNA;RAC1;TMSB10;CAVIN1;LMO4;DDX58;RCC2;NRG1;RHOA;FGF17;KIF2A;AMOTL2;PLXNB1;PKN2;PHPT1;CRK;HBEGF
bone cell development (GO:0098751),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,MED1;ANXA2;FOXP1
bundle of His cell to Purkinje myocyte communication (GO:0086069),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,JUP;PKP2;DSC2
CD40 signaling pathway (GO:0023035),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,ITGB1;PHB;PHB2
embryonic digestive tract morphogenesis (GO:0048557),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,ID2;SOX11;FGFR2
isoprenoid biosynthetic process (GO:0008299),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,IDI1;GGPS1;HMGCR
maintenance of apical/basal cell polarity (GO:0035090),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,PDCD6IP;WDR1;LIN7C
maintenance of epithelial cell apical/basal polarity (GO:0045199),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,PDCD6IP;WDR1;LIN7C
mitochondrial respirasome assembly (GO:0097250),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,COX7A2L;COX7A2;HIGD1A
negative regulation of necroptotic process (GO:0060546),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,ARHGEF2;SLC25A4;YBX3
ornithine metabolic process (GO:0006591),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,ODC1;ASL;AZIN1
peroxisome fission (GO:0016559),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,FIS1;PEX19;DNM1L
positive regulation of ATP biosynthetic process (GO:2001171),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,VCP;TMSB4X;ENO1
positive regulation of B cell differentiation (GO:0045579),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,MMP14;XBP1;IL2
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,TJP1;AFDN;FLOT1
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,BNIP3L;BNIP3;VDAC2
regulation of endothelial cell development (GO:1901550),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,PPP1R12A;ROCK1;ROCK2
regulation of epidermis development (GO:0045682),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,KLF7;MAFF;NME2
regulation of nuclear cell cycle DNA replication (GO:0033262),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,TIPIN;DBF4;ATRX
regulation of protein deacetylation (GO:0090311),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,SPRED2;SPRED1;EP300
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,NSD1;TMSB4X;EP300
regulation of skeletal muscle cell differentiation (GO:2001014),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,DDX5;UQCC2;GPC1
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,ZFP36;PARK7;FOXP1
small RNA loading onto RISC (GO:0070922),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,DHX9;AGO2;DICER1
tetrahydrofolate interconversion (GO:0035999),09-Mar,0.315906109,0.999996398,0,0,1.772737608,2.042743688,MTHFD1;MTHFD2;MTHFD2L
central nervous system neuron axonogenesis (GO:0021955),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,HSP90AA1;HSP90AB1;MYCBP2;PTEN
cytoplasmic sequestering of protein (GO:0051220),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,YWHAB;FLNA;GOPC;DBN1
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,BMS1;TSR1;RPS21;NOP9
entry into host (GO:0044409),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,CDH1;CTNND1;CTNNB1;PPIA
kinetochore organization (GO:0051383),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,CENPE;CENPW;POGZ;CENPA
negative regulation by host of viral transcription (GO:0043922),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,JUN;REST;PSMC3;TARDBP
negative regulation of locomotion (GO:0040013),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,DUSP3;TACSTD2;SPINT2;CRK
negative regulation of stem cell differentiation (GO:2000737),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,REST;YTHDF2;TCF15;HNRNPU
plasma membrane repair (GO:0001778),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,SYT11;ANXA6;MYH9;ARL8B
polyamine metabolic process (GO:0006595),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,AMD1;ODC1;SMS;SRM
positive regulation of cell aging (GO:0090343),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,LMNA;HMGA1;EEF1E1;YPEL3
positive regulation of heterochromatin assembly (GO:0031453),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,TRIM28;TPR;PPHLN1;MPHOSPH8
positive regulation of protein acetylation (GO:1901985),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,DDX3X;CEP295;TAOK1;DIP2B
positive regulation of sodium ion transport (GO:0010765),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,AHCYL1;WNK3;PKP2;PRSS8
purine nucleotide catabolic process (GO:0006195),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,NT5C;HINT1;PNP;ITPA
pyrimidine deoxyribonucleotide catabolic process (GO:0009223),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,NT5C;DUT;TDG;DCTPP1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,DUSP1;USP44;TPR;MAD2L1
regulation of nucleocytoplasmic transport (GO:0046822),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,KHDRBS1;NEDD4;TPR;PTPN14
regulation of protein acetylation (GO:1901983),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,DDX3X;CEP295;TAOK1;PARK7
regulation of tube diameter (GO:0035296),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,GCLC;ROCK1;ROCK2;GCLM
tRNA 5'-leader removal (GO:0001682),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,SSB;POP4;RPP30;RPP14
vascular process in circulatory system (GO:0003018),13-Apr,0.316218905,0.999996398,0,0,1.575821899,1.814276163,GCLC;ROCK1;ROCK2;GCLM
histone exchange (GO:0043486),10/38,0.317489871,0.999996398,0,0,1.266470378,1.453033322,NPM1;CENPW;NASP;RUVBL1;CENPK;ANP32E;RBBP7;KNL1;CENPA;CENPS
negative regulation of proteasomal protein catabolic process (GO:1901799),10/38,0.317489871,0.999996398,0,0,1.266470378,1.453033322,USP25;USP7;HSP90AB1;LAMP3;RPL11;TAF9;TLK2;EIF3H;PARK7;UCHL5
protein localization to organelle (GO:0033365),34/142,0.31826234,0.999996398,0,0,1.116738332,1.278530563,YWHAE;APP;MTCH2;TRAM1;DDX3X;DHX9;DDX1;RPL11;YBX1;UBE2J2;FAM83H;SERP1;SIX4;LAMP3;TTC21B;SEC61G;LMNA;SEC61B;RAB6A;GBP2;ATP6V1D;EMD;PRNP;CYB5A;TIA1;COG7;SSB;RPA1;ANK2;RAB11A;VAPA;CALR;OPTN;ARF6
Ras protein signal transduction (GO:0007265),34/142,0.31826234,0.999996398,0,0,1.116738332,1.278530563,NCKAP1;ROCK1;SHC1;ROCK2;ARHGAP1;PARK7;RASGRP2;ARHGAP5;RAP1B;NRAS;TRIM28;ARHGDIA;CFL1;G3BP1;GNA12;PDPN;G3BP2;SHOC2;RAC1;CTNNAL1;JUN;ARHGAP29;RRAS2;MAPK14;RHOA;CCNA2;CNKSR1;RAP2B;ABI2;GNB1;KRAS;SOS1;KPNB1;ERAS
negative regulation of MAPK cascade (GO:0043409),23/94,0.318795156,0.999996398,0,0,1.14897149,1.313511705,DUSP3;SEMA6A;DUSP1;SPRY4;PTEN;PEBP1;PIK3CB;PHB;SYNJ2BP;DUSP9;DUSP6;FOXO1;SPRED2;RPS6KA6;SPRED1;UCHL1;MYC;DAG1;SPRY2;SPRY1;EZR;PPIA;CDK5RAP3
neutrophil mediated immunity (GO:0002446),112/488,0.321675966,0.999996398,0,0,1.05724193,1.199134959,SRP14;PSMD6;PSMD7;PNP;PSMD2;ANPEP;FTH1;PSMD1;GOLGA7;KCMF1;ATP11B;MIF;ILF2;EEF1A1;RAB31;PPIE;PPIA;KPNB1;PSMD12;VCP;PSMD11;PSMD14;COPB1;UBR4;MGST1;IQGAP1;GNS;PLAC8;RAP1B;CNN2;CYB5R3;RAB6A;ATP6V1D;S100A11;HSPA8;XRCC6;TRAPPC1;JUP;SURF4;RAB27A;DNAJC13;PA2G4;ARPC5;EEF2;PRDX6;NFKB1;CYSTM1;CDK13;NIT2;HSP90AB1;ITGAM;DDX3X;SLC44A2;GDI2;SLC2A3;HMGB1;AP2A2;HEBP2;NAPRT;TIMP2;PGM2;RAC1;SPTAN1;ACTR2;CCT2;HSP90AA1;ANXA2;ANXA3;PGAM1;NME2;PLAUR;NDUFC2;DYNLL1;DDOST;RHOA;APRT;PSMA5;PKM;RAP2B;PSMA2;DNAJC5;ALDOA;ROCK1;PLA2G1B;PSMB7;NRAS;PGRMC1;CAND1;PSMB1;CXCR2;MAPK1;CCT8;GSN;GCA;HUWE1;PDAP1;TUBB4B;MAPK14;RAB10;PFKL;FABP5;PSMC3;RAB14;VAPA;IMPDH2;PSMC2;RAB18;LAMTOR2;LAMTOR1;YPEL5;LAMTOR3;ACTR10
mesenchymal cell differentiation (GO:0048762),13/51,0.323674521,0.999996398,0,0,1.213195077,1.368504468,DDX5;TGFB2;ROCK1;ROCK2;RBPJ;HIF1A;HNRNPAB;LOXL2;TRIM28;CTNNB1;FGFR2;FGFR1;LIMS1
negative regulation of protein ubiquitination (GO:0031397),13/51,0.323674521,0.999996398,0,0,1.213195077,1.368504468,IVNS1ABP;ARRB1;PARK7;GTPBP4;SMAD7;GNL3L;BAG2;SVBP;RPS3;CHP1;SPOPL;SPRY2;SOX4
cell-substrate junction assembly (GO:0007044),9/34,0.325265864,0.999996398,0,0,1.276557377,1.433717405,CD151;DST;CTTN;ACTN1;RCC2;ITGA6;PTPRK;FERMT2;PLEC
regulation of keratinocyte differentiation (GO:0045616),9/34,0.325265864,0.999996398,0,0,1.276557377,1.433717405,MED1;ZFP36;ROCK1;ROCK2;NME2;SRSF6;ETV4;GRHL2;ZFP36L1
regulation of lamellipodium assembly (GO:0010591),9/34,0.325265864,0.999996398,0,0,1.276557377,1.433717405,CDC42;ACTR3;NCKAP1;ACTR2;CAPZB;ABI2;ARPC2;RAC1;WASF2
protein targeting (GO:0006605),30/125,0.327142493,0.999996398,0,0,1.120109815,1.25156528,ZDHHC20;ZFAND6;RPL11;TIMM13;ZDHHC6;SRP14;TOMM22;SEC61A1;SEC61G;TIMM17A;TSPO;GOLGA7;AP1M2;TIMM8B;FIS1;PRKCI;PEX19;EDEM1;TOMM34;TIMM23;TIMM10B;SPCS3;SPCS2;MYO1C;SPCS1;NACA;CDC37;TOMM7;MGARP;TOMM5
peptidyl-serine modification (GO:0018209),40/169,0.328235843,0.999996398,0,0,1.099953961,1.225373897,CAMK2D;ROCK1;ROCK2;PDGFB;STK4;RPS6KA6;MAPK8;GRK2;NTMT1;RPS6KA1;TLK2;TLK1;MAPK1;MARK3;PAK2;SRPK2;PRKCI;CSNK2A1;CHUK;PARP1;GALNT3;NAA10;PARP2;CSNK1A1;NEK6;CSNK2A2;LMTK2;MASTL;HIPK1;MAPK14;MAPK12;MAPK13;LATS2;MAPKAPK3;RPS6KB1;WNK1;CDK1;PKN2;TDGF1;CSNK1G2
epidermal growth factor receptor signaling pathway (GO:0007173),12/47,0.331808499,0.999996398,0,0,1.215818768,1.341287965,GRB7;DGKD;SHC1;GAB1;PTK2B;BRAF;IQGAP1;PIK3C2A;SOS1;TDGF1;BCAR1;HBEGF
epithelial to mesenchymal transition (GO:0001837),12/47,0.331808499,0.999996398,0,0,1.215818768,1.341287965,DDX5;TGFB2;ROCK1;TRIM28;ROCK2;CTNNB1;RBPJ;HIF1A;HNRNPAB;LOXL2;FGFR1;LIMS1
morphogenesis of an epithelium (GO:0002009),30-Aug,0.333489432,0.999996398,0,0,1.289406701,1.415954363,LAMA5;AHI1;DAG1;LIN7C;ACTB;FGFR2;ACTG1;ARHGAP12
regulation of type I interferon-mediated signaling pathway (GO:0060338),30-Aug,0.333489432,0.999996398,0,0,1.289406701,1.415954363,TRIM6;HSP90AB1;YTHDF2;CNOT7;CDC37;SAMHD1;ABCE1;UBE2K
transcription by RNA polymerase II (GO:0006366),74/320,0.333762616,0.999996398,0,0,1.067340447,1.171219644,RARG;PHAX;RBPJ;AFF4;CDC73;SNAPC3;PAPOLA;ELOB;SNRPD3;ELOC;TEAD1;GTF2I;MED1;KLF13;PARP1;SSU72;GTF2F2;WDR33;TFDP1;NFX1;SNRPG;SNRPE;SNRPF;YAP1;SLBP;GTF2A1;DDX5;GTF2A2;ELOF1;HDAC3;RNMT;SRRT;TAF9;DDX21;WDR61;RTF1;PMF1;GTF2E2;FIP1L1;POLR2B;NOCT;LEO1;POLR2F;POLR2G;TBL1X;POLR2H;POLR2I;POLR2J;POLR2K;POLR2L;TCFL5;BTF3;XBP1;TAF12;CPSF3;CPSF2;DEK;SSRP1;GTF2H3;GTF2H5;NFKB1;SETX;CDK7;NR6A1;SP1;COPS2;NABP2;PIR;TCEA1;NABP1;CDK12;CDK13;MNAT1;TAF2
neutrophil activation involved in immune response (GO:0002283),111/485,0.334683029,0.999996398,0,0,1.053298306,1.152910178,SRP14;PSMD6;PSMD7;PNP;PSMD2;ANPEP;FTH1;PSMD1;GOLGA7;KCMF1;ATP11B;MIF;ILF2;EEF1A1;RAB31;PPIE;PPIA;KPNB1;PSMD12;VCP;PSMD11;PSMD14;COPB1;UBR4;MGST1;IQGAP1;GNS;PLAC8;RAP1B;CNN2;CYB5R3;RAB6A;ATP6V1D;S100A11;HSPA8;XRCC6;TRAPPC1;JUP;SURF4;RAB27A;DNAJC13;PA2G4;ARPC5;EEF2;PRDX6;NFKB1;CYSTM1;CDK13;NIT2;HSP90AB1;ITGAM;DDX3X;SLC44A2;GDI2;SLC2A3;HMGB1;AP2A2;HEBP2;NAPRT;TIMP2;PGM2;RAC1;SPTAN1;ACTR2;CCT2;HSP90AA1;ANXA2;ANXA3;PGAM1;NME2;PLAUR;NDUFC2;DYNLL1;DDOST;RHOA;APRT;PSMA5;PKM;RAP2B;PSMA2;DNAJC5;ALDOA;ROCK1;PSMB7;NRAS;PGRMC1;CAND1;PSMB1;CXCR2;MAPK1;CCT8;GSN;GCA;HUWE1;PDAP1;TUBB4B;MAPK14;RAB10;PFKL;FABP5;PSMC3;RAB14;VAPA;IMPDH2;PSMC2;RAB18;LAMTOR2;LAMTOR1;YPEL5;LAMTOR3;ACTR10
cellular glucose homeostasis (GO:0001678),11/43,0.34044964,0.999996398,0,0,1.218942198,1.313395669,XBP1;LIN28A;TRA2B;RACK1;NUCKS1;HIF1A;SLC39A14;FOXO1;HK2;SOX4;IGF1R
DNA synthesis involved in DNA repair (GO:0000731),11/43,0.34044964,0.999996398,0,0,1.218942198,1.313395669,VCP;PCNA;RFC4;UBB;RFC1;RFC2;RPA3;UBC;PCLAF;RPA1;RPS27A
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),20/82,0.341057811,0.999996398,0,0,1.144016317,1.230622106,CDKN1C;CCNI;GADD45A;BCCIP;PTEN;PDGFB;CDC25C;ACTB;GTPBP4;IPO5;CCNA2;CCNB2;CDK7;LATS2;CCNE2;CCNE1;CDC37;CCNG2;MNAT1;CDK5RAP3
chaperone cofactor-dependent protein refolding (GO:0051085),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,HSPA9;HSPA8;HSPA5;ST13;PTGES3;SDF2;HSPE1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,SFRP2;KDM1A;TAF9;MIF;CLU;TPT1;BCL2L1
positive regulation of ion transmembrane transporter activity (GO:0032414),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,NDUFA4;WNK1;COX17;AKAP9;WNK3;ANK2;ATP1B3
regulation of actin filament bundle assembly (GO:0032231),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,CDC42;ROCK1;ROCK2;RDX;RAC1;PFN1;ACTG1
regulation of potassium ion transmembrane transporter activity (GO:1901016),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,ITGB1;YWHAE;NEDD4;FHL1;AKAP9;ANK2;ATP1B3
regulation of telomere maintenance (GO:0032204),26-Jul,0.342219344,0.999996398,0,0,1.306326809,1.400778665,USP7;MYC;ERCC1;ATRX;HNRNPD;PML;GNL3
cellular response to decreased oxygen levels (GO:0036294),17/69,0.342398457,0.999996398,0,0,1.159368859,1.242588519,EGLN1;SUV39H2;BNIP3L;EGLN3;BNIP3;HIF1A;MT3;ZFP36L1;NPEPPS;FAM162A;MYC;LMNA;PGK1;UBQLN1;PMAIP1;MGARP;P4HB
Rho protein signal transduction (GO:0007266),14/56,0.342548843,0.999996398,0,0,1.182053035,1.266381908,ROCK1;ROCK2;ARHGAP1;ARHGAP29;ARHGAP5;RHOA;CDC42;CNKSR1;ARHGDIA;CFL1;GNA12;PDPN;RHOU;CTNNAL1
negative regulation of blood vessel morphogenesis (GO:2000181),19/78,0.349171374,0.999996398,0,0,1.142037147,1.201642846,TGFB2;SEMA6A;ROCK1;ROCK2;PDE3B;ECSCR;SEMA3E;SYNJ2BP;HSPG2;THBS1;PML;AMOT;SPRED1;COL4A2;ADAMTS1;PGK1;CTNNB1;SPRY2;GTF2I
protein monoubiquitination (GO:0006513),10/39,0.349679369,0.999996398,0,0,1.222720455,1.284759619,UBE2B;UBE2R2;CUL3;UBE2D3;LEO1;HUWE1;UBE2E1;CDC73;RAD18;RBX1
regulation of cellular component biogenesis (GO:0044087),10/39,0.349679369,0.999996398,0,0,1.222720455,1.284759619,RAP1B;TJP1;HSPA8;HSP90AA1;ROCK1;ROCK2;RDX;MSN;ANKRA2;EZR
vesicle cytoskeletal trafficking (GO:0099518),10/39,0.349679369,0.999996398,0,0,1.222720455,1.284759619,CCDC186;MYO1C;KIF5B;BICDL1;MYO5A;BICDL2;WASL;KIF1A;ACTN4;FNBP1L
regulation of cell-matrix adhesion (GO:0001952),16/65,0.350938487,0.999996398,0,0,1.157936379,1.212526503,DUSP3;ROCK1;JUP;ROCK2;SEMA3E;PIK3CB;EFNA5;THBS1;RHOA;ACTG1;CORO1C;SLK;PTPRA;PTK2B;EPHA1;UTRN
cell projection assembly (GO:0030031),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,CDC42;NCKAP1;GSN;PARVA;RHOU;RAC1
peptidyl-threonine dephosphorylation (GO:0035970),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,PPP2CA;PPP2CB;DUSP1;DUSP9;DUSP6;PPP1CA
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,SETX;MED1;JUN;BCLAF1;MED14;SUB1
protein localization to cell junction (GO:1902414),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,TJP1;PAK2;CGNL1;FERMT2;JAK1;TJP2
regulation of macrophage chemotaxis (GO:0010758),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,MDK;MAPK1;PTK2B;MIF;THBS1;MAPK3
regulation of viral release from host cell (GO:1902186),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,DDB1;TSG101;TRIM28;CHMP2A;CHMP3;PML
rRNA methylation (GO:0031167),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,TRMT112;EMG1;METTL5;BUD23;METTL16;FTSJ3
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),22-Jun,0.351522983,0.999996398,0,0,1.329607509,1.390078301,TOM1L1;TSG101;VPS4B;NEDD4;PLAA;VPS36
mitochondrion organization (GO:0007005),41/175,0.35221263,0.999996398,0,0,1.085281734,1.132513437,TIMM13;COX7A2;MTFR1L;PARK7;PHB;HIGD1A;PHB2;HSD17B10;HK2;TOMM22;HSPD1;CHCHD3;TIMM17A;TSPO;DNM1L;TIMM8B;BNIP3L;FIS1;MIGA1;PARP1;BNIP3;TOMM34;TIMM23;TIMM10B;COX7A2L;HAX1;POLG2;FMC1;TMEM11;TOMM7;TFAM;YME1L1;CYCS;BAX;NDUFS1;MGARP;SLIRP;SSBP1;SLC25A4;TOMM5;BCL2L1
negative regulation of angiogenesis (GO:0016525),21/87,0.354811802,0.999996398,0,0,1.128383147,1.169194242,TGFB2;SEMA6A;ROCK1;ROCK2;PDE3B;ECSCR;SEMA3E;PIK3CB;SYNJ2BP;HSPG2;THBS1;EPN1;PML;AMOT;SPRED1;COL4A2;ADAMTS1;PGK1;CTNNB1;SPRY2;GTF2I
negative regulation of Ras protein signal transduction (GO:0046580),9/35,0.359603619,0.999996398,0,0,1.227380202,1.255306675,TGFB2;ITGA3;KCTD10;CUL3;STMN1;SPRY4;SPRY2;SPRY1;TNFAIP1
regulation of muscle cell differentiation (GO:0051147),9/35,0.359603619,0.999996398,0,0,1.227380202,1.255306675,CDC42;PTBP1;ID2;CTNNA1;IGF2;CTNNB1;MAPK14;MAPK12;FGFR2
respiratory system development (GO:0060541),9/35,0.359603619,0.999996398,0,0,1.227380202,1.255306675,SMCHD1;BASP1;ZIC3;ITGA3;WNT7B;CHD7;PDPN;FGFR2;CCDC40
"regulation of DNA-templated transcription, initiation (GO:2000142)",15/61,0.359963125,0.999996398,0,0,1.156322489,1.181476761,MED1;CEBPB;JUN;PTEN;MED8;MED6;NFKB1;SETX;MED14;BCLAF1;TRIM28;CDK4;CDK1;BAX;CTNNB1
positive regulation of blood vessel endothelial cell migration (GO:0043536),12/48,0.36105523,0.999996398,0,0,1.181970077,1.204101687,NUS1;FGFBP1;SP1;TMSB4X;PDGFB;HMGB1;PIK3C2A;MAPK14;ETS1;HIF1A;THBS1;FGFR1
regulation of mitochondrion organization (GO:0010821),12/48,0.36105523,0.999996398,0,0,1.181970077,1.204101687,FIS1;GSK3A;GOLPH3;HAX1;INF2;FBXW7;CSNK2A2;EP300;VDAC1;MGARP;DNM1L;PARL
negative regulation of fibroblast proliferation (GO:0048147),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,FTH1;MYC;PEX2;EMD;CDC73
negative regulation of Rho protein signal transduction (GO:0035024),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,ITGA3;KCTD10;CUL3;STMN1;TNFAIP1
positive regulation of amyloid-beta formation (GO:1902004),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,GSK3A;IFNGR1;ROCK2;SP1;CLU
positive regulation of cardiac muscle hypertrophy (GO:0010613),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,MTPN;CAMK2D;PARP1;ROCK1;ROCK2
positive regulation of cell cycle phase transition (GO:1901989),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,NPM1;CUL3;PHB2;CDC73;EZH2
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,TGFB2;TAOK3;PDCD10;TAOK1;MID1
rRNA catabolic process (GO:0016075),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,EXOSC7;DIS3;EXOSC8;EXOSC3;EXOSC2
tRNA metabolic process (GO:0006399),18-May,0.361469565,0.999996398,0,0,1.363652271,1.387621777,SSB;RPP30;DARS2;DTD1;DTD2
cellular response to transforming growth factor beta stimulus (GO:0071560),27/114,0.367219453,0.999996398,0,0,1.100610189,1.102586493,ITGB1;USP15;PDCD5;PTPRK;F11R;ZFP36L1;UBB;ZMIZ2;UBC;RPS27A;JUN;TGFB2;LEFTY1;USP9X;FOXH1;CGN;SMAD5;RHOA;SMAD7;DUSP22;FKBP1A;TWSG1;ID1;ZYX;FERMT2;BMPR1A;LIMS1
histone modification (GO:0016570),27/114,0.367219453,0.999996398,0,0,1.100610189,1.102586493,ENY2;PRDM5;EHMT1;PARK7;PHB;RUVBL2;NTMT1;NSD1;RUVBL1;EP300;TBL1X;NAA50;PHC1;UBE2B;PRMT2;PARP2;USP22;HUWE1;UBE2A;MT3;CCNA2;PHF20L1;MORF4L1;MORF4L2;CARM1;UBE2N;EZH2
dicarboxylic acid metabolic process (GO:0043648),14/57,0.369535399,0.999996398,0,0,1.154489215,1.149304104,GOT1;MDH1;MDH2;DLST;DHFR;GCLC;MTHFD1;MTHFD2;MTHFD2L;OGDH;ME2;GCLM;NIT2;SLC19A1
positive regulation of Rho protein signal transduction (GO:0035025),31-Aug,0.37036438,0.999996398,0,0,1.233266362,1.224963949,PRAG1;LPAR6;F2R;F2RL1;ARRB1;LPAR4;RAC1;F11R
mRNA catabolic process (GO:0006402),11/44,0.37128508,0.999996398,0,0,1.181928626,1.171037274,DDX5;RIDA;ZFP36;YTHDF2;PDE12;THRAP3;MRTO4;RC3H1;METTL16;LSM5;NUDT16L1
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),11/44,0.37128508,0.999996398,0,0,1.181928626,1.171037274,CDC42;TSG101;DUSP3;SPRY2;SPRY1;EPS15;SOCS4;EPN1;SNX6;HBEGF;PTPN3
branching involved in blood vessel morphogenesis (GO:0001569),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,SFRP2;COL4A1;CTNNB1;SEMA3E
cell junction maintenance (GO:0034331),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,CLDN3;F2R;MYADM;F2RL1
cellular copper ion homeostasis (GO:0006878),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,APP;PRNP;ARF1;ATOX1
histone H3-K4 trimethylation (GO:0080182),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,KMT2A;SETD1B;BEND3;WDR61
microvillus organization (GO:0032528),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,RAP1B;RAP2B;STK26;EZR
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,CARD10;PDCD10;THBS1;RHOA
peptidyl-serine dephosphorylation (GO:0070262),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,PPP2CA;PPP2CB;DUSP1;PPP1CA
positive regulation of cyclase activity (GO:0031281),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,MAPK8;AKAP5;MAPK14;MAPK3
positive regulation of macrophage chemotaxis (GO:0010759),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,MDK;MAPK1;THBS1;MAPK3
positive regulation of mitochondrial translation (GO:0070131),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,COA3;MRPS27;UQCC2;C1QBP
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,WNK1;WNK3;CHP1;ACTN4
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,TRIM28;TET1;PPHLN1;MPHOSPH8
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,KDM1A;TAF9;MIF;RPL26
regulation of trophoblast cell migration (GO:1901163),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,GJA1;C1QBP;AGO2;CALR
smooth muscle contraction (GO:0006939),14-Apr,0.372098037,0.999996398,0,0,1.418148738,1.40197889,ACTA2;ROCK1;ROCK2;PIK3C2A
positive regulation of cell motility (GO:2000147),51/221,0.375029648,0.999996398,0,0,1.064068966,1.043585845,ITGB1;FLT1;ACTG1;CXCL16;IGF1R;MDK;RACK1;SEMA6A;F2R;ACTN4;RHOC;F3;PTP4A1;CLDN4;MMP14;CLDN3;MYADM;ITGA6;EPHA1;MAPRE1;PHPT1;HBEGF;GRB7;CD151;ROCK2;CCDC25;PDGFB;SEMA3E;THBS1;FAM83H;PAK1;MIEN1;PDCD10;PODXL;PDPN;PTK2B;CARMIL1;TCAF2;XBP1;CAVIN1;HSPA5;RDX;LAMB1;TJP1;DAB2;MYO1C;F2RL1;SPRY2;TDGF1;FERMT2;BCAR1
negative regulation of binding (GO:0051100),21/88,0.376589571,0.999996398,0,0,1.111470047,1.085460932,JUN;PEX19;KDM1A;ROCK1;PDGFB;PARK7;ACTB;GTPBP4;WAPL;PPP1CA;MAPK8;DAB2;BTAF1;GNL3L;SUMO1;BAG2;SUMO3;RACK1;BAX;TMBIM6;MITD1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),28/119,0.37820779,0.999996398,0,0,1.091171349,1.060958479,MTCH1;BEX3;VCP;DDX3X;PDCD6;PDCD5;RPS27L;HMGB1;BBC3;HSPD1;FAM162A;MYC;RACK1;RPS3;PMAIP1;FIS1;EGLN3;GSN;DAPK1;F2R;CFLAR;HSPE1;F3;SENP1;REST;CYCS;BAX;ANP32B
response to amino acid starvation (GO:1990928),18/75,0.381383948,0.999996398,0,0,1.119780972,1.079411382,SH3GLB1;ATP6V1G1;SEC13;CEBPB;SEH1L;EIF2S1;IMPACT;MAPK8;LARP1;RHEB;BMT2;MAPK1;LAMTOR2;LAMTOR1;ATP6V1D;LAMTOR3;ATP6V1F;MAPK3
cellular response to cadmium ion (GO:0071276),27-Jul,0.382159142,0.999996398,0,0,1.240930815,1.193673881,MAPK8;JUN;SUMO1;CHUK;MAPK1;MT3;MAPK3
cellular response to unfolded protein (GO:0034620),27-Jul,0.382159142,0.999996398,0,0,1.240930815,1.193673881,HSPA9;HSPA8;HSPA5;BAX;TMBIM6;OPTN;HSPD1
positive regulation of mitotic cell cycle (GO:0045931),27-Jul,0.382159142,0.999996398,0,0,1.240930815,1.193673881,APP;DUSP3;RPS6KB1;CUL3;USP22;PKN2;EIF4E
regulation of epidermal growth factor-activated receptor activity (GO:0007176),27-Jul,0.382159142,0.999996398,0,0,1.240930815,1.193673881,APP;TSG101;SHC1;FBXW7;SOCS4;SNX6;HBEGF
response to glucocorticoid (GO:0051384),27-Jul,0.382159142,0.999996398,0,0,1.240930815,1.193673881,ZFP36;REST;BCL2L11;GOT1;HNRNPU;UBE2L3;ZFP36L1
negative regulation of cell-substrate adhesion (GO:0010812),10/40,0.382320402,0.999996398,0,0,1.181887194,1.136380133,FZD7;RCC2;SPRY4;TACSTD2;SEMA3E;ACTN4;EFNA5;THBS1;RHOA;CORO1C
negative regulation of ERBB signaling pathway (GO:1901185),10/40,0.382320402,0.999996398,0,0,1.181887194,1.136380133,CDC42;TSG101;DUSP3;SPRY2;SPRY1;PTPN12;EPS15;EPN1;HBEGF;PTPN3
positive regulation of wound healing (GO:0090303),10/40,0.382320402,0.999996398,0,0,1.181887194,1.136380133,ITGB1;FERMT1;XBP1;CLDN4;CLDN3;F2R;THBS1;FERMT2;ACTG1;HBEGF
regulation of microtubule polymerization (GO:0031113),10/40,0.382320402,0.999996398,0,0,1.181887194,1.136380133,CLIP3;PAK1;STMN1;AKAP9;STMN2;RPS3;DRG1;ARL2;RAC1;MAPRE1
apical protein localization (GO:0045176),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,SHROOM2;GOPC;ACTB
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,DDX58;PHB;PHB2
dosage compensation (GO:0007549),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,SMCHD1;HNRNPU;LRIF1
endodermal cell fate commitment (GO:0001711),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,LEO1;RTF1;CDC73
fructose 6-phosphate metabolic process (GO:0006002),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PFKL;GFPT2;HK2
genetic imprinting (GO:0071514),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,DNMT3L;DNMT3A;IGF2
histone H2B ubiquitination (GO:0033523),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,LEO1;UBE2E1;CDC73
lung epithelium development (GO:0060428),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,RCN3;WNT7B;GRHL2
morphogenesis of an epithelial sheet (GO:0002011),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,SOX11;LIN7C;ARHGAP12
myelin assembly (GO:0032288),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,GPC1;PMP22;DICER1
myelin maintenance (GO:0043217),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,MYRF;PTEN;CLU
negative regulation of cAMP-mediated signaling (GO:0043951),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CDC34;UBE2B;PDE3B
negative regulation of lymphocyte apoptotic process (GO:0070229),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,NOC2L;IL2;FOXP1
negative regulation of sodium ion transmembrane transport (GO:1902306),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CAMK2D;NEDD4;COMMD1
negative regulation of transcription by competitive promoter binding (GO:0010944),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CREB1;PHB;SMAD7
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,SEMA6A;SPRY2;PIK3CB
peptidyl-lysine acetylation (GO:0018394),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,ESCO1;BLOC1S1;EP300
pinocytosis (GO:0006907),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CARMIL1;MAPKAPK3;SNX5
positive regulation of myoblast fusion (GO:1901741),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,EHD2;FLOT1;MAPK14
positive regulation of tissue remodeling (GO:0034105),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,ROCK1;ROCK2;IL2
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,NCL;NOL11;SMARCA4
primary miRNA processing (GO:0031053),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,HNRNPA2B1;SRRT;MRPL44
protein poly-ADP-ribosylation (GO:0070212),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PARP1;TNKS2;PARP2
regulation of actin filament-based movement (GO:1903115),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PDPN;ANK2;SRI
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CDC42;RCC2;ECT2
regulation of cell-cell adhesion mediated by integrin (GO:0033632),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PODXL;WNK1;ADA
regulation of DNA damage checkpoint (GO:2000001),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,DDX39B;FEM1B;THOC1
regulation of high voltage-gated calcium channel activity (GO:1901841),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,CALM3;SRI;CALM1
regulation of microtubule nucleation (GO:0010968),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PAK1;CKAP5;GIT1
regulation of tau-protein kinase activity (GO:1902947),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,HSP90AA1;HSP90AB1;CLU
regulation of type B pancreatic cell development (GO:2000074),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,GSK3A;RHEB;FOXO1
removal of superoxide radicals (GO:0019430),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,PRDX2;PRDX1;MT3
sequestering of actin monomers (GO:0042989),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,GSN;TMSB4X;TMSB10
small nucleolar ribonucleoprotein complex assembly (GO:0000491),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,RUVBL2;RUVBL1;TAF9
sulfur amino acid catabolic process (GO:0000098),10-Mar,0.383270421,0.999996398,0,0,1.519391931,1.457118861,BLMH;ADO;TXN2
regulation of cellular localization (GO:0060341),12/49,0.390650598,0.999996398,0,0,1.149951045,1.080886975,HSP90AA1;CAMK2D;PARD6B;HSP90AB1;GSN;KDM1A;PARP1;REEP5;WWC1;PARD6G;EFNA5;TRIM67
response to glucose (GO:0009749),12/49,0.390650598,0.999996398,0,0,1.149951045,1.080886975,EIF2B3;XBP1;PFKL;LIN28A;TRA2B;RACK1;EIF2B1;SLC39A14;THBS1;SOX4;IGF1R;KHK
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,BAX;CYCS
adherens junction maintenance (GO:0034334),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,TJP1;FERMT2
ATP synthesis coupled electron transport (GO:0042773),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,NDUFB6;NDUFA12
axo-dendritic transport (GO:0008088),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,APP;HSPA8
cardiac ventricle formation (GO:0003211),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SOX11;SOX4
cellular hyperosmotic response (GO:0071474),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ARHGEF2;YBX3
cellular lipid biosynthetic process (GO:0097384),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,AGPS;FAR1
cellular response to salt (GO:1902075),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,HNRNPA1;MAPK13
cellular response to X-ray (GO:0071481),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,XRCC6;NUCKS1
contact inhibition (GO:0060242),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,YAP1;PAK1
detection of virus (GO:0009597),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DDX58;SERINC3
determination of liver left/right asymmetry (GO:0071910),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ZIC3;CCDC40
ear development (GO:0043583),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SHROOM2;ECE1
endoplasmic reticulum localization (GO:0051643),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,POLR2M;MOSPD3
epithelial tube formation (GO:0072175),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,PODXL;FGFR2
foam cell differentiation (GO:0090077),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SOAT1;EP300
free ubiquitin chain polymerization (GO:0010994),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,TRIM6;UBE2K
galactose catabolic process (GO:0019388),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,PGM2;GALK1
glandular epithelial cell differentiation (GO:0002067),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,FGFR2;WDR77
glycerol ether biosynthetic process (GO:0046504),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,AGPS;FAR1
hepatocyte differentiation (GO:0070365),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,E2F7;E2F8
hexose import across plasma membrane (GO:0140271),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SLC2A1;SLC2A3
IMP biosynthetic process (GO:0006188),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ATIC;AMPD2
ISG15-protein conjugation (GO:0032020),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,UBE2E1;UBE2E2
macrophage derived foam cell differentiation (GO:0010742),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SOAT1;EP300
maintenance of DNA methylation (GO:0010216),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,HELLS;USP7
mitotic DNA replication initiation (GO:1902975),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MCM4;MCM2
morphogenesis of an endothelium (GO:0003159),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,CTNNB1;CCM2
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,PDCD10;THBS1
negative regulation of cellular response to hypoxia (GO:1900038),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,TMBIM6;ENO1
negative regulation of cytokinesis (GO:0032466),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,E2F7;E2F8
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,FIS1;RAP1GDS1
negative regulation of ERAD pathway (GO:1904293),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,USP14;USP25
negative regulation of excitatory postsynaptic potential (GO:0090394),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MTMR2;PTEN
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,TCF15;MYB
negative regulation of histone H3-K9 methylation (GO:0051573),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,KDM1A;DNMT3B
negative regulation of trophoblast cell migration (GO:1901164),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,GJA1;CALR
nephric duct morphogenesis (GO:0072178),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,AHI1;GPC3
nuclear cell cycle DNA replication initiation (GO:1902315),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MCM4;MCM2
positive regulation of centriole replication (GO:0046601),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,CEP295;VPS4B
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,BCL2L11;PMAIP1
positive regulation of focal adhesion disassembly (GO:0120183),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DUSP3;ARF6
positive regulation of gluconeogenesis (GO:0045722),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DDB1;ARPP19
positive regulation of nuclear cell cycle DNA replication (GO:0010571),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DBF4;ATRX
positive regulation of plasminogen activation (GO:0010756),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,HPN;ENO1
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,FLOT1;F2RL1
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ZRANB1;USP9X
protein ufmylation (GO:0071569),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,UFM1;CDK5RAP3
protein-DNA complex subunit organization (GO:0071824),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MYC;RPL23
purine deoxyribonucleotide catabolic process (GO:0009155),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,PNP;SAMHD1
purine ribonucleoside catabolic process (GO:0046130),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,PNP;ADA
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,LARP4B;METTL16
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,LMNA;FOXO1
regulation of cellular response to hypoxia (GO:1900037),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ROCK2;AJUBA
regulation of focal adhesion disassembly (GO:0120182),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DUSP3;ARF6
regulation of macromolecule biosynthetic process (GO:0010556),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MED1;MTPN
regulation of macrophage proliferation (GO:0120040),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MAPK1;MAPK3
regulation of membrane tubulation (GO:1903525),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,SH3GLB1;WASL
regulation of mitotic sister chromatid segregation (GO:0033047),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DUSP1;USP44
regulation of mitotic spindle checkpoint (GO:1903504),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,DUSP1;USP44
regulation of mRNA export from nucleus (GO:0010793),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,NSUN2;TPR
regulation of protein depolymerization (GO:1901879),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,WDR1;MAP1B
regulation of protein lipidation (GO:1903059),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,RAB3GAP2;DBI
regulation of protein targeting (GO:1903533),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,HAX1;PARL
regulation of ribonucleoprotein complex localization (GO:2000197),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,NSUN2;TPR
regulation of T-helper cell differentiation (GO:0045622),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,MYB;RC3H1
response to catecholamine (GO:0071869),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,GNG2;GNB1
response to testosterone (GO:0033574),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,ROCK2;MSN
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,NUP107;RAE1
valine metabolic process (GO:0006573),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,HIBADH;BCAT2
ventricular compact myocardium morphogenesis (GO:0003223),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,LRP2;BMPR1A
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),06-Feb,0.393820982,0.999996398,0,0,1.772561946,1.651777508,CALR;TAPBP
regulation of protein serine/threonine kinase activity (GO:0071900),26/111,0.39488004,0.999996398,0,0,1.084676303,1.007852213,TSG101;DDX3X;CCNI;BCCIP;ACTB;PPP2CA;CCNB2;PDCD10;CDK5RAP3;GADD45A;CDC25C;GTPBP4;RHOA;CCNA2;CDK7;CCNE2;CCNE1;CDC37;CCNG2;CALM3;CDK12;CALM1;MNAT1;CALM2;TELO2;EZH2
ERK1 and ERK2 cascade (GO:0070371),23-Jun,0.395275859,0.999996398,0,0,1.251314997,1.161434769,MYC;CDK1;MAPK1;MT3;ZFP36L1;MAPK3
positive regulation of protein autophosphorylation (GO:0031954),23-Jun,0.395275859,0.999996398,0,0,1.251314997,1.161434769,TOM1L1;DDX3X;PDGFB;CALM3;CALM1;CALM2
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),23-Jun,0.395275859,0.999996398,0,0,1.251314997,1.161434769,HSP90AB1;SUMO1;IFNGR1;CDC37;PIAS1;JAK1
regulation of neural precursor cell proliferation (GO:2000177),23-Jun,0.395275859,0.999996398,0,0,1.251314997,1.161434769,TRIM71;KDM1A;MDK;ID2;NAP1L1;SLC16A2
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),23-Jun,0.395275859,0.999996398,0,0,1.251314997,1.161434769,CAMK2D;ANK2;CALM3;SRI;CALM1;CALM2
positive regulation of mitotic cell cycle phase transition (GO:1901992),14/58,0.396804894,0.999996398,0,0,1.128178295,1.042787123,DDX3X;CUL3;VPS4B;RCC2;RDX;UBE2E2;CDC25C;PHB2;RAB11A;TFDP1;ADAMTS1;CDK4;CDC27;CDK1
cellular response to insulin stimulus (GO:0032869),30/129,0.399038184,0.999996398,0,0,1.074575543,0.987210583,GRB7;GSK3A;SHC1;PLA2G1B;PDE3B;IDE;PIK3C2A;FOXO1;IGF1R;ZFP36L1;NAMPT;ATP6V1D;ATP6V1F;ATP6V1G1;PRKCI;XBP1;GOT1;PARP1;IGF2;GAB1;MYO5A;SLC39A14;RAB10;RAB31;PKM;RPS6KB1;RAB15;PHIP;SOS1;BCAR1
regulation of peptidyl-serine phosphorylation (GO:0033135),23/98,0.401354956,0.999996398,0,0,1.087412822,0.992709023,APP;HSP90AA1;HSP90AB1;RAMP3;TFRC;DOCK7;PTEN;BRAF;PARK7;MIF;STK4;SMAD7;TRIM6;PAK1;SFRP2;HAX1;PDCD10;NSD1;AKAP9;DDIT4;RACK1;SPRY2;CNOT9
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),16/67,0.40153752,0.999996398,0,0,1.112384019,1.01499958,RHBDF1;AFAP1L2;DGKD;DUSP3;TSG101;RHBDF2;PLAUR;PTPN12;EPN1;CDC42;SPRY2;SPRY1;EPS15;CNOT9;HBEGF;PTPN3
chromosome condensation (GO:0030261),11/45,0.402411376,0.999996398,0,0,1.147092322,1.044175647,TOP2A;SET;CSNK2A1;NCAPH2;CSNK2A2;CDK1;BANF1;NCAPD2;KMT5A;SMC4;SMC2
regulation of signal transduction by p53 class mediator (GO:1901796),36/156,0.403525754,0.999996398,0,0,1.063848797,0.965458707,RPL5;PAK1IP1;RPL11;TAF9;EHMT1;CHD4;NOC2L;RPF2;NUAK1;PPP1R13L;EP300;KMT5A;RPL37;RBBP7;CDK5RAP3;MBD3;PLK3;USP7;RFC4;CSNK2A1;TAF12;RFC2;RPL23;CSNK2A2;RPA1;PPP2R5C;SSRP1;HIPK1;MAPK14;PML;TPX2;RPA3;CDK1;RAD1;TAF2;RHNO1
regulation of protein-containing complex assembly (GO:0043254),27/116,0.405709168,0.999996398,0,0,1.07573866,0.970443974,VCP;DDX3X;TFRC;SAR1A;FAF1;PARK7;CLU;CDC42;BCL2L11;SUMO1;RACK1;RPS3;EP300;SH3GLB1;HSPA8;HSP90AA1;GSN;HSPA5;RIOK3;NRG1;RHOC;IMPACT;GNL3L;BAX;ANKRA2;AJUBA;CRYAB
DNA metabolic process (GO:0006259),63/277,0.405814068,0.999996398,0,0,1.04408229,0.941616248,TOP2A;RIF1;MCM7;GMNN;NUDT1;PARK7;HMGB1;TRIM28;SUMO1;HELLS;USP7;RFC4;PARP1;RFC1;PARP2;RFC2;SMC1A;TSN;DDB1;CDC34;DBF4;PSME4;MCM4;DCTPP1;MCM2;VCP;PCNA;DDX21;PDS5A;SAMHD1;PURA;ORC4;UBB;RAD21;TDG;ORC2;UBC;RPS27A;SRPK2;XRCC6;NPM1;STN1;UBE2B;GADD45A;PTGES3;CNBP;RPA1;UBE2A;LRWD1;GTF2H3;POLA2;TDP1;RPA3;ERCC1;CDK1;NABP2;UBE2N;NABP1;RAD1;MNAT1;RAD18;RAN;CENPS
cellular response to glucose stimulus (GO:0071333),8/32,0.40751632,0.999996398,0,0,1.181804386,1.060875423,XBP1;LIN28A;PTPRN;TRA2B;RACK1;SLC39A14;SOX4;IGF1R
liver development (GO:0001889),8/32,0.40751632,0.999996398,0,0,1.181804386,1.060875423,CEBPB;XBP1;ZIC3;LSR;CDK5RAP3;E2F7;E2F8;CCDC40
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),8/32,0.40751632,0.999996398,0,0,1.181804386,1.060875423,DAB2;FOXH1;PHB;CALR;CNOT9;STRN3;FOXP1;SMARCA4
regulation of centrosome duplication (GO:0010824),8/32,0.40751632,0.999996398,0,0,1.181804386,1.060875423,NPM1;PDCD6IP;VPS4B;CEP295;CHMP2A;NAT10;CHMP3;CHMP5
regulation of chemotaxis (GO:0050920),8/32,0.40751632,0.999996398,0,0,1.181804386,1.060875423,EFNB2;USP14;YTHDF1;DUSP3;MYCBP2;PDGFB;F2RL1;THBS1
regulation of cell cycle G2/M phase transition (GO:1902749),20/85,0.408314656,0.999996398,0,0,1.091004864,0.977231807,CEP57;YWHAE;DYNC1I2;HSP90AA1;NPM1;DCTN3;HAUS3;HMMR;DYNLL1;TUBB4B;CKAP5;HAUS1;TPX2;PCM1;TUBA1A;AKAP9;CDK1;MAPRE1;SFI1;YWHAG
aspartate family amino acid catabolic process (GO:0009068),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,GOT1;OGDH;DLST;ALDH7A1;DLD
establishment of melanosome localization (GO:0032401),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,MKKS;SHROOM2;MYO5A;RAB27A;RAB11A
folic acid metabolic process (GO:0046655),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,DHFR;MTHFD1;MTHFD2;MTHFD2L;SLC19A1
heart trabecula morphogenesis (GO:0061384),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,FKBP1A;TGFB2;NRG1;RBPJ;BMPR1A
histone deubiquitination (GO:0016578),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,ENY2;USP15;USP7;USP22;BRCC3
maintenance of protein localization in organelle (GO:0072595),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,HSPA5;ARL2;HNRNPU;HK2;PML
positive regulation of focal adhesion assembly (GO:0051894),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,ROCK1;RAC1;FERMT2;LIMS1;S100A10
regulation of stem cell population maintenance (GO:2000036),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,REST;MYC;ELAVL1;WDR43;LOXL2
vesicle transport along actin filament (GO:0030050),19-May,0.410161296,0.999996398,0,0,1.266167295,1.128414361,MYO1C;MYO5A;ACTN4;WASL;FNBP1L
endosome organization (GO:0007032),10/41,0.415172444,0.999996398,0,0,1.143688336,1.005372174,PI4K2B;LAPTM4B;ALS2CL;HOOK1;RAB27A;DNAJC13;LAMTOR1;TMEM9;CORO1C;PLEKHJ1
positive regulation of TOR signaling (GO:0032008),10/41,0.415172444,0.999996398,0,0,1.143688336,1.005372174,SEC13;GOLPH3;HDAC3;SEH1L;LIN28A;RHEB;LAMTOR2;LAMTOR1;LAMTOR3;TELO2
regulation of response to DNA damage stimulus (GO:2001020),10/41,0.415172444,0.999996398,0,0,1.143688336,1.005372174,FXR1;BCLAF1;FEM1B;MYC;USP1;UBE2N;KMT5A;UBE2V1;IER3;MCL1
cytoskeleton-dependent cytokinesis (GO:0061640),17/72,0.415877568,0.999996398,0,0,1.095919044,0.961520322,PDCD6IP;ROCK1;ROCK2;DCTN3;KIF23;RHOC;CENPA;RHOA;CECR2;ANLN;SON;STMN1;SPIRE1;MITD1;ECT2;MYH10;SPTBN1
positive regulation of secretion by cell (GO:1903532),17/72,0.415877568,0.999996398,0,0,1.095919044,0.961520322,TGFB2;TMED10;PLA2G1B;RAB27A;SOX11;IER3IP1;CD2AP;GOLPH3;GRK2;PLA2G10;MYO18A;DNM1L;EZR;PPIA;MYH10;PPID;ARF6
actin polymerization or depolymerization (GO:0008154),12/50,0.420417728,0.999996398,0,0,1.119617225,0.97015557,ENAH;GSN;WDR1;ABI2;PSTPIP2;CFL2;CFL1;DSTN;SPIRE1;WASL;RAC1;WASHC3
internal peptidyl-lysine acetylation (GO:0018393),28-Jul,0.422213207,0.999996398,0,0,1.18176301,1.018969084,NAA50;PHF20L1;MORF4L1;RUVBL2;MORF4L2;RUVBL1;EP300
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),28-Jul,0.422213207,0.999996398,0,0,1.18176301,1.018969084,YWHAE;FKBP1A;UBQLN1;CALM3;SRI;CALM1;CALM2
positive regulation of fibroblast proliferation (GO:0048146),28-Jul,0.422213207,0.999996398,0,0,1.18176301,1.018969084,DHX9;PLA2G1B;CDK4;MYC;PDGFB;S100A6;MIF
protein localization to Golgi apparatus (GO:0034067),28-Jul,0.422213207,0.999996398,0,0,1.18176301,1.018969084,GOLPH3;TMED10;ARL5C;COG7;RAB6A;ARL5A;OPTN
transcription by RNA polymerase III (GO:0006383),28-Jul,0.422213207,0.999996398,0,0,1.18176301,1.018969084,IVNS1ABP;GTF3C6;SNAPC3;POLR3G;POLR3K;POLR2K;POLR2L
response to UV (GO:0009411),23/99,0.422454239,0.999996398,0,0,1.073035633,0.924607064,NPM1;PCNA;KDM1A;UBE2B;PARP1;UBE4B;UBE2A;PTPRK;NOC2L;EIF2S1;MAPK13;MAPK8;MYC;RUVBL2;UVSSA;NEDD4;PCLAF;USP1;EP300;RPL26;MAP3K4;RHNO1;COPS9
positive regulation of apoptotic signaling pathway (GO:2001235),14/59,0.42422025,0.999996398,0,0,1.10303675,0.945856772,FIS1;TNFRSF12A;PML;BBC3;BCLAF1;BCL2L11;RACK1;RPS3;PMAIP1;BAX;DNM1L;PAK2;BCL2L1;GSDME
cellular response to arsenic-containing substance (GO:0071243),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,VCP;DDX3X;HNRNPA1;MAPK13
GTP metabolic process (GO:0046039),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,IMPDH2;GNAI3;AK3;RAN
modulation by host of viral genome replication (GO:0044827),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,VAPA;NUCKS1;PHB;PPIB
negative regulation of cellular component movement (GO:0051271),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,ACTN1;TACSTD2;SPINT2;CRK
negative regulation of protein processing (GO:0010955),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,PRNP;TMEM59;SERPINE2;THBS1
neurotrophin TRK receptor signaling pathway (GO:0048011),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,SORT1;DDIT4;SOS1;BCAR1
nucleobase-containing small molecule catabolic process (GO:0034656),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,NUDT9;NUDT1;NUDT5;ADPRM
peptidyl-tyrosine autophosphorylation (GO:0038083),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,DDR1;PTK2B;IGF1R;MAPK3
positive regulation of chromosome organization (GO:2001252),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,RAD21;ATRX;PML;GNL3
positive regulation of response to cytokine stimulus (GO:0060760),15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,DDX58;DHX9;TAF9;TRIM44
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",15-Apr,0.427570492,0.999996398,0,0,1.289143424,1.095302804,DDX1;ZBTB8OS;FAM98B;RTRAF
negative regulation of stress-activated MAPK cascade (GO:0032873),9/37,0.429142911,0.999996398,0,0,1.139563817,0.964031435,HDAC3;DUSP3;TAOK3;DUSP1;MYC;F2RL1;EZR;PPIA;FOXO1
regulation of actin cytoskeleton reorganization (GO:2000249),9/37,0.429142911,0.999996398,0,0,1.139563817,0.964031435,CDC42;TJP1;HAX1;MDK;ARHGDIA;PTK2B;SEMA3E;F11R;PHPT1
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),9/37,0.429142911,0.999996398,0,0,1.139563817,0.964031435,DDX5;UFM1;KDM1A;PRMT2;RNF14;CARM1;EP300;PARK7;CALR
regulation of transport (GO:0051049),9/37,0.429142911,0.999996398,0,0,1.139563817,0.964031435,YRDC;CLDN3;RAB25;REEP5;WWC1;GAPVD1;ACTB;RAB11A;ACTG1
positive regulation of endothelial cell migration (GO:0010595),20/86,0.431042964,0.999996398,0,0,1.074405318,0.904163118,NUS1;ANXA3;ROCK2;PDCD6;PDGFB;HMGB1;PIK3CB;MAPK14;ETS1;HIF1A;THBS1;FOXP1;SP1;TMSB4X;PTK2B;RAC1;CALR;TDGF1;BCAR1;FGFR1
positive regulation of proteasomal protein catabolic process (GO:1901800),20/86,0.431042964,0.999996398,0,0,1.074405318,0.904163118,GSK3A;VCP;RNF14;FBXW7;CSNK1A1;ECSCR;CLU;PIAS1;RBX1;SMAD7;DAB2;HECTD1;PSMC6;SUMO1;BAG2;PSMC3;SUMO2;PSMC2;RACK1;ELOB
regulation of cellular protein localization (GO:1903827),11/46,0.433626805,0.999996398,0,0,1.114246664,0.931032211,VCP;HSP90AA1;HSP90AB1;KDM1A;PARP1;GPC1;SUMO3;GPC3;CTNNB1;GPC4;TRIM67
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),13/55,0.436732107,0.999996398,0,0,1.097370534,0.909100487,YWHAE;BEX3;DDX3X;CSNK2A1;PLAUR;DHCR24;PARK7;THBS1;MT3;LAMP3;RPS6KA1;SFN;PAK2
histone monoubiquitination (GO:0010390),24-Jun,0.438882724,0.999996398,0,0,1.181721653,0.973175015,DDB1;UBE2E1;LEO1;CDC73;RNF2;CUL4B
positive regulation of protein targeting to membrane (GO:0090314),24-Jun,0.438882724,0.999996398,0,0,1.181721653,0.973175015,FIS1;PRNP;TCAF2;ITGAM;MYO1C;CHP1
regulation of cardiac muscle hypertrophy (GO:0010611),24-Jun,0.438882724,0.999996398,0,0,1.181721653,0.973175015,MTPN;CAMK2D;GLRX3;PARP1;ROCK1;ROCK2
insulin receptor signaling pathway (GO:0008286),17/73,0.440644948,0.999996398,0,0,1.076279816,0.882028351,GRB7;GSK3A;ATP6V1G1;SHC1;GAB1;IGF2;IDE;PIK3C2A;SLC39A14;FOXO1;IGF1R;NAMPT;PHIP;SOS1;ATP6V1D;BCAR1;ATP6V1F
cell-cell junction organization (GO:0045216),19/82,0.4419074,0.999996398,0,0,1.069251556,0.873209546,PRKCI;TGFB2;JUP;CTNND1;F2R;TJP1;AFDN;PARD6B;MARVELD2;CDH1;MYADM;PKP2;CTNNA1;F2RL1;TLN1;NECTIN3;NECTIN2;LIMS1;TJP2
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),8/33,0.444608722,0.999996398,0,0,1.134459367,0.919548134,PDIA3;SEC13;CANX;IDE;CALR;SEC24C;SEC31A;TAPBP
positive regulation of histone modification (GO:0031058),8/33,0.444608722,0.999996398,0,0,1.134459367,0.919548134,TADA2A;KDM1A;RUVBL2;UBE2N;TET1;ARRB1;MAPK3;GLYR1
positive regulation of organelle organization (GO:0010638),8/33,0.444608722,0.999996398,0,0,1.134459367,0.919548134,TMED9;ANXA2;KATNBL1;SURF4;RAB3GAP2;PFDN2;MGARP;SORBS3
regulation of sprouting angiogenesis (GO:1903670),8/33,0.444608722,0.999996398,0,0,1.134459367,0.919548134,TJP1;SEMA6A;PKM;PIK3CB;SYNJ2BP;THBS1;EPN1;JAK1
regulation of protein binding (GO:0043393),27/118,0.444613637,0.999996398,0,0,1.051960385,0.852666075,APP;KDM1A;ROCK1;NVL;RPL11;PDGFB;NMD3;PARK7;IDE;STK4;ACTB;PPP2CA;MAPK8;BAG2;FLOT1;RACK1;MARK3;SNAPIN;PPP1CA;FKBP1A;DAB2;GNL3L;BAX;TMBIM6;MITD1;CRK;RAN
negative regulation of protein catabolic process (GO:0042177),10/42,0.448003913,0.999996398,0,0,1.107876907,0.889573433,ROCK1;SNRNP70;TIMP2;FLNA;HMGCR;PHB;CDK5RAP3;AZIN1;MAD2L1;PTPN3
actin filament network formation (GO:0051639),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,CARMIL1;ACTN1;SPIRE1
axonal transport of mitochondrion (GO:0019896),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,MGARP;ACTR10;HIF1A
cell proliferation in forebrain (GO:0021846),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,NUMBL;PCM1;DOCK7
cellular response to superoxide (GO:0071451),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,PRDX2;PRDX1;MT3
central nervous system myelination (GO:0022010),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,MYRF;PTEN;CLU
copper ion transport (GO:0006825),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,COX17;STEAP2;ATOX1
glutamine family amino acid biosynthetic process (GO:0009084),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,GLUD1;PYCR2;GLS
glutathione biosynthetic process (GO:0006750),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,GGCT;GCLC;GCLM
mitochondrion morphogenesis (GO:0070584),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,FIS1;SLIRP;DNM1L
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,FOXH1;CNOT9;STRN3
negative regulation of nuclear division (GO:0051784),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,TOM1L1;NME6;AURKAIP1
negative regulation of programmed necrotic cell death (GO:0062099),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,ARHGEF2;SLC25A4;YBX3
negative regulation of protein maturation (GO:1903318),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,PRNP;TMEM59;SERPINE2
nuclear DNA replication (GO:0033260),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,MCM7;MCM4;MCM2
peptidyl-proline hydroxylation (GO:0019511),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,EGLN1;EGLN3;P4HB
positive regulation of cellular respiration (GO:1901857),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,PRELID1;VCP;PARK7
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,TRIM28;PPHLN1;MPHOSPH8
positive regulation of integrin activation (GO:0033625),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,RAP1B;FERMT1;FERMT2
positive regulation of myelination (GO:0031643),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,RNF10;MYRF;DICER1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,DDX5;LIN28A;MYCN
positive regulation of vacuole organization (GO:0044090),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,SH3GLB1;ANXA2;RAB3GAP2
protein kinase C signaling (GO:0070528),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,PLVAP;FLOT1;PDGFB
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,GAP43;DGKD;F2R
regulation of cardiac muscle cell apoptotic process (GO:0010665),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,CAMK2D;MDK;BMPR1A
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,GSN;PLAUR;PARK7
regulation of endocytic recycling (GO:2001135),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,EHD2;INPP5F;ARHGAP1
regulation of lymphocyte migration (GO:2000401),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,MSN;MIA3;WASL
somite development (GO:0061053),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,SFRP2;MTHFD1;SOX11
synaptic vesicle transport (GO:0048489),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,SNAPIN;KIF5B;RAB27A
urate metabolic process (GO:0046415),11-Mar,0.448949783,0.999996398,0,0,1.329382674,1.064628456,CARMIL1;PNP;ABCG2
mitotic metaphase plate congression (GO:0007080),12/51,0.450184859,0.999996398,0,0,1.090838986,0.870595303,CENPE;NUDC;PDCD6IP;SEH1L;CUL3;VPS4B;CHMP2A;CHMP3;CDCA8;KPNB1;RAB11A;CHMP5
embryonic digestive tract development (GO:0048566),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,TGFB2;ID2;SOX11;GLI3;FGFR2
folic acid-containing compound metabolic process (GO:0006760),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,DHFR;MTHFD1;MTHFD2;MTHFD2L;SLC19A1
granulocyte differentiation (GO:0030851),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,CDK4;EP300;DEK;LBR;PML
maintenance of protein location in nucleus (GO:0051457),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,ARL2;HNRNPU;PARK7;RANGAP1;PML
mitochondrial cytochrome c oxidase assembly (GO:0033617),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,COA3;SURF1;COX16;COX17;TIMM21
myeloid cell development (GO:0061515),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,APP;MED1;ANXA2;LYAR;FOXP1
positive regulation of activated T cell proliferation (GO:0042104),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,IGFBP2;IGF2;RPS3;HMGB1;IL2
positive regulation of interferon-alpha production (GO:0032727),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,DDX3X;CHUK;DDX58;DHX9;HSPD1
positive regulation of protein processing (GO:0010954),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,GSN;BAG2;HPN;MYH9;ENO1
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,GPC1;SPRY4;SPRY2;SPRY1;THBS1
regulation of nuclear division (GO:0051783),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,CUL9;CDC25C;MKI67;CDK13;KIF20B
regulation of protein kinase A signaling (GO:0010738),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,AKAP12;RAMP3;AKAP7;AKAP5;MIF
regulation of protein localization to cell periphery (GO:1904375),20-May,0.45826817,0.999996398,0,0,1.181680315,0.922066027,MMP14;STX7;ACTB;SPTBN1;VTI1B
negative regulation of transferase activity (GO:0051348),29-Jul,0.461975562,0.999996398,0,0,1.127974097,0.871070422,CDKN1C;GSK3A;ZFP36;HNRNPU;PARK7;PHPT1;SMAD7
response to cadmium ion (GO:0046686),29-Jul,0.461975562,0.999996398,0,0,1.127974097,0.871070422,MAPK8;JUN;SUMO1;CHUK;MAPK1;MT3;MAPK3
positive regulation of programmed cell death (GO:0043068),64/286,0.462446118,0.999996398,0,0,1.022137194,0.788297994,TOP2A;ITGB1;MTCH1;RARG;MTCH2;TNFAIP8;DDX3X;FAF1;PDCD5;HMGB1;CLU;FAM162A;C1QBP;RACK1;DNM1L;PHLDA1;SOX4;BNIP3L;PLEKHG2;PRMT2;TNFRSF12A;UTP11;DAPK1;IGFBP3;RPS6;ARHGEF16;DUSP9;DUSP6;CLIP3;SFRP2;MELK;LATS2;ITGA6;ARHGEF2;EEF1E1;SOS1;RNF122;ARHGEF5;PPID;STK4;FOXO1;HSPD1;PTPA;BCLAF1;MAPK8;BCL2L11;UBB;UBC;MAP3K20;PMAIP1;SAP18;RPS27A;ECT2;JUN;GADD45A;BNIP3;PNMA2;RRP1B;GADD45G;MLLT11;REST;CTNNB1;BAX;RNPS1
regulation of cell communication (GO:0010646),9/38,0.463793841,0.999996398,0,0,1.100197852,0.845298659,MTCH1;CAMK2D;GRK2;GRK6;ANK2;SRI;CRK;TDGF1;YWHAG
positive regulation of neuron death (GO:1901216),11/47,0.464737943,0.999996398,0,0,1.083225766,0.830055968,EFNB2;SRPK2;PRNP;TGFB2;REST;ITGAM;DDIT4;BAX;CTNNB1;CLU;EIF2S1
positive regulation of cell cycle process (GO:0090068),23/101,0.464773972,0.999996398,0,0,1.045387192,0.800979924,RANBP1;CUL3;RCC2;CEP295;ATRX;PDGFB;IGF2;KIF23;RHOA;CDC14B;CDC42;DBF4;RAD21;TPR;MAP3K20;PHIP;PKN2;KIF20B;ECT2;E2F7;RHNO1;E2F8;MAD2L1
protein-containing complex disassembly (GO:0032984),13/56,0.465206107,0.999996398,0,0,1.071781391,0.820207215,HSPA8;GABARAPL1;VCP;TSG101;CSNK1A1;RPL23;PPP1CA;MAP1LC3A;MYC;UBQLN1;CHMP3;CTNNB1;VTI1B
cellular response to amino acid starvation (GO:0034198),17/74,0.465386162,0.999996398,0,0,1.057329684,0.808738535,SH3GLB1;ATP6V1G1;SEC13;CEBPB;SEH1L;EIF2S1;IMPACT;MAPK8;RHEB;BMT2;MAPK1;LAMTOR2;LAMTOR1;ATP6V1D;LAMTOR3;ATP6V1F;MAPK3
mitotic nuclear division (GO:0140014),17/74,0.465386162,0.999996398,0,0,1.057329684,0.808738535,BCCIP;CDCA8;KIF11;SMC3;SMC1A;SMC4;RHOA;RAB11A;TPX2;STAG2;KIF2A;KIFC2;CENPK;CHMP2A;FLNA;KPNB1;RAN
proteolysis involved in cellular protein catabolic process (GO:0051603),17/74,0.465386162,0.999996398,0,0,1.057329684,0.808738535,VCP;ZRANB1;PDCD6IP;USP9X;VPS4B;NEDD8;IDE;DDB1;PSMA6;UBB;CLPP;UBC;CAPN2;YME1L1;PMAIP1;RPS27A;CUL4B
small GTPase mediated signal transduction (GO:0007264),24/106,0.474953719,0.999996398,0,0,1.03759675,0.77253012,JUN;RGS19;SHC1;ARHGAP1;RRAS2;PARK7;RASGRP2;MAPK14;CCNA2;CNKSR1;NRAS;TRIM28;RHEB;G3BP1;GNB1;G3BP2;RAB18;CHP1;SHOC2;KRAS;RAC1;SOS1;RHEBL1;ERAS
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),18/79,0.477310022,0.999996398,0,0,1.046083415,0.773671847,PLK3;GSK3A;VCP;RNF14;CSNK1A1;CLU;PIAS1;RBX1;SMAD7;CDC20;DAB2;HECTD1;SUMO1;BAG2;SUMO2;RACK1;UBQLN1;ELOB
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),18/79,0.477310022,0.999996398,0,0,1.046083415,0.773671847,GSK3A;VCP;RNF14;FBXW7;CSNK1A1;PTEN;CLU;PIAS1;RBX1;SMAD7;DAB2;HECTD1;SUMO1;BAG2;SUMO2;RACK1;ELOB;CDK5RAP3
recombinational repair (GO:0000725),18/79,0.477310022,0.999996398,0,0,1.046083415,0.773671847,PARP1;PSMD14;RPA1;NUCKS1;SMC6;SAMHD1;SEM1;MMS22L;MORF4L1;SFPQ;SFR1;RPA3;SWI5;NABP2;UBE2N;NABP1;ZSWIM7;RHNO1
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GNG2;GNB1
calcitonin family receptor signaling pathway (GO:0097646),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CALCRL;RAMP3
cardiolipin biosynthetic process (GO:0032049),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TAMM41;PLA2G6
catecholamine catabolic process (GO:0042424),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,MOXD1;MAOA
Cdc42 protein signal transduction (GO:0032488),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CDC42;RHOU
cellular response to monoamine stimulus (GO:0071868),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GNG2;GNB1
cellular response to prostaglandin E stimulus (GO:0071380),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GNG2;GNB1
cleavage furrow formation (GO:0036089),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SPIRE1;RHOA
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DDR1;COL4A2
definitive hemopoiesis (GO:0060216),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,HIPK1;CDK5RAP3
dense core granule cytoskeletal transport (GO:0099519),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,KIF5B;KIF1A
desmosome organization (GO:0002934),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,JUP;PKP2
determination of digestive tract left/right asymmetry (GO:0071907),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,ZIC3;CCDC40
DNA ligation (GO:0006266),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TOP2A;XRCC6
dorsal aorta development (GO:0035907),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RBPJ;BMPR1A
dorsal aorta morphogenesis (GO:0035912),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RBPJ;BMPR1A
establishment of centrosome localization (GO:0051660),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,EZR;MAD2L1
G-quadruplex DNA unwinding (GO:0044806),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DHX9;HNRNPA2B1
glomerular epithelial cell development (GO:0072310),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PODXL;IQGAP1
glomerular visceral epithelial cell development (GO:0072015),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PODXL;IQGAP1
glutamine transport (GO:0006868),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SLC38A1;SLC38A2
glyceraldehyde-3-phosphate metabolic process (GO:0019682),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TPI1;KHK
Golgi disassembly (GO:0090166),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PLK3;CDK1
hexose catabolic process (GO:0019320),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PGM2;GALK1
histone H3-K4 dimethylation (GO:0044648),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,KMT2A;SETD1B
hyperosmotic response (GO:0006972),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,ARHGEF2;YBX3
left/right pattern formation (GO:0060972),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,AHI1;PITX2
macropinocytosis (GO:0044351),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CARMIL1;MAPKAPK3
membrane invagination (GO:0010324),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CHMP2A;FNBP1L
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,AGO2;DICER1
mitral valve development (GO:0003174),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SOX4;BMPR1A
negative regulation of axon regeneration (GO:0048681),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PTPRS;INPP5F
negative regulation of cell cycle phase transition (GO:1901988),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PTEN;ZFP36L1
negative regulation of dendritic spine development (GO:0061000),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PTPRS;PTEN
negative regulation of epidermal cell differentiation (GO:0045605),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SRSF6;GRHL2
negative regulation of intracellular transport (GO:0032387),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,ARHGAP1;CRYAB
negative regulation of neurotransmitter secretion (GO:0046929),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RAP1B;SYT11
negative regulation of p38MAPK cascade (GO:1903753),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DUSP1;EZR
negative regulation of protein import (GO:1904590),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,UFM1;CHP1
negative regulation of protein import into nucleus (GO:0042308),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,UFM1;CHP1
negative regulation of retinoic acid receptor signaling pathway (GO:0048387),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CALR;EZH2
negative regulation of T-helper 17 type immune response (GO:2000317),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RC3H1;SMAD7
neuron projection arborization (GO:0140058),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,ROCK1;LRP2
noradrenergic neuron differentiation (GO:0003357),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SOX11;SOX4
nucleobase catabolic process (GO:0046113),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DPYSL2;CRMP1
parallel actin filament bundle assembly (GO:0030046),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SPIRE1;ESPN
platelet dense granule organization (GO:0060155),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,BLOC1S1;F2R
positive regulation of B cell receptor signaling pathway (GO:0050861),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SLC39A10;FOXP1
positive regulation of blood circulation (GO:1903524),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GSK3A;TGFB2
positive regulation of gliogenesis (GO:0014015),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PRKCI;LRP2
positive regulation of hormone metabolic process (GO:0032352),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,HPN;HIF1A
positive regulation of integrin-mediated signaling pathway (GO:2001046),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,FLNA;LIMS1
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,YAP1;PAK1
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,BCL2L11;BAX
positive regulation of membrane depolarization (GO:1904181),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,MLLT11;RACK1
positive regulation of miRNA metabolic process (GO:2000630),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,LIN28B;NFKB1
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TPR;MAD2L1
positive regulation of oxidative stress-induced cell death (GO:1903209),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,REST;SFPQ
positive regulation of spindle checkpoint (GO:0090232),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TPR;MAD2L1
positive regulation of synaptic plasticity (GO:0031915),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CDC20;DBN1
positive regulation of trophoblast cell migration (GO:1901165),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,C1QBP;AGO2
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TRIM6;UBE2K
protein desumoylation (GO:0016926),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SENP3;SENP1
protein localization to basolateral plasma membrane (GO:1903361),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RAB10;LIN7C
protein localization to endoplasmic reticulum exit site (GO:0070973),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SEC16A;MIA3
pyrimidine ribonucleotide biosynthetic process (GO:0009220),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CTPS2;UMPS
pyrimidine-containing compound biosynthetic process (GO:0072528),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CTPS2;UMPS
receptor-mediated endocytosis of virus by host cell (GO:0019065),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SIGLEC1;EPS15
regulation by virus of viral protein levels in host cell (GO:0046719),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DDB1;STAU1
regulation of blood-brain barrier permeability (GO:1905603),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TJP1;TJP2
regulation of chromatin assembly or disassembly (GO:0001672),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,TLK2;TLK1
regulation of glycogen (starch) synthase activity (GO:2000465),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GSK3A;IGF2
regulation of histamine secretion by mast cell (GO:1903593),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SNX6;VAMP3
regulation of lysosomal protein catabolic process (GO:1905165),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,LAPTM4B;LRP2
regulation of MDA-5 signaling pathway (GO:0039533),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,RIOK3;C1QBP
regulation of microtubule binding (GO:1904526),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PPP2CA;PPP2CB
regulation of morphogenesis of an epithelium (GO:1905330),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GJA1;FOXP1
regulation of phospholipid transport (GO:2001138),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,PRELID1;DBI
regulation of relaxation of muscle (GO:1901077),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,CAMK2D;SRI
regulation of T cell mediated immune response to tumor cell (GO:0002840),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,HMGB1;HSPD1
regulation of transforming growth factor beta1 production (GO:0032908),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,LAPTM4B;THBS1
regulation of tubulin deacetylation (GO:0090043),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,BEX4;EP300
ribonucleoprotein complex disassembly (GO:0032988),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,VCP;KIF5B
serine transport (GO:0032329),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SFXN1;SLC38A2
smooth muscle cell migration (GO:0014909),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,DDR1;PARVA
tRNA transcription by RNA polymerase III (GO:0042797),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,GTF3C6;POLR2L
zinc ion import across plasma membrane (GO:0071578),07-Feb,0.477690911,0.999996398,0,0,1.417958627,1.04757562,SLC39A10;SLC39A14
cellular response to light stimulus (GO:0071482),16/70,0.478128477,0.999996398,0,0,1.050382195,0.775051604,NPM1;PCNA;KDM1A;PARP1;PTPRK;NOC2L;EIF2S1;MAPK13;MYC;RUVBL2;NEDD4;GNB1;EP300;RPL26;RHNO1;COPS9
positive regulation of apoptotic process (GO:0043065),69/310,0.479343342,0.999996398,0,0,1.015028563,0.746389224,TOP2A;ITGB1;MTCH1;RARG;MTCH2;TNFAIP8;DDX3X;FAF1;PDCD5;HMGB1;CLU;FAM162A;C1QBP;RACK1;DNM1L;PHLDA1;SOX4;BNIP3L;PLEKHG2;PRMT2;TNFRSF12A;UTP11;DAPK1;IGFBP3;RPS6;ARHGEF16;DUSP9;DUSP6;CLIP3;SFRP2;MELK;LATS2;PTRH2;ITGA6;ARHGEF2;EEF1E1;SOS1;RNF122;ARHGEF5;PPID;STK4;FOXO1;HSPD1;PTPA;BCLAF1;MAPK8;BCL2L11;UBB;UBC;RPS3;MAP3K20;PMAIP1;SAP18;RPS27A;ECT2;SRPK2;PRNP;JUN;TGFB2;GADD45A;BNIP3;PNMA2;RRP1B;GADD45G;MLLT11;REST;CTNNB1;BAX;RNPS1
peptidyl-serine phosphorylation (GO:0018105),35/156,0.479556799,0.999996398,0,0,1.025448337,0.753594739,CAMK2D;ROCK1;ROCK2;PDGFB;STK4;RPS6KA6;MAPK8;GRK2;RPS6KA1;TLK2;TLK1;MAPK1;MARK3;PAK2;SRPK2;PRKCI;CSNK2A1;CHUK;CSNK1A1;NEK6;CSNK2A2;LMTK2;MASTL;HIPK1;MAPK14;MAPK12;MAPK13;LATS2;MAPKAPK3;RPS6KB1;WNK1;CDK1;PKN2;TDGF1;CSNK1G2
plasma membrane bounded cell projection morphogenesis (GO:0120039),12/52,0.479787852,0.999996398,0,0,1.063499658,0.781046111,NCKAP1;PAK1;SNX2;CTTN;UBB;TAOK3;NRK;TAOK1;PLXNB1;DICER1;KIF20B;DBN1
positive regulation of protein localization to cell periphery (GO:1904377),12/52,0.479787852,0.999996398,0,0,1.063499658,0.781046111,ITGB1;CLIP3;PRKCI;RAMP3;ITGA3;KIF5B;EPB41L2;ARHGEF16;WNK3;AKAP5;SPTBN1;ARF6
positive regulation of protein localization to plasma membrane (GO:1903078),12/52,0.479787852,0.999996398,0,0,1.063499658,0.781046111,ITGB1;CLIP3;PRKCI;RAMP3;ITGA3;KIF5B;ARHGEF16;WNK3;RACK1;AKAP5;SPTBN1;ARF6
regulation of cell-substrate adhesion (GO:0010810),10/43,0.480596104,0.999996398,0,0,1.074235868,0.787122767,FZD7;PDPN;PDGFB;MYADM;ARL2;PIK3CB;RAC1;RHOA;CORO1C;LIMS1
negative regulation of mitochondrion organization (GO:0010823),8/34,0.481329586,0.999996398,0,0,1.090756273,0.797564296,PRELID1;TFRC;BNIP3;HUWE1;GHITM;SLC25A5;CLU;BCL2L1
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),8/34,0.481329586,0.999996398,0,0,1.090756273,0.797564296,JUN;TGFB2;PDGFB;ETS1;HIF1A;TEAD1;GNL3;SMARCA4
regulation of amyloid-beta formation (GO:1902003),8/34,0.481329586,0.999996398,0,0,1.090756273,0.797564296,PRNP;GSK3A;TMED10;ROCK1;ROCK2;IFNGR1;SP1;CLU
response to steroid hormone (GO:0048545),8/34,0.481329586,0.999996398,0,0,1.090756273,0.797564296,YAP1;MED1;URI1;TGFB2;UBE3A;MGARP;THBS1;UBE2L3
basement membrane organization (GO:0071711),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,COL4A1;HPN;PXDN;LAMB1
dendrite self-avoidance (GO:0070593),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,BSG;NEXN;EMB;IGSF9
Golgi to endosome transport (GO:0006895),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,RAB14;SORT1;WIPI1;EPS15
histone H2A acetylation (GO:0043968),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,MORF4L1;MORF4L2;RUVBL2;RUVBL1
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,TMEM50A;VTA1;VPS36;CHMP5
negative regulation of epithelial cell differentiation (GO:0030857),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,SPRED2;SPRED1;SPRY2;SPRY1
negative regulation of release of cytochrome c from mitochondria (GO:0090201),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,PRELID1;GHITM;CLU;BCL2L1
neural tube development (GO:0021915),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,TRIM71;SOX11;GRHL2;SOX4
regulation of amyloid-beta clearance (GO:1900221),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,ROCK1;IFNGR1;HMGCR;CLU
regulation of ATP biosynthetic process (GO:2001169),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,VCP;PARP1;TMSB4X;ENO1
regulation of ERBB signaling pathway (GO:1901184),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,RHBDF1;RHBDF2;PTPN12;RBPJ
regulation of interleukin-1 production (GO:0032652),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,TMED10;F2R;HMGB1;FOXP1
regulation of mitotic sister chromatid separation (GO:0010965),16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,CENPE;NEK6;CDC27;TPR
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",16-Apr,0.481655094,0.999996398,0,0,1.181638996,0.863219185,DDX1;ZBTB8OS;FAM98B;RTRAF
energy derivation by oxidation of organic compounds (GO:0015980),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,MYC;GFPT2;CYCS;NDUFS1;SDHAF4;MT3
organophosphate ester transport (GO:0015748),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,PRELID1;PITPNB;PCTP;PITPNC1;PRELID3A;PRELID3B
receptor catabolic process (GO:0032801),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,SH3GLB1;NEDD4;CLTC;AP2B1;AP2A2;AP2M1
regulation of interferon-alpha production (GO:0032647),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,DDX3X;PTPRS;CHUK;DHX9;DDX58;HSPD1
regulation of microtubule depolymerization (GO:0031114),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,TPX2;MID1IP1;MAP1B;TAOK1;STMN2;ARHGEF2
ventricular cardiac muscle tissue development (GO:0003229),25-Jun,0.481846189,0.999996398,0,0,1.119453925,0.81734726,FKBP1A;ID2;TPM1;PKP2;FGFR2;SMAD7
response to insulin (GO:0032868),19/84,0.488519434,0.999996398,0,0,1.036218095,0.742321801,GSK3A;PRKCI;XBP1;PARP1;GOT1;PLA2G1B;SORT1;PDE3B;MYO5A;SLC39A14;FOXO1;KHK;ZFP36L1;RAB10;PKM;RAB31;EIF6;RPS6KB1;RAB15
positive regulation of cell death (GO:0010942),15/66,0.491643668,0.999996398,0,0,1.042622247,0.740262918,PRNP;RARG;ITGAM;RAMP3;CELF1;FAF1;BNIP3;PHB;CLU;EIF2S1;MT3;EFNB2;HEBP2;SLC6A6;DDIT4
regulation of protein localization (GO:0032880),15/66,0.491643668,0.999996398,0,0,1.042622247,0.740262918,HSP90AA1;HSP90AB1;KDM1A;PARP1;FBXW7;FKBP1A;AFDN;RSL1D1;TRIM6;MAPK8;SUMO1;RAB14;TPR;RACK1;TRIM67
cellular response to oxidative stress (GO:0034599),28/125,0.492533391,0.999996398,0,0,1.023280156,0.724679867,SRXN1;PARK7;PTPRK;HIF1A;FOXO1;PRDX2;PRDX5;MAPK8;PRDX1;RPS3;MAPK1;ROMO1;MAPK3;SLC25A24;JUN;CHUK;PARP1;DAPK1;GPX3;TXNRD1;TPM1;PYCR2;EIF2S1;MT3;PRDX6;SETX;CYCS;PPIA
regulation of mitotic nuclear division (GO:0007088),13/57,0.493472442,0.999996398,0,0,1.047355391,0.739734821,CUL9;DUSP1;USP44;PDGFB;IGF2;MKI67;CDC25C;TOM1L1;NME6;PHIP;AURKAIP1;KIF20B;CDK13
Golgi to plasma membrane transport (GO:0006893),11/48,0.495562521,0.999996398,0,0,1.053881672,0.739890016,RAB10;GOLGA4;GOLPH3;RAB31;KIF13A;GOPC;COMMD1;GOLGA7;STEAP2;SPTBN1;OPTN
positive regulation of DNA repair (GO:0045739),11/48,0.495562521,0.999996398,0,0,1.053881672,0.739890016,SMCHD1;PCNA;FAM168A;TRIM28;PARP1;DHX9;RPS3;UBE2N;SPIRE1;BRCC3;HMGB1
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),22/98,0.497248553,0.999996398,0,0,1.026147522,0.716933638,DYNC1I2;ARF1;SEC13;CLTC;DCTN3;KIF23;KIF11;AP2B1;DYNLL1;AP2A2;KIF15;CENPE;CAPZB;KIF2A;CAPZA1;CANX;CAPZA2;ACTR10;SEC24C;AP2M1;AP1M2;SEC31A
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),20/89,0.499096544,0.999996398,0,0,1.027493557,0.714062532,YWHAE;BEX3;FIS1;DDX3X;CSNK2A1;DAPK1;PDCD6;PDCD5;F2R;DHCR24;HMGB1;THBS1;MT3;REST;LAMP3;MYC;RPS6KA1;PMAIP1;CYCS;SFN
cell projection organization (GO:0030030),30-Jul,0.501080019,0.999996398,0,0,1.07886248,0.745482615,ITGB1;CDC42;NCKAP1;GSN;PARVA;RHOU;RAC1
"negative regulation of gene expression, epigenetic (GO:0045814)",30-Jul,0.501080019,0.999996398,0,0,1.07886248,0.745482615,DNMT3A;DNMT3B;RBBP7;PPHLN1;JARID2;MPHOSPH8;EZH2
plasma membrane invagination (GO:0099024),30-Jul,0.501080019,0.999996398,0,0,1.07886248,0.745482615,CDC42;ITGAM;GSN;MYH9;SPIRE1;RHOA;ARHGAP12
positive regulation of phosphate metabolic process (GO:0045937),30-Jul,0.501080019,0.999996398,0,0,1.07886248,0.745482615,APP;FZD7;PTGES3;GLMN;ITGA6;MIF;THBS1
regulation of striated muscle contraction (GO:0006942),30-Jul,0.501080019,0.999996398,0,0,1.07886248,0.745482615,GRK2;ANK2;CALM3;SRI;CALM1;CALM2;SMAD7
regulation of TOR signaling (GO:0032006),16/71,0.503422278,0.999996398,0,0,1.031217995,0.707751662,GSK3A;SEC13;HDAC3;SEH1L;PDCD6;TTI1;GOLPH3;LIN28A;RHEB;DDIT4;TBC1D7;GNA12;LAMTOR2;LAMTOR1;LAMTOR3;TELO2
response to metal ion (GO:0010038),16/71,0.503422278,0.999996398,0,0,1.031217995,0.707751662,AHCYL1;PDCD6;CRIP1;HIF1A;THBS1;MT3;KHK;LOXL2;PPP1CA;PPP2CA;PPP2CB;NEDD4;CALM3;CALM1;CALM2;SEC31A
regulation of cytoskeleton organization (GO:0051493),25/112,0.504807048,0.999996398,0,0,1.018617748,0.696305707,CLIC4;ROCK1;ROCK2;RHOBTB3;NEXN;IQGAP1;F11R;EFNA5;PAK1;CAPN2;MAPK1;RAC1;PAK2;MAPK3;RHOC;SORBS3;RHOA;TJP1;KATNBL1;TAOK1;PLXNB1;PFDN2;EZR;CRK;ARHGEF5
actin filament-based transport (GO:0099515),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,MYO1C;MYO5A;ACTN4;WASL;FNBP1L
focal adhesion assembly (GO:0048041),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,CTTN;ACTN1;RCC2;PTPRK;FERMT2
hydrogen peroxide catabolic process (GO:0042744),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,PRDX2;PRDX5;GPX3;PRDX1;PXDN
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,DDIT4;RPS27L;EP300;HIPK1;PML
melanosome localization (GO:0032400),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,MKKS;SHROOM2;MYO5A;RAB27A;RAB11A
mitochondrial calcium ion transmembrane transport (GO:0006851),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,PMPCB;YME1L1;PHB;PHB2;PARL
negative regulation of ion transmembrane transporter activity (GO:0032413),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,YWHAE;TCAF2;CAMK2D;NEDD4;GOPC
negative regulation of microtubule depolymerization (GO:0007026),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,TPX2;MID1IP1;TAOK1;STMN2;ARHGEF2
negative regulation of peptidyl-serine phosphorylation (GO:0033137),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,GADD45A;DDIT4;PTEN;RACK1;SMAD7
neuron apoptotic process (GO:0051402),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,APP;FAM162A;BNIP3;NAE1;GAPDH
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,CNOT6;ZFP36;CNOT7;PARN;CNOT9
poly(A)+ mRNA export from nucleus (GO:0016973),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,NXF1;ENY2;DDX25;POLDIP3;SARNP
positive regulation of phosphatase activity (GO:0010922),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,PTPA;HSP90AB1;CALM3;CALM1;CALM2
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,JUN;GJA1;ADAMTS1;PDGFB;BMPR1A
protein localization to chromatin (GO:0071168),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,RAD21;RUVBL2;LRWD1;PPHLN1;WAPL
regulation of fibroblast migration (GO:0010762),21-May,0.505171168,0.999996398,0,0,1.107754208,0.756438781,ITGB1;GNA12;RAC1;THBS1;CORO1C
ATP transport (GO:0015867),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,SLC25A5;SLC25A4;SLC25A24
double-strand break repair via break-induced replication (GO:0000727),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,MCM7;MCM4;MCM2
endoplasmic reticulum membrane organization (GO:0090158),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,ATL2;BNIP1;MOSPD3
glomerular visceral epithelial cell differentiation (GO:0072112),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,BASP1;PODXL;IQGAP1
glutamine metabolic process (GO:0006541),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,GLUD1;NIT2;GLS
glycine metabolic process (GO:0006544),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,RIDA;GLDC;DLD
histone H3-K9 demethylation (GO:0033169),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,KDM1A;JMJD1C;KDM7A
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,STK24;PDCD10;PDK1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,ANKRD13C;HSPA5;RER1
microtubule anchoring (GO:0034453),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,PCM1;BCCIP;DAG1
mitotic nuclear membrane disassembly (GO:0007077),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,CCNB2;NEK6;CDK1
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,SEMA6A;SPRY2;PIK3CB
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,TCERG1;HNRNPU;EAPP
neurotransmitter uptake (GO:0001504),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,SLC38A1;SLC1A3;SLC29A1
nonribosomal peptide biosynthetic process (GO:0019184),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,GGCT;GCLC;GCLM
positive regulation of cellular senescence (GO:2000774),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,HMGA1;EEF1E1;YPEL3
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,XBP1;BCL2L11;BAX
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,ITGAM;DDX58;F2RL1
positive regulation of sodium ion transmembrane transport (GO:1902307),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,WNK1;WNK3;ATP1B3
positive regulation of ubiquitin protein ligase activity (GO:1904668),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,CDC20;PTEN;CDC14B
pyrimidine-containing compound metabolic process (GO:0072527),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,CTPS2;ERH;ENPP3
regulation of axon regeneration (GO:0048679),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,PTPRS;INPP5F;STK24
regulation of B cell apoptotic process (GO:0002902),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,NOC2L;IL2;FOXP1
regulation of chromatin binding (GO:0035561),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,BTAF1;GMNN;WAPL
regulation of leukocyte cell-cell adhesion (GO:1903037),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,MDK;WNK1;MIA3
regulation of sequestering of calcium ion (GO:0051282),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,ANXA6;PTK2B;ANK2
regulation of ventricular cardiac muscle cell action potential (GO:0098911),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,JUP;PKP2;DSC2
sno(s)RNA 3'-end processing (GO:0031126),12-Mar,0.511562419,0.999996398,0,0,1.181597696,0.792008004,PARN;EXOSC3;EXOSC2
"base-excision repair, gap-filling (GO:0006287)",8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,PCNA;RFC4;PARP1;RFC1;RFC2;TDG;RPA3;RPA1
cellular response to hydrogen peroxide (GO:0070301),8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,OSER1;SETX;IMPACT;PLEKHA1;RPS3;PARK7;ECT2;MAPK13
lung development (GO:0030324),8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,RCN3;ZIC3;ITGA3;WNT7B;PDPN;SOX11;FGFR2;CCDC40
peptidyl-tyrosine dephosphorylation (GO:0035335),8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,DUSP22;PTPRS;DUSP3;DUSP1;PTPN12;DUSP9;PTPRF;DUSP6
positive regulation of cell cycle G1/S phase transition (GO:1902808),8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,DDX3X;TFDP1;ADAMTS1;RDX;UBE2E2;PHB2;CDC73;EZH2
regulation of protein polymerization (GO:0032271),8/35,0.517396522,0.999996398,0,0,1.050290445,0.692084405,HSP90AA1;TPPP3;PLEKHG2;HAX1;CTTN;ARL2;PFN1;DBN1
cellular iron ion homeostasis (GO:0006879),13/58,0.52139861,0.999996398,0,0,1.02401499,0.666879976,ATP6V1G1;TFRC;GLRX3;SLC40A1;CUL1;NEDD8;ERFE;SLC39A14;CAND1;FTH1;MYC;BOLA2;ABCG2
negative regulation of hydrolase activity (GO:0051346),13/58,0.52139861,0.999996398,0,0,1.02401499,0.666879976,EGLN1;URI1;RCC2;ZCCHC9;RDX;ARL2;RRP1B;F11R;SLC39A14;GCHFR;WNK1;CHP1;TMED2
receptor metabolic process (GO:0043112),13/58,0.52139861,0.999996398,0,0,1.02401499,0.666879976,ITGB1;SH3GLB1;CALCRL;RAMP3;TFRC;CLTC;LMTK2;RAB31;GRK2;NEDD4;CXCR2;AP2M1;PLEKHJ1
positive regulation of autophagy (GO:0010508),20/90,0.521498044,0.999996398,0,0,1.012749861,0.65935055,SH3GLB1;BNIP3L;PLK3;GSK3A;SCOC;ROCK1;DAPK1;BNIP3;GNAI3;HMGB1;PARK7;PIK3CB;PIK3C2A;PHB2;FOXO1;MTDH;TMEM59;TRIM6;LARP1;OPTN
negative regulation of protein localization to membrane (GO:1905476),26-Jun,0.523734221,0.999996398,0,0,1.063412969,0.687784601,TMEM59;DAB2;CLTC;PPP2R5A;AP2M1;BCL2L1
regulation of mitotic metaphase/anaphase transition (GO:0030071),26-Jun,0.523734221,0.999996398,0,0,1.063412969,0.687784601,CENPE;DUSP1;CUL3;NEK6;USP44;CDC27
regulation of viral life cycle (GO:1903900),26-Jun,0.523734221,0.999996398,0,0,1.063412969,0.687784601,TRIM6;TSG101;LAMP3;KPNA6;PPIA;NECTIN2
TOR signaling (GO:0031929),26-Jun,0.523734221,0.999996398,0,0,1.063412969,0.687784601,LARP1;RPS6KB1;RPS6;TIPRL;EIF4EBP2;RHEBL1
negative regulation of protein modification process (GO:0031400),18/81,0.524736264,0.999996398,0,0,1.012744044,0.653077614,BEX4;PRNP;YWHAB;IGFBP3;PTEN;DBI;PARK7;CDYL;ARPP19;CORO1C;PTPA;IMPACT;ENSA;MYADM;CHP1;TARDBP;PPIA;CDK5RAP3
negative regulation of cell projection organization (GO:0031345),11/49,0.525931749,0.999996398,0,0,1.026082005,0.659343704,EFNB2;PRNP;PTPRS;PRAG1;PTEN;STMN2;CRMP1;SPRY2;FKBP4;MT3;YWHAH
receptor internalization (GO:0031623),11/49,0.525931749,0.999996398,0,0,1.026082005,0.659343704,ITGB1;RAB31;CALCRL;RAMP3;GRK2;TFRC;NEDD4;CLTC;CXCR2;ARRB1;AP2M1
response to hydrogen peroxide (GO:0042542),11/49,0.525931749,0.999996398,0,0,1.026082005,0.659343704,OSER1;SETX;IMPACT;PLEKHA1;STK24;PDCD10;STK26;RPS3;PARK7;ECT2;MAPK13
protein localization to plasma membrane (GO:0072659),30/136,0.527699305,0.999996398,0,0,1.003159762,0.641248466,RAMP3;ROCK1;ROCK2;F11R;CDH1;TMEM88;BSG;FLOT1;FLOT2;TMED2;FLNA;SPTBN1;S100A10;JUP;SEC16A;RDX;MYO5A;ANK2;ATP1B3;RAB11A;RAB10;AFDN;EHD2;RAB15;WNK3;MYADM;PKP2;EZR;NECTIN3;CRB3
intraciliary transport involved in cilium assembly (GO:0035735),9/40,0.53162073,0.999996398,0,0,1.02908514,0.650201675,PCM1;IFT43;TTC21B;DYNLRB1;TNPO1;DYNLL1;IFT46;SSX2IP;HSPB11
actin cytoskeleton reorganization (GO:0031532),14/63,0.532744237,0.999996398,0,0,1.012732424,0.637731609,GSN;NRK;GAB1;PARVA;RHOA;PAK1;CLDN3;EFS;CTTN;PTK7;MYH9;FLNA;EZR;BCAR1
modified amino acid transport (GO:0072337),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,PDPN;MGST1;FOLR1;SLC19A1
negative regulation of ATP metabolic process (GO:1903579),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,FIS1;PARP1;PDE12;GIT1
negative regulation of insulin secretion (GO:0046676),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,KLF7;MIDN;REST;PIM3
pharyngeal system development (GO:0060037),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,TGFB2;SIX4;FOLR1;BMPR1A
positive regulation of DNA replication (GO:0045740),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,STN1;PCNA;DHX9;FAF1
regulation of cell killing (GO:0031341),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,TGFB2;MAPK8;FZD7;RAC1
regulation of establishment of endothelial barrier (GO:1903140),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,PPP1R12A;ROCK1;ROCK2;F11R
stem cell development (GO:0048864),17-Apr,0.533574576,0.999996398,0,0,1.090673711,0.685113706,PDCD6;NOLC1;NRG1;SOX11
aminoglycan catabolic process (GO:0006026),31-Jul,0.539205394,0.999996398,0,0,1.033843499,0.638562447,GPC1;GPC3;SDC1;GPC4;AGRN;GNS;HSPG2
organelle transport along microtubule (GO:0072384),31-Jul,0.539205394,0.999996398,0,0,1.033843499,0.638562447,CDC42;ARHGAP21;UBB;KIF5B;BICDL1;BICDL2;RAB6A
regulation of cellular senescence (GO:2000772),31-Jul,0.539205394,0.999996398,0,0,1.033843499,0.638562447,RSL1D1;NUAK1;NEK6;HMGA1;YBX1;EEF1E1;YPEL3
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),22/100,0.539773383,0.999996398,0,0,0.999707227,0.616425364,DYNC1I2;ARF1;SEC13;CLTC;DCTN3;KIF23;KIF11;AP2B1;DYNLL1;AP2A2;KIF15;CENPE;CAPZB;KIF2A;CAPZA1;CANX;CAPZA2;ACTR10;SEC24C;AP2M1;AP1M2;SEC31A
membrane organization (GO:0061024),53/242,0.541130945,0.999996398,0,0,0.993864478,0.6103262,MTCH1;TFRC;CLTC;ARRB1;WASL;FNBP1L;PIK3C2A;AP2A2;ACTB;ACTG1;SERP1;CHP1;DNM1L;EMD;AP2M1;SH3GLB1;ACTR3;ACTR2;PRKCI;PDCD6IP;ANK2;GAPVD1;EPN1;CTTN;MYADM;CHMP3;HBEGF;VAMP3;CHMP5;SAR1A;VPS4B;USO1;LRP2;MOSPD3;CORO1C;UBB;UBC;RPS27A;EPS15;SPTBN1;VTI1B;HSPA8;GCA;HUWE1;ARPC4;AP2B1;ARPC5;SYNJ2;DAB2;ARPC2;VAPA;CHMP2A;MITD1
mitotic G2/M transition checkpoint (GO:0044818),10/45,0.544270665,0.999996398,0,0,1.012720825,0.616046797,TAOK3;TAOK1;CDK1;NABP2;NABP1;BRCC3;NAE1;FOXN3;CDK5RAP3;CDC14B
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),10/45,0.544270665,0.999996398,0,0,1.012720825,0.616046797,DDX5;JUN;TGFB2;REST;PDGFB;ETS1;HIF1A;TEAD1;GNL3;SMARCA4
cellular response to osmotic stress (GO:0071470),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,DDX3X;WNK3;ARHGEF2;YBX3;ZFP36L1
glutamate metabolic process (GO:0006536),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,GLUD1;GCLC;GOT1;GCLM;GLS
negative regulation of phosphate metabolic process (GO:0045936),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,CDKN1C;ANKLE2;ROCK1;PRKRIP1;DYNLL1
positive regulation of amyloid precursor protein catabolic process (GO:1902993),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,GSK3A;IFNGR1;ROCK2;SP1;CLU
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,VMP1;ANK2;CALM3;CALM1;CALM2
positive regulation of neural precursor cell proliferation (GO:2000179),22-May,0.550361784,0.999996398,0,0,1.04252529,0.622574656,KDM1A;MDK;CTNNB1;NAP1L1;LRP2
axonal transport (GO:0098930),8/36,0.552560203,0.999996398,0,0,1.012715034,0.600735354,AP3M1;SNAPIN;DST;BLOC1S1;KIF1B;KIF1A;MGARP;HIF1A
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),8/36,0.552560203,0.999996398,0,0,1.012715034,0.600735354,DDX5;HINT1;DDIT4;RPS27L;EP300;PMAIP1;HIPK1;PML
membrane fusion (GO:0061025),8/36,0.552560203,0.999996398,0,0,1.012715034,0.600735354,GCA;VAPA;USO1;HUWE1;CHP1;DNM1L;VTI1B;VAMP3
regulation of cell cycle G1/S phase transition (GO:1902806),8/36,0.552560203,0.999996398,0,0,1.012715034,0.600735354,FBXW7;ID2;PSME3;PTEN;PSME2;PHB2;CDC73;EZH2
regulation of embryonic development (GO:0045995),8/36,0.552560203,0.999996398,0,0,1.012715034,0.600735354,RPS6KA6;RAB14;TDG;CFL1;DAG1;CDK1;EHMT1;TRIP12
regulation of actin filament-based process (GO:0032970),16/73,0.553077864,0.999996398,0,0,0.99490688,0.589240051,ROCK1;ROCK2;RHOBTB3;ABRACL;IQGAP1;F11R;RHOC;EFNA5;RHOA;CNN2;PAK1;TAOK1;RAC1;EZR;CRK;ARHGEF5
regulation of Rho protein signal transduction (GO:0035023),16/73,0.553077864,0.999996398,0,0,0.99490688,0.589240051,PRAG1;ITGA3;CUL3;F2R;ARRB1;TNFAIP1;LPAR4;F11R;KCTD10;PDCD10;LPAR6;ARHGDIA;STMN1;F2RL1;RAC1;ARHGEF2
aspartate family amino acid biosynthetic process (GO:0009067),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,GOT1;MTHFD1
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,GJA1;ANK2
cell migration involved in heart development (GO:0060973),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PITX2;FOLR1
cell-cell adhesion mediated by cadherin (GO:0044331),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,AFDN;CTNND1
cellular response to angiotensin (GO:1904385),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,AHCYL1;NFKB1
cellular response to hepatocyte growth factor stimulus (GO:0035729),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,TDGF1;BCAR1
cellular response to interferon-alpha (GO:0035457),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PDE12;TPR
coronary vasculature morphogenesis (GO:0060977),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,SPRED1;LRP2
DNA damage induced protein phosphorylation (GO:0006975),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,MAPK12;MAPK3
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,RPS21;NOP9
establishment of protein localization to chromatin (GO:0071169),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,RUVBL2;LRWD1
establishment of protein localization to peroxisome (GO:0072663),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PEX19;ZFAND6
fructose metabolic process (GO:0006000),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ALDOA;KHK
fusion of virus membrane with host plasma membrane (GO:0019064),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PPIA;NECTIN2
hair cell differentiation (GO:0035315),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,CTNNB1;PITX2
histone H3-K4 demethylation (GO:0034720),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,KDM1A;RIOX2
histone H3-K4 monomethylation (GO:0097692),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,KMT2A;SETD1B
isoprenoid metabolic process (GO:0006720),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,GGPS1;HMGCR
kidney mesenchyme development (GO:0072074),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,SIX4;BASP1
lens fiber cell development (GO:0070307),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ABI2;WNT7B
meiotic sister chromatid cohesion (GO:0051177),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,BUB1B;BUB1
membrane fusion involved in viral entry into host cell (GO:0039663),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PPIA;NECTIN2
methionine metabolic process (GO:0006555),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,MTHFD1;SMS
mitochondrial DNA replication (GO:0006264),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,POLG2;SSBP1
mitochondrial tRNA processing (GO:0090646),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,TRNT1;HSD17B10
negative regulation of alpha-beta T cell differentiation (GO:0046639),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,HMGB1;GLI3
negative regulation of amyloid-beta clearance (GO:1900222),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,IFNGR1;HMGCR
negative regulation of lipid kinase activity (GO:0090219),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PIK3IP1;PPP2R5A
negative regulation of neuron projection regeneration (GO:0070571),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PTPRS;INPP5F
negative regulation of nitrogen compound metabolic process (GO:0051172),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,HSP90AB1;CLTC
negative regulation of regulated secretory pathway (GO:1903306),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,RAP1B;REST
negative regulation of T-helper 17 cell differentiation (GO:2000320),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,RC3H1;SMAD7
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PIK3CB;PIK3C2A
platelet activating factor metabolic process (GO:0046469),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PLA2G10;PLA2G6
positive regulation of astrocyte differentiation (GO:0048711),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,SERPINE2;ID2
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,MYO1C;GAB1
positive regulation of dendritic cell chemotaxis (GO:2000510),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,C1QBP;CALR
positive regulation of endocytic recycling (GO:2001137),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,EHD2;AKAP5
positive regulation of fibroblast migration (GO:0010763),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ITGB1;THBS1
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,YAP1;PAK1
positive regulation of membrane invagination (GO:1905155),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,RAB31;F2RL1
positive regulation of myotube differentiation (GO:0010831),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,MMP14;MAPK14
protein retention in ER lumen (GO:0006621),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ANKRD13C;RER1
pyrimidine nucleobase catabolic process (GO:0006208),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,DPYSL2;CRMP1
regulation of alpha-beta T cell differentiation (GO:0046637),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,PNP;GLI3
regulation of dendritic cell chemotaxis (GO:2000508),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,C1QBP;CALR
regulation of establishment of protein localization to mitochondrion (GO:1903747),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,HAX1;PARL
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,CENPE;NEK6
regulation of myeloid leukocyte differentiation (GO:0002761),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,CEBPB;FOXP1
regulation of positive chemotaxis (GO:0050926),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,F2RL1;F3
regulation of protein glycosylation (GO:0060049),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,CHP1;MT3
regulation of protein K63-linked ubiquitination (GO:1900044),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,DDX3X;PLAA
regulation of protein localization to chromatin (GO:1905634),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,VCP;WAPL
regulation of protein localization to nucleolus (GO:1904749),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,NVL;NMD3
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,HIF1A;MT3
regulation of translational termination (GO:0006449),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ETF1;GSPT1
response to hepatocyte growth factor (GO:0035728),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,TDGF1;BCAR1
skeletal myofibril assembly (GO:0014866),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ACTA1;CFLAR
spermidine metabolic process (GO:0008216),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,AMD1;SRM
tRNA transcription (GO:0009304),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,GTF3C6;POLR2L
vascular associated smooth muscle contraction (GO:0014829),08-Feb,0.554009896,0.999996398,0,0,1.181556414,0.697794996,ACTA2;PIK3C2A
cellular senescence (GO:0090398),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,ID2;HMGA1;SMC6;CALR;MAPK14;PML
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,UBB;DDX58;UBC;UBE2N;UBE2V1;RPS27A
entrainment of circadian clock by photoperiod (GO:0043153),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,PPP1CB;PER3;ID2;BHLHE40;PML;PPP1CA
microtubule polymerization or depolymerization (GO:0031109),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,TPPP3;KIF2A;MAP7D3;STMN1;STMN2;CKAP5
negative regulation of cation channel activity (GO:2001258),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,FKBP1A;UBQLN1;CALM3;SRI;CALM1;CALM2
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,YAP1;ODF2L;CAPZB;LIMK2;TBC1D7;TACSTD2
negative regulation of protein polymerization (GO:0032272),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,CLIP3;STMN1;STMN2;MYADM;MAPRE1;PFN1
positive regulation of cellular component movement (GO:0051272),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,CAVIN1;CCDC25;PDPN;ACTN4;PHPT1;ETS1
positive regulation of muscle cell differentiation (GO:0051149),27-Jun,0.56418422,0.999996398,0,0,1.012709248,0.579648898,CDC42;CTNNA1;CTNNB1;NRG1;MAPK14;MAPK12
cortical cytoskeleton organization (GO:0030865),9/41,0.564371793,0.999996398,0,0,0.996862193,0.57024708,NCKAP1;ROCK1;ROCK2;RHOBTB3;RAC1;RHOC;EZR;RHOA;ARF6
import into cell (GO:0098657),9/41,0.564371793,0.999996398,0,0,0.996862193,0.57024708,SLC6A6;SLC12A4;SLC38A1;SLC1A3;LRP2;SLC16A2;SLC29A1;SLC39A14;SLC19A1
negative regulation of cell-cell adhesion (GO:0022408),9/41,0.564371793,0.999996398,0,0,0.996862193,0.57024708,CDH1;EPCAM;PODXL;WNK1;RDX;MYADM;MIA3;SPINT2;GTPBP4
regulation of filopodium assembly (GO:0051489),9/41,0.564371793,0.999996398,0,0,0.996862193,0.57024708,CDC42;FXR1;GAP43;MIEN1;CAPZB;WASL;FNBP1L;AGRN;ARF6
regulation of blood vessel endothelial cell migration (GO:0043535),12/55,0.56612699,0.999996398,0,0,0.989111256,0.562741854,NUS1;JUP;GADD45A;SP1;TMSB4X;PDGFB;HMGB1;MAPK14;ETS1;HIF1A;THBS1;FGFR1
positive regulation of protein polymerization (GO:0032273),15/69,0.568434686,0.999996398,0,0,0.984508791,0.556118358,NCKAP1;CARMIL1;HSP90AA1;ARL2;PAK1;TPPP3;CTTN;AKAP9;RPS3;DRG1;PTK2B;RAC1;MAPRE1;PFN1;ARF6
protein-containing complex assembly (GO:0065003),58/267,0.568764345,0.999996398,0,0,0.983400666,0.554922263,PDCD6;SLC2A1;WASL;CDC73;MYC;RUVBL1;TMED2;EP300;ELOB;DNM1L;TEAD1;KPNA3;AP2M1;TLE4;CARD10;SEC13;CD2AP;RBX1;TAPBP;TRAPPC6A;GEMIN5;PPIH;PPID;VAMP3;YAP1;CDC123;TMED10;KMT2A;DHX9;CUL3;GOSR2;USO1;CUL1;PARD6B;CAND1;TSPAN4;LEO1;PTK2B;MDN1;SEC31A;ANKRD28;TRAPPC1;ST13;CSNK1A1;SEC16A;TRAPPC4;PML;SMARCA4;AFDN;BCL9;CNIH1;CAPZA1;CAPZA2;CTNNB1;MNAT1;FOLR1;SEC24C;FERMT2
AMP metabolic process (GO:0046033),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,ADSL;AK3;AMPD2
cardiac right ventricle morphogenesis (GO:0003215),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,TGFB2;SOX4;BMPR1A
cell part morphogenesis (GO:0032990),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,FIS1;SLIRP;DNM1L
detection of calcium ion (GO:0005513),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,CALM3;CALM1;CALM2
DNA replication-independent nucleosome organization (GO:0034724),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,NASP;ATRX;HAT1
establishment of protein localization to chromosome (GO:0070199),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,RUVBL2;NABP2;LRWD1
extracellular transport (GO:0006858),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,TSG101;ARRDC1;CCDC40
glucose import (GO:0046323),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,SORT1;SLC2A1;SLC2A3
Golgi ribbon formation (GO:0090161),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,GOLPH3;MYO18A;OPTN
homeostasis of number of cells (GO:0048872),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,F2R;OCIAD1;UBAP2L
mitochondrion transport along microtubule (GO:0047497),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,UBB;MGARP;HIF1A
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,TSG101;SOCS4;SNX6
negative regulation of histone methylation (GO:0031061),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,KDM1A;DNMT3B;JARID2
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,KDM1A;TAF9;MIF
negative regulation of mononuclear cell migration (GO:0071676),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,DUSP1;MIA3;WASL
negative regulation of viral release from host cell (GO:1902187),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,TRIM28;CHMP3;PML
pathway-restricted SMAD protein phosphorylation (GO:0060389),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,TGFB2;USP15;SMAD7
positive regulation of insulin receptor signaling pathway (GO:0046628),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,IGF2;ERFE;SNX5
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,SAR1A;EDEM1;SEC16A
positive regulation of purine nucleotide biosynthetic process (GO:1900373),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,VCP;TMSB4X;ENO1
pre-mRNA cleavage required for polyadenylation (GO:0098789),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,CPSF6;FIP1L1;CPSF2
pseudouridine synthesis (GO:0001522),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,NHP2;PUS7;NOP10
pteridine-containing compound metabolic process (GO:0042558),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,GCHFR;HSP90AA1;CALM1
purine ribonucleoside triphosphate metabolic process (GO:0009205),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,GNAI3;AK3;RAN
purine-containing compound catabolic process (GO:0072523),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,NT5C;PNP;ITPA
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,F2RL1;HMGB1;FOXP1
regulation of histone modification (GO:0031056),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,IGF2;UBE2N;PARK7
regulation of homotypic cell-cell adhesion (GO:0034110),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,RDX;PLAUR;JAK1
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,MDK;ETS1;RHOA
response to interleukin-6 (GO:0070741),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,PHB;TDGF1;NFKB1
response to nitric oxide (GO:0071731),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,EGLN1;MT3;FOXO1
response to thyroid hormone (GO:0097066),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,MED1;HPN;RDX
spinal cord development (GO:0021510),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,SOX11;SOX12;SOX4
synaptic vesicle localization (GO:0097479),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,SNAPIN;KIF5B;RAB27A
transcription preinitiation complex assembly (GO:0070897),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,GTF2A2;TAF12;BDP1
UV-damage excision repair (GO:0070914),13-Mar,0.570165435,0.999996398,0,0,1.063369714,0.597431649,DDB1;ERCC1;CUL4B
cytoskeleton organization (GO:0007010),26/120,0.571558755,0.999996398,0,0,0.980255319,0.548343056,RHOBTB3;LIMD1;CNN2;CECR2;CAPZB;MDK;DPYSL2;CFL1;RAC1;PDZD8;PRKCI;ZRANB1;SEMA6A;DST;TPM1;ARAP3;PRPF40A;LARP4;RHOC;RHOA;ABI2;PHIP;RHOU;AJUBA;BRWD3;NECTIN2
double-strand break repair via homologous recombination (GO:0000724),21/97,0.573542101,0.999996398,0,0,0.979280822,0.544405647,PSMD14;MCM7;PARP1;RPA1;NUCKS1;SMC6;SAMHD1;SEM1;MORF4L1;MMS22L;SFPQ;SFR1;RAD21;RPA3;SWI5;NABP2;UBE2N;NABP1;MCM4;ZSWIM7;MCM2
peptidyl-threonine phosphorylation (GO:0018107),13/60,0.575751147,0.999996398,0,0,0.980313815,0.541211405,GSK3A;CAMK2D;CSNK2A1;ROCK1;ROCK2;CSNK2A2;LMTK2;HIPK1;MAPK8;WNK1;WNK3;CDK1;MAPK1
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),7/32,0.576078314,0.999996398,0,0,0.992426036,0.547334536,YAP1;PAK1;UFM1;CARM1;FOXH1;CNOT9;STRN3
regulation of intracellular protein transport (GO:0033157),7/32,0.576078314,0.999996398,0,0,0.992426036,0.547334536,PLK3;PCM1;PDCD10;TPR;KIF20B;OAZ1;PTPN14
response to amino acid (GO:0043200),7/32,0.576078314,0.999996398,0,0,0.992426036,0.547334536,XBP1;CAPN2;LAMTOR2;TMBIM6;LAMTOR1;LAMTOR3;IPO5
negative regulation of protein binding (GO:0032091),16/74,0.577268666,0.999996398,0,0,0.977690402,0.537189542,KDM1A;ROCK1;PDGFB;ATP2A2;PARK7;ACTB;PTPRF;PPP1CA;MAPK8;DAB2;GNL3L;BAG2;RACK1;BAX;TMBIM6;MITD1
intrinsic apoptotic signaling pathway (GO:0097193),22/102,0.581225061,0.999996398,0,0,0.974588947,0.528828754,DDX5;CEBPB;DDX3X;CUL3;BNIP3;CUL1;ITPR1;SELENOK;CRIP1;PML;BBC3;MLLT11;HINT1;BCL2L11;STK24;C1QBP;PMAIP1;BAX;SFN;PDK1;MCL1;BCL2L1
adenine nucleotide transport (GO:0051503),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,SLC25A5;SLC25A4;SLC19A1;SLC25A24
DNA conformation change (GO:0071103),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,TOP2A;NAA10;HAT1;HMGB1
DNA strand elongation involved in DNA replication (GO:0006271),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,PCNA;RFC4;MCM7;MCM4
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,GRK2;GNA11;GNB1;AGRN
melanosome transport (GO:0032402),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,MKKS;MYO5A;RAB27A;RAB11A
microtubule depolymerization (GO:0007019),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,KIF2A;STMN1;STMN2;CKAP5
mitochondrial fusion (GO:0008053),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,FIS1;CHCHD3;MIGA1;BAX
pigment granule transport (GO:0051904),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,MKKS;MYO5A;RAB27A;RAB11A
positive regulation of glial cell differentiation (GO:0045687),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,SERPINE2;MDK;ID2;DICER1
positive regulation of nitric-oxide synthase activity (GO:0051000),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,DHFR;NUS1;PIK3CB;HIF1A
positive regulation of response to endoplasmic reticulum stress (GO:1905898),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,XBP1;BCL2L11;BAX;PMAIP1
regulation of B cell differentiation (GO:0045577),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,XBP1;MMP14;ID2;ZFP36L1
regulation of catabolic process (GO:0009894),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,ITGB1;FAF1;ODC1;TMEM9
regulation of membrane depolarization (GO:0003254),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,CAMK2D;FHL1;SMAD7;PTPN3
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,SFPQ;UBQLN1;P4HB;PPIA
regulation of protein-containing complex disassembly (GO:0043244),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,BNIP3;ETF1;GSPT1;IGF1R
regulation of spindle organization (GO:0090224),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,TPX2;CLTC;FSD1;RAE1
response to axon injury (GO:0048678),18-Apr,0.582747404,0.999996398,0,0,1.012703467,0.546861346,DHFR;GAP43;NREP;FOLR1
positive regulation of angiogenesis (GO:0045766),25/116,0.583385441,0.999996398,0,0,0.973592221,0.524675836,ITGB1;FLT1;PDCD6;ETS1;HIF1A;THBS1;HK2;MTDH;MDK;JAK1;XBP1;JUP;ANXA3;VASH2;GAB1;HIPK1;F3;TJP1;PDCL3;SFRP2;PKM;SP1;AGO2;AGGF1;EPHA1
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),11/51,0.584706574,0.999996398,0,0,0.97465262,0.523042593,BCL2L11;DDIT4;EP300;RPS27L;BAX;SFN;HIPK1;CRIP1;PML;MCL1;BCL2L1
positive regulation of fat cell differentiation (GO:0045600),11/51,0.584706574,0.999996398,0,0,0.97465262,0.523042593,ZFP36;CEBPB;XBP1;CREB1;SFRP2;NOCT;CARM1;ID2;HNRNPU;METRNL;ZFP36L1
axon development (GO:0061564),17/79,0.585580689,0.999996398,0,0,0.97174844,0.520032434,APP;RYK;DOCK7;VASH2;LMTK2;NREP;ACTB;DHFR;RAB10;KLF7;GAP43;PARD6B;MAP1B;SVBP;S100A6;FOLR1;FGFR2
ncRNA metabolic process (GO:0034660),8/37,0.586606333,0.999996398,0,0,0.97773103,0.521523029,TRIM71;DDX4;AGO2;PARN;DICER1;DTD1;DTD2;RAN
positive regulation of cytokinesis (GO:0032467),8/37,0.586606333,0.999996398,0,0,0.97773103,0.521523029,CDC42;CUL3;KIF23;PKN2;ECT2;KIF20B;RHOA;CDC14B
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),8/37,0.586606333,0.999996398,0,0,0.97773103,0.521523029,CNN1;GJA1;JUN;ADAMTS1;TPM1;PDGFB;PTEN;BMPR1A
spindle assembly (GO:0051225),18/84,0.593435145,0.999996398,0,0,0.966523552,0.504358421,HDAC3;NEK6;BCCIP;HAUS3;KIF11;SMC3;SMC1A;RHOA;RAB11A;HAUS1;TPX2;STAG2;KIF2A;KIFC2;RPS3;FLNA;MAPRE1;KPNB1
blood vessel endothelial cell migration (GO:0043534),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,EFNB2;ID1;MYH9;MIA3;TDGF1
"DNA catabolic process, endonucleolytic (GO:0000737)",23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,CECR2;DICER1;HMGB1;KPNB1;KPNA1
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,GRK2;YWHAB;APLP1;STMN1;ADA
positive regulation of epithelial cell apoptotic process (GO:1904037),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,PRKCI;GSN;PLA2G1B;ECSCR;THBS1
positive regulation of histone acetylation (GO:0035066),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,TADA2A;RUVBL2;ARRB1;GLYR1;MAPK3
positive regulation of JUN kinase activity (GO:0043507),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,PAK1;TAOK3;RPS3;ARHGEF5;MAP3K4
regulation of mononuclear cell migration (GO:0071675),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,MDK;MSN;MAPK1;THBS1;MAPK3
regulation of peptidase activity (GO:0052547),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,RCN3;PSMA3;SVBP;A2ML1;MAPK12
respiratory chain complex IV assembly (GO:0008535),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,COA3;SURF1;COX16;COX17;TIMM21
vesicle transport along microtubule (GO:0047496),23-May,0.59344118,0.999996398,0,0,0.98454403,0.513751986,KIF5B;KIF13A;BICDL1;BICDL2;KIF1A
positive regulation of ATPase activity (GO:0032781),9/42,0.596108468,0.999996398,0,0,0.966592151,0.500049664,VMP1;DHX9;TPM1;HNRNPU;DNAJC24;ATP1B3;SSBP1;DYNLL1;PFN1
positive regulation of epithelial to mesenchymal transition (GO:0010718),9/42,0.596108468,0.999996398,0,0,0.966592151,0.500049664,TGFB2;DAB2;GLIPR2;MDK;PDPN;CTNNB1;FERMT2;LOXL2;EZH2
neuron projection morphogenesis (GO:0048812),30/140,0.598611172,0.999996398,0,0,0.966431647,0.495917653,APP;NCKAP1;ROCK1;NRK;DOCK7;PTEN;IQGAP1;WASL;LRP2;ACTB;CDC42;PAK1;PARD6B;UBB;RYK;LMTK2;DICER1;RAB10;KLF7;IMPACT;CTTN;TAOK3;MAP1B;TAOK1;S100A6;CTNNB1;PLXNB1;KIF20B;FGFR2;DBN1
post-Golgi vesicle-mediated transport (GO:0006892),19/89,0.600884859,0.999996398,0,0,0.961892808,0.489941973,APP;HSPA8;ARF1;SORT1;CLTC;MYO5A;ARRB1;COMMD1;CLINT1;RAB10;RAB14;BLOC1S1;FTH1;CHMP2A;GOPC;GOLGA7;STEAP2;EPS15;AP1M2
integrin-mediated signaling pathway (GO:0007229),16/75,0.600932701,0.999996398,0,0,0.961057534,0.489440009,ITGB1;LAMA5;DST;CUL3;RCC2;NME2;CDC42;DAB2;ADAMTS1;PTPRA;ZYX;MYH9;PTK2B;CCM2;BCAR1;FERMT2
antigen processing and presentation of exogenous peptide antigen (GO:0002478),22/103,0.601423348,0.999996398,0,0,0.962494961,0.489386518,DYNC1I2;ARF1;SEC13;CLTC;DCTN3;KIF23;KIF11;AP2B1;DYNLL1;AP2A2;KIF15;CENPE;CAPZB;KIF2A;CAPZA1;CANX;CAPZA2;ACTR10;SEC24C;AP2M1;AP1M2;SEC31A
cellular response to organonitrogen compound (GO:0071417),22/103,0.601423348,0.999996398,0,0,0.962494961,0.489386518,XBP1;JUP;ACTB;IPO5;HSP90B1;SLC5A5;ZFP36L1;MAPK13;RAP1B;IMPACT;GOLPH3;LARP1;CDH1;AKAP9;CAPN2;CTNNA1;CTNNB1;LAMTOR2;LAMTOR1;EZR;FOLR1;LAMTOR3
cellular response to acid chemical (GO:0071229),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,XBP1;CAPN2;LAMTOR2;LAMTOR1;LAMTOR3;IPO5
negative regulation of axonogenesis (GO:0050771),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,PTPRS;ARHGDIA;PTEN;DIP2B;MT3;RHOA
photoperiodism (GO:0009648),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,PPP1CB;PER3;ID2;BHLHE40;PML;PPP1CA
positive regulation of response to wounding (GO:1903036),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,ITGB1;CLDN4;CLDN3;MDK;ACTG1;HBEGF
regulation of microtubule polymerization or depolymerization (GO:0031110),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,MAP1B;STMN1;STMN2;ARL2;FKBP4;MAPRE1
regulation of muscle contraction (GO:0006937),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,CNN1;TPM1;ANXA6;ENO1;SRI;MYL9
RNA phosphodiester bond hydrolysis (GO:0090501),28-Jun,0.602903562,0.999996398,0,0,0.966614955,0.489105259,PDE12;RPP30;CPSF3;PARN;NHP2;DICER1
regulation of cell migration (GO:0030334),88/408,0.604588146,0.999996398,0,0,0.974200093,0.490225089,ITGB1;CLIC4;FLT1;SERPINE2;PTEN;MIA3;PTPRK;CXCL16;ACTG1;AMOT;IGF1R;SLK;CDH1;MDK;TMSB4X;RACK1;DAG1;RAC1;ARID2;TMSB10;DUSP3;SEMA6A;LMO4;DDX58;F2R;TPM1;ACTN4;MIF;RHOC;F3;GTPBP4;RHOA;DUSP22;PTP4A1;CLDN4;MMP14;CLDN3;SFRP2;RAP2B;KIF2A;MYADM;ITGA6;EPHA1;MAPRE1;HBEGF;BEX4;GRB7;CD151;ROCK1;ROCK2;PDGFB;NEXN;SEMA3E;THBS1;CORO1C;FAM83H;PARD6B;PAK1;MIEN1;PDCD10;PODXL;LMNA;PDPN;GNA12;FLNA;PTK2B;CARMIL1;TCAF2;XBP1;HSPA5;RCC2;RDX;LAMB1;SMAD7;TJP1;FGF17;AFDN;DAB2;MYO1C;STK24;STK26;F2RL1;SPRY2;PLXNB1;AMOTL2;TDGF1;FERMT2;BCAR1
regulation of wound healing (GO:0061041),10/47,0.604806958,0.999996398,0,0,0.957856057,0.481654039,ITGB1;CLDN4;CLDN3;TNFRSF12A;F2R;F2RL1;SRSF6;CRK;ACTG1;HBEGF
positive regulation of cell cycle (GO:0045787),14/66,0.609748899,0.999996398,0,0,0.954121443,0.472011556,SRPK2;APP;TGFB2;DUSP3;USP22;PDGFB;TGM1;RPS15A;RPS6KB1;CDK4;PKN2;CALR;EIF4E;FGFR2
mitotic G2 DNA damage checkpoint signaling (GO:0007095),7/33,0.61147395,0.999996398,0,0,0.954194531,0.469351997,TAOK3;TAOK1;CDK1;BRCC3;FOXN3;CDK5RAP3;CDC14B
positive regulation of ATP metabolic process (GO:1903580),7/33,0.61147395,0.999996398,0,0,0.954194531,0.469351997,APP;VCP;PFKFB3;TMSB4X;BEND3;ENO1;HIF1A
negative regulation of protein-containing complex assembly (GO:0031333),11/52,0.612855482,0.999996398,0,0,0.95081949,0.465546064,CDC42;IMPACT;DDX3X;HSPA5;RIOK3;EP300;RPL13A;HMGB1;PARK7;CLU;CRYAB
regulation of release of sequestered calcium ion into cytosol (GO:0051279),11/52,0.612855482,0.999996398,0,0,0.95081949,0.465546064,FKBP1A;SELENON;CAMK2D;F2R;PTK2B;ANK2;CALM3;SRI;CALM1;JPH1;CALM2
positive regulation of protein catabolic process (GO:0045732),18/85,0.615418362,0.999996398,0,0,0.952036532,0.46216897,PLK3;GSK3A;HSP90AA1;VCP;CSNK2A1;TIPARP;FAF1;RDX;HUWE1;MSN;WWP1;IDE;OAZ1;FOXO1;DDB1;NEDD4;GPC3;EZR
histone acetylation (GO:0016573),15/71,0.617074705,0.999996398,0,0,0.94922562,0.458253083,NAA50;TAF12;TAF9;JADE2;PHF20L1;MORF4L1;TADA2A;YEATS2;RUVBL2;MORF4L2;RUVBL1;HAT1;BEND3;MBIP;EP300
tRNA aminoacylation (GO:0043039),8/38,0.619356309,0.999996398,0,0,0.945079293,0.452763439,AIMP1;AIMP2;LARS2;PPA1;DARS2;IARS2;EEF1E1;FARSB
negative regulation of DNA recombination (GO:0045910),12/57,0.620365079,0.999996398,0,0,0.94502924,0.451201505,SMCHD1;RIF1;POLR2B;ATRX;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;UBQLN4;POLR2K;POLR2L
basement membrane assembly (GO:0070831),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PXDN;LAMB1
cellular response to muramyl dipeptide (GO:0071225),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ARHGEF2;CHMP5
cellular response to nitric oxide (GO:0071732),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,MT3;FOXO1
cellular response to reactive nitrogen species (GO:1902170),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,MT3;FOXO1
collagen-activated signaling pathway (GO:0038065),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,DDR1;COL4A2
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,MKKS;HPN
DNA topological change (GO:0006265),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,TOP2A;HMGB1
epithelial cell apoptotic process (GO:1904019),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,GSN;HIPK1
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PFKL;ALDOA
galactose metabolic process (GO:0006012),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PGM2;GALK1
IMP metabolic process (GO:0046040),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PNP;AMPD2
inositol metabolic process (GO:0006020),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ISYNA1;PPIP5K2
L-phenylalanine metabolic process (GO:0006558),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,FAH;ASRGL1
lysosomal lumen acidification (GO:0007042),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,TMEM9;CLN6
mesodermal cell differentiation (GO:0048333),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ITGB1;ITGA3
mitral valve morphogenesis (GO:0003183),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,SOX4;BMPR1A
negative regulation of alpha-beta T cell activation (GO:0046636),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,TWSG1;GLI3
negative regulation of biomineralization (GO:0110150),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ROCK1;ROCK2
negative regulation of RNA catabolic process (GO:1902369),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PHAX;SLIRP
neuronal ion channel clustering (GO:0045161),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,MTCH1;AGRN
nuclear RNA surveillance (GO:0071027),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,EXOSC7;EXOSC8
nucleoside triphosphate biosynthetic process (GO:0009142),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,NME2;AK3
organic acid catabolic process (GO:0016054),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ADO;TXN2
peptidyl-cysteine modification (GO:0018198),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PARK7;RAB6A
peroxisomal transport (GO:0043574),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PEX19;ZFAND6
phosphatidylglycerol biosynthetic process (GO:0006655),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,TAMM41;PLA2G6
positive regulation of autophagosome assembly (GO:2000786),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,SH3GLB1;RAB3GAP2
positive regulation of mitochondrial calcium ion concentration (GO:0051561),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,FIS1;RAP1GDS1
"positive regulation of phagocytosis, engulfment (GO:0060100)",09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,RAB31;F2RL1
positive regulation of protein kinase A signaling (GO:0010739),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,RAMP3;MIF
positive regulation of smooth muscle contraction (GO:0045987),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,CTTN;F2R
protein hexamerization (GO:0034214),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,MAT2A;YME1L1
purine nucleobase metabolic process (GO:0006144),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,GMPS;PAICS
regulation of DNA-templated transcription in response to stress (GO:0043620),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,BCLAF1;RPS6KA1
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,USP14;UBQLN1
regulation of fibroblast apoptotic process (GO:2000269),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,BCL2L11;IER3IP1
regulation of glial cell proliferation (GO:0060251),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,PRKCI;SOX11
regulation of mitotic centrosome separation (GO:0046602),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,RANBP1;KIF11
regulation of sterol biosynthetic process (GO:0106118),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,KPNB1;RAN
regulation of transmembrane transporter activity (GO:0022898),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,AHCYL1;ACTB
response to UV-C (GO:0010225),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,IMPACT;MAP3K4
skeletal muscle fiber development (GO:0048741),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,ACTA1;SELENON
T-helper 1 type immune response (GO:0042088),09-Feb,0.622039495,0.999996398,0,0,1.012697691,0.480779941,TMEM98;HMGB1
2-oxoglutarate metabolic process (GO:0006103),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,GOT1;OGDH;DLST
antiviral innate immune response (GO:0140374),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,DDX58;PHB;PHB2
cardiac left ventricle morphogenesis (GO:0003214),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,GSK3A;SFRP2;RBPJ
cytoplasmic sequestering of transcription factor (GO:0042994),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,FAF1;TMSB4X;G3BP2
ether lipid metabolic process (GO:0046485),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,AGPS;FAR1;PLA2G6
heterochromatin organization (GO:0070828),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,SMCHD1;SETD7;LOXL2
mRNA cleavage involved in mRNA processing (GO:0098787),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,CPSF6;FIP1L1;CPSF2
ncRNA transcription (GO:0098781),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,CAVIN1;SNAPC3;SPIN1
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,TCERG1;HNRNPU;EAPP
negative regulation of smooth muscle cell migration (GO:0014912),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,IGFBP3;TPM1;BMPR1A
nuclear membrane disassembly (GO:0051081),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,CCNB2;NEK6;CDK1
nucleoside phosphate biosynthetic process (GO:1901293),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,PNP;NME2;AK3
nucleoside phosphate catabolic process (GO:1901292),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,ENPP3;DCTPP1;ITPA
positive regulation of cardiac muscle cell proliferation (GO:0060045),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,RBPJ;FGFR2;BMPR1A
positive regulation of cellular response to insulin stimulus (GO:1900078),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,IGF2;ERFE;SNX5
positive regulation of glucose metabolic process (GO:0010907),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,DDB1;PMAIP1;ARPP19
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,AKAP9;ANK2;ATP1B3
positive regulation of protein-containing complex disassembly (GO:0043243),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,SETX;BNIP3;IGF1R
positive regulation of SMAD protein signal transduction (GO:0060391),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,DAB2;RBPMS;BMPR1A
positive regulation of transmembrane transport (GO:0034764),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,CLIP3;BRAF;AZIN1
protein maturation by iron-sulfur cluster transfer (GO:0097428),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,NFU1;GLRX3;BOLA2
regulation of histone methylation (GO:0031060),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,NSD1;TET1;JARID2
regulation of IRE1-mediated unfolded protein response (GO:1903894),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,BCL2L11;HSPA5;BAX
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,NCL;NOL11;SMARCA4
response to chemokine (GO:1990868),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,DUSP1;WNK1;RHOA
response to X-ray (GO:0010165),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,XRCC6;NUCKS1;BRCC3
striated muscle cell development (GO:0055002),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,TMOD3;TMOD2;SDC1
synaptic membrane adhesion (GO:0099560),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,PTPRS;GPC4;PTPRF
T-helper cell differentiation (GO:0042093),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,TMEM98;HMGB1;FOXP1
vascular endothelial growth factor signaling pathway (GO:0038084),14-Mar,0.624183774,0.999996398,0,0,0.966637728,0.455586457,NUS1;MYO1C;GAB1
regulation of cell-cell adhesion (GO:0022407),9/43,0.626685251,0.999996398,0,0,0.9381027,0.438385577,AFDN;CDH1;PODXL;FLOT2;SPINT2;EFNA5;GTPBP4;ADA;SMAD7
negative regulation of kinase activity (GO:0033673),13/62,0.627418821,0.999996398,0,0,0.940180083,0.438256471,CDKN1C;PRKRIP1;HNRNPU;PPP2R5A;PARK7;SPRED1;CHP1;SFN;EPHA1;PPIA;PAK2;YWHAG;RTRAF
positive regulation of cysteine-type endopeptidase activity (GO:2001056),13/62,0.627418821,0.999996398,0,0,0.940180083,0.438256471,CYFIP2;FIS1;DDX3X;DAPK1;PDCD6;PDCD5;F2R;HMGB1;REST;MYC;PERP;PMAIP1;CYCS
ciliary basal body-plasma membrane docking (GO:0097711),20/95,0.628535098,0.999996398,0,0,0.944928859,0.438790386,CEP57;YWHAE;DYNC1I2;HSP90AA1;DCTN3;HAUS3;DYNLL1;TUBB4B;CKAP5;RAB11A;HAUS1;AHI1;PCM1;TUBA1A;TCTN2;AKAP9;CDK1;MAPRE1;SFI1;YWHAG
actin filament capping (GO:0051693),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,GSN;CAPZB;CAPZA1;CAPZA2
aspartate family amino acid metabolic process (GO:0009066),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,GOT1;MTHFD1;SMS;NIT2
barbed-end actin filament capping (GO:0051016),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,GSN;CAPZB;CAPZA1;CAPZA2
diol metabolic process (GO:0034311),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,GCHFR;HSP90AA1;CALM1;PLPP2
establishment of skin barrier (GO:0061436),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,CLDN4;STMN1;LSR;SFN
establishment or maintenance of apical/basal cell polarity (GO:0035088),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,CLIC4;PATJ;PRKCI;SYNJ2BP
mesenchymal cell development (GO:0014031),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,PDCD6;NOLC1;NRG1;SOX11
negative regulation of amyloid precursor protein catabolic process (GO:1902992),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,PRNP;ROCK1;FLOT2;CLU
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,NONO;PARK7;HIF1A;PPIA
negative regulation of protein localization to nucleus (GO:1900181),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,UFM1;LATS2;CTNNA1;CHP1
negative regulation of RNA metabolic process (GO:0051253),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,RPS26;PTBP1;TMBIM6;RPS13
negative regulation of striated muscle cell differentiation (GO:0051154),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,GSK3A;XBP1;HDAC3;FZD7
negative regulation of T cell receptor signaling pathway (GO:0050860),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,PRNP;DUSP3;EZR;PHPT1
neural crest cell differentiation (GO:0014033),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,PDCD6;NOLC1;NRG1;SOX11
positive regulation of macrophage migration (GO:1905523),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,MDK;MAPK1;THBS1;MAPK3
positive regulation of mitochondrial fission (GO:0090141),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,FIS1;BNIP3;SPIRE1;DNM1L
positive regulation of neutrophil chemotaxis (GO:0090023),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,MDK;C1QBP;RAC1;DNM1L
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,TJP1;AFDN;EPCAM;FLOT1
regulation of glucose transmembrane transport (GO:0010827),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,CLIP3;PLA2G1B;SLC2A1;BRAF
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,IGFBP4;IGFBP3;IGFBP2;PHIP
regulation of nervous system process (GO:0031644),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,APP;ROCK2;AKAP9;NPTXR
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,SEMA6A;MYO1C;SPRY2;PIK3CB
regulation of water loss via skin (GO:0033561),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,CLDN4;STMN1;LSR;SFN
striated muscle cell differentiation (GO:0051146),19-Apr,0.628770332,0.999996398,0,0,0.945129255,0.438529787,MYEF2;SORT1;SDC1;NRG1
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),17/81,0.630581468,0.999996398,0,0,0.941260122,0.434027204,MTCH1;BEX3;VCP;EGLN3;F2R;RPS27L;CFLAR;HSPE1;F3;BBC3;SENP1;HSPD1;FAM162A;RACK1;BAX;CYCS;ANP32B
regulation of cell differentiation (GO:0045595),33/156,0.632585622,0.999996398,0,0,0.950571786,0.435304555,DDX5;CEBPB;HSP90AB1;ROCK1;LTBP4;NREP;ZFP36L1;PPP2CA;PURB;PTBP1;MDK;PPP1R13L;MCRIP1;RPS6KA1;DAG1;FLOT2;CDK5RAP3;YWHAG;YWHAH;TCFL5;ZFHX3;UQCC2;NSUN2;IGF2;PA2G4;SMAD7;SLC6A6;REST;ID2;OCIAD1;ANP32B;FGFR2;FGFR1
nucleus organization (GO:0006997),10/48,0.633555475,0.999996398,0,0,0.932589387,0.42564099,NDC1;NUP205;SEH1L;PDCD6IP;PITPNB;VPS4B;TPR;CHMP2A;CHMP3;CHMP5
positive regulation of endocytosis (GO:0045807),10/48,0.633555475,0.999996398,0,0,0.932589387,0.42564099,CDC42;CLIP3;DAB2;CD151;HNRNPK;RAB31;FLOT1;GPC3;F2RL1;CLU
peptidyl-threonine modification (GO:0018210),14/67,0.634080642,0.999996398,0,0,0.936058939,0.426448923,GSK3A;CAMK2D;CSNK2A1;ROCK1;GALNT3;ROCK2;CSNK2A2;LMTK2;HIPK1;MAPK8;WNK1;WNK3;CDK1;MAPK1
axon extension (GO:0048675),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,HSP90AA1;PPP3CB;HSP90AB1;USP9X;MAP1B
cellular response to catecholamine stimulus (GO:0071870),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,GNG2;APLP1;GNB1;MAPK1;MAPK3
negative regulation of protein depolymerization (GO:1901880),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,TPX2;MID1IP1;TAOK1;STMN2;ARHGEF2
negative regulation of synaptic transmission (GO:0050805),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,ATAD1;ARF1;MTMR2;SYT11;PTEN
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,UBB;UBC;UBE2N;UBE2V1;RPS27A
positive regulation of carbohydrate metabolic process (GO:0045913),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,APP;PFKFB3;PDGFB;HIF1A;NFKB1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,CDKN1C;DAB2;HSP90AB1;EP300;THBS1
positive regulation of phospholipase activity (GO:0010518),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,ARF4;FLT1;PLAA;FGFR2;FGFR1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,CEBPB;HSPA5;RBPJ;HIF1A;MT3
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,CDKN1C;DAB2;HSP90AB1;EP300;THBS1
protein kinase B signaling (GO:0043491),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,SETX;PLK3;PTEN;MT3;ZFP36L1
sulfur amino acid metabolic process (GO:0000096),24-May,0.634114427,0.999996398,0,0,0.93266606,0.424853505,GCLC;MTHFD1;SMS;ADO;TXN2
negative regulation of phosphorylation (GO:0042326),18/86,0.636849653,0.999996398,0,0,0.937975601,0.423234922,CDKN1C;PRNP;ANKLE2;ROCK1;IGFBP3;PRKRIP1;PTEN;HNRNPU;PARK7;DYNLL1;CORO1C;IMPACT;MYADM;CHP1;TARDBP;PPIA;CDK5RAP3;GIT1
actin filament polymerization (GO:0030041),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,GSN;PSTPIP2;SPIRE1;WASL;RAC1;WASHC3
hydrogen peroxide metabolic process (GO:0042743),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,PRDX2;PRDX5;GPX3;PRDX1;PXDN;PARK7
lamellipodium organization (GO:0097581),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,ITGB1;CARMIL1;GOLPH3;SNX2;CTTN;RAC1
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,PPP2R1B;TNFRSF12A;PMAIP1;THBS1;PAK2;PML
regulation of actin polymerization or depolymerization (GO:0008064),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,PLEKHG2;HAX1;WDR1;CTTN;PFN1;DBN1
regulation of protein targeting to membrane (GO:0090313),29-Jun,0.63966736,0.999996398,0,0,0.924528862,0.413085955,FIS1;PRNP;TCAF2;ITGAM;MYO1C;CHP1
positive regulation of macroautophagy (GO:0016239),11/53,0.640036767,0.999996398,0,0,0.928121271,0.414155235,SH3GLB1;BNIP3L;SCOC;LARP1;BNIP3;GNAI3;RAB3GAP2;VDAC1;SLC25A5;SLC25A4;OPTN
cell morphogenesis involved in differentiation (GO:0000904),15/72,0.640400917,0.999996398,0,0,0.93251254,0.415584346,LAMA5;YTHDF2;ACTN1;LAMB1;PARVA;GRHL2;RHOA;CLDN3;RAB25;ABI2;RILPL1;RAC1;EPHA1;FERMT2;VAMP3
negative regulation of epithelial cell proliferation (GO:0050680),15/72,0.640400917,0.999996398,0,0,0.93251254,0.415584346,CDKN1C;MED1;TGFB2;FBXW7;HPN;PEX2;PTPRK;SYNJ2BP;THBS1;CDC73;MTSS1;WDR77;AIMP1;SFRP2;FGFR2
positive regulation of supramolecular fiber organization (GO:1902905),19/91,0.642840043,0.999996398,0,0,0.935053121,0.413161967,APP;NCKAP1;CARMIL1;WDR1;STMN2;ARL2;CLU;PAK1;CTTN;CFL2;AKAP9;RPS3;DRG1;PTK2B;F2RL1;RAC1;MAPRE1;PFN1;ARF6
regulation of actin cytoskeleton organization (GO:0032956),19/91,0.642840043,0.999996398,0,0,0.935053121,0.413161967,ROCK1;ROCK2;RHOBTB3;SEMA3E;IQGAP1;F11R;RHOC;EFNA5;RHOA;PAK1;MDK;ARHGDIA;TAOK1;PTK2B;RAC1;EZR;PHPT1;CRK;ARHGEF5
histone lysine methylation (GO:0034968),7/34,0.645215057,0.999996398,0,0,0.91879499,0.402589868,SUV39H2;TRMT112;KMT2A;SETD1B;PRDM5;DPY30;EZH2
negative regulation of blood vessel endothelial cell migration (GO:0043537),7/34,0.645215057,0.999996398,0,0,0.91879499,0.402589868,CARD10;JUP;PDCD10;GADD45A;HMGB1;THBS1;RHOA
phosphatidylinositol 3-kinase signaling (GO:0014065),7/34,0.645215057,0.999996398,0,0,0.91879499,0.402589868,PLEKHA1;C1QBP;PTEN;PIK3CB;PIK3C2A;IGF1R;ZFP36L1
protein destabilization (GO:0031648),7/34,0.645215057,0.999996398,0,0,0.91879499,0.402589868,PRNP;GSN;CUL3;EP300;PEX2;CDC73;SERF2
regulation of activated T cell proliferation (GO:0046006),7/34,0.645215057,0.999996398,0,0,0.91879499,0.402589868,PRNP;IGFBP2;RPS3;IGF2;RC3H1;HMGB1;IL2
positive regulation of protein binding (GO:0032092),12/58,0.646182401,0.999996398,0,0,0.924425689,0.403672164,PPP2CA;FKBP1A;APP;PPP2CB;NVL;RPL11;FLOT1;NMD3;IDE;STK4;MARK3;RAN
cellular transition metal ion homeostasis (GO:0046916),20/96,0.648579997,0.999996398,0,0,0.932435517,0.403716536,APP;PRNP;ARF1;ATP6V1G1;SLC30A9;TFRC;GLRX3;SLC40A1;CUL1;SLC39A10;NEDD8;ERFE;SLC39A14;MT3;ATOX1;CAND1;FTH1;MYC;BOLA2;ABCG2
positive regulation of intracellular transport (GO:0032388),8/39,0.650666774,0.999996398,0,0,0.91453412,0.393028021,PLK3;EHD2;PCM1;PDCD10;NEDD4;TPR;KIF20B;OAZ1
protein acylation (GO:0043543),8/39,0.650666774,0.999996398,0,0,0.91453412,0.393028021,PORCN;NAA10;ZDHHC20;NAT10;ZDHHC6;EP300;SELENOK;FOXO1
regulation of receptor-mediated endocytosis (GO:0048259),8/39,0.650666774,0.999996398,0,0,0.91453412,0.393028021,ARF1;HNRNPK;FLOT1;BMP2K;PIK3CB;RAC1;CLU;ARF6
intracellular steroid hormone receptor signaling pathway (GO:0030518),9/44,0.655983793,0.999996398,0,0,0.911241218,0.384196789,YAP1;MED1;DDX5;RNF14;NEDD4;UBR5;UBE3A;PHB;ARID1A
positive regulation of cell division (GO:0051781),9/44,0.655983793,0.999996398,0,0,0.911241218,0.384196789,CDC42;CUL3;KIF23;PKN2;ECT2;KIF20B;RHOA;FGFR2;CDC14B
positive regulation of cell-matrix adhesion (GO:0001954),9/44,0.655983793,0.999996398,0,0,0.911241218,0.384196789,ROCK1;JUP;PTK2B;RAC1;EPHA1;UTRN;FERMT2;S100A10;LIMS1
positive regulation of receptor-mediated endocytosis (GO:0048260),9/44,0.655983793,0.999996398,0,0,0.911241218,0.384196789,ATAD1;AHI1;DAB2;DGKD;HNRNPK;ANXA2;ARRB1;WASL;CLU
protein dephosphorylation (GO:0006470),29/139,0.660172434,0.999996398,0,0,0.934003576,0.387848921,MTMR2;PTPRS;PTEN;PTPRK;PTPRF;CDC14B;PPP1CB;PPP2CA;PPP2CB;PPP3CB;PPP4R1;PPP2R1B;PPP2R5E;DUSP3;PPP1R12A;DUSP1;SSU72;PPP2R5A;PPP2R5C;PTPN12;DUSP9;PTPN14;DUSP6;PPP1CA;DUSP22;SDHAF2;PTPRA;PHPT1;PTPN3
phosphorylation (GO:0016310),85/400,0.662795434,0.999996398,0,0,0.955573209,0.393016637,APP;GSK3A;GMFB;DGKD;PRAG1;NRK;PIK3CB;LIMD1;NRBP2;PPP3CB;PPP4R1;TLK2;TLK1;PIM3;JAK1;PDK1;CDKL2;PRKCI;CSNK2A1;CHUK;DAPK1;IGFBP3;HUNK;LMTK2;PRPF4B;YWHAZ;ILF3;MELK;CREB1;LATS2;CCNE1;BMP2K;BIRC5;BIRC6;CSNK1G2;CAMK2D;ROCK1;ROCK2;PDGFB;STK4;NUAK1;PAK1;MAPK8;FGGY;GRK2;GRK6;MAP3K20;PGK1;MAPK1;PTK2B;MAP4K5;MAPK6;PAK2;MARK3;NADK;MAPK3;CDK17;SRPK2;TGFB2;MAP3K1;CSNK1A1;RYK;NEK6;LIMK2;BRAF;HIPK1;CDK11B;SRPK1;BCKDK;CDK7;TAOK3;STK24;CDK4;WNK1;TAOK1;COPS2;STK26;WNK3;CDK1;PKN2;CDK12;CDK13;CDK14;BMPR1A;FGFR1
regulation of lipid metabolic process (GO:0019216),19/92,0.662975164,0.999996398,0,0,0.922184778,0.379034312,MED1;IDI1;HDAC3;GGPS1;HMGCS1;CHD9;NFYB;MID1IP1;HMGCR;ADIPOR1;LSS;ACACA;SQLE;SP1;CARM1;ID2;PMVK;SC5D;TBL1X
regulation of proteolysis (GO:0030162),11/54,0.666165938,0.999996398,0,0,0.906478784,0.368226624,CYFIP2;SERPINE2;PERP;PLAUR;LTBP4;SPOP;SPOPL;NEDD8;AURKAIP1;CLN6;PARL
Golgi organization (GO:0007030),27/130,0.666885154,0.999996398,0,0,0.928682728,0.376244134,USP6NL;PI4K2B;TMED10;GOSR2;ATL2;CDC42;ARHGAP21;PDCD10;MYO18A;TMED3;TMED2;VTI1B;RAB2A;PLK3;TMED9;COG7;FBXW8;CSNK1A1;SEC16A;SURF4;HUWE1;LYSMD3;YWHAZ;VMP1;GOLPH3;CDK1;OPTN
protein modification process (GO:0036211),16/78,0.668133189,0.999996398,0,0,0.914378195,0.368739228,UBL4A;USP25;UBE2I;PARP1;RPN2;UBE2D3;NEDD8;RABGGTB;LOXL2;UBE2L3;TGM1;UBL5;SERP1;CDC34;UBA3;SEPHS1
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,CLDN6;CLDN4;CLDN12;CLDN7
cellular modified amino acid biosynthetic process (GO:0042398),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,GGCT;GATM;GCLC;GCLM
cellular response to nitrogen compound (GO:1901699),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,RIOK3;ROCK2;PDE12;ATRX
cortical actin cytoskeleton organization (GO:0030866),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,NCKAP1;ROCK1;ROCK2;ARF6
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,CDKN1C;LATS2;PTEN;IPO5
positive regulation of epidermal cell differentiation (GO:0045606),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,MED1;NME2;SFN;ETV4
positive regulation of lymphocyte differentiation (GO:0045621),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,XBP1;XRCC6;MMP14;MDK
protein targeting to lysosome (GO:0006622),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,HSPA8;AP3M1;NEDD4;CLU
regulation of granulocyte chemotaxis (GO:0071622),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,MDK;MAPK1;THBS1;MAPK3
regulation of smooth muscle cell migration (GO:0014910),20-Apr,0.671395835,0.999996398,0,0,0.886001819,0.352979934,IGFBP3;PDGFB;S100A11;BMPR1A
negative regulation of actin filament polymerization (GO:0030837),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,GSN;TMSB4X;MYADM;PFN1;TMSB10
negative regulation of ion transport (GO:0043271),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,SYT11;WNK1;NEDD4;WNK3;PTK2B
outflow tract septum morphogenesis (GO:0003148),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,TGFB2;PARVA;LRP2;FGFR2;BMPR1A
peptide catabolic process (GO:0043171),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,NPEPPS;XPNPEP1;ANPEP;ECE1;IDE
positive regulation of ERBB signaling pathway (GO:1901186),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,AFAP1L2;DGKD;PLAUR;RBPJ;CNOT9
regulation of mitochondrial fission (GO:0090140),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,FIS1;INF2;BNIP3;SPIRE1;DNM1L
response to hexose (GO:0009746),25-May,0.672181455,0.999996398,0,0,0.885975887,0.351933502,EIF2B3;PFKL;EIF2B1;THBS1;KHK
positive regulation of vasculature development (GO:1904018),21/102,0.672984338,0.999996398,0,0,0.91853543,0.363770545,ITGB1;XBP1;FLT1;JUP;ANXA3;PDCD6;VASH2;GAB1;HIPK1;ETS1;HIF1A;F3;THBS1;HK2;MTDH;PDCL3;SFRP2;SP1;AGO2;AGGF1;EPHA1
regulation of protein catabolic process (GO:0042176),21/102,0.672984338,0.999996398,0,0,0.91853543,0.363770545,VCP;GSK3A;CSNK2A1;TIPARP;FAF1;ODC1;HUWE1;WWP1;PHB;IDE;HMGCR;OAZ1;FOXO1;AZIN1;EEF1A1;DDB1;NEDD4;GPC3;FLNA;TMEM9;MAD2L1
acetyl-CoA metabolic process (GO:0006084),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,HMGCS1;PMVK;ACACA
androgen receptor signaling pathway (GO:0030521),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,DDX5;RNF14;ARID1A
anterograde synaptic vesicle transport (GO:0048490),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,AP3M1;SNAPIN;BLOC1S1
cellular response to exogenous dsRNA (GO:0071360),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,DDX58;DHX9;FLOT1
central nervous system neuron development (GO:0021954),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,HSP90AA1;HSP90AB1;PTEN
clathrin coat assembly (GO:0048268),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,CLTC;PIK3C2A;EPS15
embryonic cranial skeleton morphogenesis (GO:0048701),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,MTHFD1;EIF4A3;FGFR2
endoplasmic reticulum to cytosol transport (GO:1903513),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,VCP;SEC61B;HSP90B1
endoplasmic reticulum tubular network organization (GO:0071786),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,RAB10;ATL2;RAB18
integrated stress response signaling (GO:0140467),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,IMPACT;HSPA5;EIF2S1
phosphatidylethanolamine biosynthetic process (GO:0006646),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,CHKA;ETNK1;SELENOI
placenta development (GO:0001890),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,PHLDA2;E2F7;E2F8
positive regulation of cell killing (GO:0031343),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,MAPK8;FZD7;RAC1
positive regulation of double-strand break repair via homologous recombination (GO:1905168),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,ACTR2;PARP1;ARID2
positive regulation of keratinocyte differentiation (GO:0045618),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,MED1;NME2;ETV4
positive regulation of sprouting angiogenesis (GO:1903672),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,TJP1;PKM;JAK1
"protein localization to chromosome, telomeric region (GO:0070198)",15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,TNKS2;ATRX;NABP2
pyrimidine nucleoside metabolic process (GO:0006213),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,NT5C;ERH;UMPS
regulation of dephosphorylation (GO:0035303),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,MTMR2;SMG7;CDK5RAP3
regulation of integrin activation (GO:0033623),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,RAP1B;FERMT1;FERMT2
synaptic vesicle transport along microtubule (GO:0099517),15-Mar,0.673337049,0.999996398,0,0,0.88602774,0.350432174,AP3M1;SNAPIN;BLOC1S1
peptidyl-lysine trimethylation (GO:0018023),30-Jun,0.674314167,0.999996398,0,0,0.885949943,0.349116685,SUV39H2;KMT2A;SETD1B;BEND3;ETFBKMT;WDR61
protein N-linked glycosylation via asparagine (GO:0018279),30-Jun,0.674314167,0.999996398,0,0,0.885949943,0.349116685,OST4;RPN2;DAD1;OSTC;STT3B;DDOST
respiratory tube development (GO:0030323),30-Jun,0.674314167,0.999996398,0,0,0.885949943,0.349116685,ZIC3;ITGA3;WNT7B;PDPN;FGFR2;CCDC40
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),13/64,0.675748996,0.999996398,0,0,0.903194094,0.353992095,MED1;CEBPB;PTEN;MED8;MED6;NFKB1;MED14;TRIM28;CDK4;SUB1;CDK1;BAX;CTNNB1
protein localization to cell periphery (GO:1990778),29/140,0.676255998,0.999996398,0,0,0.925529372,0.362051893,RAMP3;ROCK1;ROCK2;F11R;LIN7C;CDH1;TMEM88;BSG;FLOT1;FLOT2;TMED2;FLNA;SPTBN1;S100A10;JUP;SEC16A;RDX;MYO5A;ANK2;ATP1B3;RAB11A;RAB10;EHD2;RAB15;WNK3;MYADM;PKP2;EZR;CRB3
negative regulation of epithelial cell migration (GO:0010633),7/35,0.677169664,0.999996398,0,0,0.885923987,0.345362783,SVBP;PTEN;TACSTD2;ADIPOR1;SYNJ2BP;THBS1;CORO1C
positive regulation of immunoglobulin production (GO:0002639),7/35,0.677169664,0.999996398,0,0,0.885923987,0.345362783,XBP1;RIF1;TFRC;PHB;PHB2;IL2;VAMP3
regulation of T cell receptor signaling pathway (GO:0050856),7/35,0.677169664,0.999996398,0,0,0.885923987,0.345362783,PRNP;DUSP3;RPS3;RC3H1;EZR;PHPT1;NECTIN2
autophagy of mitochondrion (GO:0000422),8/40,0.680428261,0.999996398,0,0,0.88589802,0.341099869,FUNDC2;FIS1;GABARAPL1;MAP1LC3A;BNIP3;CISD2;WIPI1;PHB2
carboxylic acid metabolic process (GO:0019752),8/40,0.680428261,0.999996398,0,0,0.88589802,0.341099869,CYB5A;GLUD1;CYB5R3;SLC23A1;SLC2A1;SLC2A3;MIF;LIAS
positive regulation of catalytic activity (GO:0043085),8/40,0.680428261,0.999996398,0,0,0.88589802,0.341099869,MAPK8;YWHAB;MID1IP1;IGF2;SSBP1;MAPK14;MT3;MAPK3
acetyl-CoA biosynthetic process (GO:0006085),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,PDHA1;PDHB
cellular response to acidic pH (GO:0071468),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,IMPACT;CHP1
cellular response to dopamine (GO:1903351),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MAPK1;MAPK3
cellular response to prostaglandin stimulus (GO:0071379),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,GNG2;GNB1
defense response to tumor cell (GO:0002357),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,PRDX2;DAPK1
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RPS6KA6;RPS27L
DNA replication-dependent nucleosome assembly (GO:0006335),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,NASP;HAT1
DNA replication-dependent nucleosome organization (GO:0034723),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,NASP;HAT1
ectoderm development (GO:0007398),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ITGAM;ITGA6
ether lipid biosynthetic process (GO:0008611),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,AGPS;FAR1
granulocyte activation (GO:0036230),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,CXCR2;F2RL1
histone H3-K36 demethylation (GO:0070544),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RIOX2;KDM7A
histone H4 deacetylation (GO:0070933),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,REST;HDAC3
ionotropic glutamate receptor signaling pathway (GO:0035235),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,APP;PTK2B
iron ion transmembrane transport (GO:0034755),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,SLC40A1;SLC39A14
leptin-mediated signaling pathway (GO:0033210),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MKKS;MT3
lipoprotein transport (GO:0042953),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,VMP1;MIA3
long-chain fatty acid import into cell (GO:0044539),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RPS6KB1;SLC2A1
mesenchymal to epithelial transition (GO:0060231),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,BASP1;FZD7
methylguanosine-cap decapping (GO:0110156),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LSM1;PNRC2
mitotic DNA replication (GO:1902969),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MCM4;MCM2
muscle cell migration (GO:0014812),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,DDR1;ROCK1
negative regulation of cell adhesion mediated by integrin (GO:0033629),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,WNK1;PDE3B
negative regulation of cellular protein catabolic process (GO:1903363),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ANXA2;CDK5RAP3
negative regulation of circadian rhythm (GO:0042754),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,SUV39H2;SFPQ
negative regulation of heterotypic cell-cell adhesion (GO:0034115),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,WNK1;MYADM
negative regulation of peptidyl-lysine acetylation (GO:2000757),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,SET;NOC2L
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,PIK3IP1;PTEN
negative regulation of protein autophosphorylation (GO:0031953),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,IMPACT;CHP1
negative regulation of receptor binding (GO:1900121),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ATP2A2;PTPRF
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,CAMK2D;NEDD4
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,IMPACT;JUN
negative regulation of transforming growth factor beta production (GO:0071635),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LAPTM4B;HSP90AB1
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,PPP2CA;INPP5F
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RIOK3;C1QBP
negative regulation of voltage-gated calcium channel activity (GO:1901386),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,CALM3;CALM1
neuron projection maintenance (GO:1990535),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,APP;PRNP
nuclear mRNA surveillance (GO:0071028),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,EXOSC7;EXOSC8
nucleoside metabolic process (GO:0009116),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ERH;NME4
phosphatidylcholine catabolic process (GO:0034638),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,PLA2G10;PLA2G6
positive regulation by symbiont of entry into host (GO:0075294),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LGALS1;P4HB
positive regulation of coagulation (GO:0050820),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,F2R;THBS1
positive regulation of dendritic spine morphogenesis (GO:0061003),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,CAPRIN1;DBN1
positive regulation of hemostasis (GO:1900048),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,F2R;THBS1
positive regulation of mesenchymal cell proliferation (GO:0002053),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MYC;FGFR2
positive regulation of mRNA 3'-end processing (GO:0031442),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LEO1;CDC73
positive regulation of RIG-I signaling pathway (GO:1900246),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,USP15;PUM2
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,HIF1A;MT3
positive regulation of viral entry into host cell (GO:0046598),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LGALS1;P4HB
Rap protein signal transduction (GO:0032486),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RAP1B;RAP2B
receptor recycling (GO:0001881),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,LMTK2;PLEKHJ1
regulation of axon guidance (GO:1902667),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,YTHDF1;MYCBP2
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,WNK1;MYADM
regulation of hydrogen peroxide-induced cell death (GO:1903205),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,STK26;PARK7
regulation of low-density lipoprotein particle clearance (GO:0010988),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,HNRNPK;ANXA2
regulation of peptidyl-lysine acetylation (GO:2000756),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,DIP2B;PARK7
"regulation of phagocytosis, engulfment (GO:0060099)",10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RAB31;F2RL1
regulation of phospholipid metabolic process (GO:1903725),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MTMR2;PHB2
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,AKAP9;NPTXR
regulation of receptor binding (GO:1900120),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ATP2A2;PTPRF
regulation of T-helper 17 cell differentiation (GO:2000319),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RC3H1;SMAD7
response to dopamine (GO:1903350),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,MAPK1;MAPK3
retinoic acid receptor signaling pathway (GO:0048384),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RARG;ACTN4
RNA polymerase II preinitiation complex assembly (GO:0051123),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,GTF2A2;TAF12
rRNA pseudouridine synthesis (GO:0031118),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,NHP2;NOP10
sarcoplasmic reticulum calcium ion transport (GO:0070296),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ATP2A2;ANK2
secretory granule organization (GO:0033363),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,BLOC1S1;F2R
serine family amino acid catabolic process (GO:0009071),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,GLDC;DLD
urea cycle (GO:0000050),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,ASL;NMRAL1
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),10-Feb,0.681731705,0.999996398,0,0,0.886053649,0.33946407,RYK;CTNNB1
iron ion transport (GO:0006826),10/50,0.687516057,0.999996398,0,0,0.885846049,0.331900022,ATP6V1G1;TFRC;FTH1;CLTC;ARHGAP1;SLC40A1;LMTK2;SLC39A14;ATP6V1D;ATP6V1F
regulation of neuron differentiation (GO:0045664),16/79,0.689098889,0.999996398,0,0,0.899806338,0.33506133,MED1;ZFHX3;ROCK1;SOX11;NREP;RHOA;IMPACT;REST;ID2;ARHGEF2;CALR;ECT2;CDK5RAP3;YWHAG;YWHAH;FGFR1
cellular protein catabolic process (GO:0044257),12/60,0.694849862,0.999996398,0,0,0.885794031,0.322481717,BNIP3L;PSMA6;CLPP;BNIP3;CLTC;CAPN2;YME1L1;UBE2G1;IDE;AP2B1;AP2A2;AP2M1
regulation of type I interferon production (GO:0032479),18/89,0.697393265,0.999996398,0,0,0.898169303,0.323705428,XRCC6;DDX58;DHX9;NFKB1;POLR1C;G3BP1;PCBP2;TAX1BP1;EP300;POLR2F;CTNNB1;POLR3G;LRRFIP1;POLR2H;GAPDH;POLR3K;POLR2K;POLR2L
positive regulation of epithelial cell migration (GO:0010634),19/94,0.701377438,0.999996398,0,0,0.89747756,0.318343465,TGFB2;ANXA3;ROCK2;PDCD6;PIK3CB;ETS1;HIF1A;THBS1;RAB11A;FOXP1;RAB25;GLIPR2;PTK2B;RAC1;CALR;PFN1;TDGF1;BCAR1;ARF6
wound healing (GO:0042060),14/70,0.702145177,0.999996398,0,0,0.885741965,0.313211727,TGFB2;DST;FZD7;TPM1;MIA3;NRG1;CFLAR;PPL;PAK1;SYT11;ANXA6;MYH9;ARL8B;PLEC
cellular protein modification process (GO:0006464),219/1025,0.705812619,0.999996398,0,0,0.96112816,0.334862326,APP;GMFB;ZDHHC6;UBE2L3;PSMD8;PSMD6;PPP4R1;PSMD7;LGALS1;PSMD4;PPP2R1B;PSMD2;PSMD1;SEPHS1;SKP2;PDK1;PRKCI;COG7;CSNK2A1;DAPK1;CDC34;PSME3;PSME4;PSME2;MTMR2;RPN2;PDGFB;DCUN1D1;COPS7A;HIF1A;NUAK1;CDK17;SRPK2;NUS1;TIPARP;BRAF;SRPK1;WNK1;WNK3;CDK12;CDK13;CDK14;ARF4;PTPRS;MIA3;PTPRK;HIF3A;PTPRF;UBL5;PPP3CB;SERP1;UBXN7;ELOB;ELOC;JAK1;PARP1;DUSP1;PARP2;COMMD1;UCHL3;DUSP9;DUSP6;DDB1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;SDHAF2;B3GNT7;PSMA2;MATN3;NEDD8;FSTL1;PSMA7;PSMB6;PPP2CA;PSMB7;PPP2CB;PSMB4;PAK1;PSMB5;PSMB2;PSMB3;PSMB1;GPC3;MAP4K5;PAK2;UBL4A;EGLN3;MAP3K1;CSNK1A1;RYK;HIPK1;RAB11A;PSMB9;PPP1CA;KTN1;KLHL9;PSMC6;PSMC3;TAOK3;PSMC4;PSMC1;TAOK1;PSMC2;PKN2;PRAG1;NRK;UBE2D3;PARK7;LOXL2;CDC14B;TGM1;PPP1CB;NRBP2;PIM3;CDKL2;RAB2A;CISH;FBXW8;FBXW7;IGFBP4;IGFBP3;APLP2;UBE2E1;UBE2E2;LMTK2;PRPF4B;PDIA6;RBX1;ILF3;MELK;CCNE1;PHPT1;CSNK1G2;CUL9;PSMD12;PSMD11;PSMD14;CUL3;CUL1;KLHL13;STK4;HSP90B1;PORCN;GRK2;GRK6;MAP3K20;NAE1;MARK3;UBE2F;TGFB2;UBE2I;NEK6;MT3;COPS4;COPS3;CDK7;COPS6;STK24;PTPRA;CDK4;STK26;COPS2;UBA3;CDK1;STT3B;BMPR1A;FGFR1;GSK3A;PTEN;PPP2R5E;TLK2;TLK1;PPP1R12A;CHUK;HUNK;PPP2R5A;WIPI1;PPP2R5C;RABGGTB;YWHAZ;DDOST;PTP4A2;CREB1;LATS2;DAD1;BMP2K;BIRC5;BIRC6;CAMK2D;ROCK1;ROCK2;THBS1;PSMB10;MAPK8;CAND1;TNKS2;PTK2B;MAPK1;FEM1C;RBBP7;MAPK6;MAPK3;USP25;FEM1B;FBXL19;LIMK2;LAMB1;PTPN12;CDK11B;PTPN14;BCKDK;P4HB;METAP1;PTPN3;CUL4B;METAP2
peptidyl-asparagine modification (GO:0018196),6/31,0.706740242,0.999996398,0,0,0.850457338,0.295187014,OST4;RPN2;DAD1;OSTC;STT3B;DDOST
positive regulation of locomotion (GO:0040017),6/31,0.706740242,0.999996398,0,0,0.850457338,0.295187014,CAVIN1;CCDC25;PDGFB;F2RL1;PHPT1;THBS1
protein palmitoylation (GO:0018345),6/31,0.706740242,0.999996398,0,0,0.850457338,0.295187014,CLIP3;PORCN;ZDHHC20;ZDHHC6;SELENOK;GOLGA7
tube closure (GO:0060606),6/31,0.706740242,0.999996398,0,0,0.850457338,0.295187014,TGFB2;MTHFD1;LMO4;LRP2;GRHL2;FOLR1
membrane assembly (GO:0071709),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,ANXA2;PTEN;FLOT1;CHMP2A;FLOT2;SPTBN1;S100A10
mitochondrion disassembly (GO:0061726),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,FUNDC2;FIS1;GABARAPL1;MAP1LC3A;BNIP3;CISD2;WIPI1
positive regulation of interferon-beta production (GO:0032728),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,HSP90AA1;DDX3X;DHX9;DDX58;RIOK3;FLOT1;POLR3G
regulation of cardiac muscle contraction (GO:0055117),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,ATP2A2;ANK2;CALM3;SRI;CALM1;CALM2;SMAD7
regulation of receptor internalization (GO:0002090),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,ATAD1;AHI1;ARF1;MTMR2;ATXN2;FLOT1;ARRB1
regulation of sodium ion transport (GO:0002028),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,AHCYL1;WNK1;NEDD4;WNK3;PKP2;PRSS8;YWHAH
transferrin transport (GO:0033572),7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,ATP6V1G1;TFRC;CLTC;ARHGAP1;LMTK2;ATP6V1D;ATP6V1F
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",7/36,0.707247782,0.999996398,0,0,0.85531995,0.296260768,PPP3CB;PPP3R1;GNG2;AGO2;GNB1;CTNNB1;CALM1
negative regulation of receptor-mediated endocytosis (GO:0048261),26-May,0.707526,0.999996398,0,0,0.843732397,0.291915295,APP;MTMR2;ATXN2;RAC1;ARF6
organelle fission (GO:0048285),26-May,0.707526,0.999996398,0,0,0.843732397,0.291915295,FIS1;PEX19;MTFR1L;DNM1L;CORO1C
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),26-May,0.707526,0.999996398,0,0,0.843732397,0.291915295,PLA2G12A;PLA2G1B;PLA2G10;MBOAT1;PLA2G6
positive regulation of filopodium assembly (GO:0051491),26-May,0.707526,0.999996398,0,0,0.843732397,0.291915295,CDC42;MIEN1;WASL;FNBP1L;AGRN
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),26-May,0.707526,0.999996398,0,0,0.843732397,0.291915295,DDX3X;TFDP1;ADAMTS1;RDX;UBE2E2
carboxylic acid transmembrane transport (GO:1905039),8/41,0.708563137,0.999996398,0,0,0.858997441,0.295938457,SLC38A1;SLC16A1;SLC7A7;SLC23A1;SLC7A11;SLC38A2;SLC19A1;SLC38A4
positive regulation of smooth muscle cell proliferation (GO:0048661),9/46,0.710402921,0.999996398,0,0,0.861874169,0.29469458,GJA1;JUN;ADAMTS1;ID2;PDGFB;PHB;THBS1;FOXP1;BMPR1A
acetylcholine receptor signaling pathway (GO:0095500),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,GRK2;GNA11;GNB1;AGRN
aerobic respiration (GO:0009060),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,SURF1;MDH2;BLOC1S1;MTFR1L
cellular response to steroid hormone stimulus (GO:0071383),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,MED1;URI1;MGARP;UBE2L3
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,GSK3A;BAX;BCL2L1;MCL1
negative regulation of reproductive process (GO:2000242),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,GJA1;DUSP1;CALR;WDR77
neurotrophin signaling pathway (GO:0038179),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,SORT1;DDIT4;SOS1;BCAR1
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,RPS3;SLC39A10;NECTIN2;FOXP1
positive regulation of immune system process (GO:0002684),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,TGFB2;PLA2G1B;MIA3;PIK3CB
regulation of anoikis (GO:2000209),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,ANKRD13C;ITGB1;PTRH2;MCL1
regulation of dendritic spine development (GO:0060998),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,PTPRS;KIF1A;LLPH;ARF6
regulation of mitochondrial translation (GO:0070129),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,COA3;MRPS27;UQCC2;C1QBP
response to progesterone (GO:0032570),21-Apr,0.710507481,0.999996398,0,0,0.833830553,0.284983106,YAP1;TGFB2;UBE3A;THBS1
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PRPS2
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PRPS2
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
amino-acid betaine biosynthetic process (GO:0006578),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ALDH9A1
anion homeostasis (GO:0055081),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GLS
anterograde dendritic transport (GO:0098937),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KIF5B
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KIF5B
apoptotic chromosome condensation (GO:0030263),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TOP2A
beta-catenin destruction complex assembly (GO:1904885),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,CSNK1A1
BMP signaling pathway involved in heart development (GO:0061312),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BMPR1A
bone marrow development (GO:0048539),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SBDS
cadmium ion transmembrane transport (GO:0070574),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC39A14
cadmium ion transport (GO:0015691),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC39A14
cardiac endothelial cell differentiation (GO:0003348),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NRG1
cardiac muscle cell proliferation (GO:0060038),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
carnitine biosynthetic process (GO:0045329),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ALDH9A1
"CD4-positive, alpha-beta T cell activation (GO:0035710)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HMGB1
cell migration involved in gastrulation (GO:0042074),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GPC3
cell-cell adhesion mediated by integrin (GO:0033631),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGB1
cellular response to nicotine (GO:0071316),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NFKB1
cellular response to nutrient (GO:0031670),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,XBP1
cellular response to salt stress (GO:0071472),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ZFP36L1
cellular response to vitamin (GO:0071295),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FOLR1
centriole assembly (GO:0098534),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,E2F4
cerebellar granule cell differentiation (GO:0021707),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KNDC1
chronic inflammatory response (GO:0002544),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,THBS1
copper ion import (GO:0015677),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,STEAP2
coronary artery morphogenesis (GO:0060982),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LRP2
cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC19A1
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PNRC2
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SSU72
determination of left/right asymmetry in lateral mesoderm (GO:0003140),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FOXH1
diadenosine hexaphosphate catabolic process (GO:1901909),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
diadenosine hexaphosphate metabolic process (GO:1901908),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
diadenosine pentaphosphate catabolic process (GO:1901907),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
diadenosine pentaphosphate metabolic process (GO:1901906),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
diaphragm development (GO:0060539),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BASP1
diphosphoinositol polyphosphate metabolic process (GO:0071543),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT4
disaccharide biosynthetic process (GO:0046351),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC2A1
"DNA replication, synthesis of RNA primer (GO:0006269)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,POLA2
dopamine biosynthetic process (GO:0042416),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
drug transport (GO:0015893),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC19A1
embryonic skeletal joint morphogenesis (GO:0060272),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,CTNNB1
embryonic viscerocranium morphogenesis (GO:0048703),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MTHFD1
endocardial cell differentiation (GO:0060956),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NRG1
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NOP9
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NOP9
endothelial cell apoptotic process (GO:0072577),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HIPK1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FAH
establishment of monopolar cell polarity (GO:0061162),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PATJ
establishment of protein localization to telomere (GO:0070200),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NABP2
establishment of protein localization to vacuole (GO:0072666),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,VPS36
fatty acid omega-oxidation (GO:0010430),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ADH5
female genitalia development (GO:0030540),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LRP2
forebrain regionalization (GO:0021871),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,WNT7B
"fructose 2,6-bisphosphate metabolic process (GO:0006003)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PFKFB3
fructose catabolic process (GO:0006001),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KHK
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KHK
glucuronate catabolic process (GO:0006064),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,AKR1A1
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,AKR1A1
glutamate catabolic process (GO:0006538),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GLUD1
glutathione transport (GO:0034635),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MGST1
glycerol biosynthetic process (GO:0006114),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GOT1
heart field specification (GO:0003128),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LRP2
His-Purkinje system development (GO:0003164),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ID2
histone H3-K27 demethylation (GO:0071557),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KDM7A
histone H4-K20 methylation (GO:0034770),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BEND3
histone H4-K20 trimethylation (GO:0034773),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BEND3
insulin metabolic process (GO:1901142),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,IDE
isocitrate metabolic process (GO:0006102),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,IDH3A
L-arginine import across plasma membrane (GO:0097638),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC7A3
L-aspartate transmembrane transport (GO:0070778),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC1A3
L-phenylalanine catabolic process (GO:0006559),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FAH
late endosome to lysosome transport (GO:1902774),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ARL8B
lipid transport across blood-brain barrier (GO:1990379),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FABP5
long-chain fatty acid catabolic process (GO:0042758),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ACADL
lymph node development (GO:0048535),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PDPN
maintenance of animal organ identity (GO:0048496),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PKP2
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,EDEM1
mature conventional dendritic cell differentiation (GO:0097029),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,F2RL1
meiotic mismatch repair (GO:0000710),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ERCC1
membrane depolarization during SA node cell action potential (GO:0086046),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ANK2
mesonephric duct development (GO:0072177),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GPC3
metanephric epithelium development (GO:0072207),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,WNT7B
mitochondrial DNA repair (GO:0043504),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PARP1
mitochondrial tRNA methylation (GO:0070901),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HSD17B10
mRNA cleavage (GO:0006379),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,CPSF3
mRNA cleavage involved in gene silencing by miRNA (GO:0035279),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,AGO2
negative regulation of autophagosome maturation (GO:1901097),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,UBQLN4
negative regulation of B cell differentiation (GO:0045578),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ID2
negative regulation of calcium ion-dependent exocytosis (GO:0045955),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,REST
negative regulation of cellular respiration (GO:1901856),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PDE12
negative regulation of cGMP-mediated signaling (GO:0010754),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,THBS1
negative regulation of collateral sprouting (GO:0048671),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PTPRS
negative regulation of gonadotropin secretion (GO:0032277),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GJA1
negative regulation of heterochromatin assembly (GO:0031452),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TET1
negative regulation of interferon-alpha production (GO:0032687),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PTPRS
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HSPA5
negative regulation of lipid transport (GO:0032369),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FIS1
negative regulation of macrophage chemotaxis (GO:0010760),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MIF
negative regulation of macrophage cytokine production (GO:0010936),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
negative regulation of mast cell activation involved in immune response (GO:0033007),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ENPP3
negative regulation of metallopeptidase activity (GO:1905049),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TIMP2
negative regulation of myelination (GO:0031642),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TMEM98
negative regulation of protein acetylation (GO:1901984),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PARK7
negative regulation of regulatory T cell differentiation (GO:0045590),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MDK
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TMSB4X
negative regulation of skeletal muscle cell differentiation (GO:2001015),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SIX4
negative regulation of transcription by RNA polymerase I (GO:0016479),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FLNA
negative regulation of transforming growth factor beta1 production (GO:0032911),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LAPTM4B
negative regulation of tubulin deacetylation (GO:1904428),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BEX4
negative regulation of vascular endothelial cell proliferation (GO:1905563),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FLT1
negative regulation of vitamin D biosynthetic process (GO:0010957),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NFKB1
neuroinflammatory response (GO:0150076),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGB1
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FZD7
nucleoside transport (GO:0015858),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC29A1
ornithine transport (GO:0015822),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC7A3
oxidative DNA demethylation (GO:0035511),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TDG
pentose catabolic process (GO:0019323),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT5
peptidyl-cysteine S-nitrosylation (GO:0018119),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GAPDH
peptidyl-lysine oxidation (GO:0018057),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LOXL2
plus-end-directed vesicle transport along microtubule (GO:0072383),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KIF13A
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LARP4B
positive regulation of amine transport (GO:0051954),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GRK2
positive regulation of anoikis (GO:2000210),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PTRH2
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DAG1
positive regulation of bicellular tight junction assembly (GO:1903348),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,CLDN3
positive regulation of cardioblast differentiation (GO:0051891),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RBPJ
positive regulation of DNA ligation (GO:0051106),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HMGB1
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
positive regulation of gamma-delta T cell activation (GO:0046645),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SOX4
positive regulation of glial cell proliferation (GO:0060252),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PRKCI
positive regulation of Golgi to plasma membrane protein transport (GO:0042998),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RACK1
positive regulation of hippo signaling (GO:0035332),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SOX11
positive regulation of histone ubiquitination (GO:0033184),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,KDM1A
positive regulation of interleukin-18 production (GO:0032741),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DHX9
positive regulation of neutrophil extravasation (GO:2000391),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MDK
positive regulation of prostaglandin secretion (GO:0032308),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PLA2G10
positive regulation of protein localization to cell cortex (GO:1904778),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,EPB41L2
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,HMGB1
proline biosynthetic process (GO:0006561),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PYCR2
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DPY19L1
protein C-linked glycosylation via tryptophan (GO:0018317),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DPY19L1
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,EDEM1
protein K29-linked deubiquitination (GO:0035523),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ZRANB1
protein K69-linked ufmylation (GO:1990592),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,UFM1
protein localization to microtubule end (GO:1905725),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MAPRE1
protein localization to microtubule plus-end (GO:1904825),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MAPRE1
protein polyufmylation (GO:1990564),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,UFM1
protein processing involved in protein targeting to mitochondrion (GO:0006627),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PMPCB
protein retention in Golgi apparatus (GO:0045053),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GOLPH3
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,VPS36
pulmonary artery morphogenesis (GO:0061156),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LRP2
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DUT
pyrimidine nucleoside transport (GO:0015864),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC29A1
pyrimidine ribonucleotide metabolic process (GO:0009218),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,AK3
regulation of adherens junction organization (GO:1903391),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RDX
regulation of antifungal innate immune response (GO:1905034),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,USP15
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,DAG1
regulation of cardioblast differentiation (GO:0051890),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
regulation of cell proliferation involved in heart morphogenesis (GO:2000136),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RBPJ
regulation of chloride transport (GO:2001225),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PRNP
regulation of circadian sleep/wake cycle (GO:0042749),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PER3
regulation of endothelial tube morphogenesis (GO:1901509),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FOXP1
regulation of germinal center formation (GO:0002634),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RC3H1
regulation of glomerular mesangial cell proliferation (GO:0072124),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PDGFB
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,STMN1
regulation of hippocampal neuron apoptotic process (GO:0110089),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGAM
regulation of histone H3-K9 trimethylation (GO:1900112),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ATRX
regulation of inositol trisphosphate biosynthetic process (GO:0032960),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PTK2B
regulation of integrin biosynthetic process (GO:0045113),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
regulation of intracellular cholesterol transport (GO:0032383),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUS1
regulation of inward rectifier potassium channel activity (GO:1901979),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGB1
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ANXA2
regulation of lyase activity (GO:0051339),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PHPT1
regulation of microglial cell mediated cytotoxicity (GO:1904149),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGAM
regulation of microvillus assembly (GO:0032534),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PODXL
regulation of miRNA catabolic process (GO:2000625),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LIN28B
regulation of morphogenesis of a branching structure (GO:0060688),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FGFR2
regulation of neutrophil degranulation (GO:0043313),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ITGAM
regulation of phosphatidylinositol biosynthetic process (GO:0010511),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PDGFB
regulation of phosphatidylinositol dephosphorylation (GO:0060304),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MTMR2
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PTPN12
regulation of postsynaptic density organization (GO:1905874),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,CRIPT
regulation of receptor catabolic process (GO:2000644),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MTMR2
regulation of ribonuclease activity (GO:0060700),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NPM1
regulation of skeletal muscle tissue development (GO:0048641),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,FLOT1
regulation of sterol transport (GO:0032371),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TSPO
regulation of system process (GO:0044057),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ROCK2
regulation of systemic arterial blood pressure by endothelin (GO:0003100),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ECE1
response to acetylcholine (GO:1905144),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ROCK2
response to salt stress (GO:0009651),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ZFP36L1
ribose phosphate metabolic process (GO:0019693),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NUDT5
RNA import into mitochondrion (GO:0035927),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,MRPL18
Roundabout signaling pathway (GO:0035385),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,RHOA
rRNA 5'-end processing (GO:0000967),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,NOP9
SA node cell to atrial cardiac muscle cell signaling (GO:0086018),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,ANK2
salivary gland development (GO:0007431),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
Schwann cell differentiation (GO:0014037),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,GPC1
secondary heart field specification (GO:0003139),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,LRP2
striated muscle cell proliferation (GO:0014855),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,TGFB2
T cell extravasation (GO:0072683),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,F11R
thorax and anterior abdomen determination (GO:0007356),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BASP1
transcription initiation from RNA polymerase III promoter (GO:0006384),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BDP1
tricuspid valve development (GO:0003175),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BMPR1A
tricuspid valve morphogenesis (GO:0003186),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BMPR1A
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,EDEM1
uridine transport (GO:0015862),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,SLC29A1
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,PDCD6
xylulose 5-phosphate biosynthetic process (GO:1901159),05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,AKR1A1
"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",05-Jan,0.711415073,0.999996398,0,0,0.886079545,0.301709404,BASP1
regulation of protein modification process (GO:0031399),10/51,0.712591519,0.999996398,0,0,0.864184502,0.292826262,PPP2CA;SPRED2;SPRED1;IGF2;PHIP;PPIB;MT3;PML;PUM3;CORO1C
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),27/133,0.714914689,0.999996398,0,0,0.902224552,0.302779396,ITGB1;DDX5;USP15;PTPRK;F11R;UBB;ZMIZ2;UBC;RPS27A;MAPK3;JUN;TGFB2;LEFTY1;USP9X;FOXH1;BMP8B;CGN;SMAD5;RHOA;SMAD7;DUSP22;FKBP1A;TWSG1;ID1;ZYX;FERMT2;BMPR1A
negative regulation of cell motility (GO:2000146),23/114,0.71635077,0.999996398,0,0,0.895295659,0.298657497,CLIC4;DUSP3;TPM1;TACSTD2;PTEN;MIA3;SPINT2;MIF;PTPRK;GTPBP4;SMAD7;DUSP22;AFDN;CLDN3;SFRP2;RAP2B;STK24;CDH1;STK26;DAG1;ARID2;EPHA1;CRK
dendritic spine morphogenesis (GO:0060997),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,CDC42;PTEN;WASL
digestive tract morphogenesis (GO:0048546),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,ID2;SOX11;FGFR2
male meiosis I (GO:0007141),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,DNMT3L;DDX4;MEIOC
negative regulation of anoikis (GO:2000811),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,ITGB1;PTRH2;MCL1
negative regulation of histone modification (GO:0031057),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,SET;NOC2L;JARID2
negative regulation of lyase activity (GO:0051350),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,GNAI3;AKAP5;PHPT1
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,PPP2CA;INPP5F;ADIPOR1
negative regulation of telomere maintenance (GO:0032205),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,PARP1;TNKS2;ERCC1
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,YTHDF2;CNOT7;SAMHD1
neuron projection organization (GO:0106027),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,APP;PRNP;ARF1
oligodendrocyte development (GO:0014003),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,EIF2B3;MYRF;EIF2B1
platelet-derived growth factor receptor signaling pathway (GO:0048008),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,PDGFB;PIK3C2A;BCAR1
positive regulation of endothelial cell apoptotic process (GO:2000353),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,PRKCI;ECSCR;THBS1
positive regulation of immunoglobulin mediated immune response (GO:0002891),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,RIF1;TFRC;NECTIN2
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,MDK;ETS1;RHOA
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,EHD2;FLOT1;MAPK14
regulation of activin receptor signaling pathway (GO:0032925),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,FKBP1A;IGSF1;SMAD7
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,FGFBP1;PDCD10;THBS1
regulation of cellular carbohydrate metabolic process (GO:0010675),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,BCKDK;ADIPOR1;PDK1
regulation of ceramide biosynthetic process (GO:2000303),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,SAMD8;RACK1;PLA2G6
regulation of defense response to virus (GO:0050688),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,DHX9;C1QBP;PCBP2
regulation of hormone secretion (GO:0046883),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,SOX11;SNX6;VAMP3
regulation of leukocyte activation (GO:0002694),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,PLA2G10;MYO18A;MIF
regulation of monocyte differentiation (GO:0045655),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,MYC;FOXP1;ZFP36L1
regulation of phosphate metabolic process (GO:0019220),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,MCM7;PGAM1;SMG7
serine family amino acid metabolic process (GO:0009069),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,GCLC;MTHFD1;PSPH
sympathetic nervous system development (GO:0048485),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,CTNNB1;SOX11;SOX4
transepithelial transport (GO:0070633),16-Mar,0.717571299,0.999996398,0,0,0.817819288,0.27142029,SLC23A1;SLC1A3;ABCG2
iron ion homeostasis (GO:0055072),12/61,0.717596912,0.999996398,0,0,0.867660803,0.28793087,ATP6V1G1;CAND1;TFRC;GLRX3;FTH1;MYC;BOLA2;SLC40A1;CUL1;NEDD8;ERFE;ABCG2
intracellular protein transport (GO:0006886),70/336,0.719469673,0.999996398,0,0,0.931655507,0.306739101,IPO13;USP6NL;VPS29;ARF4;ARF1;NUP107;CSE1L;PDCD6;CLTC;HIKESHI;PHB2;IPO5;XPO1;IPO9;ARL5C;XPO4;KIF13A;TMED3;TMED2;CHP1;TLK1;EIF2D;TNPO1;VPS36;ARL5A;YWHAH;SEC13;TMED9;COG7;STX7;NUTF2;COPZ1;CLIP3;ARL4C;ARL4A;RAB31;CTTN;CDC37;ARHGEF2;NUP62CL;ARF5;KPNB1;ARF6;COPB2;POM121;RABGAP1;TMED10;SAR1A;RPL11;USO1;SNX27;NUP85;TPR;RAB6A;AP1M2;TBC1D15;SEC31A;SNX6;NPM1;SEC16A;SURF4;XPO7;NUP153;ARCN1;MYO1C;RAB14;RAB18;RAB3GAP2;CALR;RAN
cellular component assembly (GO:0022607),54/261,0.719866138,0.999996398,0,0,0.923695502,0.303609478,NCKAP1;SLC2A1;WASL;NOC2L;ESPN;ACTB;ACTG1;ELOB;RAC1;DNM1L;TEAD1;KPNA3;CARD10;STX7;SHROOM2;YWHAZ;RHOA;CD2AP;TAPBP;PKP2;GEMIN5;RHOU;PPIH;EZR;PPID;VAMP3;CCDC40;YAP1;KMT2A;CDC42;PARD6B;PDCD10;CALD1;RAD21;TSPAN4;FLNA;PTK2B;FLNC;SPTBN1;MDN1;YTHDF1;GSN;YTHDF2;ST13;PARVA;GRHL2;PML;AIF1L;VMP1;CAPZA1;CAPZA2;MNAT1;FERMT2;LIMS1
regulation of G1/S transition of mitotic cell cycle (GO:2000045),14/71,0.723039661,0.999996398,0,0,0.870146645,0.282180902,DDX3X;PRMT2;FHL1;RDX;PTEN;UBE2E2;CDC73;TFDP1;ADAMTS1;CDK4;PSME3;ID2;PSME2;E2F7
dephosphorylation (GO:0016311),31/153,0.728786237,0.999996398,0,0,0.899926848,0.284714193,MTMR2;PTPRS;PTEN;PTPRK;PTPRF;CDC14B;PPP1CB;NT5C;PPP2CA;PPP2CB;PPP3CB;PPP4R1;PPP2R1B;PPP2R5E;PSPH;DUSP3;PPP1R12A;DUSP1;PPP2R5A;PPP2R5C;PTPN12;HDHD2;DUSP9;PTPN14;DUSP6;PPP1CA;SDHAF2;PTPRA;PHPT1;PLPP2;PTPN3
response to endoplasmic reticulum stress (GO:0034976),22/110,0.729377789,0.999996398,0,0,0.885533227,0.279441923,PDIA3;VCP;JUN;CEBPB;HSPA5;SEC16A;ITPR1;ATP2A2;SELENOK;EIF2S1;THBS1;HSP90B1;BBC3;TMCO1;RCN3;UFM1;BCL2L11;FLOT1;UBQLN1;BAX;P4HB;CDK5RAP3
positive regulation of macromolecule metabolic process (GO:0010604),80/384,0.730667974,0.999996398,0,0,0.931497339,0.292300261,APP;RPL5;GSK3A;DDX3X;TFRC;CELF1;PDCD5;ARRB1;ECE1;PARK7;PIK3CB;RBPJ;CLU;ETS1;ACTG1;GJA1;HMGN5;TRIM28;MYC;LAMP3;DNMT3B;MED1;ANXA2;RPS7;IFNGR1;DDX58;RPL23;ANK2;SOX11;PPHLN1;POU3F1;F3;ACTA2;ACTA1;CLDN3;MYCN;EZR;VAMP3;YAP1;MTPN;RAMP3;ROCK1;ROCK2;HPN;RPL11;PDGFB;PHB;HIF1A;MAPK8;INPP5F;PDCD10;UBR5;RPS3;MBIP;MAPK1;SLC38A2;MAPK3;SRPK2;ATAD1;GSN;RDX;RAB27A;MSN;BRAF;MAPK14;MT3;FGF17;PDCL3;AFDN;AHI1;FUBP3;SP1;FUBP1;ID2;AGO2;SPRY2;FAM98B;KRAS;MPHOSPH8;LIMS1
atrial septum morphogenesis (GO:0060413),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,TGFB2;SOX4
calcineurin-NFAT signaling cascade (GO:0033173),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PPP3CB;PPP3R1
carnitine shuttle (GO:0006853),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MID1IP1;ACACA
cellular response to increased oxygen levels (GO:0036295),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,ATP6V1G1;FOXO1
columnar/cuboidal epithelial cell differentiation (GO:0002065),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,SOX11;SOX4
desensitization of G protein-coupled receptor signaling pathway (GO:0002029),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,GRK2;ARRB1
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,RPS6KA6;RPS27L
erythrocyte development (GO:0048821),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MED1;LYAR
glycerol metabolic process (GO:0006071),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,TPI1;GOT1
hematopoietic stem cell proliferation (GO:0071425),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,SFRP2;YTHDF2
inositol phosphate dephosphorylation (GO:0046855),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PTEN;SYNJ2
insulin-like growth factor receptor signaling pathway (GO:0048009),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,GIGYF2;IGF1R
interleukin-35-mediated signaling pathway (GO:0070757),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,CANX;JAK1
isotype switching (GO:0045190),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,EXOSC3;HSPD1
lipoprotein biosynthetic process (GO:0042158),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PORCN;WIPI1
lipoprotein localization (GO:0044872),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,VMP1;MIA3
metanephric mesenchyme development (GO:0072075),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,SIX4;BASP1
midbrain dopaminergic neuron differentiation (GO:1904948),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,RYK;CTNNB1
mitochondrial protein processing (GO:0034982),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PMPCB;YME1L1
mitochondrial transcription (GO:0006390),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,TFAM;MRPL12
monocyte differentiation (GO:0030224),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PIR;MYH9
myotube cell development (GO:0014904),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,ACTA1;SELENON
negative regulation of activated T cell proliferation (GO:0046007),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PRNP;RC3H1
negative regulation of cholesterol transport (GO:0032375),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PLA2G10;NFKB1
negative regulation of defense response to virus (GO:0050687),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,C1QBP;PCBP2
negative regulation of homotypic cell-cell adhesion (GO:0034111),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,SERPINE2;RDX
negative regulation of lymphocyte migration (GO:2000402),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MIA3;WASL
negative regulation of protein localization to cell surface (GO:2000009),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,GOPC;COMMD1
negative regulation of T-helper cell differentiation (GO:0045623),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,RC3H1;SMAD7
PERK-mediated unfolded protein response (GO:0036499),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,HSPA5;EIF2S1
phosphorylated carbohydrate dephosphorylation (GO:0046838),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PTEN;SYNJ2
positive regulation of cellular extravasation (GO:0002693),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PLVAP;MDK
positive regulation of ceramide biosynthetic process (GO:2000304),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,RACK1;PLA2G6
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,FBXW7;HBEGF
positive regulation of keratinocyte proliferation (GO:0010838),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,TGM1;MDK
positive regulation of lipid localization (GO:1905954),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PLA2G10;NFKB1
positive regulation of neuroblast proliferation (GO:0002052),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,KDM1A;CTNNB1
positive regulation of phospholipid transport (GO:2001140),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PRELID1;DBI
positive regulation of sphingolipid biosynthetic process (GO:0090154),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,RACK1;PLA2G6
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,CEBPB;HSPA5
positive regulation of transforming growth factor beta production (GO:0071636),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,THBS1;BMPR1A
regulation of amyloid precursor protein biosynthetic process (GO:0042984),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,SOAT1;AGO2
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,CAMK2D;SESTD1
regulation of cardiac muscle cell differentiation (GO:2000725),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,EFNB2;FZD7
regulation of coagulation (GO:0050818),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,F2R;F2RL1
regulation of lamellipodium morphogenesis (GO:2000392),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PDPN;CORO1C
regulation of mesenchymal cell proliferation (GO:0010464),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MYC;FGFR2
regulation of mitochondrial depolarization (GO:0051900),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MLLT11;RACK1
regulation of phospholipase activity (GO:0010517),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,FGFR2;FGFR1
regulation of stress-activated protein kinase signaling cascade (GO:0070302),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,MAPK1;MAPK3
regulation of synapse maturation (GO:0090128),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,CDC20;YWHAZ
regulation of toll-like receptor 9 signaling pathway (GO:0034163),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,PTPRS;HMGB1
response to prostaglandin E (GO:0034695),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,GNG2;GNB1
telomere maintenance via recombination (GO:0000722),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,ERCC1;SMC6
vasoconstriction (GO:0042310),11-Feb,0.73346096,0.999996398,0,0,0.787552727,0.244126309,ACTA2;PIK3C2A
cellular respiration (GO:0045333),8/42,0.735023033,0.999996398,0,0,0.833679249,0.256651027,SURF1;NDUFA5;BLOC1S1;MDH2;CYCS;NDUFS1;SDHAF4;MTFR1L
regulation of double-strand break repair (GO:2000779),8/42,0.735023033,0.999996398,0,0,0.833679249,0.256651027,ACTR2;PPP4C;KDM1A;UBR5;SPIRE1;TRIP12;DEK;PML
acyl-CoA metabolic process (GO:0006637),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,HMGCS1;ACOT2;OGDH;DLST;ACOT13;DBI;ACACA
anterograde axonal transport (GO:0008089),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,AP3M1;SNAPIN;BLOC1S1;KIF5B;KIF1B;KIF1A;MGARP
glutamine family amino acid metabolic process (GO:0009064),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,GLUD1;GCLC;GOT1;PYCR2;GCLM;NIT2;GLS
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,PLK3;PRMT2;CDK4;FHL1;PTEN;CDC73;E2F7
"phagocytosis, engulfment (GO:0006911)",7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,CDC42;ITGAM;GSN;MYH9;RAC1;THBS1;ARHGAP12
positive regulation of exocytosis (GO:0045921),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,TSG101;PDCD6IP;RAB15;VPS4B;CHMP2A;RAB27A;SDC1
regulation of erythrocyte differentiation (GO:0045646),7/37,0.735397425,0.999996398,0,0,0.826756183,0.254098727,HSPA9;MED1;ZFP36;MAPK14;ETS1;HIF1A;ZFP36L1
response to peptide hormone (GO:0043434),10/52,0.736338173,0.999996398,0,0,0.843554457,0.258183163,EIF2B3;XBP1;CREB1;ROCK1;EIF6;ROCK2;SORT1;EIF2B1;KHK;ZFP36L1
sprouting angiogenesis (GO:0002040),10/52,0.736338173,0.999996398,0,0,0.843554457,0.258183163,EFNB2;PTK2B;MIA3;SEMA3E;PARVA;THBS1;TDGF1;E2F7;LOXL2;E2F8
cellular response to topologically incorrect protein (GO:0035967),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,HSPA9;HSPA8;HSPA5;BAX;TMBIM6;OPTN
endodermal cell differentiation (GO:0035987),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,MMP14;COL4A2;LEO1;LAMB1;RTF1;CDC73
intra-Golgi vesicle-mediated transport (GO:0006891),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,COPB2;COPB1;GOSR2;RAB6A;COPZ1;VTI1B
negative regulation of cell-matrix adhesion (GO:0001953),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,DUSP22;RCC2;PTEN;SEMA3E;THBS1;CORO1C
negative regulation of DNA biosynthetic process (GO:2000279),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,STN1;GNL3L;HNRNPU;NAT10;HNRNPC;HNRNPA1
negative regulation of double-strand break repair (GO:2000780),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,SMCHD1;RIF1;UBR5;TRIP12;NUDT16L1;UBQLN4
protein K63-linked deubiquitination (GO:0070536),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,OTUD4;USP25;USP7;ZRANB1;PSMD14;BRCC3
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,CARD10;FGFBP1;PDCD10;PIK3C2A;THBS1;RHOA
regulation of dendritic spine morphogenesis (GO:0061001),6/32,0.736892963,0.999996398,0,0,0.817694933,0.249652591,ABI2;CAPRIN1;CFL1;PTEN;KIF1A;DBN1
glucose metabolic process (GO:0006006),12/62,0.739239634,0.999996398,0,0,0.850252905,0.256889582,TPI1;GOT1;MDH1;MDH2;PGAM1;AKR1A1;PGK1;ENO1;ALDOA;ENO3;SLC39A14;GAPDH
melanosome organization (GO:0032438),27-May,0.740103641,0.999996398,0,0,0.805329225,0.242375948,TRAPPC6A;SNAPIN;BLOC1S1;KIF13A;SHROOM2
regulation of Wnt signaling pathway (GO:0030111),22/111,0.745411676,0.999996398,0,0,0.875526966,0.257246132,APP;ZRANB1;CSNK2A1;ITGA3;FZD7;CDC73;SMARCA4;PPP1CA;PPP2CA;SFRP2;HMGXB4;PTK7;TMEM237;RACK1;SPIN1;GPC3;DACT3;CTNNB1;CDK14;EMD;FOLR1;FGFR2
amino acid import (GO:0043090),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,SLC6A6;SLC1A3;SFXN1;SLC16A2
glutathione derivative biosynthetic process (GO:1901687),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,MGST3;ESD;AKR1A1;MGST1
glutathione derivative metabolic process (GO:1901685),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,MGST3;ESD;AKR1A1;MGST1
heme biosynthetic process (GO:0006783),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,PGRMC1;CPOX;TSPO;ABCG2
lipid droplet organization (GO:0034389),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,SQLE;RAB18;PPIA;PPID
microglial cell activation (GO:0001774),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,APP;ITGAM;IFNGR1;CLU
mitochondrial calcium ion homeostasis (GO:0051560),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,FIS1;RAP1GDS1;ANXA6;PDZD8
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,CDKN1C;LATS2;PTEN;IPO5
negative regulation of small molecule metabolic process (GO:0062014),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,BCKDK;GSK3A;EP300;ERFE
organelle fusion (GO:0048284),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,FIS1;CHCHD3;MIGA1;BAX
osteoclast differentiation (GO:0030316),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,ANXA2;GLO1;MAPK14;FOXP1
phosphatidylserine acyl-chain remodeling (GO:0036150),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,PLA2G12A;PLA2G1B;PLA2G10;MBOAT1
positive regulation of granulocyte chemotaxis (GO:0071624),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,MDK;C1QBP;RAC1;DNM1L
positive regulation of neutrophil migration (GO:1902624),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,MDK;C1QBP;RAC1;DNM1L
protein import into peroxisome membrane (GO:0045046),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,ATAD1;FIS1;PEX19;PEX2
regulation of chromosome organization (GO:0033044),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,MYC;HNRNPD;BUB1;WAPL
regulation of lipid storage (GO:0010883),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,FBXW7;PLA2G10;MEST;NFKB1
regulation of vacuole organization (GO:0044088),22-Apr,0.746095373,0.999996398,0,0,0.787456094,0.23064734,LAPTM4B;ANXA2;ENO1;ENO3
protein targeting to membrane (GO:0006612),17/87,0.749401334,0.999996398,0,0,0.860248306,0.248164958,ATAD1;SRP19;FIS1;TRAM1;PRKCI;PEX19;ZDHHC20;SSR2;ZDHHC6;PEX2;SRP14;SEC61A1;MYO1C;NACA;SSR1;SEC62;GOLGA7
negative regulation of intracellular signal transduction (GO:1902532),40/198,0.755989348,0.999996398,0,0,0.896380171,0.250742626,URI1;GSK3A;DGKD;DDX3X;PDCD6;WWC1;PDE3B;ITPR1;PTEN;PEBP1;PIK3CB;NOC2L;LIMD1;ADIPOR1;THBS1;ARHGAP12;SPRED1;TMSB4X;DAG1;RACK1;MARK3;CGNL1;MCL1;DUSP3;PLEKHA1;UBE2B;DUSP1;RIOK3;PLAUR;PPP2R5C;MAPK14;CD2AP;CDC34;PIK3IP1;DDIT4;TBC1D7;MYADM;TRIM59;AJUBA;BCL2L1
cell junction assembly (GO:0034329),20/102,0.756221607,0.999996398,0,0,0.863874491,0.241384514,RYK;CTNND1;PTEN;GRHL2;ACTB;RHOA;ACTG1;CDC42;TJP1;VMP1;PARD6B;CDH1;CAPZA1;PKP2;FLNA;ITGA6;FLNC;TLN1;FERMT2;LIMS1
negative regulation of amyloid-beta formation (GO:1902430),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,PRNP;ROCK1;CLU
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,KDM1A;TAF9;MIF
negative regulation of phagocytosis (GO:0050765),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,SYT11;RACK1;HMGB1
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,CNN1;TPM1;PTEN
positive regulation of blood coagulation (GO:0030194),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,F2R;F3;THBS1
positive regulation of cardiac muscle tissue growth (GO:0055023),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,RBPJ;FGFR2;BMPR1A
positive regulation of stem cell differentiation (GO:2000738),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,TGFB2;TCF15;TACSTD2
positive regulation of transcription of Notch receptor target (GO:0007221),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,WWC1;EP300;RBPJ
preassembly of GPI anchor in ER membrane (GO:0016254),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,PIGQ;PIGM;PIGF
protein heterooligomerization (GO:0051291),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,CPSF6;MAT2A;FARSB
purine ribonucleotide transport (GO:0015868),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,SLC25A4;SLC19A1;SLC25A24
pyrimidine-containing compound catabolic process (GO:0072529),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,NT5C;DPYSL2;CRMP1
regulation of cellular respiration (GO:0043457),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,PRELID1;VCP;IDE
regulation of cellular response to growth factor stimulus (GO:0090287),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,TWSG1;ITGA3;FSTL1
regulation of metal ion transport (GO:0010959),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,ANK2;SRI;CAMK2G
regulation of osteoblast proliferation (GO:0033688),17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,PLXNB1;RHOA;FGFR2
"retrograde protein transport, ER to cytosol (GO:0030970)",17-Mar,0.756999119,0.999996398,0,0,0.759354902,0.211399233,VCP;SEC61B;HSP90B1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),10/53,0.758733825,0.999996398,0,0,0.823883949,0.227477863,YWHAE;BEX3;DDX3X;CSNK2A1;LAMP3;RPS6KA1;SFN;DHCR24;THBS1;MT3
positive regulation of NIK/NF-kappaB signaling (GO:1901224),10/53,0.758733825,0.999996398,0,0,0.823883949,0.227477863,APP;DDX3X;RPS3;EP300;ACTN4;PHB;PHB2;RHOA;TRIM44;LIMS1
base-excision repair (GO:0006284),9/48,0.758917903,0.999996398,0,0,0.817570408,0.22553634,PCNA;RFC4;PARP1;RFC1;RFC2;TDG;RPA3;HUWE1;RPA1
histone H4 acetylation (GO:0043967),9/48,0.758917903,0.999996398,0,0,0.817570408,0.22553634,MORF4L1;KMT2A;RUVBL2;MORF4L2;RUVBL1;HAT1;BEND3;EP300;JADE2
muscle organ development (GO:0007517),11/58,0.759055676,0.999996398,0,0,0.829118403,0.228571485,SGCE;FXR1;TAGLN;EVC;FHL1;SPEG;SRI;UTRN;EMD;MAPK12;HBEGF
positive regulation of Ras protein signal transduction (GO:0046579),12/63,0.75975854,0.999996398,0,0,0.833527669,0.229015567,PRAG1;SHC1;LPAR6;F2R;F2RL1;ARRB1;SHOC2;PIK3CB;RAC1;LPAR4;F11R;RASGRP4
myofibril assembly (GO:0030239),8/43,0.759785928,0.999996398,0,0,0.809807811,0.222469235,KRT19;CSRP2;WDR1;SIX4;TMOD3;TMOD2;TPM1;CFLAR
tRNA aminoacylation for protein translation (GO:0006418),8/43,0.759785928,0.999996398,0,0,0.809807811,0.222469235,AIMP1;AIMP2;LARS2;PPA1;DARS2;IARS2;EEF1E1;FARSB
positive regulation of production of molecular mediator of immune response (GO:0002702),7/38,0.761600229,0.999996398,0,0,0.800035239,0.217876393,TRIM6;XBP1;F2RL1;PHB;PHB2;IL2;VAMP3
ventricular septum development (GO:0003281),7/38,0.761600229,0.999996398,0,0,0.800035239,0.217876393,TGFB2;HECTD1;SOX11;MATR3;SOX4;SMAD7;BMPR1A
negative regulation of cell adhesion (GO:0007162),14/73,0.761970546,0.999996398,0,0,0.840541971,0.22849913,CD164;SEMA6A;DUSP1;FZD7;PDE3B;MIA3;SPINT2;GTPBP4;RHOA;CDH1;MDK;PODXL;ARHGDIA;PLXNB1
positive regulation of JNK cascade (GO:0046330),14/73,0.761970546,0.999996398,0,0,0.840541971,0.22849913,APP;GADD45A;FZD7;WNT7B;HMGB1;MAPK8IP1;GADD45G;DUSP22;TRAF4;TAOK3;TAOK1;MBIP;PTK2B;F2RL1
actin filament bundle assembly (GO:0051017),6/33,0.764763822,0.999996398,0,0,0.787359373,0.21116051,CALD1;SHROOM2;ESPN;EZR;HSP90B1;AIF1L
phosphatidylcholine biosynthetic process (GO:0006656),6/33,0.764763822,0.999996398,0,0,0.787359373,0.21116051,PCYT1B;CHKA;CSNK2A1;SLC44A2;CSNK2A2;PCTP
positive regulation of peptidyl-serine phosphorylation (GO:0033138),18/93,0.768246015,0.999996398,0,0,0.850047912,0.224111107,APP;HSP90AA1;HSP90AB1;RAMP3;TFRC;DOCK7;BRAF;PARK7;MIF;STK4;TRIM6;PAK1;HAX1;SFRP2;PDCD10;AKAP9;SPRY2;CNOT9
regulation of epithelial cell proliferation (GO:0050678),18/93,0.768246015,0.999996398,0,0,0.850047912,0.224111107,CDKN1C;YAP1;TGFB2;HPN;NME2;PEX2;LAMB1;CDC73;MTSS1;NME1;ZFP36L1;ZFP36;SFRP2;SIX4;MYC;SRSF6;FGFR2;LIMS1
cellular response to interleukin-6 (GO:0071354),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,YAP1;PHB;TDGF1;NFKB1;JAK1
leukocyte cell-cell adhesion (GO:0007159),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,ITGB1;ROCK1;MSN;F11R;EZR
macromolecule catabolic process (GO:0009057),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,SH3GLB1;NEDD4;IDE;UCHL3;CLN6
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,UBB;UBC;UBE2N;UBE2V1;RPS27A
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,CALCA;LPAR6;F2R;F2RL1;LPAR4
positive regulation of monooxygenase activity (GO:0032770),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,DHFR;NUS1;PARK7;PIK3CB;HIF1A
protein localization to cell surface (GO:0034394),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,FLNA;CTNNB1;ANK2;PTPRK;ARF6
regulation of immunoglobulin production (GO:0002637),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,XBP1;PHB;PHB2;IL2;VAMP3
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,KLF7;PPP3CB;PIM3;EFNA5;PLA2G6
regulation of neuron migration (GO:2001222),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,SEMA6A;MDK;PLAA;ARHGEF2;KIF20B
regulation of protein transport (GO:0051223),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,RHBDF1;HSPA8;RHBDF2;CHP1;GAPVD1
regulation of sodium ion transmembrane transport (GO:1902305),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,CAMK2D;COMMD1;UTRN;YWHAH;PTPN3
sarcomere organization (GO:0045214),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,KRT19;CSRP2;WDR1;SIX4;TPM1
ventricular septum morphogenesis (GO:0060412),28-May,0.769929709,0.999996398,0,0,0.770265459,0.201390568,TGFB2;SOX11;SOX4;SMAD7;BMPR1A
supramolecular fiber organization (GO:0097435),72/351,0.770511594,0.999996398,0,0,0.913270591,0.23809017,APP;COL18A1;HSP90AB1;STMN2;PPP1R9A;LOXL2;PCM1;SLK;MPRIP;STMN1;CHP1;RAC1;CGNL1;TPM4;DST;ACTN1;TMOD3;TPM2;TMOD2;TPM1;SHROOM2;RHOC;HSPG2;CKAP5;RHOA;SHROOM4;CD2AP;CLIP3;KIF2A;COL4A2;MAP7D3;COL4A1;PXDN;ITGA6;ARHGEF2;ALDOA;PPIB;DBN1;PLEC;CALCA;CD151;PLA2G1B;VPS4B;RHOBTB3;FIGNL2;FIGN;ARHGAP12;CORO1C;SPTA1;CDC42;UBB;UBC;SERPINH1;FSD1;RPS27A;CARMIL1;PLK3;TGFB2;MARCKSL1;GSN;USP9X;CRIPT;MYO5A;FKBP1A;TPPP3;MARCKS;BMP1;MYO1C;HOOK1;FAT1;P4HB;BCAR1
5S class rRNA transcription by RNA polymerase III (GO:0042791),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GTF3C6
activation of Janus kinase activity (GO:0042976),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PTK2B
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NRG1
adiponectin-activated signaling pathway (GO:0033211),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ADIPOR1
aminophospholipid transport (GO:0015917),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ATP11B
amylin receptor signaling pathway (GO:0097647),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAMP3
"anterior/posterior axis specification, embryo (GO:0008595)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TDGF1
aspartate metabolic process (GO:0006531),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GOT1
astrocyte development (GO:0014002),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MT3
cellular heat acclimation (GO:0070370),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RBBP7
cellular response to cold (GO:0070417),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FOXO1
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ZFP36
cellular response to lipoteichoic acid (GO:0071223),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MAPK14
cellular triglyceride homeostasis (GO:0035356),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,XBP1
choline catabolic process (GO:0042426),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ALDH7A1
choline transport (GO:0015871),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC44A2
chromatin organization involved in negative regulation of transcription (GO:0097549),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SMCHD1
dehydroascorbic acid transport (GO:0070837),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC23A1
dendrite extension (GO:0097484),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,LLPH
dermatan sulfate proteoglycan metabolic process (GO:0050655),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DSE
diadenosine polyphosphate catabolic process (GO:0015961),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NUDT4
double-strand break repair via classical nonhomologous end joining (GO:0097680),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,XRCC6
embryonic hindlimb morphogenesis (GO:0035116),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RARG
epithelial tube branching involved in lung morphogenesis (GO:0060441),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FGFR2
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ASRGL1
establishment of lymphocyte polarity (GO:0001767),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SNX27
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,UBB
gamma-aminobutyric acid transport (GO:0015812),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC6A6
glomerular epithelial cell differentiation (GO:0072311),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,BASP1
growth hormone secretion (GO:0030252),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,LTBP4
guanine nucleotide transmembrane transport (GO:1903790),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC19A1
heat acclimation (GO:0010286),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RBBP7
"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HS6ST2
histone H4-K12 acetylation (GO:0043983),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,JADE2
inner ear auditory receptor cell differentiation (GO:0042491),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC4A7
isoleucine metabolic process (GO:0006549),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HSD17B10
L-arginine transmembrane transport (GO:1903400),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC7A3
L-ornithine transmembrane transport (GO:1903352),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC7A3
leukocyte chemotaxis involved in inflammatory response (GO:0002232),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MDK
lymphocyte apoptotic process (GO:0070227),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,BAX
macromolecule biosynthetic process (GO:0009059),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,EIF4G2
magnesium ion homeostasis (GO:0010960),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CNNM4
megakaryocyte development (GO:0035855),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MED1
melanosome assembly (GO:1903232),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TRAPPC6A
metanephric collecting duct development (GO:0072205),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,WNT7B
metaphase/anaphase transition of cell cycle (GO:0044784),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CDC27
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CDC27
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FMC1
mitochondrial ribosome assembly (GO:0061668),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DHX30
multinuclear osteoclast differentiation (GO:0072674),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SH3PXD2A
negative regulation of actin filament depolymerization (GO:0030835),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GSN
negative regulation of amino acid transport (GO:0051956),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC43A2
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,AGO2
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GMFB
negative regulation of cardiac muscle cell apoptotic process (GO:0010667),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MDK
negative regulation of cardiac muscle cell differentiation (GO:2000726),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FZD7
negative regulation of cardiac muscle tissue growth (GO:0055022),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GSK3A
negative regulation of fat cell proliferation (GO:0070345),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TFDP1
negative regulation of fibroblast migration (GO:0010764),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAC1
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PHB
negative regulation of glycogen biosynthetic process (GO:0045719),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GSK3A
negative regulation of lipoprotein lipase activity (GO:0051005),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SORT1
negative regulation of mast cell activation (GO:0033004),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ENPP3
negative regulation of meiotic cell cycle (GO:0051447),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DUSP1
negative regulation of monocyte chemotaxis (GO:0090027),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DUSP1
negative regulation of morphogenesis of an epithelium (GO:1905331),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TACSTD2
negative regulation of myeloid cell apoptotic process (GO:0033033),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MAEA
negative regulation of relaxation of muscle (GO:1901078),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,GRK2
negative regulation of triglyceride metabolic process (GO:0090209),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FBXW7
negative regulation of vitamin metabolic process (GO:0046137),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NFKB1
nephron tubule development (GO:0072080),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MTSS1
"neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAB11A
norepinephrine biosynthetic process (GO:0042421),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MOXD1
peptide antigen assembly with MHC protein complex (GO:0002501),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CALR
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DPH3
peptidyl-diphthamide metabolic process (GO:0017182),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DPH3
peptidyl-glutamine methylation (GO:0018364),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TRMT112
peroxisome proliferator activated receptor signaling pathway (GO:0035357),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ACTN4
photoreceptor cell outer segment organization (GO:0035845),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,AHI1
piRNA biosynthetic process (GO:1990511),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DDX4
plasma membrane raft assembly (GO:0044854),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FLOT1
plus-end-directed organelle transport along microtubule (GO:0072386),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,KIF13A
positive regulation of animal organ morphogenesis (GO:0110110),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SIX4
positive regulation of anion transport (GO:1903793),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CEBPB
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PODXL
positive regulation of deacetylase activity (GO:0090045),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MAPK8
positive regulation of endothelial cell development (GO:1901552),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,F11R
positive regulation of establishment of endothelial barrier (GO:1903142),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,F11R
positive regulation of granulocyte differentiation (GO:0030854),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HAX1
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TPM1
positive regulation of histone phosphorylation (GO:0033129),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MAPK3
positive regulation of immune response to tumor cell (GO:0002839),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HSPD1
positive regulation of ion transmembrane transport (GO:0034767),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,WNK3
positive regulation of kidney development (GO:0090184),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MYC
positive regulation of lipoprotein particle clearance (GO:0010986),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ANXA2
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NECTIN2
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NECTIN2
positive regulation of protein glycosylation (GO:0060050),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CHP1
positive regulation of receptor binding (GO:1900122),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ANXA2
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HSPD1
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,F2RL1
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DDX3X
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MYO1C
"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DAB2
postsynaptic density assembly (GO:0097107),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PTEN
prepulse inhibition (GO:0060134),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PTEN
pronephros development (GO:0048793),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SEC61A1
protein geranylgeranylation (GO:0018344),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RABGGTB
protein localization to ciliary transition zone (GO:1904491),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TCTN2
protein localization to nuclear envelope (GO:0090435),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NUTF2
protein localization to perinuclear region of cytoplasm (GO:1905719),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HOOK1
protein repair (GO:0030091),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PCMT1
protein-DNA covalent cross-linking repair (GO:0106300),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,VCP
proton-transporting V-type ATPase complex assembly (GO:0070070),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TMEM9
pteridine-containing compound biosynthetic process (GO:0042559),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DHFR
regulation of adipose tissue development (GO:1904177),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,KLF7
regulation of cell cycle checkpoint (GO:1901976),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FEM1B
regulation of DNA-dependent DNA replication initiation (GO:0030174),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,WDR18
regulation of endoplasmic reticulum tubular network organization (GO:1903371),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAB3GAP2
regulation of glucagon secretion (GO:0070092),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,AIMP1
regulation of glucokinase activity (GO:0033131),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MIDN
regulation of glutamate receptor signaling pathway (GO:1900449),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PRNP
regulation of hormone biosynthetic process (GO:0046885),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,HIF1A
regulation of hydrogen peroxide metabolic process (GO:0010310),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAC1
regulation of immunoglobulin mediated immune response (GO:0002889),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NECTIN2
regulation of interleukin-1-mediated signaling pathway (GO:2000659),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,OTUD4
regulation of long-chain fatty acid import across plasma membrane (GO:0010746),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,THBS1
regulation of neutrophil extravasation (GO:2000389),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MDK
regulation of nitric oxide mediated signal transduction (GO:0010749),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,THBS1
regulation of protein autoubiquitination (GO:1902498),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RBX1
regulation of relaxation of cardiac muscle (GO:1901897),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,CAMK2D
regulation of resting membrane potential (GO:0060075),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,KCNK1
"regulation of retrograde transport, endosome to Golgi (GO:1905279)",06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,USP7
regulation of superoxide metabolic process (GO:0090322),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,DHFR
regulation of t-circle formation (GO:1904429),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ERCC1
regulation of translational elongation (GO:0006448),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,EIF5A
regulation of type B pancreatic cell proliferation (GO:0061469),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PTPRN
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SMAD7
regulation of vitamin D biosynthetic process (GO:0060556),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NFKB1
renal filtration cell differentiation (GO:0061318),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,BASP1
replication-born double-strand break repair via sister chromatid exchange (GO:1990414),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,RAD21
response to DNA damage checkpoint signaling (GO:0072423),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SMC1A
response to gonadotropin (GO:0034698),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SLC5A5
response to granulocyte macrophage colony-stimulating factor (GO:0097012),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ZFP36
response to lipoteichoic acid (GO:0070391),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,MAPK14
skeletal muscle thin filament assembly (GO:0030240),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ACTA1
snoRNA localization (GO:0048254),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,NOP58
spinal cord motor neuron differentiation (GO:0021522),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SOX4
T-tubule organization (GO:0033292),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ANK2
tongue development (GO:0043586),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,SIX4
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PTPRF
tripartite regional subdivision (GO:0007351),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,TDGF1
tRNA pseudouridine synthesis (GO:0031119),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,PUS7
tyrosine catabolic process (GO:0006572),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,FAH
xenobiotic transport across blood-brain barrier (GO:1990962),06-Jan,0.774933799,0.999996398,0,0,0.708818182,0.180732811,ABCG2
adipose tissue development (GO:0060612),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,XBP1;NAMPT
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CENPE;SEH1L
brain morphogenesis (GO:0048854),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,MKKS;PTEN
calcineurin-mediated signaling (GO:0097720),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PPP3CB;PPP3R1
cardiocyte differentiation (GO:0035051),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,TGFB2;NRG1
carnitine metabolic process (GO:0009437),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,ACADL;ALDH9A1
catecholamine biosynthetic process (GO:0042423),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,MOXD1;TGFB2
cellular response to fluid shear stress (GO:0071498),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,HDAC3;MTSS1
cellular response to nitrogen levels (GO:0043562),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,GABARAPL1;MAP1LC3A
cellular response to nitrogen starvation (GO:0006995),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,GABARAPL1;MAP1LC3A
cellular response to thyroid hormone stimulus (GO:0097067),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,MED1;RDX
chromatin assembly or disassembly (GO:0006333),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,SUV39H2;NOC2L
dermatan sulfate biosynthetic process (GO:0030208),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,NCAN;DSE
inositol phosphate catabolic process (GO:0071545),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PTEN;SYNJ2
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,UQCRQ;CYCS
mitochondrial genome maintenance (GO:0000002),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PARP1;SLC25A4
mitochondrion distribution (GO:0048311),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,ARMC1;DNM1L
mitotic G1/S transition checkpoint signaling (GO:0044819),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PLK3;RPS27L
modulation by host of viral process (GO:0044788),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CFL1;PPIB
motile cilium assembly (GO:0044458),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,E2F4;CCDC40
mRNA transcription (GO:0009299),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,MED1;DDX5
negative regulation by host of viral process (GO:0044793),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PSMC3;VAPA
negative regulation of calcineurin-mediated signaling (GO:0106057),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PRNP;CHP1
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PRNP;CHP1
negative regulation of gene silencing by miRNA (GO:0060965),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,DND1;ELAVL1
negative regulation of heart contraction (GO:0045822),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,GRK2;SRI
negative regulation of histone acetylation (GO:0035067),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,SET;NOC2L
negative regulation of leukocyte chemotaxis (GO:0002689),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,DUSP1;MIF
negative regulation of oxidoreductase activity (GO:0051354),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,ETFBKMT;MT3
negative regulation of receptor internalization (GO:0002091),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,ATXN2;MTMR2
phagolysosome assembly (GO:0001845),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,RAB14;ARL8B
phosphate ion transmembrane transport (GO:0035435),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,SLC25A3;SLC20A1
positive regulation of cardiocyte differentiation (GO:1905209),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,EFNB2;TGFB2
positive regulation of leukocyte proliferation (GO:0070665),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,MAPK1;MAPK3
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CUL3;CDC27
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CUL3;CDC27
positive regulation of mitotic sister chromatid separation (GO:1901970),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CUL3;CDC27
positive regulation of protein maturation (GO:1903319),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,BAG2;SOX4
positive regulation of pseudopodium assembly (GO:0031274),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CDC42;F2RL1
positive regulation of vascular permeability (GO:0043117),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,TJP1;TJP2
regulation of actin nucleation (GO:0051125),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,ARF1;GSN
regulation of alcohol biosynthetic process (GO:1902930),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,KPNB1;RAN
regulation of astrocyte differentiation (GO:0048710),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,SERPINE2;ID2
regulation of dendritic cell differentiation (GO:2001198),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,LGALS1;HMGB1
regulation of hemopoiesis (GO:1903706),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PURB;MYSM1
regulation of keratinocyte migration (GO:0051547),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,PTEN;ARF6
regulation of pseudopodium assembly (GO:0031272),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,CDC42;F2RL1
regulation of response to oxidative stress (GO:1902882),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,HEBP2;SELENON
tricarboxylic acid metabolic process (GO:0072350),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,GLUD1;IDH3A
very-low-density lipoprotein particle assembly (GO:0034379),12-Feb,0.777840605,0.999996398,0,0,0.708751989,0.178062352,SOAT1;P4HB
negative regulation of intracellular protein transport (GO:0090317),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,UFM1;CHP1;PARK7;RANGAP1
negative regulation of smoothened signaling pathway (GO:0045879),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,VCP;GPC3;RACK1;GLI3
peptidyl-L-cysteine S-palmitoylation (GO:0018230),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,CLIP3;ZDHHC20;ZDHHC6;GOLGA7
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,CLIP3;ZDHHC20;ZDHHC6;GOLGA7
regulation of calcium ion transmembrane transport (GO:1903169),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,PRNP;CAMK2D;PTK2B;ANK2
regulation of supramolecular fiber organization (GO:1902903),23-Apr,0.778233055,0.999996398,0,0,0.745963157,0.187034777,HSPA8;MAP1B;ARL2;PARK7
regulation of extrinsic apoptotic signaling pathway (GO:2001236),12/64,0.779145337,0.999996398,0,0,0.817445712,0.203999857,TNFRSF12A;FEM1B;PSME3;BIRC6;ITGA6;PHIP;PARK7;CFLAR;THBS1;PAK2;PML;FGFR1
selective autophagy (GO:0061912),11/59,0.779228175,0.999996398,0,0,0.811792901,0.20250285,DYNC1I2;UFM1;UBB;UBC;UBQLN1;UBE2N;PARK7;UBE2V1;DYNLL1;RPS27A;PHB2
regulation of anatomical structure morphogenesis (GO:0022603),24/123,0.779487661,0.999996398,0,0,0.85848201,0.213863682,EGLN1;ZRANB1;VASH2;RC3H1;KNDC1;EFNA5;LARP4;ETS1;CLDN4;PAK1;CLDN3;INF2;CAPZB;ABI2;NEDD4;CFL1;DAG1;CTNNB1;PHIP;KIF1A;PDZD8;PAK2;FERMT2;FGFR2
glycosaminoglycan metabolic process (GO:0030203),10/54,0.779771958,0.999996398,0,0,0.805107555,0.200273534,EXT1;GPC1;GPC3;SDC1;GPC4;AGRN;HSPG2;GNS;HS6ST2;CLN6
regulation of cytokine-mediated signaling pathway (GO:0001959),14/74,0.779982452,0.999996398,0,0,0.826479751,0.205366876,HSP90AB1;CHUK;IFNGR1;CFLAR;HIPK1;PIAS1;CLIP3;SUMO1;CDC37;RACK1;TAX1BP1;ABCE1;TRIM44;JAK1
aminoglycan biosynthetic process (GO:0006023),9/49,0.780915367,0.999996398,0,0,0.797079918,0.197108697,EXT1;B3GNT7;GPC1;GPC3;SDC1;GPC4;AGRN;HSPG2;HS6ST2
inner mitochondrial membrane organization (GO:0007007),9/49,0.780915367,0.999996398,0,0,0.797079918,0.197108697,HSPA9;TIMM8B;TIMM10B;APOO;CHCHD3;TMEM11;TIMM13;ROMO1;GHITM
positive regulation of actin filament polymerization (GO:0030838),9/49,0.780915367,0.999996398,0,0,0.797079918,0.197108697,NCKAP1;CARMIL1;GSN;CTTN;PTK2B;SPIRE1;ARPC4;PFN1;ARF6
RNA catabolic process (GO:0006401),9/49,0.780915367,0.999996398,0,0,0.797079918,0.197108697,EXOSC7;ZFP36;RIDA;YTHDF2;PABPC4;HNRNPD;METTL16;NUDT16L1;LSM5
positive regulation of potassium ion transmembrane transport (GO:1901381),8/44,0.782853041,0.999996398,0,0,0.787262564,0.192729975,GNG2;WNK1;AKAP9;GNB1;WNK3;FLNA;ANK2;ATP1B3
protein K63-linked ubiquitination (GO:0070534),8/44,0.782853041,0.999996398,0,0,0.787262564,0.192729975,HECTD1;UBE2B;UBE2NL;NEDD4;UBE2N;UBE2E2;UBE2G1;UBE2V1
negative regulation of protein secretion (GO:0050709),7/39,0.785866892,0.999996398,0,0,0.774984354,0.186746313,RHBDF1;MIDN;REST;DPH3;F2R;RHBDF2;HMGCR
regulation of heart rate by cardiac conduction (GO:0086091),7/39,0.785866892,0.999996398,0,0,0.774984354,0.186746313,YWHAE;CAMK2D;JUP;AKAP9;PKP2;ANK2;DSC2
regulation of nitric-oxide synthase activity (GO:0050999),7/39,0.785866892,0.999996398,0,0,0.774984354,0.186746313,DHFR;NUS1;HSP90AA1;PIK3CB;WASL;CALM1;HIF1A
replication fork processing (GO:0031297),7/39,0.785866892,0.999996398,0,0,0.774984354,0.186746313,MMS22L;PCNA;ATRX;THOC1;NUCKS1;SAMHD1;CENPS
nitrogen compound transport (GO:0071705),28/143,0.787266562,0.999996398,0,0,0.862112369,0.206207262,CALCRL;RAMP3;SLC43A2;SLC44A2;SLC23A1;HIKESHI;MIA3;SLC7A11;LRP2;HSP90B1;SLC7A3;PDPN;SLC38A2;SLC38A4;ARRDC4;NDC1;SLC38A1;ARRDC1;ARRDC3;ATP11B;RCN3;SLC6A6;SLC7A7;CHMP2A;TXNIP;CHMP3;MYH9;ABCG2
receptor-mediated endocytosis (GO:0006898),28/143,0.787266562,0.999996398,0,0,0.862112369,0.206207262,ITGB1;CALCRL;ITGAM;RAMP3;TFRC;CLTC;LRP2;FNBP1L;AP2A2;CXCL16;HSP90B1;GRK2;INPP5F;CXCR2;EPS15;AP2M1;PDLIM7;HSP90AA1;DNAJC13;AP2B1;HSPG2;DAB2;RAB31;CTTN;NEDD4;CANX;CALR;FOLR1
cellular response to amino acid stimulus (GO:0071230),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,XBP1;CAPN2;LAMTOR2;LAMTOR1;LAMTOR3;IPO5
cellular response to vascular endothelial growth factor stimulus (GO:0035924),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,NUS1;FLT1;SEMA6A;GAB1;SPRY2;MAPK14
epithelial tube morphogenesis (GO:0060562),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,PAK1;PODXL;COL4A1;CTNNB1;CCM2;MTSS1
neural tube closure (GO:0001843),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,TGFB2;MTHFD1;LMO4;LRP2;GRHL2;FOLR1
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,AFAP1L2;DGKD;FBXW7;PLAUR;CNOT9;HBEGF
protein localization to chromosome (GO:0034502),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,TNKS2;RAD21;ATRX;RPA1;CENPA;WAPL
regulation of glucose metabolic process (GO:0010906),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,BCKDK;USP7;PMAIP1;ADIPOR1;KHK;PDK1
sister chromatid segregation (GO:0000819),6/34,0.790381382,0.999996398,0,0,0.759190639,0.178591769,TOP2A;CENPK;CDCA8;SMC1A;SMC4;RAN
acidic amino acid transport (GO:0015800),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,SLC6A6;GJA1;SLC1A3
cell migration involved in sprouting angiogenesis (GO:0002042),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,EFNB2;MIA3;TDGF1
DNA strand elongation (GO:0022616),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,RFC4;MCM7;MCM4
embryonic digit morphogenesis (GO:0042733),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,MAP3K20;ECE1;GLI3
leukocyte tethering or rolling (GO:0050901),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,ITGB1;GOLPH3;ROCK1
mitochondrial fission (GO:0000266),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,FIS1;MTFR1L;DNM1L
negative regulation of cation transmembrane transport (GO:1904063),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,CAMK2D;SLC43A2;COMMD1
negative regulation of double-strand break repair via homologous recombination (GO:2000042),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,SMCHD1;RIF1;UBQLN4
negative regulation of leukocyte cell-cell adhesion (GO:1903038),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,DUSP3;WNK1;MIA3
phosphatidylglycerol acyl-chain remodeling (GO:0036148),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,PLA2G12A;PLA2G1B;PLA2G10
phosphatidylinositol acyl-chain remodeling (GO:0036149),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,PLA2G12A;PLA2G1B;PLA2G10
positive regulation of cartilage development (GO:0061036),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,BMP1;MDK;LOXL2
positive regulation of cell adhesion mediated by integrin (GO:0033630),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,TGFB2;SFRP2;PODXL
positive regulation of nervous system process (GO:0031646),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,RNF10;MYRF;DICER1
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,GSK3A;BAX;SLC25A5
regulation of platelet aggregation (GO:0090330),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,SERPINE2;PDPN;F11R
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,DDX5;LIN28A;MYCN
regulation of telomere maintenance via telomere lengthening (GO:1904356),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,PARP1;TNKS2;HNRNPA2B1
response to interferon-alpha (GO:0035455),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,PDE12;LAMP3;TPR
rRNA transcription (GO:0009303),18-Mar,0.791849411,0.999996398,0,0,0.708685766,0.165395949,CAVIN1;GTF3C6;SPIN1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),113/547,0.793981864,0.999996398,0,0,0.92082341,0.212429043,KDM1A;NAB1;GMNN;EIF4A3;PRDM5;EHMT1;ENO1;RBPJ;PHB2;LOXL2;TRIM28;BASP1;MYB;KMT5A;DAPK1;SFMBT2;PUS7;GTPBP4;FOXP1;ILF3;SFRP2;NCL;KHDRBS1;GRB7;DDX6;CALCA;SET;SHC1;PDGFB;PHB;PDS5A;MRPL13;GIGYF2;FOXO1;FXR1;MBTD1;LARP1;S100A11;SNX6;HSPA8;JUN;XRCC6;PHC1;CBX5;UBE2I;PHF10;CBX3;NONO;HMGA1;PA2G4;FOXN3;MT3;WAPL;SMARCA4;DHFR;GCLC;CNOT7;LIN28A;YEATS2;ID2;CAPRIN1;SP3;ID1;BHLHE40;CALR;CNOT9;EZH2;CDKN1C;TRIM71;SUV39H2;GSK3A;DDX3X;DBI;PTPRK;YBX1;LIMD1;GLI3;SYNCRIP;DNMT3L;SUMO1;BCL7A;SIX4;YWHAQ;ENC1;RACK1;JARID2;PRMT2;RPL13A;NRG1;SFPQ;BIRC5;EIF4E2;CRYAB;GAPDH;PFDN5;HDAC3;BCLAF1;RIDA;BTAF1;RPS3;IGF2BP1;SAP18;PAIP2;SMARCE1;WWP1;PML;GATAD2A;REST;RLIM;CTNNB1;MPHOSPH8;TRIM33;LIMS1
organelle organization (GO:0006996),86/420,0.794015392,0.999996398,0,0,0.910894318,0.21009999,USP6NL;PI4K2B;PITPNB;MIA3;PARK7;WASL;FNBP1L;LIMD1;PHB2;SEC61A1;CAPZB;MDK;DPYSL2;MYC;CFL1;TMED3;MYO18A;TMED2;DNM1L;RAB2A;PRKCI;TMED9;SEMA6A;PDCD6IP;COG7;FBXW8;DST;PARP1;STX7;TPM1;ARAP3;PRPF40A;PEX2;RAB31;HAX1;POLG2;YME1L1;TFAM;CHMP3;PHIP;RHOU;AJUBA;PPIA;OPTN;PPID;CHMP5;TMED10;SAR1A;VPS4B;ATL2;CDCA8;PHB;HSD17B10;CDC42;CNN2;CECR2;ARHGAP21;BNIP1;EPS15;PDZD8;SEC31A;YTHDF1;ZRANB1;CENPW;YTHDF2;PEX19;CSNK1A1;SORT1;SEC16A;SURF4;HUWE1;LYSMD3;LARP4;VMP1;GOLPH3;ABI2;REEP5;RAB14;VAPA;TMEM11;RAB18;CHMP2A;CYCS;SSBP1;NECTIN2;BRWD3
"DNA-templated transcription, initiation (GO:0006352)",33/168,0.796865585,0.999996398,0,0,0.865404965,0.19650687,YAP1;GTF2A1;RARG;GTF2A2;HDAC3;RRN3;TAF9;RBPJ;GTF2E2;TAF1D;POLR2B;POLR2F;POLR2G;POLR2H;TBL1X;POLR2I;TEAD1;POLR2J;POLR2K;MAPK3;POLR2L;MED1;CAVIN1;TAF12;GTF2H3;GTF2F2;GTF2H5;CDK7;NR6A1;POLR1C;TFAM;MNAT1;TAF2
determination of bilateral symmetry (GO:0009855),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,LEFTY1;MKKS;ZIC3;PITX2;TDGF1
dicarboxylic acid transport (GO:0006835),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,GJA1;PDPN;SLC1A3;FOLR1;SLC19A1
establishment of mitotic spindle localization (GO:0040001),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,ITGB1;GJA1;CENPA;KPNB1;MAD2L1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,CEBPB;ITPR1;BAX;SELENOK;BBC3
mismatch repair (GO:0006298),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,PCNA;TDG;ERCC1;RPA3;RPA1
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,MAP3K1;UBB;UBC;RPS27A;HSPD1
protein ADP-ribosylation (GO:0006471),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,ARF4;TNKS2;PARP1;PARP2;TIPARP
protein targeting to peroxisome (GO:0006625),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,ATAD1;FIS1;PEX19;ZFAND6;PEX2
regulation of gluconeogenesis (GO:0006111),29-May,0.797067661,0.999996398,0,0,0.738123673,0.167418045,DDB1;USP7;EP300;ERFE;ARPP19
negative regulation of cellular component organization (GO:0051129),15/80,0.797265872,0.999996398,0,0,0.817320846,0.185177985,CARMIL1;HSPA8;MTMR2;DDX3X;HSPA5;RIOK3;RDX;WASL;CLU;CDC42;IMPACT;SYT11;EP300;SPRY2;CRYAB
protein autoubiquitination (GO:0051865),12/65,0.797401885,0.999996398,0,0,0.801970621,0.181563325,TRIM71;RNF10;UBE2B;NFX1;CUL3;UBE2D3;UBE3A;UBE2A;RNF141;RNF122;RAD18;RNF187
positive regulation of binding (GO:0051099),17/90,0.798369959,0.999996398,0,0,0.824736276,0.185716738,APP;NVL;DHX9;GMNN;RPL11;PLAUR;NMD3;HMGB1;IDE;STK4;NME1;FKBP1A;STMN1;DPH3;FLOT1;MARK3;RAN
interstrand cross-link repair (GO:0036297),10/55,0.799460001,0.999996398,0,0,0.787165667,0.176182458,VCP;UBB;ERCC1;RPA3;UBC;USP1;RPA1;NUCKS1;RPS27A;CENPS
negative regulation of cell migration (GO:0030336),28/144,0.799549022,0.999996398,0,0,0.854625169,0.191186002,CLIC4;TACSTD2;PTEN;MIA3;PTPRK;ADIPOR1;CORO1C;GJA1;CDH1;DAG1;RAC1;ARID2;DUSP3;IGFBP3;TPM1;MIF;GTPBP4;SMAD7;DUSP22;AFDN;CLDN3;SFRP2;RAP2B;STK24;STK26;CALR;EPHA1;BMPR1A
cellular response to DNA damage stimulus (GO:0006974),71/350,0.800969582,0.999996398,0,0,0.900378289,0.199823032,TOP2A;RIF1;MCM7;SETD7;NUDT1;SMC6;PARK7;TRIM28;SUMO1;MYC;PCLAF;TLK2;RFC4;PARP1;PARP2;RFC2;UBE2E2;MASTL;SMC1A;FOXP1;DDB1;KIN;PSME4;YAP1;VCP;DCUN1D5;UBA6;TAF9;PDS5A;SAMHD1;CRIP1;FOXO1;PAK1;BCL2L11;UBR5;RPS3;SFN;RBBP6;UBQLN4;MCL1;MAPK3;PLK3;NPM1;CBX5;UBE2B;GADD45A;CBX3;CBX1;RPA1;UBE2A;GTF2H3;MAPK14;MAPK12;PML;SETX;TAOK3;TDP1;TAOK1;ERCC1;CDK1;NABP2;NABP1;BAX;RAD1;TRIP12;UBA1;MNAT1;RAD18;CENPS;BCL2L1;CUL4B
positive regulation of cellular metabolic process (GO:0031325),20/105,0.801088608,0.999996398,0,0,0.83322368,0.184795444,ATAD1;PRELID1;RAMP3;ANXA2;GADD45A;HPN;PDGFB;ARRB1;ECE1;GHITM;MAPK14;MT3;THBS1;ACACA;AHI1;INPP5F;PLA2G10;CDK1;ROMO1;VAMP3
amino acid transport (GO:0006865),9/50,0.801417628,0.999996398,0,0,0.777588964,0.172137267,SLC6A6;SLC38A1;SLC7A7;SLC43A2;PDPN;SLC7A11;SLC38A2;SLC7A3;SLC38A4
organic hydroxy compound biosynthetic process (GO:1901617),9/50,0.801417628,0.999996398,0,0,0.777588964,0.172137267,SQLE;PSAT1;OSBPL3;PMVK;SC5D;PARK7;HMGCR;LBR;HSD17B10
apoptotic process (GO:0006915),46/231,0.801695288,0.999996398,0,0,0.88006206,0.194517198,CYFIP2;APP;NCKAP1;CSRNP1;AHCYL1;TNFAIP1;EFNA5;STK4;FOXO1;HK2;BBC3;HSPD1;FXR1;PPP2CA;BCLAF1;BCL2L11;FAM162A;MYC;BNIP1;EP300;PMAIP1;PTK2B;NAE1;PHLDA2;IER3;PLK3;EGLN3;SEMA6A;PARP1;DAPK1;GADD45A;FEM1B;BNIP3;THOC1;DHCR24;CFLAR;CDK11B;MELK;DDIT4;BAX;VDAC1;NDUFS1;PPIA;GAPDH;BCL2L1;MCM2
positive regulation of protein kinase activity (GO:0045860),30/154,0.802897944,0.999996398,0,0,0.856543494,0.188034995,CALCA;DDX3X;HSP90AB1;NRK;PDGFB;IQGAP1;STK4;CLU;PPP2CA;PAK1;PDCD10;PTK2B;ECT2;PAK2;PRNP;TGFB2;XRCC6;HSP90AA1;RHOA;TOM1L1;TPX2;CENPE;TRAF4;TAOK3;TAOK1;CALM3;CALM1;CALM2;TELO2;EZH2
amino acid transmembrane transport (GO:0003333),8/45,0.804245659,0.999996398,0,0,0.765935979,0.166859544,SLC6A6;SLC38A1;SLC7A7;SFXN1;SLC7A11;SLC16A2;SLC38A2;SLC38A4
neural crest cell development (GO:0014032),8/45,0.804245659,0.999996398,0,0,0.765935979,0.166859544,SEMA6A;PDCD6;ANXA6;NOLC1;SEMA3E;NRG1;SOX11;CORO1C
amino acid import across plasma membrane (GO:0089718),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,SLC6A6;SLC1A3;SLC16A2;SLC7A3
DNA packaging (GO:0006323),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,NAA10;HAT1;BANF1;NOC2L
establishment of mitotic spindle orientation (GO:0000132),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,ITGB1;GJA1;CENPA;MAD2L1
heterochromatin assembly (GO:0031507),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,HELLS;SMCHD1;HMGA1;BEND3
iron-sulfur cluster assembly (GO:0016226),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,HSPA9;NFU1;GLRX3;BOLA2
negative regulation of ossification (GO:0030279),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,CHSY1;MDK;PTK2B;RBPJ
negative regulation of protein tyrosine kinase activity (GO:0061099),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,DUSP22;TSG101;SOCS4;SNX6
neuromuscular junction development (GO:0007528),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,PPFIBP1;NEDD4;F2R;AGRN
porphyrin-containing compound biosynthetic process (GO:0006779),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,PGRMC1;CPOX;TSPO;ABCG2
"protein alpha-1,2-demannosylation (GO:0036508)",24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,UBB;EDEM1;UBC;RPS27A
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),24-Apr,0.807056737,0.999996398,0,0,0.708619513,0.151900605,PDCD6;NEDD4;HIF1A;MT3
negative regulation of protein kinase B signaling (GO:0051898),7/40,0.808232631,0.999996398,0,0,0.751451704,0.15998809,PLEKHA1;PDCD6;PTEN;DAG1;RACK1;PIK3CB;PPP2R5C
regulation of sodium ion transmembrane transporter activity (GO:2000649),7/40,0.808232631,0.999996398,0,0,0.751451704,0.15998809,CAMK2D;WNK1;NEDD4;WNK3;UTRN;YWHAH;PTPN3
stem cell differentiation (GO:0048863),7/40,0.808232631,0.999996398,0,0,0.751451704,0.15998809,DNMT3L;TGFB2;PSMD11;EPCAM;METTL5;JARID2;FGFR2
regulation of angiogenesis (GO:0045765),40/203,0.809744542,0.999996398,0,0,0.86860249,0.183306796,ITGB1;FLT1;ROCK1;ROCK2;PDCD6;PDE3B;ECSCR;SEMA3E;HIF1A;ETS1;THBS1;HK2;MTDH;AMOT;SPRED1;ADAMTS1;PGK1;GTF2I;EGLN1;XBP1;TGFB2;SEMA6A;JUP;ANXA3;GAB1;VASH2;HIPK1;SYNJ2BP;HSPG2;F3;PML;PDCL3;SFRP2;COL4A2;SP1;AGO2;AGGF1;CTNNB1;SPRY2;EPHA1
transcription initiation from RNA polymerase II promoter (GO:0006367),27/140,0.809931311,0.999996398,0,0,0.845952147,0.17833165,YAP1;GTF2A1;RARG;GTF2A2;HDAC3;TAF9;RBPJ;GTF2E2;POLR2B;POLR2F;POLR2G;POLR2H;TBL1X;POLR2I;TEAD1;POLR2J;POLR2K;POLR2L;MED1;TAF12;GTF2H3;GTF2F2;GTF2H5;CDK7;NR6A1;MNAT1;TAF2
cellular response to organic cyclic compound (GO:0071407),29/150,0.812759983,0.999996398,0,0,0.84849115,0.175908708,URI1;RAMP3;ROCK2;PDGFB;ACTB;UBE2L3;HSP90B1;SLC5A5;ZFP36L1;RAP1B;LARP1;GNG2;CDH1;RUVBL2;CTNNA1;MED1;JUP;TIPARP;RIOK3;MSN;IMPACT;GOLPH3;PDE12;AKAP9;GNB1;CTNNB1;MGARP;EZR;FOLR1
transport across blood-brain barrier (GO:0150104),16/86,0.812870721,0.999996398,0,0,0.809460824,0.167706681,SLC38A1;SLC16A1;TFRC;SLC2A1;SLC1A3;SLC2A3;LRP2;SLC5A5;SLC7A3;SLC6A6;FABP5;SLC16A2;SLC29A1;SLC38A2;SLC19A1;ABCG2
phosphatidylinositol-mediated signaling (GO:0048015),13/71,0.813634288,0.999996398,0,0,0.793830352,0.163722979,PLEKHA1;PTEN;PIK3CB;PIK3C2A;RHOA;IGF1R;ZFP36L1;INPP5F;RPS6KB1;C1QBP;EZR;PLCD1;FGFR1
blood vessel diameter maintenance (GO:0097746),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,GCLC;ROCK1;ROCK2;F2RL1;ECE1;GCLM
negative regulation of cell cycle G1/S phase transition (GO:1902807),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,PRMT2;CDK4;FHL1;PTEN;CDC73;E2F7
negative regulation of neurogenesis (GO:0050768),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,PCM1;REST;ARHGDIA;PTEN;RHOA;YWHAH
regulation of ion transmembrane transport (GO:0034765),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,YWHAE;AHCYL1;WNK1;NEDD4;AKAP9;WNK3
regulation of JUN kinase activity (GO:0043506),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,PAK1;TAOK3;RPS3;MAP3K4;ARHGEF5;MAPK8IP1
semaphorin-plexin signaling pathway (GO:0071526),6/35,0.813804461,0.999996398,0,0,0.732964576,0.151016475,SEMA6A;ARHGDIA;FLNA;SEMA3E;PLXNB1;RAC1
atrial cardiac muscle cell action potential (GO:0086014),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,GJA1;ANK2
cellular response to interleukin-15 (GO:0071350),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,SHC1;JAK1
dermatan sulfate metabolic process (GO:0030205),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,NCAN;DSE
interleukin-15-mediated signaling pathway (GO:0035723),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,SHC1;JAK1
intraciliary retrograde transport (GO:0035721),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,IFT43;TTC21B
microtubule-based transport (GO:0099111),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,DYNC1I2;CCDC40
negative regulation of adenylate cyclase activity (GO:0007194),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,GNAI3;AKAP5
negative regulation of alcohol biosynthetic process (GO:1902931),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,REST;NFKB1
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,TWSG1;HMGB1
negative regulation of DNA-dependent DNA replication (GO:2000104),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,TIPIN;GMNN
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,HSPA5;RACK1
negative regulation of gluconeogenesis (GO:0045721),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,EP300;ERFE
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,RACK1;PARK7
negative regulation of myotube differentiation (GO:0010832),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,XBP1;HDAC3
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,PDCD6;NEDD4
plasma membrane tubulation (GO:0097320),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,EHD2;FNBP1L
positive regulation of calcineurin-mediated signaling (GO:0106058),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,PTBP1;CAMTA1
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,PTBP1;CAMTA1
positive regulation of calcium ion import (GO:0090280),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,RAMP3;PDGFB
positive regulation of lipid transport (GO:0032370),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,PRELID1;DBI
positive regulation of mRNA metabolic process (GO:1903313),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,CNOT7;RC3H1
positive regulation of transporter activity (GO:0032411),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,KMT2A;WNK3
protein heterotetramerization (GO:0051290),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,CPSF6;FARSB
protein localization to mitochondrion (GO:0070585),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,MTCH2;HK2
regulation of lysosomal lumen pH (GO:0035751),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,TMEM9;CLN6
regulation of membrane repolarization (GO:0060306),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,YWHAE;AKAP9
regulation of protein exit from endoplasmic reticulum (GO:0070861),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,SAR1A;SEC16A
relaxation of cardiac muscle (GO:0055119),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,CAMK2D;GSN
response to muramyl dipeptide (GO:0032495),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,ARHGEF2;CHMP5
spliceosomal tri-snRNP complex assembly (GO:0000244),13-Feb,0.815599662,0.999996398,0,0,0.644278658,0.131324385,PRPF8;SRSF10
negative regulation of macromolecule metabolic process (GO:0010605),38/194,0.816199767,0.999996398,0,0,0.862194914,0.17510846,YAP1;APP;MTMR2;HSP90AB1;CELF1;ROCK2;PDGFB;PARK7;HIF1A;TRIM6;ATXN2;PDCD10;NOCT;RACK1;FLOT2;TGFB2;TIPARP;FBXW7;SFMBT2;TET1;SOX11;DICER1;MIF;NFKB1;FOXP1;REST;CLDN3;SFRP2;MYCN;CNOT7;SUB1;ID2;PTRH2;AGO2;MYADM;TARDBP;OPTN;BMPR1A
glycosaminoglycan catabolic process (GO:0006027),10/56,0.817817579,0.999996398,0,0,0.770003862,0.154860078,NCAN;GPC1;GPC3;CHP1;SDC1;HMMR;GPC4;AGRN;HSPG2;GNS
sensory organ development (GO:0007423),10/56,0.817817579,0.999996398,0,0,0.770003862,0.154860078,AHI1;SMCHD1;TGFB2;SIX4;CHD7;SHROOM2;RAB18;PBX2;ECE1;HIPK1
gonad development (GO:0008406),9/51,0.820451768,0.999996398,0,0,0.759026151,0.150211392,MKKS;TGFB2;NUP107;SIX4;BASP1;CSDE1;LRP2;MEA1;UTF1
inositol lipid-mediated signaling (GO:0048017),9/51,0.820451768,0.999996398,0,0,0.759026151,0.150211392,INPP5F;RPS6KB1;PIK3CB;PIK3C2A;EZR;RHOA;PLCD1;IGF1R;FGFR1
regulation of epithelial cell migration (GO:0010632),9/51,0.820451768,0.999996398,0,0,0.759026151,0.150211392,TGFB2;RAB25;GLIPR2;TACSTD2;PFN1;ADIPOR1;HIF1A;RAB11A;CORO1C
artery morphogenesis (GO:0048844),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,TGFB2;LRP2;FOLR1;SMAD7;BMPR1A
heterotypic cell-cell adhesion (GO:0034113),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,ITGB1;JUP;PKP2;PARVA;DSC2
histone H3-K4 methylation (GO:0051568),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,KMT2A;SETD1B;BEND3;DPY30;WDR61
ion homeostasis (GO:0050801),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,SLC4A7;CAMK2D;WNK1;FHL1;WNK3
microtubule polymerization (GO:0046785),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,TPX2;TPPP3;MAP7D3;AKAP9;CKAP5
negative regulation of Notch signaling pathway (GO:0045746),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,MMP14;YTHDF2;ARRDC1;FBXW7;ARRB1
phosphatidylcholine acyl-chain remodeling (GO:0036151),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,PLA2G12A;PLA2G1B;PLA2G10;DBI;PLA2G6
positive regulation of DNA recombination (GO:0045911),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,ACTR2;RIF1;TFRC;PARP1;ARID2
primary neural tube formation (GO:0014020),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,TGFB2;MTHFD1;LMO4;LRP2;GRHL2
regulation of macrophage activation (GO:0043030),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,PLA2G10;MYO18A;MIF;THBS1;HSPD1
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),30-May,0.821618321,0.999996398,0,0,0.70855323,0.139216058,UBB;CHUK;UBE2D3;UBC;RPS27A
atrioventricular valve morphogenesis (GO:0003181),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,TGFB2;SOX4;BMPR1A
cardiac muscle cell contraction (GO:0086003),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,CAMK2D;GSN;PKP2
cellular response to interleukin-7 (GO:0098761),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,CISH;SMARCA4;JAK1
dopamine metabolic process (GO:0042417),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,MOXD1;TGFB2;MAOA
endoplasmic reticulum mannose trimming (GO:1904380),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,UBB;UBC;RPS27A
fatty acid transmembrane transport (GO:1902001),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,MID1IP1;SLC2A1;ACACA
interleukin-7-mediated signaling pathway (GO:0038111),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,CISH;SMARCA4;JAK1
leukocyte adhesion to vascular endothelial cell (GO:0061756),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,ITGB1;GOLPH3;ROCK1
nuclear membrane organization (GO:0071763),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,CHMP2A;TARDBP;EMD
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,GSK3A;PHB;SLC39A14
positive regulation of leukocyte activation (GO:0002696),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,THBS1;NECTIN2;HSPD1
Rac protein signal transduction (GO:0016601),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,NCKAP1;ABI2;RAC1
regulation of epithelial cell differentiation (GO:0030856),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,KLF7;CEBPB;MAFF
regulation of leukocyte chemotaxis (GO:0002688),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,MDK;F2RL1;PTK2B
regulation of RIG-I signaling pathway (GO:0039535),19-Mar,0.822426686,0.999996398,0,0,0.664350273,0.129877778,USP15;C1QBP;PUM2
regulation of double-strand break repair via homologous recombination (GO:0010569),8/46,0.824001996,0.999996398,0,0,0.745731846,0.144360506,ACTR2;SMCHD1;PPP4C;KDM1A;RIF1;PARP1;ARID2;UBQLN4
aldehyde biosynthetic process (GO:0046184),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TPI1
aldehyde catabolic process (GO:0046185),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ADH5
angiotensin-activated signaling pathway (GO:0038166),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,AHCYL1
astrocyte differentiation (GO:0048708),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MT3
axon ensheathment in central nervous system (GO:0032291),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MYRF
bleb assembly (GO:0032060),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PMP22
cardiac pacemaker cell development (GO:0060926),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,BMPR1A
cardiolipin acyl-chain remodeling (GO:0035965),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PLA2G6
cation homeostasis (GO:0055080),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CNNM4
cellular amino acid biosynthetic process (GO:0008652),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,BCAT2
cellular cation homeostasis (GO:0030003),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MT3
cellular response to gonadotropin stimulus (GO:0071371),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SLC5A5
cellular response to interleukin-18 (GO:0071351),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PDGFB
chemical homeostasis within a tissue (GO:0048875),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RCN3
"complement activation, alternative pathway (GO:0006957)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CR2
coronary vasculature development (GO:0060976),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GPC3
creatine metabolic process (GO:0006600),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GATM
cyclic nucleotide transport (GO:0070729),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SLC19A1
cytochrome complex assembly (GO:0017004),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SURF1
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,LSM1
delamination (GO:0060232),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,YTHDF2
detection of muscle stretch (GO:0035995),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CTNNB1
dolichyl diphosphate biosynthetic process (GO:0006489),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NUS1
dolichyl diphosphate metabolic process (GO:0046465),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NUS1
endothelial cell morphogenesis (GO:0001886),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,COL18A1
epithelial cell differentiation involved in kidney development (GO:0035850),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MTSS1
exocrine system development (GO:0035272),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FGFR2
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ELOVL1
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ELOVL1
"fatty acid elongation, saturated fatty acid (GO:0019367)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ELOVL1
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ELOVL1
G protein-coupled receptor internalization (GO:0002031),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ARRB1
gap junction assembly (GO:0016264),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GJA1
glial cell migration (GO:0008347),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TGFB2
heart trabecula formation (GO:0060347),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FKBP1A
hindlimb morphogenesis (GO:0035137),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RARG
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PTPRN
interleukin-18-mediated signaling pathway (GO:0035655),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PDGFB
intermediate filament bundle assembly (GO:0045110),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PKP2
iron import into cell (GO:0033212),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SLC39A14
keratinocyte proliferation (GO:0043616),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FERMT1
leucine metabolic process (GO:0006551),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,BCAT2
long-term synaptic depression (GO:0060292),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ARF1
lymphoid progenitor cell differentiation (GO:0002320),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SOX4
marginal zone B cell differentiation (GO:0002315),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PTK2B
metanephric nephron tubule development (GO:0072234),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,WNT7B
mitochondrial DNA metabolic process (GO:0032042),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PARP1
mRNA pseudouridine synthesis (GO:1990481),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PUS7
mRNA transcription by RNA polymerase II (GO:0042789),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MED1
negative regulation by host of viral genome replication (GO:0044828),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,VAPA
negative regulation of cardiocyte differentiation (GO:1905208),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FZD7
negative regulation of catecholamine secretion (GO:0033604),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SYT11
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NUDT16L1
negative regulation of glycogen metabolic process (GO:0070874),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GSK3A
negative regulation of heart rate (GO:0010459),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SRI
negative regulation of low-density lipoprotein receptor activity (GO:1905598),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,APP
negative regulation of lymphocyte differentiation (GO:0045620),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ID2
negative regulation of meiotic nuclear division (GO:0045835),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RAD1
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SLC25A5
negative regulation of nervous system process (GO:0031645),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TMEM98
negative regulation of oligodendrocyte differentiation (GO:0048715),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TMEM98
negative regulation of RIG-I signaling pathway (GO:0039536),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,C1QBP
negative regulation of ruffle assembly (GO:1900028),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TACSTD2
negative regulation of telomere capping (GO:1904354),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ERCC1
"neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RAB11A
nodal signaling pathway (GO:0038092),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TDGF1
norepinephrine metabolic process (GO:0042415),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MOXD1
oxygen transport (GO:0015671),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MYC
pantothenate metabolic process (GO:0015939),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,AASDHPPT
pentose metabolic process (GO:0019321),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FGGY
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GNA11
positive regulation by symbiont of host autophagy (GO:0075044),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PHB2
positive regulation of adenylate cyclase activity (GO:0045762),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,AKAP5
positive regulation of amyloid-beta clearance (GO:1900223),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ROCK1
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ROCK2
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TGFB2
positive regulation of cardiac muscle cell differentiation (GO:2000727),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,EFNB2
positive regulation of catecholamine secretion (GO:0033605),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GRK2
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,HMGB1
positive regulation of epithelial tube formation (GO:1905278),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SIX4
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,UBQLN1
positive regulation of fibroblast apoptotic process (GO:2000271),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,BCL2L11
positive regulation of gastrulation (GO:2000543),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RACK1
positive regulation of helicase activity (GO:0051096),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SSBP1
positive regulation of histone H4 acetylation (GO:0090240),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ARRB1
positive regulation of humoral immune response (GO:0002922),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PHB
positive regulation of icosanoid secretion (GO:0032305),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PLA2G10
positive regulation of lamellipodium morphogenesis (GO:2000394),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CORO1C
positive regulation of lymphocyte apoptotic process (GO:0070230),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PRELID1
positive regulation of mast cell activation (GO:0033005),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NECTIN2
positive regulation of mitochondrial membrane potential (GO:0010918),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,VCP
positive regulation of multicellular organism growth (GO:0040018),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PPIB
positive regulation of phospholipid biosynthetic process (GO:0071073),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CHP1
positive regulation of pinocytosis (GO:0048549),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CDC42
positive regulation of protein deubiquitination (GO:1903003),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,VCP
positive regulation of vesicle fusion (GO:0031340),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ANXA2
proline metabolic process (GO:0006560),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PYCR2
proton-transporting ATP synthase complex assembly (GO:0043461),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FMC1
purine-containing compound metabolic process (GO:0072521),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GUK1
regulation of aldosterone biosynthetic process (GO:0032347),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,REST
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FLNA
regulation of bone remodeling (GO:0046850),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MDK
regulation of calcidiol 1-monooxygenase activity (GO:0060558),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NFKB1
regulation of cardiac muscle cell membrane potential (GO:0086036),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ATP2A2
regulation of cGMP-mediated signaling (GO:0010752),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,THBS1
regulation of cilium beat frequency (GO:0003356),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CCDC40
regulation of cortisol biosynthetic process (GO:2000064),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,REST
regulation of defense response to bacterium (GO:1900424),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FOXP1
regulation of dopamine metabolic process (GO:0042053),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ITGAM
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FGFR1
regulation of fat cell proliferation (GO:0070344),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,TFDP1
regulation of glial cell apoptotic process (GO:0034350),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PRKCI
regulation of glial cell differentiation (GO:0045685),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CDK1
regulation of glucocorticoid receptor signaling pathway (GO:2000322),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PHB
regulation of growth hormone secretion (GO:0060123),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CHD7
regulation of histone deacetylase activity (GO:1901725),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CAMK2D
regulation of inositol phosphate biosynthetic process (GO:0010919),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PTK2B
regulation of mesenchymal stem cell differentiation (GO:2000739),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,REST
regulation of muscle organ development (GO:0048634),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,MTPN
regulation of NAD(P)H oxidase activity (GO:0033860),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PARK7
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NECTIN2
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,DUSP22
regulation of protein deubiquitination (GO:0090085),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,OTUD4
regulation of skeletal muscle satellite cell proliferation (GO:0014842),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CFLAR
regulation of smooth muscle cell differentiation (GO:0051150),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FGFR2
regulation of striated muscle cell differentiation (GO:0051153),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,NRG1
regulation of toll-like receptor 7 signaling pathway (GO:0034155),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,DDX3X
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RBPJ
regulation of transforming growth factor beta activation (GO:1901388),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,HSP90AB1
regulation of vascular associated smooth muscle cell differentiation (GO:1905063),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PDGFB
regulation of vesicle size (GO:0097494),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,AP2M1
response to increased oxygen levels (GO:0036296),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ATP6V1G1
ribose phosphate biosynthetic process (GO:0046390),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,PRPS2
SA node cell action potential (GO:0086015),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ANK2
skin morphogenesis (GO:0043589),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,ITGA6
SMAD protein complex assembly (GO:0007183),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,FKBP1A
"substrate-dependent cell migration, cell extension (GO:0006930)",07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,CD2AP
surfactant homeostasis (GO:0043129),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RCN3
T cell apoptotic process (GO:0070231),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GLI3
tachykinin receptor signaling pathway (GO:0007217),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,GRK2
thyroid hormone transport (GO:0070327),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,SLC16A2
vitamin A metabolic process (GO:0006776),07-Jan,0.824474188,0.999996398,0,0,0.590643939,0.113999858,RBP1
regulation of macromolecule metabolic process (GO:0060255),39/200,0.827346033,0.999996398,0,0,0.857322272,0.162490221,APP;MTMR2;ARF1;ROCK2;PRDM5;YBX1;HIF1A;CRIP1;AFF4;YBX3;ZFP36L1;NPAT;TRIM6;PCBP4;CDH1;MYC;PCBP1;PCBP2;POGZ;FLOT1;IGF2BP1;TRIM44;PEG3;SORT1;HNRNPAB;FOXP1;TAPBP;REST;HNRNPK;FUBP3;CDK4;FUBP1;C1D;HNRNPD;UBAP2;LAMTOR1;ANKRA2;TARDBP;RNF187
regulation of macroautophagy (GO:0016241),21/112,0.828038332,0.999996398,0,0,0.817070601,0.154177816,SH3GLB1;BNIP3L;SCOC;ATP6V1G1;BNIP3;GNAI3;NRBP2;UCHL1;MAPK8;LARP1;CAPNS1;RHEB;NEDD4;UBQLN1;LAMTOR2;LAMTOR1;ATP6V1D;GAPDH;LAMTOR3;SNX5;SNX6
positive regulation of endothelial cell proliferation (GO:0001938),14/77,0.828217979,0.999996398,0,0,0.786971608,0.148327543,FGFBP1;PDCD6;VASH2;PDGFB;IGF2;HMGB1;F3;HIF1A;PDCL3;NRAS;MDK;SP1;AGGF1;FGFR1
protein phosphorylation (GO:0006468),101/496,0.828408657,0.999996398,0,0,0.904094201,0.170194557,APP;GMFB;PRAG1;NRK;IGF1R;NRBP2;RPS6KA6;PPP4R1;SLK;RPS6KA1;PIM3;PDK1;CDKL2;PRKCI;CSNK2A1;DAPK1;IGFBP3;CSNK2A2;LMTK2;PRPF4B;ILF3;MELK;MAPKAPK3;CCNE1;EPHA1;CSNK1G2;PDGFB;STK4;NUAK1;GRK2;GRK6;MAP3K20;MARK3;CDK17;SRPK2;TGFB2;NEK6;BRAF;SRPK1;SMAD7;CDK7;STK24;CDK4;WNK1;COPS2;STK26;WNK3;CDK1;CDK12;CDK13;CDK14;TDGF1;FGFR2;BMPR1A;FGFR1;DDR1;GSK3A;FLT1;PPP3CB;TLK2;TLK1;JAK1;CHUK;HUNK;MASTL;YWHAZ;CCNA2;CREB1;LATS2;BMP2K;BIRC5;BIRC6;CAMK2D;USP15;ROCK1;ROCK2;PAK1;MAPK8;MAPK1;PTK2B;MAP4K5;MAPK6;PAK2;MAPK3;MAP3K1;CSNK1A1;RYK;LIMK2;GTF2H3;HIPK1;MAPK14;CDK11B;GTF2H5;MAPK12;MAPK13;BCKDK;ABI2;TAOK3;RPS6KB1;TAOK1;PKN2
epithelial cell migration (GO:0010631),7/41,0.82875279,0.999996398,0,0,0.729303328,0.136987503,ANLN;FERMT1;ROCK1;PKN2;FSTL1;RHOA;LOXL2
JNK cascade (GO:0007254),7/41,0.82875279,0.999996398,0,0,0.729303328,0.136987503,MAPK8;UBB;UBC;UBE2N;UBE2V1;RPS27A;DUSP9
nucleobase-containing compound catabolic process (GO:0034655),7/41,0.82875279,0.999996398,0,0,0.729303328,0.136987503,EXOSC7;NUDT9;PABPC4;NUDT1;HNRNPD;NUDT5;ADPRM
regulation of cell development (GO:0060284),7/41,0.82875279,0.999996398,0,0,0.729303328,0.136987503,YAP1;YTHDF2;RHEB;DOCK7;BHLHE40;CTNNB1;FOXO1
neuron projection development (GO:0031175),33/171,0.82878291,0.999996398,0,0,0.846427576,0.158956583,APP;NCKAP1;ROCK1;NRK;DOCK7;STMN2;PTEN;BICDL1;HMGB1;WASL;PPP1R9A;CDC42;PAK1;UBB;BLOC1S1;SVBP;STMN1;SNAPIN;RYK;VASH2;LAMB1;DICER1;RAB11A;MANF;CTTN;TAOK3;VAPA;NEDD4;TAOK1;PLXNB1;ATXN10;KIF20B;DBN1
positive regulation of catabolic process (GO:0009896),12/67,0.830575927,0.999996398,0,0,0.772708631,0.143442486,DDB1;GSK3A;VCP;CSNK2A1;TIPARP;NEDD4;GPC3;HUWE1;WWP1;IDE;OAZ1;FOXO1
regulation of neurogenesis (GO:0050767),11/62,0.832430101,0.999996398,0,0,0.763892983,0.140102574,YAP1;PCM1;NUMBL;REST;YTHDF2;DOCK7;BHLHE40;CTNNB1;SOX11;NAP1L1;LRP2
in utero embryonic development (GO:0001701),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,WNT7B;CHD7;IGF2;FGFR2
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,PRNP;DUSP3;EZR;PHPT1
negative regulation of cellular carbohydrate metabolic process (GO:0010677),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,GSK3A;EP300;ERFE;GIT1
negative regulation of endocytosis (GO:0045806),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,MTMR2;SYT11;RAC1;ARF6
peroxisome organization (GO:0007031),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,FIS1;PEX19;PEX2;DNM1L
phosphatidylinositol dephosphorylation (GO:0046856),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,MTMR2;INPP5F;PTEN;SYNJ2
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,VCP;CUL3;CLPP;YME1L1
regulation of calcium ion import (GO:0090279),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,PRNP;WNK3;PDGFB;CTNNB1
regulation of cholesterol transport (GO:0032374),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,NUS1;TSPO;LAMTOR1;NFKB1
regulation of heterotypic cell-cell adhesion (GO:0034114),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,WNK1;FLOT1;MYADM;FLOT2
regulation of myotube differentiation (GO:0010830),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,XBP1;MMP14;HDAC3;MAPK14
regulation of neutrophil chemotaxis (GO:0090022),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,MDK;C1QBP;RAC1;DNM1L
regulation of protein processing (GO:0070613),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,PRNP;TMEM59;SERPINE2;BAG2
regulation of rhodopsin mediated signaling pathway (GO:0022400),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,NMT1;CALM1;METAP1;METAP2
response to dsRNA (GO:0043331),25-Apr,0.832747223,0.999996398,0,0,0.674832407,0.123511294,DDX58;RIOK3;PDE12;PMAIP1
cellular response to peptide (GO:1901653),10/57,0.834874764,0.999996398,0,0,0.753572346,0.135999876,APP;PRNP;GJA1;XBP1;RPL23;ARHGEF2;IGF1R;CHMP5;ZFP36L1;SNX6
regulation of reactive oxygen species metabolic process (GO:2000377),10/57,0.834874764,0.999996398,0,0,0.753572346,0.135999876,ARF4;EIF6;GADD45A;PDGFB;ROMO1;RAC1;MAPK14;THBS1;MT3;PARL
embryonic limb morphogenesis (GO:0030326),6/36,0.835115763,0.999996398,0,0,0.708486917,0.127658663,RARG;TGFB2;MAP3K20;CTNNB1;ECE1;GLI3
regulation of ossification (GO:0030278),6/36,0.835115763,0.999996398,0,0,0.708486917,0.127658663,TGFB2;CHSY1;MDK;BMP2K;SOX11;RBPJ
transition metal ion transport (GO:0000041),6/36,0.835115763,0.999996398,0,0,0.708486917,0.127658663,SLC30A9;TFRC;FTH1;COX17;MT3;ATOX1
endocytic recycling (GO:0032456),9/52,0.838056913,0.999996398,0,0,0.741326725,0.130969648,ARL4C;VPS29;EHD2;SNX27;RAB14;LMTK2;ANKRD50;EPS15;ARF6
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),15/83,0.841384125,0.999996398,0,0,0.781111692,0.134903437,ACTR3;NCKAP1;ACTR2;WASL;FNBP1L;CDC42;ANLN;MIEN1;ABI2;ARPC2;F2RL1;RAC1;PFN1;AGRN;WASF2
histone deacetylation (GO:0016575),8/47,0.842174178,0.999996398,0,0,0.726563822,0.124800723,MORF4L1;REST;SFPQ;HDAC3;MORF4L2;PRDM5;PHB;TBL1X
negative regulation of cold-induced thermogenesis (GO:0120163),8/47,0.842174178,0.999996398,0,0,0.726563822,0.124800723,RHEB;DOCK7;ARRDC3;ID1;ACOT13;PCTP;RBPJ;LGR4
positive regulation of cell-cell adhesion (GO:0022409),8/47,0.842174178,0.999996398,0,0,0.726563822,0.124800723,TJP1;AFDN;MDK;PODXL;FLOT1;PLAUR;JAK1;SMAD7
regulation of DNA binding (GO:0051101),8/47,0.842174178,0.999996398,0,0,0.726563822,0.124800723,MAPK8;JUN;KDM1A;SUMO1;SUMO3;PLAUR;HMGB1;NME1
telomere organization (GO:0032200),8/47,0.842174178,0.999996398,0,0,0.726563822,0.124800723,STN1;XRCC6;PCNA;RIF1;PARP1;PTGES3;RPA3;RPA1
activation of protein kinase B activity (GO:0032148),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,PDGFB;NRG1;PARK7;MT3;PPIA
cellular response to cAMP (GO:0071320),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,RAP1B;AKAP9;EZR;SLC5A5;ZFP36L1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,UBB;CHUK;UBE2D3;UBC;RPS27A
negative regulation of axon extension (GO:0030517),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,PTPRS;SEMA6A;SEMA3E;DIP2B;MT3
negative regulation of DNA binding (GO:0043392),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,JUN;KDM1A;SUMO1;SUMO3;SOX11
phosphatidylethanolamine metabolic process (GO:0046337),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,CHKA;ETNK1;PLA2G10;PLA2G6;SELENOI
vitamin transport (GO:0051180),31-May,0.84371022,0.999996398,0,0,0.681257437,0.115777102,SLC23A1;PDPN;FOLR1;SLC19A1;ABCG2
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),12/68,0.845538105,0.999996398,0,0,0.758861439,0.127323323,FKBP1A;SPRED2;SPRED1;UBB;PEG10;UBC;SPRY2;SPRY1;RPS27A;SKIL;SNX6;SMAD7
regulation of myeloid cell differentiation (GO:0045637),12/68,0.845538105,0.999996398,0,0,0.758861439,0.127323323,PURB;HSPA9;KMT2A;EIF6;LEO1;DPY30;EP300;PTK2B;WDR61;MYL9;THBS1;CDC73
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),7/42,0.84749871,0.999996398,0,0,0.708420574,0.117219492,DDX3X;FEM1B;PMAIP1;CFLAR;ARHGEF2;THBS1;BCL2L1
activation of cysteine-type endopeptidase activity (GO:0097202),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,CYFIP2;PERP
atrial septum development (GO:0003283),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,TGFB2;ANK2
atrioventricular valve development (GO:0003171),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,TGFB2;BMPR1A
cardiolipin metabolic process (GO:0032048),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,TAMM41;PLA2G6
dicarboxylic acid catabolic process (GO:0043649),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,GLUD1;GOT1
intestinal absorption (GO:0050892),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,F11R;TJP2
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,NAPRT;NAMPT
negative regulation of cyclase activity (GO:0031280),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,GNAI3;AKAP5
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,KDM1A;MIF
negative regulation of interleukin-12 production (GO:0032695),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,C1QBP;THBS1
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,REST;PDGFB
negative regulation of secretion (GO:0051048),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,NRG1;VAMP3
negative regulation of T cell differentiation (GO:0045581),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,MDK;GLI3
neurotransmitter biosynthetic process (GO:0042136),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,MOXD1;ALDH9A1
nuclear migration (GO:0007097),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,PCM1;DOCK7
pancreas development (GO:0031016),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,ZIC3;CCDC40
positive regulation of alpha-beta T cell differentiation (GO:0046638),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,PNP;GLI3
positive regulation of brown fat cell differentiation (GO:0090336),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,HNRNPU;METRNL
positive regulation of glycoprotein biosynthetic process (GO:0010560),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,SOAT1;CHP1
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,PPP3CB;PLA2G6
positive regulation of leukocyte degranulation (GO:0043302),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,ITGAM;F2RL1
positive regulation of long-term synaptic potentiation (GO:1900273),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,APP;AKAP5
positive regulation of lymphocyte migration (GO:2000403),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,APP;RHOA
positive regulation of superoxide anion generation (GO:0032930),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,ITGAM;F2RL1
positive regulation of T cell receptor signaling pathway (GO:0050862),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,RPS3;NECTIN2
protein localization to vacuole (GO:0072665),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,SH3GLB1;RNF128
pyrimidine nucleoside biosynthetic process (GO:0046134),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,UCK2;UMPS
regulation of gastrulation (GO:0010470),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,DAG1;RACK1
regulation of integrin-mediated signaling pathway (GO:2001044),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,FLNA;LIMS1
regulation of lipase activity (GO:0060191),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,RHOC;RHOA
regulation of protein kinase C signaling (GO:0090036),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,DGKD;MYADM
regulation of response to endoplasmic reticulum stress (GO:1905897),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,CLU;MANF
regulation of retinoic acid receptor signaling pathway (GO:0048385),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,CALR;EZH2
relaxation of muscle (GO:0090075),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,CAMK2D;GSN
renal absorption (GO:0070293),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,CLDN4;GSN
respiratory electron transport chain (GO:0022904),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,NDUFA5;GPD2
secondary palate development (GO:0062009),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,TGFB2;CHD7
T cell differentiation in thymus (GO:0033077),14-Feb,0.847502245,0.999996398,0,0,0.590550883,0.097713607,GLI3;ZFP36L1
organonitrogen compound catabolic process (GO:1901565),11/63,0.847802908,0.999996398,0,0,0.749154547,0.123690728,BCKDK;NPEPPS;RIDA;ANPEP;PLA2G10;IDE;ADO;UCHL3;PLA2G6;CLN6;TXN2
cardiac epithelial to mesenchymal transition (GO:0060317),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,TGFB2;SPRY1;RBPJ
cellular response to interferon-beta (GO:0035458),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,TRIM6;CDC34;UBE2K
dopaminergic neuron differentiation (GO:0071542),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,RYK;CTNNB1;MANF
energy reserve metabolic process (GO:0006112),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,GFPT2;MYC;MT3
glucose transmembrane transport (GO:1904659),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,SORT1;SLC2A1;SLC2A3
hepaticobiliary system development (GO:0061008),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,XBP1;LSR;CDK5RAP3
insulin secretion (GO:0030073),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,PTPRN;PARK7;CAMK2G
natural killer cell mediated immunity (GO:0002228),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,KIF5B;TUBB4B;ARL8B
oligodendrocyte differentiation (GO:0048709),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,EIF2B3;MYRF;EIF2B1
positive regulation of dendrite morphogenesis (GO:0050775),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,FBXW8;CAPRIN1;DBN1
positive regulation of heart contraction (GO:0045823),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,GSK3A;TGFB2;ATP2A2
regulation of lymphocyte differentiation (GO:0045619),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,PRELID1;XRCC6;ZFP36L1
regulation of smooth muscle contraction (GO:0006940),20-Mar,0.849079137,0.999996398,0,0,0.62523072,0.102289549,CNN1;CTTN;F2R
negative regulation of neuron projection development (GO:0010977),10/58,0.850670381,0.999996398,0,0,0.737825476,0.119328925,EFNB2;PTPRS;PRAG1;ARHGDIA;PTEN;STMN2;CRMP1;FKBP4;MT3;RHOA
RNA modification (GO:0009451),10/58,0.850670381,0.999996398,0,0,0.737825476,0.119328925,DTWD1;SSB;TYW5;NSUN2;PARN;NAT10;LCMT2;PUS7;NOP10;FTSJ3
positive regulation of stress-activated MAPK cascade (GO:0032874),18/99,0.85198118,0.999996398,0,0,0.786777195,0.126034501,APP;TGFB2;GADD45A;FZD7;WNT7B;HMGB1;MID1;MAPK8IP1;GADD45G;DUSP22;TRAF4;TAOK3;PDCD10;TAOK1;MBIP;PTK2B;F2RL1;MAP3K4
positive regulation of hydrolase activity (GO:0051345),28/149,0.853599644,0.999996398,0,0,0.819045495,0.129649165,USP6NL;ITGB1;RAP1GDS1;F11R;RASGRP2;MAPK8;RACK1;RPS3;ECT2;ZC3H15;S100A10;F2R;RHOC;RHOA;MAPK12;RCN3;AFDN;TBC1D7;F2RL1;CALM3;PLXNB1;ITGA6;CALM1;AGRN;CALM2;FERMT2;EZH2;LIMS1
vascular transport (GO:0010232),15/84,0.854350948,0.999996398,0,0,0.769741668,0.121167517,SLC38A1;SLC16A1;TFRC;SLC2A1;SLC1A3;SLC2A3;LRP2;SLC5A5;SLC7A3;SLC6A6;SLC16A2;SLC29A1;SLC38A2;SLC19A1;ABCG2
lysosome localization (GO:0032418),6/37,0.854416051,0.999996398,0,0,0.685588462,0.107868449,SNAPIN;BLOC1S1;KIF5B;MYH9;LAMTOR1;ARL8B
neural crest cell migration (GO:0001755),6/37,0.854416051,0.999996398,0,0,0.685588462,0.107868449,SEMA6A;ANXA6;SEMA3E;PITX2;FOLR1;CORO1C
phospholipid biosynthetic process (GO:0008654),6/37,0.854416051,0.999996398,0,0,0.685588462,0.107868449,IDI1;NUS1;SAMD8;MBOAT1;FAR1;AGPAT4
positive regulation of signaling receptor activity (GO:2000273),6/37,0.854416051,0.999996398,0,0,0.685588462,0.107868449,ITGB1;FBXW7;BUD31;PARK7;HIF1A;HBEGF
regulation of microtubule cytoskeleton organization (GO:0070507),6/37,0.854416051,0.999996398,0,0,0.685588462,0.107868449,ROCK1;TAOK1;STMN1;STMN2;EFNA5;MAPRE1
double-strand break repair (GO:0006302),31/164,0.855502846,0.999996398,0,0,0.824910101,0.128740303,VCP;RIF1;PSMD14;DDX1;NUCKS1;SMC6;BRCC3;HMGB1;SAMHD1;MAPK8;SFR1;SUMO1;RAD21;SWI5;NSD2;ZSWIM7;XRCC6;PARP1;PARP2;RPA1;SEM1;SETX;MORF4L1;MMS22L;SFPQ;TDP1;ERCC1;RPA3;NABP2;UBE2N;NABP1
DNA geometric change (GO:0032392),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,DHX9;DDX1;HNRNPA2B1;HMGB1
DNA modification (GO:0006304),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,PARP1;PARP2;TDG;EXOSC3
histone lysine demethylation (GO:0070076),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,KDM1A;RIOX2;JMJD1C;KDM7A
lamellipodium assembly (GO:0030032),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,ITGB1;CARMIL1;GOLPH3;RAC1
meiosis I (GO:0007127),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,DNMT3L;DDX4;BCL2L11;MEIOC
negative regulation of cell development (GO:0010721),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,GSK3A;PCM1;REST;FBXW7
negative regulation of protein transport (GO:0051224),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,RHBDF1;DPH3;RHBDF2;HMGCR
negative regulation of signaling receptor activity (GO:2000272),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,RAMP3;TSG101;SOCS4;SNX6
positive regulation of interleukin-2 production (GO:0032743),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,PNP;GLMN;RPS3;SPTBN1
regulation of biomineral tissue development (GO:0070167),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,CEBPB;ROCK1;ROCK2;BMP2K
regulation of myelination (GO:0031641),26-Apr,0.855514673,0.999996398,0,0,0.644116857,0.100515746,RNF10;MYRF;TMEM98;DICER1
cellular response to alcohol (GO:0097306),8/48,0.858825404,0.999996398,0,0,0.7083542,0.107804166,GOLPH3;GNG2;LARP1;JUP;CDH1;GNB1;CTNNA1;CTNNB1
negative regulation of MAP kinase activity (GO:0043407),8/48,0.858825404,0.999996398,0,0,0.7083542,0.107804166,UCHL1;DUSP1;SPRY4;SPRY2;SPRY1;PIK3CB;CDK5RAP3;MAPK8IP1
substrate adhesion-dependent cell spreading (GO:0034446),8/48,0.858825404,0.999996398,0,0,0.7083542,0.107804166,LAMA5;LAMB1;PARVA;RAC1;EPHA1;RHOA;FERMT2;VAMP3
negative regulation of cellular catabolic process (GO:0031330),12/69,0.859457256,0.999996398,0,0,0.745500114,0.112909113,GSK3A;MTMR2;ROCK1;TIMP2;TLK2;EIF4E;MT3;EIF4G3;CDK5RAP3;EIF4G2;MCL1;PTPN3
macroautophagy (GO:0016236),22/120,0.861895899,0.999996398,0,0,0.794660043,0.118102998,GABARAPL1;VCP;TSG101;CSNK2A1;VTA1;MTMR14;VPS4B;CSNK2A2;WIPI1;DYNLL1;TOMM22;MAP1LC3A;CHMP2A;UBQLN1;TOMM7;PLAA;CHMP3;VDAC1;VPS36;TOMM5;ARL8B;VTI1B
protein catabolic process (GO:0030163),11/64,0.862052568,0.999996398,0,0,0.734972278,0.109098569,DDB1;HSPA8;HSP90AA1;VCP;PMAIP1;UBE2G1;IDE;STT3B;UCHL3;CLN6;CUL4B
protein secretion (GO:0009306),11/64,0.862052568,0.999996398,0,0,0.734972278,0.109098569,RCN3;RAB10;PORCN;GOLPH3;RAB15;PTPRN;SVBP;CANX;MIA3;PARK7;CAMK2G
tRNA processing (GO:0008033),11/64,0.862052568,0.999996398,0,0,0.734972278,0.109098569,DTWD1;SSB;TYW5;RPP30;NSUN2;DDX1;ZBTB8OS;LCMT2;FAM98B;TRNT1;RTRAF
ammonium transmembrane transport (GO:0072488),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SLC12A4
anterograde axonal protein transport (GO:0099641),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,KIF5B
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,IDE
aromatic compound biosynthetic process (GO:0019438),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PSAT1
autophagosome-lysosome fusion (GO:0061909),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ARL8B
axo-dendritic protein transport (GO:0099640),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,KIF5B
basic amino acid transport (GO:0015802),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SLC7A7
brown fat cell differentiation (GO:0050873),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,METRNL
carbohydrate phosphorylation (GO:0046835),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FGGY
cardiac atrium development (GO:0003230),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ANK2
cardiac muscle hypertrophy (GO:0003300),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,INPP5F
cellular response to interleukin-21 (GO:0098757),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,JAK1
cellular response to UV-B (GO:0071493),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CRIP1
collecting duct development (GO:0072044),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,WNT7B
commissural neuron axon guidance (GO:0071679),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,RYK
cysteine metabolic process (GO:0006534),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,GCLC
depyrimidination (GO:0045008),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TDG
dynamin family protein polymerization involved in membrane fission (GO:0003373),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DNM1L
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DNM1L
ER overload response (GO:0006983),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TMCO1
excitatory synapse assembly (GO:1904861),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PTEN
forebrain neuron development (GO:0021884),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FGFR2
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,EXT1
immunological synapse formation (GO:0001771),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MSN
integrin activation (GO:0033622),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FERMT2
interleukin-21-mediated signaling pathway (GO:0038114),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,JAK1
kidney epithelium development (GO:0072073),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,WNT7B
lens fiber cell differentiation (GO:0070306),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,WNT7B
lipid import into cell (GO:0140354),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,RPS6KB1
lymphatic endothelial cell differentiation (GO:0060836),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PDPN
macromolecule depalmitoylation (GO:0098734),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ABHD17C
mammary gland epithelial cell differentiation (GO:0060644),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ID2
mitochondrial respiratory chain complex III assembly (GO:0034551),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,UQCC2
mitophagy (GO:0000423),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PHB2
mitotic spindle elongation (GO:0000022),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,KIF23
mitotic spindle midzone assembly (GO:0051256),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,KIF23
multi-ciliated epithelial cell differentiation (GO:1903251),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,E2F4
myeloid leukocyte mediated immunity (GO:0002444),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PLA2G1B
myoblast migration (GO:0051451),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ROCK1
negative regulation of actin nucleation (GO:0051126),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,GMFB
negative regulation of appetite (GO:0032099),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MKKS
negative regulation of calcium ion import (GO:0090281),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,VDAC1
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PKIG
"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TWSG1
"negative regulation of complement activation, classical pathway (GO:0045959)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CR2
negative regulation of fatty acid oxidation (GO:0046322),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ACADL
negative regulation of glial cell apoptotic process (GO:0034351),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PRKCI
negative regulation of glucose import (GO:0046325),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,GSK3A
negative regulation of long-term synaptic potentiation (GO:1900272),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,APP
negative regulation of macrophage migration (GO:1905522),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MIF
negative regulation of microglial cell activation (GO:1903979),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SYT11
negative regulation of monooxygenase activity (GO:0032769),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,NFKB1
negative regulation of mRNA polyadenylation (GO:1900364),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ZC3H14
negative regulation of muscle hypertrophy (GO:0014741),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,GLRX3
negative regulation of neural precursor cell proliferation (GO:2000178),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SLC16A2
negative regulation of osteoblast proliferation (GO:0033689),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PLXNB1
negative regulation of response to reactive oxygen species (GO:1901032),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PARK7
negative regulation of striated muscle cell apoptotic process (GO:0010664),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MDK
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PDGFB
neurotransmitter receptor diffusion trapping (GO:0099628),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CACNG7
neurotransmitter reuptake (GO:0098810),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SLC29A1
osteoblast development (GO:0002076),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,LIMD1
peptidyl-serine autophosphorylation (GO:0036289),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MARK3
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DUSP3
positive regulation of aspartic-type peptidase activity (GO:1905247),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ROCK2
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MYB
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,GSN
positive regulation of dendritic cell cytokine production (GO:0002732),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DDX58
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FZD7
positive regulation of extracellular matrix disassembly (GO:0090091),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PDPN
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PHIP
positive regulation of MHC class II biosynthetic process (GO:0045348),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,XBP1
positive regulation of myeloid cell apoptotic process (GO:0033034),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PIK3CB
positive regulation of oligodendrocyte differentiation (GO:0048714),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MDK
postsynapse organization (GO:0099173),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ARF1
postsynaptic density organization (GO:0097106),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PTEN
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CACNG7
protein deglycosylation (GO:0006517),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PARK7
protein depalmitoylation (GO:0002084),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ABHD17C
protein localization to presynapse (GO:1905383),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,KIF5B
purine ribonucleoside monophosphate catabolic process (GO:0009169),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PNP
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PDK1
regulation of acyl-CoA biosynthetic process (GO:0050812),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PDK1
regulation of alpha-beta T cell proliferation (GO:0046640),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MAPK8IP1
regulation of apoptotic cell clearance (GO:2000425),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,HMGB1
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,VMP1
"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TWSG1
"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MAPK8IP1
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DDX3X
regulation of chemokine-mediated signaling pathway (GO:0070099),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,HIF1A
regulation of collateral sprouting (GO:0048670),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PTPRS
regulation of cytoplasmic translational elongation (GO:1900247),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DPH3
regulation of dendritic spine maintenance (GO:1902950),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PRNP
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TGFB2
regulation of extent of cell growth (GO:0061387),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CTTN
regulation of extracellular matrix constituent secretion (GO:0003330),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,IER3IP1
regulation of Golgi to plasma membrane protein transport (GO:0042996),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,RACK1
regulation of interleukin-18 production (GO:0032661),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DHX9
regulation of microvillus organization (GO:0032530),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PODXL
regulation of mitochondrial gene expression (GO:0062125),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,METTL4
regulation of nitric oxide metabolic process (GO:0080164),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,RAC1
regulation of nitrogen compound metabolic process (GO:0051171),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,ROCK2
regulation of osteoclast development (GO:2001204),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FBXW7
regulation of oxidative stress-induced neuron death (GO:1903203),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,REST
regulation of phospholipase A2 activity (GO:0032429),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PLAA
regulation of protein ADP-ribosylation (GO:0010835),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PUM3
regulation of protein localization to cell cortex (GO:1904776),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,EPB41L2
regulation of proton transport (GO:0010155),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PHB2
regulation of stem cell division (GO:2000035),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SFRP2
regulation of striated muscle tissue development (GO:0016202),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MTPN
regulation of vascular wound healing (GO:0061043),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,XBP1
replication fork protection (GO:0048478),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TIPIN
respiratory chain complex III assembly (GO:0017062),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,UQCC2
sequestering of BMP from receptor via BMP binding (GO:0038098),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,FSTL1
single strand break repair (GO:0000012),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,TDP1
skeletal muscle tissue regeneration (GO:0043403),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CFLAR
snRNA transcription by RNA polymerase III (GO:0042796),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SNAPC3
somatic hypermutation of immunoglobulin genes (GO:0016446),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,SAMHD1
spleen development (GO:0048536),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,PITX2
store-operated calcium entry (GO:0002115),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,CRACR2B
stress-induced premature senescence (GO:0090400),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MAPK14
sulfur amino acid biosynthetic process (GO:0000097),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,MTHFD1
TORC1 signaling (GO:0038202),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,LARP1
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),08-Jan,0.863111852,0.999996398,0,0,0.506233766,0.074523173,DARS2
cardiac muscle tissue morphogenesis (GO:0055008),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,FKBP1A;TPM1;PKP2;FGFR2;SMAD7
negative regulation of developmental growth (GO:0048640),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,PTPRS;WWC1;PTEN;DIP2B;MT3
positive regulation of glucose transmembrane transport (GO:0010828),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,CLIP3;PRKCI;BRAF;ERFE;ARPP19
positive regulation of immune effector process (GO:0002699),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,XBP1;MYB;MYO18A;PHB;IL2
regulation of dendrite morphogenesis (GO:0048814),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,FBXW8;CAPRIN1;NEDD4;KNDC1;YWHAH
skeletal muscle organ development (GO:0060538),5/32,0.863491155,0.999996398,0,0,0.655983554,0.096279772,FXR1;MYL6;SIX4;BASP1;CFLAR
negative regulation of multicellular organismal process (GO:0051241),41/214,0.863657462,0.999996398,0,0,0.838502943,0.12290696,GSK3A;PPP1R11;ROCK1;ROCK2;WWC1;HPN;DOCK7;TACSTD2;PTEN;PCTP;HMGCR;RBPJ;ADIPOR1;LOXL2;CORO1C;PPP2CA;SPRED2;GJA1;RPS6KA6;SPRED1;CHSY1;MDK;IFNGR1;ARRDC3;F2R;ACOT13;GRHL2;WDR77;SMAD7;KLF7;TWSG1;SFRP2;SDHAF2;RHEB;SYT11;ID1;SPRY2;SPRY1;CALR;SRSF6;LGR4
positive regulation of protein modification process (GO:0031401),41/214,0.863657462,0.999996398,0,0,0.838502943,0.12290696,APP;ANKLE2;DDX3X;HDAC3;TFRC;ROCK2;KNDC1;ARRB1;EFNA5;STK4;FXR1;PTPA;PTBP1;PAK1;PPP1R7;RACK1;FLOT1;CHP1;CAMTA1;RAC1;MAPK3;HSP90AA1;CEP295;LIMK2;IGF2;PLAUR;PPP2R5A;MT3;CLIP3;FGF17;DAB2;CLDN3;TAOK1;UBE2N;RAB3GAP2;CDK2AP1;CALM3;KRAS;CALM1;CALM2;PPIA
cellular response to glucose starvation (GO:0042149),7/43,0.864553941,0.999996398,0,0,0.688697972,0.100234191,SH3GLB1;NUAK1;XBP1;IMPACT;HSPA5;PMAIP1;HNRNPA1
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),7/43,0.864553941,0.999996398,0,0,0.688697972,0.100234191,MMS22L;TIPIN;PCNA;ATRX;THOC1;NUCKS1;CENPS
positive regulation of neuron differentiation (GO:0045666),7/43,0.864553941,0.999996398,0,0,0.688697972,0.100234191,IMPACT;REST;SOX11;ARHGEF2;ECT2;RHOA;FGFR1
spermatid development (GO:0007286),7/43,0.864553941,0.999996398,0,0,0.688697972,0.100234191,CEP57;MKKS;DDX25;MEIOC;CDYL;TDRD5;NECTIN2
negative regulation of protein kinase activity (GO:0006469),16/90,0.865199898,0.999996398,0,0,0.765508953,0.110841641,CDKN1C;NPM1;DUSP3;GADD45A;PRKRIP1;PARK7;CORO1C;SPRED1;CHP1;SFN;EPHA1;PPIA;PAK2;CDK5RAP3;YWHAG;RTRAF
protein transport (GO:0015031),73/369,0.865651095,0.999996398,0,0,0.872008012,0.125807512,USP6NL;VPS29;ARF4;ARF1;TFRC;PDCD6;CLTC;ARHGAP1;MIA3;HIKESHI;CLU;GOLGA4;ARL5C;KIF13A;TMED3;TMED2;TLK1;EIF2D;GOLGA7;ARL5A;YWHAH;ARRDC4;NDC1;ATP6V1G1;SEC13;TMED9;COG7;ARRDC1;ARRDC3;STX7;LMTK2;COPZ1;ARL4C;RCN3;ARL4A;RAB31;CTTN;CANX;TXNIP;CHMP3;MYH9;ARHGEF2;OPTN;ARF5;ARF6;COPB2;RABGAP1;RAMP3;CALCRL;TMED10;SAR1A;USO1;LRP2;HSP90B1;SNX27;SVBP;RAB6A;ATP6V1D;SPTBN1;TBC1D15;SEC31A;SNX6;ATP6V1F;NPM1;ARCN1;VMP1;RAB10;GOLPH3;RAB14;RAB15;CHMP2A;RAB18;RAB3GAP2
negative regulation of cellular response to growth factor stimulus (GO:0090288),14/80,0.868071318,0.999996398,0,0,0.751055115,0.106260332,PDCD6;UBE2D3;SPRY4;LRP2;THBS1;SMAD5;SMAD7;GPC1;NEDD4;SPRY2;SPRY1;SKIL;TRIM33;BMPR1A
regulation of NIK/NF-kappaB signaling (GO:1901222),14/80,0.868071318,0.999996398,0,0,0.751055115,0.106260332,APP;DDX3X;ACTN4;PHB;ADIPOR1;PHB2;RHOA;TRIM6;TMSB4X;RPS3;EP300;EZR;TRIM44;LIMS1
protein localization to membrane (GO:0072657),37/195,0.868200694,0.999996398,0,0,0.828581664,0.117105416,RAMP3;ROCK1;ROCK2;F11R;LIN7C;ARL5C;TMEM88;CDH1;BSG;FLOT1;TMED2;FLNA;FLOT2;ARL5A;SPTBN1;S100A10;NDC1;SH3GLB1;JUP;SEC16A;RDX;MYO5A;ANK2;BRAF;ATP1B3;SYNJ2BP;RAB11A;RAB10;EHD2;RAB15;WNK3;MYADM;PKP2;EZR;AGRN;FERMT2;CRB3
negative regulation of endothelial cell migration (GO:0010596),6/38,0.871818983,0.999996398,0,0,0.66412116,0.091099801,JUP;GADD45A;SVBP;HMGB1;SYNJ2BP;THBS1
positive regulation of insulin secretion (GO:0032024),6/38,0.871818983,0.999996398,0,0,0.66412116,0.091099801,GLUD1;PPP3CB;NNAT;ACSL4;PLA2G6;SOX4
positive regulation of potassium ion transport (GO:0043268),6/38,0.871818983,0.999996398,0,0,0.66412116,0.091099801,GNG2;KIF5B;FHL1;GNB1;FLNA;ANK2
positive regulation of signaling (GO:0023056),6/38,0.871818983,0.999996398,0,0,0.66412116,0.091099801,RAMP3;INPP5F;ANXA2;ECE1;SOX11;VAMP3
regulation of axon extension (GO:0030516),6/38,0.871818983,0.999996398,0,0,0.66412116,0.091099801,GOLGA4;PTPRS;CTTN;DIP2B;MT3;DBN1
beta-catenin destruction complex disassembly (GO:1904886),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,CSNK1A1;CTNNB1;PPP1CA
cellular response to inorganic substance (GO:0071241),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,ATRX;MT3;FOXO1
chondroitin sulfate biosynthetic process (GO:0030206),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,CHSY1;NCAN;CHST15
heparan sulfate proteoglycan metabolic process (GO:0030201),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,EXT1;GPC1;HS6ST2
myotube differentiation (GO:0014902),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,MYEF2;SIX4;SORT1
positive regulation of glycolytic process (GO:0045821),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,APP;PFKFB3;HIF1A
positive regulation of purine nucleotide metabolic process (GO:1900544),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,APP;PFKFB3;HIF1A
positive regulation of transcription regulatory region DNA binding (GO:2000679),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,TRIM6;EP300;PARK7
purinergic nucleotide receptor signaling pathway (GO:0035590),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,APP;HSP90AB1;TXNIP
regulation of cardiac muscle cell proliferation (GO:0060043),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,RBPJ;FGFR2;BMPR1A
regulation of cholesterol metabolic process (GO:0090181),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,ACADL;KPNB1;RAN
zinc ion transport (GO:0006829),21-Mar,0.87217436,0.999996398,0,0,0.590457784,0.080754502,SLC30A9;MT3;SLC39A14
establishment of protein localization to membrane (GO:0090150),12/70,0.872369793,0.999996398,0,0,0.732599524,0.10003051,RAB10;AFDN;PRKCI;MYO1C;ZDHHC20;NACA;ZDHHC6;RAB3GAP2;BRAF;GOLGA7;NECTIN3;RAB11A
regulation of MAPK cascade (GO:0043408),31/166,0.872852172,0.999996398,0,0,0.812584117,0.110502559,FLT1;ROCK1;SHC1;ROCK2;NRK;WWC1;PDGFB;PEBP1;IQGAP1;HMGB1;STK4;IGF1R;SPRED1;PAK1;DAG1;MAPK1;PAK2;MAPK3;DUSP3;DUSP1;RYK;F2R;IGF2;YWHAZ;TAOK3;TAOK1;LAMTOR1;FGFR2;ARHGEF5;FGFR1;GSDME
cellular response to mechanical stimulus (GO:0071260),8/49,0.874027333,0.999996398,0,0,0.691032852,0.093043172,CNN2;MAPK8;MAP3K1;GADD45A;BNIP3;F11R;NFKB1;MAPK3
positive regulation of reactive oxygen species metabolic process (GO:2000379),8/49,0.874027333,0.999996398,0,0,0.691032852,0.093043172,ITGAM;GADD45A;PDGFB;RAB27A;F2RL1;ROMO1;MAPK14;THBS1
regulation of interferon-beta production (GO:0032648),8/49,0.874027333,0.999996398,0,0,0.691032852,0.093043172,HSP90AA1;DDX3X;PTPRS;DDX58;DHX9;RIOK3;FLOT1;POLR3G
regulation of smooth muscle cell proliferation (GO:0048660),8/49,0.874027333,0.999996398,0,0,0.691032852,0.093043172,XRCC6;IGFBP3;ID2;PDGFB;CTNNB1;PHB;THBS1;FOXP1
cellular response to chemical stress (GO:0062197),18/101,0.874080148,0.999996398,0,0,0.76771975,0.103322184,DDX3X;SRXN1;PARP1;GPX3;TXNRD1;PYCR2;PARK7;EIF2S1;MT3;PRDX6;FOXO1;SETX;PRDX2;PRDX5;PRDX1;CYCS;PPIA;SLC25A24
aflatoxin metabolic process (GO:0046222),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,MGST3;MGST1
C21-steroid hormone biosynthetic process (GO:0006700),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,STARD3NL;TSPO
cellular response to estrogen stimulus (GO:0071391),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,SFR1;SRA1
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,NCAN;DSE
detection of mechanical stimulus involved in sensory perception (GO:0050974),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,MKKS;HPN
engulfment of apoptotic cell (GO:0043652),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,RAC1;THBS1
establishment of spindle localization (GO:0051293),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,CFL1;KPNB1
glucan catabolic process (GO:0009251),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PGM2;CALM1
glycogen catabolic process (GO:0005980),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PGM2;CALM1
heterocycle biosynthetic process (GO:0018130),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PYCR2;LIAS
histone H3 deacetylation (GO:0070932),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,SFPQ;HDAC3
histone mRNA catabolic process (GO:0071044),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,SSB;LSM1
icosanoid biosynthetic process (GO:0046456),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PLA2G1B;MGST3
interleukin-27-mediated signaling pathway (GO:0070106),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,CANX;JAK1
macrophage differentiation (GO:0030225),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,CDC42;PARP1
mammary gland epithelium development (GO:0061180),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,WNT7B;ID2
mitochondrial RNA metabolic process (GO:0000959),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,TFAM;MRPL12
mitotic recombination (GO:0006312),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,ERCC1;SMC6
mRNA methylation (GO:0080009),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,NSUN2;METTL16
mycotoxin metabolic process (GO:0043385),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,MGST3;MGST1
nitric oxide biosynthetic process (GO:0006809),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,GCHFR;CYB5R3
organic heteropentacyclic compound metabolic process (GO:1901376),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,MGST3;MGST1
peptidyl-arginine modification (GO:0018195),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,KRTCAP2;PARK7
"phototransduction, visible light (GO:0007603)",15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,GNA11;GNB1
positive regulation of chromatin organization (GO:1905269),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,ATRX;UBE2N
positive regulation of endothelial cell chemotaxis (GO:2001028),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,TMSB4X;FGFR1
positive regulation of lyase activity (GO:0051349),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,AKAP5;PARK7
positive regulation of pattern recognition receptor signaling pathway (GO:0062208),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,USP15;PUM2
prostanoid biosynthetic process (GO:0046457),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PTGES3;MIF
protein kinase A signaling (GO:0010737),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,RDX;EZR
regulation of branching involved in ureteric bud morphogenesis (GO:0090189),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,SIX4;TACSTD2
regulation of endothelial cell chemotaxis (GO:2001026),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,TMSB4X;THBS1
regulation of establishment of protein localization (GO:0070201),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,CEP295;GAPVD1
regulation of extracellular matrix disassembly (GO:0010715),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,DDR1;PDPN
regulation of phospholipase C activity (GO:1900274),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,FLT1;FGFR1
regulation of superoxide anion generation (GO:0032928),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,ITGAM;F2RL1
response to acidic pH (GO:0010447),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,IMPACT;CHP1
response to muscle stretch (GO:0035994),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,GSN;CTNNB1
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,RPP30;DICER1
T cell proliferation (GO:0042098),15-Feb,0.874296825,0.999996398,0,0,0.545088919,0.073224708,PPP3CB;MSN
modulation of excitatory postsynaptic potential (GO:0098815),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,APP;MTMR2;PTEN;PTK2B
negative regulation of catalytic activity (GO:0043086),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,CAND1;PPP1R12A;PHPT1;MT3
peptide hormone secretion (GO:0030072),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,PTPRN;LTBP4;PARK7;CAMK2G
peroxisomal membrane transport (GO:0015919),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,ATAD1;FIS1;PEX19;PEX2
positive regulation of erythrocyte differentiation (GO:0045648),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,MED1;MAPK14;ETS1;HIF1A
positive regulation of striated muscle cell differentiation (GO:0051155),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,EFNB2;MMP14;NRG1;MAPK14
positive regulation of toll-like receptor signaling pathway (GO:0034123),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,DDX3X;FLOT1;F2RL1;HMGB1
regulation of blood coagulation (GO:0030193),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,SERPINE2;F2R;F2RL1;THBS1
regulation of toll-like receptor signaling pathway (GO:0034121),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,OTUD4;FLOT1;FLOT2;LGR4
regulation of transcription regulatory region DNA binding (GO:2000677),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,TRIM6;NSD1;SOX11;PARK7
regulation of vasculature development (GO:1901342),27-Apr,0.875586112,0.999996398,0,0,0.616072223,0.081852449,EGLN1;VASH2;CTNNB1;ETS1
regulation of neuron death (GO:1901214),15/86,0.877811204,0.999996398,0,0,0.747962467,0.097477265,PRNP;EGLN3;ITGAM;RRAS2;DHCR24;PARK7;CLU;EIF2S1;EFNB2;REST;UBB;RILPL1;DDIT4;CHP1;NAE1
regulation of autophagy (GO:0010506),44/231,0.880471392,0.999996398,0,0,0.832305013,0.105950632,VPS29;GSK3A;ROCK1;ITPR1;CISD2;HMGB1;PIK3CB;PIK3C2A;FOXO1;MTDH;TRIM6;UCHL1;MAPK8;CAPNS1;LAMP3;TLK2;UBQLN1;EP300;DNM1L;ATP6V1D;EIF4E;SNX5;SNX6;MCL1;SH3GLB1;ATP6V1G1;DAPK1;FBXW7;BNIP3;CSNK2A2;MT3;EEF1A1;TMEM59;HAX1;RHEB;NEDD4;VDAC1;LAMTOR2;LAMTOR1;LAMTOR3;EIF4G3;GAPDH;OPTN;EIF4G2
actin filament bundle organization (GO:0061572),5/33,0.881120996,0.999996398,0,0,0.632514949,0.080051296,CALD1;SHROOM2;ESPN;EZR;AIF1L
negative regulation of JNK cascade (GO:0046329),5/33,0.881120996,0.999996398,0,0,0.632514949,0.080051296,HDAC3;DUSP3;TAOK3;F2RL1;MAPK8IP1
signal transduction by p53 class mediator (GO:0072331),5/33,0.881120996,0.999996398,0,0,0.632514949,0.080051296,DDX5;HINT1;ATRX;PMAIP1;E2F7
vasculogenesis (GO:0001570),5/33,0.881120996,0.999996398,0,0,0.632514949,0.080051296,SPRED1;WNT7B;GLMN;AGGF1;CCM2
positive regulation of growth (GO:0045927),13/76,0.881756605,0.999996398,0,0,0.730592814,0.091937229,MTPN;TGFB2;DDX3X;CSNK2A1;HPN;IL2;CXCL16;CDC42;MMP14;SFRP2;RPS6KA1;EXOSC2;EIF4G2
myeloid leukocyte differentiation (GO:0002573),12/71,0.884315974,0.999996398,0,0,0.720136242,0.088534157,CDC42;PARP1;CDK4;GLO1;PIR;EP300;MYH9;F2RL1;DEK;MAPK14;PML;FOXP1
negative regulation of neuron apoptotic process (GO:0043524),12/71,0.884315974,0.999996398,0,0,0.720136242,0.088534157,NRBP2;PRKCI;SET;SIX4;MDK;NONO;F2R;PTK2B;PARK7;HIF1A;MT3;SNX6
positive regulation of cellular protein localization (GO:1903829),12/71,0.884315974,0.999996398,0,0,0.720136242,0.088534157,YAP1;CARD10;HSP90AB1;GNL3L;TFRC;SYT11;LIMK2;CDK1;PARK7;CDK5RAP3;FERMT2;GNL3
cellular response to ketone (GO:1901655),6/39,0.8874466,0.999996398,0,0,0.643954907,0.076892677,GOLPH3;GNG2;LARP1;ROCK2;GNB1;MSN
DNA recombination (GO:0006310),6/39,0.8874466,0.999996398,0,0,0.643954907,0.076892677,RAD21;ERCC1;RPA1;HMGB1;TSN;RHNO1
negative regulation of secretion by cell (GO:1903531),6/39,0.8874466,0.999996398,0,0,0.643954907,0.076892677,RHBDF1;SYT11;DPH3;RHBDF2;HMGCR;VAMP3
positive regulation of ion transport (GO:0043270),8/50,0.887857723,0.999996398,0,0,0.674536329,0.080231894,AHCYL1;KIF5B;FHL1;F2R;WNK3;PKP2;ANK2;PRSS8
cellular response to starvation (GO:0009267),29/158,0.888375983,0.999996398,0,0,0.795460187,0.094150843,CEBPB;SEH1L;FOXO1;NUAK1;MAPK8;MAP1LC3A;PMAIP1;MAPK1;HNRNPA1;ATP6V1D;ATP6V1F;MAPK3;SH3GLB1;HSPA8;ATP6V1G1;GABARAPL1;XBP1;SEC13;HSPA5;WIPI1;EIF2S1;IMPACT;STK24;RHEB;STK26;BMT2;LAMTOR2;LAMTOR1;LAMTOR3
plasma membrane bounded cell projection organization (GO:0120036),23/128,0.889495635,0.999996398,0,0,0.775222433,0.090779073,APP;CARMIL1;SNAPIN;ROCK1;PLEKHA1;RYK;TPM1;DOCK7;STMN2;BICDL1;LAMB1;HMGB1;PPP1R9A;RAB11A;MANF;CTTN;RAB25;VAPA;BLOC1S1;NEDD4;STMN1;RAC1;ATXN10
positive regulation of epithelial cell proliferation (GO:0050679),22/123,0.890015716,0.999996398,0,0,0.770907052,0.089823128,YAP1;XBP1;PDCD6;FZD7;PTPRN;HPN;VASH2;PDGFB;NME2;SOX11;LAMB1;HIF1A;F3;NME1;TGM1;PDCL3;NRAS;MDK;MYC;AGGF1;SRSF6;FGFR2
positive regulation of cytoskeleton organization (GO:0051495),14/82,0.890323826,0.999996398,0,0,0.728871398,0.084673015,NCKAP1;CARMIL1;WDR1;SORBS3;CDC42;HAX1;CTTN;KATNBL1;CFL2;PTK2B;F2RL1;PFDN2;PFN1;ARF6
fatty-acyl-CoA metabolic process (GO:0035337),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,ACSL4;FAR1;ACACA
mRNA modification (GO:0016556),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,NSUN2;PUS7;METTL16
natural killer cell mediated cytotoxicity (GO:0042267),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,KIF5B;TUBB4B;ARL8B
negative regulation of biomineral tissue development (GO:0070168),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,ROCK1;ROCK2;PTK2B
negative regulation of interleukin-2 production (GO:0032703),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,PRNP;ZFP36;EZR
positive regulation of dendritic spine development (GO:0060999),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,CAPRIN1;LLPH;DBN1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,AKAP9;FLNA;ANK2
regulation of membrane protein ectodomain proteolysis (GO:0051043),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,ROCK1;TIMP2;PTPN3
regulation of response to cytokine stimulus (GO:0060759),22-Mar,0.892081516,0.999996398,0,0,0.559345157,0.063875967,DDX58;DHX9;TAF9
cholesterol metabolic process (GO:0008203),13/77,0.892631617,0.999996398,0,0,0.719131011,0.081679839,IDI1;GGPS1;HMGCS1;DHCR24;HMGCR;LSS;MT3;ACAT2;CLN6;SQLE;SOAT1;PMVK;LBR
negative regulation of developmental process (GO:0051093),13/77,0.892631617,0.999996398,0,0,0.719131011,0.081679839,PTPRS;TFRC;ROCK1;ROCK2;BNIP3;HUWE1;RC3H1;MIF;LOXL2;WDR77;KLF7;RPS6KA6;ANP32B
regulation of organelle assembly (GO:1902115),13/77,0.892631617,0.999996398,0,0,0.719131011,0.081679839,USP6NL;NPM1;PDCD6IP;RABGAP1;TSG101;GSN;CEP295;RDX;MSN;ATXN2L;ATXN2;EZR;TBC1D15
amide transport (GO:0042886),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,PDPN;FOLR1;SLC19A1;ABCG2
carbohydrate derivative biosynthetic process (GO:1901137),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,RRM1;GOLPH3;RRM2;TPI1
cellular zinc ion homeostasis (GO:0006882),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,SLC30A9;SLC39A10;MT3;SLC39A14
glycerophospholipid catabolic process (GO:0046475),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,INPP5F;PLA2G10;PLA2G6;PRDX6
GPI anchor metabolic process (GO:0006505),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,PYURF;PIGQ;PIGM;PIGF
L-amino acid transport (GO:0015807),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,SLC1A3;SFXN1;SLC38A2;SLC7A3
neutral amino acid transport (GO:0015804),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,SLC6A6;SLC38A1;SLC43A2;SLC38A2
positive regulation of defense response to virus by host (GO:0002230),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,TRIM6;HSP90AA1;DDX58;TRIM44
regulation of calcineurin-NFAT signaling cascade (GO:0070884),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,PTBP1;PRNP;CAMTA1;CHP1
"regulation of DNA-templated transcription, elongation (GO:0032784)",28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,DDX39B;THOC1;WDR43;HMGN1
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,PPP2R1B;MCL1;BCL2L1;FGFR1
regulation of plasma membrane bounded cell projection organization (GO:0120035),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,GSK3A;PTEN;MBOAT1;CAMK2G
regulation of postsynapse organization (GO:0099175),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,ABI2;CFL1;ABHD17C;KIF1A
regulation of small molecule metabolic process (GO:0062012),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,BCKDK;ACADL;ADIPOR1;PDK1
response to ketone (GO:1901654),28-Apr,0.893195468,0.999996398,0,0,0.590364643,0.066681588,YAP1;TGFB2;UBE3A;THBS1
adenosine metabolic process (GO:0046085),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ADA
alpha-amino acid biosynthetic process (GO:1901607),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MTHFD1
androgen biosynthetic process (GO:0006702),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MED1
bone resorption (GO:0045453),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,PTK2B
cellular response to interleukin-9 (GO:0071355),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,JAK1
cellular response to leptin stimulus (GO:0044320),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MT3
cholesterol catabolic process (GO:0006707),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MT3
cytolysis by host of symbiont cells (GO:0051838),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ROMO1
cytolysis in other organism involved in symbiotic interaction (GO:0051801),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ROMO1
development of primary female sexual characteristics (GO:0046545),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,NUP107
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CCDC40
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,RBPJ
glycerolipid biosynthetic process (GO:0045017),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,FAR1
histone arginine methylation (GO:0034969),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CARM1
histone phosphorylation (GO:0016572),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CCNA2
hormone transport (GO:0009914),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SLC16A2
inner ear receptor cell development (GO:0060119),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SLC4A7
interleukin-23-mediated signaling pathway (GO:0038155),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,P4HB
interleukin-9-mediated signaling pathway (GO:0038113),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,JAK1
intestinal epithelial cell differentiation (GO:0060575),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,YAP1
ketone biosynthetic process (GO:0042181),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,TPI1
mitochondrial tRNA modification (GO:0070900),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,HSD17B10
negative regulation of bone resorption (GO:0045779),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CALCA
negative regulation of exocytosis (GO:0045920),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,VPS4B
negative regulation of fibrinolysis (GO:0051918),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,THBS1
negative regulation of glial cell differentiation (GO:0045686),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,TMEM98
negative regulation of glycoprotein biosynthetic process (GO:0010561),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,AGO2
negative regulation of leukocyte proliferation (GO:0070664),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ENPP3
negative regulation of lipase activity (GO:0060192),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SORT1
negative regulation of mRNA 3'-end processing (GO:0031441),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ZC3H14
negative regulation of nitric oxide biosynthetic process (GO:0045019),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ROCK2
negative regulation of nitric oxide metabolic process (GO:1904406),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ROCK2
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SMAD7
negative regulation of platelet aggregation (GO:0090331),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SERPINE2
negative regulation of protein activation cascade (GO:2000258),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,F3
negative regulation of protein-containing complex disassembly (GO:0043242),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,UBQLN4
negative regulation of smooth muscle cell differentiation (GO:0051151),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,PDGFB
negative regulation of T cell cytokine production (GO:0002725),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SMAD7
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,RAB11A
nucleoside diphosphate catabolic process (GO:0009134),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,NUDT5
nucleoside diphosphate phosphorylation (GO:0006165),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,NME2
nucleotide phosphorylation (GO:0046939),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,NME2
phenol-containing compound biosynthetic process (GO:0046189),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MOXD1
plasminogen activation (GO:0031639),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,PGK1
positive regulation of blood pressure (GO:0045777),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ID2
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,FGFBP1
positive regulation of chromatin binding (GO:0035563),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,GMNN
positive regulation of extracellular matrix assembly (GO:1901203),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,DAG1
positive regulation of membrane potential (GO:0045838),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,VCP
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,DDX3X
positive regulation of protein polyubiquitination (GO:1902916),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,DDX3X
positive regulation of synapse maturation (GO:0090129),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CDC20
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,UBE2K
protein O-linked glycosylation via threonine (GO:0018243),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,GALNT3
regulation of actin filament organization (GO:0110053),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,RDX
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ROCK2
"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MAPK8IP1
regulation of cell adhesion molecule production (GO:0060353),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,FLOT1
regulation of cellular extravasation (GO:0002691),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,PLVAP
regulation of cellular response to oxidative stress (GO:1900407),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,DHFR
"regulation of complement activation, classical pathway (GO:0030450)",09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CR2
regulation of complement-dependent cytotoxicity (GO:1903659),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,TGFB2
regulation of dendritic cell antigen processing and presentation (GO:0002604),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,THBS1
regulation of helicase activity (GO:0051095),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,SSBP1
regulation of histone H4 acetylation (GO:0090239),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ARRB1
regulation of interleukin-23 production (GO:0032667),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,RAC1
regulation of nephron tubule epithelial cell differentiation (GO:0072182),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CTNNB1
regulation of PERK-mediated unfolded protein response (GO:1903897),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,HSPA5
regulation of pinocytosis (GO:0048548),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CDC42
regulation of respiratory burst (GO:0060263),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,RAC1
regulation of vesicle fusion (GO:0031338),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ANXA2
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,DAB2
response to leptin (GO:0044321),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,LRP2
response to magnesium ion (GO:0032026),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,THBS1
response to misfolded protein (GO:0051788),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CLU
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,PLXNB1
sensory organ morphogenesis (GO:0090596),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,GLI3
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,EXOSC3
sterol catabolic process (GO:0016127),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,MT3
sympathetic ganglion development (GO:0061549),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,CTNNB1
synapse pruning (GO:0098883),09-Jan,0.893245807,0.999996398,0,0,0.442926136,0.050003471,ITGAM
cellular response to radiation (GO:0071478),7/45,0.893967547,0.999996398,0,0,0.652366864,0.073121065,GADD45A;EEF1D;SWI5;RAD1;ECT2;MAPK14;RHNO1
positive regulation of Notch signaling pathway (GO:0045747),7/45,0.893967547,0.999996398,0,0,0.652366864,0.073121065,YAP1;PRKCI;TGFB2;PDCD10;BMP2K;EP300;RBPJ
protein deacetylation (GO:0006476),7/45,0.893967547,0.999996398,0,0,0.652366864,0.073121065,MORF4L1;HDAC3;MORF4L2;PRDM5;FLNA;PHB;TBL1X
regulation of insulin receptor signaling pathway (GO:0046626),7/45,0.893967547,0.999996398,0,0,0.652366864,0.073121065,GRB7;GSK3A;RPS6KB1;IGF2;NUCKS1;ERFE;SNX5
regulation of neuron apoptotic process (GO:0043523),17/98,0.894823748,0.999996398,0,0,0.742897855,0.082557132,SRPK2;PRNP;PRKCI;TGFB2;EGLN3;SET;F2R;PARK7;MT3;NRBP2;SIX4;MDK;PTK2B;BAX;CTNNB1;NAE1;SNX6
blood vessel morphogenesis (GO:0048514),9/56,0.895274027,0.999996398,0,0,0.678060691,0.075010757,EFNB2;FLT1;COL4A1;GLMN;ID1;AGGF1;CCM2;RBPJ;SMAD7
negative regulation of metabolic process (GO:0009892),9/56,0.895274027,0.999996398,0,0,0.678060691,0.075010757,FIS1;RHEB;DOCK7;ARRDC3;ID1;ACOT13;PCTP;RBPJ;LGR4
telomere maintenance (GO:0000723),9/56,0.895274027,0.999996398,0,0,0.678060691,0.075010757,STN1;XRCC6;PCNA;RIF1;PARP1;PTGES3;RPA3;RPA1;SMC6
regulation of programmed cell death (GO:0043067),36/194,0.89660102,0.999996398,0,0,0.806002871,0.087970627,RARG;VCP;SRA1;PHB;CLU;PRDX2;LGALS1;SLK;BCL2L11;PERP;RPS3;PMAIP1;NAE1;SKP2;BNIP3L;PRELID1;HSP90AA1;DAPK1;ACTN1;IGFBP3;BNIP3;NME2;ACTN4;RABGGTB;NME1;RSL1D1;HAX1;STK26;ANP32E;BIRC5;BAX;ANP32B;CALR;TARDBP;BCAR1;TPT1
cellular polysaccharide catabolic process (GO:0044247),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,PGM2;CALM1
dendritic cell chemotaxis (GO:0002407),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,CXCR2;HMGB1
glutamine family amino acid catabolic process (GO:0009065),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,GLUD1;GLS
heme catabolic process (GO:0042167),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,BLVRA;ABCG2
killing by host of symbiont cells (GO:0051873),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,ROMO1;GAPDH
mesenchyme development (GO:0060485),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,SFRP2;FGFR2
negative regulation of immune effector process (GO:0002698),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,RC3H1;ENPP3
negative regulation of platelet activation (GO:0010544),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,SERPINE2;PDGFB
negative regulation of transcription regulatory region DNA binding (GO:2000678),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,TMSB4X;SOX11
neutrophil activation (GO:0042119),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,CXCR2;F2RL1
nitric oxide metabolic process (GO:0046209),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,GCHFR;CYB5R3
polyol biosynthetic process (GO:0046173),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,ISYNA1;PPIP5K2
porphyrin-containing compound catabolic process (GO:0006787),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,BLVRA;ABCG2
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,SMCHD1;RIF1
positive regulation of isotype switching (GO:0045830),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,RIF1;TFRC
positive regulation of TORC1 signaling (GO:1904263),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,SEH1L;TELO2
regulation of isotype switching (GO:0045191),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,RIF1;TFRC
regulation of Rac protein signal transduction (GO:0035020),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,PIK3CB;ARF6
resolution of meiotic recombination intermediates (GO:0000712),16-Feb,0.89668612,0.999996398,0,0,0.506121521,0.055192248,TOP2A;CENPS
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),5/34,0.896765718,0.999996398,0,0,0.610664868,0.066538432,DDX3X;PARK7;CFLAR;ARHGEF2;BCL2L1
phosphatidylserine metabolic process (GO:0006658),5/34,0.896765718,0.999996398,0,0,0.610664868,0.066538432,PLA2G12A;PLA2G1B;PLA2G10;MBOAT1;SERINC1
positive regulation of DNA binding (GO:0043388),5/34,0.896765718,0.999996398,0,0,0.610664868,0.066538432,TRIM6;PLAUR;HMGB1;PARK7;NME1
regulation of myoblast differentiation (GO:0045661),5/34,0.896765718,0.999996398,0,0,0.610664868,0.066538432,IGFBP3;SRA1;FLOT2;MAPK14;ZFP36L1
tRNA methylation (GO:0030488),5/34,0.896765718,0.999996398,0,0,0.610664868,0.066538432,TRMT112;NSUN2;THUMPD3;LCMT2;HSD17B10
protein N-linked glycosylation (GO:0006487),11/67,0.898512443,0.999996398,0,0,0.69546453,0.074424945,OST4;KRTCAP2;TMEM258;RPN2;DAD1;GFPT2;OSTC;ALG14;MOGS;STT3B;DDOST
activation of protein kinase activity (GO:0032147),20/114,0.899980675,0.999996398,0,0,0.753009854,0.079353676,CARD10;CALCA;TGFB2;NRK;PDGFB;NRG1;PARK7;PHB;STK4;PHB2;MT3;TOM1L1;TPX2;PAK1;TAOK3;TAOK1;PTK2B;ECT2;PPIA;PAK2
regulation of Notch signaling pathway (GO:0008593),14/83,0.9002536,0.999996398,0,0,0.718261795,0.075474072,YAP1;PRKCI;TGFB2;YTHDF2;PRAG1;ARRDC1;FBXW7;ARRB1;RBPJ;SYNJ2BP;MMP14;PDCD10;BMP2K;EP300
positive regulation of double-strand break repair (GO:2000781),6/40,0.901425501,0.999996398,0,0,0.624974905,0.06485857,ACTR2;SMCHD1;RIF1;PARP1;SPIRE1;ARID2
negative regulation of protein serine/threonine kinase activity (GO:0071901),13/78,0.902676931,0.999996398,0,0,0.708021878,0.072494758,CDKN1C;DUSP1;GADD45A;SPRY4;PTEN;PIK3CB;IPO5;UCHL1;LATS2;SPRY2;SPRY1;PKIG;CDK5RAP3
regulation of hydrolase activity (GO:0051336),12/73,0.905484286,0.999996398,0,0,0.696435575,0.069145854,RABGAP1;TDG;RDX;RAB3GAP2;PLXNB1;EPHA1;EFNA5;CRK;CDK5RAP3;ARHGEF5;TBC1D15;ARHGAP12
axonogenesis (GO:0007409),45/240,0.905600573,0.999996398,0,0,0.816062725,0.080918282,APP;GRB7;LAMA5;HSP90AB1;SHC1;DOCK7;PTEN;NEXN;SEMA3E;PIK3CB;EFNA5;ACTB;IGSF9;EFNB2;SPTA1;PPP3CB;PARD6B;GPC1;KIF5B;BSG;DAG1;MAPK1;EMB;SPTAN1;SPTBN1;PDLIM7;MAPK3;HSP90AA1;SEMA6A;RYK;USP9X;GAB1;LMTK2;ENAH;RAB10;KLF7;DOK2;PTPRA;MAP1B;PLA2G10;S100A6;EPHA1;EZR;SOS1;FGFR2
platelet degranulation (GO:0002576),22/125,0.906097546,0.999996398,0,0,0.75584043,0.074532149,CHID1;APP;TGFB2;WDR1;ACTN1;APLP2;PDGFB;IGF2;OLA1;ACTN4;CLU;THBS1;MANF;TMSB4X;PCYOX1L;FLNA;TAGLN2;FAM3C;TLN1;CALM1;ALDOA;VTI1B
regulation of protein secretion (GO:0050708),22/125,0.906097546,0.999996398,0,0,0.75584043,0.074532149,RHBDF1;TGFB2;TMED10;UQCC2;PLA2G1B;RHBDF2;ITPR1;SLC2A1;HMGCR;IER3IP1;CD2AP;PPP3CB;GOLPH3;DPH3;ENSA;MYO18A;EZR;DNM1L;PPIA;MYH10;PPID;ARF6
erythrocyte differentiation (GO:0030218),7/46,0.906525434,0.999996398,0,0,0.63559866,0.062375232,HSPA9;RPS14;MED1;ID2;SLC25A5;LYAR;CDK5RAP3
establishment of protein localization to extracellular region (GO:0035592),7/46,0.906525434,0.999996398,0,0,0.63559866,0.062375232,RAB10;RCN3;GOLPH3;RAB15;SVBP;CANX;MIA3
positive regulation of organelle assembly (GO:1902117),7/46,0.906525434,0.999996398,0,0,0.63559866,0.062375232,SH3GLB1;CNOT6;PDCD6IP;G3BP1;G3BP2;RAB3GAP2;SDC1
glial cell differentiation (GO:0010001),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,MYRF;GPC1;SOX11;SOX4
negative regulation of wound healing (GO:0061045),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,CLDN3;SERPINE2;PTEN;CRK
positive regulation of leukocyte migration (GO:0002687),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,PLVAP;MDK;F2RL1;MIA3
regulation of DNA biosynthetic process (GO:2000278),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,TOM1L1;MYC;PDGFB;NABP2
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,ACTR2;SMCHD1;RIF1;NUDT16L1
regulation of fatty acid biosynthetic process (GO:0042304),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,ACADL;EIF6;MID1IP1;ADIPOR1
transition metal ion homeostasis (GO:0055076),29-Apr,0.908575873,0.999996398,0,0,0.566713668,0.054334739,SLC40A1;COMMD1;MT3;SLC39A14
canonical Wnt signaling pathway (GO:0060070),11/68,0.908735537,0.999996398,0,0,0.683219438,0.065384897,BCL9;RARG;PORCN;SFRP2;CSNK1A1;RYK;FZD7;WNT7B;PTEN;CTNNB1;PPP1CA
positive regulation of morphogenesis of an epithelium (GO:1905332),23-Mar,0.909158733,0.999996398,0,0,0.531343793,0.050602832,GJA1;SIX4;MDK
positive regulation of receptor internalization (GO:0002092),23-Mar,0.909158733,0.999996398,0,0,0.531343793,0.050602832,ATAD1;AHI1;ARRB1
regulation of cysteine-type endopeptidase activity (GO:2000116),23-Mar,0.909158733,0.999996398,0,0,0.531343793,0.050602832,BEX3;MT3;PSMB9
regulation of SMAD protein signal transduction (GO:0060390),23-Mar,0.909158733,0.999996398,0,0,0.531343793,0.050602832,DAB2;RBPMS;BMPR1A
response to copper ion (GO:0046688),23-Mar,0.909158733,0.999996398,0,0,0.531343793,0.050602832,PRNP;MT3;LOXL2
cellular response to amyloid-beta (GO:1904646),5/35,0.910592554,0.999996398,0,0,0.590271459,0.055284667,APP;PRNP;GJA1;IGF1R;SNX6
ameboidal-type cell migration (GO:0001667),8/52,0.911733111,0.999996398,0,0,0.643792811,0.059491589,SEMA6A;ANXA6;GPC3;SEMA3E;AMOTL2;PKN2;AMOT;CORO1C
negative regulation of BMP signaling pathway (GO:0030514),8/52,0.911733111,0.999996398,0,0,0.643792811,0.059491589,UBE2D3;LRP2;FSTL1;SKIL;SMAD5;TRIM33;SMAD7;BMPR1A
protein homotetramerization (GO:0051289),8/52,0.911733111,0.999996398,0,0,0.643792811,0.059491589,ACOT13;SSBP1;ALDOA;SAMHD1;HSD17B10;ACACA;GLS;ALDH9A1
signal transduction in response to DNA damage (GO:0042770),8/52,0.911733111,0.999996398,0,0,0.643792811,0.059491589,GADD45A;ATRX;TIPRL;MAP3K20;RAD1;MAPK14;E2F7;RHNO1
aorta morphogenesis (GO:0035909),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,RBPJ;BMPR1A
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,GJA1;PKP2
cell surface receptor signaling pathway involved in heart development (GO:0061311),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,RBPJ;BMPR1A
cellular biogenic amine biosynthetic process (GO:0042401),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,MOXD1;SRM
DNA replication checkpoint signaling (GO:0000076),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,TIPIN;NAE1
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,NUS1;ALG14
mesenchyme morphogenesis (GO:0072132),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,TGFB2;BMPR1A
negative regulation of cell aging (GO:0090344),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,MIF;YBX1
negative regulation of cytokine production involved in immune response (GO:0002719),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,TGFB2;SMAD7
negative regulation of execution phase of apoptosis (GO:1900118),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,PAK2;BCL2L1
phosphate ion transport (GO:0006817),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,SLC25A3;SLC20A1
positive regulation of dendrite extension (GO:1903861),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,ITSN2;PLAA
positive regulation of heart rate (GO:0010460),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,TPM1;ATP2A2
positive regulation of macrophage activation (GO:0043032),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,THBS1;HSPD1
positive regulation of positive chemotaxis (GO:0050927),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,F2RL1;F3
positive regulation of regulated secretory pathway (GO:1903307),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,RAB15;RAB27A
regulation of cholesterol biosynthetic process (GO:0045540),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,KPNB1;RAN
regulation of leukocyte migration (GO:0002685),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,MIA3;RAC1
regulation of neuroblast proliferation (GO:1902692),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,KDM1A;CTNNB1
regulation of transferase activity (GO:0051338),17-Feb,0.915310989,0.999996398,0,0,0.472349776,0.041798889,FEM1B;NABP2
cellular amino acid catabolic process (GO:0009063),15/90,0.915665148,0.999996398,0,0,0.707888737,0.062368211,ECHS1;HIBADH;GOT1;GLDC;DLST;FAH;HSD17B10;GLS;BCKDK;GLUD1;OGDH;BLMH;ALDH7A1;DLD;BCAT2
adrenal gland development (GO:0030325),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,MDK
alanine transport (GO:0032328),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SLC6A6
amino sugar metabolic process (GO:0006040),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GFPT2
arachidonate transport (GO:1903963),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PLA2G1B
arachidonic acid secretion (GO:0050482),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PLA2G1B
aromatic amino acid family metabolic process (GO:0009072),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ASRGL1
cellular biogenic amine catabolic process (GO:0042402),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ALDH7A1
cellular response to acetylcholine (GO:1905145),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ROCK2
cellular response to hydroxyurea (GO:0072711),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ATRX
cellular response to interleukin-4 (GO:0071353),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,XBP1
cellular response to leucine starvation (GO:1990253),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,IMPACT
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,MIA3
cellular response to oxygen levels (GO:0071453),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ATP6V1G1
chloride ion homeostasis (GO:0055064),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SLC12A4
chondroitin sulfate proteoglycan metabolic process (GO:0050654),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,DSE
chylomicron assembly (GO:0034378),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,P4HB
endothelium development (GO:0003158),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,FSTL1
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ACADL
I-kappaB phosphorylation (GO:0007252),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,CHUK
L-glutamate transmembrane transport (GO:0015813),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SLC1A3
lipid droplet formation (GO:0140042),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SQLE
lipid phosphorylation (GO:0046834),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,DGKD
microtubule anchoring at centrosome (GO:0034454),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PCM1
mitotic DNA replication checkpoint signaling (GO:0033314),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,NAE1
monocyte activation (GO:0042117),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,FOXP1
monovalent inorganic anion homeostasis (GO:0055083),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SLC12A4
negative regulation of alpha-beta T cell proliferation (GO:0046642),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,TWSG1
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,EPCAM
negative regulation of delayed rectifier potassium channel activity (GO:1902260),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SUMO1
negative regulation of glycolytic process (GO:0045820),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GIT1
negative regulation of hormone secretion (GO:0046888),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GJA1
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,CR2
negative regulation of interferon-beta production (GO:0032688),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PTPRS
negative regulation of purine nucleotide metabolic process (GO:1900543),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GIT1
negative regulation of transmembrane transport (GO:0034763),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,THBS1
neuron remodeling (GO:0016322),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,APP
phagosome-lysosome fusion (GO:0090385),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ARL8B
positive regulation of cell activation (GO:0050867),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,RPS6KA1
positive regulation of circadian rhythm (GO:0042753),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,THRAP3
positive regulation of epidermis development (GO:0045684),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SFN
positive regulation of keratinocyte migration (GO:0051549),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ARF6
positive regulation of monocyte differentiation (GO:0045657),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ZFP36L1
positive regulation of skeletal muscle tissue development (GO:0048643),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,FLOT1
positive regulation of T cell apoptotic process (GO:0070234),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PRELID1
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,F2RL1
presynaptic membrane assembly (GO:0097105),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PTEN
protein localization to endosome (GO:0036010),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ARF6
protein O-linked glycosylation via serine (GO:0018242),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GALNT3
protein prenylation (GO:0018342),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,RABGGTB
regulation of carbohydrate biosynthetic process (GO:0043255),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,USP7
regulation of cilium movement (GO:0003352),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,CCDC40
regulation of glycoprotein biosynthetic process (GO:0010559),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,MT3
regulation of granulocyte differentiation (GO:0030852),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,HAX1
regulation of histone phosphorylation (GO:0033127),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,MAPK3
regulation of macrophage migration (GO:1905521),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,PTK2B
regulation of mast cell activation (GO:0033003),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,NECTIN2
regulation of neutrophil migration (GO:1902622),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,RAC1
regulation of podosome assembly (GO:0071801),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,GSN
regulation of T-helper 17 type immune response (GO:2000316),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SMAD7
renal filtration (GO:0097205),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,ITGA3
response to interleukin-4 (GO:0070670),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,XBP1
response to laminar fluid shear stress (GO:0034616),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,SMAD7
SNARE complex assembly (GO:0035493),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,VAMP3
telomere maintenance in response to DNA damage (GO:0043247),10-Jan,0.916747285,0.999996398,0,0,0.393686869,0.034220614,RIF1
negative regulation of protein phosphorylation (GO:0001933),27/152,0.916751235,0.999996398,0,0,0.764148148,0.066419089,PRKRIP1;PTEN;PARK7;CORO1C;SPRED2;SPRED1;RACK1;CHP1;SFN;PAK2;CDK5RAP3;YWHAG;RTRAF;PRNP;IGFBP3;SMAD7;IMPACT;SFRP2;DDIT4;MYADM;SPRY2;CALM3;EPHA1;CALM1;TARDBP;PPIA;CALM2
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),7/47,0.917786872,0.999996398,0,0,0.619668867,0.053161442,LEFTY1;TGFB2;DAB2;TWSG1;RBPMS;BMP8B;BMPR1A
regulation of cellular metabolic process (GO:0031323),7/47,0.917786872,0.999996398,0,0,0.619668867,0.053161442,ARF4;ARF1;EIF6;FLOT1;LAMTOR1;ACACA;PARL
cellular response to peptide hormone stimulus (GO:0071375),18/106,0.918052815,0.999996398,0,0,0.72386597,0.061890799,PRKCI;XBP1;GSK3A;GOT1;PARP1;PLA2G1B;PDE3B;MYO5A;SLC39A14;FOXO1;NFKB1;ZFP36L1;RAB10;RAB31;PKM;RPS6KB1;RAB15;MGARP
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),18/106,0.918052815,0.999996398,0,0,0.72386597,0.061890799,TGFB2;FLT1;F2R;PDGFB;PTEN;GAB1;PIK3CB;PPP2R5C;IGF1R;HAX1;PIK3IP1;NEDD4;MAPK1;F2RL1;PLXNB1;IER3;FGFR1;MAPK3
epithelial cell differentiation (GO:0030855),17/101,0.919633472,0.999996398,0,0,0.716227298,0.060005586,TAGLN;PCNA;FZD7;FSTL1;GRHL2;CNN3;RAB10;DAB2;BASP1;PGK1;CDK1;TAGLN2;VDAC1;E2F4;FGFR2;E2F7;E2F8
positive regulation of cell adhesion (GO:0045785),13/80,0.920444416,0.999996398,0,0,0.68679846,0.056934675,TGFB2;ZFHX3;TPM1;PDGFB;ARL2;SMAD7;AFDN;SFRP2;MDK;C1QBP;RAC1;P4HB;LIMS1
chondroitin sulfate metabolic process (GO:0030204),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,CHSY1;NCAN;DSE;CHST15
establishment of spindle orientation (GO:0051294),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,ITGB1;GJA1;CENPA;MAD2L1
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,DDX3X;DDX47;SORT1;BAX
negative regulation of cytoskeleton organization (GO:0051494),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,TJP1;MYADM;FKBP4;PFN1
positive regulation of endopeptidase activity (GO:0010950),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,PRELID1;ROCK2;PSME3;PSME2
snRNA 3'-end processing (GO:0034472),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,EXOSC7;EXOSC8;EXOSC3;EXOSC2
zinc ion homeostasis (GO:0055069),30-Apr,0.921953913,0.999996398,0,0,0.544882,0.044277134,SLC30A9;SLC39A10;MT3;SLC39A14
cellular response to growth factor stimulus (GO:0071363),28/158,0.922333943,0.999996398,0,0,0.761899066,0.06159796,URI1;FLT1;SHC1;PDCD5;STMN2;PDGFB;IQGAP1;LRP2;ZFP36L1;ZFP36;RACK1;EMD;MED1;SEMA6A;DUSP3;PTPN12;MAPK14;SMAD7;EEF1A1;SETX;DUSP22;RPS6KB1;CTNNB1;SPRY2;TDGF1;BCAR1;BMPR1A;LIMS1
macrophage activation (GO:0042116),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,APP;ITGAM;IFNGR1;CLU;FOXP1
negative regulation of cellular protein localization (GO:1903828),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,LATS2;ROCK2;CTNNA1;GOPC;COMMD1
negative regulation of DNA metabolic process (GO:0051053),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,DNMT3L;KMT2A;ERCC1;SUB1;RPS3
positive regulation of innate immune response (GO:0045089),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,TRIM6;DHX9;RIOK3;POLR3G;UBE2K
positive regulation of mitotic nuclear division (GO:0045840),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,CUL3;CDC27;PDGFB;IGF2;PHIP
regulation of defense response to virus by host (GO:0050691),5/36,0.922766192,0.999996398,0,0,0.571193754,0.045912205,TRIM6;HSP90AA1;DHX9;DDX58;TRIM44
positive regulation of transport (GO:0051050),15/91,0.923431222,0.999996398,0,0,0.698529412,0.055644125,GSK3A;CD151;ANXA2;KMT2A;RAB27A;ACTB;CLIP3;DAB2;FLOT1;GPC3;CHP1;PLAA;BAX;CALR;LYAR
C21-steroid hormone metabolic process (GO:0008207),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,STARD3NL;TSPO;HSD17B10
inner ear morphogenesis (GO:0042472),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,CHD7;HPN;FGFR2
long-chain fatty-acyl-CoA metabolic process (GO:0035336),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,ELOVL1;ACSL4;FAR1
mammary gland development (GO:0030879),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,WNT7B;NRG1;TDGF1
negative regulation of neuron differentiation (GO:0045665),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,MED1;REST;CALR
negative regulation of NIK/NF-kappaB signaling (GO:1901223),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,DDX3X;TMSB4X;ADIPOR1
peptidyl-glutamic acid modification (GO:0018200),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,TTLL4;NAA10;PARP1
positive regulation of p38MAPK cascade (GO:1900745),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,GADD45A;MAP3K4;GADD45G
protein K48-linked deubiquitination (GO:0071108),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,OTUD4;USP25;USP34
purine ribonucleotide catabolic process (GO:0009154),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,HINT1;PNP;NUDT4
regulation of monooxygenase activity (GO:0032768),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,HSP90AA1;WASL;CALM1
regulation of ruffle assembly (GO:1900027),24-Mar,0.923744681,0.999996398,0,0,0.506009225,0.040136432,RDX;TACSTD2;PFN1
determination of left/right symmetry (GO:0007368),6/42,0.924947766,0.999996398,0,0,0.590178233,0.046044533,LEFTY1;MKKS;ZIC3;PITX2;TDGF1;CCDC40
histone H3 acetylation (GO:0043966),6/42,0.924947766,0.999996398,0,0,0.590178233,0.046044533,TADA2A;TAF12;YEATS2;TAF9;MBIP;JADE2
regulation of nervous system development (GO:0051960),6/42,0.924947766,0.999996398,0,0,0.590178233,0.046044533,YAP1;YTHDF2;GBX1;DOCK7;BHLHE40;CTNNB1
endomembrane system organization (GO:0010256),36/199,0.925641699,0.999996398,0,0,0.781025868,0.060348348,USP6NL;PI4K2B;TMED10;ATL2;MIA3;CDC42;LAPTM4B;ARHGAP21;SEC61A1;SERP1;ALS2CL;TMED3;MYO18A;BNIP1;TMED2;DNM1L;SPTBN1;SEC31A;PLEKHJ1;RAB2A;TMED9;COG7;FBXW8;CSNK1A1;SEC16A;SURF4;HUWE1;DNAJC13;LYSMD3;VMP1;GOLPH3;REEP5;VAPA;HOOK1;LAMTOR1;OPTN
mitotic DNA damage checkpoint signaling (GO:0044773),9/59,0.926163168,0.999996398,0,0,0.637254098,0.048880482,TIPIN;TAOK3;TAOK1;CDK1;RPS27L;BRCC3;FOXN3;CDK5RAP3;CDC14B
regulation of plasma membrane bounded cell projection assembly (GO:0120032),11/70,0.926603872,0.999996398,0,0,0.659974518,0.050309282,USP6NL;CDC42;FXR1;GAP43;RABGAP1;CAPZB;PODXL;RDX;RAC1;TBC1D15;ARF6
positive regulation of cell growth (GO:0030307),17/102,0.926736927,0.999996398,0,0,0.707755474,0.05384996,ITSN2;MTPN;TGFB2;DDX3X;CSNK2A1;HPN;IL2;CXCL16;CDC42;GOLGA4;MMP14;SFRP2;RPS6KA1;PLAA;EXOSC2;EIF4G2;DBN1
regulation of interleukin-2 production (GO:0032663),7/48,0.927853433,0.999996398,0,0,0.604516136,0.045267074,PRNP;ZFP36;PNP;GLMN;RPS3;EZR;SPTBN1
BMP signaling pathway (GO:0030509),10/65,0.930321858,0.999996398,0,0,0.643630567,0.046486004,LEFTY1;DDX5;USP15;TGFB2;USP9X;BMP8B;SMAD5;MAPK3;SMAD7;BMPR1A
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),15/92,0.930587351,0.999996398,0,0,0.689413186,0.049595924,APP;PRNP;PDGFB;IGF2;MIF;EFNA5;PDCL3;HAX1;RAP2B;SFRP2;CNOT7;PTK2B;ARHGEF2;PAK2;TDGF1
regulation of cellular component organization (GO:0051128),24/139,0.930670252,0.999996398,0,0,0.738278154,0.053045471,HSPA8;URI1;HSP90AA1;CAMK2D;TFRC;CISH;DCUN1D5;ROCK1;ROCK2;LTBP4;HNRNPU;PARK7;SSRP1;MKI67;RASGRP2;CDK11B;RAP1B;TJP1;NEDD4;METTL4;LAMTOR2;LAMTOR1;ANKRA2;BCAR1
carbohydrate derivative transport (GO:1901264),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,PLA2G10;SLC29A1
cellular response to pH (GO:0071467),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,IMPACT;CHP1
dendritic cell migration (GO:0036336),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,CXCR2;HMGB1
glycoprotein catabolic process (GO:0006516),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,EDEM1;STT3B
hyaluronan catabolic process (GO:0030214),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,CHP1;HMMR
interleukin-6-mediated signaling pathway (GO:0070102),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,YAP1;JAK1
intracellular estrogen receptor signaling pathway (GO:0030520),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,DDX5;ARID1A
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,ELOVL1;ACSL4
negative regulation of interleukin-8 production (GO:0032717),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,TMSB4X;ARRB1
negative regulation of peptide hormone secretion (GO:0090278),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,MIDN;REST
negative regulation of signal transduction by p53 class mediator (GO:1901797),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,KDM1A;MIF
neuron maturation (GO:0042551),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,APP;MTCH1
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,FGFBP1;PIK3C2A
positive regulation of excitatory postsynaptic potential (GO:2000463),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,PTEN;PTK2B
positive regulation of extracellular matrix organization (GO:1903055),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,PDPN;IER3IP1
positive regulation of lymphocyte chemotaxis (GO:0140131),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,WNK1;PTK2B
positive regulation of macrophage derived foam cell differentiation (GO:0010744),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,PLA2G10;NFKB1
positive regulation of myoblast differentiation (GO:0045663),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,IGFBP3;MAPK14
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,CACNG7;PTK2B
protein localization to centrosome (GO:0071539),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,NUDCD3;PCM1
regulation of brown fat cell differentiation (GO:0090335),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,HNRNPU;METRNL
regulation of cartilage development (GO:0061035),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,BMP1;MDK
regulation of dendrite extension (GO:1903859),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,ITSN2;PLAA
regulation of fatty acid metabolic process (GO:0019217),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,EIF6;ADIPOR1
regulation of mRNA polyadenylation (GO:1900363),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,CPSF6;ZC3H14
regulation of multicellular organism growth (GO:0040014),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,APP;PPIB
regulation of presynapse assembly (GO:1905606),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,APP;GPC4
regulation of presynapse organization (GO:0099174),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,APP;GPC4
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,TOP2A;MPHOSPH8
regulation of transforming growth factor beta production (GO:0071634),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,TGFB2;HIF1A
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,AKAP9;ANK2
T cell migration (GO:0072678),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,MSN;CXCL16
ventricular cardiac muscle cell action potential (GO:0086005),18-Feb,0.930743624,0.999996398,0,0,0.4427995,0.031780348,PKP2;ANK2
positive regulation of leukocyte chemotaxis (GO:0002690),8/54,0.931122668,0.999996398,0,0,0.615722642,0.043940585,MDK;C1QBP;MAPK1;F2RL1;HMGB1;CALR;THBS1;MAPK3
regulation of BMP signaling pathway (GO:0030510),12/76,0.9311241,0.999996398,0,0,0.663661996,0.04736072,TWSG1;ITGA3;UBE2D3;SOX11;LRP2;RBPJ;FSTL1;SKIL;SMAD5;TRIM33;SMAD7;BMPR1A
water-soluble vitamin metabolic process (GO:0006767),12/76,0.9311241,0.999996398,0,0,0.663661996,0.04736072,DHFR;CYB5A;CYB5R3;MTHFD1;MTHFD2;SLC23A1;MTHFD2L;SLC2A1;SLC2A3;MMADHC;AASDHPPT;SLC19A1
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),18/108,0.931658918,0.999996398,0,0,0.707688798,0.050096228,IGSF1;UBE2D3;LRP2;SMAD5;SMAD7;FKBP1A;SPRED2;SPRED1;UBB;PEG10;UBC;SPRY2;SPRY1;RPS27A;SKIL;TRIM33;SNX6;BMPR1A
negative regulation of endothelial cell proliferation (GO:0001937),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,AIMP1;FLT1;PDCD10;SYNJ2BP;THBS1
phagosome maturation (GO:0090382),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,ATP6V1G1;RAB31;RAB14;ATP6V1D;ATP6V1F
positive regulation of calcium ion transport (GO:0051928),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,PLA2G1B;F2R;WNK3;PDGFB;ANK2
regulation of glucose import (GO:0046324),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,GSK3A;PRKCI;PLA2G1B;ERFE;ARPP19
regulation of p38MAPK cascade (GO:1900744),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,DUSP1;GADD45A;EZR;MAP3K4;GADD45G
skeletal muscle tissue development (GO:0007519),5/37,0.933445863,0.999996398,0,0,0.553308405,0.038107629,ACTA1;SELENON;MYL6;SIX4;CFLAR
positive regulation of leukocyte cell-cell adhesion (GO:1903039),4/31,0.933545528,0.999996398,0,0,0.524667492,0.036079046,MDK;ETS1;RHOA;HSPD1
regulation of developmental growth (GO:0048638),4/31,0.933545528,0.999996398,0,0,0.524667492,0.036079046,APP;LATS2;SIX4;CTTN
regulation of potassium ion transport (GO:0043266),4/31,0.933545528,0.999996398,0,0,0.524667492,0.036079046,KIF5B;FHL1;PTK2B;ANK2
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),9/60,0.934544922,0.999996398,0,0,0.62471874,0.042290699,ITGB1;TRO;CDH1;BSG;NEXN;EMB;NECTIN3;IGSF9;NECTIN2
cellular response to retinoic acid (GO:0071300),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,SETX;CREB1;PTK7;FZD7;WNT7B;PTK2B
development of primary male sexual characteristics (GO:0046546),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,TGFB2;SIX4;CSDE1;LRP2;MEA1;UTF1
male gonad development (GO:0008584),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,TGFB2;SIX4;CSDE1;LRP2;MEA1;UTF1
negative regulation of proteolysis (GO:0045861),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,PRNP;TMEM59;ROCK1;SERPINE2;TIMP2;PTPN3
positive regulation of phospholipase C activity (GO:0010863),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,FLT1;LPAR2;PHB;PHB2;RASGRP4;FGFR1
positive regulation of T cell differentiation (GO:0045582),6/43,0.934741325,0.999996398,0,0,0.574190573,0.038749507,XBP1;PNP;MDK;SOX12;GLI3;SOX4
alcohol catabolic process (GO:0046164),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,MT3
aminoglycan metabolic process (GO:0006022),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,CLN6
camera-type eye morphogenesis (GO:0048593),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SHROOM2
cardiac muscle cell membrane repolarization (GO:0099622),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,YWHAE
cell differentiation in spinal cord (GO:0021515),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SOX4
cellular response to UV-A (GO:0071492),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PPID
coenzyme A biosynthetic process (GO:0015937),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,DCAKD
cyclooxygenase pathway (GO:0019371),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PTGES3
embryonic eye morphogenesis (GO:0048048),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,RARG
ER-associated misfolded protein catabolic process (GO:0071712),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,VCP
fatty acid homeostasis (GO:0055089),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,XBP1
formation of extrachromosomal circular DNA (GO:0001325),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ERCC1
glucocorticoid metabolic process (GO:0008211),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,YWHAH
Golgi to lysosome transport (GO:0090160),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SORT1
inhibitory synapse assembly (GO:1904862),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PLXNB1
inositol phosphate biosynthetic process (GO:0032958),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PPIP5K2
lipoprotein catabolic process (GO:0042159),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ABHD17C
negative regulation of activin receptor signaling pathway (GO:0032926),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,IGSF1
negative regulation of bone remodeling (GO:0046851),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,CALCA
negative regulation of centrosome duplication (GO:0010826),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,NPM1
negative regulation of interleukin-17 production (GO:0032700),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PRNP
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PTPN12
negative regulation of receptor signaling pathway via STAT (GO:1904893),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ADIPOR1
negative regulation of steroid biosynthetic process (GO:0010894),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,NFKB1
negative regulation of voltage-gated potassium channel activity (GO:1903817),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SUMO1
Notch signaling involved in heart development (GO:0061314),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,RBPJ
positive regulation of acrosome reaction (GO:2000344),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PLA2G10
positive regulation of chondrocyte differentiation (GO:0032332),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,LOXL2
positive regulation of histone exchange (GO:1900051),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ATRX
positive regulation of leukocyte apoptotic process (GO:2000108),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PIK3CB
positive regulation of macrophage differentiation (GO:0045651),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ID2
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,NAMPT
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,DAB2
presynaptic membrane organization (GO:0097090),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PTEN
protein localization to phagophore assembly site (GO:0034497),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,WIPI1
protein oxidation (GO:0018158),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,LOXL2
protein polyglutamylation (GO:0018095),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,TTLL4
purine nucleoside bisphosphate biosynthetic process (GO:0034033),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,DCAKD
pyrimidine nucleoside catabolic process (GO:0046135),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,NT5C
pyrimidine nucleoside salvage (GO:0043097),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,UCK2
pyrimidine-containing compound salvage (GO:0008655),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,UCK2
rDNA heterochromatin assembly (GO:0000183),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,BEND3
regulation of biosynthetic process (GO:0009889),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,MID1IP1
"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,TWSG1
regulation of ERAD pathway (GO:1904292),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,USP25
regulation of histone exchange (GO:1900049),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ATRX
regulation of histone H3-K9 acetylation (GO:2000615),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,KMT2A
regulation of lipid kinase activity (GO:0043550),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PPP2R5A
regulation of long-term neuronal synaptic plasticity (GO:0048169),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,APP
regulation of mast cell activation involved in immune response (GO:0033006),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ENPP3
regulation of microtubule-based movement (GO:0060632),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,TTC21B
regulation of T cell apoptotic process (GO:0070232),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PRELID1
regulation of T cell mediated immunity (GO:0002709),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,HMGB1
regulation of toll-like receptor 2 signaling pathway (GO:0034135),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,F2RL1
response to corticosteroid (GO:0031960),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,GOT1
response to hydroxyurea (GO:0072710),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ATRX
response to sterol (GO:0036314),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PMVK
rhodopsin mediated signaling pathway (GO:0016056),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,GNB1
ribonucleoside bisphosphate biosynthetic process (GO:0034030),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,DCAKD
skeletal muscle cell differentiation (GO:0035914),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SIX4
sphingomyelin metabolic process (GO:0006684),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,SAMD8
T cell chemotaxis (GO:0010818),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,CXCL16
T cell homeostasis (GO:0043029),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,PMAIP1
t-circle formation (GO:0090656),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ERCC1
telomere maintenance via telomere trimming (GO:0090737),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,ERCC1
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,GFPT2
V(D)J recombination (GO:0033151),11-Jan,0.935075831,0.999996398,0,0,0.354295455,0.023783021,HMGB1
regulation of G protein-coupled receptor signaling pathway (GO:0008277),13/82,0.935397077,0.999996398,0,0,0.666805385,0.044532037,RAMP3;ROCK1;YWHAB;ROCK2;PHB;SLC39A14;RASGRP4;GRK6;NMT1;CALM1;GIT1;METAP1;METAP2
regulation of cell cycle (GO:0051726),55/296,0.935888333,0.999996398,0,0,0.806474404,0.053436278,HSP90AB1;GMNN;HNRNPU;SRA1;PTPRK;CDC14B;CKS1B;TGM1;MAEA;CDC26;MYC;PCLAF;RACK1;EP300;PIM3;SKP2;JUNB;CDK5RAP3;CSNK2A1;DUSP1;RPL23;CSNK2A2;MIF;MASTL;MLF1;BIRC5;KIF20B;CDC123;IQGAP1;THBS1;TBRG1;CCNB2;RPS15A;PES1;MAP3K20;SRPK2;AFAP1L2;JUN;TGFB2;GADD45A;NEK6;DHCR24;WDR12;CDK11B;MAPK12;PML;GADD45G;CDK7;SON;CDK4;ID2;CALR;TARDBP;EIF4G2;FGFR2
cardiac conduction system development (GO:0003161),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,GJA1;SMAD5;BMPR1A
divalent inorganic cation homeostasis (GO:0072507),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,SELENON;MT3;CNNM4
negative regulation of sequestering of calcium ion (GO:0051283),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,F2R;ITPR1;ANXA6
phosphatidylglycerol metabolic process (GO:0046471),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,PLA2G12A;PLA2G1B;PLA2G10
positive regulation of T cell migration (GO:2000406),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,APP;WNK1;RHOA
regulation of cAMP-mediated signaling (GO:0043949),25-Mar,0.936153374,0.999996398,0,0,0.4829778,0.031864921,CDC34;UBE2B;PDE3B
negative regulation of catabolic process (GO:0009895),7/49,0.936824418,0.999996398,0,0,0.590084964,0.038508592,PDE3B;FLNA;HMGCR;PHB;GIT1;AZIN1;MAD2L1
embryonic organ development (GO:0048568),10/66,0.937993825,0.999996398,0,0,0.632096496,0.040461706,TGFB2;KMT2A;RPL10;WNT7B;PBX2;RBPJ;TEAD1;GLI3;FGFR2;BMPR1A
phosphatidylcholine metabolic process (GO:0046470),12/77,0.938230383,0.999996398,0,0,0.653409748,0.041661242,PCYT1B;PLA2G12A;CSNK2A1;CHKA;SLC44A2;PLA2G1B;CSNK2A2;PLA2G10;MBOAT1;DBI;PCTP;PLA2G6
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),12/77,0.938230383,0.999996398,0,0,0.653409748,0.041661242,TGFB2;FLT1;HAX1;NEDD4;F2R;GAB1;PDGFB;F2RL1;PLXNB1;PIK3CB;IGF1R;FGFR1
"retrograde transport, endosome to Golgi (GO:0042147)",14/88,0.939423303,0.999996398,0,0,0.669514967,0.041837388,VPS29;TMED9;GOSR2;CLTC;SURF4;RHOBTB3;SNX2;RAB6A;YKT6;SNX5;PLEKHJ1;VAMP3;SNX6;VTI1B
positive regulation of cellular catabolic process (GO:0031331),24/141,0.941254912,0.999996398,0,0,0.725564284,0.043926592,SH3GLB1;APP;GSK3A;HSP90AA1;PFKFB3;ROCK1;DAPK1;FAF1;BNIP3;RDX;RC3H1;MSN;HMGB1;PIK3CB;PIK3C2A;HIF1A;FOXO1;MTDH;TMEM59;LIN28B;TRIM6;CNOT7;EZR;OPTN
extrinsic apoptotic signaling pathway (GO:0097191),11/72,0.941392569,0.999996398,0,0,0.638253856,0.03854737,MLLT11;GSK3A;TGFB2;DDX3X;SIVA1;DDX47;SORT1;BAX;HIPK1;MCL1;BCL2L1
positive regulation of neurogenesis (GO:0050769),11/72,0.941392569,0.999996398,0,0,0.638253856,0.03854737,NUMBL;KDM1A;FBXW8;ARHGDIA;CAPRIN1;CTNNB1;SOX11;NAP1L1;PLXNB1;LRP2;RHOA
response to ionizing radiation (GO:0010212),11/72,0.941392569,0.999996398,0,0,0.638253856,0.03854737,EEF1D;GADD45A;MYC;SWI5;NABP2;NABP1;RAD1;BRCC3;ECT2;MAPK14;RHNO1
positive regulation of protein metabolic process (GO:0051247),19/115,0.941810254,0.999996398,0,0,0.700205861,0.041978359,APP;MTPN;VCP;GSK3A;CSNK2A1;TIPARP;DDX58;ROCK2;HUWE1;WWP1;IDE;CLU;OAZ1;FOXO1;DDB1;MAPK8;NEDD4;PLA2G10;GPC3
protein lipidation (GO:0006497),9/61,0.942085975,0.999996398,0,0,0.612665511,0.036550852,PYURF;PORCN;ZDHHC20;PIGQ;ZDHHC6;WIPI1;PIGM;SELENOK;PIGF
actin-myosin filament sliding (GO:0033275),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,ACTA1;MYL6;TPM4;TPM2;TPM1
lymphocyte proliferation (GO:0046651),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,HELLS;PPP3CB;CR2;MSN;HSPD1
muscle filament sliding (GO:0030049),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,ACTA1;MYL6;TPM4;TPM2;TPM1
negative regulation of innate immune response (GO:0045824),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,USP15;YTHDF2;CNOT7;SAMHD1;LYAR
negative regulation of TOR signaling (GO:0032007),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,GSK3A;PDCD6;BMT2;DDIT4;TBC1D7
regulation of apoptotic signaling pathway (GO:2001233),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,CSNK2A1;CSNK2A2;RPS3;TMBIM6;PPIA
response to cAMP (GO:0051591),5/38,0.942783231,0.999996398,0,0,0.536507017,0.0316104,RAP1B;AKAP9;EZR;SLC5A5;ZFP36L1
negative regulation of cell death (GO:0060548),15/94,0.943208674,0.999996398,0,0,0.671873106,0.039282897,BNIP3L;VPS4B;BNIP3;TXNDC12;SOX11;PARK7;CLU;MT3;IMPACT;PDE12;CHMP2A;SRSF6;SOX4;FERMT2;RAD18
nucleosome organization (GO:0034728),15/94,0.943208674,0.999996398,0,0,0.671873106,0.039282897,SMARCE1;SMARCD1;SMARCC1;NPM1;SET;ATRX;HMGA1;NAP1L1;ARID1A;SMARCA4;NASP;ANP32E;ANP32B;ARID2;BPTF
branching morphogenesis of an epithelial tube (GO:0048754),6/44,0.943382947,0.999996398,0,0,0.559044369,0.032582774,PAK1;SFRP2;COL4A1;MYC;CTNNB1;SEMA3E
response to amyloid-beta (GO:1904645),6/44,0.943382947,0.999996398,0,0,0.559044369,0.032582774,APP;PRNP;GJA1;RAMP3;IGF1R;SNX6
carbohydrate derivative catabolic process (GO:1901136),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,STT3B;SAMHD1
cellular response to copper ion (GO:0071280),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,PRNP;MT3
detection of mechanical stimulus (GO:0050982),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,JUP;CTNNB1
endocardial cushion morphogenesis (GO:0003203),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,TGFB2;BMPR1A
heparan sulfate proteoglycan biosynthetic process (GO:0015012),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,EXT1;HS6ST2
histone H4-K16 acetylation (GO:0043984),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,KMT2A;JADE2
leukotriene biosynthetic process (GO:0019370),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,PLA2G1B;MGST3
negative regulation of nervous system development (GO:0051961),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,PCM1;REST
nucleotide-sugar biosynthetic process (GO:0009226),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,GFPT2;NANS
positive regulation of actin cytoskeleton reorganization (GO:2000251),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,CDC42;HAX1
prostaglandin biosynthetic process (GO:0001516),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,PTGES3;MIF
pyroptosis (GO:0070269),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,DHX9;GSDME
regulation of centriole replication (GO:0046599),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,NPM1;CEP295
regulation of oligodendrocyte differentiation (GO:0048713),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,TMEM98;MDK
regulation of synaptic vesicle exocytosis (GO:2000300),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,RAP1B;SNAPIN
response to fatty acid (GO:0070542),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,GLDC;FOXO1
ureteric bud development (GO:0001657),19-Feb,0.943486731,0.999996398,0,0,0.416725726,0.024242176,GPC3;FGFR2
activation of phospholipase C activity (GO:0007202),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,LPAR2;PHB;PHB2;RASGRP4
DNA damage checkpoint signaling (GO:0000077),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,TIPRL;MAP3K20;RAD1;RHNO1
GPI anchor biosynthetic process (GO:0006506),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,PYURF;PIGQ;PIGM;PIGF
hematopoietic progenitor cell differentiation (GO:0002244),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,FLT1;SBDS;PRRC2C;MLF1
long-chain fatty acid transport (GO:0015909),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,FABP5;RPS6KB1;MID1IP1;ACACA
negative regulation of chemotaxis (GO:0050922),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,DUSP3;SEMA6A;SEMA3E;THBS1
regulation of cellular biosynthetic process (GO:0031326),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,MED1;EIF6;RAC1;ADIPOR1
superoxide metabolic process (GO:0006801),4/32,0.943553253,0.999996398,0,0,0.505896878,0.02939386,PRDX2;SH3PXD2A;PRDX1;MT3
regulation of JNK cascade (GO:0046328),17/105,0.944955865,0.999996398,0,0,0.683495251,0.038697489,APP;DUSP3;HDAC3;GADD45A;FZD7;WNT7B;HMGB1;IGF1R;MAPK8IP1;GADD45G;DUSP22;TRAF4;TAOK3;TAOK1;MBIP;PTK2B;F2RL1
collagen fibril organization (GO:0030199),14/89,0.945428165,0.999996398,0,0,0.660545551,0.037068079,COL18A1;TGFB2;CD151;DST;LOXL2;BMP1;COL4A2;COL4A1;PXDN;SERPINH1;ITGA6;P4HB;PPIB;PLEC
regulation of endothelial cell migration (GO:0010594),14/89,0.945428165,0.999996398,0,0,0.660545551,0.037068079,ANXA3;ROCK2;PDCD6;PIK3CB;SYNJ2BP;ETS1;THBS1;FOXP1;SVBP;PTK2B;RAC1;CALR;TDGF1;BCAR1
cellular response to drug (GO:0035690),26-Mar,0.946671416,0.999996398,0,0,0.461949107,0.025316299,REST;TFRC;MYC
metanephros development (GO:0001656),26-Mar,0.946671416,0.999996398,0,0,0.461949107,0.025316299,SIX4;BASP1;WNT7B
positive regulation of glucose import (GO:0046326),26-Mar,0.946671416,0.999996398,0,0,0.461949107,0.025316299,PRKCI;ERFE;ARPP19
regulation of regulatory T cell differentiation (GO:0045589),26-Mar,0.946671416,0.999996398,0,0,0.461949107,0.025316299,MDK;SOX12;IL2
regulation of synapse organization (GO:0050807),26-Mar,0.946671416,0.999996398,0,0,0.461949107,0.025316299,NEDD4;ABHD17C;YWHAZ
regulation of actin filament polymerization (GO:0030833),11/73,0.94776337,0.999996398,0,0,0.627919024,0.033688118,NCKAP1;MTPN;CARMIL1;PLEKHG2;HAX1;CTTN;MYADM;PTK2B;PFN1;DBN1;ARF6
regulation of GTPase activity (GO:0043087),33/189,0.948730392,0.999996398,0,0,0.747891131,0.039361972,USP6NL;ITGB1;RABGAP1;RAP1GDS1;ARL2;F11R;EFNA5;RASGRP2;ARHGAP12;RACK1;TMED2;ECT2;TBC1D15;ZC3H15;S100A10;RCC2;F2R;RDX;RRP1B;AFDN;WNK1;TBC1D7;F2RL1;RAB3GAP2;PLXNB1;ITGA6;EPHA1;AGRN;CRK;FERMT2;ARHGEF5;EZH2;LIMS1
double-strand break repair via nonhomologous end joining (GO:0006303),9/62,0.948853485,0.999996398,0,0,0.60106712,0.031556553,XRCC6;RIF1;SUMO1;PSMD14;ERCC1;NSD2;UBE2N;HMGB1;BRCC3
actin crosslink formation (GO:0051764),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,FLNA
amino sugar biosynthetic process (GO:0046349),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,GFPT2
carboxylic acid catabolic process (GO:0046395),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,BCKDK
cell differentiation in hindbrain (GO:0021533),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,KNDC1
cochlea morphogenesis (GO:0090103),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,HPN
digestive system development (GO:0055123),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,FGFR2
epithelial cell-cell adhesion (GO:0090136),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,JUP
ethanol oxidation (GO:0006069),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,ADH5
exit from mitosis (GO:0010458),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,CHMP2A
ganglion development (GO:0061548),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,CTNNB1
gas transport (GO:0015669),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,MYC
homocysteine metabolic process (GO:0050667),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,BLMH
keratan sulfate catabolic process (GO:0042340),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,GNS
magnesium ion transport (GO:0015693),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,CNNM4
megakaryocyte differentiation (GO:0030219),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,MED1
microtubule anchoring at microtubule organizing center (GO:0072393),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,PCM1
negative regulation of B cell proliferation (GO:0030889),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,RC3H1
negative regulation of complement activation (GO:0045916),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,CR2
negative regulation of fatty acid biosynthetic process (GO:0045717),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,ACADL
negative regulation of glucose transmembrane transport (GO:0010829),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,GSK3A
negative regulation of hemostasis (GO:1900047),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,SERPINE2
negative regulation of JUN kinase activity (GO:0043508),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,MAPK8IP1
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,LIN28B
negative regulation of vascular permeability (GO:0043116),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,FERMT2
nucleoside catabolic process (GO:0009164),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,NT5C
nucleoside salvage (GO:0043174),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,UCK2
nucleotide-sugar metabolic process (GO:0009225),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,GFPT2
phospholipid homeostasis (GO:0055091),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,RCN3
poly-N-acetyllactosamine biosynthetic process (GO:0030311),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,B3GNT7
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,SIX4
protein import into peroxisome matrix (GO:0016558),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,PEX2
protein mono-ADP-ribosylation (GO:0140289),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,TIPARP
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,HMGB1
regulation of cholesterol esterification (GO:0010872),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,LAMTOR1
regulation of glycogen metabolic process (GO:0070873),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,KHK
regulation of MHC class II biosynthetic process (GO:0045346),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,XBP1
regulation of sensory perception (GO:0051931),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,F2R
replicative senescence (GO:0090399),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,ROMO1
sphingoid metabolic process (GO:0046519),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,PLPP2
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,SNAP47
thyroid hormone generation (GO:0006590),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,SLC5A5
tyrosine metabolic process (GO:0006570),12-Jan,0.949369859,0.999996398,0,0,0.322066116,0.016733531,FAH
negative regulation of NF-kappaB transcription factor activity (GO:0032088),12/79,0.950562212,0.999996398,0,0,0.633823364,0.032135901,USP7;CHUK;PRMT2;FAF1;TMSB4X;TAX1BP1;G3BP2;CHP1;ARRB1;COMMD1;COMMD6;CDK5RAP3
DNA integrity checkpoint signaling (GO:0031570),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,TIPIN;TIPRL;MAP3K20;RAD1;RHNO1
endothelial cell migration (GO:0043542),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,ID1;MYH9;FSTL1;RHOA;LOXL2
membrane protein proteolysis (GO:0033619),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,CLPP;DAG1;MYH9;PARL;NFKB1
negative regulation of cellular metabolic process (GO:0031324),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,MTMR2;ATXN2;MT3;NFKB1;OPTN
phospholipid dephosphorylation (GO:0046839),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,MTMR2;INPP5F;PTEN;SYNJ2;PLPP2
regulation of intracellular transport (GO:0032386),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,INPP5F;REEP5;WWC1;TTC21B;CRYAB
regulation of protein tyrosine kinase activity (GO:0061097),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,APP;PRNP;RAP2B;SHC1;PDGFB
regulation of viral entry into host cell (GO:0046596),5/39,0.950920933,0.999996398,0,0,0.520693946,0.02620359,TRIM6;LGALS1;GSN;P4HB;NECTIN2
positive regulation of chemotaxis (GO:0050921),6/45,0.950985282,0.999996398,0,0,0.544674893,0.027373559,MDK;TMSB4X;PDGFB;F2RL1;THBS1;F3
negative regulation of transport (GO:0051051),7/51,0.951858898,0.999996398,0,0,0.563190508,0.027786959,YRDC;MTMR2;SYT11;PTEN;RACK1;NRG1;CRYAB
regulation of interleukin-12 production (GO:0032655),7/51,0.951858898,0.999996398,0,0,0.563190508,0.027786959,MDK;C1QBP;HMGB1;MAPK14;THBS1;FOXP1;HSPD1
regulation of smoothened signaling pathway (GO:0008589),7/51,0.951858898,0.999996398,0,0,0.563190508,0.027786959,VCP;EVC;RACK1;GPC3;GLI3;UCHL5;FGFR2
lytic vacuole organization (GO:0080171),4/33,0.952164556,0.999996398,0,0,0.488420788,0.02394112,SNAPIN;HOOK1;LAMTOR1;CLN6
negative regulation of smooth muscle cell proliferation (GO:0048662),4/33,0.952164556,0.999996398,0,0,0.488420788,0.02394112,CNN1;IGFBP3;TPM1;PTEN
regulation of protein localization to cell surface (GO:2000008),4/33,0.952164556,0.999996398,0,0,0.488420788,0.02394112,HSP90AB1;CTNNB1;GOPC;COMMD1
regulation of cell adhesion (GO:0030155),22/133,0.952447518,0.999996398,0,0,0.701003355,0.034153074,CD164;ZFHX3;PPP1R12A;YTHDF2;ROCK1;DUSP1;ROCK2;TPM1;PDE3B;MIA3;EFNA5;PPP1CB;PPP2CA;NUAK1;PODXL;MDK;ARHGDIA;C1QBP;MYADM;PTK2B;PLXNB1;P4HB
positive regulation of cell junction assembly (GO:1901890),8/57,0.953233449,0.999996398,0,0,0.577913843,0.02767944,CLDN3;ROCK1;FLOT1;RAC1;FERMT2;S100A10;CRB3;LIMS1
regulated exocytosis (GO:0045055),31/180,0.953424241,0.999996398,0,0,0.735567398,0.035083115,APP;TMED10;WDR1;PDGFB;OLA1;CLU;THBS1;PPP3CB;TMSB4X;FLNA;FAM3C;VTI1B;CHID1;TGFB2;SNAPIN;ACTN1;APLP2;IGF2;ACTN4;MANF;RAB10;RAB31;SYT11;DNAJC5;PCYOX1L;MYH9;TAGLN2;TLN1;CALM1;ALDOA;STEAP2
cardiac ventricle development (GO:0003231),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,HECTD1;MATR3
cellular response to misfolded protein (GO:0071218),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,VCP;CUL3
early endosome to late endosome transport (GO:0045022),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,HOOK1;LMTK2
eye morphogenesis (GO:0048592),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,RARG;SHROOM2
gastrulation (GO:0007369),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,MKKS;GPC3
inositol phosphate-mediated signaling (GO:0048016),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,PPP3CB;PPP3R1
mesoderm development (GO:0007498),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,TCF15;MEST
mesoderm formation (GO:0001707),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,ITGB1;ITGA3
microtubule nucleation (GO:0007020),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,TPX2;AKAP9
modulation by symbiont of entry into host (GO:0052372),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,TRIM6;NECTIN2
negative regulation of axon extension involved in axon guidance (GO:0048843),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,SEMA6A;SEMA3E
negative regulation of viral life cycle (GO:1903901),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,GSN;PPIA
positive regulation of alpha-beta T cell activation (GO:0046635),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,PNP;GLI3
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,HSP90AB1;PDGFB
positive regulation of embryonic development (GO:0040019),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,CFL1;RACK1
positive regulation of epithelial cell differentiation (GO:0030858),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,AHI1;SFN
regulation of T cell migration (GO:2000404),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,APP;RHOA
regulation of tissue remodeling (GO:0034103),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,MDK;IL2
xenobiotic transport (GO:0042908),20-Feb,0.953976404,0.999996398,0,0,0.393549039,0.018542591,GJA1;ABCG2
response to calcium ion (GO:0051592),17/107,0.954813218,0.999996398,0,0,0.668220296,0.0308982,CPNE8;CLIC4;CAMK2D;AHCYL1;PDCD6;BRAF;IQGAP1;RASGRP2;THBS1;SYT11;NEDD4;CALM3;ECT2;CALM1;CALM2;SEC31A;SLC25A24
amyloid fibril formation (GO:1990000),9/63,0.954911965,0.999996398,0,0,0.5898983,0.027215622,FKBP1A;APP;CALCA;GSN;UBB;USP9X;UBC;RPS27A;HSPG2
calcium-ion regulated exocytosis (GO:0017156),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,PPP3CB;SYT11;ARL8B
cellular lipid catabolic process (GO:0044242),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,ACADL;NUDT19;MT3
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,CHSY1;NCAN;CHST15
L-alpha-amino acid transmembrane transport (GO:1902475),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,SLC38A1;SLC1A3;SLC7A3
negative regulation of insulin receptor signaling pathway (GO:0046627),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,GRB7;GSK3A;RPS6KB1
positive regulation of BMP signaling pathway (GO:0030513),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,SOX11;RBPJ;BMPR1A
positive regulation of calcium ion transmembrane transport (GO:1904427),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,RAMP3;F2R;ANK2
positive regulation of nitric oxide biosynthetic process (GO:0045429),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,HSP90AA1;HSP90AB1;CLU
positive regulation of nuclear division (GO:0051785),27-Mar,0.95555703,0.999996398,0,0,0.442672806,0.020124274,PDGFB;IGF2;PHIP
regulation of fat cell differentiation (GO:0045598),12/80,0.955877096,0.999996398,0,0,0.624462225,0.028179442,YAP1;ZFP36;CEBPB;XBP1;CREB1;SFRP2;NOCT;CARM1;ID2;FOXO1;FERMT2;ZFP36L1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),26/155,0.956667787,0.999996398,0,0,0.712682171,0.03157117,APP;MTPN;TFRC;DHX9;PLA2G1B;CLU;MTDH;TRIM6;UBB;UBC;FLOT1;RPS3;EP300;FLOT2;RPS27A;PRKCI;NPM1;CHUK;CFLAR;NFKB1;PSMA6;UBE2N;UBE2V1;ARHGEF2;RHEBL1;PPIA
peptidyl-tyrosine phosphorylation (GO:0018108),10/69,0.956765462,0.999996398,0,0,0.599840197,0.026511134,DDR1;FLT1;ABI2;PDGFB;PTK2B;EPHA1;FGFR2;IGF1R;MAPK3;FGFR1
positive regulation of MAP kinase activity (GO:0043406),10/69,0.956765462,0.999996398,0,0,0.599840197,0.026511134,PAK1;FLT1;TAOK3;PDCD10;PDGFB;RPS3;MAP3K4;ARHGEF5;EZH2;FGFR1
regulation of cell growth (GO:0001558),38/217,0.957348119,0.999996398,0,0,0.750290982,0.032703828,MTPN;URI1;CAMK2D;NDRG3;DDX3X;TFRC;DCUN1D5;HPN;FHL1;LTBP4;ENO1;PHB;RASGRP2;CXCL16;PPP2CA;CDC42;GJA1;RPS6KA1;RACK1;DACT3;RBBP7;EXOSC2;TGFB2;CSNK2A1;CISH;CGRRF1;MT3;CDK11B;IL2;PML;SMARCA4;MMP14;SFRP2;NME6;LAMTOR2;LAMTOR1;EIF4G2;BCAR1
muscle contraction (GO:0006936),21/129,0.957672085,0.999996398,0,0,0.687702943,0.02974305,TPM4;ROCK1;ROCK2;TMOD3;TPM2;TMOD2;TPM1;SORBS3;MYL12A;MYL12B;ACTA2;ACTA1;MYL6;CALD1;TLN1;UTRN;CALM1;ALDOA;MYL9;EMD;CRYAB
digestive tract development (GO:0048565),5/40,0.957991673,0.999996398,0,0,0.505784479,0.021706344,TGFB2;ZIC3;GLI3;FGFR2;CCDC40
positive regulation of cation channel activity (GO:2001259),5/40,0.957991673,0.999996398,0,0,0.505784479,0.021706344,TMSB4X;ANK2;CALM3;CALM1;CALM2
regulation of nitric oxide biosynthetic process (GO:0045428),5/40,0.957991673,0.999996398,0,0,0.505784479,0.021706344,HSP90AA1;HSP90AB1;ROCK2;RAC1;CLU
chordate embryonic development (GO:0043009),8/58,0.959051347,0.999996398,0,0,0.566319144,0.023678179,TRIM71;SIX4;WNT7B;CHD7;IGF2;GRHL2;FGFR2;FGFR1
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),8/58,0.959051347,0.999996398,0,0,0.566319144,0.023678179,LEFTY1;TWSG1;TGFB2;DAB2;RBPMS;BMP8B;SMAD7;BMPR1A
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),8/58,0.959051347,0.999996398,0,0,0.566319144,0.023678179,CLIP3;CHUK;RACK1;TAX1BP1;F2RL1;CFLAR;HIPK1;UBE2K
positive regulation of protein kinase B signaling (GO:0051897),27/161,0.959461129,0.999996398,0,0,0.712410171,0.029482009,ITGB1;HSP90AB1;RAMP3;PDGFB;PARK7;PHB;PIK3CB;LRP2;THBS1;IGF1R;MTDH;C1QBP;RAC1;HSP90AA1;IGF2;GAB1;NRG1;F3;FGF17;LIN28A;HAX1;SPRY2;STRN;FERMT2;FGFR2;FGFR1;HBEGF
cardiac muscle contraction (GO:0060048),4/34,0.959551027,0.999996398,0,0,0.472109772,0.019493311,CAMK2D;GRK2;GSN;TPM1
central nervous system neuron differentiation (GO:0021953),4/34,0.959551027,0.999996398,0,0,0.472109772,0.019493311,RYK;CTNNB1;KNDC1;SOX4
positive regulation of interleukin-12 production (GO:0032735),4/34,0.959551027,0.999996398,0,0,0.472109772,0.019493311,MDK;HMGB1;MAPK14;HSPD1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),4/34,0.959551027,0.999996398,0,0,0.472109772,0.019493311,F2R;CALM3;CALM1;CALM2
regulation of cell adhesion mediated by integrin (GO:0033628),4/34,0.959551027,0.999996398,0,0,0.472109772,0.019493311,TGFB2;SFRP2;PDE3B;ADA
plasma membrane organization (GO:0007009),9/64,0.960322897,0.999996398,0,0,0.579135618,0.023446711,EHD2;SERP1;SYT11;ANXA6;MYH9;ANK2;FNBP1L;SPTBN1;ARL8B
alpha-linolenic acid metabolic process (GO:0036109),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ELOVL1
cellular potassium ion homeostasis (GO:0030007),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ATP1B3
central nervous system projection neuron axonogenesis (GO:0021952),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,MYCBP2
chondroitin sulfate catabolic process (GO:0030207),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,NCAN
cranial nerve development (GO:0021545),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,CHD7
DNA deamination (GO:0045006),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,EXOSC3
embryonic appendage morphogenesis (GO:0035113),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,TGFB2
embryonic hemopoiesis (GO:0035162),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,KMT2A
fatty acid elongation (GO:0030497),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ELOVL1
glucan biosynthetic process (GO:0009250),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PGM2
glycogen biosynthetic process (GO:0005978),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PGM2
high-density lipoprotein particle assembly (GO:0034380),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,BMP1
icosanoid secretion (GO:0032309),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PLA2G1B
inner dynein arm assembly (GO:0036159),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,CCDC40
lipid oxidation (GO:0034440),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ADIPOR1
mature B cell differentiation involved in immune response (GO:0002313),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PTK2B
mitotic DNA integrity checkpoint signaling (GO:0044774),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,NAE1
muscle tissue development (GO:0060537),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,CSRP2
myelination in peripheral nervous system (GO:0022011),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,DICER1
negative regulation of cellular senescence (GO:2000773),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,YBX1
negative regulation of chromatin organization (GO:1905268),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,HMGA1
negative regulation of chromatin silencing (GO:0031936),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,HMGA1
negative regulation of gene silencing (GO:0060969),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,HMGA1
negative regulation of macromolecule biosynthetic process (GO:0010558),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,CLTC
negative regulation of myoblast differentiation (GO:0045662),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,SRA1
negative regulation of potassium ion transport (GO:0043267),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PTK2B
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PARK7
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ALG14
pentose-phosphate shunt (GO:0006098),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PGM2
poly-N-acetyllactosamine metabolic process (GO:0030309),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,B3GNT7
positive regulation of cellular carbohydrate metabolic process (GO:0010676),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PMAIP1
positive regulation of ERAD pathway (GO:1904294),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,UBQLN1
positive regulation of fatty acid biosynthetic process (GO:0045723),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,MID1IP1
positive regulation of protein localization to cell surface (GO:2000010),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,HSP90AB1
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,RAB27A
positive regulation of ruffle assembly (GO:1900029),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PFN1
regulation of antigen receptor-mediated signaling pathway (GO:0050854),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,RC3H1
regulation of autophagosome maturation (GO:1901096),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,UBQLN4
regulation of fibrinolysis (GO:0051917),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,THBS1
regulation of oxidoreductase activity (GO:0051341),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,MT3
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,F3
regulation of response to stress (GO:0080134),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,SLC38A2
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,EDEM1
response to iron ion (GO:0010039),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,HIF1A
response to UV-B (GO:0010224),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,CRIP1
reticulophagy (GO:0061709),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,UFM1
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,PLXNB1
sodium ion export across plasma membrane (GO:0036376),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ATP1B3
UDP-N-acetylglucosamine metabolic process (GO:0006047),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,GFPT2
very long-chain fatty acid biosynthetic process (GO:0042761),13-Jan,0.960517296,0.999996398,0,0,0.295208333,0.011891963,ELOVL1
positive regulation of developmental process (GO:0051094),30/177,0.960806645,0.999996398,0,0,0.721452617,0.028845185,CEBPB;HSP90AB1;RIF1;TFRC;PDGFB;ZDHHC6;CORO1C;CDC20;GJA1;BASP1;MDK;PPP1R13L;C1QBP;CFL1;RPS6KA1;LMNA;DAG1;LLPH;DNM1L;FIS1;XBP1;BNIP3;PA2G4;SLC6A6;REST;BMP1;AGO2;SPIRE1;BMPR1A;FGFR1
negative regulation of viral process (GO:0048525),10/70,0.96179237,0.999996398,0,0,0.589804904,0.022976843,SRPK2;TRIM6;ZFP36;ILF3;TRIM28;CHMP3;BANF1;PPIA;PML;SRPK1
androgen metabolic process (GO:0008209),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,MED1;HSD17B10
autonomic nervous system development (GO:0048483),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,SOX11;SOX4
calcium-mediated signaling using intracellular calcium source (GO:0035584),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,FIS1;PRNP
cellular response to estradiol stimulus (GO:0071392),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,RAMP3;RUVBL2
endocardial cushion development (GO:0003197),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,TGFB2;BMPR1A
innate immune response in mucosa (GO:0002227),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,PLA2G1B;RPL39
intracellular lipid transport (GO:0032365),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,MID1IP1;ACACA
NAD biosynthetic process (GO:0009435),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,NAPRT;NAMPT
positive regulation of lipid storage (GO:0010884),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,PLA2G10;NFKB1
positive regulation of smoothened signaling pathway (GO:0045880),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,EVC;UCHL5
regulation of transcription by RNA polymerase III (GO:0006359),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,PRDX5;POLR3G
vacuolar acidification (GO:0007035),21-Feb,0.962587087,0.999996398,0,0,0.372812003,0.014215597,TMEM9;CLN6
negative regulation of cellular response to insulin stimulus (GO:1900077),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,GRB7;GSK3A;RPS6KB1
negative regulation of oxidative stress-induced cell death (GO:1903202),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,REST;PARK7;PPIA
phagosome acidification (GO:0090383),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,ATP6V1G1;ATP6V1D;ATP6V1F
positive regulation of nitric oxide metabolic process (GO:1904407),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,HSP90AA1;HSP90AB1;CLU
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,FLT1;PDGFB;PTK2B
protein localization to lysosome (GO:0061462),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,AP3M1;RNF128;NEDD4
receptor clustering (GO:0043113),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,FLNA;SYNJ2BP;AGRN
response to interferon-beta (GO:0035456),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,TRIM6;CDC34;UBE2K
sulfur compound transport (GO:0072348),28-Mar,0.963040369,0.999996398,0,0,0.424938608,0.016003166,SLC6A6;MGST1;ABCG2
cell morphogenesis involved in neuron differentiation (GO:0048667),11/76,0.963375989,0.999996398,0,0,0.598822499,0.022342971,RAB10;APP;KLF7;PARD6B;RYK;MAP1B;DOCK7;S100A6;LMTK2;ACTB;FGFR2
cellular response to hormone stimulus (GO:0032870),11/76,0.963375989,0.999996398,0,0,0.598822499,0.022342971,MED1;URI1;XBP1;RAMP3;SFR1;RDX;SRA1;MGARP;UBE2L3;SLC5A5;ZFP36L1
polyol metabolic process (GO:0019751),6/47,0.963488441,0.999996398,0,0,0.518038791,0.019268343,ISYNA1;PPIP5K2;PTEN;CALM1;PLCD1;NUDT4
organic substance transport (GO:0071702),22/136,0.963846537,0.999996398,0,0,0.682423689,0.025129018,ARRDC4;NDC1;CALCRL;RAMP3;PEX19;CHKA;ARRDC1;SLC23A1;ARRDC3;HIKESHI;MIA3;PCTP;NME4;LRP2;HSP90B1;RCN3;CHMP2A;TXNIP;CHMP3;MYH9;SLC19A1;ABCG2
hexose metabolic process (GO:0019318),5/41,0.964117752,0.999996398,0,0,0.491703316,0.017967745,CHST15;AKR1A1;ALDOA;KHK;GALK1
T cell differentiation (GO:0030217),5/41,0.964117752,0.999996398,0,0,0.491703316,0.017967745,CHD7;GLI3;SOX4;IL2;ZFP36L1
visual system development (GO:0150063),5/41,0.964117752,0.999996398,0,0,0.491703316,0.017967745,TGFB2;ITGAM;RAB18;PBX2;HIPK1
negative regulation of autophagy (GO:0010507),8/59,0.96421025,0.999996398,0,0,0.55517914,0.020234007,NRBP2;SNRNP70;TLK2;EIF4E;MT3;EIF4G3;EIF4G2;MCL1
phospholipid transport (GO:0015914),8/59,0.96421025,0.999996398,0,0,0.55517914,0.020234007,PRELID1;PITPNB;PLA2G10;PCTP;ATP11B;PITPNC1;PRELID3A;PRELID3B
regulation of heart contraction (GO:0008016),14/93,0.964577753,0.999996398,0,0,0.626938625,0.022610438,GSK3A;CAMK2D;TGFB2;AHCYL1;TPM1;ITPR1;ATP2A2;ANK2;ATP1B3;SRI;SMAD7;CALM3;CALM1;CALM2
intracellular pH reduction (GO:0051452),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,ATP6V1G1;TMEM9;ATP6V1D;ATP6V1F
negative regulation of organelle assembly (GO:1902116),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,YAP1;ODF2L;LIMK2;TBC1D7
negative regulation of T cell proliferation (GO:0042130),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,PRNP;CEBPB;GLMN;RC3H1
oxoacid metabolic process (GO:0043436),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,PPA1;MIF;LIAS;SULT4A1
regulation of blood circulation (GO:1903522),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,CAMK2D;TPM1;ECE1;SRI
regulation of lipid biosynthetic process (GO:0046890),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,CREB1;EIF6;MID1IP1;ADIPOR1
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,FLT1;PIK3IP1;PDGFB;PTK2B
regulation of regulated secretory pathway (GO:1903305),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,SNAPIN;RAB15;SYT11;RAB27A
response to estrogen (GO:0043627),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,KRT19;SFR1;SRA1;EP300
smoothened signaling pathway (GO:0007224),4/35,0.965868209,0.999996398,0,0,0.456851079,0.015865471,EVC2;TCTN2;HIPK1;GLI3
negative regulation of cell growth (GO:0030308),20/126,0.96607397,0.999996398,0,0,0.667246644,0.023029934,TGFB2;GSK3A;NDRG3;DDX3X;PTPRS;FHL1;ENO1;PHB;CGRRF1;MT3;PML;SMARCA4;PPP2CA;GJA1;SFRP2;NME6;RACK1;DACT3;DIP2B;RBBP7
regulation of protein phosphorylation (GO:0001932),47/266,0.966135188,0.999996398,0,0,0.758091547,0.026117397,APP;CEBPB;HDAC3;TFRC;ROCK2;PTEN;KNDC1;ARRB1;PARK7;EFNA5;STK4;CORO1C;FXR1;PPP2CA;PAK1;PPP2R5E;NSD1;RACK1;FLOT1;CHP1;RAC1;ECT2;CDK5RAP3;MAPK3;PRNP;NPM1;HSP90AA1;IGFBP3;LIMK2;IGF2;PLAUR;PPP2R5A;PPP2R5C;MT3;PML;CLIP3;FGF17;PDCL3;DAB2;IMPACT;CLDN3;MYADM;CDK2AP1;PHIP;KRAS;TARDBP;PPIA
cellular response to BMP stimulus (GO:0071773),10/71,0.966290008,0.999996398,0,0,0.580098637,0.019892322,LEFTY1;DDX5;USP15;TGFB2;USP9X;BMP8B;SMAD5;MAPK3;SMAD7;BMPR1A
protein tetramerization (GO:0051262),10/71,0.966290008,0.999996398,0,0,0.580098637,0.019892322,CPSF6;ACOT13;SSBP1;ALDOA;SAMHD1;HSD17B10;ACACA;GLS;ALDH9A1;FARSB
regulation of endopeptidase activity (GO:0052548),10/71,0.966290008,0.999996398,0,0,0.580098637,0.019892322,PSMA3;PRELID1;SERPINE2;PSME3;TIMP2;SERPINH1;PSME2;A2ML1;GAPDH;PSMB9
regulation of protein kinase activity (GO:0045859),17/110,0.966714547,0.999996398,0,0,0.646539714,0.021886676,XRCC6;PRKRIP1;PARK7;IQGAP1;CENPE;SPRED1;RAP2B;TRAF4;CHP1;PTK2B;SFN;EPHA1;ECT2;PPIA;PAK2;YWHAG;RTRAF
regulation of intracellular signal transduction (GO:1902531),81/437,0.968228545,0.999996398,0,0,0.802826545,0.025920956,RPL5;ARHGAP8;PAK1IP1;NRK;WWC1;ZFAND6;ARHGAP1;PTEN;EHMT1;CHD4;NOC2L;ARHGAP5;AKAP12;SYDE2;TRIM6;SPRED1;PPP1R13L;TMSB4X;ARHGDIA;EP300;KMT5A;RAC1;IER3;USP7;PLEKHG2;RFC4;CSNK2A1;RFC2;CSNK2A2;ARHGEF16;ARAP3;PPP2R5C;RHOC;RHOA;TTI1;RCN3;TRAF4;DDIT4;RHOU;ARHGEF2;SOS1;EZR;CRK;OPTN;TELO2;ARHGEF5;RHNO1;RPL11;TAF9;AKAP7;AKAP5;RPF2;STK4;ARHGAP12;CDC42;ARHGAP21;NUAK1;PAK1;GNA12;MAPK1;RBBP7;ECT2;PAK2;MAPK3;MBD3;PLK3;TAF12;RPA1;ARHGAP29;SSRP1;HIPK1;MAPK14;PML;TPX2;TAOK3;TAOK1;RPA3;CDK1;F2RL1;RAD1;TAF2
hemopoiesis (GO:0030097),14/94,0.968317323,0.999996398,0,0,0.619062001,0.019930969,CD164;TGFB2;FLT1;YTHDF2;KMT2A;PDGFB;PRRC2C;HIPK1;RASGRP4;MELK;SFRP2;SBDS;CDK13;FGFR2
inositol phosphate metabolic process (GO:0043647),6/48,0.968579124,0.999996398,0,0,0.50567203,0.016143631,ISYNA1;PPIP5K2;PTEN;CALM1;PLCD1;NUDT4
RNA methylation (GO:0001510),8/60,0.968774119,0.999996398,0,0,0.544467597,0.017272582,TRMT112;NSUN2;THUMPD3;METTL5;LCMT2;BUD23;METTL16;FTSJ3
negative regulation of DNA-binding transcription factor activity (GO:0043433),23/143,0.969093994,0.999996398,0,0,0.677662936,0.021274327,EGLN1;PRNP;USP7;KDM1A;CHUK;PRMT2;FOXH1;ARRB1;COMMD1;COMMD6;PHB2;RNF2;SMAD7;SUMO1;ID2;TMSB4X;PLA2G10;BHLHE40;ID1;TAX1BP1;CHP1;FLNA;CDK5RAP3
antigen processing and presentation of endogenous peptide antigen (GO:0002483),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,IDE
aorta development (GO:0035904),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,HECTD1
bone morphogenesis (GO:0060349),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,FGFR2
carbohydrate transport (GO:0008643),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SLC23A1
cellular response to low-density lipoprotein particle stimulus (GO:0071404),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,ITGB1
coenzyme A metabolic process (GO:0015936),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,DCAKD
defense response to protozoan (GO:0042832),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,GBP2
endothelial cell differentiation (GO:0045446),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,FSTL1
genitalia development (GO:0048806),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,CHD7
heart process (GO:0003015),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,RAMP3
low-density lipoprotein particle remodeling (GO:0034374),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PLA2G10
manganese ion transport (GO:0006828),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SLC39A14
membrane repolarization during action potential (GO:0086011),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,YWHAE
myeloid dendritic cell activation (GO:0001773),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,HMGB1
negative regulation of bone mineralization (GO:0030502),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PTK2B
negative regulation of cell activation (GO:0050866),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PDGFB
negative regulation of coagulation (GO:0050819),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SERPINE2
negative regulation of neuroinflammatory response (GO:0150079),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SYT11
negative regulation of T cell mediated immunity (GO:0002710),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SMAD7
negative regulation of TORC1 signaling (GO:1904262),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,BMT2
negative regulation of viral transcription (GO:0032897),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,ZFP36
neuron fate commitment (GO:0048663),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,ID2
ovarian follicle development (GO:0001541),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,CEBPB
positive regulation of glycogen biosynthetic process (GO:0045725),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,IGF2
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,DDX58
positive regulation of regulatory T cell differentiation (GO:0045591),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SOX12
positive regulation of T cell chemotaxis (GO:0010820),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,WNK1
positive regulation of T-helper cell differentiation (GO:0045624),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,MYB
regulation of acrosome reaction (GO:0060046),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PLA2G10
regulation of cAMP-dependent protein kinase activity (GO:2000479),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PKIG
regulation of cell projection organization (GO:0031344),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SPRY2
regulation of histone deacetylation (GO:0031063),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,CAMK2D
regulation of macrophage cytokine production (GO:0010935),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,TGFB2
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,NAMPT
regulation of sensory perception of pain (GO:0051930),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,F2R
response to UV-A (GO:0070141),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PPID
secretion (GO:0046903),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,PRKCI
sequestering of extracellular ligand from receptor (GO:0035581),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,FSTL1
sodium-independent organic anion transport (GO:0043252),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,SLC16A2
steroid catabolic process (GO:0006706),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,YWHAH
substrate-dependent cell migration (GO:0006929),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,CD2AP
tRNA wobble base modification (GO:0002097),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,DPH3
tRNA wobble uridine modification (GO:0002098),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,DPH3
vasodilation (GO:0042311),14-Jan,0.969210684,0.999996398,0,0,0.272482517,0.008521418,F2RL1
limb development (GO:0060173),29-Mar,0.969324688,0.999996398,0,0,0.40856858,0.012729219,CHD7;MAP3K20;GLI3
lipid catabolic process (GO:0016042),29-Mar,0.969324688,0.999996398,0,0,0.40856858,0.012729219,ACADL;PLA2G1B;MT3
negative regulation of interferon-gamma production (GO:0032689),29-Mar,0.969324688,0.999996398,0,0,0.40856858,0.012729219,PRNP;C1QBP;HMGB1
response to zinc ion (GO:0010043),29-Mar,0.969324688,0.999996398,0,0,0.40856858,0.012729219,CRIP1;MT3;KHK
protein autophosphorylation (GO:0046777),26/159,0.969395224,0.999996398,0,0,0.691069388,0.021480429,DDR1;CAMK2D;FLT1;STK4;IGF1R;PAK1;SLK;PTK2B;PIM3;MARK3;PAK2;MAPK3;DAPK1;NEK6;LMTK2;MELK;MAPKAPK3;STK24;TAOK3;STK26;TAOK1;WNK3;CDK12;EPHA1;FGFR2;FGFR1
phosphatidylinositol phosphate biosynthetic process (GO:0046854),5/42,0.969410958,0.999996398,0,0,0.478383297,0.014861767,PI4K2B;CISH;PIK3CB;PIK3C2A;SOCS4
extracellular matrix disassembly (GO:0022617),9/66,0.969431386,0.999996398,0,0,0.558743169,0.017346505,MMP14;GSN;BMP1;CAPNS1;BSG;HPN;CAPN2;FLOT1;TIMP2
female gonad development (GO:0008585),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,CEBPB;NUP107
limb morphogenesis (GO:0035108),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,TGFB2;GLI3
metallo-sulfur cluster assembly (GO:0031163),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,HSPA9;NFU1
negative regulation of B cell activation (GO:0050869),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,ID2;RC3H1
negative regulation of lipid biosynthetic process (GO:0051055),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,ACADL;FBXW7
negative regulation of lymphocyte activation (GO:0051250),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,DUSP3;SOX11
positive regulation of axon extension (GO:0045773),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,GOLGA4;DBN1
regulation of adenylate cyclase activity (GO:0045761),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,GNAI3;AKAP5
zinc ion transmembrane transport (GO:0071577),22-Feb,0.969637587,0.999996398,0,0,0.35414867,0.01091943,SLC39A10;SLC39A14
DNA repair (GO:0006281),53/298,0.969697406,0.999996398,0,0,0.76390928,0.023506412,NUDT1;NUCKS1;PARK7;TRIM28;SUMO1;SLC30A9;RFC4;PARP1;PARP2;RFC2;COMMD1;SMC1A;RAD23B;WDR33;DDB1;PSME4;UBE2V1;RHNO1;VCP;PCNA;DDX1;BRCC3;PDS5A;MAPK8;UBB;RAD21;TDG;UBE2NL;NSD2;UBC;USP1;RPS27A;NPM1;UBE2B;GADD45A;HUWE1;RPA1;UBE2A;GTF2H3;GTF2H5;SETX;TDP1;RPA3;ERCC1;CDK1;NABP2;UBE2N;NABP1;RAD1;MNAT1;RAD18;CENPS;CUL4B
cell-matrix adhesion (GO:0007160),15/100,0.969931586,0.999996398,0,0,0.624205359,0.019056827,DDR1;ITGB1;ITGA3;ACTN1;RCC2;PTPRK;TIMM10B;SGCE;FERMT1;BCAM;CTTN;ZYX;RAC1;SIGLEC1;FERMT2
negative regulation of cell differentiation (GO:0045596),32/191,0.97082435,0.999996398,0,0,0.711243164,0.021059713,YAP1;HPN;PTEN;HNRNPU;SRA1;WDR61;ADIPOR1;LIMD1;FOXO1;CDC73;PPP2CA;PTBP1;SPRED2;SPRED1;NOCT;MYB;LEO1;PTK2B;MED1;YTHDF2;IGF2;SMAD7;REST;SFRP2;SDHAF2;ID2;PKP2;SPRY2;SPRY1;ANP32B;CALR;FERMT2
dendrite morphogenesis (GO:0048813),4/36,0.971255921,0.999996398,0,0,0.442546054,0.01290698,CDC42;KLF7;PTEN;WASL
endoderm formation (GO:0001706),4/36,0.971255921,0.999996398,0,0,0.442546054,0.01290698,MMP14;COL4A2;DUSP1;LAMB1
negative regulation of toll-like receptor signaling pathway (GO:0034122),4/36,0.971255921,0.999996398,0,0,0.442546054,0.01290698,OTUD4;PTPRS;F2RL1;LGR4
positive regulation of cytokine-mediated signaling pathway (GO:0001961),4/36,0.971255921,0.999996398,0,0,0.442546054,0.01290698,TRIM6;HIF1A;UBE2K;TRIM44
phosphate-containing compound metabolic process (GO:0006796),36/212,0.971385888,0.999996398,0,0,0.722727273,0.02098184,ISYNA1;PFKFB3;SLC20A1;PTEN;PIK3CB;NUDT5;LIMD1;HK2;NUDT4;NT5C;PPP3CB;PAK1;PPIP5K2;PGK1;ENPP3;PAK2;PSPH;NADK;MAPK3;DUSP3;GPX4;GFPT2;LIMK2;HDHD2;PPP1CA;BCKDK;PFKL;PPA1;TAOK1;GPD2;PLA2G10;PLAA;CALM1;ALDOA;PLPP2;PLCD1
positive regulation of interleukin-8 production (GO:0032757),8/61,0.972802492,0.999996398,0,0,0.534160264,0.014729045,AFAP1L2;DDX58;PLA2G1B;F2R;F2RL1;HMGB1;PARK7;F3
regulation of endocytosis (GO:0030100),8/61,0.972802492,0.999996398,0,0,0.534160264,0.014729045,CLIP3;MTMR2;DAB2;CD151;ROCK1;SYT11;FLOT1;GPC3
response to light stimulus (GO:0009416),8/61,0.972802492,0.999996398,0,0,0.534160264,0.014729045,COPS3;MAPK8;UBE2B;UVSSA;PCLAF;USP1;UBE4B;UBE2A
ubiquitin-dependent ERAD pathway (GO:0030433),10/73,0.973883826,0.999996398,0,0,0.561610509,0.014862044,VCP;PSMC6;HSPA5;EDEM1;UBQLN1;UBE4B;SEC61B;STT3B;UBE2J2;HSP90B1
anion transport (GO:0006820),5/43,0.973972717,0.999996398,0,0,0.465764331,0.012283131,TSPO;VDAC2;VDAC1;SLC19A1;ABCG2
glutathione metabolic process (GO:0006749),5/43,0.973972717,0.999996398,0,0,0.465764331,0.012283131,GGCT;GCLC;GSTT2;PARK7;GCLM
heart looping (GO:0001947),5/43,0.973972717,0.999996398,0,0,0.465764331,0.012283131,AHI1;MKKS;ZIC3;FOLR1;CCDC40
positive regulation of axonogenesis (GO:0050772),5/43,0.973972717,0.999996398,0,0,0.465764331,0.012283131,GOLGA4;ARHGDIA;PLXNB1;RHOA;DBN1
positive regulation of peptide hormone secretion (GO:0090277),5/43,0.973972717,0.999996398,0,0,0.465764331,0.012283131,AIMP1;GLUD1;NNAT;ACSL4;SOX4
axon guidance (GO:0007411),34/203,0.97437787,0.999996398,0,0,0.710845055,0.018450761,GRB7;LAMA5;SHC1;NEXN;SEMA3E;PIK3CB;EFNA5;IGSF9;EFNB2;SPTA1;GPC1;KIF5B;BSG;DAG1;MAPK1;EMB;RAC1;SPTAN1;SPTBN1;PDLIM7;MAPK3;SEMA6A;RYK;GAB1;ENAH;KLF7;DOK2;GAP43;PTPRA;PLA2G10;PLXNB1;EPHA1;EZR;SOS1
alpha-amino acid catabolic process (GO:1901606),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,BLMH;FAH;HSD17B10
cardiac muscle cell action potential (GO:0086001),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,YWHAE;PKP2;ANK2
fatty-acyl-CoA biosynthetic process (GO:0046949),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,ELOVL1;ACSL4;ACACA
positive regulation of B cell proliferation (GO:0030890),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,TFRC;MIF;IL2
positive regulation of lipid kinase activity (GO:0090218),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,FLT1;PDGFB;PTK2B
positive regulation of small GTPase mediated signal transduction (GO:0051057),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,SHC1;SHOC2;RASGRP4
regulation of long-term synaptic potentiation (GO:1900271),30-Mar,0.974588062,0.999996398,0,0,0.393411146,0.010126559,APP;YTHDF1;AKAP5
artery development (GO:0060840),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,HECTD1;SMAD7
ear morphogenesis (GO:0042471),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,CHD7;FGFR2
glucose 6-phosphate metabolic process (GO:0051156),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,PGM2;HK2
hexose transmembrane transport (GO:0008645),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,SLC2A1;SLC2A3
hyaluronan metabolic process (GO:0030212),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,CHP1;HMMR
membrane protein ectodomain proteolysis (GO:0006509),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,DAG1;MYH9
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,BCL2L1;MCL1
negative regulation of reactive oxygen species metabolic process (GO:2000378),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,PARK7;MT3
negative regulation of signal transduction in absence of ligand (GO:1901099),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,BCL2L1;MCL1
positive regulation of interleukin-17 production (GO:0032740),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,PHB;IL2
protein deacylation (GO:0035601),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,HDAC3;ABHD17C
regulation of B cell receptor signaling pathway (GO:0050855),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,SLC39A10;FOXP1
regulation of steroid metabolic process (GO:0019218),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,ACADL;LAMTOR1
regulation of toll-like receptor 4 signaling pathway (GO:0034143),23-Feb,0.975397423,0.999996398,0,0,0.337262798,0.00840131,FLOT1;F2RL1
positive regulation of myeloid cell differentiation (GO:0045639),4/37,0.97583892,0.999996398,0,0,0.429108001,0.010495015,MED1;MAPK14;ETS1;HIF1A
acute-phase response (GO:0006953),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,CEBPB
cellular response to ATP (GO:0071318),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,HSP90B1
cellular sodium ion homeostasis (GO:0006883),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,ATP1B3
electron transport chain (GO:0022900),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,NDUFA5
endoderm development (GO:0007492),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,DUSP1
fibrinolysis (GO:0042730),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,PLAUR
histone H4-K5 acetylation (GO:0043981),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,JADE2
histone H4-K8 acetylation (GO:0043982),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,JADE2
lipoxygenase pathway (GO:0019372),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,GPX4
membrane repolarization during cardiac muscle cell action potential (GO:0086013),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,YWHAE
mitotic intra-S DNA damage checkpoint signaling (GO:0031573),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,TIPIN
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,MPHOSPH8
photoreceptor cell development (GO:0042461),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,AHI1
positive regulation of acute inflammatory response (GO:0002675),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,PARK7
positive regulation of glycogen metabolic process (GO:0070875),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,IGF2
positive regulation of heterotypic cell-cell adhesion (GO:0034116),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,FLOT1
positive regulation of secretion (GO:0051047),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,XBP1
protein homotrimerization (GO:0070207),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,MIF
protein hydroxylation (GO:0018126),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,EGLN3
protein trimerization (GO:0070206),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,MIF
regulation of extracellular matrix organization (GO:1903053),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,DDR1
regulation of macrophage differentiation (GO:0045649),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,ID2
regulation of microglial cell activation (GO:1903978),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,SYT11
regulation of non-canonical Wnt signaling pathway (GO:2000050),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,GPC3
regulation of secretion (GO:0051046),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,NRG1
regulation of T cell chemotaxis (GO:0010819),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,WNK1
regulation of triglyceride biosynthetic process (GO:0010866),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,FBXW7
steroid hormone mediated signaling pathway (GO:0043401),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,MED1
synaptonemal complex assembly (GO:0007130),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,RAD21
synaptonemal complex organization (GO:0070193),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,RAD21
vitamin D metabolic process (GO:0042359),15-Jan,0.975990172,0.999996398,0,0,0.253003247,0.006148678,LRP2
peptidyl-tyrosine modification (GO:0018212),7/56,0.976396367,0.999996398,0,0,0.505559529,0.012076129,FLT1;ABI2;PDGFB;PTK2B;EPHA1;FGFR2;FGFR1
sensory perception of sound (GO:0007605),13/91,0.976526397,0.999996398,0,0,0.589524461,0.014003267,TIMM8B;NDUFB9;MKKS;WDR1;HPN;TIMM13;LRP2;MARVELD2;BIRC5;TBL1X;ALDH7A1;CCDC50;GSDME
phosphatidic acid metabolic process (GO:0046473),6/50,0.976857353,0.999996398,0,0,0.482624884,0.011300489,PLA2G12A;DGKD;PLA2G1B;PLA2G10;PLA2G6;AGPAT4
protein maturation (GO:0051604),14/97,0.977511879,0.999996398,0,0,0.59657092,0.013568907,NAA50;GLRX3;NAA10;ECE1;F3;HSPD1;NFU1;MMP14;BOLA2;NNAT;NDUFAB1;NAA16;NAA15;METAP2
regulation of MAP kinase activity (GO:0043405),14/97,0.977511879,0.999996398,0,0,0.59657092,0.013568907,TSG101;FLT1;DUSP1;SPRY4;PDGFB;PIK3CB;UCHL1;PDCD10;SPRY2;SPRY1;CDK12;CDK5RAP3;EZH2;FGFR1
regulation of small GTPase mediated signal transduction (GO:0051056),22/141,0.977591254,0.999996398,0,0,0.653539333,0.014811578,ARHGAP8;PLEKHG2;ARHGEF16;ARHGAP1;ARHGAP29;ARAP3;ARHGAP5;RHOC;RHOA;CD2AP;ARHGAP12;SYDE2;CDC42;ARHGAP21;ARHGDIA;RHOU;RAC1;ARHGEF2;ECT2;SOS1;CGNL1;ARHGEF5
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),11/80,0.977677791,0.999996398,0,0,0.563962893,0.01273153,DDX3X;PSME3;BIRC6;ITGA6;PHIP;PARK7;ARHGEF2;CFLAR;THBS1;MCL1;BCL2L1
skin development (GO:0043588),11/80,0.977677791,0.999996398,0,0,0.563962893,0.01273153,TGM1;MED1;CLIC4;CLDN4;ITGA3;STMN1;TXNIP;LSR;ITGA6;SFN;DHCR24
positive regulation of osteoblast differentiation (GO:0045669),5/44,0.977894449,0.999996398,0,0,0.453792492,0.010143869,YAP1;WNT7B;SOX11;FERMT2;BMPR1A
regulation of Ras protein signal transduction (GO:0046578),12/86,0.978391365,0.999996398,0,0,0.573608468,0.012530775,TGFB2;SHC1;PDCD10;ARHGDIA;RDX;SPRY4;SPRY2;SHOC2;SPRY1;ARHGEF2;RASGRP4;ARF6
positive regulation of cell population proliferation (GO:0008284),87/474,0.978850101,0.999996398,0,0,0.792710231,0.016945579,FLT1;KDM1A;PTEN;HNRNPU;RBPJ;IGF1R;RPS4X;GJA1;HMGN5;CAPNS1;MDK;MYC;NAMPT;SOX4;PRKCI;RPS9;TIPIN;CSNK2A1;RPL23;F2R;RPS6;NME2;TET1;SOX11;NRG1;MIF;WDR77;FOXP1;NME1;SFRP2;S100A6;BIRC5;PHIP;SLC25A5;EPHA1;KIF20B;EAPP;HBEGF;YAP1;CDC123;SHC1;DHX9;PLA2G1B;CUL3;COX17;PDGFB;PHB;THBS1;EFNB2;PAK1;RPS15A;RAB25;EPCAM;PDCD10;CXCR2;SSR1;PTK2B;ROMO1;MCTS1;SRPK2;XBP1;NPM1;TGFB2;CNBP;IGF2;LAMB1;NAP1L1;UBE2A;IL2;TJP1;FGF17;CNOT6;CNOT7;CDK4;ID2;DNAJA2;FAM98B;KRAS;CALR;CDK13;TDGF1;FGFR2;EZH2;COPS9;RNF187;BMPR1A;FGFR1
cardiac muscle cell action potential involved in contraction (GO:0086002),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,GJA1;PKP2;ANK2
embryonic skeletal system morphogenesis (GO:0048704),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,EIF4A3;SOX11;FGFR2
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,PPP2CA;SFRP2;INPP5F
negative regulation of response to biotic stimulus (GO:0002832),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,C1QBP;PCBP2;LYAR
positive regulation of mononuclear cell migration (GO:0071677),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,C1QBP;HMGB1;CALR
prostaglandin metabolic process (GO:0006693),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,PTGES3;PLAA;MIF
purine nucleoside bisphosphate metabolic process (GO:0034032),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,ACOT2;ACOT13;DBI
regulation of cellular pH (GO:0030641),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,SLC4A7;CHP1;SLC9B1
ribonucleoside bisphosphate metabolic process (GO:0033875),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,ACOT2;ACOT13;DBI
steroid hormone biosynthetic process (GO:0120178),31-Mar,0.978985433,0.999996398,0,0,0.379336387,0.008056542,MED1;STARD3NL;TSPO
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),13/92,0.979171595,0.999996398,0,0,0.582024624,0.012250673,CDKN1C;LEFTY1;TGFB2;HSP90AB1;RBPMS;BMP8B;SOX11;RBPJ;THBS1;TWSG1;DAB2;EP300;BMPR1A
monocarboxylic acid biosynthetic process (GO:0072330),8/63,0.979468769,0.999996398,0,0,0.514670033,0.010676792,XBP1;GATM;PLA2G1B;OSBPL3;NDUFAB1;PARK7;HSD17B10;ACACA
cellular response to calcium ion (GO:0071277),9/69,0.979577748,0.999996398,0,0,0.530703552,0.010950362,CPNE8;CLIC4;CAMK2D;SYT11;BRAF;IQGAP1;RASGRP2;ECT2;SLC25A24
carboxylic acid transport (GO:0046942),7/57,0.979639148,0.999996398,0,0,0.495416477,0.010191208,SLC6A6;SLC38A1;SLC16A1;SLC23A1;SLC16A2;SLC16A3;SLC38A2
positive regulation of proteolysis (GO:0045862),7/57,0.979639148,0.999996398,0,0,0.495416477,0.010191208,CYFIP2;RCN3;BAG2;PERP;AURKAIP1;CLN6;MAPK12
lysosome organization (GO:0007040),4/38,0.979727787,0.999996398,0,0,0.416460421,0.008529324,SNAPIN;HOOK1;LAMTOR1;CLN6
positive regulation of cell development (GO:0010720),4/38,0.979727787,0.999996398,0,0,0.416460421,0.008529324,NUMBL;NAP1L1;SOX11;LRP2
response to estradiol (GO:0032355),4/38,0.979727787,0.999996398,0,0,0.416460421,0.008529324,RAMP3;RUVBL2;CTNNB1;STRN3
positive regulation of immune response (GO:0050778),10/75,0.979890047,0.999996398,0,0,0.544260112,0.011056596,TGFB2;XBP1;ITGAM;DHX9;PLA2G1B;RIOK3;MYB;F2RL1;POLR3G;IL2
positive regulation of cell differentiation (GO:0045597),44/258,0.98007916,0.999996398,0,0,0.726020433,0.014608936,YAP1;CEBPB;HSP90AB1;TACSTD2;LOXL2;ZFP36L1;CDC42;GJA1;ZFP36;GLIPR2;MDK;PPP1R13L;GPC1;NOCT;RPS6KA1;PDPN;CTNNA1;ECT2;XBP1;TGFB2;TCF15;WNT7B;IGFBP3;SOX11;PA2G4;MAPK14;RHOA;NFKB1;MAPK12;SLC6A6;DAB2;IMPACT;REST;SFRP2;CREB1;ID2;CARM1;PLA2G10;CTNNB1;ARHGEF2;FERMT2;EZH2;BMPR1A;FGFR1
extracellular matrix assembly (GO:0085029),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,PXDN;LAMB1
leukotriene metabolic process (GO:0006691),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,PLA2G1B;MGST3
lymphocyte activation involved in immune response (GO:0002285),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,MDK;F2RL1
ncRNA 3'-end processing (GO:0043628),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,SSB;TRNT1
negative regulation of lipid metabolic process (GO:0045833),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,PDE3B;PPP2R5A
potassium ion homeostasis (GO:0055075),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,SLC12A4;ATP1B3
regulation of axon extension involved in axon guidance (GO:0048841),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,SEMA6A;SEMA3E
regulation of cytokine production involved in immune response (GO:0002718),24-Feb,0.980093074,0.999996398,0,0,0.321912005,0.006472922,TRIM6;F2RL1
regulation of axonogenesis (GO:0050770),6/51,0.98019045,0.999996398,0,0,0.471869549,0.00944135,PAK1;ARHGDIA;PTEN;PLXNB1;PAK2;RHOA
positive regulation of phosphorylation (GO:0042327),43/253,0.980319888,0.999996398,0,0,0.723056666,0.014371723,DDR1;APP;PFKFB3;FLT1;HDAC3;TFRC;ROCK2;KNDC1;ARRB1;EFNA5;STK4;HIF1A;THBS1;IGF1R;FXR1;PAK1;RACK1;FLOT1;RAC1;MAPK3;HSP90AA1;RYK;LMO4;FZD7;PTGES3;LIMK2;GLMN;IGF2;PLAUR;LMTK2;MIF;MT3;CLIP3;FGF17;DAB2;CLDN3;CDK2AP1;ITGA6;KRAS;EPHA1;PPIA;FGFR2;FGFR1
positive regulation of response to biotic stimulus (GO:0002833),5/45,0.981258062,0.999996398,0,0,0.442419245,0.008370481,USP15;DHX9;RIOK3;POLR3G;PUM2
activation of NF-kappaB-inducing kinase activity (GO:0007250),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,CARD10
aromatic amino acid family catabolic process (GO:0009074),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,FAH
autophagy of nucleus (GO:0044804),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,WIPI1
B cell activation involved in immune response (GO:0002312),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,EXOSC3
filopodium assembly (GO:0046847),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,EZR
membrane repolarization (GO:0086009),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,ATP1B3
motor neuron axon guidance (GO:0008045),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,RAC1
necroptotic process (GO:0070266),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,DNM1L
negative regulation of macrophage activation (GO:0043031),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,SYT11
nucleoside diphosphate metabolic process (GO:0009132),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,NME2
oogenesis (GO:0048477),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,MDK
positive regulation of collagen biosynthetic process (GO:0032967),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,F2R
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,DDX58
positive regulation of small molecule metabolic process (GO:0062013),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,PMAIP1
positive regulation of vasoconstriction (GO:0045907),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,F2R
protein localization to microtubule organizing center (GO:1905508),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,PCM1
regulation of chromatin silencing (GO:0031935),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,HMGA1
regulation of fatty acid oxidation (GO:0046320),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,ACADL
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,DDX58
regulation of neurotransmitter transport (GO:0051588),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,FLOT1
regulation of systemic arterial blood pressure (GO:0003073),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,GSK3A
regulation of systemic arterial blood pressure by hormone (GO:0001990),16-Jan,0.981277038,0.999996398,0,0,0.236121212,0.004462798,ECE1
regulation of protein kinase B signaling (GO:0051896),34/207,0.981630709,0.999996398,0,0,0.694229316,0.012871082,ITGB1;RAMP3;HSP90AB1;PDCD6;PDGFB;PTEN;PARK7;PHB;PIK3CB;LRP2;THBS1;MTDH;IGF1R;C1QBP;DAG1;RACK1;RAC1;HSP90AA1;PLEKHA1;IGF2;GAB1;NRG1;PPP2R5C;F3;FGF17;RCN3;LIN28A;HAX1;SPRY2;STRN;FERMT2;FGFR2;HBEGF;FGFR1
diterpenoid metabolic process (GO:0016101),8/64,0.982203869,0.999996398,0,0,0.505446977,0.009076001,GPC1;RBP1;GPC3;SDC1;LRP2;GPC4;AGRN;HSPG2
regulation of innate immune response (GO:0045088),8/64,0.982203869,0.999996398,0,0,0.505446977,0.009076001,HSP90AB1;DHX9;RIOK3;CDC37;POLR3G;SAMHD1;ABCE1;LYAR
positive regulation of interleukin-6 production (GO:0032755),10/76,0.982392155,0.999996398,0,0,0.535979241,0.009521514,APP;XBP1;DDX58;DHX9;F2R;F2RL1;HMGB1;ARHGEF2;HSPD1;MAPK13
cytosolic transport (GO:0016482),17/116,0.982526225,0.999996398,0,0,0.607120475,0.010702468,VPS29;SORT1;GOSR2;CLTC;RHOBTB3;LMTK2;SNX2;RAB14;HOOK1;RAB6A;EPS15;YKT6;SNX5;PLEKHJ1;SNX6;VTI1B;VAMP3
positive regulation of interleukin-10 production (GO:0032733),3/32,0.982650789,0.999996398,0,0,0.3662323,0.006409605,F2RL1;HMGB1;HSPD1
regulation of NMDA receptor activity (GO:2000310),3/32,0.982650789,0.999996398,0,0,0.3662323,0.006409605,APP;DAPK1;PTK2B
RNA biosynthetic process (GO:0032774),3/32,0.982650789,0.999996398,0,0,0.3662323,0.006409605,SETX;POLA2;TAF12
negative regulation of lymphocyte proliferation (GO:0050672),4/39,0.983019962,0.999996398,0,0,0.40453556,0.006928016,CEBPB;GLMN;RC3H1;SOX11
odontogenesis (GO:0042476),4/39,0.983019962,0.999996398,0,0,0.40453556,0.006928016,TGFB2;LAMB1;PITX2;FGFR2
organophosphate biosynthetic process (GO:0090407),4/39,0.983019962,0.999996398,0,0,0.40453556,0.006928016,TPI1;PPIP5K2;MBOAT1;AGPAT4
regulation of T cell differentiation (GO:0045580),4/39,0.983019962,0.999996398,0,0,0.40453556,0.006928016,PRELID1;XBP1;MDK;IL2
response to peptide (GO:1901652),4/39,0.983019962,0.999996398,0,0,0.40453556,0.006928016,PRNP;EIF2B3;RAMP3;EIF2B1
negative regulation of cellular biosynthetic process (GO:0031327),6/52,0.983071698,0.999996398,0,0,0.461581837,0.00788069,ACADL;FBXW7;ROCK2;EP300;ERFE;NFKB1
positive regulation of developmental growth (GO:0048639),6/52,0.983071698,0.999996398,0,0,0.461581837,0.00788069,ITSN2;GOLGA4;PLAA;PPIB;AGRN;DBN1
regulation of kinase activity (GO:0043549),13/94,0.983665708,0.999996398,0,0,0.567580495,0.009347578,CDKN1C;DDR1;FLT1;LMO4;RYK;HNRNPU;LMTK2;IGF1R;EEF1A1;EPHA1;ECT2;FGFR2;FGFR1
cellular polysaccharide biosynthetic process (GO:0033692),25-Feb,0.983913867,0.999996398,0,0,0.307896063,0.004993126,EXT1;B3GNT7
fat-soluble vitamin metabolic process (GO:0006775),25-Feb,0.983913867,0.999996398,0,0,0.307896063,0.004993126,RBP1;LRP2
negative regulation of signaling (GO:0023057),25-Feb,0.983913867,0.999996398,0,0,0.307896063,0.004993126,IGFBP3;OPTN
peripheral nervous system development (GO:0007422),25-Feb,0.983913867,0.999996398,0,0,0.307896063,0.004993126,GPC1;PMP22
alpha-amino acid metabolic process (GO:1901605),5/46,0.984136546,0.999996398,0,0,0.43160079,0.006901566,GLUD1;GOT1;MTHFD1;PYCR2;GLS
organic acid transport (GO:0015849),14/100,0.984222582,0.999996398,0,0,0.575648984,0.009154665,SLC38A1;SLC16A1;SLC43A2;SLC23A1;SLC7A11;SLC7A3;SLC6A6;SLC7A7;PDPN;SLC38A2;FOLR1;SLC19A1;ABCG2;SLC38A4
gland development (GO:0048732),9/71,0.984511549,0.999996398,0,0,0.51351798,0.008015836,XBP1;MDK;MSN;LSR;NRG1;EZR;TDGF1;CDK5RAP3;FGFR2
steroid biosynthetic process (GO:0006694),8/65,0.984598146,0.999996398,0,0,0.496547538,0.007707259,SQLE;OSBPL3;PMVK;SC5D;HMGCR;LBR;LSS;HSD17B10
tRNA modification (GO:0006400),8/65,0.984598146,0.999996398,0,0,0.496547538,0.007707259,DTWD1;TRMT112;SSB;TYW5;NSUN2;THUMPD3;LCMT2;PUS7
fatty acid oxidation (GO:0019395),7/59,0.984922228,0.999996398,0,0,0.476300725,0.007236245,ECHS1;ACADL;PEX2;ADIPOR1;HSD17B10;ACAT2;ADH5
cellular response to organic substance (GO:0071310),18/123,0.985085935,0.999996398,0,0,0.606003716,0.009106053,URI1;RAMP3;SHC1;TIPARP;FOXH1;PDGFB;PARK7;LRP2;PTPN12;PTPN14;RHOA;MAPK8;HAX1;RPS6KB1;RACK1;CTNNB1;EMD;BMPR1A
regulation of cation channel activity (GO:2001257),12/89,0.985161475,0.999996398,0,0,0.551153563,0.00823959,ITGB1;FKBP1A;APP;SELENON;CACNG7;CAMK2D;DAPK1;PTK2B;ANK2;CALM1;JPH1;CALM2
acyl-CoA biosynthetic process (GO:0071616),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,ACACA
amyloid-beta metabolic process (GO:0050435),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,IDE
detection of visible light (GO:0009584),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,GNA11
diol biosynthetic process (GO:0034312),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,DHFR
DNA biosynthetic process (GO:0071897),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,PPIA
gliogenesis (GO:0042063),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,TGFB2
membrane depolarization during cardiac muscle cell action potential (GO:0086012),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,ANK2
mesonephric tubule development (GO:0072164),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,FGFR2
monosaccharide transmembrane transport (GO:0015749),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,SLC23A1
negative regulation of ATPase activity (GO:0032780),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,PAM16
negative regulation of chemokine production (GO:0032682),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,F2RL1
negative regulation of fatty acid metabolic process (GO:0045922),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,ACADL
negative regulation of viral entry into host cell (GO:0046597),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,GSN
positive regulation of collagen metabolic process (GO:0010714),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,F2R
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,PDGFB
positive regulation of cytokine production involved in inflammatory response (GO:1900017),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,HIF1A
protein autoprocessing (GO:0016540),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,MYRF
pulmonary valve morphogenesis (GO:0003184),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,TGFB2
regulation of NLRP3 inflammasome complex assembly (GO:1900225),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,DDX3X
reverse cholesterol transport (GO:0043691),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,CLU
stabilization of membrane potential (GO:0030322),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,KCNK1
sulfation (GO:0051923),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,SULT4A1
synaptic vesicle membrane organization (GO:0048499),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,SNAP47
tail-anchored membrane protein insertion into ER membrane (GO:0071816),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,UBL4A
vasculature development (GO:0001944),17-Jan,0.98539985,0.999996398,0,0,0.221349432,0.003255559,FBXW7
cellular macromolecule catabolic process (GO:0044265),6/53,0.98555712,0.999996398,0,0,0.4517319,0.006571883,EXOSC7;PABPC4;HNRNPD;UBE2G1;IDE;STT3B
epidermal cell differentiation (GO:0009913),6/53,0.98555712,0.999996398,0,0,0.4517319,0.006571883,TGM1;MED1;CLIC4;TXNIP;CTNNB1;PITX2
positive regulation of B cell activation (GO:0050871),6/53,0.98555712,0.999996398,0,0,0.4517319,0.006571883,MMP14;XBP1;RIF1;TFRC;MIF;IL2
positive regulation of phagocytosis (GO:0050766),6/53,0.98555712,0.999996398,0,0,0.4517319,0.006571883,RAB31;MYO18A;RAB27A;F2RL1;CALR;LYAR
apoptotic cell clearance (GO:0043277),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,HMGB1;RAC1;THBS1
muscle cell development (GO:0055001),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,KDM1A;SDC1;ANK2
negative chemotaxis (GO:0050919),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,SEMA6A;SEMA3E;RHOA
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,F2R;OCIAD1;PTK2B
regulation of interleukin-17 production (GO:0032660),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,PRNP;PHB;IL2
very long-chain fatty acid metabolic process (GO:0000038),3/33,0.985699371,0.999996398,0,0,0.354001819,0.005098996,ELOVL1;ACOT2;PEX2
bone development (GO:0060348),4/40,0.985800848,0.999996398,0,0,0.393273191,0.00562417,GJA1;SBDS;PPIB;FGFR2
glycolipid biosynthetic process (GO:0009247),4/40,0.985800848,0.999996398,0,0,0.393273191,0.00562417,PYURF;PIGQ;PIGM;PIGF
negative regulation of blood coagulation (GO:0030195),4/40,0.985800848,0.999996398,0,0,0.393273191,0.00562417,SERPINE2;PDGFB;PLAUR;F3
sulfur compound catabolic process (GO:0044273),4/40,0.985800848,0.999996398,0,0,0.393273191,0.00562417,NCAN;ADO;GNS;TXN2
determination of heart left/right asymmetry (GO:0061371),5/47,0.986594623,0.999996398,0,0,0.4212975,0.005685848,AHI1;MKKS;ZIC3;FOLR1;CCDC40
embryonic heart tube morphogenesis (GO:0003143),5/47,0.986594623,0.999996398,0,0,0.4212975,0.005685848,AHI1;MKKS;ZIC3;FOLR1;CCDC40
cellular component disassembly (GO:0022411),8/66,0.986690089,0.999996398,0,0,0.487954975,0.006538246,MMP14;GSN;BMP1;CAPNS1;BSG;CAPN2;FLOT1;TIMP2
positive regulation of T cell proliferation (GO:0042102),8/66,0.986690089,0.999996398,0,0,0.487954975,0.006538246,PNP;TFRC;IGFBP2;RPS3;IGF2;HMGB1;IL2;CD276
sulfur compound biosynthetic process (GO:0044272),16/113,0.987013004,0.999996398,0,0,0.58313134,0.00762273,MGST3;NCAN;MGST1;AKR1A1;MAT2B;LIAS;GGCT;GCLC;B3GNT7;CHSY1;MAT2A;ESD;DSE;CHST15;GCLM;METTL16
mononuclear cell differentiation (GO:1903131),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,PIR;MYH9
negative regulation of macroautophagy (GO:0016242),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,NRBP2;UBQLN4
positive regulation of T cell mediated cytotoxicity (GO:0001916),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,STX7;NECTIN2
regulation of chondrocyte differentiation (GO:0032330),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,MDK;LOXL2
regulation of glycogen biosynthetic process (GO:0005979),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,GSK3A;IGF2
regulation of monocyte chemotaxis (GO:0090025),26-Feb,0.987017356,0.999996398,0,0,0.295048117,0.003855587,DUSP1;HMGB1
Notch signaling pathway (GO:0007219),7/60,0.987054971,0.999996398,0,0,0.46728386,0.006088497,MDK;WWC1;MYC;EP300;YBX1;RBPJ;MIB1
negative regulation of viral genome replication (GO:0045071),6/54,0.98769677,0.999996398,0,0,0.442292378,0.005475377,SRPK2;TRIM6;ILF3;BANF1;MPHOSPH8;SRPK1
regulation of megakaryocyte differentiation (GO:0045652),6/54,0.98769677,0.999996398,0,0,0.442292378,0.005475377,KMT2A;EIF6;DPY30;EP300;MYL9;THBS1
regulation of potassium ion transmembrane transport (GO:1901379),6/54,0.98769677,0.999996398,0,0,0.442292378,0.005475377,YWHAE;GNG2;NEDD4;FHL1;GNB1;FLNA
keratinocyte differentiation (GO:0030216),4/41,0.988144931,0.999996398,0,0,0.382619599,0.004563083,TGM1;MED1;CLIC4;TXNIP
positive regulation of cation transmembrane transport (GO:1904064),4/41,0.988144931,0.999996398,0,0,0.382619599,0.004563083,GNG2;GNB1;FLNA;ANK2
B cell receptor signaling pathway (GO:0050853),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,PLEKHA1;BAX;BCAR1
female gamete generation (GO:0007292),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,MDK;USP9X;PARN
organic cyclic compound biosynthetic process (GO:1901362),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,PYCR2;LIAS;LSS
positive regulation of calcium ion transport into cytosol (GO:0010524),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,RAMP3;PLA2G1B;F2R
regulation of transmembrane transport (GO:0034762),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,NEDD4;SLC2A1;ACTB
striated muscle tissue development (GO:0014706),3/34,0.988229815,0.999996398,0,0,0.342560401,0.004055916,MYL6;SIX4;CFLAR
neurotransmitter transport (GO:0006836),9/73,0.988320817,0.999996398,0,0,0.497406506,0.005843492,HSPA8;SLC38A1;SNAPIN;DNAJC5;SLC1A3;SLC29A1;LIN7C;SLC38A2;GLS
cellular response to metal ion (GO:0071248),19/131,0.988586476,0.999996398,0,0,0.599557035,0.00688241,CPNE8;PRNP;JUN;CLIC4;CAMK2D;CHUK;BNIP3;BRAF;IQGAP1;RASGRP2;MT3;MAPK8;SUMO1;CDH1;SYT11;MAPK1;ECT2;MAPK3;SLC25A24
cellular response to zinc ion (GO:0071294),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,MT3
embryonic axis specification (GO:0000578),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,TDGF1
embryonic heart tube development (GO:0035050),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PITX2
endothelial cell proliferation (GO:0001935),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,LOXL2
fluid transport (GO:0042044),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PDPN
intermediate filament organization (GO:0045109),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PKP2
negative regulation of biosynthetic process (GO:0009890),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PARK7
negative regulation of lipid catabolic process (GO:0050995),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PDE3B
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,F2RL1
positive regulation of fatty acid metabolic process (GO:0045923),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,MID1IP1
positive regulation of interleukin-4 production (GO:0032753),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,CEBPB
presynapse assembly (GO:0099054),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PTEN
programmed necrotic cell death (GO:0097300),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,DNM1L
prostanoid metabolic process (GO:0006692),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PLAA
pulmonary valve development (GO:0003177),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,TGFB2
regulation of delayed rectifier potassium channel activity (GO:1902259),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,SUMO1
water transport (GO:0006833),18-Jan,0.988614858,0.999996398,0,0,0.208315508,0.002385306,PDPN
myelination (GO:0042552),5/48,0.988689417,0.999996398,0,0,0.411473433,0.004680524,MYRF;GPC1;PMP22;MAL2;SBF2
phosphatidic acid biosynthetic process (GO:0006654),5/48,0.988689417,0.999996398,0,0,0.411473433,0.004680524,PLA2G12A;DGKD;PLA2G1B;PLA2G10;AGPAT4
purine ribonucleotide biosynthetic process (GO:0009152),5/48,0.988689417,0.999996398,0,0,0.411473433,0.004680524,ADSL;DCAKD;IMPDH2;GMPS;AMPD2
glycosaminoglycan biosynthetic process (GO:0006024),13/97,0.988762958,0.999996398,0,0,0.547203955,0.006183763,NCAN;HSPG2;HS6ST2;EXT1;B3GNT7;CHSY1;GPC1;DSE;CHST15;GPC3;SDC1;GPC4;AGRN
acute inflammatory response (GO:0002526),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,CEBPB;F3
bile acid biosynthetic process (GO:0006699),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,OSBPL3;HSD17B10
camera-type eye development (GO:0043010),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,SHROOM2;PITX2
monocarboxylic acid catabolic process (GO:0072329),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,NUDT19;FAH
presynaptic endocytosis (GO:0140238),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,CANX;SYNJ2
release of sequestered calcium ion into cytosol (GO:0051209),27-Feb,0.989534134,0.999996398,0,0,0.283228006,0.002979847,F2R;ITPR1
regulation of neuron projection development (GO:0010975),25/165,0.989595477,0.999996398,0,0,0.630835401,0.006597925,GSK3A;PTPRS;PRAG1;STMN2;PTEN;CRMP1;KNDC1;EFNB2;PAK1;MDK;CFL1;EP300;PTK2B;KIF1A;CAMK2G;PAK2;PRKCI;MBOAT1;MT3;SETX;ABI2;PTK7;ITGA6;FKBP4;DBN1
neuron development (GO:0048666),21/143,0.989614004,0.999996398,0,0,0.608236021,0.006350171,APP;TGFB2;XBP1;SNAPIN;ROCK1;RYK;DOCK7;STMN2;PBX2;BICDL1;LAMB1;HMGB1;PPP1R9A;RAB11A;MANF;VAPA;BLOC1S1;WNK1;NEDD4;STMN1;ATXN10
glycerophospholipid metabolic process (GO:0006650),10/80,0.989794146,0.999996398,0,0,0.50522172,0.005182711,PLA2G1B;PIGQ;PLA2G10;FAR1;PIGM;SERINC1;PLA2G6;PIGF;PRDX6;PLCD1
lipid biosynthetic process (GO:0008610),10/80,0.989794146,0.999996398,0,0,0.50522172,0.005182711,XBP1;GGPS1;PLA2G1B;AGPS;NDUFAB1;MBOAT1;HMGCR;LSS;ACACA;AGPAT4
negative regulation of cell cycle (GO:0045786),10/80,0.989794146,0.999996398,0,0,0.50522172,0.005182711,CDKN1C;BTG3;LATS2;DUSP1;GMNN;PTEN;PTPRK;IPO5;MAD2L1;PTPN3
T cell activation (GO:0042110),12/92,0.98992841,0.999996398,0,0,0.530382775,0.00536888,FKBP1A;PPP3CB;MDK;CHD7;MSN;F2RL1;SOX4;DDOST;IL2;ADA;HSPD1;CD276
positive regulation of protein tyrosine kinase activity (GO:0061098),4/42,0.990116895,0.999996398,0,0,0.372526723,0.003700035,PRNP;FBXW7;PDGFB;HBEGF
regulation of chemokine production (GO:0032642),4/42,0.990116895,0.999996398,0,0,0.372526723,0.003700035,APP;F2RL1;HIF1A;FOXP1
regulation of DNA recombination (GO:0000018),4/42,0.990116895,0.999996398,0,0,0.372526723,0.003700035,PPP4C;KDM1A;THOC1;KPNA1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),26/171,0.990146072,0.999996398,0,0,0.633385616,0.006272291,GOLT1B;TFRC;SLC44A2;SLC20A1;DDX1;DDX21;LITAF;MTDH;GJA1;TRIM6;LGALS1;FLNA;ECT2;CHUK;NEK6;F2R;CFLAR;RHOC;RHOA;FKBP1A;VAPA;EEF1D;UBE2N;F2RL1;UBE2V1;GAPDH
positive regulation of DNA-binding transcription factor activity (GO:0051091),40/246,0.990201115,0.999996398,0,0,0.685377675,0.006749058,APP;MTPN;BEX1;TFRC;KDM1A;DHX9;PLA2G1B;PTEN;PARK7;PHB2;CLU;MTDH;TRIM6;UBB;UBC;RPS3;FLOT1;EP300;FLOT2;RPS27A;PRKCI;NPM1;JUP;CHUK;TAF12;ANXA3;DDX58;BUD31;CFLAR;NFKB1;SMARCA4;PSMA6;TFDP1;UBE2N;CTNNB1;ARHGEF2;UBE2V1;RHEBL1;PPIA;ARHGEF5
muscle cell differentiation (GO:0042692),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,KDM1A;GLMN;SPEG
positive regulation of lipid biosynthetic process (GO:0046889),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,CREB1;MID1IP1;CHP1
positive regulation of reproductive process (GO:2000243),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,C1QBP;AGO2;PLA2G10
protein localization to cilium (GO:0061512),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,TCTN2;TTC21B;ATP6V1D
regulation of TORC1 signaling (GO:1903432),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,SEH1L;BMT2;TELO2
response to exogenous dsRNA (GO:0043330),3/35,0.990326177,0.999996398,0,0,0.331834072,0.003225732,DHX9;DDX58;FLOT1
response to retinoic acid (GO:0032526),7/62,0.990499994,0.999996398,0,0,0.45023379,0.00429767,SETX;RARG;CREB1;PTK7;FZD7;WNT7B;PTK2B
defense response to virus (GO:0051607),19/133,0.990869505,0.999996398,0,0,0.588962422,0.005402219,BNIP3L;DDX58;BNIP3;PHB;SAMHD1;PHB2;CNOT7;PDE12;NDUFAF4;DDIT4;PLA2G10;G3BP1;PMAIP1;FLNA;F2RL1;SKP2;SERINC3;ABCE1;BCL2L1
ERAD pathway (GO:0036503),11/87,0.991107836,0.999996398,0,0,0.511788155,0.004571259,RCN3;VCP;PSMC6;HSPA5;EDEM1;UBQLN1;UBE4B;SEC61B;STT3B;UBE2J2;HSP90B1
brain development (GO:0007420),22/150,0.991110143,0.999996398,0,0,0.6072341,0.005422362,ZFHX3;MKKS;SLC23A1;PTEN;SHROOM2;PBX2;UBE3A;SYNJ2;SMARCA1;IER3IP1;HSPG2;GRHL2;SHROOM4;UFM1;COL4A1;DDIT4;NNAT;RAB18;PHGDH;CDK5RAP3;ADGRL2;BPTF
autophagosome organization (GO:1905037),6/56,0.991111808,0.999996398,0,0,0.424546075,0.003790316,VMP1;GABARAPL1;MAP1LC3A;UBQLN1;ATP2A2;WIPI1
activin receptor signaling pathway (GO:0032924),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,TDGF1
branching involved in ureteric bud morphogenesis (GO:0001658),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,MYC
cardiac atrium morphogenesis (GO:0003209),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,TGFB2
DNA double-strand break processing (GO:0000729),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,UBE2N
ethanol metabolic process (GO:0006067),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,ADH5
excitatory postsynaptic potential (GO:0060079),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,GSK3A
glycerolipid catabolic process (GO:0046503),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,PRDX6
long-term memory (GO:0007616),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,PRNP
mitochondrion localization (GO:0051646),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,NECTIN2
myeloid cell activation involved in immune response (GO:0002275),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,ENPP3
negative regulation of calcium ion transport (GO:0051926),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,TMBIM6
negative regulation of cytokine production involved in inflammatory response (GO:1900016),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,CHID1
neuromuscular process (GO:0050905),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,MYCBP2
piRNA metabolic process (GO:0034587),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,DDX4
positive regulation of monocyte chemotaxis (GO:0090026),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,HMGB1
positive regulation of oxidoreductase activity (GO:0051353),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,PARK7
purine ribonucleoside bisphosphate metabolic process (GO:0034035),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,SULT4A1
regulation of collagen biosynthetic process (GO:0032965),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,F2R
regulation of lymphocyte proliferation (GO:0050670),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,SOX11
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,GADD45A
regulation of T cell cytokine production (GO:0002724),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,SMAD7
response to ATP (GO:0033198),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,HSP90B1
response to cholesterol (GO:0070723),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,PMVK
sphingosine metabolic process (GO:0006670),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,PLPP2
telomere capping (GO:0016233),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,STN1
ureteric bud morphogenesis (GO:0060675),19-Jan,0.991121915,0.999996398,0,0,0.196729798,0.001754383,MYC
regulation of interleukin-8 production (GO:0032677),10/81,0.991124483,0.999996398,0,0,0.498073845,0.004440397,AFAP1L2;DDX58;PLA2G1B;TMSB4X;F2R;F2RL1;ARRB1;HMGB1;PARK7;F3
negative regulation of nucleic acid-templated transcription (GO:1903507),82/464,0.991488593,0.999996398,0,0,0.756303876,0.006464761,CDKN1C;SUV39H2;KDM1A;NAB1;GMNN;PRDM5;EHMT1;ENO1;PTPRK;RBPJ;LIMD1;PHB2;GLI3;LOXL2;DNMT3L;SUMO1;TRIM28;BCL7A;SIX4;YWHAQ;BASP1;MYB;KMT5A;JARID2;PRMT2;SFMBT2;NRG1;FOXP1;ILF3;NIF3L1;SFPQ;SFRP2;BIRC5;CRYAB;PFDN5;KHDRBS1;CALCA;SET;HDAC3;SHC1;PDGFB;PHB;FOXO1;MBTD1;BCLAF1;BTAF1;SAP18;SNX6;SMARCE1;HSPA8;JUN;XRCC6;PHC1;CBX5;UBE2I;PHF10;CBX3;NONO;HMGA1;WWP1;PA2G4;FOXN3;MT3;PML;GATAD2A;SMARCA4;GCLC;REST;CNOT7;YEATS2;COPS2;ID2;SP3;ID1;BHLHE40;RLIM;CTNNB1;CALR;MPHOSPH8;TRIM33;EZH2;LIMS1
cristae formation (GO:0042407),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,APOO;CHCHD3
cytosolic calcium ion transport (GO:0060401),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,ATP2A2;JPH1
glycogen metabolic process (GO:0005977),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,PGM2;CALM1
mucosal immune response (GO:0002385),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,PLA2G1B;RPL39
regulation of reactive oxygen species biosynthetic process (GO:1903426),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,RAB27A;PARK7
T cell activation involved in immune response (GO:0002286),28-Feb,0.991572071,0.999996398,0,0,0.272317135,0.002304796,MDK;F2RL1
lipid modification (GO:0030258),4/43,0.991772675,0.999996398,0,0,0.36295143,0.002998471,PORCN;DGKD;MBOAT1;PLPP2
negative regulation of type I interferon production (GO:0032480),4/43,0.991772675,0.999996398,0,0,0.36295143,0.002998471,PTPRS;DDX58;PCBP2;TAX1BP1
signal release from synapse (GO:0099643),4/43,0.991772675,0.999996398,0,0,0.36295143,0.002998471,HSPA8;SNAPIN;DNAJC5;LIN7C
positive regulation of cellular process (GO:0048522),114/625,0.991808837,0.999996398,0,0,0.78516719,0.006457917,SMC6;ETS1;CXCL16;IGF1R;TGM1;ZFP36;HMGN5;CAPNS1;MYC;NAMPT;RPS6KA1;SOX4;RPS9;TIPIN;CSNK2A1;RPL23;F2R;RPS6;TPM1;SOX11;DICER1;ACTN4;WDR77;SFRP2;PHIP;EPHA1;KIF20B;SHC1;CUL3;HPN;COX17;PDGFB;PHB;ACACA;ZFP36L1;FXR1;EFNB2;PDCD10;SSR1;LYAR;MCTS1;SRPK2;XBP1;TGFB2;ZFHX3;FZD7;IGF2;RAB27A;PA2G4;UBE2A;MT3;IL2;FGF17;SLC6A6;CNOT6;CNOT7;CDK4;CALR;CDK13;TDGF1;RAD18;EIF4G2;FGFR2;EZH2;COPS9;RNF187;FGFR1;RNF10;FLT1;HSP90AB1;DDX3X;CELF1;FAF1;PTEN;RPS4X;MDK;PPP1R13L;C1QBP;FLOT1;RAC1;TET1;NRG1;MMP14;BIRC5;SLC25A5;EAPP;HBEGF;MTPN;CDC123;RAMP3;MYRF;PLA2G1B;THBS1;CDC42;BCLAF1;PAK1;MAPK8;RPS15A;RAB25;EPCAM;CXCR2;LMNA;PDPN;PTK2B;ROMO1;EXOSC2;NPM1;CNBP;NAP1L1;TJP1;DNAJA2;FAM98B;KRAS;P4HB
neuron migration (GO:0001764),5/50,0.991983755,0.999996398,0,0,0.393135173,0.003164167,USP9X;MAP1B;DDIT4;RAC1;FGFR1
regulation of complement activation (GO:0030449),5/50,0.991983755,0.999996398,0,0,0.393135173,0.003164167,CR2;C1QBP;PHB;CLU;PHB2
negative regulation of fat cell differentiation (GO:0045599),3/36,0.992059799,0.999996398,0,0,0.321757824,0.002565019,YAP1;FOXO1;FERMT2
positive regulation of myeloid leukocyte differentiation (GO:0002763),3/36,0.992059799,0.999996398,0,0,0.321757824,0.002565019,HAX1;ID2;ZFP36L1
regulation of microtubule-based process (GO:0032886),3/36,0.992059799,0.999996398,0,0,0.321757824,0.002565019,ROCK1;TAOK1;EFNA5
retina homeostasis (GO:0001895),3/36,0.992059799,0.999996398,0,0,0.321757824,0.002565019,PRDX1;ACTB;ACTG1
sensory perception of mechanical stimulus (GO:0050954),11/88,0.99224343,0.999996398,0,0,0.505109014,0.003933187,TIMM8B;NDUFB9;WDR1;MARVELD2;TIMM13;BIRC5;LRP2;TBL1X;ALDH7A1;CCDC50;GSDME
phosphatidylinositol metabolic process (GO:0046488),15/112,0.992647646,0.999996398,0,0,0.546560988,0.004033356,PI4K2B;MTMR2;ARF1;PLA2G12A;PLEKHA1;PLA2G1B;MTMR14;PTEN;SYNJ2;PIK3CB;PIK3C2A;INPP5F;RAB14;PLA2G10;PLCD1
defense response to symbiont (GO:0140546),17/124,0.993052252,0.999996398,0,0,0.561438366,0.003914346,BNIP3L;DDX58;BNIP3;SAMHD1;CNOT7;PDE12;NDUFAF4;DDIT4;PLA2G10;G3BP1;PMAIP1;FLNA;F2RL1;SKP2;SERINC3;ABCE1;BCL2L1
regulation of cilium assembly (GO:1902017),7/64,0.993067007,0.999996398,0,0,0.434380215,0.003022043,USP6NL;YAP1;ODF2L;RABGAP1;LIMK2;TBC1D7;TBC1D15
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,PHB
"base-excision repair, AP site formation (GO:0006285)",20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,TDG
cellular monovalent inorganic cation homeostasis (GO:0030004),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,ATP1B3
epithelial cilium movement involved in extracellular fluid movement (GO:0003351),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,CCDC40
fatty acid transport (GO:0015908),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,FABP5
ganglioside metabolic process (GO:0001573),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,CLN6
lipopolysaccharide-mediated signaling pathway (GO:0031663),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,MTDH
negative regulation of osteoclast differentiation (GO:0045671),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,FBXW7
neuromuscular synaptic transmission (GO:0007274),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,KIF1B
organic cation transport (GO:0015695),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,SLC44A2
positive regulation of hormone secretion (GO:0046887),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,SOX11
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,NECTIN2
toll-like receptor 4 signaling pathway (GO:0034142),20-Jan,0.993076884,0.999996398,0,0,0.186363636,0.001294704,ITGAM
antibacterial humoral response (GO:0019731),4/44,0.993160466,0.999996398,0,0,0.353854901,0.002428517,PLA2G1B;PLA2G6;RPL39;WFDC13
embryonic organ morphogenesis (GO:0048562),4/44,0.993160466,0.999996398,0,0,0.353854901,0.002428517,RARG;ID2;SOX11;FGFR2
metal ion homeostasis (GO:0055065),4/44,0.993160466,0.999996398,0,0,0.353854901,0.002428517,SELENON;SLC12A4;MT3;CNNM4
neurotransmitter secretion (GO:0007269),4/44,0.993160466,0.999996398,0,0,0.353854901,0.002428517,HSPA8;SNAPIN;DNAJC5;LIN7C
positive regulation of biosynthetic process (GO:0009891),4/44,0.993160466,0.999996398,0,0,0.353854901,0.002428517,MTPN;CREB1;F2R;RAB27A
regulation of neuronal synaptic plasticity (GO:0048168),2/29,0.993219981,0.999996398,0,0,0.262214476,0.001783873,APP;DBN1
regulation of response to biotic stimulus (GO:0002831),2/29,0.993219981,0.999996398,0,0,0.262214476,0.001783873,SAMHD1;FOXP1
blood circulation (GO:0008015),5/51,0.993265608,0.999996398,0,0,0.384564031,0.002598565,GCLC;CYB5R3;ROCK1;ROCK2;GCLM
regulation of osteoblast differentiation (GO:0045667),10/83,0.993312818,0.999996398,0,0,0.484365592,0.003249919,YAP1;DDX5;REST;NOCT;WNT7B;SOX11;LIMD1;FERMT2;FGFR2;BMPR1A
positive regulation of tumor necrosis factor production (GO:0032760),9/77,0.993465648,0.999996398,0,0,0.46802676,0.003068287,APP;DDX58;IFNGR1;DHX9;HMGB1;MIF;ARHGEF2;CLU;THBS1
purine ribonucleotide metabolic process (GO:0009150),9/77,0.993465648,0.999996398,0,0,0.46802676,0.003068287,HINT1;ACOT2;GNAI3;ACOT13;AK3;DBI;AMPD2;SULT4A1;RAN
regulation of intracellular pH (GO:0051453),3/37,0.993491017,0.999996398,0,0,0.312274296,0.002039232,SLC4A7;CHP1;SLC9B1
positive regulation of protein phosphorylation (GO:0001934),63/371,0.993501806,0.999996398,0,0,0.721001509,0.004700496,APP;DDX3X;HSP90AB1;TFRC;DOCK7;KNDC1;ARRB1;PARK7;TRIM6;RACK1;FLOT1;RAC1;LEFTY1;HSP90AA1;PLAUR;MIF;CLIP3;TOM1L1;TWSG1;CLDN3;SFRP2;HAX1;TRAF4;AKAP9;ARHGEF2;PPIA;RAMP3;HDAC3;ROCK2;PDGFB;IQGAP1;EFNA5;STK4;FXR1;PAK1;PDCD10;MAPK1;PTK2B;PAK2;MAPK3;PRNP;XRCC6;TGFB2;RBPMS;LIMK2;IGF2;BMP8B;BRAF;MT3;FGF17;CENPE;DAB2;WNK3;CDK2AP1;SPRY2;CALM3;KRAS;CALM1;CALM2;TDGF1;CNOT9;UBE2K;BMPR1A
positive regulation of metabolic process (GO:0009893),15/113,0.993510076,0.999996398,0,0,0.540948938,0.003522159,CEBPB;HDAC3;KDM1A;EHMT1;ADIPOR1;ACACA;IGF1R;GADD45G;PLAC8;PYURF;GJA1;GATM;ACADL;FABP5;BEND3
autophagosome assembly (GO:0000045),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,VMP1;GABARAPL1;MAP1LC3A;UBQLN1;ATP2A2;WIPI1
eye development (GO:0001654),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,TGFB2;SHROOM2;RAB18;PBX2;PITX2;HIPK1
fat cell differentiation (GO:0045444),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,CLIP3;MED1;MKKS;EP300;METRNL;FOXO1
nucleosome assembly (GO:0006334),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,NPM1;NASP;ATRX;HAT1;NAP1L1;ANP32B
regulation of calcium ion transport (GO:0051924),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,F2R;WNK3;CTNNB1;ANK2;SRI;CAMK2G
regulation of neurotransmitter receptor activity (GO:0099601),6/58,0.993614936,0.999996398,0,0,0.408164873,0.002614515,APP;CACNG7;DAPK1;AKAP9;PTK2B;NPTXR
chemical homeostasis (GO:0048878),7/65,0.994089087,0.999996398,0,0,0.426863434,0.002530639,SLC4A7;DDX3X;FBXW7;WNK1;RBP1;WNK3;USF2
regulation of cellular catabolic process (GO:0031329),7/65,0.994089087,0.999996398,0,0,0.426863434,0.002530639,VPS29;ROCK1;DAPK1;LAMP3;ITPR1;CISD2;EP300
protein complex oligomerization (GO:0051259),11/90,0.994119214,0.999996398,0,0,0.492258009,0.00290341,PDCD6IP;CPSF6;MAT2A;ATL2;BEND3;G3BP2;CHMP2A;YME1L1;DNM1L;ECT2;ELAVL1
central nervous system development (GO:0007417),43/268,0.994199283,0.999996398,0,0,0.674195095,0.003922202,NCKAP1;ANKLE2;COX7B;ITGAM;MYRF;SLC23A1;NCAN;CHD7;PTEN;SLC2A1;UBE3A;IER3IP1;DHX30;RPS6KA6;ZIC3;ADAM23;NNAT;PHGDH;JARID2;CDK5RAP3;SOX4;BPTF;ZFHX3;MARCKSL1;GSN;SHROOM2;PBX2;WWP1;SOX11;LSR;SOX12;SYNJ2;SMARCA1;HSPG2;GRHL2;SHROOM4;AHI1;MARCKS;UFM1;COL4A1;DDIT4;RAB18;ADGRL2
positive regulation of nervous system development (GO:0051962),4/45,0.994321645,0.999996398,0,0,0.345202106,0.001965767,NUMBL;NAP1L1;SOX11;LRP2
zymogen activation (GO:0031638),4/45,0.994321645,0.999996398,0,0,0.345202106,0.001965767,CYFIP2;MMP14;PERP;PGK1
fatty acid beta-oxidation (GO:0006635),5/52,0.994350038,0.999996398,0,0,0.376357617,0.002132436,ECHS1;ACADL;PEX2;HSD17B10;ACAT2
circulatory system development (GO:0072359),17/126,0.994539951,0.999996398,0,0,0.551065593,0.003017089,TGFB2;MKKS;FBXW7;TCF25;PDGFB;PTEN;ECE1;CACYBP;HSPG2;CRIP1;PDLIM2;MTHFD1;ID2;PKP2;TDGF1;SOX4;PDLIM7
negative regulation of growth (GO:0045926),17/126,0.994539951,0.999996398,0,0,0.551065593,0.003017089,TGFB2;NDRG3;DDX3X;FHL1;ENO1;PHB;CGRRF1;MT3;PML;SMARCA4;PPP2CA;GJA1;SFRP2;NME6;RACK1;DACT3;RBBP7
phosphatidylinositol biosynthetic process (GO:0006661),17/126,0.994539951,0.999996398,0,0,0.551065593,0.003017089,PI4K2B;MTMR2;ARF1;CISH;PLEKHA1;MTMR14;PIGQ;PTEN;SYNJ2;PIK3CB;PIK3C2A;PYURF;INPP5F;RAB14;PIGM;PIGF;SOCS4
regulation of catecholamine secretion (GO:0050433),2/30,0.99455079,0.999996398,0,0,0.252833436,0.00138151,GRK2;SYT11
regulation of cation transmembrane transport (GO:1904062),2/30,0.99455079,0.999996398,0,0,0.252833436,0.00138151,WNK1;WNK3
regulation of vasoconstriction (GO:0019229),2/30,0.99455079,0.999996398,0,0,0.252833436,0.00138151,F2R;ECE1
synaptic vesicle cycle (GO:0099504),2/30,0.99455079,0.999996398,0,0,0.252833436,0.00138151,SNAPIN;DNAJC5
anterior/posterior axis specification (GO:0009948),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,TDGF1
calcium ion transport into cytosol (GO:0060402),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,JPH1
cobalamin metabolic process (GO:0009235),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,MMADHC
cyclic purine nucleotide metabolic process (GO:0052652),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,AMPD2
linoleic acid metabolic process (GO:0043651),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,ELOVL1
long-term synaptic potentiation (GO:0060291),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,PTK2B
negative regulation of cell communication (GO:0010648),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,IGFBP3
nuclear envelope organization (GO:0006998),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,EMD
regulation of lipid catabolic process (GO:0050994),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,PDE3B
regulation of lipoprotein lipase activity (GO:0051004),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,SORT1
regulation of transposition (GO:0010528),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,DDX4
response to glucagon (GO:0033762),21-Jan,0.994601318,0.999996398,0,0,0.177034091,9.58E-04,CREB1
glycerophospholipid biosynthetic process (GO:0046474),26/177,0.994665376,0.999996398,0,0,0.607981835,0.003252036,PI4K2B;MTMR2;ARF1;DGKD;TAMM41;SLC44A2;PLA2G1B;MTMR14;PTEN;PCTP;PIK3CB;PIK3C2A;SELENOI;AGPAT4;INPP5F;PCYT1B;PLA2G12A;CSNK2A1;CHKA;PLEKHA1;CSNK2A2;SYNJ2;RAB14;ETNK1;PLA2G10;FAR1
synaptic vesicle endocytosis (GO:0048488),3/38,0.994670687,0.999996398,0,0,0.303332684,0.001620878,ITSN2;CANX;SYNJ2
positive regulation of cold-induced thermogenesis (GO:0120162),12/97,0.994845759,0.999996398,0,0,0.499022958,0.002578736,PLAC8;GJA1;CEBPB;GATM;HDAC3;KDM1A;ACADL;FABP5;EHMT1;ADIPOR1;IGF1R;GADD45G
toll-like receptor signaling pathway (GO:0002224),11/91,0.994888351,0.999996398,0,0,0.486073462,0.002491009,ITGAM;MAP3K1;CHUK;MAPKAPK3;UBB;UBE2D3;UBC;HMGB1;RPS27A;HSP90B1;HSPD1
cellular response to nutrient levels (GO:0031669),7/66,0.994966912,0.999996398,0,0,0.41960146,0.002117224,HSPA8;XBP1;MAP1LC3A;STK24;STK26;WIPI1;FOXO1
protein homooligomerization (GO:0051260),16/121,0.99505351,0.999996398,0,0,0.538424282,0.002669919,PDCD6IP;ATL2;ACOT13;MIF;SAMHD1;ELAVL1;HSD17B10;ACACA;GLS;G3BP2;CHMP2A;BEND3;SSBP1;ECT2;ALDOA;ALDH9A1
heart morphogenesis (GO:0003007),5/53,0.99526594,0.999996398,0,0,0.368493138,0.001748611,FKBP1A;LEFTY1;TGFB2;CHD7;BMPR1A
positive regulation of chemokine production (GO:0032722),5/53,0.99526594,0.999996398,0,0,0.368493138,0.001748611,APP;DDX3X;F2RL1;HMGB1;HIF1A
regulation of B cell proliferation (GO:0030888),4/46,0.995291624,0.999996398,0,0,0.336961348,0.001590288,TFRC;RC3H1;MIF;IL2
response to organic cyclic compound (GO:0014070),6/60,0.995437191,0.999996398,0,0,0.392997093,0.001797274,DHFR;GLDC;TIPARP;PMAIP1;CTNNB1;STRN3
cellular protein localization (GO:0034613),54/329,0.995494046,0.999996398,0,0,0.692219085,0.003126156,USP6NL;VPS29;ARF4;ARF1;PDCD6;CLTC;PTPRK;AMOT;GJA1;ARL5C;KIF13A;TMED3;TMED2;TLK1;EIF2D;ARL5A;YWHAH;SEC13;TMED9;COG7;STX7;ANK2;WIPI1;COPZ1;ARL4C;ARL4A;RAB31;CTTN;ARHGEF2;ARF5;ARF6;COPB2;RABGAP1;TMED10;SAR1A;USO1;SNX27;FLNA;RAB6A;TBC1D15;SEC31A;SNX6;NPM1;ARCN1;AHI1;RAB14;ID1;RAB18;CTNNB1;RAB3GAP2;LAMTOR2;LAMTOR1;LAMTOR3;FERMT2
regulation of endothelial cell proliferation (GO:0001936),11/92,0.995561905,0.999996398,0,0,0.480041621,0.002135212,AIMP1;PDCL3;NRAS;PDCD6;VASH2;PDGFB;AGGF1;SYNJ2BP;F3;HIF1A;THBS1
cellular nitrogen compound biosynthetic process (GO:0044271),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,GCHFR;CYB5R3
negative regulation of interleukin-6 production (GO:0032715),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,SYT11;ARRB1
negative regulation of osteoblast differentiation (GO:0045668),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,NOCT;LIMD1
peptide cross-linking (GO:0018149),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,TGM1;THBS1
regulation of calcium ion-dependent exocytosis (GO:0017158),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,REST;SYT11
regulation of macrophage derived foam cell differentiation (GO:0010743),2/31,0.995624222,0.999996398,0,0,0.244099364,0.001070468,PLA2G10;NFKB1
epithelium development (GO:0060429),16/122,0.995635952,0.999996398,0,0,0.533310385,0.002332486,TRIM71;TAGLN;PCNA;WNT7B;SOX11;GRHL2;CNN3;RCN3;AHI1;MTHFD1;DAG1;PGK1;CDK1;TAGLN2;VDAC1;FGFR2
regulation of dendrite development (GO:0050773),3/39,0.995641546,0.999996398,0,0,0.294887828,0.001288064,NEDD4;KNDC1;DBN1
glucose homeostasis (GO:0042593),10/86,0.99566584,0.999996398,0,0,0.465156001,0.002020442,KLF7;RPS6;NUCKS1;PARK7;ADIPOR1;HIF1A;HK2;SOX4;FOXO1;IGF1R
cytokine-mediated signaling pathway (GO:0019221),111/621,0.995689338,0.999996398,0,0,0.765518991,0.003307026,PLVAP;TXNDC17;PSMD8;PSMD6;PSMD7;PSMD4;MYC;PSMD2;CFL1;PSMD1;JUNB;CISH;ACTN4;MIF;MID1;RBX1;PSME3;PSME4;BOLA2;PSME2;UBE2V1;PPIA;NUMBL;PSMD12;PSMD11;PSMD14;SHC1;MAOA;PDGFB;CUL1;ADIPOR1;HIF1A;FOXO1;HSP90B1;RAP1B;CNN2;BCL2L11;UBB;UBC;MCL1;HSPA9;HSPA8;MSN;MT3;NFKB1;IL2;SMARCA4;UBE2N;SDC1;BCL2L1;ITGB1;ARF1;ITGAM;RPLP0;PIK3CB;LMNB1;TMSB4X;JAK1;EIF5A;HSP90AA1;ANXA2;CHUK;TNFRSF12A;IFNGR1;F3;YWHAZ;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TCP1;CANX;BIRC5;SNRPA1;RHOU;SOS1;CRK;YAP1;LAMA5;CAMK2D;SAMHD1;PSMA7;PSMB10;PSMB6;CDC42;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;CXCR2;PTK2B;RPS27A;GBP2;PAK2;CAMK2G;MAPK3;PML;PSMB9;PSMC6;PSMC3;PSMC4;PSMC1;CAPZA1;PSMC2;HNRNPA2B1;P4HB;LIMS1
anion transmembrane transport (GO:0098656),7/67,0.995719669,0.999996398,0,0,0.412581551,0.001769776,SLC23A1;SLC1A3;SFXN1;SLC25A5;SLC25A4;SLC19A1;SLC7A3
cellular response to nerve growth factor stimulus (GO:1990090),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,STMN2
membrane lipid metabolic process (GO:0006643),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,SERINC1
membrane protein intracellular domain proteolysis (GO:0031293),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,NFKB1
protein mannosylation (GO:0035268),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,DPY19L1
regulation of execution phase of apoptosis (GO:1900117),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,BCL2L1
regulation of platelet activation (GO:0010543),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,PDGFB
regulation of voltage-gated calcium channel activity (GO:1901385),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,SRI
tetrapyrrole metabolic process (GO:0033013),22-Jan,0.995790014,0.999996398,0,0,0.168593074,7.11E-04,MMADHC
positive regulation of intracellular signal transduction (GO:1902533),96/546,0.995852437,0.999996398,0,0,0.750705381,0.003120073,ITGB1;APP;FLT1;HSP90AB1;DDX3X;TFRC;GOLT1B;SLC44A2;WWC1;PARK7;PIK3CB;HMGB1;PHB2;LITAF;BBC3;IGF1R;GJA1;TRIM6;LGALS1;C1QBP;RACK1;EP300;RPL37;RAC1;DNM1L;CDK5RAP3;HSP90AA1;SEC13;CHUK;RPL23;F2R;GAB1;SOX11;NRG1;ACTN4;MIF;RHOC;F3;RHOA;HAX1;EEF1D;UBE2V1;GAPDH;HBEGF;USP15;SEH1L;HDAC3;RAMP3;ROCK1;SHC1;ROCK2;SLC20A1;DDX1;PDGFB;DDX21;IQGAP1;PHB;LRP2;THBS1;MTDH;BCLAF1;BCL2L11;RPS3;FLNA;PMAIP1;ECT2;TRIM44;FIS1;TGFB2;RYK;NEK6;IGF2;CFLAR;PUM2;FKBP1A;FGF17;GOLPH3;LIN28A;VAPA;RHEB;NEDD4;UBE2N;F2RL1;BAX;SPRY2;STRN;LAMTOR2;PLXNB1;LAMTOR1;LAMTOR3;FERMT2;FGFR2;GSDME;LIMS1;BCL2L1;FGFR1
positive regulation of nucleic acid-templated transcription (GO:1903508),89/511,0.995991601,0.999996398,0,0,0.74230902,0.00298145,CDKN1C;RNF10;RNF14;ETS1;GLI3;MED14;PPP3CB;HMGN5;TRIM28;SFR1;SIX4;CDH1;ZIC3;MYC;MYB;RPS6KA1;SPIN1;EP300;TEAD1;SOX4;YWHAH;MED1;SMARCC1;ANKRD49;CHUK;PRMT2;F2R;FOXH1;NME2;SOX11;POU3F1;ARID1A;ILF2;ACTA2;DNAJC2;ILF3;NIF3L1;MYCN;CREB1;THRAP3;TFAM;PHIP;UBE2V1;YAP1;ENY2;CEBPB;MYRF;KMT2A;SHC1;PDGFB;PHB;MRPL12;HIF1A;FOXO1;NPAT;NUP85;NSD1;TBL1X;TRIM44;SNX5;AFAP1L2;JUN;XRCC6;NPM1;ZFHX3;FZD7;CNBP;USP22;HMGA1;SMARCA1;HNRNPAB;MT3;SMAD5;NFKB1;PML;SMARCA4;MLLT11;KLF6;REST;PHF5A;FUBP3;SP1;ID2;SP3;HNRNPD;CTNNB1;NAA16;NAA15;RNF187
activation of GTPase activity (GO:0090630),13/105,0.996062829,0.999996398,0,0,0.499363382,0.00196996,USP6NL;RABGAP1;DOCK7;ARHGEF16;ARHGAP29;RANGAP1;CORO1C;SYDE2;TBC1D7;EPHA1;ECT2;TBC1D15;ARHGEF5
pattern recognition receptor signaling pathway (GO:0002221),6/61,0.996150043,0.999996398,0,0,0.385826869,0.001488284,MAPKAPK3;UBB;UBC;HMGB1;RPS27A;HSP90B1
organelle assembly (GO:0070925),72/425,0.996271518,0.999996398,0,0,0.7183335,0.002683299,ARF4;DDX3X;ATP2A2;FNBP1L;LIMD1;HSPB11;CDC14B;NUDCD3;PCM1;MAP1LC3A;TCTN2;POGZ;UBAP2L;VPS36;EIF2A;ACTR3;ACTR2;GABARAPL1;MKKS;PDCD6IP;TMOD3;STX7;TMOD2;RC3H1;HAUS3;WIPI1;DYNLL1;HAUS1;ATXN2L;TRAPPC6A;IFT43;RILPL1;CSDE1;CHMP3;MAPRE1;IFT46;SSX2IP;CHMP5;GRB7;DDX6;HDAC3;TSG101;VPS4B;CENPA;ATXN2;G3BP1;RPS3;UBQLN1;FLNA;E2F4;ATP6V1D;YTHDF1;NPM1;CENPW;GSN;YTHDF2;NEK6;VTA1;PRRC2C;PARVA;EIF2S1;LSM3;RAB11A;MRPL22;VMP1;EHD2;SQLE;CENPE;ANLN;AHI1;TMEM237;CHMP2A
interferon-gamma-mediated signaling pathway (GO:0060333),7/68,0.996364207,0.999996398,0,0,0.405791803,0.001478064,CAMK2D;IFNGR1;GBP2;MID1;CAMK2G;PML;JAK1
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),9/81,0.996415899,0.999996398,0,0,0.44191143,0.0015867,APP;DDX58;IFNGR1;DHX9;HMGB1;MIF;ARHGEF2;CLU;THBS1
positive regulation of ossification (GO:0045778),3/40,0.996439408,0.999996398,0,0,0.286899451,0.001023355,TGFB2;SOX11;BMPR1A
response to organonitrogen compound (GO:0010243),3/40,0.996439408,0.999996398,0,0,0.286899451,0.001023355,DHFR;RCN3;VCP
synaptic vesicle exocytosis (GO:0016079),3/40,0.996439408,0.999996398,0,0,0.286899451,0.001023355,SNAP47;SNAPIN;DNAJC5
aortic valve morphogenesis (GO:0003180),2/32,0.996489078,0.999996398,0,0,0.235947564,8.30E-04,ROCK1;ROCK2
B cell proliferation (GO:0042100),2/32,0.996489078,0.999996398,0,0,0.235947564,8.30E-04,CR2;HSPD1
metal ion export (GO:0070839),2/32,0.996489078,0.999996398,0,0,0.235947564,8.30E-04,SLC40A1;ATP1B3
positive regulation of receptor signaling pathway via STAT (GO:1904894),2/32,0.996489078,0.999996398,0,0,0.235947564,8.30E-04,F2R;OCIAD1
positive regulation of protein serine/threonine kinase activity (GO:0071902),13/106,0.9965633,0.999996398,0,0,0.493962027,0.001700523,DDX3X;FLT1;PDGFB;RHOA;PPP2CA;PDCD10;CALM3;CALM1;CALM2;TELO2;FERMT2;EZH2;FGFR1
negative regulation of cytokine-mediated signaling pathway (GO:0001960),5/55,0.996688561,0.999996398,0,0,0.353707916,0.001173226,OTUD4;YTHDF2;CNOT7;F2RL1;SAMHD1
regulation of cardiac conduction (GO:1903779),5/55,0.996688561,0.999996398,0,0,0.353707916,0.001173226,AHCYL1;ITPR1;ATP2A2;ANK2;ATP1B3
diacylglycerol metabolic process (GO:0046339),23-Jan,0.9967169,0.999996398,0,0,0.160919421,5.29E-04,DGKD
positive regulation of natural killer cell mediated immunity (GO:0002717),23-Jan,0.9967169,0.999996398,0,0,0.160919421,5.29E-04,NECTIN2
regulation of interleukin-4 production (GO:0032673),23-Jan,0.9967169,0.999996398,0,0,0.160919421,5.29E-04,CEBPB
response to nutrient levels (GO:0031667),23-Jan,0.9967169,0.999996398,0,0,0.160919421,5.29E-04,RPS6KB1
triglyceride catabolic process (GO:0019433),23-Jan,0.9967169,0.999996398,0,0,0.160919421,5.29E-04,FABP5
I-kappaB kinase/NF-kappaB signaling (GO:0007249),6/62,0.996755382,0.999996398,0,0,0.378912725,0.001231426,CHUK;ROCK1;UBB;ROCK2;UBC;RPS27A
metal ion transport (GO:0030001),10/88,0.996772412,0.999996398,0,0,0.453170529,0.001465013,CACNG7;SLC30A9;CALCRL;RAMP3;ITPR1;LRP2;SELENOK;MT3;CNNM4;TPT1
positive regulation of neuron projection development (GO:0010976),10/88,0.996772412,0.999996398,0,0,0.453170529,0.001465013,SETX;PRKCI;MDK;PTK7;CAPRIN1;STMN2;EP300;PTK2B;ITGA6;DBN1
bile acid metabolic process (GO:0008206),2/33,0.99718515,0.999996398,0,0,0.228321686,6.44E-04,OSBPL3;HSD17B10
keratan sulfate metabolic process (GO:0042339),2/33,0.99718515,0.999996398,0,0,0.228321686,6.44E-04,B3GNT7;GNS
positive regulation of cytokine production involved in immune response (GO:0002720),2/33,0.99718515,0.999996398,0,0,0.228321686,6.44E-04,TRIM6;F2RL1
regulation of cholesterol efflux (GO:0010874),2/33,0.99718515,0.999996398,0,0,0.228321686,6.44E-04,PLA2G10;LAMTOR1
regulation of neurotransmitter secretion (GO:0046928),2/33,0.99718515,0.999996398,0,0,0.228321686,6.44E-04,SNAPIN;SYT11
secondary alcohol metabolic process (GO:1902652),4/49,0.997334589,0.999996398,0,0,0.314436611,8.39E-04,SQLE;SOAT1;CLN6;IDH3A
positive regulation of kinase activity (GO:0033674),14/114,0.99736788,0.999996398,0,0,0.494611352,0.001303593,DDR1;XRCC6;FLT1;LMO4;RYK;LMTK2;IQGAP1;IGF1R;CENPE;TRAF4;PTK2B;EPHA1;FGFR2;FGFR1
sterol metabolic process (GO:0016125),7/70,0.997385769,0.999996398,0,0,0.392858949,0.001028369,SQLE;SOAT1;PMVK;SC5D;HMGCR;LBR;CLN6
cardiac muscle cell differentiation (GO:0055007),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,NRG1
cholesterol efflux (GO:0033344),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,SOAT1
defense response to fungus (GO:0050832),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,GAPDH
dendritic cell differentiation (GO:0097028),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,F2RL1
dorsal/ventral pattern formation (GO:0009953),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,BMPR1A
endocrine system development (GO:0035270),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,MDK
immune response-activating cell surface receptor signaling pathway (GO:0002429),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,BCAR1
lipid translocation (GO:0034204),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,ATP11B
phospholipid catabolic process (GO:0009395),24-Jan,0.997439626,0.999996398,0,0,0.153913043,3.95E-04,PRDX6
monocyte chemotaxis (GO:0002548),3/42,0.997630886,0.999996398,0,0,0.272151677,6.46E-04,CALCA;FLT1;PDGFB
skeletal system morphogenesis (GO:0048705),3/42,0.997630886,0.999996398,0,0,0.272151677,6.46E-04,SOX11;FGFR2;FGFR1
lipid homeostasis (GO:0055088),6/64,0.997703308,0.999996398,0,0,0.365799694,8.41E-04,RCN3;XBP1;DDX3X;FBXW7;RBP1;USF2
synaptic vesicle recycling (GO:0036465),2/34,0.997744821,0.999996398,0,0,0.221172426,4.99E-04,CANX;SYNJ2
fatty acid biosynthetic process (GO:0006633),7/71,0.997786911,0.999996398,0,0,0.386695636,8.57E-04,ELOVL1;XBP1;GPX4;PLA2G1B;NDUFAB1;LIAS;ACACA
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,SULT4A1
"chemical synaptic transmission, postsynaptic (GO:0099565)",25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,GSK3A
positive regulation of lipid metabolic process (GO:0045834),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,CREB1
positive regulation of vascular endothelial growth factor production (GO:0010575),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,HIF1A
receptor signaling pathway via STAT (GO:0097696),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,PIAS1
regulation of AMPA receptor activity (GO:2000311),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,CACNG7
regulation of dopamine secretion (GO:0014059),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,SYT11
sodium ion homeostasis (GO:0055078),25-Jan,0.998003153,0.999996398,0,0,0.14749053,2.95E-04,ATP1B3
enzyme linked receptor protein signaling pathway (GO:0007167),18/140,0.998016828,0.999996398,0,0,0.520988319,0.001034235,DDR1;FLT1;SHC1;RYK;LMTK2;PIK3CB;RASGRP4;PTPRF;MTSS1;IGF1R;AHI1;CNKSR1;EFS;PTK2B;EPHA1;FGFR2;BCAR1;FGFR1
regulation of interleukin-6 production (GO:0032675),13/110,0.998024472,0.999996398,0,0,0.473470289,9.36E-04,APP;AFAP1L2;XBP1;DHX9;DDX58;F2R;ARRB1;HMGB1;HSPD1;MAPK13;SYT11;F2RL1;ARHGEF2
natural killer cell activation (GO:0030101),3/43,0.998070221,0.999996398,0,0,0.265330832,5.13E-04,SNX27;PRDX1;IL2
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),3/43,0.998070221,0.999996398,0,0,0.265330832,5.13E-04,ITGAM;STX7;NECTIN2
regulation of cytokine production involved in inflammatory response (GO:1900015),3/43,0.998070221,0.999996398,0,0,0.265330832,5.13E-04,CHID1;MAPK14;HIF1A
regulation of insulin secretion (GO:0050796),12/104,0.99807222,0.999996398,0,0,0.46084579,8.89E-04,GLUD1;MIDN;PPP3CB;REST;UQCC2;ENSA;NNAT;ITPR1;SLC2A1;ACSL4;EFNA5;SOX4
membrane lipid biosynthetic process (GO:0046467),5/58,0.998079086,0.999996398,0,0,0.333622332,6.41E-04,ELOVL1;SAMD8;VAPA;PLPP2;CSNK1G2
regulation of phagocytosis (GO:0050764),5/58,0.998079086,0.999996398,0,0,0.333622332,6.41E-04,SYT11;RACK1;RAB27A;CALR;LYAR
negative regulation of neuron death (GO:1901215),11/98,0.998140805,0.999996398,0,0,0.446762496,8.31E-04,NRBP2;PRKCI;REST;SET;SIX4;MDK;F2R;PTK2B;PARK7;MT3;SNX6
positive regulation of lymphocyte activation (GO:0051251),2/35,0.9981944,0.999996398,0,0,0.214456454,3.88E-04,XRCC6;HSPD1
regulation of autophagosome assembly (GO:2000785),2/35,0.9981944,0.999996398,0,0,0.214456454,3.88E-04,SH3GLB1;RAB3GAP2
regulation of trans-synaptic signaling (GO:0099177),2/35,0.9981944,0.999996398,0,0,0.214456454,3.88E-04,FABP5;EIF4EBP2
positive regulation of cell projection organization (GO:0031346),14/117,0.998252629,0.999996398,0,0,0.480112247,8.40E-04,CARMIL1;PRKCI;FBXW8;STMN2;RHOA;SETX;PTK7;MDK;ARHGDIA;CAPRIN1;EP300;PTK2B;PLXNB1;ITGA6
regulation of secretion by cell (GO:1903530),5/59,0.998401293,0.999996398,0,0,0.327423078,5.24E-04,RHBDF1;RAB10;RAB15;RHBDF2;VAMP3
response to molecule of bacterial origin (GO:0002237),7/73,0.998418919,0.999996398,0,0,0.374929311,5.93E-04,TRIM6;MAPKAPK3;NOCT;F2R;LIAS;FOXP1;HNRNPA0
neurogenesis (GO:0022008),3/44,0.998429442,0.999996398,0,0,0.258842711,4.07E-04,TGFB2;SIX4;RYK
regulation of endothelial cell apoptotic process (GO:2000351),3/44,0.998429442,0.999996398,0,0,0.258842711,4.07E-04,PRKCI;ECSCR;THBS1
membrane depolarization during action potential (GO:0086010),26-Jan,0.99844254,0.999996398,0,0,0.141581818,2.21E-04,YWHAH
negative regulation of interleukin-1 beta production (GO:0032691),26-Jan,0.99844254,0.999996398,0,0,0.141581818,2.21E-04,GIT1
negative regulation of transposition (GO:0010529),26-Jan,0.99844254,0.999996398,0,0,0.141581818,2.21E-04,DDX4
response to interferon-gamma (GO:0034341),8/80,0.998493955,0.999996398,0,0,0.392720743,5.92E-04,SYNCRIP;DAPK1;PDE12;RPL13A;GBP2;GAPDH;TDGF1;CXCL16
myeloid cell differentiation (GO:0030099),4/52,0.998505331,0.999996398,0,0,0.294727466,4.41E-04,HSPA9;RPS14;SLC25A5;RASGRP4
regulation of exocytosis (GO:0017157),4/52,0.998505331,0.999996398,0,0,0.294727466,4.41E-04,RAB10;RAB15;CHMP3;RAB27A
activation of adenylate cyclase activity (GO:0007190),2/36,0.998555224,0.999996398,0,0,0.208135539,3.01E-04,LGR5;LGR4
aortic valve development (GO:0003176),2/36,0.998555224,0.999996398,0,0,0.208135539,3.01E-04,ROCK1;ROCK2
positive regulation of T cell mediated immunity (GO:0002711),2/36,0.998555224,0.999996398,0,0,0.208135539,3.01E-04,STX7;HSPD1
action potential (GO:0001508),3/45,0.998722827,0.999996398,0,0,0.252663548,3.23E-04,GNA11;SRI;YWHAH
microtubule bundle formation (GO:0001578),3/45,0.998722827,0.999996398,0,0,0.252663548,3.23E-04,TPPP3;CHP1;CCDC40
negative regulation of T cell activation (GO:0050868),3/45,0.998722827,0.999996398,0,0,0.252663548,3.23E-04,CEBPB;DUSP3;GLMN
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),3/45,0.998722827,0.999996398,0,0,0.252663548,3.23E-04,F2R;OCIAD1;ADIPOR1
cardiac muscle tissue development (GO:0048738),4/53,0.998769746,0.999996398,0,0,0.288694054,3.55E-04,GJA1;NRG1;SMAD5;BMPR1A
regulation of immune effector process (GO:0002697),4/53,0.998769746,0.999996398,0,0,0.288694054,3.55E-04,CR2;C1QBP;CLU;PHB2
cellular response to oxygen-containing compound (GO:1901701),50/323,0.998776458,0.999996398,0,0,0.645129788,7.90E-04,PTPRK;HMGB1;ACTB;CDC73;IPO5;ZFP36;RUVBL2;CAPN2;GIT1;CHUK;DAPK1;TPM1;RHOA;IMPACT;CREB1;AKAP9;PLAA;EZR;CHMP5;VCP;RAMP3;ROCK2;PDGFB;FOXO1;SLC5A5;HSP90B1;ZFP36L1;RAP1B;PRDX5;MAPK8;GNG2;RPS3;MAPK1;PTK2B;ROMO1;MAPK3;JUN;XBP1;FZD7;WNT7B;MAPK14;MT3;NFKB1;SETX;PTK7;GNB1;LAMTOR2;LAMTOR1;LAMTOR3;FOLR1
monovalent inorganic cation homeostasis (GO:0055067),27-Jan,0.998785127,0.999996398,0,0,0.136127622,1.65E-04,SLC12A4
regulation of vascular endothelial growth factor production (GO:0010574),27-Jan,0.998785127,0.999996398,0,0,0.136127622,1.65E-04,HIF1A
synapse organization (GO:0050808),15/126,0.99882736,0.999996398,0,0,0.47719402,5.60E-04,APP;PTPRS;RYK;WNT7B;F2R;PTEN;SEMA3E;PTPRF;CDC42;PPFIBP1;REST;CDH1;NEDD4;GPC4;AGRN
glutamate receptor signaling pathway (GO:0007215),2/37,0.998844574,0.999996398,0,0,0.202175819,2.34E-04,APP;PTK2B
negative regulation of epithelial cell apoptotic process (GO:1904036),2/37,0.998844574,0.999996398,0,0,0.202175819,2.34E-04,YAP1;MDK
positive regulation of T cell activation (GO:0050870),7/75,0.998874838,0.999996398,0,0,0.363855123,4.10E-04,XBP1;PNP;TFRC;MDK;FLOT2;HSPD1;CD276
response to lipid (GO:0033993),13/114,0.998880999,0.999996398,0,0,0.454601659,5.09E-04,RARG;GPX3;VPS4B;F2R;LIAS;FOXO1;FOXP1;STRN3;TRIM6;MAPKAPK3;NOCT;CTNNB1;HNRNPA0
negative regulation of response to stimulus (GO:0048585),5/61,0.998895772,0.999996398,0,0,0.315688776,3.49E-04,KLF7;IGFBP3;PIM3;YBX1;CLU
"regulation of synaptic transmission, glutamatergic (GO:0051966)",3/46,0.998962184,0.999996398,0,0,0.246771788,2.56E-04,ATAD1;CACNG7;PTK2B
regulation of cellular macromolecule biosynthetic process (GO:2000112),77/468,0.998966863,0.999996398,0,0,0.692628546,7.16E-04,APP;NUP107;RNF14;NAB1;WWC1;GMNN;CHD7;JMJD1C;NUCKS1;YBX1;SMC3;LIMD1;RPL6;UBE2L3;RBM3;HINT1;HMGN5;GPBP1;MYB;SPIN1;EP300;SOX4;EIF2A;ESCO1;ATRX;SOX11;SOX12;MLF1;TOM1L1;CCNA2;SFPQ;NFX1;GEMIN5;PPIE;UBE2V1;AJUBA;PFDN5;MTPN;CEBPB;MYCBP;RPL10;DDX25;IGSF1;SRRT;NOLC1;PHB;HIF1A;PPP2CA;ATXN2;NSD1;NSD2;ATXN1L;RBBP6;SRSF10;EIF4E;TCFL5;ZFHX3;NFYB;FZD7;SNAI3;CNBP;NONO;IGF2;HMGA1;FOXN3;CDK11B;PML;PUM3;REST;SP1;CARM1;SP3;BHLHE40;HNRNPD;CALR;METAP1;EZH2
inorganic anion transport (GO:0015698),4/54,0.998988238,0.999996398,0,0,0.282901979,2.86E-04,CLIC4;TTYH3;ENPP3;SLC5A5
regulation of humoral immune response (GO:0002920),4/54,0.998988238,0.999996398,0,0,0.282901979,2.86E-04,CR2;C1QBP;CLU;PHB2
regulation of vesicle-mediated transport (GO:0060627),10/96,0.999046938,0.999996398,0,0,0.410803282,3.92E-04,RAB10;USP7;INPP5F;RAB25;RAB15;CHMP3;MAPK1;DNAJC13;RAB11A;MAPK3
cell chemotaxis (GO:0060326),6/69,0.999048999,0.999996398,0,0,0.336659624,3.20E-04,ARHGEF16;CXCR2;PDGFB;PARVA;BCAR1;HBEGF
phospholipid metabolic process (GO:0006644),7/76,0.999052117,0.999996398,0,0,0.358558773,3.40E-04,GPX4;PLA2G10;MBOAT1;PLAA;PLPP2;PLCD1;AGPAT4
calcium ion import (GO:0070509),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,ATP2A2
keratan sulfate biosynthetic process (GO:0018146),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,B3GNT7
positive regulation of cell communication (GO:0010647),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,SOX11
positive regulation of synapse assembly (GO:0051965),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,AGRN
regulation of B cell activation (GO:0050864),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,ZFP36L1
regulation of calcium-mediated signaling (GO:0050848),28-Jan,0.999052236,0.999996398,0,0,0.131077441,1.24E-04,ITPR1
regulation of ERK1 and ERK2 cascade (GO:0070372),34/238,0.999056302,0.999996398,0,0,0.587550569,5.55E-04,APP;ARHGAP8;RAMP3;SHC1;PDGFB;PTEN;ARRB1;PHB;HMGB1;PHB2;SPRED2;RPS6KA6;SPRED1;GLIPR2;PTK2B;MAPK3;DUSP3;SEMA6A;FBXW7;F2R;BRAF;MIF;SYNJ2BP;DUSP9;MT3;YWHAZ;DUSP6;F2RL1;SPRY2;SPRY1;EZR;FERMT2;ARHGEF5;FGFR2
connective tissue development (GO:0061448),2/38,0.999076423,0.999996398,0,0,0.196547195,1.82E-04,XBP1;NAMPT
peptide metabolic process (GO:0006518),8/83,0.999081511,0.999996398,0,0,0.37693907,3.46E-04,NPEPPS;SPCS3;SPCS2;SPCS1;ANPEP;GSTT2;IDE;PARL
organonitrogen compound biosynthetic process (GO:1901566),20/158,0.999093075,0.999996398,0,0,0.511464195,4.64E-04,ELOVL1;PCYT1B;SAMD8;CSNK2A1;TYW5;CHKA;SLC44A2;MGST3;CSNK2A2;MGST1;AKR1A1;PCTP;NMRAL1;GOLPH3;VAPA;ESD;ASL;LCMT2;PLPP2;CSNK1G2
regulation of T cell activation (GO:0050863),3/47,0.999157263,0.999996398,0,0,0.241147836,2.03E-04,PRELID1;DUSP3;HSPD1
ceramide metabolic process (GO:0006672),4/55,0.99916858,0.999996398,0,0,0.277337044,2.31E-04,PPP2CA;SAMD8;PLPP2;CLN6
glycoprotein metabolic process (GO:0009100),4/55,0.99916858,0.999996398,0,0,0.277337044,2.31E-04,GOLPH3;PARK7;STT3B;HIF1A
response to tumor necrosis factor (GO:0034612),12/110,0.99920017,0.999996398,0,0,0.432463348,3.46E-04,ZFP36;CHUK;DHX9;ZFAND6;RPS3;ARHGEF2;GBP2;TDGF1;YBX3;CXCL16;ZFP36L1;GSDME
carbohydrate homeostasis (GO:0033500),6/70,0.999204906,0.999996398,0,0,0.331377986,2.64E-04,KLF7;RPS6;PARK7;ADIPOR1;SOX4;IGF1R
fatty acid catabolic process (GO:0009062),6/70,0.999204906,0.999996398,0,0,0.331377986,2.64E-04,ECHS1;ACADL;NUDT19;PEX2;HSD17B10;ACAT2
neutrophil chemotaxis (GO:0030593),6/70,0.999204906,0.999996398,0,0,0.331377986,2.64E-04,TGFB2;PLA2G1B;BSG;CXCR2;PPIB;PPIA
negative regulation of endopeptidase activity (GO:0010951),5/63,0.999239931,0.999996398,0,0,0.304763735,2.32E-04,SERPINE2;TIMP2;SERPINH1;GAPDH;MT3
negative regulation of peptidase activity (GO:0010466),5/63,0.999239931,0.999996398,0,0,0.304763735,2.32E-04,SERPINE2;TIMP2;SERPINH1;PARK7;GAPDH
homologous chromosome pairing at meiosis (GO:0007129),29-Jan,0.99926049,0.999996398,0,0,0.126387987,9.35E-05,RAD21
negative regulation of myeloid leukocyte differentiation (GO:0002762),29-Jan,0.99926049,0.999996398,0,0,0.126387987,9.35E-05,MYC
regulation of T cell mediated cytotoxicity (GO:0001914),29-Jan,0.99926049,0.999996398,0,0,0.126387987,9.35E-05,STX7
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),31/224,0.999310752,0.999996398,0,0,0.566256032,3.90E-04,TFRC;GOLT1B;SLC44A2;SLC20A1;ZFAND6;DDX1;DDX21;LITAF;MTDH;GJA1;TRIM6;LGALS1;FLNA;ECT2;CHUK;RIOK3;NEK6;F2R;CFLAR;RHOC;RHOA;FKBP1A;TRAF4;VAPA;EEF1D;UBE2N;F2RL1;TRIM59;UBE2V1;GAPDH;OPTN
cognition (GO:0050890),3/48,0.999316098,0.999996398,0,0,0.235773837,1.61E-04,APP;CHD7;SHROOM4
regulation of interleukin-10 production (GO:0032653),3/48,0.999316098,0.999996398,0,0,0.235773837,1.61E-04,F2RL1;HMGB1;HSPD1
regulation of response to external stimulus (GO:0032101),15/130,0.999327272,0.999996398,0,0,0.460477012,3.10E-04,USP14;CELF1;F2R;PARK7;SAMHD1;FOXP1;EFNB2;PSMA6;STK24;TMSB4X;NMT1;F2RL1;CALM1;METAP1;METAP2
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),5/64,0.999370132,0.999996398,0,0,0.29957897,1.89E-04,PLA2G1B;ROMO1;HMGN2;RPL39;GAPDH
fatty acid derivative biosynthetic process (GO:1901570),2/40,0.999410589,0.999996398,0,0,0.186178677,1.10E-04,FAR1;ACACA
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),2/40,0.999410589,0.999996398,0,0,0.186178677,1.10E-04,RIOK3;TRIM59
positive regulation of GTPase activity (GO:0043547),29/214,0.999411739,0.999996398,0,0,0.552664375,3.25E-04,USP6NL;ITGB1;RABGAP1;DOCK7;RAP1GDS1;F11R;RASGRP2;CORO1C;SYDE2;RACK1;ECT2;TBC1D15;ZC3H15;S100A10;F2R;ARHGEF16;ARHGAP29;RANGAP1;AFDN;TBC1D7;F2RL1;PLXNB1;ITGA6;EPHA1;AGRN;FERMT2;ARHGEF5;EZH2;LIMS1
regulation of cell population proliferation (GO:0042127),133/764,0.99941544,0.999996398,0,0,0.739199468,4.32E-04,APP;TFRC;PDCD5;CLU;ETS1;IGF1R;HMGN5;CAPNS1;MYC;FTH1;NAMPT;ARID2;JUNB;SOX4;RPS9;TIPIN;CSNK2A1;RPL23;IGFBP3;F2R;RPS6;SOX11;CGRRF1;GTPBP4;WDR77;PIAS1;CLDN3;SFRP2;PHIP;EPHA1;KIF20B;BEX4;SHC1;CUL3;COX17;CDCA7;PDGFB;PHB;ZFP36L1;EFNB2;NUAK1;PDCD10;SSR1;S100A11;MCTS1;SRPK2;CD164;JUN;XBP1;XRCC6;TGFB2;JUP;GLMN;IGF2;HMGA1;UBE2A;IL2;FGF17;SQLE;CNOT6;CNOT7;CDK4;ID2;STRN;CALR;CDK13;TDGF1;FGFR2;EZH2;GSDME;COPS9;RNF187;BMPR1A;FGFR1;TRIM71;BTG3;COL18A1;RARG;FLT1;CELF1;PTEN;PTPRK;CDC73;RPS4X;SIX4;ADAMTS1;TSPO;SPEG;FGFBP1;PBRM1;TET1;NRG1;PPP2R5C;RHOA;GNL3;NME1;DUSP22;BIRC5;BIRC6;ARHGEF2;SLC25A5;EEF1E1;EAPP;HBEGF;YAP1;CDC123;PLA2G1B;THBS1;TBRG1;PAK1;RPS15A;RAB25;EPCAM;CXCR2;LMNA;PDPN;PTK2B;ROMO1;E2F7;TCFL5;EGLN3;NPM1;CNBP;NAP1L1;PTPN14;PML;TJP1;REST;DNAJA2;CTNNB1;FAM98B;KRAS;LIMS1
estrogen metabolic process (GO:0008210),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,HSD17B10
long-chain fatty acid biosynthetic process (GO:0042759),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,GPX4
negative regulation of interleukin-1 production (GO:0032692),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,GIT1
non-motile cilium assembly (GO:1905515),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,PCM1
regulation of natural killer cell mediated cytotoxicity (GO:0042269),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,NECTIN2
response to alcohol (GO:0097305),30-Jan,0.999422855,0.999996398,0,0,0.122021944,7.04E-05,PMVK
monocarboxylic acid transport (GO:0015718),4/57,0.999439738,0.999996398,0,0,0.266837166,1.50E-04,SLC16A1;SLC16A2;SLC16A3;ABCG2
cellular defense response (GO:0006968),3/49,0.9994453,0.999996398,0,0,0.23063349,1.28E-04,ITGB1;CXCR2;PTK2B
inorganic anion transmembrane transport (GO:0098661),5/65,0.999478385,0.999996398,0,0,0.294567031,1.54E-04,SLC25A3;SLC12A4;SLC20A1;SLC1A3;SLC5A5
heart contraction (GO:0060047),2/41,0.999529348,0.999996398,0,0,0.181393207,8.54E-05,GRK2;TPM1
positive regulation of biomineral tissue development (GO:0070169),2/41,0.999529348,0.999996398,0,0,0.181393207,8.54E-05,CEBPB;BMPR1A
calcium ion transmembrane transport (GO:0070588),8/87,0.999530387,0.999996398,0,0,0.357761341,1.68E-04,FKBP1A;ATP2A2;PMPCB;YME1L1;PHB;PHB2;PARL;TMCO1
granulocyte chemotaxis (GO:0071621),6/73,0.999537427,0.999996398,0,0,0.316479038,1.46E-04,TGFB2;PLA2G1B;BSG;CXCR2;PPIB;PPIA
phospholipid translocation (GO:0045332),31-Jan,0.999549438,0.999996398,0,0,0.11794697,5.32E-05,ATP11B
proteoglycan biosynthetic process (GO:0030166),31-Jan,0.999549438,0.999996398,0,0,0.11794697,5.32E-05,EXT1
receptor signaling pathway via JAK-STAT (GO:0007259),31-Jan,0.999549438,0.999996398,0,0,0.11794697,5.32E-05,PIAS1
renal water homeostasis (GO:0003091),31-Jan,0.999549438,0.999996398,0,0,0.11794697,5.32E-05,RAB11A
triglyceride homeostasis (GO:0070328),31-Jan,0.999549438,0.999996398,0,0,0.11794697,5.32E-05,XBP1
cellular response to interferon-gamma (GO:0071346),13/121,0.99959849,0.999996398,0,0,0.424944715,1.71E-04,CAMK2D;DAPK1;IFNGR1;RPL13A;MID1;PML;SYNCRIP;PDE12;GBP2;TDGF1;GAPDH;CAMK2G;JAK1
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),7/81,0.999602456,0.999996398,0,0,0.334224188,1.33E-04,CALCA;LPAR6;GNA11;F2R;CXCR2;F2RL1;LPAR4
regulation of peptide hormone secretion (GO:0090276),6/74,0.999614334,0.999996398,0,0,0.311804858,1.20E-04,PPP3CB;UQCC2;CHD7;ENSA;SLC2A1;ITPR1
calcium ion transmembrane import into cytosol (GO:0097553),2/42,0.999624241,0.999996398,0,0,0.176847011,6.65E-05,F2R;ITPR1
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/42,0.999624241,0.999996398,0,0,0.176847011,6.65E-05,CD164;NECTIN3
potassium ion import across plasma membrane (GO:1990573),2/42,0.999624241,0.999996398,0,0,0.176847011,6.65E-05,SLC12A4;ATP1B3
axonemal dynein complex assembly (GO:0070286),1/32,0.999648122,0.999996398,0,0,0.114134897,4.02E-05,CCDC40
chondrocyte differentiation (GO:0002062),1/32,0.999648122,0.999996398,0,0,0.114134897,4.02E-05,SLC39A14
membrane depolarization (GO:0051899),1/32,0.999648122,0.999996398,0,0,0.114134897,4.02E-05,YWHAH
positive regulation of ERK1 and ERK2 cascade (GO:0070374),21/172,0.999675925,0.999996398,0,0,0.490501678,1.59E-04,APP;ARHGAP8;RAMP3;FBXW7;SHC1;F2R;PDGFB;BRAF;ARRB1;MIF;PHB;HMGB1;PHB2;MT3;GLIPR2;PTK2B;F2RL1;SPRY2;FERMT2;FGFR2;MAPK3
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),4/60,0.999691353,0.999996398,0,0,0.252493583,7.79E-05,AKAP12;GNAI3;FLNA;AKAP5
cellular response to chemokine (GO:1990869),4/60,0.999691353,0.999996398,0,0,0.252493583,7.79E-05,DUSP1;WNK1;PTK2B;RHOA
amide biosynthetic process (GO:0043604),3/52,0.999704736,0.999996398,0,0,0.216471309,6.39E-05,SAMD8;ASL;NMRAL1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),5/68,0.999704737,0.999996398,0,0,0.280485867,8.28E-05,PPP2CA;CNOT7;INPP5F;STAP2;IL2
glycoprotein biosynthetic process (GO:0009101),7/83,0.999720376,0.999996398,0,0,0.325386891,9.10E-05,NUS1;GOLPH3;SERP1;COG7;B3GNT7;DAD1;DDOST
primary alcohol metabolic process (GO:0034308),1/33,0.999725055,0.999996398,0,0,0.11056108,3.04E-05,GPD2
negative regulation of signal transduction (GO:0009968),37/267,0.999741263,0.999996398,0,0,0.566545451,1.47E-04,OTUD4;GRB7;MTMR2;VCP;GSK3A;YWHAB;PDCD6;PTEN;ARRB1;PIK3CB;THBS1;GLI3;HMGXB4;GPC1;RACK1;GPC3;DACT3;YTHDF2;SEMA6A;CSNK2A1;ARRDC1;FBXW7;IGFBP3;CSNK2A2;SPRY4;PTPN12;MMP14;SFRP2;RPS6KB1;NEDD4;DDIT4;SPRY2;TMBIM6;SPRY1;CALR;LGR4;EZH2
regulation of tumor necrosis factor production (GO:0032680),13/124,0.999743578,0.999996398,0,0,0.413379651,1.06E-04,APP;DHX9;DDX58;IFNGR1;DICER1;MIF;HMGB1;CLU;THBS1;FOXP1;ZFP36;SYT11;ARHGEF2
B cell differentiation (GO:0030183),4/61,0.999747161,0.999996398,0,0,0.248047911,6.27E-05,ITGB1;CR2;KLF6;SLC25A5
neuron differentiation (GO:0030182),21/174,0.999749975,0.999996398,0,0,0.484027218,1.21E-04,MTPN;TGFB2;XBP1;MYEF2;RYK;FZD7;WNT7B;PBX2;ACSL4;SOX11;OLIG2;SMARCA1;MANF;NRBP2;NIF3L1;WNK1;ID2;DDIT4;CTNNB1;PITX2;SOX4
cation transmembrane transport (GO:0098655),2/44,0.999760493,0.999996398,0,0,0.168404075,4.03E-05,SFXN1;SLC7A3
negative regulation of response to external stimulus (GO:0032102),12/118,0.999762331,0.999996398,0,0,0.399618257,9.50E-05,CLDN3;FNDC4;PTPRS;DUSP3;INPP5F;C1QBP;PCBP2;PTEN;ENPP3;METRNL;LYAR;CRK
positive regulation of defense response (GO:0031349),9/98,0.999765149,0.999996398,0,0,0.357109965,8.39E-05,APP;DHX9;MDK;RIOK3;POLR3G;ETS1;OPTN;IL2;MAPK13
lymphocyte differentiation (GO:0030098),7/84,0.999765626,0.999996398,0,0,0.321140398,7.53E-05,ITGB1;CR2;KLF6;CHD7;SLC25A5;SOX4;IL2
positive regulation of MAPK cascade (GO:0043410),38/274,0.99977579,0.999996398,0,0,0.566973044,1.27E-04,APP;ARHGAP8;RAMP3;FLT1;ROCK1;SHC1;ROCK2;WWC1;PDGFB;ARRB1;IQGAP1;PHB;HMGB1;PHB2;IGF1R;PDCD10;GLIPR2;PTK2B;MAPK3;TGFB2;RYK;FBXW7;F2R;IGF2;BRAF;MIF;MID1;MT3;TAOK3;TAOK1;F2RL1;SPRY2;LAMTOR1;FERMT2;FGFR2;EZH2;GSDME;FGFR1
neutrophil migration (GO:1990266),6/77,0.999777084,0.999996398,0,0,0.298572321,6.66E-05,TGFB2;PLA2G1B;BSG;CXCR2;PPIB;PPIA
axoneme assembly (GO:0035082),1/34,0.999785027,0.999996398,0,0,0.107203857,2.30E-05,CCDC40
positive regulation of interleukin-1 production (GO:0032732),4/62,0.999792909,0.999996398,0,0,0.243755539,5.05E-05,APP;TMED10;F2RL1;HMGB1
defense response to Gram-positive bacterium (GO:0050830),5/70,0.999798314,0.999996398,0,0,0.271820536,5.48E-05,PPP1R11;PLA2G1B;ROMO1;GBP2;RPL39
retinoid metabolic process (GO:0001523),8/92,0.999799641,0.999996398,0,0,0.336357625,6.74E-05,GPC1;RBP1;GPC3;SDC1;LRP2;GPC4;AGRN;HSPG2
B cell activation (GO:0042113),7/85,0.999803602,0.999996398,0,0,0.317002789,6.23E-05,ITGB1;CR2;KLF6;PHB;SLC25A5;PHB2;HSPD1
striated muscle contraction (GO:0006941),3/54,0.999806231,0.999996398,0,0,0.207955488,4.03E-05,GRK2;TPM1;ALDOA
unsaturated fatty acid metabolic process (GO:0033559),3/54,0.999806231,0.999996398,0,0,0.207955488,4.03E-05,ELOVL1;GPX4;PLA2G10
protein processing (GO:0016485),10/106,0.999806613,0.999996398,0,0,0.367774045,7.11E-05,SPCS3;MMP14;SPCS2;SPCS1;MYRF;YME1L1;ECE1;F3;PARL;METAP2
heart development (GO:0007507),19/164,0.999813287,0.999996398,0,0,0.462119328,8.63E-05,TGFB2;LEFTY1;MKKS;TCF25;CHD7;PDGFB;PTEN;ECE1;CACYBP;CRIP1;FKBP1A;PDLIM2;MTHFD1;ID2;PKP2;GPC3;TDGF1;SOX4;PDLIM7
cellular response to lipopolysaccharide (GO:0071222),12/120,0.999825316,0.999996398,0,0,0.392167287,6.85E-05,ZFP36;XBP1;MAPK8;PLAA;HMGB1;MAPK14;NFKB1;CDC73;GIT1;RHOA;MTDH;CHMP5
acylglycerol catabolic process (GO:0046464),1/35,0.999831776,0.999996398,0,0,0.104044118,1.75E-05,FABP5
bicarbonate transport (GO:0015701),1/35,0.999831776,0.999996398,0,0,0.104044118,1.75E-05,SLC4A7
embryonic skeletal system development (GO:0048706),1/35,0.999831776,0.999996398,0,0,0.104044118,1.75E-05,SOX11
regulation of postsynaptic membrane potential (GO:0060078),1/35,0.999831776,0.999996398,0,0,0.104044118,1.75E-05,GSK3A
cholesterol homeostasis (GO:0042632),5/71,0.999833335,0.999996398,0,0,0.26768481,4.46E-05,XBP1;SOAT1;CNBP;PLA2G10;LAMTOR1
response to interleukin-1 (GO:0070555),7/86,0.999835446,0.999996398,0,0,0.31296993,5.15E-05,APP;TAF9;RC3H1;GBP2;HIF1A;NFKB1;MAPK13
response to lipopolysaccharide (GO:0032496),18/159,0.999841235,0.999996398,0,0,0.450230824,7.15E-05,XBP1;F2R;HMGB1;LIAS;MAPK14;NFKB1;CDC73;RHOA;FOXP1;ZFP36;TRIM6;MAPK8;MAPKAPK3;NOCT;PLAA;GIT1;CHMP5;HNRNPA0
regulation of ion transport (GO:0043269),6/79,0.999845491,0.999996398,0,0,0.290354855,4.49E-05,SYT11;WNK1;NEDD4;YWHAH;VAMP3;SNX6
negative regulation of tumor necrosis factor production (GO:0032720),2/46,0.99984718,0.999996398,0,0,0.160728678,2.46E-05,SYT11;DICER1
negative regulation of cellular process (GO:0048523),91/566,0.999848039,0.999996398,0,0,0.672259861,1.02E-04,BTG3;APP;COL18A1;RARG;DDX3X;CELF1;GMNN;PDCD5;FHL1;PDE3B;PTEN;TXNDC12;MIA3;ENO1;PARK7;PTPRK;CLU;ETS1;CDC73;GJA1;ADAMTS1;MDK;MYC;FTH1;ARHGDIA;ANXA6;RACK1;DACT3;SPEG;ARID2;SOX4;BNIP3L;FGFBP1;PBRM1;DUSP1;IGFBP3;ACTN1;F2R;SOX11;MIF;PPP2R5C;CGRRF1;GTPBP4;NME1;IMPACT;CLDN3;SFRP2;NME6;PDE12;TXNIP;MYH9;TMBIM6;SRSF6;EEF1E1;CRYAB;VAMP3;DDX4;NDRG3;VPS4B;PHB;PPP2CA;TBRG1;PODXL;LMNA;PDPN;PTK2B;RBBP7;S100A11;E2F7;CD164;NPM1;TGFB2;BNIP3;GLMN;HMGA1;PTPN14;MT3;PML;SMARCA4;REST;CNOT7;TMEM98;SYT11;CHMP2A;CTNNB1;STRN;PLXNB1;ANP32B;FERMT2;RAD18;GSDME
negative regulation of cell population proliferation (GO:0008285),56/379,0.999860179,0.999996398,0,0,0.609544439,8.52E-05,CDKN1C;APP;BTG3;COL18A1;RARG;CELF1;PDCD5;PTEN;PTPRK;ETS1;CDC73;ADAMTS1;FTH1;MYC;SPEG;ARID2;SLC16A2;EMD;SOX4;FGFBP1;PBRM1;IGFBP3;F2R;SOX11;PEX2;PPP2R5C;CGRRF1;GTPBP4;MTSS1;NME1;CLDN3;SFRP2;TFDP1;EEF1E1;HPN;PHB;TBRG1;PAK1;LMNA;PDPN;PTK2B;S100A11;E2F7;CD164;NPM1;TGFB2;GLMN;HMGA1;PTPN14;PML;REST;CNOT7;CTNNB1;STRN;PLXNB1;GSDME
sterol homeostasis (GO:0055092),5/72,0.999862258,0.999996398,0,0,0.263672538,3.63E-05,XBP1;SOAT1;CNBP;PLA2G10;LAMTOR1
calcium ion transport (GO:0006816),11/115,0.999865092,0.999996398,0,0,0.373324426,5.04E-05,FKBP1A;CACNG7;CALCRL;CRACR2B;RAMP3;ITPR1;ATP2A2;ANK2;SELENOK;TPT1;TMCO1
cellular amide metabolic process (GO:0043603),11/115,0.999865092,0.999996398,0,0,0.373324426,5.04E-05,DHFR;PPP2CA;MTHFD1;MTHFD2;MTHFD2L;ACOT2;ACOT13;DBI;PLPP2;SLC19A1;AASDHPPT
cellular response to molecule of bacterial origin (GO:0071219),11/115,0.999865092,0.999996398,0,0,0.373324426,5.04E-05,ZFP36;XBP1;MAPK8;PLAA;HMGB1;MAPK14;NFKB1;CDC73;GIT1;RHOA;CHMP5
cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.999868216,0.999996398,0,0,0.101064935,1.33E-05,NUDT4
positive regulation of bone mineralization (GO:0030501),1/36,0.999868216,0.999996398,0,0,0.101064935,1.33E-05,BMPR1A
regulation of osteoclast differentiation (GO:0045670),1/36,0.999868216,0.999996398,0,0,0.101064935,1.33E-05,CEBPB
glycosphingolipid metabolic process (GO:0006687),2/47,0.999877816,0.999996398,0,0,0.157146826,1.92E-05,ESYT2;CLN6
regulation of synapse assembly (GO:0051963),2/47,0.999877816,0.999996398,0,0,0.157146826,1.92E-05,APP;GPC4
lipid transport (GO:0006869),10/109,0.999880999,0.999996398,0,0,0.356560366,4.24E-05,PRELID1;PEX19;CHKA;FABP5;PITPNB;PCTP;NME4;PRELID3A;PITPNC1;PRELID3B
chromatin assembly (GO:0031497),5/73,0.999886123,0.999996398,0,0,0.259778274,2.96E-05,NPM1;ATRX;NAP1L1;ANP32B;NOC2L
positive regulation of synaptic transmission (GO:0050806),5/73,0.999886123,0.999996398,0,0,0.259778274,2.96E-05,APP;CACNG7;FLOT1;PTK2B;AKAP5
cellular calcium ion homeostasis (GO:0006874),14/136,0.999887401,0.999996398,0,0,0.40484367,4.56E-05,YWHAE;CALCA;CAMK2D;ATP2A2;ANK2;SELENOK;PML;TMCO1;ANXA6;BAX;CALR;ATP13A3;PDZD8;TPT1
positive regulation of signal transduction (GO:0009967),33/252,0.99989253,0.999996398,0,0,0.530571027,5.70E-05,YAP1;PTEN;PHB;ERFE;RBPJ;HIF1A;CDC73;PDCD10;SPIN1;RPS3;FLNA;EP300;PTK2B;SNX5;TRIM44;PRKCI;XBP1;ZRANB1;TGFB2;CSNK2A1;IGF2;F3;SLC39A14;MT3;UCHL5;SMARCA4;EVC;MYO1C;BMP2K;BAX;PHIP;FGFR2;LIMS1
protein glycosylation (GO:0006486),13/130,0.99989613,0.999996398,0,0,0.392028765,4.07E-05,NUS1;COG7;RPN2;GFPT2;TET1;MOGS;DDOST;KRTCAP2;SERP1;TMEM258;B3GNT7;DAD1;STT3B
external encapsulating structure organization (GO:0045229),27/217,0.999896137,0.999996398,0,0,0.500617284,5.20E-05,DDR1;ITGB1;APP;COL18A1;LAMA5;ITGAM;NCAN;PDGFB;F11R;THBS1;TGM1;SH3PXD2A;CDH1;ADAMTS1;BSG;DAG1;ITGA3;APLP1;LAMB1;HSPG2;MMP14;COL4A2;COL4A1;PXDN;ITGA6;AGRN;MATN3
proton transmembrane transport (GO:1902600),1/37,0.999896619,0.999996398,0,0,0.098251263,1.02E-05,ATP6V1F
arachidonic acid metabolic process (GO:0019369),3/57,0.999896762,0.999996398,0,0,0.196364509,2.03E-05,GPX4;PTGES3;PLA2G10
positive regulation of interferon-gamma production (GO:0032729),3/57,0.999896762,0.999996398,0,0,0.196364509,2.03E-05,F2RL1;HSPD1;CD276
regulation of bone mineralization (GO:0030500),3/57,0.999896762,0.999996398,0,0,0.196364509,2.03E-05,BMP2K;PTK2B;BMPR1A
renal system development (GO:0072001),3/57,0.999896762,0.999996398,0,0,0.196364509,2.03E-05,TGFB2;GREB1L;HSPB11
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/48,0.999902213,0.999996398,0,0,0.153720707,1.50E-05,SYT11;DICER1
response to cytokine (GO:0034097),16/150,0.999904086,0.999996398,0,0,0.421109958,4.04E-05,APP;FOXH1;TAF9;PTPN12;PTPN14;DDOST;RHOA;PML;CXCL16;MAPK8;HAX1;MAPKAPK3;LAMP3;TIMP2;MCL1;BCL2L1
sphingolipid biosynthetic process (GO:0030148),5/74,0.999905799,0.999996398,0,0,0.255996888,2.41E-05,ELOVL1;SAMD8;VAPA;PLPP2;CSNK1G2
cellular divalent inorganic cation homeostasis (GO:0072503),10/111,0.99991381,0.999996398,0,0,0.349454668,3.01E-05,SLC30A9;ATP2A2;SLC39A10;ANK2;CALR;ATP13A3;MT3;SLC39A14;TPT1;TMCO1
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),19/170,0.999916795,0.999996398,0,0,0.443584683,3.69E-05,ITGB1;CD164;TGFB2;ITGAM;PTPRS;NEXN;IGSF9;PTPRF;CLDN6;TRO;CLDN4;CDH1;BSG;CLDN7;CLDN12;EMB;GPC4;NECTIN3;NECTIN2
positive regulation of lymphocyte proliferation (GO:0050671),5/75,0.999922008,0.999996398,0,0,0.252323541,1.97E-05,PNP;TFRC;MIF;IL2;CD276
skeletal system development (GO:0001501),17/158,0.999923534,0.999996398,0,0,0.425121007,3.25E-05,TGFB2;NCAN;CHD7;IGF2;BMP8B;SOX11;EXT1;GJA1;MMP14;BMP1;EVC;PRDX1;PPIB;SOX4;FGFR2;MATN3;FGFR1
epidermis development (GO:0008544),6/83,0.999925506,0.999996398,0,0,0.275200567,2.05E-05,FABP5;ATP2A2;FLOT2;YBX1;GRHL2;FGFR2
long-chain fatty acid metabolic process (GO:0001676),6/83,0.999925506,0.999996398,0,0,0.275200567,2.05E-05,ELOVL1;ACADL;GPX4;PLA2G10;ACOT2;ACSL4
regulation of defense response (GO:0031347),6/83,0.999925506,0.999996398,0,0,0.275200567,2.05E-05,PSMA6;CELF1;TMSB4X;PARK7;SAMHD1;FOXP1
positive regulation of response to external stimulus (GO:0032103),14/139,0.999927517,0.999996398,0,0,0.395050832,2.86E-05,APP;USP15;DHX9;RIOK3;PDGFB;ETS1;THBS1;IL2;PUM2;MAPK13;MDK;F2RL1;POLR3G;OPTN
cilium assembly (GO:0060271),43/314,0.999933531,0.999996398,0,0,0.558081249,3.71E-05,CEP57;YWHAE;ARF4;DYNC1I2;DCTN3;FNBP1L;HSPB11;CDC14B;NUDCD3;PCM1;TUBA1A;TCTN2;TTC21B;FLNA;E2F4;TNPO1;ATP6V1D;YWHAG;ACTR3;ACTR2;HSP90AA1;MKKS;GSN;HAUS3;PARVA;DYNLL1;TUBB4B;CKAP5;RAB11A;HAUS1;EHD2;AHI1;IFT43;RILPL1;TMEM237;AKAP9;CDK1;DYNLRB1;MAPRE1;IFT46;SFI1;SSX2IP;CCDC40
regulation of T cell proliferation (GO:0042129),5/76,0.999935349,0.999996398,0,0,0.248753669,1.61E-05,CEBPB;PNP;TFRC;GLMN;CD276
regulation of gene expression (GO:0010468),188/1079,0.999936799,0.999996398,0,0,0.736617966,4.66E-05,RPL5;APP;NUP107;TFRC;NAB1;WWC1;PDCD5;PRDM5;JMJD1C;PARK7;RBPJ;ETS1;CLU;RPL6;UBE2L3;ACTG1;GJA1;HMGN5;CDH1;MYC;LAMP3;GPBP1;MYB;POGZ;EP300;SOX4;MED1;MBNL2;RPS7;FBXW7;SFMBT2;RPL23;RC3H1;ANK2;SOX11;DICER1;MIF;SOX12;POU3F1;FOXP1;CLDN3;SFRP2;MYCN;MYADM;PPIE;MATR3;UBE2V1;ANKRA2;EZR;AJUBA;IGSF1;HPN;PDGFB;PHB;HIF1A;ZFP36L1;NPAT;LARP1;PCBP4;PDCD10;PCBP1;PCBP2;UBR5;MBIP;RBM12;SLC38A2;CD276;SRPK2;ZFHX3;TGFB2;TIPARP;FZD7;SNAI3;NONO;RDX;GLMN;IGF2;HMGA1;RAB27A;MSN;BRAF;FOXN3;LARP4;MT3;NFKB1;PUM2;FGF17;HNRNPL;AFDN;SON;HNRNPK;CNOT7;FUBP3;SP1;CDK4;ID2;FUBP1;AGO2;SP3;BHLHE40;HNRNPD;CALR;EZH2;RNF187;BMPR1A;TRIM71;GSK3A;DDX3X;CELF1;RNF14;CHD7;PIK3CB;YBX1;LIMD1;AFF4;YBX3;PTBP1;TRIM6;HINT1;SNRNP70;RACK1;SPIN1;DNMT3B;FLOT2;METTL16;PEG3;DDX58;IFNGR1;ATRX;F3;MLF1;TAPBP;ACTA2;ACTA1;SFPQ;HNRNPH1;NFX1;PTRH2;ESRP1;C1D;HNRNPH2;PFDN5;YAP1;CEBPB;RAMP3;MYCBP;ROCK1;ROCK2;SRRT;RPL11;CRIP1;PPP2CA;MAPK8;TDG;TRA2B;NSD1;NOCT;ATXN1L;NSD2;IGF2BP1;RPS3;METTL4;MAPK1;MBNL3;SRSF10;TRIM44;MAPK3;TCFL5;GSN;YTHDF2;SORT1;NFYB;CNBP;RRP1B;MAPK14;HNRNPAB;CDK11B;PML;PDCL3;REST;CARM1;RLIM;SPRY2;UBAP2;FAM98B;KRAS;TARDBP;LIMS1
chloride transmembrane transport (GO:1902476),2/50,0.999937077,0.999996398,0,0,0.147296734,9.27E-06,SLC12A4;SLC1A3
organic anion transport (GO:0015711),8/99,0.999939215,0.999996398,0,0,0.310343879,1.89E-05,SLC4A7;SLC23A1;MGST1;SLC16A2;SLC25A4;SLC19A1;ABCG2;SLC25A24
extracellular structure organization (GO:0043062),26/216,0.999943029,0.999996398,0,0,0.481965714,2.75E-05,DDR1;ITGB1;APP;COL18A1;LAMA5;ITGAM;NCAN;PDGFB;F11R;THBS1;SH3PXD2A;CDH1;ADAMTS1;BSG;DAG1;ITGA3;APLP1;LAMB1;HSPG2;MMP14;COL4A2;COL4A1;PXDN;ITGA6;AGRN;MATN3
negative regulation of defense response (GO:0031348),6/85,0.999947962,0.999996398,0,0,0.268198903,1.40E-05,FNDC4;C1QBP;PCBP2;ENPP3;METRNL;LYAR
synapse assembly (GO:0007416),4/69,0.999948076,0.999996398,0,0,0.217406973,1.13E-05,CDH1;RYK;PTEN;PLXNB1
cholesterol transport (GO:0030301),2/51,0.999949358,0.999996398,0,0,0.1442814,7.31E-06,SOAT1;CLU
lymphocyte migration (GO:0072676),1/40,0.999949448,0.999996398,0,0,0.090675991,4.58E-06,MSN
organic hydroxy compound transport (GO:0015850),1/40,0.999949448,0.999996398,0,0,0.090675991,4.58E-06,SLC16A1
extracellular matrix organization (GO:0030198),40/300,0.999951864,0.999996398,0,0,0.541125007,2.60E-05,DDR1;ITGB1;APP;COL18A1;LAMA5;CD151;ITGAM;NCAN;PDGFB;F11R;THBS1;LOXL2;CAPNS1;SH3PXD2A;CDH1;ADAMTS1;BSG;DAG1;SERPINH1;TIMP2;CAPN2;FLOT1;TGFB2;GSN;DST;ITGA3;APLP1;LAMB1;HSPG2;MMP14;BMP1;COL4A2;COL4A1;PXDN;ITGA6;P4HB;AGRN;PPIB;MATN3;PLEC
O-glycan processing (GO:0016266),3/61,0.999954656,0.999996398,0,0,0.182775086,8.29E-06,B3GNT7;GALNT3;GXYLT1
regulation of interferon-gamma production (GO:0032649),6/86,0.999956384,0.999996398,0,0,0.264829352,1.16E-05,PRNP;C1QBP;F2RL1;HMGB1;HSPD1;CD276
kidney development (GO:0001822),4/70,0.999957133,0.999996398,0,0,0.214099145,9.18E-06,TGFB2;GREB1L;HSPB11;SOX4
plasma membrane bounded cell projection assembly (GO:0120031),36/278,0.999957496,0.999996398,0,0,0.523370538,2.22E-05,ITGB1;ARF4;FNBP1L;HSPB11;CDC14B;RAP1B;NUDCD3;PCM1;TCTN2;FLNA;RAC1;ATP6V1D;ACTR3;CARMIL1;ACTR2;MKKS;GSN;PARVA;DYNLL1;MTSS1;RAB11A;CD2AP;AIF1L;EHD2;AHI1;GOLPH3;RAP2B;IFT43;RILPL1;TMEM237;STK26;PMP22;EZR;IFT46;SSX2IP;ARF6
monocarboxylic acid metabolic process (GO:0032787),14/143,0.999959182,0.999996398,0,0,0.38270224,1.56E-05,PDHA1;SLC16A1;GLO1;ACSL4;PDHB;LDHA;GATM;BSG;ACOT2;VDAC1;ME2;SLC16A3;DLD;AASDHPPT
acylglycerol metabolic process (GO:0006639),1/41,0.999959921,0.999996398,0,0,0.088403409,3.54E-06,DGKD
cellular response to lipid (GO:0071396),26/219,0.999959951,0.999996398,0,0,0.474381643,1.90E-05,URI1;RAMP3;ROCK2;MGST1;HMGB1;CDC73;UBE2L3;ZFP36;MAPK8;RUVBL2;PTK2B;GIT1;MED1;XBP1;FZD7;WNT7B;MSN;MAPK14;RHOA;NFKB1;SETX;CREB1;PTK7;PLAA;MGARP;CHMP5
ion transport (GO:0006811),10/116,0.999960848,0.999996398,0,0,0.332863533,1.30E-05,LASP1;SLC12A4;WNK1;SLC20A1;VDAC2;SLC1A3;TSPO;ATP11B;VDAC1;SLC5A5
calcium-mediated signaling (GO:0019722),8/102,0.999962941,0.999996398,0,0,0.300381167,1.11E-05,FIS1;PRNP;PPP3CB;CXCR2;ATP2A2;ANK2;PPP1R9A;NUDT4
generation of neurons (GO:0048699),23/202,0.999966078,0.999996398,0,0,0.452567561,1.54E-05,YAP1;MTPN;TGFB2;MYEF2;YTHDF2;RYK;USP9X;FZD7;WNT7B;DOCK7;ACSL4;SOX11;OLIG2;SMARCA1;NRBP2;NIF3L1;SIX4;MAP1B;DDIT4;BHLHE40;CTNNB1;RAC1;FGFR1
ceramide biosynthetic process (GO:0046513),1/42,0.999968079,0.999996398,0,0,0.086241685,2.75E-06,SAMD8
anterior/posterior pattern specification (GO:0009952),3/63,0.999969462,0.999996398,0,0,0.176659845,5.39E-06,BASP1;BHLHE40;TDGF1
positive regulation of transcription by RNA polymerase II (GO:0045944),152/908,0.999969649,0.999996398,0,0,0.702355114,2.13E-05,APP;TCERG1;KDM1A;WWC1;HNRNPU;PARK7;RBPJ;ETS1;RUVBL2;MYC;ZMIZ2;MYB;NAMPT;RPS6KA1;POGZ;EP300;PITX2;JUNB;SOX4;MED1;SLC30A9;FOXH1;SOX11;SOX12;MED6;SFRP2;MYCN;SUB1;PHIP;GLYR1;BEX1;KMT2A;DHX9;PDGFB;HIF1A;FOXO1;PLAC8;NPAT;PPP3R1;UBB;PCBP1;UBC;BPTF;JUN;XBP1;XRCC6;ZFHX3;TGFB2;JUP;PHF10;IGF2;HMGA1;PBX2;SMARCA1;SMAD5;NFKB1;SMARCA4;FOSL2;SMAD7;SETX;AHI1;BCL9;CDK7;DAB2;FUBP3;SP1;AGO2;SP3;MAFF;CDK12;CDK13;FGFR2;BMPR1A;ARF4;CSRNP1;RNF10;RARG;DDX3X;PTPRN;ARRB1;TCF20;WASL;HMGB1;YBX1;LITAF;MYSM1;CDC73;GLI3;MED14;PPP3CB;ZIC3;TEAD1;ACTR3;EIF5A;SS18;ACTR2;PPP1R12A;PEG3;TCF15;CHUK;PARP1;DDX58;ATRX;NME2;TET1;ETV4;UTF1;GNL3;SENP1;SFPQ;HAX1;CREB1;TFDP1;THRAP3;ITGA6;NCOA7;ARHGEF2;EAPP;YAP1;SMARCD1;CEBPB;HDAC3;PLA2G1B;TAF9;BCLAF1;EPCAM;LEO1;E2F4;TBL1X;RPS27A;E2F7;E2F8;RTRAF;MAPK3;NPM1;PCGF5;NFYB;CNBP;RRP1B;USF2;GRHL2;KLF7;REST;KLF6;PSMC3;ZGLP1;TCEA1;CTNNB1;F2RL1;CEBPZ;AGRN;SSBP3
cellular metal ion homeostasis (GO:0006875),8/104,0.999973001,0.999996398,0,0,0.294085287,7.94E-06,ATP2A2;ANK2;ATP1B3;CALR;ATP13A3;MT3;TPT1;TMCO1
positive regulation of cytokine production (GO:0001819),45/335,0.999973389,0.999996398,0,0,0.545347677,1.45E-05,APP;CEBPB;TMED10;DHX9;PLA2G1B;ROCK2;PARK7;PHB;HMGB1;HIF1A;HSPD1;TRIM6;PNP;MDK;G3BP1;RPS3;FLOT1;EP300;POLR2F;LRRFIP1;POLR2H;SPTBN1;POLR2K;CD276;POLR2L;AFAP1L2;XBP1;XRCC6;DDX58;F2R;GLMN;MIF;MAPK14;F3;IL2;NFKB1;FOXP1;MAPK13;POLR1C;CTNNB1;F2RL1;POLR3G;ARHGEF2;GAPDH;POLR3K
regulation of signal transduction (GO:0009966),22/198,0.999973835,0.999996398,0,0,0.440254624,1.15E-05,APP;MTCH1;PRNP;PRAG1;IGFBP4;ITGA3;IGFBP3;IGFBP2;NUCKS1;SYNJ2BP;CLU;RASGRP4;PPP2CA;GRK2;TMEM237;GRK6;TDGF1;PPIA;CRK;GIT1;FGFR2;YWHAG
positive regulation of inflammatory response (GO:0050729),6/89,0.999973861,0.999996398,0,0,0.255207862,6.67E-06,APP;MDK;DHX9;ETS1;IL2;MAPK13
calcium ion homeostasis (GO:0055074),7/97,0.999975023,0.999996398,0,0,0.27452334,6.86E-06,SELENON;ATP2A2;ANK2;CALR;ATP13A3;TPT1;TMCO1
sodium ion transport (GO:0006814),6/90,0.999977784,0.999996398,0,0,0.252153421,5.60E-06,SLC6A6;SLC23A1;ATP1B3;KCNK1;SLC9B2;SLC5A5
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),12/134,0.999978149,0.999996398,0,0,0.346850733,7.58E-06,PRNP;HAX1;PDGFB;IGF2;PTK2B;STAP2;MIF;ARHGEF2;EFNA5;TDGF1;PAK2;IL2
cellular response to type I interferon (GO:0071357),3/65,0.999979043,0.999996398,0,0,0.170939137,3.58E-06,SAMHD1;GBP2;JAK1
type I interferon signaling pathway (GO:0060337),3/65,0.999979043,0.999996398,0,0,0.170939137,3.58E-06,SAMHD1;GBP2;JAK1
lymphocyte chemotaxis (GO:0048247),1/44,0.999979382,0.999996398,0,0,0.082219873,1.70E-06,CXCL16
regulation of nucleic acid-templated transcription (GO:1903506),61/430,0.999981005,0.999996398,0,0,0.580114396,1.10E-05,NUP107;RNF14;NAB1;WWC1;CHD7;JMJD1C;YBX1;LIMD1;RPL6;UBE2L3;HINT1;HMGN5;GPBP1;MYB;SPIN1;EP300;SOX4;ATRX;SOX11;SOX12;ACTN4;MLF1;NIF3L1;SFPQ;NFX1;PPIE;UBE2V1;AJUBA;PFDN5;CEBPB;MYCBP;IGSF1;SRRT;PHB;HIF1A;PPP2CA;NSD1;NSD2;ATXN1L;SRSF10;TCFL5;ZFHX3;NFYB;FZD7;SNAI3;CNBP;NONO;IGF2;HMGA1;FOXN3;CDK11B;PML;REST;SP1;COPS2;CARM1;SP3;BHLHE40;HNRNPD;CALR;EZH2
regulation of interleukin-1 beta production (GO:0032651),5/83,0.999981221,0.999996398,0,0,0.226327547,4.25E-06,APP;F2R;F2RL1;GIT1;FOXP1
positive regulation of multicellular organismal process (GO:0051240),46/345,0.99998131,0.999996398,0,0,0.540492802,1.01E-05,CEBPB;HDAC3;TFRC;KDM1A;RIF1;ROCK1;PDGFB;EHMT1;ENO1;ADIPOR1;IGF1R;LOXL2;PLAC8;GJA1;ACADL;SIX4;GLIPR2;MDK;C1QBP;PDPN;CFL1;FLOT1;MED1;XBP1;TGFB2;F2R;GLMN;NME2;SOX11;MIF;ETV4;IL2;GADD45G;GATM;DAB2;REST;BMP1;FABP5;AGO2;CTNNB1;F2RL1;PPIB;GAPDH;FERMT2;EZH2;BMPR1A
chemokine-mediated signaling pathway (GO:0070098),2/56,0.999981783,0.999996398,0,0,0.130879914,2.38E-06,WNK1;PTK2B
positive regulation of interleukin-1 beta production (GO:0032731),2/56,0.999981783,0.999996398,0,0,0.130879914,2.38E-06,APP;F2RL1
regulation of cytokine production (GO:0001817),14/150,0.999983585,0.999996398,0,0,0.362840076,5.96E-06,AFAP1L2;PPP1R11;DDX58;GLMN;MIF;MAPK14;FOXP1;TWSG1;SYT11;FLOT1;IGF2BP1;GAPDH;LGR4;CD276
"negative regulation of transcription, DNA-templated (GO:0045892)",157/948,0.999984348,0.999996398,0,0,0.692538942,1.08E-05,TCERG1;RIF1;KDM1A;NAB1;WWC1;GMNN;UBE2D3;PRDM5;EHMT1;HNRNPU;ENO1;NOC2L;RBPJ;PHB2;LOXL2;RPS14;ZFP36;TRIM28;BASP1;MYC;MYB;EP300;KMT5A;MED1;SFMBT2;RPL23;SOX11;DICER1;FOXP1;ILF3;SFRP2;EZR;PPID;KHDRBS1;URI1;CALCA;DDX5;SET;SHC1;PDGFB;RTF1;PHB;FOXO1;PHF21A;MTDH;MBTD1;PRDX5;UBB;ORC2;TPR;UBC;LYAR;SKIL;SNX6;BPTF;PLK3;HSPA8;JUN;XRCC6;ZFHX3;UBE2I;PHC1;CBX5;PHF10;GADD45A;CBX3;NONO;IGF2;HMGA1;FOXN3;PA2G4;MT3;NFKB1;SMARCA4;SMAD7;GCLC;DAB2;CNOT7;YEATS2;ID2;SP3;ID1;BHLHE40;CALR;FGFR2;EZH2;CDKN1C;SUV39H2;RARG;TCF25;PTPRK;HMGB1;LIMD1;PHF6;CDC73;GLI3;DNMT3L;SUMO1;BCL7A;YWHAQ;SIX4;C1QBP;DNMT3B;LRRFIP1;JARID2;TGIF1;LEFTY1;PEG3;PARP1;PRMT2;DNMT3A;NRG1;PEX2;DUSP22;IMPACT;SFPQ;CREB1;NFX1;BIRC5;CRYAB;PFDN5;YAP1;CEBPB;HDAC3;RPL10;SATB1;RNF2;PURA;BCLAF1;BTAF1;NSD1;BEND3;FLNA;SAP18;TBL1X;RPS27A;E2F7;E2F8;TCFL5;SMARCE1;USP9X;CNBP;PCGF2;WWP1;PML;GATAD2A;KLF7;REST;PER3;NR6A1;ZGLP1;RLIM;CTNNB1;HDGF;MPHOSPH8;TRIM33;LIMS1
icosanoid metabolic process (GO:0006690),2/57,0.999984852,0.999996398,0,0,0.128492013,1.95E-06,GPX4;PLA2G10
chloride transport (GO:0006821),4/76,0.999985145,0.999996398,0,0,0.19618174,2.91E-06,CLIC4;SLC12A4;TTYH3;SLC1A3
fatty acid metabolic process (GO:0006631),10/124,0.999987043,0.999996398,0,0,0.309344872,4.01E-06,XBP1;GPX4;PLA2G1B;NDUFAB1;NUDT19;ACOT2;ACSL4;PEX2;ADIPOR1;ACACA
inorganic cation import across plasma membrane (GO:0098659),4/77,0.999987254,0.999996398,0,0,0.193481857,2.47E-06,SLC12A4;SLC39A10;ATP1B3;SLC39A14
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),9/118,0.999988891,0.999996398,0,0,0.291209204,3.23E-06,CALCA;CALCRL;RAMP3;GNG2;GNB1;LPAR2;LGR5;ADGRL2;LGR4
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/59,0.999989206,0.999996398,0,0,0.123967568,1.34E-06,STAP2;IL2
negative regulation of cytokine production (GO:0001818),18/182,0.999990036,0.999996398,0,0,0.386512746,3.85E-06,CHID1;PRNP;PPP1R11;DDX58;ARRB1;HMGB1;THBS1;ZFP36;TWSG1;SYT11;C1QBP;TMSB4X;PCBP2;TAX1BP1;F2RL1;RAC1;EZR;LGR4
negative regulation of transcription by RNA polymerase II (GO:0000122),104/684,0.999990774,0.999996398,0,0,0.626730758,5.78E-06,TCERG1;RIF1;KDM1A;WWC1;UBE2D3;PRDM5;HNRNPU;ENO1;NOC2L;RBPJ;LOXL2;RPS14;ZFP36;MYC;MYB;EP300;KMT5A;MED1;RPL23;SOX11;DICER1;FOXP1;EZR;PPID;URI1;DDX5;PDGFB;PHB;RTF1;PHF21A;MTDH;UBB;ORC2;TPR;UBC;SKIL;LYAR;BPTF;PLK3;JUN;ZFHX3;CBX5;UBE2I;GADD45A;IGF2;NFKB1;SMARCA4;SMAD7;DAB2;YEATS2;ID2;ID1;BHLHE40;CALR;FGFR2;EZH2;SUV39H2;RARG;TCF25;HMGB1;PHF6;GLI3;CDC73;SUMO1;C1QBP;DNMT3B;LRRFIP1;TGIF1;LEFTY1;PEG3;PARP1;ATRX;DNMT3A;PEX2;DUSP22;IMPACT;SFPQ;NFX1;YAP1;CEBPB;HDAC3;RPL10;SATB1;RNF2;PURA;NSD1;BEND3;TBL1X;RPS27A;E2F7;E2F8;TCFL5;USP9X;PCGF2;CNBP;GATAD2A;KLF7;REST;NR6A1;PER3;ZGLP1;NEDD4;HDGF;TRIM33
"regulation of transcription, DNA-templated (GO:0006355)",272/2244,0.999990796,0.999996398,0,0,0.455215841,4.19E-06,NUP107;EHMT1;JMJD1C;ENO1;RBPJ;PHB2;RPL6;UBE2L3;TIAL1;TRIM28;ZMIZ2;MYC;GPBP1;RPS6KA1;MYB;BBX;JUNB;SOX4;MED1;SMARCC1;SFMBT2;IFRD1;FOXH1;MED8;SOX11;SOX12;MED6;WDR77;NIF3L1;SFRP2;SUB1;TFAM;URI1;SET;DHX9;IGSF1;PDGFB;MRPL12;HIF1A;MTDH;MBTD1;NUP85;RAD21;SNX5;SNX6;CDK17;JUN;AFAP1L2;XRCC6;PHC1;SNAI3;FZD7;IGF2;PBX2;PA2G4;SMARCA1;MED13L;SMARCA4;FOSL2;DHFR;MLLT11;HNRNPK;TADA2A;FUBP3;ID2;ID1;HNRNPD;CALR;CDK14;EZH2;CDKN1C;CSRNP1;SUV39H2;SRA1;TCF20;PTPRK;HIF3A;LIMD1;PHF6;LITAF;GLI3;MED14;PPP3CB;HINT1;SPIN1;ELOC;JARID2;TEAD1;BRD3;TCF15;PRMT2;NME2;BAZ1A;MLF1;PHF20L1;SLTM;NFX1;NCOA7;CRYAB;VGLL3;YAP1;PCNA;MYCBP;MYRF;SATB1;SRRT;PPP2CA;PURB;PURA;BCLAF1;BTAF1;GBX1;NSD1;NSD2;METTL4;TBL1X;SRSF10;NPM1;PCGF5;NFYB;PCGF3;WWP1;GRHL2;GATAD2A;PHF5A;NR6A1;RLIM;CTNNB1;HDGF;MPHOSPH8;LIMS1;KDM1A;NAB1;WWC1;GMNN;PRDM5;ARID4B;NUCKS1;ETS1;LOXL2;HMGN5;CDH1;BASP1;SALL4;RUVBL2;RUVBL1;EP300;KMT5A;PITX2;ANKRD49;F2R;THOC1;POU3F1;ILF2;PIAS1;FOXP1;ILF3;MYCN;CCNE1;PPIE;PHIP;UBE2V1;AJUBA;KHDRBS1;DDX5;CALCA;ENY2;KMT2A;SHC1;PHB;FOXO1;NPAT;TTC21B;CAMTA1;BPTF;HSPA8;ZFHX3;UBE2I;CBX5;PHF10;CBX3;NONO;HMGA1;FOXN3;MT3;SMAD5;NFKB1;SMAD7;GCLC;CNOT7;YEATS2;SP1;SP3;BHLHE40;MAFF;MNAT1;BRWD3;RNF187;RNF10;RNF14;CHD7;PSIP1;ARRB1;CHD4;YBX1;HMGB1;CHD1;DNMT3L;SIX4;SUMO1;BCL7A;SFR1;YWHAQ;ZIC3;PPP1R13L;LRRFIP1;YWHAH;TGIF1;KLF13;PEG3;CHUK;ATRX;NRG1;OLIG2;ARID1A;ETV4;UTF1;ACTA2;DNAJC2;SFPQ;TFDP1;CREB1;THRAP3;BIRC5;CRK;PFDN5;KDM7A;SMARCD1;CEBPB;CAMK2D;HDAC3;HSPD1;ATXN1L;SAP18;E2F4;E2F7;TRIM44;POLR2K;E2F8;POLR2L;TCFL5;SMARCE1;RRM2;CNBP;FBXL19;MGA;USP22;DEK;MAPK14;HNRNPAB;CDK11B;USF2;PML;KLF7;REST;KLF6;ZGLP1;CARM1;POLR3G;NAA16;NAA15;TRIM33
regulation of transcription by RNA polymerase II (GO:0006357),270/2206,0.999990827,0.999996398,0,0,0.461263707,4.23E-06,TCERG1;APP;HNRNPU;JMJD1C;ENO1;NOC2L;RBPJ;TIAL1;RPS14;TRIM28;ZMIZ2;MYC;NAMPT;RPS6KA1;MYB;BBX;JUNB;SOX4;MED1;SMARCC1;RPL23;IFRD1;FOXH1;MED8;SOX11;DICER1;SOX12;MED6;WDR77;SFRP2;SUB1;EZR;URI1;BEX1;DHX9;RTF1;HIF1A;MTDH;PLAC8;PPP3R1;PCBP1;RAD21;LYAR;PLK3;JUN;XBP1;XRCC6;JUP;GADD45A;IGF2;PBX2;SMARCA1;MED13L;SMARCA4;FOSL2;SETX;HNRNPK;TADA2A;FUBP3;ID2;AGO2;ID1;CALR;CDK12;CDK13;EZH2;CSRNP1;ARF4;SUV39H2;RARG;TCF25;PTPRN;SRA1;TCF20;WASL;HIF3A;PHF6;LITAF;GLI3;MED14;PPP3CB;C1QBP;ELOC;TEAD1;BRD3;SS18;LEFTY1;PARP1;TCF15;NME2;TET1;BAZ1A;PHF20L1;SLTM;NFX1;NCOA7;ARHGEF2;VGLL3;YAP1;RPL10;SATB1;PURB;PURA;BCLAF1;EPCAM;GBX1;NSD1;TBL1X;RPS27A;RTRAF;NPM1;PCGF5;NFYB;USP9X;PCGF2;PCGF3;RRP1B;GTF2H3;GRHL2;GTF2H5;GATAD2A;NR6A1;PER3;PSMC3;TCEA1;F2RL1;CTNNB1;HDGF;AGRN;RIF1;KDM1A;WWC1;PRDM5;UBE2D3;ARID4B;NUCKS1;PARK7;ETS1;LOXL2;ZFP36;SALL4;RUVBL2;RUVBL1;POGZ;EP300;KMT5A;PITX2;SLC30A9;SSU72;POU3F1;PIAS1;FOXP1;MYCN;PHIP;PPID;GLYR1;DDX5;ENY2;KMT2A;PHB;FOXO1;PHF21A;NPAT;UBB;TTC21B;ORC2;TPR;UBC;CAMTA1;SKIL;BPTF;ZFHX3;UBE2I;CBX5;PHF10;HMGA1;SMAD5;NFKB1;SMAD7;AHI1;BCL9;DAB2;CDK7;YEATS2;SP1;CDK4;SP3;BHLHE40;MAFF;CDK1;MNAT1;BRWD3;FGFR2;BMPR1A;RNF10;DDX3X;RNF14;PTEN;PSIP1;ARRB1;CHD4;YBX1;HMGB1;MYSM1;CHD1;CDC73;SIX4;SUMO1;ZIC3;PPP1R13L;DNMT3B;LRRFIP1;ACTR3;EIF5A;TGIF1;ACTR2;PPP1R12A;KLF13;PEG3;CHUK;DDX58;BUD31;ATRX;DNMT3A;PEX2;OLIG2;ARID1A;ETV4;UTF1;SENP1;DUSP22;IMPACT;SFPQ;TFDP1;HAX1;CREB1;THRAP3;ITGA6;CRK;KDM7A;SMARCD1;CEBPB;CAMK2D;HDAC3;PLA2G1B;TAF9;RNF2;HSPD1;BEND3;SAP18;E2F4;E2F7;E2F8;MAPK3;TCFL5;SMARCE1;CNBP;FBXL19;MGA;DEK;MAPK14;USF2;KLF7;REST;KLF6;ZGLP1;BAX;CEBPZ;SSBP3;TRIM33
"positive regulation of transcription, DNA-templated (GO:0045893)",196/1183,0.999991288,0.999996398,0,0,0.690053213,6.01E-06,APP;TCERG1;HNRNPU;RBPJ;TRIM28;MYC;ZMIZ2;MYB;NAMPT;RPS6KA1;JUNB;SOX4;MED1;SMARCC1;FOXH1;WDR75;SOX11;SOX12;MED6;NIF3L1;SFRP2;DDX39B;TFAM;BEX1;CDCA4;DHX9;PDGFB;MRPL12;HIF1A;PLAC8;PPP3R1;NUP85;PCBP1;LYAR;SNX5;JUN;XBP1;XRCC6;AFAP1L2;JUP;FZD7;IGF2;PBX2;SMARCA1;SMARCA4;FOSL2;MLLT11;SETX;FUBP3;ID2;AGO2;HNRNPD;CDKN1C;ARF4;CSRNP1;RARG;PTPRN;TCF20;WASL;LITAF;GLI3;WDR43;MED14;PPP3CB;SPIN1;TEAD1;SS18;TCF15;PARP1;PRMT2;NME2;TET1;NCOA7;ARHGEF2;YAP1;ELOF1;MYRF;HEATR1;BCLAF1;EPCAM;NSD1;TBL1X;RPS27A;RTRAF;NPM1;PCGF5;NFYB;RRP1B;GRHL2;PHF5A;PSMC3;TCEA1;CTNNB1;F2RL1;AGRN;KDM1A;PARK7;ETS1;HMGN5;CDH1;RUVBL2;POGZ;EP300;PITX2;HMGN1;SLC30A9;ANKRD49;F2R;THOC1;POU3F1;ILF2;ILF3;MYCN;PHIP;UBE2V1;GLYR1;ENY2;KMT2A;SHC1;PHB;FOXO1;NPAT;UBB;UBC;BPTF;ZFHX3;PHF10;HMGA1;MT3;SMAD5;NFKB1;SMAD7;AHI1;BCL9;CDK7;DAB2;SP1;SP3;MAFF;FGFR2;RNF187;BMPR1A;RNF10;DDX3X;RNF14;ARRB1;HMGB1;YBX1;MYSM1;SFR1;SIX4;ZIC3;YWHAH;ACTR3;EIF5A;ACTR2;PPP1R12A;PEG3;CHUK;DDX58;ATRX;ARID1A;ETV4;UTF1;SENP1;ACTA2;DNAJC2;SFPQ;HAX1;CREB1;TFDP1;THRAP3;ITGA6;SMARCD1;CEBPB;HDAC3;PLA2G1B;TAF9;E2F4;E2F7;TRIM44;E2F8;MAPK3;CNBP;USP22;HNRNPAB;USF2;PML;KLF7;REST;KLF6;ZGLP1;NAA16;CEBPZ;NAA15;SSBP3
second-messenger-mediated signaling (GO:0019932),5/89,0.999991696,0.999996398,0,0,0.210080051,1.74E-06,PPP2CA;DGKD;CXCR2;PPP1R9A;NUDT4
cellular response to cytokine stimulus (GO:0071345),65/482,0.999993,0.999996398,0,0,0.545779244,3.82E-06,ITGB1;GSK3A;ITGAM;ZFAND6;HNRNPU;PIK3CB;YBX3;SYNCRIP;TRIM6;ZFP36;MYC;JUNB;JAK1;HSP90AA1;CHUK;DAPK1;DUSP1;IFNGR1;FOXH1;RC3H1;RPL13A;F3;YWHAZ;RHOA;HAX1;CDC34;PDE12;BIRC5;RHOU;ARHGEF2;SOS1;CRK;GAPDH;LAMA5;NUMBL;SHC1;DHX9;MAOA;PHB;HIF1A;FOXO1;HSP90B1;ZFP36L1;MAPK8;BCL2L11;UBB;TPR;UBC;RPS3;RPS27A;GBP2;MCL1;HSPA8;XBP1;PTPN12;PTPN14;NFKB1;IL2;MAPK13;WNK1;SDC1;TDGF1;UBE2K;GSDME;BCL2L1
sphingolipid metabolic process (GO:0006665),8/116,0.999993295,0.999996398,0,0,0.261206802,1.75E-06,PPP2CA;ELOVL1;SAMD8;VAPA;SERINC1;ESYT2;PLPP2;CSNK1G2
nervous system development (GO:0007399),44/447,0.999993659,0.999996398,0,0,0.38079335,2.41E-06,TRIM71;YAP1;NCKAP1;ANKLE2;NUMBL;COX7B;GMFB;NCAN;NAB1;CHD7;PTEN;SLC2A1;CRMP1;HMGCR;EFNA5;DHX30;RPS6KA6;CDH1;MDK;ZIC3;DPYSL2;ADAM23;IGF2BP1;EP300;JARID2;ECT2;TEAD1;MARCKSL1;GSN;SEMA6A;UTP11;RYK;APLP1;TMOD2;WWP1;NRG1;NAV2;POU3F1;GRHL2;FGF17;AHI1;MARCKS;PMP22;ATXN10
cilium organization (GO:0044782),23/228,0.999994082,0.999996398,0,0,0.394502446,2.33E-06,ACTR3;ARF4;ACTR2;MKKS;GSN;PARVA;FNBP1L;DYNLL1;HSPB11;RAB11A;CDC14B;EHD2;AHI1;NUDCD3;PCM1;IFT43;RILPL1;TMEM237;TCTN2;FLNA;IFT46;ATP6V1D;SSX2IP
chemical synaptic transmission (GO:0007268),15/306,0.999994278,0.999996398,0,0,0.179907014,1.03E-06,HSPA8;SLC12A4;SNAPIN;PTEN;SLC1A3;AKAP5;SYNJ2BP;LIN7C;DNAJC5;RPS6KA1;AKAP9;PMP22;MAPK1;KIF1B;CALM1
innate immune response (GO:0045087),24/302,0.999994299,0.999996398,0,0,0.302187859,1.72E-06,SRPK2;APP;CR2;DDX3X;CHUK;DDX58;PLA2G1B;PHB;HMGB1;PHB2;PML;SRPK1;CXCL16;TRIM6;TRIM28;CAPZA1;CAPZA2;PTK2B;TRIM59;SKP2;SERINC3;RPL39;WFDC13;RNF187
proteolysis (GO:0006508),29/287,0.999994348,0.999996398,0,0,0.394413534,2.23E-06,TINAGL1;HPN;NEDD8;UBE3A;ECE1;IDE;PARL;NPEPPS;PSMD6;PSMB5;ANPEP;SVBP;CAPN2;TBL1X;USP25;VASH2;F3;SENP1;PSMA6;SPCS3;MMP14;SPCS1;BMP1;XPNPEP1;PSMC4;CLPP;UBA3;YME1L1;METAP2
cartilage development (GO:0051216),1/52,0.999994371,0.999996398,0,0,0.069286988,3.90E-07,SLC39A14
cilium movement (GO:0003341),1/52,0.999994371,0.999996398,0,0,0.069286988,3.90E-07,CCDC40
glycolipid metabolic process (GO:0006664),1/52,0.999994371,0.999996398,0,0,0.069286988,3.90E-07,ESYT2
inorganic cation transmembrane transport (GO:0098662),11/274,0.999994453,0.999996398,0,0,0.146111539,8.10E-07,FKBP1A;SLC6A6;HPN;SLC40A1;SLC1A3;ATP2A2;ATP1B3;KCNK1;SLC39A14;TMCO1;ATP6V1F
anterograde trans-synaptic signaling (GO:0098916),9/244,0.999994634,0.999996398,0,0,0.133972794,7.19E-07,SLC12A4;RPS6KA1;AKAP9;PMP22;SLC1A3;MAPK1;AKAP5;CALM1;SYNJ2BP
inflammatory response (GO:0006954),18/230,0.999994723,0.999996398,0,0,0.29807059,1.57E-06,AFAP1L2;CEBPB;CHUK;TUSC2;F2R;HMGB1;F11R;LIAS;HSPG2;THBS1;NFKB1;PRDX5;NFX1;CXCR2;RAC1;SIGLEC1;ABCF1;HNRNPA0
negative regulation of inflammatory response (GO:0050728),14/212,0.999994849,0.999996398,0,0,0.248224207,1.28E-06,CALCA;RAMP3;CALCRL;RHBDF2;METRNL;MAPK14;FNDC4;CREB1;GNG2;MDK;GNB1;MYH9;ENPP3;GIT1
positive regulation of cytosolic calcium ion concentration (GO:0007204),11/147,0.999994881,0.999996398,0,0,0.284893809,1.46E-06,FIS1;CALCA;LPAR6;PLA2G1B;F2R;CXCR2;LPAR2;F2RL1;LPAR4;HMGB1;JPH1
regulation of inflammatory response (GO:0050727),16/206,0.999994884,0.999996398,0,0,0.295917902,1.51E-06,APP;DHX9;CELF1;PARK7;METRNL;ETS1;IL2;FOXP1;MAPK13;PSMA6;FNDC4;MDK;TMSB4X;ENPP3;SNX6;VAMP3
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),13/165,0.999994944,0.999996398,0,0,0.3010768,1.52E-06,CALCA;CALCRL;RAMP3;GNAI3;LPAR2;AKAP5;AKAP12;GNA11;GNA12;WASF2;LGR5;ADGRL2;LGR4
negative regulation of immune response (GO:0050777),14/178,0.999995011,0.999996398,0,0,0.300346923,1.50E-06,CALCA;CALCRL;RAMP3;RHBDF2;RC3H1;MAPK14;CREB1;GNG2;C1QBP;PCBP2;GNB1;MYH9;ENPP3;LYAR
regulation of immune response (GO:0050776),9/179,0.999995103,0.999996398,0,0,0.185981196,9.11E-07,ITGB1;FKBP1A;TGFB2;PIANP;PLA2G1B;SAMHD1;NECTIN2;FOXP1;CD276
defense response to bacterium (GO:0042742),11/176,0.999995126,0.999996398,0,0,0.234381169,1.14E-06,CEBPB;PPP1R11;SHC1;ANXA3;PLA2G1B;ROMO1;PLA2G6;GBP2;RPL39;OPTN;WFDC13
cation transport (GO:0006812),7/174,0.999995145,0.999996398,0,0,0.147212176,7.15E-07,SLC6A6;SLC23A1;CHP1;LRP2;KCNK1;SLC9B2;SLC5A5
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),9/136,0.999995268,0.999996398,0,0,0.249645024,1.18E-06,CALCA;CALCRL;CREB1;RAMP3;GNG2;GNB1;RHBDF2;MYH9;MAPK14
regulation of inflammatory response to antigenic stimulus (GO:0002861),9/137,0.999995298,0.999996398,0,0,0.247678663,1.16E-06,CALCA;CALCRL;CREB1;RAMP3;GNG2;GNB1;RHBDF2;MYH9;MAPK14
regulation of cytosolic calcium ion concentration (GO:0051480),8/148,0.999995377,0.999996398,0,0,0.201086144,9.30E-07,YWHAE;FIS1;CALCA;F2R;CXCR2;LPAR2;F2RL1;HMGB1
modulation of chemical synaptic transmission (GO:0050804),6/109,0.999995405,0.999996398,0,0,0.205387852,9.44E-07,ITGB1;APP;AKAP9;PTEN;EIF4EBP2;NPTXR
potassium ion transmembrane transport (GO:0071805),5/139,0.999995471,0.999996398,0,0,0.13126757,5.95E-07,SLC12A4;HPN;SLC1A3;ATP1B3;KCNK1
triglyceride metabolic process (GO:0006641),1/55,0.999995564,0.999996398,0,0,0.065425084,2.90E-07,FABP5
potassium ion transport (GO:0006813),5/122,0.999995651,0.999996398,0,0,0.150505899,6.55E-07,HPN;CHP1;SLC1A3;ATP1B3;KCNK1
steroid metabolic process (GO:0008202),5/104,0.999995685,0.999996398,0,0,0.178077407,7.68E-07,TSPO;DHCR24;LRP2;LSS;HSD17B10
sensory perception of smell (GO:0007608),1/111,0.999995786,0.999996398,0,0,0.032002066,1.35E-07,MKKS
protein O-linked glycosylation (GO:0006493),4/102,0.999995862,0.999996398,0,0,0.143892171,5.95E-07,B3GNT7;GALNT3;GXYLT1;TET1
sensory perception of chemical stimulus (GO:0007606),1/99,0.999995942,0.999996398,0,0,0.035948516,1.46E-07,MKKS
sodium ion transmembrane transport (GO:0035725),3/87,0.999995989,0.999996398,0,0,0.12599071,5.05E-07,SLC6A6;ATP1B3;KCNK1
sensory perception of light stimulus (GO:0050953),2/95,0.999995996,0.999996398,0,0,0.075804129,3.03E-07,COL18A1;RABGGTB
visual perception (GO:0007601),2/93,0.999996024,0.999996398,0,0,0.077480147,3.08E-07,COL18A1;RABGGTB
defense response to Gram-negative bacterium (GO:0050829),2/73,0.999996068,0.999996398,0,0,0.09943361,3.91E-07,ROMO1;OPTN
neuropeptide signaling pathway (GO:0007218),1/63,0.999996376,0.999996398,0,0,0.056953812,2.06E-07,SORT1
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.999996398,0.999996398,0,0,0.055166903,1.99E-07,CALCRL
